Citrus Sinensis ID: 012192
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 468 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.844 | 0.877 | 0.629 | 1e-153 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | yes | no | 0.630 | 0.709 | 0.755 | 1e-142 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | yes | no | 0.630 | 0.709 | 0.752 | 1e-142 | |
| P49674 | 416 | Casein kinase I isoform e | yes | no | 0.630 | 0.709 | 0.752 | 1e-142 | |
| Q06486 | 415 | Casein kinase I isoform d | no | no | 0.630 | 0.710 | 0.742 | 1e-141 | |
| Q9DC28 | 415 | Casein kinase I isoform d | no | no | 0.630 | 0.710 | 0.742 | 1e-141 | |
| P48730 | 415 | Casein kinase I isoform d | no | no | 0.630 | 0.710 | 0.742 | 1e-141 | |
| P35508 | 415 | Casein kinase I isoform d | no | no | 0.630 | 0.710 | 0.742 | 1e-141 | |
| Q7T2E3 | 403 | Casein kinase I isoform d | no | no | 0.630 | 0.732 | 0.749 | 1e-141 | |
| Q6P647 | 415 | Casein kinase I isoform d | no | no | 0.630 | 0.710 | 0.742 | 1e-140 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 542 bits (1397), Expect = e-153, Method: Compositional matrix adjust.
Identities = 272/432 (62%), Positives = 322/432 (74%), Gaps = 37/432 (8%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G KF+LGRKIGSGSFGE+YLG N+ T EE+A+KLE VKTKHPQL YESKLY +LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTG+P++KWFGVEGDYN++V+DLLGPSLEDLFN+C+RK SLK+VLMLADQ+INRVE+ H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ FLHRD+KPDNFLMGLGR+ANQVYIID+GLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKY++ISEKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY----- 303
C+ YPSEF SYFHYCRSLRF+DKPDY+YLKR+FRDLFIREGFQFDYVFDWT+LKY
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 304 ---------PQIGSSSKGRHSSGKVGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKN 354
P +G+S+ + G RP S R ++SGA++ + N
Sbjct: 301 TAPPSRALNPAVGTSAALPPGISNIDRYTGEEEGRPHMESS----RRRVSGALD--NSGN 354
Query: 355 AAGTPHRDHPRHKS-------SDDGPSSKHVN---------PDSEKGRSFSRYGSTSRKA 398
+ P R + SS+ V P SE+ SR G SR
Sbjct: 355 ISNQPTSSSARDSMIPSSSLFAQSAGSSRRVTAVSGSRDNFPGSEELLQRSRTGDVSR-G 413
Query: 399 VIASTKPGSSGE 410
VI PG +G+
Sbjct: 414 VIPRNSPGEAGK 425
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 504 bits (1299), Expect = e-142, Method: Compositional matrix adjust.
Identities = 223/295 (75%), Positives = 269/295 (91%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G K++LGRKIGSGSFG++YLG N+ TGEE+A+KLE VKTKHPQLH ESK Y ++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP +KW G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 504 bits (1298), Expect = e-142, Method: Compositional matrix adjust.
Identities = 222/295 (75%), Positives = 269/295 (91%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G K++LGRKIGSGSFG++YLG N+ +GEE+A+KLE VKTKHPQLH ESK Y ++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP +KW G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49674|KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1296), Expect = e-142, Method: Compositional matrix adjust.
Identities = 222/295 (75%), Positives = 269/295 (91%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G K++LGRKIGSGSFG++YLG N+ +GEE+A+KLE VKTKHPQLH ESK Y ++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP +KW G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 500 bits (1288), Expect = e-141, Method: Compositional matrix adjust.
Identities = 219/295 (74%), Positives = 269/295 (91%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G +++LGRKIGSGSFG++YLG ++ GEE+A+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP ++W G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 500 bits (1288), Expect = e-141, Method: Compositional matrix adjust.
Identities = 219/295 (74%), Positives = 269/295 (91%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G +++LGRKIGSGSFG++YLG ++ GEE+A+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP ++W G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 500 bits (1288), Expect = e-141, Method: Compositional matrix adjust.
Identities = 219/295 (74%), Positives = 269/295 (91%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G +++LGRKIGSGSFG++YLG ++ GEE+A+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP ++W G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2 | Back alignment and function description |
|---|
Score = 500 bits (1288), Expect = e-141, Method: Compositional matrix adjust.
Identities = 219/295 (74%), Positives = 269/295 (91%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G +++LGRKIGSGSFG++YLG ++ GEE+A+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP ++W G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q7T2E3|KC1DA_DANRE Casein kinase I isoform delta-A OS=Danio rerio GN=csnk1da PE=2 SV=1 | Back alignment and function description |
|---|
Score = 500 bits (1288), Expect = e-141, Method: Compositional matrix adjust.
Identities = 221/295 (74%), Positives = 270/295 (91%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G +++LGRKIGSGSFG++YLG ++ TGEE+A+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDITTGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP +KW G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 500 bits (1287), Expect = e-140, Method: Compositional matrix adjust.
Identities = 219/295 (74%), Positives = 268/295 (90%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G +++LGRKIGSGSFG++YLG ++ EE+A+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP +KW G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 468 | ||||||
| 359477666 | 464 | PREDICTED: casein kinase I isoform delta | 0.976 | 0.984 | 0.838 | 0.0 | |
| 224066225 | 456 | predicted protein [Populus trichocarpa] | 0.967 | 0.993 | 0.818 | 0.0 | |
| 224099929 | 463 | predicted protein [Populus trichocarpa] | 0.967 | 0.978 | 0.826 | 0.0 | |
| 449468566 | 454 | PREDICTED: casein kinase I isoform delta | 0.957 | 0.986 | 0.826 | 0.0 | |
| 224107441 | 462 | predicted protein [Populus trichocarpa] | 0.972 | 0.984 | 0.834 | 0.0 | |
| 225433171 | 456 | PREDICTED: casein kinase I isoform delta | 0.959 | 0.984 | 0.821 | 0.0 | |
| 449432534 | 461 | PREDICTED: casein kinase I isoform delta | 0.965 | 0.980 | 0.817 | 0.0 | |
| 255575881 | 463 | casein kinase, putative [Ricinus communi | 0.974 | 0.984 | 0.823 | 0.0 | |
| 225438081 | 458 | PREDICTED: casein kinase I isoform delta | 0.976 | 0.997 | 0.817 | 0.0 | |
| 449458832 | 463 | PREDICTED: casein kinase I isoform delta | 0.972 | 0.982 | 0.795 | 0.0 |
| >gi|359477666|ref|XP_002285287.2| PREDICTED: casein kinase I isoform delta-like isoform 1 [Vitis vinifera] gi|296083671|emb|CBI23660.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2011), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/459 (83%), Positives = 417/459 (90%), Gaps = 2/459 (0%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MDHVIGGKFKLGRKIGSGSFGELYLG+NVQTGEE+AVKLE VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLEPVKTKHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTG+PHLKWFGVEG+YN MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGVPHLKWFGVEGEYNAMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD QTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDFQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK+ TPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308
CKSYPSEF SYFHYCRSLRF+DKPDYSYLKRLFRDLFIREG+QFDYVFDWTVLKYPQIGS
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 309 SSKGRHSSGKVGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTP-HRDHPRHK 367
SS+ R SGK L PGPSAER ER SVG+EIRD+ SGAVEAFSR+N +G+ H D RH+
Sbjct: 301 SSRVRQPSGKPALNPGPSAERMERPSVGQEIRDRFSGAVEAFSRRNNSGSGYHGDQSRHR 360
Query: 368 SSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECRSSRLVSSSGRLS 427
S+D PSSK V DSE+ RS SR GSTS++AV++S++P SSGE +E R+SRLVS SGRLS
Sbjct: 361 GSEDVPSSKDVQTDSERPRSSSRNGSTSKRAVVSSSRPSSSGEPTETRASRLVSGSGRLS 420
Query: 428 TTQRLQSGYDSRQSSFNRTAGGRICTRDDPIRSFEMLSI 466
TTQR Q G++S+ SSF R + R R+DP+RSFE+L+I
Sbjct: 421 TTQRSQPGFESKSSSFTRASAAR-GGREDPLRSFELLTI 458
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066225|ref|XP_002302034.1| predicted protein [Populus trichocarpa] gi|222843760|gb|EEE81307.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1967), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/464 (81%), Positives = 412/464 (88%), Gaps = 11/464 (2%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYM 65
K ++DH++GGKFKLGRKIGSGSFGEL+LGVNVQTGEE+AVKLE VKTKHPQLHYESKLYM
Sbjct: 3 KTKIDHMVGGKFKLGRKIGSGSFGELFLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYM 62
Query: 66 LLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVE 125
LLQGGTGIPHLKWFGVE +YN+MVIDLLGPSLEDLFNYCNRKF+LKTVLMLADQLINRVE
Sbjct: 63 LLQGGTGIPHLKWFGVEAEYNVMVIDLLGPSLEDLFNYCNRKFTLKTVLMLADQLINRVE 122
Query: 126 YMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTA 185
YMHSRGFLHRDIKPDNFLMGLGRKANQVY ID+GLAKKYRDLQTHKHIPYRENKNLTGTA
Sbjct: 123 YMHSRGFLHRDIKPDNFLMGLGRKANQVYAIDFGLAKKYRDLQTHKHIPYRENKNLTGTA 182
Query: 186 RYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245
RYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI
Sbjct: 183 RYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 242
Query: 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305
EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG+QFDYVFDWTVLKYPQ
Sbjct: 243 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQ 302
Query: 306 IGSSSKGRHSSGKVGLTPGPSAERP-ERGSVGKEIRDKLSGAVEAFSRKNAAGTPHRDHP 364
IG+SS+GRHSSGK G GPSAERP ER SVGKEIR++ SGAVEAFS K +G+ D+
Sbjct: 303 IGASSRGRHSSGKPGHA-GPSAERPAERVSVGKEIRERFSGAVEAFSTKRVSGSSQHDNS 361
Query: 365 RHKSSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECRSSRLVSSSG 424
R+K D+ P+ EKGR+ SRYGS SRKAVI++ +P SSGE SE RS RL+SS G
Sbjct: 362 RNKGLDN-------PPEPEKGRNSSRYGSNSRKAVISNGRPSSSGEPSEGRSGRLLSSGG 414
Query: 425 RLSTTQRLQSGYDSRQSSFNRTAGGRICTRDDPIRSFEMLSIRK 468
RL++ QR+Q GY+ + SS R A R T +D RSFE LSIRK
Sbjct: 415 RLTSAQRIQPGYELK-SSQTRPAAAR-GTHEDTFRSFEFLSIRK 456
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099929|ref|XP_002311677.1| predicted protein [Populus trichocarpa] gi|222851497|gb|EEE89044.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/462 (82%), Positives = 415/462 (89%), Gaps = 9/462 (1%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MDHVIGGKFKLGRKIGSGSFGELYLG+NVQ+GEE+AVKLE VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYLGINVQSGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKWFGVE DYN MVIDLLGPSLEDLFNYCNRK SLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEVDYNAMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG+KAG KKQKYDKISEKK+ PIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGMKAGNKKQKYDKISEKKMLVPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308
CK+YPSEF SYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG+QFDYVFDWT+LKYPQI
Sbjct: 241 CKNYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQI-G 299
Query: 309 SSKGRHSSGKVGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTP-HRDHPRHK 367
SS SGK + PGPSAER ER SVG+E+RD+ SG VEAF+R+N++G H D RH+
Sbjct: 300 SSSRSRPSGKPAVYPGPSAERVERPSVGQEVRDRFSGGVEAFARRNSSGHALHSDQSRHR 359
Query: 368 SSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECRSSRLVSSSGRLS 427
SSDD PSSK V+PDSE+ RS SR GSTS++AV++S++P SSGE SE RSSRLVSSSGRLS
Sbjct: 360 SSDDAPSSKDVHPDSERPRSSSRNGSTSKRAVMSSSRPSSSGEPSENRSSRLVSSSGRLS 419
Query: 428 TTQRLQSGYDSRQSSFNR---TAGGRICTRDDPIRSFEMLSI 466
TTQR+Q G++S+ SSF R T+GGR+ T +RSFE+LSI
Sbjct: 420 TTQRVQPGFESKSSSFTRASATSGGRVNT----LRSFELLSI 457
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449468566|ref|XP_004151992.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] gi|449479905|ref|XP_004155742.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/466 (82%), Positives = 419/466 (89%), Gaps = 18/466 (3%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MDHVI GKFKLGRKIGSGSFGELYL VNVQTGEE+AVKLE VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIAGKFKLGRKIGSGSFGELYLAVNVQTGEEVAVKLEPVKTKHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKWFGVE DYNIMVIDLLGPSLEDLFNYCNRKF+LKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVESDYNIMVIDLLGPSLEDLFNYCNRKFTLKTVLMLADQLINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK+STPIEVL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308
CKS+P EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG+QFDYVFDWT+LKYPQIG
Sbjct: 241 CKSHPPEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQIGG 300
Query: 309 SSKGRHSSGK-VGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKN-AAGTPHRDHPRH 366
SS+GRHSSGK TPGPSAERPER SVGKEIR++LSGAVEAFSR+N ++ +PH DH +
Sbjct: 301 SSRGRHSSGKAAAATPGPSAERPERTSVGKEIRERLSGAVEAFSRRNISSSSPHVDHSKQ 360
Query: 367 KSSDDGPSSKHVNPDSE-KGRSFSRYGSTSRKAVIASTKPGSSGEFSECRSSRLVSSSGR 425
K+ +D V+ DS+ S SRYGS+SR+A+I ++KP SSG+ SE R R+V+S+GR
Sbjct: 361 KTYED------VHHDSDRGRGSSSRYGSSSRRAIITNSKPTSSGDHSEGR--RVVASTGR 412
Query: 426 LS-TTQRLQSGYDSRQSSFNRTA--GGRICTRDDPIRSFEMLSIRK 468
S TTQRL S Y+++ SSF RT+ GG RDDP+RSFE+LSIRK
Sbjct: 413 PSTTTQRLHSSYETKPSSFVRTSTRGG----RDDPLRSFELLSIRK 454
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224107441|ref|XP_002314480.1| predicted protein [Populus trichocarpa] gi|222863520|gb|EEF00651.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/459 (83%), Positives = 412/459 (89%), Gaps = 4/459 (0%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MDHVIGGKF+LGRKIGSGSFGELYLG+NVQ+GEE+AVKLE VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIGGKFRLGRKIGSGSFGELYLGINVQSGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKWFGVEG+YN+MVIDLLGPSLEDLFNYCNRK SLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL KKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD+ISEKK+ TPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKMLTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308
CK+YPSEF SYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG+QFDYVFDWT+LKYPQI
Sbjct: 241 CKNYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQI-G 299
Query: 309 SSKGRHSSGKVGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAG-TPHRDHPRHK 367
SS SGK + PGPSAER E S G+EIRD+ SGAVEAF+RKN+ G HRD RH+
Sbjct: 300 SSSRSRLSGKPAVNPGPSAERVEWPS-GQEIRDRFSGAVEAFARKNSTGHAMHRDRSRHR 358
Query: 368 SSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECRSSRLVSSSGRLS 427
SSDD PSSK V+PDSE+ RS SR GSTS++AVI+S++P SSGE SE RSSRL SSSGRLS
Sbjct: 359 SSDDVPSSKDVHPDSERPRSSSRNGSTSKRAVISSSRPSSSGEPSENRSSRLASSSGRLS 418
Query: 428 TTQRLQSGYDSRQSSFNRTAGGRICTRDDPIRSFEMLSI 466
TTQR+Q G +S+ SSF R R RDD +RSFE+LSI
Sbjct: 419 TTQRIQPGLESKSSSFTRALATR-GGRDDTLRSFELLSI 456
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225433171|ref|XP_002285289.1| PREDICTED: casein kinase I isoform delta-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/459 (82%), Positives = 408/459 (88%), Gaps = 10/459 (2%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MDHVIGGKFKLGRKIGSGSFGELYLG+NVQTGEE+AVKLE VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLEPVKTKHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTG+PHLKWFGVEG+YN MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGVPHLKWFGVEGEYNAMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD QTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDFQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK+ TPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308
CKSYPSEF SYFHYCRSLRF+DKPDYSYLKRLFRDLFIREG+QFDYVFDWTVLKYPQIGS
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 309 SSKGRHSSGKVGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTP-HRDHPRHK 367
SS+ R SGK L PGPSAER ER SVG+EIRD+ SGAVEAFSR+N +G+ H D RH+
Sbjct: 301 SSRVR-PSGKPALNPGPSAERMERPSVGQEIRDRFSGAVEAFSRRNNSGSGYHGDQSRHR 359
Query: 368 SSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECRSSRLVSSSGRLS 427
S+D PSSK V S TS++AV++S++P SSGE +E R+SRLVS SGRLS
Sbjct: 360 GSEDVPSSKDVV-------SCCNNKITSKRAVVSSSRPSSSGEPTETRASRLVSGSGRLS 412
Query: 428 TTQRLQSGYDSRQSSFNRTAGGRICTRDDPIRSFEMLSI 466
TTQR Q G++S+ SSF R + R R+DP+RSFE+L+I
Sbjct: 413 TTQRSQPGFESKSSSFTRASAAR-GGREDPLRSFELLTI 450
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432534|ref|XP_004134054.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1912), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/461 (81%), Positives = 408/461 (88%), Gaps = 9/461 (1%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+H+IGGKFKLGRKIGSGSFGELYLG NVQTGEE+AVKLE KTKHPQLHYESKLYMLLQ
Sbjct: 1 MEHIIGGKFKLGRKIGSGSFGELYLGTNVQTGEEVAVKLESAKTKHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKWFGVEGDYN+MVIDLLGPSLEDLFNYCNRK SLK+VLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKSVLMLADQLINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK+ TP+EVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308
CKSYPSEF SYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG+QFDYVFDWT+LKYPQIGS
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQIGS 300
Query: 309 SSKGRHSSGKVGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTPHRDHPRHKS 368
SSK R SGK G TPGPSAER E+ VG+EIRD+ G EAF R+NA+G H DH RH+
Sbjct: 301 SSKAR-PSGKPGHTPGPSAERGEKHPVGQEIRDRYPGGAEAFGRRNASGHLHGDHSRHR- 358
Query: 369 SDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECRSSRLVSSSGRLST 428
SDD PSSK V PDSE+GRS R GS S++ V++S++P SSGE SE RSSRLVS+S RLS
Sbjct: 359 SDDVPSSKDVQPDSERGRSSYRNGSISKRPVLSSSRPSSSGEPSEIRSSRLVSASSRLSA 418
Query: 429 TQRLQSGYD---SRQSSFNRTAGGRICTRDDPIRSFEMLSI 466
QR+Q G++ + + + T GG RDD +RSFE+LSI
Sbjct: 419 GQRVQPGFESKTTTFTRSSTTKGG----RDDALRSFELLSI 455
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575881|ref|XP_002528838.1| casein kinase, putative [Ricinus communis] gi|223531750|gb|EEF33572.1| casein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/459 (82%), Positives = 416/459 (90%), Gaps = 3/459 (0%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MD +IGGKFKLGRKIGSGSFGELYLG+NVQ+GEE+AVKLE KTKHPQLHYESKLY+LLQ
Sbjct: 1 MDVLIGGKFKLGRKIGSGSFGELYLGINVQSGEEVAVKLESAKTKHPQLHYESKLYVLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKWFGVEGDYN+M IDLLGPSLEDLFNYCNRKFSLKTVLMLADQL+NRVE+MH
Sbjct: 61 GGTGIPHLKWFGVEGDYNVMAIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLLNRVEFMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY+DLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYKDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK+ TPIE L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEFL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308
CK+YPSEF SYFHYCRSLRFED PDYSYLKRLFRDLFIREG+QFDYVFDWT+LKYPQIGS
Sbjct: 241 CKNYPSEFTSYFHYCRSLRFEDAPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQIGS 300
Query: 309 SSKGRHSSGKVGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTP-HRDHPRHK 367
SS+ R S K + PGPSAER ER SVG+EIRD+ SGAVEAF+R+N +G H DH RH+
Sbjct: 301 SSRARPIS-KPAVNPGPSAERTERPSVGQEIRDRFSGAVEAFARRNGSGHALHGDHSRHR 359
Query: 368 SSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECRSSRLVSSSGRLS 427
SSDD PSSK V+ DSE+ RS SR GSTS++AVI+S++P SSGE +E RSSRL+SSSGRLS
Sbjct: 360 SSDDVPSSKDVHLDSERPRSSSRNGSTSKRAVISSSRPSSSGEPTESRSSRLLSSSGRLS 419
Query: 428 TTQRLQSGYDSRQSSFNRTAGGRICTRDDPIRSFEMLSI 466
TT R+Q G++S+ SSF R A R +RDD +RSFE+LS+
Sbjct: 420 TTHRVQPGFESKSSSFTRAAATR-SSRDDALRSFELLSM 457
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438081|ref|XP_002276486.1| PREDICTED: casein kinase I isoform delta-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/461 (81%), Positives = 422/461 (91%), Gaps = 4/461 (0%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+HVIGGKFK+GRKIGSGSFGELY+GVNVQ+GEE+A+K+E KTKHPQL YESKLYMLLQ
Sbjct: 1 MEHVIGGKFKMGRKIGSGSFGELYIGVNVQSGEEVAIKVEPTKTKHPQLQYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKWFGVEG+YN+MVIDLLGPSLEDLFNYCNRKF+LKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFTLKTVLMLADQLINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
SRGFLHRDIKPDNFLMGLGR+ANQVY ID+GLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK+ TPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308
CKSYPSEF SYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG+QFDYVFDWT+LKYPQIG+
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQIGA 300
Query: 309 SSKGRHSSGKVGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTP-HRDHPRHK 367
SS+GRHS+GK GL GPSAER +R S G+EIRD+ SGAVE F R+NA G+ H DH +++
Sbjct: 301 SSRGRHSTGKAGLNAGPSAERLDRTS-GQEIRDRFSGAVETFPRRNAFGSGLHSDHSKNR 359
Query: 368 SSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECRSSRLVSSSGRLS 427
+SD PSSK V DSE+GR+ SR GSTS++A+I+S++P SSGE SE RSSRLVSSS R+S
Sbjct: 360 TSDGVPSSKDVQADSERGRT-SRNGSTSKRALISSSRPSSSGEPSEGRSSRLVSSSSRMS 418
Query: 428 TTQRLQSGYDSRQSSFNRTAGGRICTRDDPIRSFEMLSIRK 468
++ R+Q G++S+ SSF RTA + TRDDP+RSFE+LSIRK
Sbjct: 419 SSHRIQPGFESKSSSFTRTAATK-GTRDDPLRSFELLSIRK 458
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458832|ref|XP_004147150.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] gi|449498610|ref|XP_004160583.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1865), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/460 (79%), Positives = 406/460 (88%), Gaps = 5/460 (1%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+HVIGGKFKLGRKIGSGSFGELYLG NVQT EE+AVKLE VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGTNVQTEEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKWFGVEG+YN+MVIDLLGPSLEDLFNYCNRK SLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL KKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL+AGTKKQKYDKISEKK+ TPIEVL
Sbjct: 181 SINTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLRAGTKKQKYDKISEKKMLTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308
CKSYP+EF SYFHYCR+LRFEDKPDYSYLKRLFRDLFIREG+QFDYVFDWT+LKYPQIGS
Sbjct: 241 CKSYPTEFTSYFHYCRALRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQIGS 300
Query: 309 SSKGRHSSGKVGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTP-HRDHPRHK 367
SS+ R +GK +TPGPSAER ER VG+++RDK SG VEAF+R+N G H DH RH+
Sbjct: 301 SSRTR-PTGKAAITPGPSAERVERPLVGQDLRDKFSGPVEAFARRNGTGIGLHSDHSRHR 359
Query: 368 SSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSE-CRSSRLVSSSGRL 426
SSDD PSSK V PD+E+ RS SR GS S++ +++S++P SSGE SE S SSS
Sbjct: 360 SSDDVPSSKDVQPDAERARSSSRQGSASKRPILSSSRPSSSGEPSELRSSRLFSSSSRLS 419
Query: 427 STTQRLQSGYDSRQSSFNRTAGGRICTRDDPIRSFEMLSI 466
+TQR+Q G +S+ SSF R++ + +RDD +RSFE+L+I
Sbjct: 420 GSTQRIQPGVESK-SSFLRSSATK-GSRDDALRSFELLTI 457
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 468 | ||||||
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.982 | 0.960 | 0.734 | 3.8e-181 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.974 | 0.968 | 0.726 | 2.7e-180 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.972 | 0.955 | 0.717 | 4.3e-173 | |
| TAIR|locus:2129640 | 457 | CKI1 "casein kinase I" [Arabid | 0.955 | 0.978 | 0.703 | 3.8e-172 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.846 | 0.895 | 0.787 | 1e-171 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.959 | 0.969 | 0.699 | 1.3e-169 | |
| UNIPROTKB|Q70YQ4 | 463 | Q70YQ4 "Putative casein kinase | 0.959 | 0.969 | 0.697 | 1.2e-168 | |
| TAIR|locus:2176431 | 480 | ckl8 "casein kinase I-like 8" | 0.978 | 0.954 | 0.672 | 1.8e-165 | |
| TAIR|locus:2018269 | 468 | CKL13 "casein kinase like 13" | 0.972 | 0.972 | 0.664 | 2.5e-161 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.634 | 0.66 | 0.818 | 1.3e-141 |
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1758 (623.9 bits), Expect = 3.8e-181, P = 3.8e-181
Identities = 352/479 (73%), Positives = 388/479 (81%)
Query: 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYML 66
L+MD+VIGGKFKLGRKIG GSFGEL+L V++QTGEE AVKLE KTKHPQLHYESK+YML
Sbjct: 3 LKMDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYML 62
Query: 67 LQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 126
LQGG+GIP LKWFGV+GDYN MVIDLLGPSLEDLFNYCNR+ +LK VLMLADQLI+RVEY
Sbjct: 63 LQGGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEY 122
Query: 127 MHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 186
MHSRGFLHRDIKPDNFLMGLGRKANQVYIID+GLAKKYRDLQTH+HIPYRENKNLTGTAR
Sbjct: 123 MHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTAR 182
Query: 187 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246
YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD+ISEKKVSTPIE
Sbjct: 183 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIE 242
Query: 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQI 306
VLCKSYP EFVSYF YCRSLRFEDKPDYSYLKRLFRDLFIREG+QFDYVFDWT LK+PQ
Sbjct: 243 VLCKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302
Query: 307 XXXXXXXXXXXXXXLTPG----PSAERPERGSVGKEIRDKLSGAVEAFSRKNAAG-TPHR 361
PG PSAE+PER SVG IRDK SGAVEAF+R+N G +PH+
Sbjct: 303 SARSHSSTHERHRTGKPGMGAGPSAEKPERISVGN-IRDKFSGAVEAFARRNVRGPSPHQ 361
Query: 362 DHPRHKSSDDGPSSKH-VNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECXXXXXX 420
+H RH++ D+ PS K VN SEKGR+ SRYGS SR+AV + ++P SSGE E
Sbjct: 362 NHTRHRTLDEIPSMKPAVNMVSEKGRNTSRYGSASRRAVASGSRPSSSGEQRESRDSSRV 421
Query: 421 XXXXXX---XTTQRLQ-----SGYDSRQSS-FNR--TAGGRICTRDDPIRSFEMLSIRK 468
QR Q SGY+S+ +S FNR A R RD+ +RSFE+LSIRK
Sbjct: 422 ASSGGGVRPSVFQRTQAAAAVSGYESKTASAFNRDRVAASRTA-RDEALRSFELLSIRK 479
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1750 (621.1 bits), Expect = 2.7e-180, P = 2.7e-180
Identities = 345/475 (72%), Positives = 389/475 (81%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MD VIGGKFKLGRKIGSGSFGELYLG+NVQTGEE+AVKLE VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTG+P+LKW+GVEGDYN+MVIDLLGPSLEDLFNYCNRK SLKTVLMLADQLINRVE+MH
Sbjct: 61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
+RGFLHRDIKPDNFLMGLGRKANQVYIID+GL KKYRDLQTH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLE+LGYVLMYFL+GSLPWQGLKAGTKKQKYD+ISEKKV+TPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIXX 308
CK+ PSEFVSYF YCRSLRF+DKPDYSYLKRLFRDLFIREG+QFDYVFDWTVLKYPQI
Sbjct: 241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 309 XXXXXXXXXXXX-----LTPGPSAERPERGSVGKEIRD-KLSGAVEAFSRKNAAGTPHRD 362
LT G S E+ ER GKE R+ + SGAVEAFSR++ A + RD
Sbjct: 301 SSGSSSRTRNHTTANPGLTAGASLEKQER-IAGKETRENRFSGAVEAFSRRHPATSTTRD 359
Query: 363 HPRHKSSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECXXXXXXXX 422
++S DGP SKH DSE+ RS SRYGS+SR+A+ +S++P S+G S+
Sbjct: 360 RSASRNSVDGPLSKHPPGDSERPRSSSRYGSSSRRAIPSSSRPSSAGGPSDSRSSSRLVT 419
Query: 423 XXX--------XXTTQRLQSGYDSRQSSFNRTAGGRICTRDDPIR-SFEMLSIRK 468
T+QR+Q+G +SR SSF+R A TR+DP+R S E+L++RK
Sbjct: 420 STGGVGTVSNRASTSQRIQAGNESRTSSFSRAARN---TREDPLRRSLELLTLRK 471
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1682 (597.2 bits), Expect = 4.3e-173, P = 4.3e-173
Identities = 345/481 (71%), Positives = 382/481 (79%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MD VIGGKFKLG+KIGSGSFGELYLGVNVQTGEE+AVKLE VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG+GIP++KWFGVEGDY++MVIDLLGPSLEDLFNYCNRK +LKTVLMLADQL+NRVE+MH
Sbjct: 61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
+RGFLHRDIKPDNFLMGLGRKANQVYIID+GL KKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLESLGYVLMYFL+GSLPWQGLKAGTKKQKYD+ISEKKVSTPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIXX 308
CK+ PSEFVSYFHYCRSLRF+DKPDYSYLKRLFRDLFIREG+QFDYVFDWTVLKYPQI
Sbjct: 241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 309 XXXXXXXXXXXXLT-PGPSA---ERPERGSVGKEI-RDKLSGAVEAFSRKNAAGTPH-RD 362
PG +A ER ER +GKE R K+ GAVEAFSR++ T RD
Sbjct: 301 SSGSSSRTRHHTTAKPGFNADPIERQER-ILGKETTRYKIPGAVEAFSRRHPTTTSSPRD 359
Query: 363 HPRHKSSDDGPSSKHVNPDSEKGRSFSRY-GSTSRKAVIAST-KPGSSGEFSECXXXXXX 420
R ++SDDGP SK + DSE+ S SRY S+SRKAV AS+ +P S+G SE
Sbjct: 360 RSRSRNSDDGPFSKQTHGDSERANSSSRYRASSSRKAVAASSSRPSSAGGPSESRTSSRL 419
Query: 421 XXXXXXXTTQRLQSGYDSRQSSFNRTAGG---------RIC----TRDDPIRSFEMLSIR 467
+ SG + R S+ R G R TR+D +RSFE+LS+R
Sbjct: 420 VSSSGGGGSG---SG-NGRPSTSQRVQAGYESKTLSFSRATAARNTREDQLRSFELLSLR 475
Query: 468 K 468
K
Sbjct: 476 K 476
|
|
| TAIR|locus:2129640 CKI1 "casein kinase I" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1673 (594.0 bits), Expect = 3.8e-172, P = 3.8e-172
Identities = 327/465 (70%), Positives = 371/465 (79%)
Query: 4 DGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKL 63
D +MDHVIGGKFKLGRK+GSGSFGELYLG+N+QTGEE+AVKLE VKT+HPQL YESK+
Sbjct: 2 DRNQKMDHVIGGKFKLGRKLGSGSFGELYLGINIQTGEEVAVKLEPVKTRHPQLQYESKI 61
Query: 64 YMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 123
YM LQGGTG+PHLKWFGVEG+Y+ MVIDLLGPSLEDLFNYC R FSLK+VLMLADQLI R
Sbjct: 62 YMFLQGGTGVPHLKWFGVEGEYSCMVIDLLGPSLEDLFNYCKRIFSLKSVLMLADQLICR 121
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 183
VEYMHSRGFLHRDIKPDNFLMGLGR+ANQVYIIDYGLAKKY+DLQT KHIPYRENKNLTG
Sbjct: 122 VEYMHSRGFLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYKDLQTQKHIPYRENKNLTG 181
Query: 184 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243
TARYASVNTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK+ T
Sbjct: 182 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 241
Query: 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303
+E LCKSYPSEF SYFHYCRSLRFEDKPDYSYL+RLFRDLFIREG+Q DYVFDWT+ KY
Sbjct: 242 SVETLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLRRLFRDLFIREGYQLDYVFDWTISKY 301
Query: 304 PQIXXXXXXXXXXXXXXLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTPHR-D 362
PQI PGP AER E+ +VG+++R + +GA+EAF+R+N + D
Sbjct: 302 PQIGSSSRPRPTPRPALDPPGPPAERAEKPTVGQDLRGRFTGAIEAFTRRNVSSQGALGD 361
Query: 363 HPRHKSSDDGPSS-KHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSECXXXXXXX 421
RH+SSDD PSS K V+ SR GSTS++ VI+ST+PGSS E SE
Sbjct: 362 RSRHRSSDDIPSSAKEVHE--------SRNGSTSKRGVISSTRPGSSAEPSENHSSRLFS 413
Query: 422 XXXXXXTTQRLQSGYDSRQSSFNRTAGGRICTRDDPIRSFEMLSI 466
TTQR+ Y+S ++ G +D IR+FE+L+I
Sbjct: 414 SGSRHATTQRVPQSYESAAAA---RPG-----HEDAIRNFELLTI 450
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1669 (592.6 bits), Expect = 1.0e-171, P = 1.0e-171
Identities = 319/405 (78%), Positives = 351/405 (86%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MDHVIGGKFKLGRKIGSGSFGELY+G+NVQTGEE+A+KLE VKTKHPQLHYESK+YMLLQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTG+PH+KWFGVEG+YN M IDLLGPSLEDLFNYC R FSLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLG+EQSRRDDLESLGYVLMYF+RGSLPWQGLKAGTKKQKY+KISEKK+ TP+EVL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIXX 308
CKSYPSEF SYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG+QFDYVFDWT+LKYPQ
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQSGS 300
Query: 309 XXXXXXXXXXXXLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTPHRDHPRHKS 368
PGPSAER E+ VG+++R++ SGAVEAF+R+N H P+H
Sbjct: 301 ISKPRPNPKPALDPPGPSAERNEKPIVGQDLRERFSGAVEAFARRNVPS--HGIRPKHIF 358
Query: 369 SDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTKPGSSGEFSE 413
SDD +SK V SEK R+ ++ AV++S++PGSSGE SE
Sbjct: 359 SDD--ASKEVQV-SEKTRN----EIATKMAVMSSSQPGSSGELSE 396
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1649 (585.5 bits), Expect = 1.3e-169, P = 1.3e-169
Identities = 326/466 (69%), Positives = 372/466 (79%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+HVIGGKFKLGRKIGSGSFGELYLGVN+Q+ EE+A+KLE VK++HPQLHYESKLYMLLQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKWFGVEG+YN+MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ+INRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
+RGFLHRDIKPDNFLMGLGRKA+QVY+IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK+ TP+EVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIXX 308
CKSYP+EF+SYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG+Q DY+FDWT Q
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT----KQGSE 296
Query: 309 XXXXXXXXXXXXLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTPHR-DHPRHK 367
L GPSAER ER + +++ D+ SG V+ F+R+ +G+ H +H +H+
Sbjct: 297 SNRLRSSGRTSGLV-GPSAERTERAAARQDVPDRFSGTVDPFARRTGSGSGHYGEHTKHR 355
Query: 368 SSDDGPSSKHVNPDSEKGR--SFSRYGSTSRKAVIASTKPGSSGEF--SECXXXXXXXXX 423
+ D + D +K R S SR GSTSRKA+++S++P S +
Sbjct: 356 NILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKALLSSSRPSSGDPIDPNRSNLIPTSSGS 415
Query: 424 XXXXTTQRL-QS-GYDSRQSSFNRTAGGRICTRDDP-IRSFEMLSI 466
T QRL QS G ++R SS +TA DDP +R+FE LSI
Sbjct: 416 SRPSTMQRLHQSTGLETR-SSLTKTARN---VHDDPTLRTFERLSI 457
|
|
| UNIPROTKB|Q70YQ4 Q70YQ4 "Putative casein kinase I" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1640 (582.4 bits), Expect = 1.2e-168, P = 1.2e-168
Identities = 325/466 (69%), Positives = 371/466 (79%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+HVIGGKFKLGRKIGSGSFGELYLGVN+Q+ EE+A+KLE VK++HPQLHYESKLYMLLQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKWFGVEG+YN+MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ+INRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
+RGFLHRDIKPDNFLMGLGRKA+QVY+IDY LAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYVLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK+ TP+EVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIXX 308
CKSYP+EF+SYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG+Q DY+FDWT Q
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT----KQGSE 296
Query: 309 XXXXXXXXXXXXLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTPHR-DHPRHK 367
L GPSAER ER + +++ D+ SG V+ F+R+ +G+ H +H +H+
Sbjct: 297 SNRLRSSGRTSGLV-GPSAERTERAAARQDVPDRFSGTVDPFARRTGSGSGHYGEHTKHR 355
Query: 368 SSDDGPSSKHVNPDSEKGR--SFSRYGSTSRKAVIASTKPGSSGEF--SECXXXXXXXXX 423
+ D + D +K R S SR GSTSRKA+++S++P S +
Sbjct: 356 NILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKALLSSSRPSSGDPIDPNRSNLIPTSSGS 415
Query: 424 XXXXTTQRL-QS-GYDSRQSSFNRTAGGRICTRDDP-IRSFEMLSI 466
T QRL QS G ++R SS +TA DDP +R+FE LSI
Sbjct: 416 SRPSTMQRLHQSTGLETR-SSLTKTARN---VHDDPTLRTFERLSI 457
|
|
| TAIR|locus:2176431 ckl8 "casein kinase I-like 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1610 (571.8 bits), Expect = 1.8e-165, P = 1.8e-165
Identities = 319/474 (67%), Positives = 371/474 (78%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MD V+GGK+KLGRK+GSGSFGEL+LGVNVQTGEE+AVKLE + +HPQLHYESKLYMLLQ
Sbjct: 1 MDRVVGGKYKLGRKLGSGSFGELFLGVNVQTGEEVAVKLEPARARHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKW+GVEG+YN MVIDLLGPS+EDLFNYC+R+F+LKTVLMLADQ+INRVEYMH
Sbjct: 61 GGTGIPHLKWYGVEGEYNCMVIDLLGPSMEDLFNYCSRRFNLKTVLMLADQMINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH+HIPYRENKNLTGTARYA
Sbjct: 121 VRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGL+AGTKKQKYDKISEKK TP+EVL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLRAGTKKQKYDKISEKKRLTPVEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIXX 308
CKS+P EF SYF Y RSLRFEDKPDY YLKRLFRDLFIREG+QFDYVFDWT+LKYPQ
Sbjct: 241 CKSFPPEFTSYFLYVRSLRFEDKPDYPYLKRLFRDLFIREGYQFDYVFDWTILKYPQFSS 300
Query: 309 XXXXXXXXXXXXLT----PGPSAERPERGSVG--KEIRDKLSGAVEAFSRKNAAGTP--H 360
P P AERP++ S G ++ RD+ SGA+EA++R+N +G+
Sbjct: 301 GSSSSSKPRSSLRPAMNPPVPIAERPDKPSAGAGQDSRDRFSGALEAYARRNGSGSGVVQ 360
Query: 361 RDHPRHKSSDDG-PSSKHVNPDS----EKGRSFSRYGSTSRKAVIASTKPGSSGEFSECX 415
D R ++S++ SSK P + E+ S +R+ S+SRKAV++S + SS +F+E
Sbjct: 361 ADRSRPRTSENVLASSKDTTPQNYERVERPISSTRHASSSRKAVVSSVRATSSADFTENR 420
Query: 416 XXXXXXXXXXXXTTQRLQSGYD--SRQSSFNRTAGGRICT-RDDPIRSFEMLSI 466
T QR Q D +R SS + T T RD ++SFE+L+I
Sbjct: 421 SSRVVPSNGRSSTAQRTQLVPDPTTRPSSSSFTRAAPSRTARDITLQSFELLTI 474
|
|
| TAIR|locus:2018269 CKL13 "casein kinase like 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1571 (558.1 bits), Expect = 2.5e-161, P = 2.5e-161
Identities = 309/465 (66%), Positives = 361/465 (77%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
MD V+GGKFKLGRK+GSGSFGE++LGVNVQTGEE+AVKLE ++ +HPQLHYESKLYMLLQ
Sbjct: 1 MDRVVGGKFKLGRKLGSGSFGEIFLGVNVQTGEEVAVKLEPLRARHPQLHYESKLYMLLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIPHLKWFGVEG++N MVIDLLGPS+E+ FNYC+R FSLKTVLMLADQ+INRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEFNCMVIDLLGPSMEEFFNYCSRSFSLKTVLMLADQMINRVEYMH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
+GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 VKGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLG+EQSRRDDLESLGY+LMYFLRGSLPWQGL+AGTKKQKYDKISEKK TP+EVL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYLLMYFLRGSLPWQGLRAGTKKQKYDKISEKKRLTPVEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIXX 308
CK++P EF SYF Y RSLRFEDKPDYSYLKRLFRDLFIREG+QFDYVFDWT+L+YPQ
Sbjct: 241 CKNFPPEFTSYFLYVRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILRYPQFGS 300
Query: 309 XXXXXX----XXXXXXLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAGTP-HRDH 363
P PSA++ E+ +G++ R++ SG EA++R+N +GT D
Sbjct: 301 SSSSNSKPRPTLRPAMNIPVPSADKAEKPPIGQDSRERFSGVFEAYTRRNGSGTGVQADQ 360
Query: 364 P-RHKSSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIAST-KPGSSGEFSECXXXXXXX 421
R ++S++ +SK + E+ S SR S+SRKA+ S+ + SS +F+E
Sbjct: 361 SSRPRTSENVLASKDTQ-NQERPNSLSRNLSSSRKAIAGSSVRATSSADFTENRLSRLIP 419
Query: 422 XXXXXXTTQRLQSGYDSRQSSFNRTAGGRICTRDDPIRSFEMLSI 466
TT R Q S SS A RD ++S E+LSI
Sbjct: 420 NNDRSSTTLRTQFAPSS--SSVATKAAPTRAARDITLQSLELLSI 462
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1367 (486.3 bits), Expect = 1.3e-141, Sum P(2) = 1.3e-141
Identities = 243/297 (81%), Positives = 278/297 (93%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G KF+LGRKIGSGSFGE+YLG N+ T EE+A+KLE VKTKHPQL YESKLY +LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTG+P++KWFGVEGDYN++V+DLLGPSLEDLFN+C+RK SLK+VLMLADQ+INRVE+ H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ FLHRD+KPDNFLMGLGR+ANQVYIID+GLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKY++ISEKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305
C+ YPSEF SYFHYCRSLRF+DKPDY+YLKR+FRDLFIREGFQFDYVFDWT+LKY Q
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.6734 | 0.6282 | 0.6901 | yes | no |
| P49674 | KC1E_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7525 | 0.6303 | 0.7091 | yes | no |
| Q6QNM1 | KC1_TOXGO | 2, ., 7, ., 1, 1, ., 1 | 0.7337 | 0.6260 | 0.9043 | N/A | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7355 | 0.6303 | 0.7108 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.6768 | 0.6987 | 0.8958 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.6983 | 0.6303 | 0.6704 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.6825 | 0.6260 | 0.9071 | yes | no |
| Q5ZLL1 | KC1E_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7559 | 0.6303 | 0.7091 | yes | no |
| Q6QNL9 | KC1_EIMTE | 2, ., 7, ., 1, 1, ., 1 | 0.7406 | 0.6260 | 0.8746 | N/A | no |
| Q5BP74 | KC1D_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7423 | 0.6303 | 0.7108 | N/A | no |
| Q9JMK2 | KC1E_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7525 | 0.6303 | 0.7091 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00020288001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (464 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 468 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-44 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-31 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-22 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-17 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-12 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-10 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-07 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-07 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-06 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 0.001 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.001 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.001 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.001 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.001 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 0.002 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.002 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.002 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.002 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.003 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.003 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.003 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.004 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.004 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 8e-44
Identities = 66/254 (25%), Positives = 107/254 (42%), Gaps = 21/254 (8%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHY----ESKLYMLLQGGTG 72
++L RK+GSGSFG +Y + TG+ +AVK+ +++ + E ++ L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 73 IPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSR 130
+ + F + D+ +V++ DLF+Y S +A Q++ +EY+HS
Sbjct: 61 VRLIDAF-EDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 190
G +HRD+KP+N L+ + V I D+GLAKK GT Y +
Sbjct: 118 GIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAP 167
Query: 191 NTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249
LG + D+ SLG +L L G P+ G + Q +I +
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227
Query: 250 KSYPSEFVSYFHYC 263
S E C
Sbjct: 228 -SGSEEAKDLIKKC 240
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 72/238 (30%), Positives = 115/238 (48%), Gaps = 11/238 (4%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQT--GEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGI 73
+++ RK+G GSFGE+YL + + + +A KLE + + E ++ L I
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 74 PHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSR 130
L F + +V++ + G SLEDL S L + Q+++ +EY+HS+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 190
G +HRDIKP+N L L R V +ID+GLAK D + IP + ++ GT Y +
Sbjct: 121 GIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGYMAP 177
Query: 191 NTHLGVEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245
LG+ S D+ SLG L L G P++G K + + KI + + +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTGIPHLKWF 79
+G G FG +YL + +TG+++A+K E + +L E ++ L I L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGV 59
Query: 80 GVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIK 138
+ ++ +V++ G SL+DL K S +L + Q++ +EY+HS G +HRD+K
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 139 PDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VE 197
P+N L L +V + D+GL+K K + GT Y + LG
Sbjct: 120 PENIL--LDSDNGKVKLADFGLSKLLTS-------DKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 198 QSRRDDLESLGYVLMYF 214
S + D+ SLG +L
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 23/241 (9%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTGI 73
+++ K+G GSFG++YL + +TG+ +A+K + +K ++ E K+ L+ I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH-PNI 59
Query: 74 PHLKWFGVEGDYNIMVIDLLGPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSRG 131
L + D +V++ DLF+ + S Q+++ +EY+HS+G
Sbjct: 60 VRLYDVFEDEDKLYLVMEYC--EGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 191
+HRD+KP+N L+ + V + D+GLA++ + GT Y +
Sbjct: 118 IVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKLTT--------FVGTPEYMAPE 166
Query: 192 THLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250
LG + D+ SLG V++Y L G P+ G + + KI + K P
Sbjct: 167 VLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPPFPPPEWDI 223
Query: 251 S 251
S
Sbjct: 224 S 224
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 22/220 (10%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTK---HPQLHYESKLYMLLQGGT 71
+++ G KIG G+FG++Y VN+ TGE +AVK + + ++ E K+ LL+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58
Query: 72 GIPHL-KWFGVE---GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 127
P+L K++GVE I + G +LE+L + R + + QL+ + Y+
Sbjct: 59 --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115
Query: 128 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 187
HS G +HRDIKP N + + + D+G A K L+ + E ++L GT Y
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVK---LKNNTTTMGEEVQSLAGTPAY 169
Query: 188 ASVNTHLGVEQS---RRDDLESLGYVLMYFLRGSLPWQGL 224
+ G + R D+ SLG V++ G PW L
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 65/195 (33%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 97 LEDLFNYCNRKFSLKTVLMLADQLINRV--------EYMHSRGFLHRDIKPDNFLMGLGR 148
LE L N K K + +LI + EY+H G H DIKP+N +M G
Sbjct: 106 LEKL--VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPEN-IMVDGN 162
Query: 149 KANQVYIIDYGLAKKYRDLQTHKHIPY-RENKNL-TGTARYASVNTHLGVEQSRRDDLES 206
N+ YIIDYG+A + + KHI Y +E K+L GT YA ++ H G +RR DLES
Sbjct: 163 --NRGYIIDYGIASHF--IIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLES 218
Query: 207 LGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSL 266
LGY ++ + LPW+G K K ++ K+ + L
Sbjct: 219 LGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKL 278
Query: 267 RFEDKPDYSYLKRLF 281
+E+KPDY L ++F
Sbjct: 279 SYEEKPDYDALIKIF 293
|
Length = 294 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 70/302 (23%), Positives = 112/302 (37%), Gaps = 80/302 (26%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LE---LVKTK-----------------HP 55
FK G+ IG GSF + L +T +E A+K L+ L+K K HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 56 ---QLHY----ESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKF 108
+L+Y E LY +L+ + G+ L
Sbjct: 63 GIIKLYYTFQDEENLYFVLE----------YAPNGE------------LLQYIRK-YGSL 99
Query: 109 SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK------ 162
K A +++ +EY+HS+G +HRD+KP+N L+ K + I D+G AK
Sbjct: 100 DEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNS 156
Query: 163 -------KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL 215
++ + R + GTA Y S + DL +LG ++ L
Sbjct: 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216
Query: 216 RGSLPWQGLKAGTKKQKYDKISEKKVSTP----------IEVLCKSYPSEFVSYFHYCRS 265
G P++G + + KI + + S P IE L P + +
Sbjct: 217 TGKPPFRG---SNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273
Query: 266 LR 267
L+
Sbjct: 274 LK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQ---LHYESKLYMLLQGGT 71
++ G +G GSFG +YL ++ TGE +AVK +EL + L E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58
Query: 72 GIPHL-KWFGVEGDYNIMVIDLL-----GPSLEDLFNYCNRKFSLKTVLMLADQLINRVE 125
P++ +++G E D +++ G SL L K + Q++ +
Sbjct: 59 --PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLA 115
Query: 126 YMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTA 185
Y+HS G +HRDIK N L+ V + D+G AK+ D++T + ++ GT
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDG---VVKLADFGCAKRLGDIETGE-----GTGSVRGTP 167
Query: 186 RYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
+ + G E R D+ SLG ++ G PW
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 65/255 (25%), Positives = 107/255 (41%), Gaps = 75/255 (29%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVK-LE-------------------LVKTKHP---QLHY 59
+G GSFG++ L TG+ A+K L+ L + HP +LHY
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 60 ----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR--KFSL 110
E KLY++L+ GG +LF++ ++ +FS
Sbjct: 61 AFQTEEKLYLVLEYAPGG----------------------------ELFSHLSKEGRFSE 92
Query: 111 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK-YRDLQT 169
+ A +++ +EY+HS G ++RD+KP+N L L + + + D+GLAK+ +
Sbjct: 93 ERARFYAAEIVLALEYLHSLGIIYRDLKPENIL--LDADGH-IKLTDFGLAKELSSEGSR 149
Query: 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 229
GT Y + LG + D SLG +L L G P+ A +
Sbjct: 150 --------TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY---AEDR 198
Query: 230 KQKYDKISEKKVSTP 244
K+ Y+KI + + P
Sbjct: 199 KEIYEKILKDPLRFP 213
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 9e-17
Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 40/241 (16%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKL-----ELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+ I G+FG +YL TG+ A+K+ + K + + E + M+ +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 76 LKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQ--------LINRVEY 126
L + DY +V++ L G L +KT+ L + ++ VE
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASL---------IKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 127 MHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 186
+H RG +HRDIKP+N L+ + + + D+GL++ ENK GT
Sbjct: 113 LHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKKFVGTPD 158
Query: 187 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246
Y + T LGV + D SLG V+ FL G P+ A T +D I ++++ P E
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRINWPEE 215
Query: 247 V 247
V
Sbjct: 216 V 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 9e-17
Identities = 48/169 (28%), Positives = 92/169 (54%), Gaps = 16/169 (9%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
F++ KIG G FGE+Y + +TG+E+A+K+ +++K + +++ +L + H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKK----CKH 56
Query: 76 ---LKWFG--VEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
+K++G ++ D +V++ G SL+DL N+ + + + +L+ +EY+HS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI---PY 175
G +HRDIK N L+ +V +ID+GL+ + D + + PY
Sbjct: 117 NGIIHRDIKAANILL--TSDG-EVKLIDFGLSAQLSDTKARNTMVGTPY 162
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGT 71
++K+ +IG G+ G ++ + +TGE +A+K ++ Q E K Q
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
+ L F G ++V++ + L ++ R V L+ V YMH+ G
Sbjct: 61 VVKLLDVF-PHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY----RDLQTHKHIP--YRENKNLTGTA 185
+HRD+KP N L+ + I D+GLA+ + L +H+ YR + L G
Sbjct: 120 IMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 186 RYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS 218
+Y GV DL ++G + L GS
Sbjct: 177 KYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 70/265 (26%), Positives = 114/265 (43%), Gaps = 47/265 (17%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----LELVKTKHPQLHYESKLYMLLQG 69
++ + R IG G GE+YL + +A+K L + E+K+ L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 70 GTGIPHLKWFGVEGD-----YNIMVIDLLGPSLEDLFNYCNRKFSL----------KTVL 114
+P + + D Y + I+ G +L+ L +K SL L
Sbjct: 62 PGIVP---VYSICSDGDPVYYTMPYIE--GYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 115 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK---KYRDLQTHK 171
+ ++ +EY+HS+G LHRD+KPDN L+GL +V I+D+G A +
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 172 HIPYREN--KNLT------GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
+ R ++T GT Y + LGV S D+ +LG +L L S P+
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-- 231
Query: 224 LKAGTKKQKYDKISEK-KVSTPIEV 247
+++K KIS + + +PIEV
Sbjct: 232 -----RRKKGRKISYRDVILSPIEV 251
|
Length = 932 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLH-----YESKLYMLLQGGT 71
+K+ +++G G+FG +YL N +TGE +A+K +K K E K L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKK--MKKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLF-NYCNRKFSLKTVLMLADQLINRVEYMHSR 130
I LK E D V + + +L L + + FS + + Q++ + ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 131 GFLHRDIKPDNFL-MGLGRKANQVYIIDYGLAKKYR 165
GF HRD+KP+N L G V I D+GLA++ R
Sbjct: 119 GFFHRDLKPENLLVSGPEV----VKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYE-SKLYMLLQGGTGIPH 75
++ G+ +G G+FG +YL +V TG E+AVK P+ E + L +Q + H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 76 ---LKWFGVEGD---YNIMVIDLLGPSLED-------LFNYCNRKFSLKTVLMLADQLIN 122
++++G D +I + + G S++D L RK++ Q++
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR--------QILE 115
Query: 123 RVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT-HKHIPYRENKNL 181
VEY+HS +HRDIK N L A V + D+G +K+ LQT K++
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKR---LQTICSSGTGM--KSV 167
Query: 182 TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 226
TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 43/178 (24%), Positives = 71/178 (39%), Gaps = 58/178 (32%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE----------------LVKTKHPQ- 56
++ K+G G++G +Y + +TGE +A+K L+ L + KHP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 57 ------LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY---CNRK 107
+H E KLY++ +Y D DL Y
Sbjct: 61 VKLLDVIHTERKLYLVF----------------EY----CD------MDLKKYLDKRPGP 94
Query: 108 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165
S + + QL+ + Y HS LHRD+KP N L+ + + + D+GLA+ +
Sbjct: 95 LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----LELVKTKH--PQLHYESKLYMLLQ 68
+++ G +GSGSFG +Y G+N+ G+ AVK + + QL E L LQ
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKF-SLKTVL--MLADQLINRVE 125
+ +L E + I + + G SL L +K+ S + + Q++ +E
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLE 116
Query: 126 YMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
Y+H R +HRDIK N L+ V + D+G+AK+
Sbjct: 117 YLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQ 151
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 68/242 (28%), Positives = 110/242 (45%), Gaps = 30/242 (12%)
Query: 20 GRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIPHLK- 77
G IG G++G +YL +NV TGE +AVK +EL T + H + M+ + I LK
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGR-HDSRQKDMVKALRSEIETLKD 64
Query: 78 --------WFGVEGDYNIMVIDL---LGPSLEDLF-NYCNRKFSLKTVLMLADQLINRVE 125
+ G E + I L G S+ Y +F + V +Q++ +
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLA 122
Query: 126 YMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTA 185
Y+HS+G LHRD+K DN L+ I D+G++KK D+ + +N ++ G+
Sbjct: 123 YLHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDND-----QNMSMQGSV 174
Query: 186 RYAS--VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243
+ + V S + D+ SLG V++ G PW +A K+ K+ +
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKRSAP 231
Query: 244 PI 245
PI
Sbjct: 232 PI 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 28/177 (15%)
Query: 18 KLGRKIGSGSFGELYLGV----NVQTGEEIAVKLELVKTKHPQ----LHYESKLYMLLQG 69
LG+K+G G+FGE+Y G + E+AVK L + Q E+++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK-TLKEDASEQQIEEFLREARIMRKLD- 59
Query: 70 GTGIPH---LKWFGV-EGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINR 123
H +K GV + + ++ L K SL +L A Q+
Sbjct: 60 -----HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD----LQTHKHIPYR 176
+EY+ S+ F+HRD+ N L+G + V I D+GL++ D + +P R
Sbjct: 115 MEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 31/166 (18%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----------HPQLHYESKLY 64
+++ G+K+G G++ +Y + +TG +A+K K K + E KL
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK----KIKLGERKEAKDGINFTALREIKLL 56
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 118
L+ I L FG + + N+ V + + LE + VL AD
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINL-VFEFMETDLEKVIK------DKSIVLTPADIKSYML 109
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
+ +EY+HS LHRD+KP+N L+ + + D+GLA+ +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSF 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 29/178 (16%)
Query: 18 KLGRKIGSGSFGELYLGV----NVQTGEEIAVKLELVKTKHPQ----LHYESKLYMLLQG 69
LG+K+G G+FGE+Y G E+AVK L + Q E+++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK-TLKEDASEQQIEEFLREARIMRKLD- 59
Query: 70 GTGIPH---LKWFGV-EGDYNIMVIDLLGP--SLED-LFNYCNRKFSLKTVLMLADQLIN 122
H +K GV + +M++ P L D L ++ SL +L A Q+
Sbjct: 60 -----HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 123 RVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH----IPYR 176
+EY+ S+ F+HRD+ N L+G V I D+GL++ D +K +P R
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 67/300 (22%), Positives = 113/300 (37%), Gaps = 64/300 (21%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGTG 72
F++ + IG G+FGE++L + TG+ A+K+ +++K + +
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 73 IPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSR 130
I L + + ++ +V++ + DL N RK F +T +L+ ++ +H
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD-----------------LQTHKHI 173
GF+HRDIKPDN L + + + + D+GL KK
Sbjct: 121 GFIHRDIKPDNIL--IDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 174 PYRENKN-----LTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG 227
+ + GT Y + G D SLG V++Y L G P +
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILYEMLYGFPP---FYSD 233
Query: 228 TKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287
T ++ Y+KI ++ SLRF P S DL R
Sbjct: 234 TLQETYNKII-----------------------NWKESLRFPPDPPVS---PEAIDLICR 267
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 64/240 (26%), Positives = 107/240 (44%), Gaps = 27/240 (11%)
Query: 20 GRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGI----- 73
G IGSGSFG +YLG+N +GE +AVK +EL + + L +
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 74 -PHL-KWFG--VEGDY-NIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
++ ++ G ++ D+ NI + + G S+ L N F V Q++ + Y+H
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH 123
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR----DLQTHKHIPYRENKNLTGT 184
+RG +HRDIK N L+ + I D+G++KK +T+ P +L G+
Sbjct: 124 NRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP-----SLQGS 175
Query: 185 ARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
+ + +R+ D+ SLG +++ L G P+ T+ Q KI E
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIFKIGENASPEI 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 65/239 (27%), Positives = 102/239 (42%), Gaps = 29/239 (12%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
F+L R IG G+FG++ + T + A+K + K K + + + + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMK-YMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 77 ----KWFGVEGDYNI-MVIDLLGPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHS 129
W+ + + N+ +V+DLL DL + KFS + V +++ +EY+HS
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT---GTAR 186
+G +HRDIKPDN L+ + V+I D+ +A K + T GT
Sbjct: 119 KGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTP-----------DTLTTSTSGTPG 164
Query: 187 YASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
Y + S D SLG V Y LRG P++G + Q K V P
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLG-VTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP 222
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 42/166 (25%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK--------LELVKT--------KHPQL-- 57
+K KIG G+ GE+Y + TG+E+A+K EL+ KHP +
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 58 HYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLML 116
+Y+S L GD +V++ + G SL D+ + + + +
Sbjct: 80 YYDSYLV------------------GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV 121
Query: 117 ADQLINRVEYMHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDYGLA 161
+++ +EY+HS+ +HRDIK DN L+ G V + D+G A
Sbjct: 122 CREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 46/190 (24%), Positives = 77/190 (40%), Gaps = 29/190 (15%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHY----ESKLYMLLQGGTG 72
+++ K+G G+FGE+Y ++TG +A+K L+ + E K+ L+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 73 IPHLKWFGVEGD---------YNI---MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQL 120
+P + D Y + M DL G L + K + + QL
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG-----LLENPSVKLTESQIKCYMLQL 124
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180
+ + Y+H LHRDIK N L+ + I D+GLA+ Y P +
Sbjct: 125 LEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDG-----PPPNPKGGG 176
Query: 181 LTGTARYASV 190
GT +Y ++
Sbjct: 177 GGGTRKYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 75/291 (25%), Positives = 121/291 (41%), Gaps = 69/291 (23%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHP-----------QLHYES--KLY 64
+IG G++G++Y N +TGE +A+K +E K P +L + + +L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 65 --MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLIN 122
+ +G I MV + + L L + KF+ + QL+
Sbjct: 65 EIVTSKGKGSI-------------YMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE 111
Query: 123 RVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ----THKHIP--YR 176
++Y+HS G LHRDIK N L + + + D+GLA+ Y T++ I YR
Sbjct: 112 GLQYLHSNGILHRDIKGSNIL--INNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYR 168
Query: 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236
+ L G RY V D+ S+G +L G +QG T+ ++ +KI
Sbjct: 169 PPELLLGATRYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEKI 214
Query: 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFED--KPDYSYLKRLFRDLF 285
E LC S P++ + L + + KP Y KR R+ F
Sbjct: 215 FE---------LCGS-PTD--ENWPGVSKLPWFENLKPKKPY-KRRLREFF 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTK---HPQLHYESKLYMLLQGGT 71
++LG IG G+FG +Y G+N++TG+ +A+K + L K K + E L L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDL---FNYCNRKFSLKTVLMLADQLINRVEYMH 128
+ ++ I++ SL + F SL V + Q++ + Y+H
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE--SLVAVYVY--QVLQGLAYLH 116
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167
+G +HRDIK N L K V + D+G+A K D+
Sbjct: 117 EQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDV 152
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 40/127 (31%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK-YRDLQTHKHIPYRE 177
+++ +EY+HS G +HRD+KPDN L+ + + D+GL+K Q + + +E
Sbjct: 101 EIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157
Query: 178 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237
+K + GT Y + LG S+ D SLG +L FL G P+ G T ++ + I
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNIL 214
Query: 238 EKKVSTP 244
K+ P
Sbjct: 215 NGKIEWP 221
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 8/146 (5%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHY-ESKLYMLLQGGTGIPHL 76
KIG G++G +Y + TGE +A+K ++ + P+ E KL L I L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 77 KWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRD 136
F +GD + V + + L L R + QL+ + + HS G LHRD
Sbjct: 65 DVFRHKGDLYL-VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123
Query: 137 IKPDNFLMGLGRKANQVYIIDYGLAK 162
+KP+N L+ + + D+GLA+
Sbjct: 124 LKPENLLI---NTEGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 50/176 (28%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------------LELVKT-KHPQ 56
K+++ ++IG GSFG++YL G+ +K ++++K HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 57 L--HYES-----KLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFS 109
+ +YES KL ++++ + GD + + + F
Sbjct: 61 IIKYYESFEEKGKLCIVME----------YADGGDLSQKI---------KKQKKEGKPFP 101
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDYGLAKKY 164
+ +L QL ++Y+HSR LHRDIKP N FL V + D+G++K
Sbjct: 102 EEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVL 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 60/239 (25%), Positives = 111/239 (46%), Gaps = 34/239 (14%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGTG 72
+ + +G+G+FG ++L + + A+K+ E+++ K Q H ++ +L +
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ-HVHNEKRVLKE---- 57
Query: 73 IPH---LKWFGVEGDYNI--MVIDLLGPSLEDLFNY--CNRKFSLKTVLMLADQLINRVE 125
+ H ++ F E D M+++ + P E LF+Y + +FS T L A +++ +E
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYV-PGGE-LFSYLRNSGRFSNSTGLFYASEIVCALE 115
Query: 126 YMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTA 185
Y+HS+ ++RD+KP+N L+ K + + D+G AKK RD L GT
Sbjct: 116 YLHSKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRD----------RTWTLCGTP 162
Query: 186 RYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
Y + ++ D +LG ++ L G P+ Y+KI K+ P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKLEFP 218
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 3e-09
Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 27/172 (15%)
Query: 17 FKLGRKIGSGSFGELYLGV----NVQTGEEIAVKLELVKTKHPQ---LHYESKLYMLLQG 69
+LG+K+G G+FGE+Y G T ++AVK + E+ + L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 70 GTGIPHL-KWFGV--EGDYNIMVIDL--LGPSLEDLFNY---CNRKFSLKTVLMLADQLI 121
P++ + GV +G+ +V + G DL ++ K +LK +L +A Q+
Sbjct: 61 ----PNIVRLLGVCTQGEPLYIVTEYMPGG----DLLDFLRKHGEKLTLKDLLQMALQIA 112
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK-KYRDLQTHKH 172
+EY+ S+ F+HRD+ N L + V I D+GL++ Y D K
Sbjct: 113 KGMEYLESKNFVHRDLAARNCL--VTEN-LVVKISDFGLSRDIYEDDYYRKR 161
|
Length = 258 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 31/226 (13%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYE-SKLYMLLQGGTGIPH 75
++LG+ +G G+FG +YL + TG E+AVK + P+ E + L +Q + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 76 ---LKWFGV-----EGDYNIMVIDLLGPSLED-------LFNYCNRKFSLKTVLMLADQL 120
++++G E +I + + G S++D L RK++ Q+
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT--------RQI 115
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180
+ V Y+HS +HRDIK N L V + D+G +K+ LQT + K+
Sbjct: 116 LEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKR---LQT-ICLSGTGMKS 168
Query: 181 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 226
+TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 37/149 (24%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH- 75
F + K+G GS+G +Y ++ +TG+ +A+K+ V+ ++ ++ +L Q + P+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEI--IKEISILKQCDS--PYI 60
Query: 76 LKWFG---VEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 132
+K++G D I++ S+ D+ N+ + + + + Q + +EY+HS
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK 120
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
+HRDIK N L+ + Q + D+G++
Sbjct: 121 IHRDIKAGNILLN---EEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 26/150 (17%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK-YRDLQTHKHIPYRE 177
++ EY+H+RG ++RD+KP+N L+ V ++D+G AKK +T
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQKTW------- 150
Query: 178 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA---------- 226
GT Y + L D SLG +L+Y L G P+
Sbjct: 151 --TFCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYNDIL 207
Query: 227 -GTKKQKYDKISEKKVSTPIEVLCKSYPSE 255
G K ++ +K I+ L + P E
Sbjct: 208 KGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 52/192 (27%), Positives = 84/192 (43%), Gaps = 24/192 (12%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIA---VKLELVKTKHP-----------QLHYES 61
KF + +IG G++G++Y + TGE +A V+L+ K P QL++ +
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 62 KLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLI 121
+ + L + +G + +V + + L L FS + QL+
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAF-YLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY----RDLQTHKHIP--Y 175
+ Y H + FLHRDIK N L+ Q+ + D+GLA+ Y T+K I Y
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 176 RENKNLTGTARY 187
R + L G RY
Sbjct: 184 RPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 36/134 (26%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
F L IG GSFGE+Y ++ +T + +A+K ++L + + + ++ L Q P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ--CRSP 59
Query: 75 HL-KWFG-VEGDYNIMVI--DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130
++ K++G + +I G S DL K + + +++ +EY+H
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE 117
Query: 131 GFLHRDIKPDNFLM 144
G +HRDIK N L+
Sbjct: 118 GKIHRDIKAANILL 131
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 31/185 (16%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESK-----------LYMLLQGG 70
+I G++G +Y + +TGE +A+K +L E + + +LL+
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALK---------KLKMEKEKEGFPITSLREINILLKLQ 62
Query: 71 -TGIPHLK--WFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 127
I +K G D MV++ + L+ L + F V L QL++ V ++
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 128 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD-LQTHKHIP----YRENKNLT 182
H LHRD+K N L+ + I D+GLA++Y L+ + + YR + L
Sbjct: 123 HDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL 179
Query: 183 GTARY 187
G Y
Sbjct: 180 GAKEY 184
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGT 71
K++ R +G G+FG ++L + + +K ++ K + E ++ LL
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSR 130
I + + F + I++ G +L + CN T+L Q++ + ++H++
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 190
LHRD+K N L+ + V I D+G++K + + K Y + GT Y S
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISK----ILSSKSKAY----TVVGTPCYISP 170
Query: 191 NTHLGVEQSRRDDLESLGYVL 211
G +++ D+ +LG VL
Sbjct: 171 ELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 41/169 (24%), Positives = 67/169 (39%), Gaps = 52/169 (30%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIA---VKLE----------------LVKTKHPQ------ 56
KIG G++G ++ N +T E +A V+L+ L + KH
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 57 -LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLM 115
LH + KL +V + L+ F+ CN + V
Sbjct: 67 VLHSDKKL-----------------------TLVFEYCDQDLKKYFDSCNGDIDPEIVKS 103
Query: 116 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
QL+ + + HS LHRD+KP N L+ K ++ + D+GLA+ +
Sbjct: 104 FMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK----LELVKTKHPQ-LHYESKLYMLLQGGT 71
F++ +KIG G F E+Y + + +A+K E++ K Q E L L
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSL---KTVLMLADQLINRVEYMH 128
I +L F + + NI++ L + Y ++ L +TV QL + VE+MH
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 129 SRGFLHRDIKPDN-FLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 187
SR +HRDIKP N F+ G V + D GL + + T H +L GT Y
Sbjct: 124 SRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPYY 172
Query: 188 ASVNTHLGVEQSRRDDLESLGYVL 211
S + + D+ SLG +L
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 10/104 (9%)
Query: 108 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167
F + VL Q+++ V Y+H G LHRDIK N + KA + + D+G++K
Sbjct: 98 FEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSE 154
Query: 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVL 211
+ + + GT Y S GV+ + + D+ +LG VL
Sbjct: 155 YSMA-------ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 17/221 (7%)
Query: 6 KLRMDHVIGG---KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYES 61
KLR +G K+ KIG G+ G +Y ++V TG+E+A+K + L + +L
Sbjct: 7 KLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINE 66
Query: 62 KLYMLLQGGTGI-PHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQL 120
L M I +L + V + +++ L G SL D+ + + +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCREC 124
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180
+ +E++HS +HRDIK DN L+G+ V + D+G + Q +
Sbjct: 125 LQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQ-------SKRST 174
Query: 181 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
+ GT + + + D+ SLG + + + G P+
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 63/182 (34%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTK----------------HP- 55
F+ + +G+GSFG + L + +G+ A+K+ ++VK K HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 56 --QLHY----ESKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR 106
L+ +S LY+++ GG +LF++ +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGG----------------------------ELFSHLRK 94
Query: 107 --KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
+F A Q++ +EY+HS ++RD+KP+N L+ + I D+G AK+
Sbjct: 95 SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRV 151
Query: 165 RD 166
+
Sbjct: 152 KG 153
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
K+ KIG G+ G +Y ++V TG+E+A++ + L + +L L M I
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 75 HLKWFGVEGDYNIMVIDLL-GPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRGF 132
+ + GD +V++ L G SL D+ C + + V + + +E++HS
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 137
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 192
+HRDIK DN L+G+ V + D+G + Q+ + + GT + +
Sbjct: 138 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 187
Query: 193 HLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
+ D+ SLG + + + G P+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLLQGGTG----IPH 75
IG G FGE+Y TG+ A+K + +K K + ++ ML TG I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 76 LKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGFL 133
+ + D ++DL+ DL + ++ FS + A ++I +E+MH+R +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 134 HRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH 193
+RD+KP N L+ + V I D GLA + + H ASV TH
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPH-----------------ASVGTH 159
Query: 194 ---------LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 229
GV D SLG +L LRG P++ K K
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 8e-08
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
K+ KIG G+ G +Y +++ TG+E+A+K + L + +L L M I
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 75 HLKWFGVEGDYNIMVIDLL-GPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRGF 132
+ + GD +V++ L G SL D+ C + + V + + ++++HS
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDFLHSNQV 136
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 192
+HRDIK DN L+G+ V + D+G + Q+ + + GT + +
Sbjct: 137 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 186
Query: 193 HLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
+ D+ SLG + + + G P+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 9e-08
Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYE-SKLYMLLQGGTGIPH 75
++ G+ +G G+FG +YL +V TG E+A K + P+ E S L +Q + H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 76 ---LKWFGVEGDY-----NIMVIDLLGPSLED-------LFNYCNRKFSLKTVLMLADQL 120
++++G D I + + G S++D L RK++ Q+
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT--------RQI 115
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180
+ + Y+HS +HRDIK N L A V + D+G +K+ LQT + ++
Sbjct: 116 LEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKR---LQT-ICMSGTGIRS 168
Query: 181 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 226
+TGT + S G R+ D+ SLG ++ L PW +A
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 26/235 (11%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQ-LHYESKLYMLLQGGT 71
F++G +G+GSFG + + + TGE A+K E++K K Q + E + M L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHS 129
+ + F E ++ ++G +LF + + +F +L+ EY+HS
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVG---GELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
+ ++RD+KP+N L L K + V + D+G AKK D L GT Y +
Sbjct: 137 KDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPD----------RTFTLCGTPEYLA 183
Query: 190 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
+ D ++G +L F+ G P+ T + Y+KI ++ P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAGRLKFP 235
|
Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ--GGTGIP 74
+KLG IG+GSFG +Y + + T E++A+K L + PQ Y+++ ++++ I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL---QDPQ--YKNRELLIMKNLNHINII 122
Query: 75 HLK-WFGVE----GDYNI---MVIDLLGPSLEDLFNYC---NRKFSLKTVLMLADQLINR 123
LK ++ E + NI +V++ + ++ + N L V + + QL
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP------YRE 177
+ Y+HS+ HRD+KP N L + + + + D+G AK L + + YR
Sbjct: 183 LAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAKNL--LAGQRSVSYICSRFYRA 238
Query: 178 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG 217
+ + G Y TH+ DL SLG ++ + G
Sbjct: 239 PELMLGATNYT---THI--------DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 19/222 (8%)
Query: 6 KLRMDHVIGG---KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYES 61
KLR IG K+ KIG G+ G ++ ++V TG+E+A+K + L K +L
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE 66
Query: 62 KLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFN-YCNRKFSLKTVLMLADQ 119
L M I + + GD +V++ L G SL D+ C + + V +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRE 123
Query: 120 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENK 179
+ +E++H+ +HRDIK DN L+G+ V + D+G + Q+ +
Sbjct: 124 CLQALEFLHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKR-------S 173
Query: 180 NLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
+ GT + + + D+ SLG + + + G P+
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 48/202 (23%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFG 80
KIG GS G + + TG+++AVK ++L K + +L + + M + +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 81 VEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 139
+ GD +V++ L G +L D+ + + + + + + ++ + Y+H++G +HRDIK
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 140 DNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS 199
D+ L+ ++ + D+G Q K +P R K+L GT + + +
Sbjct: 147 DSILL---TSDGRIKLSDFGFCA-----QVSKEVPKR--KSLVGTPYWMAPEVISRLPYG 196
Query: 200 RRDDLESLGYVLMYFLRGSLPW 221
D+ SLG +++ + G P+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 71/283 (25%), Positives = 128/283 (45%), Gaps = 49/283 (17%)
Query: 21 RKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQ-----LHYESKLYMLLQGGTGIP 74
+++G G+FG + GV +++G+E+ V ++ +K +H E+ + L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56
Query: 75 HL-KWFGV-EGDYNIMVIDL--LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130
+ + GV +G+ ++V++L LGP L+ L R+ + + LA Q+ + Y+ S+
Sbjct: 57 CIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK 114
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK------KYRDLQTHKHIPYRENKNLTGT 184
F+HRD+ N L+ +Q I D+G+++ Y T P +
Sbjct: 115 HFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK-------- 163
Query: 185 ARYA--SVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEKK 240
YA +N + S + D+ S G V ++ F G+ P+ +K + S ++
Sbjct: 164 -WYAPECINYG---KFSSKSDVWSYG-VTLWEAFSYGAKPYGEMKGAEVIAMLE--SGER 216
Query: 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283
+ P E C P E S C R ED+P +S L+ FR
Sbjct: 217 LPRPEE--C---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVKL-ELVKTKHPQLHYESKLYML-LQGGTGIPHLKWF 79
KIG GS G + + +G ++AVK+ +L K + +L + + M Q + K +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 80 GVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 139
V + +++ L G +L D+ + + + + + + + ++ + Y+HS+G +HRDIK
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 140 DNFLMGL-GRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ 198
D+ L+ L GR V + D+G Q K +P R K+L GT + +
Sbjct: 146 DSILLTLDGR----VKLSDFGFCA-----QISKDVPKR--KSLVGTPYWMAPEVISRTPY 194
Query: 199 SRRDDLESLGYVLMYFLRGSLPW 221
D+ SLG +++ + G P+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 46/190 (24%), Positives = 83/190 (43%), Gaps = 62/190 (32%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY--------MLL 67
+++L + IGSG++G + V+ +TG ++A+K K + ++ + LL
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK----KISNV---FDDLIDAKRILREIKLL 53
Query: 68 QGGTGIPHLKWFGVEGDYNIM-VIDLLGPSLEDLFN--YCNRKFSLKTVLMLAD------ 118
+ HL+ NI+ ++D+L P + FN Y + T LM D
Sbjct: 54 R------HLR------HENIIGLLDILRPPSPEDFNDVY------IVTELMETDLHKVIK 95
Query: 119 ---------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAK 162
Q++ ++Y+HS +HRD+KP N L+ +N + I D+GLA+
Sbjct: 96 SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFGLAR 151
Query: 163 KYRDLQTHKH 172
+ K
Sbjct: 152 GVDPDEDEKG 161
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 58/244 (23%), Positives = 100/244 (40%), Gaps = 67/244 (27%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK---------------------LELVKT-KH 54
++LG+ +G G+FGE+YL + TG E+AVK ++L+K +H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 55 PQL---------HYESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFN 102
++ E KL + ++ GG+ LK +G L
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA------------------LTE 105
Query: 103 YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
R+++ Q++ V Y+HS +HRDIK N L A V + D+G +K
Sbjct: 106 NVTRRYT--------RQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASK 154
Query: 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQ 222
+ + + + K++TGT + S G R+ D+ S+ ++ L PW
Sbjct: 155 RIQTI----CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210
Query: 223 GLKA 226
+A
Sbjct: 211 EYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK----LELVKTKHPQ-LHYESKLYMLLQG 69
G FK+ +KIG G F +Y + + G +A+K E++ K Q E L L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 70 GTGIPHLKWFGVEGDYNIMVIDLLGPSLEDL------FNYCNRKFSLKTVLMLADQLINR 123
I +L F +E + +V++L DL F R +T+ QL +
Sbjct: 62 PNVIKYLASF-IENNELNIVLELADAG--DLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 182
+E+MHS+ +HRDIKP N + A V + D GL + + T H +L
Sbjct: 119 LEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH-------SLV 167
Query: 183 GTARYASVNTHLGVEQSRRDDLESLGYVL 211
GT Y S + + D+ SLG +L
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHY----ESKLYMLLQGG 70
K++ KIG G+FGE++ + +T + +A+K L++ + E K+ LL+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH- 70
Query: 71 TGIPHL---------KWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLI 121
+ +L + +G + +V + L L + N KF+L + + L+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSF-YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
N + Y+H LHRD+K N L+ K + + D+GLA+ +
Sbjct: 130 NGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 70/276 (25%), Positives = 111/276 (40%), Gaps = 36/276 (13%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK----LELVKTKHPQ-LHYESKLYMLLQGGT 71
F++ +KIG G F E+Y + G +A+K +L+ K E L L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSL---KTVLMLADQLINRVEYMH 128
I + F + + NI++ L + + ++ L KTV QL + +E+MH
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 129 SRGFLHRDIKPDN-FLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 187
SR +HRDIKP N F+ G V + D GL + + T H +L GT Y
Sbjct: 124 SRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPYY 172
Query: 188 ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE- 246
S + + D+ SLG +L P+ G DK++ + IE
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----------DKMNLYSLCKKIEQ 222
Query: 247 -----VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277
+ Y E + C + E +PD +Y+
Sbjct: 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 58/205 (28%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------------LELVKT-KHPQL 57
F+ KIG G++G +Y N TGE +A+K + L+K HP +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 58 -------HYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRK-FS 109
H E+KLY+ V + L L+ +
Sbjct: 62 VKLLDVIHTENKLYL-----------------------VFEFLHQDLKKFMDASPLSGIP 98
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR-DLQ 168
L + QL+ + + HS LHRD+KP N L+ + + D+GLA+ + ++
Sbjct: 99 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVR 155
Query: 169 THKH----IPYRENKNLTGTARYAS 189
T+ H + YR + L G Y++
Sbjct: 156 TYTHEVVTLWYRAPEILLGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 44/165 (26%), Positives = 81/165 (49%), Gaps = 28/165 (16%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP--QLHYESKLYMLLQGGTGIPHLKW 78
+GSG++G + + + +++AVK K P L + + Y L+ + H+K
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRL---LKHMKH 73
Query: 79 FGVEG------------DYN--IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRV 124
V G ++N +V +L+G L ++ +K S + V L QL+ +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGL 131
Query: 125 EYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169
+Y+HS G +HRD+KP N + + ++ I+D+GLA++ D T
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 52/208 (25%), Positives = 106/208 (50%), Gaps = 27/208 (12%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIPHL-KWF 79
+IG GSFGE++ G++ +T + +A+K ++L + + + ++ +L Q + P++ K++
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS--PYVTKYY 68
Query: 80 G--VEGDYNIMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHR 135
G ++G ++++ L G +L+ L +F + T+L +++ ++Y+HS +HR
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHR 125
Query: 136 DIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG 195
DIK N L+ + V + D+G+A + D Q + GT + +
Sbjct: 126 DIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKR-------NTFVGTPFWMAPEV--- 172
Query: 196 VEQSRRD---DLESLGYVLMYFLRGSLP 220
++QS D D+ SLG + +G P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 4e-07
Identities = 22/66 (33%), Positives = 33/66 (50%), Gaps = 4/66 (6%)
Query: 99 DLFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156
DLF+ K S V + QL+ + +H +H DIK +N L R +++Y+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--YDRAKDRIYLC 152
Query: 157 DYGLAK 162
DYGL K
Sbjct: 153 DYGLCK 158
|
Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGE----EIAVKLELVKTKHPQLHYESKLYMLLQGG 70
+ + + +GSG+FG +Y GV + GE +A+K L + P+ + E +
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIK-VLREETSPKANKEILDEAYVMAS 65
Query: 71 TGIPHL-KWFGVEGDYNIMVIDLLGPSLEDLFNYC-NRKFSLKTVLML--ADQLINRVEY 126
PH+ + G+ + +I L P L L +Y N K ++ + +L Q+ + Y
Sbjct: 66 VDHPHVVRLLGICLSSQVQLITQLMP-LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 127 MHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+ + +HRD+ N L+ + V I D+GLAK
Sbjct: 125 LEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 27/88 (30%), Positives = 50/88 (56%), Gaps = 8/88 (9%)
Query: 81 VEGDYNIMVIDLL-GPSLEDLFNYCNRK---FSLKTVLMLADQLINRVEYMHSRGFL-HR 135
+E D +V+DL+ G L + FN K F+ + + + Q++ + Y+H + HR
Sbjct: 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHR 138
Query: 136 DIKPDNFLMGLGRKANQVYIIDYGLAKK 163
D+ P+N ++G + ++V I D+GLAK+
Sbjct: 139 DLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 74/251 (29%), Positives = 111/251 (44%), Gaps = 63/251 (25%)
Query: 15 GKFKLGRKIGSGSFGELYL-----GVNVQTGEEIAVKLE---LVKTKHP---QLHY---- 59
GK L RKI G+LY ++ + + K+E L + HP +LHY
Sbjct: 10 GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT 69
Query: 60 ESKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLML 116
E KLY++L +GG L S E +F + KF L L L
Sbjct: 70 EGKLYLILDFLRGGDLFTRL-------------------SKEVMFTEEDVKFYLAE-LAL 109
Query: 117 ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176
A ++++HS G ++RD+KP+N L+ + + + D+GL+K+ D H+ Y
Sbjct: 110 A------LDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY- 156
Query: 177 ENKNLTGTARYAS--VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKY 233
+ GT Y + V G QS D S G VLM+ L GSLP+QG +K+
Sbjct: 157 ---SFCGTVEYMAPEVVNRRGHTQSA--DWWSFG-VLMFEMLTGSLPFQG---KDRKETM 207
Query: 234 DKISEKKVSTP 244
I + K+ P
Sbjct: 208 TMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 40/153 (26%), Positives = 75/153 (49%), Gaps = 14/153 (9%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
++L +++GSG++G++Y N+ TGE AVK+ ++ + +++M+ + H
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE----CKHC 66
Query: 77 KWFGVEGDYN------IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130
G Y I + G SL+D+++ L+ + + L + Y+HS+
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-QGLAYLHSK 125
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
G +HRDIK N L+ V + D+G+A K
Sbjct: 126 GKMHRDIKGANILL---TDNGDVKLADFGVAAK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 67/275 (24%), Positives = 124/275 (45%), Gaps = 40/275 (14%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH- 75
F L RK+GSG FGE++ G+ + +A+K+ K L + +Q + H
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKI----LKSDDLLKQQDFQKEVQALKRLRHK 62
Query: 76 --LKWFGV--EGDYNIMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
+ F V G+ ++ +L+ G L L + + + +++ +A Q+ + Y+
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD---LQTHKHIPYRENKNLTGTAR 186
+ +HRD+ N L+G + D+GLA+ ++ L + K IPY+ TA
Sbjct: 123 QNSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTAP 173
Query: 187 YASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEK-KVST 243
A+ + S + D+ S G +L+Y F G +P+ G+ + YD+I+ ++
Sbjct: 174 EAASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPGM---NNHEVYDQITAGYRMPC 225
Query: 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278
P + C P E C + ED+P + L+
Sbjct: 226 PAK--C---PQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 6e-07
Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 55/237 (23%)
Query: 21 RKIGSGSFGELYLGV---NVQTGEEIAVKLELVKTKHP-----QLHYESKLYMLLQGGTG 72
+K+G G+FGE+Y G E+AVK +K E+++ L G
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKKL----G 54
Query: 73 IPH-LKWFGV--EGDYNIMVI------DLLG---PSLEDLFNYCNRKFSLKTVLMLADQL 120
P+ ++ GV E + +V+ DLL S + SLK +L A Q+
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK-----YRDLQTHKHIPY 175
+EY+ S+ F+HRD+ N L+G + V I D+GL++ Y +T +P
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 176 R----ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKA 226
R E S+ + +S D+ S G VL++ F G+ P+ GL
Sbjct: 172 RWMAPE-----------SLKDGIFTSKS---DVWSFG-VLLWEIFTLGATPYPGLSN 213
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 57/232 (24%), Positives = 92/232 (39%), Gaps = 47/232 (20%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----------------LE-LVKTKHPQLH 58
+ + +G GS G +Y + TG+ A+K L+ L + P +
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV- 61
Query: 59 YESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLA 117
K Y G F EG+ +I V++ + G SL DL K + +A
Sbjct: 62 --VKCY-------GA-----FYKEGEISI-VLEYMDGGSLADLLKKV-GKIPEPVLAYIA 105
Query: 118 DQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176
Q++ ++Y+H+ R +HRDIKP N L+ +V I D+G++K + +
Sbjct: 106 RQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENTLDQCN---- 158
Query: 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 228
GT Y S G S D+ SLG L+ G P+ +
Sbjct: 159 ---TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQ-LHYESKLYMLLQGGTGIPHLKWFG 80
+G G++G +Y ++ T IA+K + +++ Q LH E L+ L+ + +L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 81 VEGDYNIMVIDLLGPSLEDLF--NYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIK 138
G + I + + G SL L + K + +T++ Q++ ++Y+H +HRDIK
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 139 PDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 187
DN L + + V I D+G +K+ + P E TGT +Y
Sbjct: 136 GDNVL--VNTYSGVVKISDFGTSKRLAGIN-----PCTE--TFTGTLQY 175
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 22/49 (44%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDYGLAKKYRD 166
Q++N V Y+HS LHRD+KP N +MG G + V I D GLA+ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 27/165 (16%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGI----- 73
G +G G++G++ + TG+ +A+K K K ++ + L G GI
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIK----KVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 74 ---------PHLKWFG-----VEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ 119
H G VEGD+ +V+D++ L+ + + + + V + Q
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD-RKIRLTESQVKCILLQ 127
Query: 120 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
++N + +H F+HRD+ P N + I D+GLA++Y
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFIN---SKGICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGTG 72
+++ + IG G+FGE+ L + T + A+KL E++K +E + M
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 73 IPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
+ L + + Y MV++ + G L +L + N K +++ ++ +HS G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
F+HRD+KPDN L+ K+ + + D+G K
Sbjct: 163 FIHRDVKPDNMLLD---KSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGI------ 73
G+++G+G+F Y +V+TG +AVK V + ++ L+ +
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQ--VTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 74 PHL-KWFGV---EGDYNIMVIDLLGPSLEDLF-NYCNRKFSLKTVLMLADQLINRVEYMH 128
PH+ + G + +N+ V + G S+ L Y F ++ +QL+ + Y+H
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH 120
Query: 129 SRGFLHRDIKPDNFLM-GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 187
+HRD+K N L+ G++ + I D+G A + L L GT +
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQR---LRIADFGAAAR---LAAKGTGAGEFQGQLLGTIAF 174
Query: 188 ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
+ G + R D+ S+G V++ PW
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 39/171 (22%), Positives = 68/171 (39%), Gaps = 38/171 (22%)
Query: 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-------------LEL-VKTKHPQLHY 59
G F+L IG G++G++Y + +TG+ +A+K E + K+
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPN 64
Query: 60 ESKLY--MLLQGGTGIPHLKWFGVEGDYNIMVIDL------LGPSL-EDLFNYCNRKFSL 110
+ Y + + G W +E V DL G L E+ Y R
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR---- 120
Query: 111 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
+ + + Y+H +HRDIK N L+ K +V ++D+G++
Sbjct: 121 --------ETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 43/167 (25%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE--------------LVKTKHPQL- 57
++L ++IGSG++G++Y ++ TGE +A+K LE L + +HP +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 58 -HYESKLYMLLQGGTGIPHLKWFGVE--GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVL 114
++ S L W +E G G SL+D++ S +
Sbjct: 64 AYFGSYLRR---------DKLWIVMEYCG----------GGSLQDIYQVTRGPLSELQIA 104
Query: 115 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
+ + + + Y+H G +HRDIK N L+ + V + D+G++
Sbjct: 105 YVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 26/159 (16%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTGI 73
++L IG G+ +Y + + E++A+K LE +T +L E + +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM------SQC 56
Query: 74 PH---LKWFG--VEGDYNIMVIDLL-GPSLEDLFNYCNRK-----FSLKTVLMLADQLIN 122
H +K++ V GD +V+ L G SL D+ + + TVL +++
Sbjct: 57 NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLK 113
Query: 123 RVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
+EY+HS G +HRDIK N L+G + V I D+G++
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 31/211 (14%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL-------ELVKTKHPQLHYESKLYMLLQ 68
++ L +++G GSFG +YL + + E +K+ EL + Q + E++L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCN---RKFSLKTVLMLADQLINRVE 125
+ F + I+ G L+ + S V QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 126 YMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR---DLQTHKHIPYRENKNLT 182
YMH R LHRD+K N + K N + I D+G+++ DL T T
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT----------TFT 166
Query: 183 GTARYASVN--THLGVEQSRRDDLESLGYVL 211
GT Y S H G + + D+ SLG +L
Sbjct: 167 GTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVKL----------ELVKTKHPQLHYESKLYMLLQGGT 71
+IG GSFGE+Y G++ +T E +A+K+ E ++ + L Y+ G+
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 72 GIPHLK-WFGVEGDYNIMVIDLLGPS-LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
+ K W +E +DLL P LE+ + + T+L +++ ++Y+HS
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETY--------IATILR---EILKGLDYLHS 119
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
+HRDIK N L+ + V + D+G+A + D Q ++ GT + +
Sbjct: 120 ERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 169
Query: 190 VNTHLGVEQSRRD---DLESLGYVLMYFLRGSLPWQGL 224
++QS D D+ SLG + +G P L
Sbjct: 170 PEV---IKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVKL----------ELVKTKHPQLHYESKLYMLLQGGT 71
KIG GSFGE++ G++ +T + +A+K+ E ++ + L Y+ G+
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 72 GIPHLK-WFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130
+ K W +E +DLL P D + + T+L +++ ++Y+HS
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHSE 120
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 190
+HRDIK N L+ + +V + D+G+A + D Q ++ GT + +
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170
Query: 191 NTHLGVEQSRRD---DLESLGYVLMYFLRGSLP 220
++QS D D+ SLG + +G P
Sbjct: 171 EV---IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 18 KLGRKIGSGSFGELYLG----VNVQTGEEIAVKLELVKTKHPQ---LHYESKLYMLLQGG 70
K +++G G FG++ L + TGE++AVK + E ++ L
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 71 TGIPHLKWFGVEGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
+ + G ++ +I P SL D + +LK +L+ + Q+ ++Y+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
S+ ++HRD+ N L+ + V I D+GLAK
Sbjct: 127 SQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 51/207 (24%), Positives = 82/207 (39%), Gaps = 72/207 (34%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVK---LE----------------LVKTKHPQ------ 56
KIG G++G +Y + TGE +A+K LE L + HP
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 57 -LHYESKLYM--------LLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRK 107
+H E+KLY+ L + P L P L + Y
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTG---------------LDPPLIKSYLY---- 106
Query: 108 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR-D 166
QL+ + Y HS LHRD+KP N L+ + + + D+GLA+ +
Sbjct: 107 -----------QLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVP 152
Query: 167 LQTHKH----IPYRENKNLTGTARYAS 189
++T+ H + YR + L G+ +Y++
Sbjct: 153 VRTYTHEVVTLWYRAPEILLGSRQYST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLLQGGTG----IPH 75
IG G FGE+Y TG+ A+K + +K K + ++ ML TG I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 76 LKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGFL 133
+ + D ++DL+ DL + ++ FS K + A ++I +E+MH+R +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 134 HRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT- 192
+RD+KP N L+ + V I D GLA + + H + GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 193 HLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 231
G D SLG +L LRG P++ K K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 41/170 (24%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 22 KIGSGSFGELYLGVNVQ-TGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGI-----PH 75
K+G GSFG + G G+ I V ++ +K+ + L+ + +
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD----FLKEAAIMHSLDHEN 57
Query: 76 L-KWFGVEGDYNIMVIDLLGPS---LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
L + +GV + +M++ L P L+ L F + T+ A Q+ N + Y+ S+
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLA------KKYRDLQTHKHIPY 175
F+HRD+ N L+ K V I D+GL + + ++ H +P+
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLE---LVKTKHPQLHYESKLYMLLQGGTG 72
+ K + +GSG+FG +Y G+ V GE + + + L +T P+ + E L+
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 73 IPHL-KWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLML--ADQLINRVEYMHS 129
PHL + GV I ++ L P L K ++ + L+L Q+ + Y+
Sbjct: 68 HPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 127
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
R +HRD+ N L+ + N V I D+GLA+
Sbjct: 128 RRLVHRDLAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 43/181 (23%), Positives = 67/181 (37%), Gaps = 55/181 (30%)
Query: 18 KLGRKIGSGSFGELYLGVNVQTGEEIA---VKLELVKTKHP-----------QLHYESKL 63
KL R IG G++G +Y + +GE +A V+++ + P L + +
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN-- 67
Query: 64 YMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLF---NYCN-----------RKFS 109
I LK V G L+ +F YC FS
Sbjct: 68 ---------IVELKEVVV------------GKHLDSIFLVMEYCEQDLASLLDNMPTPFS 106
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169
V L QL+ ++Y+H +HRD+K N L+ + I D+GLA+ Y
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAK 163
Query: 170 H 170
Sbjct: 164 P 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 40/169 (23%)
Query: 17 FKLGRKIGSGSFGELYLGV-NVQTGEEIAVK------------LE----LVKTKHPQLHY 59
KL RK+G+G FGE+++G N T ++AVK L+ + K +H +L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKL-- 63
Query: 60 ESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLA 117
+LY + I Y +V + + G L+ L + +K L ++ +A
Sbjct: 64 -VQLYAVCSEEEPI-----------Y--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109
Query: 118 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
Q+ + Y+ SR ++HRD+ N L+G I D+GLA+ D
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 58/188 (30%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK--------LELVK-----------TKHP-- 55
+K+ KIG G+F E+ + +TG+ A+K LE V + HP
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 56 ----QLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRK--FS 109
++ ++ K TG L V +L+ +L +L RK
Sbjct: 61 LRLIEVLFDRK--------TGRLAL------------VFELMDMNLYELIK--GRKRPLP 98
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169
K V QL+ +++MH G HRDIKP+N L+ K + + + D+G +
Sbjct: 99 EKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLADFGSCRG-----I 149
Query: 170 HKHIPYRE 177
+ PY E
Sbjct: 150 YSKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 124 VEYMHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDYGLAK-KYRDLQT-----HKHIPYR 176
+EY+H+ G +HRD+KPDN L+ +G + + D+GL+K L T H R
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 177 E--NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
E +K + GT Y + L + D ++G +L FL G +P+ G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 55/198 (27%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVK---LE----------------LVKTKHPQ------ 56
KIG G++G +Y G N +TG+ +A+K LE L + +HP
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 57 -LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLM 115
L ES+LY++ + + LK + +D L + + V
Sbjct: 67 VLMQESRLYLIFEFLS--MDLKKY----------LDSLPK---------GQYMDAELVKS 105
Query: 116 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR---DLQTHKH 172
Q++ + + HSR LHRD+KP N L+ + + D+GLA+ + + TH+
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 173 IP--YRENKNLTGTARYA 188
+ YR + L G+ RY+
Sbjct: 163 VTLWYRAPEVLLGSPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 31/157 (19%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVK----------------LELVKTKHPQLHYESKLYML 66
+GSG++G + ++ +TGE++A+K EL KH Q + L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ---HENVIGL 79
Query: 67 LQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLE-DLFNYCNRKFSLKTVLMLADQLINRVE 125
L T F + Y +M P ++ DL S V L Q++ ++
Sbjct: 80 LDVFTSAVSGDEF--QDFYLVM------PYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 126 YMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
Y+HS G +HRD+KP N + + ++ I+D+GLA+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 13/79 (16%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKYRDLQTHKHIP--- 174
Q++ ++Y+HS G LHRDIKP N L+ +N + I D+GLA+ + KH+
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFGLARV-EEPDESKHMTQEV 165
Query: 175 ----YRENKNLTGTARYAS 189
YR + L G+ Y S
Sbjct: 166 VTQYYRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 62/267 (23%), Positives = 114/267 (42%), Gaps = 43/267 (16%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVE 82
+GSG++G + + +TG +AVK +L + +H + + Y L+ + H+K V
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVK-KLSRPFQSIIHAK-RTYRELRL---LKHMKHENVI 79
Query: 83 GDYNI--------------MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
G ++ +V L+G L ++ C +K + V L Q++ ++Y+H
Sbjct: 80 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-C-QKLTDDHVQFLIYQILRGLKYIH 137
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S +HRD+KP N + + ++ I+D+GLA+ D E T Y
Sbjct: 138 SADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD----------EMTGYVATRWYR 184
Query: 189 SVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
+ L + ++ D+ S+G ++ L G + L GT K+ + V TP
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTG----RTLFPGTDHIDQLKLILRLVGTPGAE 240
Query: 248 LCKSYPSE----FVSYFHYCRSLRFED 270
L K SE ++ + F +
Sbjct: 241 LLKKISSESARNYIQSLTQMPKMNFAN 267
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 6e-06
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 45/169 (26%)
Query: 23 IGSGSFGELYLGVNVQTGE----------------------EIAVKLELVKTKHPQLHYE 60
IG G++G +Y ++ TG EIA+ +L +HP +
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI--- 63
Query: 61 SKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLE-DLFNYCNR----KFSLKTVLM 115
+L + G + + L+ ++ DL Y ++ +T+
Sbjct: 64 VRLLDVCHGPR------------TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD 111
Query: 116 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
L QL+ V+++HS +HRD+KP N L+ QV I D+GLA+ Y
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG---QVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 39/164 (23%), Positives = 78/164 (47%), Gaps = 25/164 (15%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQL----HYESKLY 64
+G ++K IGSG++G + ++ ++G+++A+K K H P L E K+
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTLRELKIL 58
Query: 65 MLLQGGTGIPHLKWF---GVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLI 121
+ I G + +V+DL+ L + + ++ + + + QL+
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLL 117
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ---VYIIDYGLAK 162
++Y+HS +HRD+KP N L+ N+ + I D+G+A+
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 14/152 (9%)
Query: 19 LGRKIGSGSFGELYLGVNV-QTGEEIAVKLELVKTKHPQLHYE---SKLYMLLQGGTGIP 74
LGR IG G FG++Y GV + E+IAV ++ K E + Y++ Q P
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH--P 67
Query: 75 HL-KWFGVEGDYNIMVIDLLGPSLEDLFNYCN-RKFSLK--TVLMLADQLINRVEYMHSR 130
H+ K GV + + ++ L P L +L +Y K+SL ++++ + QL + Y+ S+
Sbjct: 68 HIVKLIGVITENPVWIVMELAP-LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
F+HRDI N L+ + V + D+GL++
Sbjct: 127 RFVHRDIAARNVLVS---SPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 23/178 (12%)
Query: 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 147
+V + L L+ + C S+ V + QL+ + Y H R LHRD+KP N L+
Sbjct: 80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-- 137
Query: 148 RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLES 206
+ ++ + D+GLA+ K +P + N T Y + LG E S D+
Sbjct: 138 -EKGELKLADFGLARA-------KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWG 189
Query: 207 LGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP-----SEFVSY 259
+G +L G + G T K++ I + + TP E +++P EF SY
Sbjct: 190 VGCILYEMATGRPMFPG---STVKEELHLIF-RLLGTPTE---ETWPGITSNEEFRSY 240
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 40/155 (25%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYML---LQGGTGIPH--- 75
++G G+FG++Y N +TG A K+ ++TK + E + YM+ + P+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKV--IETKSEE---ELEDYMVEIEILATCNHPYIVK 73
Query: 76 -LKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 134
L F +G IM+ G +++ + +R + + ++ Q++ ++Y+HS +H
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 135 RDIKPDNFLMGLGRKANQVYIIDYGL-AKKYRDLQ 168
RD+K N L+ L + + D+G+ AK + LQ
Sbjct: 134 RDLKAGNVLLTLD---GDIKLADFGVSAKNVKTLQ 165
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 38/151 (25%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
F+L ++IGSG++G++Y NV TGE A+K ++K + + + +++ ++
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIK--VIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 77 -KWFGVEGDYNIMVIDLL---GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 132
+FG + + I + G SL+D++ + S + ++ + + + Y+HS+G
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIY-HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+HRDIK N L+ V + D+G++ +
Sbjct: 128 MHRDIKGANILL---TDNGHVKLADFGVSAQ 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 34/110 (30%), Positives = 51/110 (46%), Gaps = 24/110 (21%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP---- 174
QL+ ++Y+HS +HRD+KP N L L V + D+GLA+ +L+ + P
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNIL--LNSDCR-VKLADFGLARSLSELEENPENPVLTD 171
Query: 175 ------YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS 218
YR + L G+ RY GV D+ S+G +L L G
Sbjct: 172 YVATRWYRAPEILLGSTRYTK-----GV------DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 9e-06
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 16/156 (10%)
Query: 17 FKLGRKIGSGSFGEL----YLGVNVQTGEEIAVKLELVKTKHPQLHYES--KLYMLLQGG 70
K R +G G FG++ Y N TGE +AVK +K + Q + K +L+
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKT--LKRECGQQNTSGWKKEINILKTL 63
Query: 71 TGIPHLKWFGV---EGDYNIMVIDLLGPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEY 126
+K+ G +G + +I P L L +Y + K +L +L+ A Q+ + Y
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVP-LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 127 MHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+HS+ ++HRD+ N L+ V I D+GLAK
Sbjct: 123 LHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 57/200 (28%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVK------------------LELVKTKHPQ------- 56
KIG G++G +Y + T E IA+K + L+K
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 57 -LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL-LGPSLEDLFNYCNRKFSLKTVL 114
+H E +LY++ + +DL L ++ ++ +KT L
Sbjct: 69 VVHSEKRLYLVFE--------------------YLDLDLKKHMDSSPDFAKNPRLIKTYL 108
Query: 115 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR-DLQTHKH- 172
Q++ + Y HS LHRD+KP N L + R+ N + + D+GLA+ + ++T H
Sbjct: 109 Y---QILRGIAYCHSHRVLHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHE 163
Query: 173 ---IPYRENKNLTGTARYAS 189
+ YR + L G+ Y++
Sbjct: 164 VVTLWYRAPEILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 40/164 (24%)
Query: 18 KLGRKIGSGSFGELYLGV-NVQTGEEIAVK-LE---------------LVKTKHPQLHYE 60
+L RK+G+G FGE++ G+ N T +AVK L+ + K +HP+L
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKL--- 63
Query: 61 SKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLAD 118
+LY + I +V +L+ G LE L R L ++ +A
Sbjct: 64 IQLYAVCTLEEPI-------------YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
Q+ + + Y+ ++ ++HRD+ N L+G + N + D+GLA+
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 28/190 (14%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQ--LHYESKLYMLLQGGTGIPHL 76
KIG G++G++Y + TG+ +A+K LE+ + P L S L ML + + L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 77 KWFGVEGDYNIMVIDLLGPSLE-DLFNYCN-------RKFSLKTVLMLADQLINRVEYMH 128
VE + L+ L+ DL + + R KT+ QL+ V + H
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA-------KKYRDLQTHKHIP--YRENK 179
G +HRD+KP N L + ++ + I D GL K Y TH+ + YR +
Sbjct: 128 KHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVKSY----THEIVTLWYRAPE 181
Query: 180 NLTGTARYAS 189
L G+ Y++
Sbjct: 182 VLLGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 58/298 (19%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVK-----LELVKTKHPQLHYESKLYMLLQGGTGIPHLK 77
+G GSFG++ L GE AVK + L+ E ++ L + HL
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 78 WFGVEGDYNIMVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGFLHR 135
++ V++ L DL + K F L A +++ ++++HS+G ++R
Sbjct: 63 CTFQTKEHLFFVMEFLNGG--DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 136 DIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTH 193
D+K DN ++ + + I D+G+ K+ + +N+ T GT Y +
Sbjct: 121 DLKLDNVMLD---RDGHIKIADFGMCKEN---------VFGDNRASTFCGTPDYIAPEIL 168
Query: 194 LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-KVSTPIEVLCKSY 252
G++ + D S G +L L G P+ G D++ E +V TP
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-------DDEDELFESIRVDTP-------- 213
Query: 253 PSEFVSYFHYCRSLRFEDKPDYSYLKRLF-RDLFIREGF-------QFDYVFDWTVLK 302
HY R + E K L++LF RD R G F +WT L+
Sbjct: 214 --------HYPRWITKESK---DILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALE 260
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 116 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL-QTHKHIP 174
+A Q+++ + Y+H R +HRDIKP N L+ + V I D+G++ R L QT P
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAK---NVKIADFGVS---RILAQTMD--P 224
Query: 175 YRENKNLTGTARYAS---VNTHLGVEQSRRD----DLESLGYVLMYFLRGSLP 220
+ GT Y S +NT L D D+ SLG ++ F G P
Sbjct: 225 CNSS---VGTIAYMSPERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 31/226 (13%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPH-- 75
L R++G G+FG+++L L VK K P L + T + H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 76 -LKWFGV--EGDYNIMVIDLL------------GPSLEDLFN----YCNRKFSLKTVLML 116
+K++GV +GD IMV + + GP L + + L +L +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 117 ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176
A Q+ + + Y+ S+ F+HRD+ N L+G V I D+G++ RD+ + + YR
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYSTDY--YR 180
Query: 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLM-YFLRGSLPW 221
+ R+ + + + + D+ S G +L F G PW
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 26/164 (15%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP--------QLHYESKLYMLLQGGTG 72
+GSG++G++ + +TG ++A+K K P + + E +L +
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIK----KLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 73 IPHLKWF----GVEGDYNI-MVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEY 126
I L F +E ++ +V L+G DL N +K S + L Q++ ++Y
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMG---ADLNNIVKCQKLSDDHIQFLVYQILRGLKY 133
Query: 127 MHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKYRDLQT 169
+HS G +HRD+KP N + + ++ I+D+GLA+ D T
Sbjct: 134 IHSAGIIHRDLKPSN----IAVNEDCELKILDFGLARHTDDEMT 173
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 33/163 (20%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELV-KTKHPQLHYE------SK--- 62
F + + I G+FG++YLG + AVK+ +++ K Q+ E SK
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 63 ---LYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ 119
LY LQ + + + + GD SL ++ Y + + ++K + +A
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVK---------SLLHIYGYFDEEMAVKYISEVALA 116
Query: 120 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
L +Y+H G +HRD+KPDN L+ + + D+GL+K
Sbjct: 117 L----DYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 64/285 (22%), Positives = 122/285 (42%), Gaps = 51/285 (17%)
Query: 22 KIGSGSFGELYLGV--NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL--- 76
++GSG+FG + G+ ++ + +AVK+ P L E LL+ + L
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDE-----LLREANVMQQLDNP 56
Query: 77 ---KWFGV-EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 132
+ G+ E + ++V++L + F N+ + K + L Q+ ++Y+ F
Sbjct: 57 YIVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 133 LHRDIKPDNFLMGLGRKANQVY--IIDYGLAK------KYRDLQTHKHIPYRENKNLTGT 184
+HRD+ N L+ Q Y I D+GL+K Y +TH P +
Sbjct: 117 VHRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK-------- 163
Query: 185 ARYAS--VNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEKK 240
YA +N + + S + D+ S G VLM+ F G P++G+K Q + ++
Sbjct: 164 -WYAPECMNYY---KFSSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES--GER 216
Query: 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285
+ P + P E C + +++P ++ ++ R+ +
Sbjct: 217 MECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--------KHPQLHYESKLYMLLQGGT 71
G +G G++G +Y G+ G+ IAVK + T ++ +L E L L+
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 72 GIPHLKWFGVEGDYNIM-----------VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQL 120
+ +L + +I +++ GP E +F K++ Q+
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF----CKYT--------KQI 111
Query: 121 INRVEYMHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDYGLAKKYRDLQ---THKHIPYR 176
++ V Y+H+ +HRDIK +N LM G + +ID+G A++ + TH ++
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRLAWVGLHGTHSNML-- 165
Query: 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
K++ GT + + R+ D+ S+G + G P
Sbjct: 166 --KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 49/202 (24%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFG 80
KIG GS G + + + TG ++AVK ++L K + +L + + M I +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 81 VEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 139
+ GD +V++ L G +L D+ + + + + + ++ + ++H++G +HRDIK
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143
Query: 140 DNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS 199
D+ L+ +V + D+G Q K +P R K+L GT + + +
Sbjct: 144 DSILL---TSDGRVKLSDFGFCA-----QVSKEVPRR--KSLVGTPYWMAPEVISRLPYG 193
Query: 200 RRDDLESLGYVLMYFLRGSLPW 221
D+ SLG +++ + G P+
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 23/225 (10%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGTGIPHLKW 78
+G G FGE+ + TG+ A+K+ L+ + E + + + IP L++
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 79 FGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 137
+ D +V++ G L L N +F +L+ + +H G++HRDI
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDI 128
Query: 138 KPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY------ASVN 191
KP+N L+ + + + D+G A + L +K + +K GT Y ++N
Sbjct: 129 KPENVLID---RTGHIKLADFGSAAR---LTANKMV---NSKLPVGTPDYIAPEVLTTMN 179
Query: 192 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236
D SLG + + G P+ GT + Y+ I
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFH---EGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 39/155 (25%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYES-KLYMLLQGGTGIPH---LK 77
+IG G++G +Y + +G +A+K V+T L + + LL+ H ++
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 78 WFGV----EGDYNIMVIDLLGPSLEDLFNYCNR----KFSLKTVLMLADQLINRVEYMHS 129
V D V + +DL Y ++ +T+ L Q + ++++H+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
+HRD+KP+N L+ G QV + D+GLA+ Y
Sbjct: 127 NCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 50/221 (22%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 3 ADGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYES 61
D + +D+ I KIG GS G + + +G+ +AVK ++L K + +L +
Sbjct: 16 GDPRTYLDNFI--------KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNE 67
Query: 62 KLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQL 120
+ M + + + GD +V++ L G +L D+ + + + + + + +
Sbjct: 68 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAV 125
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180
+ + +H++G +HRDIK D+ L+ +V + D+G Q K +P R K+
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCA-----QVSKEVPRR--KS 175
Query: 181 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
L GT + + + D+ SLG +++ + G P+
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 25/240 (10%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVK-LE---LVKTKHPQLHYESKLYMLLQGGTGIPHLKW 78
+G G FGE+ TG+ A K L+ L K K Q+ K + I L +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 79 FGVEGDYNIMVIDLL-GPSLE-DLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRD 136
D +V+ L+ G L+ ++N F + A Q+I +E++H R ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 137 IKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV 196
+KP+N L+ V I D GLA + + + K GT Y + G
Sbjct: 121 LKPENVLLD---DHGNVRISDLGLAVELKGGKK--------IKGRAGTPGYMAPEVLQGE 169
Query: 197 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEF 256
D +LG L + G P++ + K +K + + + + +E YP +F
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFR--QRKEKVEKEE-LKRRTLEMAVE-----YPDKF 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 23/178 (12%)
Query: 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 147
+V + L L+ + C ++ V + QL+ + Y H R LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-- 138
Query: 148 RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLES 206
+ ++ + D+GLA+ K IP + N T Y + LG + S + D+
Sbjct: 139 -ERGELKLADFGLARA-------KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWG 190
Query: 207 LGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP-----SEFVSY 259
+G + G + L G+ ++ + + TP E +++P EF SY
Sbjct: 191 VGCIFYEMSTG----RPLFPGSTVEEQLHFIFRILGTPTE---ETWPGILSNEEFKSY 241
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 51/194 (26%), Positives = 81/194 (41%), Gaps = 43/194 (22%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHY---------ES------KLY 64
IG G+FGE+ L TG+ A+K L+K+ K QL + ES LY
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMK-TLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRV 124
Q + + F GD M+I D F+ +F + ++ +
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKY------DTFSEDVTRFYMAECVL-------AI 114
Query: 125 EYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY------REN 178
E +H GF+HRDIKPDN L+ + + + D+GL+ + + H Y + N
Sbjct: 115 EAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFH--KQHDSAYYQKLLQGKSN 169
Query: 179 KNLTGTARYASVNT 192
KN +V++
Sbjct: 170 KNRIDNRNSVAVDS 183
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 9/160 (5%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHY-----ESKLYMLLQGGTGIPH 75
R+IG GSFG +Y +V+T E +A+K K + E K ++ I +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 76 LKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHR 135
+ E +++ LG S DL + + + + + Y+HS +HR
Sbjct: 91 KGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 136 DIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175
DIK N L+ + QV + D+G A + PY
Sbjct: 150 DIKAGNILL---TEPGQVKLADFGSASIASPANSFVGTPY 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 45/205 (21%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTGIPHLK 77
++G+G+ G + ++ TG+ +AVK LE+ + Q+ E + +
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 78 WFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRD 136
F GD +I + + G SL+ + + + + +A ++ + Y+H +HRD
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126
Query: 137 IKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV 196
+KP N L+ Q+ + D+G++ + + K GT+ Y + G
Sbjct: 127 VKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPERIQGN 174
Query: 197 EQSRRDDLESLGYVLMYFLRGSLPW 221
+ S + D+ SLG L+ G P+
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 39/157 (24%), Positives = 82/157 (52%), Gaps = 24/157 (15%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFG 80
+++GSG++G + ++ +TG ++A+K +L + +L + + Y L+ + H+K
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIK-KLYRPFQSEL-FAKRAYRELRL---LKHMKHEN 75
Query: 81 VEG-------DYNI-------MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 126
V G D ++ +V+ +G L L + K S + L Q++ ++Y
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKY 133
Query: 127 MHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+H+ G +HRD+KP N + + ++ I+D+GLA++
Sbjct: 134 IHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 39/153 (25%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLLQGGTG 72
+FK + +GSG+FG +Y G+ + GE++ + + EL + P+ + E +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 73 IPHL-KWFGVEGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
PH+ + G+ + +I L P L D + +L Q+ + Y+
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
R +HRD+ N L+ + V I D+GLAK
Sbjct: 128 RRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 34/131 (25%), Positives = 58/131 (44%), Gaps = 11/131 (8%)
Query: 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 147
+V + L L+ + C S+ V + Q++ + Y H R LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN-- 138
Query: 148 RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLES 206
+ ++ + D+GLA+ K +P + N T Y + LG E S + D+
Sbjct: 139 -ERGELKLADFGLARA-------KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWG 190
Query: 207 LGYVLMYFLRG 217
+G + G
Sbjct: 191 VGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 21 RKIGSGSFGELYL------GVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIP 74
R +G G FG++ L G N TGE++AVK ++ + K +L+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 75 HLKWFGV---EGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
+K+ G+ +G I +I P SL++ K +LK L A Q+ ++Y+ S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
R ++HRD+ N L+ +QV I D+GL K
Sbjct: 128 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 43/166 (25%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVKL---------ELVK-------TKHPQLHYESKLYM 65
K+G G +GE+Y GV + +AVK E +K KHP L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-------- 64
Query: 66 LLQGGTGIPHLKWFGV---EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLML--ADQL 120
++ GV E + I+ + +L D CNR+ + V++L A Q+
Sbjct: 65 ----------VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQI 113
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+ +EY+ + F+HRD+ N L+G + + V + D+GL++
Sbjct: 114 SSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 156
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 17/209 (8%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVK-----LELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+ +G GSFG+++L T + A+K + L+ E ++ L + H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 76 LKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 134
L + V++ L G L C+ KF L A ++I ++++HS+G ++
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 135 RDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 194
RD+K DN L+ + I D+G+ K+ + + GT Y + L
Sbjct: 120 RDLKLDNILLD---TDGHIKIADFGMCKE-------NMLGDAKTCTFCGTPDYIAPEILL 169
Query: 195 GVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
G + + D S G +L L G P+ G
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 11/108 (10%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYREN 178
QL+ + Y+H R LHRD+KP N L+ ++ + D+GLA+ K +P
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARA-------KSVPSHTY 160
Query: 179 KNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLK 225
N T Y + LG E S D+ +G + + ++G + G+K
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 50/173 (28%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVK---------LE--------LVKTKHPQL-------H 58
+G G+FG++Y + +TG A K LE L + KHP +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 59 YESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD 118
YE+KL++L++ G G + ++++L E Y R
Sbjct: 73 YENKLWILIEFCDG----------GALDSIMLELERGLTEPQIRYVCR------------ 110
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL-AKKYRDLQTH 170
Q++ + ++HS +HRD+K N L+ L V + D+G+ AK LQ
Sbjct: 111 QMLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKR 160
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 58/274 (21%), Positives = 111/274 (40%), Gaps = 25/274 (9%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
+L K+G G FGE+++G T +A+K T P+ + M + L
Sbjct: 8 LRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 66
Query: 77 KWFGVEGDYNIMVIDLL---GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 133
+ V + I ++ G L+ L + L ++ +A Q+ + + Y+ ++
Sbjct: 67 --YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 134 HRDIKPDNFLMGLGRKANQV-YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 192
HRD++ N L+G N V + D+GLA+ D + Y + ++ +
Sbjct: 125 HRDLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEA 174
Query: 193 HLGVEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251
L + + D+ S G +L +G +P+ G+ ++ D++ E+ P C
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 228
Query: 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285
P C E++P + YL+ D F
Sbjct: 229 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 9/159 (5%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVKL-----ELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
+IG GSFG +Y N T E +AVK + K + E K L+ I +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 77 KWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRD 136
+ E +++ LG S DL + + + + + Y+HS +HRD
Sbjct: 88 GCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 137 IKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175
IK N L+ + QV + D+G A K + PY
Sbjct: 147 IKAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 20/67 (29%), Positives = 35/67 (52%), Gaps = 5/67 (7%)
Query: 99 DLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156
DLF Y +R L+ + + +L+ + Y+H RG +HRD+K +N + + +
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLG 227
Query: 157 DYGLAKK 163
D+G A K
Sbjct: 228 DFGAACK 234
|
Length = 392 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 69/285 (24%), Positives = 111/285 (38%), Gaps = 57/285 (20%)
Query: 16 KFKLGRKIGSGSFGELYLG-------VNVQTGEEIAVKLE--------LVKTKHPQLHYE 60
+ L ++IGSG FG ++LG V ++T E A+ E ++K HP+L
Sbjct: 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKL--- 61
Query: 61 SKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQL 120
+LY + + I + F G L D KFS +T+L + +
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHG------------CLSDYLRAQRGKFSQETLLGMCLDV 109
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDYGLAKKYRDLQTHKHIPYRENK 179
+ Y+ S +HRD+ N L+G NQV + D+G+ + D Q Y +
Sbjct: 110 CEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQ------YTSST 159
Query: 180 NLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239
+++S + S + D+ S G VLM W+ G K Y+ S
Sbjct: 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFG-VLM--------WEVFSEG--KTPYENRSNS 208
Query: 240 KVSTPIEVLCKSY-----PSEFVSYFHYCRSLRFEDKPDYSYLKR 279
+V I + Y +C R ED+P +S L
Sbjct: 209 EVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 41/161 (25%), Positives = 68/161 (42%), Gaps = 33/161 (20%)
Query: 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLK 77
KL KIG GS+G ++ N +TG+ +A+K + P + K+ + I LK
Sbjct: 5 KLS-KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK---KIAL-----REIRMLK 55
Query: 78 WFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD----------------QLI 121
N++ + L +F YC+ TVL + Q +
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDH-----TVLNELEKNPRGVPEHLIKKIIWQTL 110
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
V + H +HRD+KP+N L+ K Q+ + D+G A+
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 40/180 (22%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYML--LQGG 70
+G +++ IG G++G + + TG ++A+K P +E + + L+
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISP---FEHQTFCQRTLRE- 53
Query: 71 TGIPHLKWFGVEGDYNIMVI-DLLGPSLEDLFN--YCNRKF---SLKTVL---MLAD--- 118
I L+ F E NI+ I D++ P + FN Y ++ L ++ L++
Sbjct: 54 --IKILRRFKHE---NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHI 108
Query: 119 -----QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKYRDLQTHKH 172
Q++ ++Y+HS LHRD+KP N L+ N + I D+GLA+ H H
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTNCDLKICDFGLARI--ADPEHDH 162
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 49/194 (25%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTG 72
F+ + IG G+FGE+ L TG A+K+ L K K H ++ +L++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKI-LRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 73 IPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSL---KTVLMLADQLINRVEYMHS 129
++ + N+ +I P D+ +K +L +T +A+ ++ ++ +H
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPG-GDMMTLLMKKDTLTEEETQFYIAETVL-AIDSIHQ 119
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRE-NKNLTGTARYA 188
GF+HRDIKPDN L+ V + D+GL + + H+ YR N +L +
Sbjct: 120 LGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSLPSDFTFQ 174
Query: 189 SVNTHLGVEQSRRD 202
++N+ E +R+
Sbjct: 175 NMNSKRKAETWKRN 188
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 20/55 (36%), Positives = 31/55 (56%), Gaps = 5/55 (9%)
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYREN 178
+E +H GF+HRDIKPDN L+ + + + D+GL +R TH Y++
Sbjct: 114 IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR--WTHDSKYYQKG 163
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 53/209 (25%)
Query: 47 LELVKTKHP---QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPS 96
LE VK HP L Y KLY++L+ GG HL+ G+
Sbjct: 54 LEAVK--HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--------------F 97
Query: 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156
+ED F L + + +E++H +G ++RD+KP+N L+ V +
Sbjct: 98 MEDT-----ACFYLSEISL-------ALEHLHQQGIIYRDLKPENILLD---AQGHVKLT 142
Query: 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FL 215
D+GL K+ T H GT Y + + + D SLG LMY L
Sbjct: 143 DFGLCKESIHEGTVTH-------TFCGTIEYMAPEILMRSGHGKAVDWWSLG-ALMYDML 194
Query: 216 RGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
G+ P+ A +K+ DKI + K++ P
Sbjct: 195 TGAPPFT---AENRKKTIDKILKGKLNLP 220
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 4/66 (6%)
Query: 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156
L+DL Y N V Q++ +E+ HS +HRDIKP+N L+ ++ V +
Sbjct: 87 LDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLC 142
Query: 157 DYGLAK 162
D+G A+
Sbjct: 143 DFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 29/154 (18%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQG--GTGIPHL-KWF 79
IG G++G +Y G +V TG +A+K+ + T + + LL + P++ K++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 80 GVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR------------VEYM 127
G L GP L + Y S++T LM A + + ++Y+
Sbjct: 69 GSY---------LKGPRLWIIMEYAEGG-SVRT-LMKAGPIAEKYISVIIREVLVALKYI 117
Query: 128 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
H G +HRDIK N L+ V + D+G+A
Sbjct: 118 HKVGVIHRDIKAANILV---TNTGNVKLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 38/160 (23%), Positives = 73/160 (45%), Gaps = 25/160 (15%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHY---------ESK-LYMLLQGGT 71
I G+ E+YLG + G + +K + K +HP+L E++ + + G
Sbjct: 4 IKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61
Query: 72 GIPHLKWFGVEGDYNIM-VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130
+P + + E +M I+ G L+DL N + + +L+ + +HS
Sbjct: 62 NVPAVYFVDPENFIIVMEYIE--GEPLKDLINSNGME--ELELSREIGRLVGK---LHSA 114
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170
G +H D+ N ++ ++Y+ID+GLA+ +DL+
Sbjct: 115 GIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKDLEDR 150
|
Length = 211 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGTGIPHLKW 78
IG G+FGE+ L + + + A+KL E++K +E + M I L +
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 79 FGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 137
+ Y MV++ + G L +L + N K +++ ++ +HS GF+HRD+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDV 168
Query: 138 KPDNFLM 144
KPDN L+
Sbjct: 169 KPDNMLL 175
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 54/276 (19%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGI-----PH 75
KIG G+FG++Y GV ++ E+AVK T L + K LQ + P+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK-----TCRSTLPPDLKR-KFLQEAEILKQYDHPN 53
Query: 76 L-KWFGVEGD-YNIMVIDLLGPSLEDLFNYCNRK---FSLKTVLMLADQLINRVEYMHSR 130
+ K GV I ++ L P L + +K ++K +L ++ +EY+ S+
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPG-GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK-----YRDLQTHKHIPYR----ENKNL 181
+HRD+ N L+G N + I D+G++++ Y K IP + E N
Sbjct: 113 NCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN- 168
Query: 182 TGTARYASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEK 239
RY S D+ S G +L++ F G P+ G+ + +Q ++I E
Sbjct: 169 --YGRYTS-----------ESDVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI-ES 210
Query: 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYS 275
P LC P E C + E++P +S
Sbjct: 211 GYRMPAPQLC---PEEIYRLMLQCWAYDPENRPSFS 243
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 33/120 (27%), Positives = 54/120 (45%), Gaps = 16/120 (13%)
Query: 107 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+F A ++I ++++H +G ++RD+K DN L+ K + I D+G+ K+
Sbjct: 92 RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENM- 147
Query: 167 LQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 223
E K T GT Y + G + + D S G VL+Y L G P+ G
Sbjct: 148 --------NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 10/146 (6%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGTGIPHLKW 78
IG G+FGE+ L + + + A+KL E++K +E + M + L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 79 FGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 137
+ Y MV++ + G L +L + N K +++ ++ +HS G +HRD+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168
Query: 138 KPDNFLMGLGRKANQVYIIDYGLAKK 163
KPDN L+ K + + D+G K
Sbjct: 169 KPDNMLLD---KHGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 64/239 (26%), Positives = 103/239 (43%), Gaps = 38/239 (15%)
Query: 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-------KHPQLHYESKL 63
H+ L R++G G+FG+++L E L VKT H E++L
Sbjct: 1 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 60
Query: 64 YMLLQGGTGIPHL-KWFGV--EGDYNIMVIDLL------------GPSLEDLFNYCN--R 106
LQ H+ K++GV EGD IMV + + GP L N
Sbjct: 61 LTNLQH----EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAV-LMAEGNRPA 115
Query: 107 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+ + +L +A Q+ + Y+ S+ F+HRD+ N L+G + V I D+G++ RD
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RD 169
Query: 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLM-YFLRGSLPWQGL 224
+ + + YR + R+ + + + + D+ SLG VL F G PW L
Sbjct: 170 VYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 49/173 (28%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----------------LELVKT-KHPQ-- 56
FK K+G G++ +Y G N TGE +A+K + L+K KH
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 57 -----LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLK 111
+H E+KL ++ + ++ D +D G
Sbjct: 62 RLHDVIHTENKLMLVFEY-----------MDKDLK-KYMDTHGVR---------GALDPN 100
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
TV QL+ + + H LHRD+KP N L+ K ++ + D+GLA+ +
Sbjct: 101 TVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LE---LVKTKHPQLHYESKLYMLLQGGTG 72
F+ R +G G FGE+ TG+ A K LE + K K + K +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 73 IPHLKWFGVEGDYNIMVIDLL-GPSLE-DLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130
+ +L + D +V+ ++ G L+ ++N N F + L A +++ +E +H
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYREN-KNLTGTARYAS 189
++RD+KP+N L+ + I D GLA K IP E+ + GT Y +
Sbjct: 122 NTVYRDLKPENILLD---DYGHIRISDLGLAVK---------IPEGESIRGRVGTVGYMA 169
Query: 190 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235
+ D LG ++ + G P++G K K+++ D+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 19/59 (32%), Positives = 31/59 (52%), Gaps = 6/59 (10%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRE 177
QL+ + Y HS +HRDIKP+N L+ ++ + + D+G A R L+ P +
Sbjct: 108 QLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFA---RALRARPASPLTD 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 51/214 (23%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFG 80
K+G GS+ +Y G++ G+ +A+K+ +KT+ E + ++ + + LK
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTE------EGVPFTAIREASLLKGLK--- 61
Query: 81 VEGDYNIMVI-DLL--GPSLEDLFNYCNRKFSL-----------KTVLMLADQLINRVEY 126
NI+++ D++ +L +F Y + + V + QL+ + Y
Sbjct: 62 ---HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 127 MHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTA 185
+H + LHRD+KP N L+ LG ++ + D+GLA+ K IP + + T
Sbjct: 119 IHGQHILHRDLKPQNLLISYLG----ELKLADFGLARA-------KSIPSQTYSSEVVTL 167
Query: 186 RYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGS 218
Y + LG + S D+ G + + L+G
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 36/152 (23%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH----LK 77
++G G+FG++Y N +TG A K+ K++ Y ++ +L P+ L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDIL--ASCDHPNIVKLLD 69
Query: 78 WFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 137
F E + I++ G +++ + R + + ++ Q + + Y+H +HRD+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 138 KPDNFLMGLGRKANQVYIIDYGL-AKKYRDLQ 168
K N L L + + D+G+ AK R +Q
Sbjct: 130 KAGNILFTLD---GDIKLADFGVSAKNTRTIQ 158
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 99 DLFNYCNRK---FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144
DL+ Y + L V +A QL++ ++Y+H G +HRDIK +N L+
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293
|
Length = 461 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 28/105 (26%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYREN 178
Q++ ++++HS G +HRD+KP N ++ + + I+D+GLA+ PY
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART--ACTNFMMTPY--- 182
Query: 179 KNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
T Y + LG+ D+ S+G ++ ++GS+ +QG
Sbjct: 183 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 49/234 (20%), Positives = 94/234 (40%), Gaps = 26/234 (11%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
FK+ +K+G GS+G +Y + + A+K + + + ++ + + P++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 77 KWFGVEG--DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVL------MLADQLINRVEYMH 128
+ E D N + I + DL +++ + ++ + QL+ ++ +H
Sbjct: 62 ISYK-EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
+ LHRD+K N L AN + K DL K + K GT Y
Sbjct: 121 EQKILHRDLKSANIL----LVANDLV--------KIGDLGISKVLKKNMAKTQIGTPHYM 168
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG-----LKAGTKKQKYDKIS 237
+ G S + D+ SLG +L + P++ L+ ++ KY I
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP 222
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 59/272 (21%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHY-ESKLYMLLQGGTGIPH 75
+L K+G G FGE+++G T ++A+K T P+ E+++ L+ +P
Sbjct: 8 LRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL 66
Query: 76 LKWFGVEGDYNIMVIDLLGP-SLEDLFNYCNRKF-SLKTVLMLADQLINRVEYMHSRGFL 133
E Y +V + +G SL D + K+ L ++ +A Q+ + + Y+ ++
Sbjct: 67 YAVVSEEPIY--IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124
Query: 134 HRDIKPDNFLMGLGRKANQV-YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 192
HRD++ N L+G N V I D+GLA+ D + Y + ++ +
Sbjct: 125 HRDLRAANILVG----DNLVCKIADFGLARLIEDNE------YTARQGAKFPIKWTAPEA 174
Query: 193 HLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251
L + + D+ S G +L + +G +P+ G+ ++ +++ E+ P C
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQV-ERGYRMPCPQGC-- 228
Query: 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283
P C +++P + Y++ D
Sbjct: 229 -PESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 60/232 (25%), Positives = 92/232 (39%), Gaps = 28/232 (12%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWF 79
IG GSFG++ L G AVK+ KT K Q H ++ +LL+ + H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN---LKHPFLV 59
Query: 80 GVEGDYNI-----MVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGF 132
G+ + V+D + +LF + R+ F A ++ + + Y+HS
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNI 117
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 192
++RD+KP+N L+ V + D+GL K+ + P GT Y +
Sbjct: 118 IYRDLKPENILLD---SQGHVVLTDFGLCKEGVE-------PEETTSTFCGTPEYLAPEV 167
Query: 193 HLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
R D LG VL L G P+ Q YD I K + P
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYE-SKLYMLLQGGTGIP 74
++++ +KIG GSFG++YL E +K E+ TK P E SK ++L P
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIK-EIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 75 HL-KWFGVEGDYNIMVIDLLGPSLEDLFNYCNRK----FSLKTVLMLADQLINRVEYMHS 129
++ +F + + I + DL NR+ FS +L Q+ ++++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 130 RGFLHRDIKPDN-FLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
R LHRDIK N FL G A + D+G+A R L + Y GT Y
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAK---LGDFGIA---RQLNDSMELAY----TCVGTPYYL 169
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
S + + D+ SLG VL P++G
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 19/47 (40%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165
+L VE +H GF+HRDIKPDN L+ + + + D+GL +R
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 111 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170
K + +A+ ++ + Y+HSR +HRDIKP N L+ + QV + D+G++ + +
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA- 160
Query: 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP 220
TGT+ Y + G S D+ SLG L+ + P
Sbjct: 161 --------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 21/58 (36%), Positives = 33/58 (56%), Gaps = 5/58 (8%)
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181
+E +H GF+HRDIKPDN L+ L + + D+GL +R TH Y++ ++
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFR--WTHNSKYYQKGSHI 166
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 20/202 (9%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTG--IPHLKWF 79
+G G+ G +Y ++ T +AVK + L T Q S+L +L + + I F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 80 GVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 139
VE +I + G SL D++ RK + +A ++ + Y+ S LHRD+KP
Sbjct: 69 FVENRISICTEFMDGGSL-DVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKP 123
Query: 140 DNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS 199
N L+ QV + D+G++ Q I K GT Y + G +
Sbjct: 124 SNMLVN---TRGQVKLCDFGVST-----QLVNSIA----KTYVGTNAYMAPERISGEQYG 171
Query: 200 RRDDLESLGYVLMYFLRGSLPW 221
D+ SLG M G P+
Sbjct: 172 IHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 46/181 (25%), Positives = 77/181 (42%), Gaps = 25/181 (13%)
Query: 105 NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
N F Q+I+ +E++H R ++RD+KP+N L+ V I D GLA +
Sbjct: 91 NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVEL 147
Query: 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL 224
+D Q+ + K GT + + G E D +LG L + P+
Sbjct: 148 KDGQS-------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF--- 197
Query: 225 KAGTKKQKYDKISEKKVSTPIEVLCKSYPSEF-VSYFHYCRSLRFEDKPDYSYLKRL-FR 282
+ + +K+ K++ I +YP +F + +C +L P+ KRL FR
Sbjct: 198 -----RARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL-LAKDPE----KRLGFR 247
Query: 283 D 283
D
Sbjct: 248 D 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 45/183 (24%), Positives = 70/183 (38%), Gaps = 51/183 (27%)
Query: 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHY--ESKLYMLLQ 68
+G ++ R +G GS G ++ V+ + +AVK ++ H E K+ L
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTV-----LMLAD----- 118
H D + V ++LGPS DL L +V M D
Sbjct: 61 ------H--------DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL 106
Query: 119 ---------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ----VYIIDYG 159
QL+ ++Y+HS LHRD+KP N + N + I D+G
Sbjct: 107 EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFG 160
Query: 160 LAK 162
LA+
Sbjct: 161 LAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 41/168 (24%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYE------SKLYMLLQGGTG 72
G+ +G+G+FG++ + AV VK P H S+L ++ G
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-- 96
Query: 73 IPHLKWFGVEGDYNIMVIDLL------GPSL--------EDLFNYCNRK----FSLKTVL 114
H NI ++LL GP L DL N+ RK +L+ +L
Sbjct: 97 -NHE---------NI--VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLL 144
Query: 115 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+ Q+ + ++ S+ +HRD+ N L+ G+ I D+GLA+
Sbjct: 145 SFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK---ICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 49/219 (22%), Positives = 90/219 (41%), Gaps = 29/219 (13%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLLQGGT 71
F++ ++G G +G+++L TGE +A+K L+ + H ++ +L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLE-----DLFNYCNRKFSLKT--VLMLADQLINRV 124
+W V+ Y + L ++E D N L ++ V
Sbjct: 61 -----EWL-VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 125 EYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGT 184
+ +H G++HRD+KP+NFL+ + + + D+GL+K ++ G+
Sbjct: 115 DALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVTYA----------NSVVGS 161
Query: 185 ARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
Y + G D SLG +L FL G P+ G
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEI----AVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
+ +GSG+FG +Y G+ + GE + A+K+ L + P+ + E + G G P++
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKV-LRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 77 -KWFGVEGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 133
+ G+ + ++ L P L D + + +L Q+ + Y+ +
Sbjct: 72 CRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131
Query: 134 HRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
HRD+ N L+ + N V I D+GLA+
Sbjct: 132 HRDLAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----LELVKTKHPQLHYESKLYMLLQGG 70
++K+ IG GS+G + ++ TGE++A+K E V L E KL LL+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 59
Query: 71 --TGIPHLKWFGVEGDYN--IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 126
I H+ ++ +V +L+ L + N + + QL+ ++Y
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALKY 118
Query: 127 MHSRGFLHRDIKPDNFLMGLGRKAN---QVYIIDYGLAK 162
+H+ HRD+KP N L AN ++ I D+GLA+
Sbjct: 119 IHTANVFHRDLKPKNIL------ANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 9e-04
Identities = 65/271 (23%), Positives = 119/271 (43%), Gaps = 33/271 (12%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKL--ELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
+++GSG FG ++LG + ++A+K+ E ++ + E+K+ M L P+L
Sbjct: 8 FLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIE-EAKVMMKLSH----PNL 61
Query: 77 -KWFGVEGDYNIMVIDLLGPSLEDLFNYCNR---KFSLKTVLMLADQLINRVEYMHSRGF 132
+ +GV + I + L NY K + +L + + +EY+ S GF
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 192
+HRD+ N L+G + N V + D+GLA+ D Q Y ++ ++A
Sbjct: 122 IHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQ------YTSSQGTKFPVKWAPPEV 172
Query: 193 HLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEK-KVSTPIEVLC 249
S + D+ S G VLM+ F G +P++ + + +S ++ P
Sbjct: 173 FDYSRFSSKSDVWSFG-VLMWEVFSEGKMPYERFSNS---EVVESVSAGYRLYRP----- 223
Query: 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRL 280
K P+E + + C + ED+P + L
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 36/160 (22%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGI 73
G F+L +G+G++G++Y G +V+TG+ A+K+ V T+ + + ++ ML +
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHR 73
Query: 74 PHLKWFGV--------EGDYNIMVIDLLGP-SLEDLF-NYCNRKFSLKTVLMLADQLINR 123
++G D +V++ G S+ DL N + + +++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+ ++H+ +HRDIK N L+ + +V ++D+G++ +
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 20/45 (44%), Positives = 29/45 (64%), Gaps = 5/45 (11%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAK 162
QL+ ++Y+HS LHRD+KP N L+ AN + I D+GLA+
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 60/275 (21%), Positives = 116/275 (42%), Gaps = 31/275 (11%)
Query: 17 FKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+L +K+G+G FGE+++G N T ++AVK T P+ E M + H
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNT--KVAVKTLKPGTMSPESFLEEAQIM-----KKLRH 60
Query: 76 ---LKWFGVEGDYNIMVIDLL---GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
++ + V + I ++ G L+ L + R L ++ +A Q+ + Y+
Sbjct: 61 DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
++HRD++ N L+G G I D+GLA+ D + Y + ++ +
Sbjct: 121 MNYIHRDLRSANILVGDGLVCK---IADFGLARLIEDNE------YTARQGAKFPIKWTA 171
Query: 190 VNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
L + + D+ S G +L + +G +P+ G+ ++ +++ E+ P
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQV-ERGYRMPCPQD 227
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283
C P C E++P + YL+ D
Sbjct: 228 C---PISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 35/176 (19%)
Query: 19 LGRKIGSGSFGELYLG-----VNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTG 72
L R++G G+FG+++LG E +AVK L+ + + +E + +L T
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELL----TN 64
Query: 73 IPH---LKWFGV--EGDYNIMVIDLL------------GPSLEDLFNYCNRKFSLKTVLM 115
H +K++GV EGD IMV + + GP L + + L +
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 116 L--ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169
L A Q+ + + Y+ S+ F+HRD+ N L+G V I D+G++ RD+ T
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMS---RDVYT 174
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 19/47 (40%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDYGLAKKY 164
Q+++ + Y+H+ LHRD+KP N L MG G + +V I D G A+ +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP----QLHYESKLYMLLQGGTGIPHL 76
+ +G G+FG + + TG+ +A+K + P + + E KL L+ I
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 77 KWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRD 136
F + V +LLG L L +R + + Q++ ++Y+HS G +HRD
Sbjct: 76 DIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 137 IKPDNFLMGLGRKANQVYIIDYGLAK 162
+KP N L+ + + I D+GLA+
Sbjct: 134 LKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTG 72
F+ + IG G+FGE+ L TG A+K+ L K K H ++ +L++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKI-LRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 73 IPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSL---KTVLMLADQLINRVEYMHS 129
++ + N+ +I P D+ +K +L T +A+ ++ ++ +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPG-GDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIHQ 119
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 182
GF+HRDIKPDN L+ V + D+GL + + H+ YR NLT
Sbjct: 120 LGFIHRDIKPDNLLLD---AKGHVKLSDFGLCTGLK--KAHRTEFYR---NLT 164
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 36/160 (22%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGI 73
G F+L +G+G++G++Y G +V+TG+ A+K+ V T + + ++ ML +
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 63
Query: 74 PHLKWFGV--------EGDYNIMVIDLLGP-SLEDLF-NYCNRKFSLKTVLMLADQLINR 123
++G D +V++ G S+ DL N + + + +++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+ ++H +HRDIK N L+ + +V ++D+G++ +
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 160
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLEL-VKTKHPQLHYESKLYMLLQG-------G 70
L R +G G+FGE+Y G+ + + AV+L++ VKT + + L++
Sbjct: 10 LLRALGHGAFGEVYEGL-YRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 71 TGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYC----NRKFSL--KTVLMLADQLINR 123
I L E ++++L+ G L+ R SL K +L A +
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 124 VEYMHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDYGLAKK-YR 165
+Y+ F+HRDI N L+ G GR A I D+G+A+ YR
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 19/47 (40%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDYGLAKKY 164
Q+++ + Y+H+ LHRD+KP N L MG G + +V I D G A+ +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 41/157 (26%), Positives = 67/157 (42%), Gaps = 18/157 (11%)
Query: 105 NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
N++F A Q++ EY+ S ++RD+KP+N L+ K + + D+G AK
Sbjct: 125 NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVV 181
Query: 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL 224
D +T+ L GT Y + L V + D +LG + L G P+
Sbjct: 182 -DTRTY---------TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-- 229
Query: 225 KAGTKKQKYDKISEKKVSTP--IEVLCKSYPSEFVSY 259
A Y KI E + P ++ CK + +S+
Sbjct: 230 -ANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSH 265
|
Length = 340 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 9/160 (5%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHY-----ESKLYMLLQGGTGIPH 75
R+IG GSFG +Y +V+ E +A+K K + E + L+ I +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 76 LKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHR 135
+ E +++ LG S DL + + + + + Y+HS +HR
Sbjct: 81 RGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 136 DIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175
D+K N L+ + V + D+G A PY
Sbjct: 140 DVKAGNILL---SEPGLVKLGDFGSASIMAPANXFVGTPY 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 17/46 (36%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
QL+ ++++HS +HRD+KP N L+ Q+ + D+GLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 8/151 (5%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHY-ESKLYMLLQGGTG 72
F++ KIG GSFG ++ V A+K L + + + E+++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 73 IPHLKWFGVEGDYNIMVIDLLGPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRG 131
I + + F +G NI++ L L R V Q++ + ++HS+
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
LHRDIK N + + V I D G+AK
Sbjct: 122 ILHRDIKSLNLFLD---AYDNVKIGDLGVAK 149
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 39/154 (25%), Positives = 61/154 (39%), Gaps = 25/154 (16%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHY-----ESKLYMLLQGGTGIP- 74
R+IG GSFG +Y +V+T E +A+K K + E + L+ I
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 75 -------HLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 127
H W +E Y LG S D+ + + + + + Y+
Sbjct: 81 KGCYLREHTAWLVME--Y------CLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYL 131
Query: 128 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
HS +HRDIK N L+ + V + D+G A
Sbjct: 132 HSHERIHRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 23/67 (34%), Positives = 35/67 (52%), Gaps = 6/67 (8%)
Query: 99 DLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYI 155
DL Y C S+ V + QL+ + Y H R LHRD+KP N L+ + ++ +
Sbjct: 88 DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKL 144
Query: 156 IDYGLAK 162
D+GLA+
Sbjct: 145 ADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 18/151 (11%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLLQGGTGIPHLKWF 79
IG GSFG++ L + G+ AVK+ + + K Q H ++ +LL+ + H F
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKN---VKHP--F 57
Query: 80 GVEGDYNIMVIDLLGPSLE-----DLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGF 132
V Y+ D L L+ +LF + R+ F A ++ + + Y+HS
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
++RD+KP+N L+ V + D+GL K+
Sbjct: 118 IYRDLKPENILLD---SQGHVVLTDFGLCKE 145
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 17/46 (36%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
Q++ ++Y+HS LHRD+KP N L+ ++ I D+GLA+ +
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 38/229 (16%)
Query: 22 KIGSGSFGELYLG--VNVQTGEE---IAVKL--ELVKTKHPQLHYESKLYMLLQGGTGIP 74
++G G+FG+++L N+ ++ +AVK E ++ E++L +LQ
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH----Q 67
Query: 75 HL-KWFGV--EGDYNIMVIDLL------------GPS---LEDLFNYCNRKFSLKTVLML 116
H+ +++GV EG +MV + + GP L + + +L +L +
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 117 ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176
A Q+ + + Y+ S F+HRD+ N L+G G V I D+G++ RD+ + + YR
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YR 179
Query: 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLM-YFLRGSLPWQGL 224
R+ + L + + D+ S G VL F G PW L
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 60/274 (21%), Positives = 117/274 (42%), Gaps = 38/274 (13%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIPH-LKWFG 80
IG G++G+++ +N + G + AVK L+ + ++ E Y +L+ + P+ +K++G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAE---YNILKALSDHPNVVKFYG 82
Query: 81 -------VEGDYNIMVIDLL-GPSLEDL----FNYCNRKFSLKTVLMLADQLINRVEYMH 128
GD +V++L G S+ DL R +L + L+ ++++H
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG-LQHLH 141
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
+HRD+K +N L+ V ++D+G++ + L + + R N ++ GT +
Sbjct: 142 VNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQ---LTSTRL---RRNTSV-GTPFWM 191
Query: 189 -----SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243
+ L R D+ SLG + G P L K + +
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ 251
Query: 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277
P + + +EF + C + +E +P S L
Sbjct: 252 P-----ELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 18/151 (11%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLLQGGTGIPHLKWF 79
IG GSFG++ L G+ AVK+ ++V + Q H ++ +LL+ + H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN---VKHPFLV 59
Query: 80 GVEGDYNIMVIDLLGPSLE-----DLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGF 132
G+ Y+ + L L+ +LF + R F A ++ + + Y+HS
Sbjct: 60 GLH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
++RD+KP+N L+ V + D+GL K+
Sbjct: 118 VYRDLKPENILLD---SQGHVVLTDFGLCKE 145
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 33/141 (23%), Positives = 58/141 (41%), Gaps = 17/141 (12%)
Query: 106 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK-Y 164
+F A +++ ++++H RG ++RD+K DN L+ + I D+G+ K+
Sbjct: 91 GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGI 147
Query: 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 223
T GT Y + D +LG VL+Y L G P++G
Sbjct: 148 LGGVT--------TSTFCGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSPFEG 198
Query: 224 LKAGTKKQKYDKISEKKVSTP 244
+ + + I E +V P
Sbjct: 199 ---DDEDELFQSILEDEVRYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 61/284 (21%), Positives = 121/284 (42%), Gaps = 55/284 (19%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP-----QLHYESKLYMLLQGGTGIPHL 76
++GSG+FG + GV ++I V ++++K ++ ++ E+++ L P++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN----PYI 57
Query: 77 -KWFGVEGDYNIMVIDLLGPS--LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 133
+ GV +M++ + L + + ++ V+ L Q+ ++Y+ + F+
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 134 HRDIKPDNFLMGLGRKANQVY--IIDYGLAK------KYRDLQTHKHIPYRENKNLTGTA 185
HRD+ N L+ NQ Y I D+GL+K Y ++ P +
Sbjct: 118 HRDLAARNVLL-----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK--------- 163
Query: 186 RYAS--VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243
YA +N + S R D+ S G + W+ G K Y K+ +V +
Sbjct: 164 WYAPECINFR---KFSSRSDVWSYGITM---------WEAFSYGQK--PYKKMKGPEVMS 209
Query: 244 PIE----VLC-KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282
IE + C P E + C ++ED+P+++ ++ R
Sbjct: 210 FIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 29/165 (17%)
Query: 60 ESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ 119
+ KL ++++ G+G GD N + L L F V +L Q
Sbjct: 137 DDKLLLIMEYGSG----------GDLNKQIKQRLKEHL---------PFQEYEVGLLFYQ 177
Query: 120 LINRVEYMHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYREN 178
++ ++ +HSR +HRD+K N FLM G + + D+G +K+Y D +
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSD-----SVSLDVA 228
Query: 179 KNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
+ GT Y + S++ D+ SLG +L L P++G
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.004
Identities = 11/44 (25%), Positives = 24/44 (54%), Gaps = 4/44 (9%)
Query: 127 MHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170
+H G +H D+ N ++ +++Y+ID+GL K +++
Sbjct: 106 LHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYSDEIEDK 145
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 23 IGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLLQGGTGIPHLKWF 79
+G G+FG++ L TG A+K+ E++ K H ++ +L T P L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN--TRHPFLTAL 60
Query: 80 GVEGDYNIMVIDLLGPSLE-----DLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGF 132
Y D L +E +LF + +R+ F+ + ++++ +EY+HSR
Sbjct: 61 ----KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKK-YRDLQTHKHIPYRENKNLTGTARYASVN 191
++RDIK +N ++ K + I D+GL K+ D T K GT Y +
Sbjct: 117 VYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM--------KTFCGTPEYLAPE 165
Query: 192 THLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
+ R D LG V+ + G LP+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 28/136 (20%), Positives = 58/136 (42%), Gaps = 11/136 (8%)
Query: 100 LFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159
++N N F + + A ++ +E +H ++RD+KP+N L+ + I D G
Sbjct: 91 IYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLG 147
Query: 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSL 219
LA + + +T + GT Y + + D LG ++ + G
Sbjct: 148 LAVEIPEGET--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 220 PWQGLKAGTKKQKYDK 235
P++ K K+++ ++
Sbjct: 200 PFRQRKEKVKREEVER 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 468 | |||
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.39 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.37 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.26 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.18 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.12 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.05 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.92 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.62 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.52 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.47 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.4 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.34 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.25 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.05 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.02 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.95 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.83 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.65 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.63 | |
| PLN02236 | 344 | choline kinase | 96.63 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.54 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.53 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.43 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.95 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.57 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.47 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.25 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.22 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.83 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.81 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.65 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.02 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.42 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.99 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.79 | |
| PTZ00296 | 442 | choline kinase; Provisional | 91.13 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 90.17 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 89.65 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 89.64 |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-62 Score=445.90 Aligned_cols=294 Identities=69% Similarity=1.269 Sum_probs=288.9
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+.|++++|+++++||+|+||.+|+|.....|++||||++.....++++.+|.+++..|++..+++++.+|+.+.++++||
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 56788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 90 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 90 ~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|+++|++|++++..|.+.|+.+++++++.||+..++|+|.+++|||||||+|+|+|.+...++++|+||||++.+.+..+
T Consensus 90 MdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 90 MDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred eeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
..|+||+...+.+||.+|++...+.+.++++++|+.|+|++|+++..|.+||+++++.+..|++++|.++++..+++.+|
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC 249 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLC 249 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
+++|.||.-++.+|..+.+++.|++.+|.++++-+|...+++.|+.|||+.++.
T Consensus 250 ~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkq 303 (341)
T KOG1163|consen 250 KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQ 303 (341)
T ss_pred CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHH
Confidence 999999999999999999999999999999999999999999999999999873
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-59 Score=439.87 Aligned_cols=292 Identities=58% Similarity=1.031 Sum_probs=285.4
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.|||-.|+++++||+|+||++|+|++.-+++.||||.+..+...+++..|.+.++.|.+.++|+.++.|+.++.+++|||
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 48999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc--CCCCeEEEEeCCccccccccc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~--~~~~~vkL~DFGla~~~~~~~ 168 (468)
+++|++|+|++..|++.|+.++++++|.||+..++|+|++.+|.|||||+|+|||.. .+.+.+.|+|||+|+.|.++.
T Consensus 104 dLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 104 DLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 999999999999999999999999999999999999999999999999999999853 346789999999999999999
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
+.+|+||++.+.+.||.+||+...|+|.++++++|+.|||-|++++|.|.+||+|+++.+.+++|++|.+.+..++++.+
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L 263 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL 263 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
|.++|.+|..++.+...+++++-|+|+.+..+|.+++.+.+..+|+.|||..+.
T Consensus 264 c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 264 CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 999999999999999999999999999999999999999999999999999886
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=378.20 Aligned_cols=268 Identities=25% Similarity=0.385 Sum_probs=231.7
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEee-----ccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLEL-----VKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~-----~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
-..+|.+++.||+|+|++||+|+.+.++.+||||++. ...+.+-+..|..+|.+|.+|++|..++.-+.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3478999999999999999999999999999999843 34455667889999999999999999999999999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+|++|+ +|.|.+++.. -+.|++.++..++.||+.||+|||++|||||||||+|||| |.+++++|+|||.|+.+..
T Consensus 151 FvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCCh
Confidence 999999 9999999996 4689999999999999999999999999999999999999 7999999999999998766
Q ss_pred ccCccccc----ccC--CCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 167 LQTHKHIP----YRE--NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 167 ~~~~~~~~----~~~--~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
.......+ +.. ...++||..|.+||++.....++.+|||+||||||+|+.|..||.+.+ ....+.+|....
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFqkI~~l~ 303 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQKIQALD 303 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHHHHHHhc
Confidence 43321111 111 256999999999999999999999999999999999999999998753 445566666666
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+..| .++|+.+.+||.++|..||.+|++.++|.+ ++|+..+||+.+-
T Consensus 304 y~fp-----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~----------HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 304 YEFP-----EGFPEDARDLIKKLLVRDPSDRLTSQQIKA----------HPFFEGVDWENLW 350 (604)
T ss_pred ccCC-----CCCCHHHHHHHHHHHccCccccccHHHHhh----------CcccccCChhhhh
Confidence 6555 567999999999999999999999976543 7888899999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=371.00 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=218.2
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---------CchhHHHHHHHHHHhCCCCCceeeEe
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---------HPQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
+-..+.+.|.+.+.||+|+||.|-+|..+.+++.||||++..... .....+|+++|++|+| |+|+.++.+
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H-P~IV~~~d~ 244 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH-PNIVRIKDF 244 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC-CCEEEEeee
Confidence 344477899999999999999999999999999999998654321 2235689999999987 677888888
Q ss_pred eEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeC
Q 012192 80 GVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDY 158 (468)
Q Consensus 80 ~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DF 158 (468)
++..++.||||||+ ||.|.+.+-. ++.+.++....++.||+.||.|||+.||+||||||+|||+..++++..+||+||
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence 89999999999999 8999998874 668999999999999999999999999999999999999987667799999999
Q ss_pred CcccccccccCcccccccCCCCccccccccccccccCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 159 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~---~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
|+|+..... ...++++||+.|.|||++.+.. +..++|+|||||+||-+++|.+||.+..... ...++
T Consensus 324 GlAK~~g~~--------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQ 393 (475)
T KOG0615|consen 324 GLAKVSGEG--------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQ 393 (475)
T ss_pred chhhccccc--------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHH
Confidence 999976532 2367899999999999999775 3458899999999999999999998754332 23445
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
|...++..- +.....++++..+||.++|..||++||++++ .|++.+.
T Consensus 394 I~~G~y~f~-p~~w~~Iseea~dlI~~mL~VdP~~R~s~~e---aL~hpW~ 440 (475)
T KOG0615|consen 394 ILKGRYAFG-PLQWDRISEEALDLINWMLVVDPENRPSADE---ALNHPWF 440 (475)
T ss_pred HhcCccccc-ChhhhhhhHHHHHHHHHhhEeCcccCcCHHH---HhcChhh
Confidence 666666543 2334667899999999999999999999984 5555444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=378.79 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=226.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeec-----cCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV-----KTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
.+|+.++.||+|||+.||.+++..+|+.||+|++.. ....+.+..|+++.+.|+| ++|+.++.|+++.++.|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~H-pnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKH-PNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCC-CcEEeeeeEeecCCceEEE
Confidence 479999999999999999999999999999998654 3445678999999998887 7888999999999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+|+| .++|..+++ ..+.+++.++..++.||+.||.|||+.+|||||||-.|+++ +++.+|||+|||||..+..+.
T Consensus 97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence 9999 899999998 47889999999999999999999999999999999999999 688899999999998876532
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. ...+.+||+.|+|||++....++..+||||+|||||-||.|++||+. .+.++.|.+|....+..|.
T Consensus 173 E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet---k~vkety~~Ik~~~Y~~P~--- 239 (592)
T KOG0575|consen 173 E-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET---KTVKETYNKIKLNEYSMPS--- 239 (592)
T ss_pred c-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc---chHHHHHHHHHhcCccccc---
Confidence 2 35689999999999999999999999999999999999999999975 4678889999999888885
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQ 291 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~ 291 (468)
.++.+..+||..+|+.||.+||++++ .|.+-|...++-
T Consensus 240 --~ls~~A~dLI~~lL~~~P~~Rpsl~~---vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 240 --HLSAEAKDLIRKLLRPNPSERPSLDE---VLDHPFFKSGFT 277 (592)
T ss_pred --ccCHHHHHHHHHHhcCCcccCCCHHH---HhcCHhhhCCCc
Confidence 44899999999999999999999985 556666655553
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=363.63 Aligned_cols=271 Identities=23% Similarity=0.299 Sum_probs=226.0
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+-.++|++.+.||+|+||+||+++.+.+++.+|+|++.+. ........|..++..+.| |.|+.+...+++.+.
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~h-PFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKH-PFIVKLIYSFQTEEK 99 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCC-CcEeeeEEecccCCe
Confidence 34468999999999999999999999999999999985543 234568889999998655 777778878889999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.|||++|+ ||.|...+.+ .+.|+++.+..++.+|+.||.|||++|||||||||+|||+ |..|+++|+|||||+..
T Consensus 100 LylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhc
Confidence 99999998 7899999985 6789999999999999999999999999999999999999 69999999999999864
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
..... ...+++||+.|||||++.+..|+..+|+||||+++|||++|..||.+. +..+.+++|...+...+
T Consensus 176 ~~~~~-------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~---~~~~~~~~I~~~k~~~~ 245 (357)
T KOG0598|consen 176 LKDGD-------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE---DVKKMYDKILKGKLPLP 245 (357)
T ss_pred ccCCC-------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc---cHHHHHHHHhcCcCCCC
Confidence 43322 245689999999999999999999999999999999999999999863 45667777777764333
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCCc
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQI 306 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~ 306 (468)
.. .++.+.++++..+++.+|++|... ..+......++++..++|+.+....+
T Consensus 246 p~----~ls~~ardll~~LL~rdp~~RLg~------~~d~~~ik~HpfF~~inW~~l~~k~l 297 (357)
T KOG0598|consen 246 PG----YLSEEARDLLKKLLKRDPRQRLGG------PGDAEEIKRHPFFKGINWEKLLAKKL 297 (357)
T ss_pred Cc----cCCHHHHHHHHHHhccCHHHhcCC------CCChHHhhcCcccccCCHHHHHhcCC
Confidence 22 247899999999999999999641 11222245688999999999865443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=381.00 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=220.9
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
-...++++++||+|.||+||+|.+..+ ..||||.+.... ....+..|+++|+.|+| ++|+.+++++..++..+||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H-~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRH-EKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcc-cCeEEEEEEEecCCceEEEEE
Confidence 345567889999999999999998533 489999877644 44678899999999998 567778888888789999999
Q ss_pred cc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~-~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|+ .|+|.+++.. .+..+.....+.++.|||+||+||+++++|||||.++|||+ +++..|||+|||||+...+..
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~- 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDE- 357 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCc-
Confidence 99 8999999986 56789999999999999999999999999999999999999 488999999999999544322
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
|.......-++.|.|||.+....++.|+|||||||+||||+| |+.||.++...+.. ..++..++.|.+..
T Consensus 358 -----Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~----~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 358 -----YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL----ELLERGYRLPRPEG 428 (468)
T ss_pred -----eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH----HHHhccCcCCCCCC
Confidence 444455566789999999999999999999999999999999 99999988764433 34477888888877
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
| |+++.++|..||+.+|++||||+.+...|++++..
T Consensus 429 C---P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 429 C---PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred C---CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 7 99999999999999999999999999999988754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=361.33 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=215.7
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCc-eeEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD-YNIMV 89 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-~~~lv 89 (468)
..+.+.++.||+|+.|+||++.++.|++.+|+|++.... ...++.+|++++..+ .+++|+.+++.+.... ...++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEee
Confidence 348889999999999999999999999999999874332 345789999999999 5578888888777777 59999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|||| +|+|++++.. .+.+++.....++.+++.||.|||+ .+||||||||.|||+ +..+.|||||||.++...+.
T Consensus 157 mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh
Confidence 9999 8999999986 4689999999999999999999995 999999999999999 68999999999999876653
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCC--CcccHHHHHHHHhhcccCCCH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL--KAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~--~~~~~~~~~~~i~~~~~~~~~ 245 (468)
...+++||..|||||.+.+..|+.++||||||++++|+++|+.||... ......+.+..|.... +
T Consensus 233 ---------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p----p 299 (364)
T KOG0581|consen 233 ---------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP----P 299 (364)
T ss_pred ---------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC----C
Confidence 246889999999999999999999999999999999999999999863 2234455555555533 2
Q ss_pred HHhhcc-CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 246 EVLCKS-YPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 246 ~~l~~~-~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
+.+... ++++|+.|+..||+.||.+||++. ++|++.|...
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~---qLl~Hpfi~~ 340 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAK---QLLQHPFIKK 340 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHH---HHhcCHHHhh
Confidence 333333 799999999999999999999998 5677777653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=349.61 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=206.6
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
.++|.+.++||.|+||+||+|+++.++.+||||.+..+. ..+.+..|+++++.+.| ++|+.+..|....++.+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H-~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKH-PNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCC-cceeeEEEEEecCCeEEEE
Confidence 368999999999999999999999999999999766553 23457889999999995 7888899999999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCC---CeEEEEeCCcccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKA---NQVYIIDYGLAKKYR 165 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~---~~vkL~DFGla~~~~ 165 (468)
|||| ||+|.+++.. .+.+++.++..++.|+|.||++||+++||||||||.|||++..... -.+||+|||+|+...
T Consensus 88 MEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999 7999999995 5589999999999999999999999999999999999999765233 578999999999766
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.. ....+++|++.|||||++....|+.|+|+||+|++||++++|+.||...+ ..+.+..+.......+.
T Consensus 167 ~~--------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t---~~eL~~~~~k~~~~~~~ 235 (429)
T KOG0595|consen 167 PG--------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET---PKELLLYIKKGNEIVPV 235 (429)
T ss_pred ch--------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC---HHHHHHHHhccccccCc
Confidence 32 23568899999999999999999999999999999999999999998643 34444444444333332
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYS 275 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~ 275 (468)
.. ..+.....+++...++.++.+|-++.
T Consensus 236 ~~--~~~s~~~~~Ll~~ll~~~~~~~~~~~ 263 (429)
T KOG0595|consen 236 LP--AELSNPLRELLISLLQRNPKDRISFE 263 (429)
T ss_pred hh--hhccCchhhhhhHHHhcCccccCchH
Confidence 21 22255667899999999999998776
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=360.14 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=211.1
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcE-EEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCc-e
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEE-IAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD-Y 85 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~-vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-~ 85 (468)
+-..++.+.+.||.|+||+||+|.+ .|.. ||||++..... ...+..|+.++.+++|+ +|+.+.+++.... .
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~Hp-NIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHP-NIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCC-CeeeEEEEEcCCCCc
Confidence 3346677888899999999999998 4556 99998654332 23799999999998875 5555666666555 6
Q ss_pred eEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCceeecccCCCC-eEEEEeCCcc
Q 012192 86 NIMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRG-FLHRDIKPDNFLMGLGRKAN-QVYIIDYGLA 161 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~g-iiHrDIKp~NiLl~~~~~~~-~vkL~DFGla 161 (468)
..+||||+ +|+|.+++... ...+++..++.||.|||.||+|||+++ ||||||||+|||+ +.+. ++||+|||++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLS 191 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccc
Confidence 88999998 99999999863 778999999999999999999999999 9999999999999 5675 9999999999
Q ss_pred cccccccCcccccccCCCCcccccccccccccc--CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHL--GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~--~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
+...... .......||+.|||||++. ...|+.|+||||||++||||++|..||.++.. .+....+...
T Consensus 192 r~~~~~~-------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~ 261 (362)
T KOG0192|consen 192 REKVISK-------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVG 261 (362)
T ss_pred eeecccc-------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhc
Confidence 8654321 1233478999999999999 55899999999999999999999999998765 3344444445
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+.+++. .+|+.+..+|..||..+|+.||++.+|...|+.+...
T Consensus 262 ~~Rp~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 262 GLRPPIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCCCCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 44444333 3599999999999999999999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=356.92 Aligned_cols=273 Identities=22% Similarity=0.310 Sum_probs=221.0
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+-.++|++++.||+|+||+||+|+-+.||..+|+|++.+. .+...+..|..+|.. ...+.|+.++..+.+.++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCe
Confidence 45668999999999999999999999999999999986554 344567889999887 667899999999999999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
+||+|||+ ||++..+|.. ...|+++.+..++.+++.|++.||+.|||||||||+|+|| |..|++||+|||||+.+
T Consensus 216 LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGL 291 (550)
T ss_pred eEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchh
Confidence 99999998 9999999985 5689999999999999999999999999999999999999 79999999999999643
Q ss_pred ccc--------------cC-c---cccc-----c-----------------cCCCCccccccccccccccCCCCCCcchH
Q 012192 165 RDL--------------QT-H---KHIP-----Y-----------------RENKNLTGTARYASVNTHLGVEQSRRDDL 204 (468)
Q Consensus 165 ~~~--------------~~-~---~~~~-----~-----------------~~~~~~~Gt~~y~APE~~~~~~~s~ksDv 204 (468)
... .. . ...+ . ......+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 220 00 0 0000 0 00234689999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc--cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 205 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 205 wSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~--~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
||||||+||||.|.+||.+..+. +.+.+|..-+ ...|.+..+ .++..+||.+|+. ||+.|....-+
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~---~T~rkI~nwr~~l~fP~~~~~---s~eA~DLI~rll~-d~~~RLG~~G~----- 439 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQ---ETYRKIVNWRETLKFPEEVDL---SDEAKDLITRLLC-DPENRLGSKGA----- 439 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhhhccCCCcCcc---cHHHHHHHHHHhc-CHHHhcCcccH-----
Confidence 99999999999999999986554 4444443333 334444333 6999999999999 99999762211
Q ss_pred HHHHHcCCCCCccccccccc
Q 012192 283 DLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 283 ~~~~~~~~~~~~~~dw~~~~ 302 (468)
-....++++..+||+.+.
T Consensus 440 --~EIK~HPfF~~v~W~~l~ 457 (550)
T KOG0605|consen 440 --EEIKKHPFFKGVDWDHLR 457 (550)
T ss_pred --HHHhcCCccccCCcchhh
Confidence 112457888999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=335.72 Aligned_cols=268 Identities=22% Similarity=0.295 Sum_probs=231.4
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
..-++|++++.||.|+||.|.+++.+.+|..+|+|++.... +.+....|..+++.+. +|.+..+.+.+.+....
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNL 119 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeE
Confidence 45578999999999999999999999999999999865443 2345778999998888 57888898888999999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
||||+|. ||.|.++++. .++|++..+..+|.||+.||+|||+++||+|||||+|||+ |..|.+||+|||+|+...
T Consensus 120 ymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEec
Confidence 9999998 8999999986 5689999999999999999999999999999999999999 789999999999999866
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.- ..+.+||+.|+|||++...+|+.++|+|+|||++|||+.|..||.+... .+.|++|.+.++..|
T Consensus 196 ~r----------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~fP- 261 (355)
T KOG0616|consen 196 GR----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVKFP- 261 (355)
T ss_pred Cc----------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcccCC-
Confidence 42 3578999999999999999999999999999999999999999987543 788999999998887
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCCcc
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIG 307 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~ 307 (468)
..+..++.+|+..+++.|-..|-. .+-.......+++++...+|+.+....+.
T Consensus 262 ----~~fs~~~kdLl~~LL~vD~t~R~g-----nlknG~~dIk~H~wF~~v~W~~i~~r~ie 314 (355)
T KOG0616|consen 262 ----SYFSSDAKDLLKKLLQVDLTKRFG-----NLKNGVEDIKNHPWFKGVDWEAILQRKIE 314 (355)
T ss_pred ----cccCHHHHHHHHHHHhhhhHhhhc-----CcCCCccccccCcccccccHHHHhhcccc
Confidence 445899999999999999988821 11112233467899999999997654443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=364.92 Aligned_cols=273 Identities=22% Similarity=0.284 Sum_probs=229.6
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+--++|.++++||+|+||+|+++..+.+++.+|||++++. ...+..+.|.+|+.....||.+..++.++...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 45558999999999999999999999999999999986544 3455788999999999999999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.|+||||+ ||++..+.+ .+.|++..+..|+++++.||.|||++||||||||-+|||+ |..|++||+|||||+..
T Consensus 444 l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEeccccccccc
Confidence 99999999 666332222 4789999999999999999999999999999999999999 78999999999999864
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.... ....+++||+.|||||++.+..|+..+|+|||||+|||||.|..||.+. +..+.++.|....+..|
T Consensus 519 m~~g-------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd---dEee~FdsI~~d~~~yP 588 (694)
T KOG0694|consen 519 MGQG-------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD---DEEEVFDSIVNDEVRYP 588 (694)
T ss_pred CCCC-------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCCCCC
Confidence 4211 1357899999999999999999999999999999999999999999974 44567777777766666
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCCccC
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~ 308 (468)
. .++.+..+||..+|..+|++|..+.+ ++.-....++|+..+||+.+...++..
T Consensus 589 ~-----~ls~ea~~il~~ll~k~p~kRLG~~e-----~d~~~i~~hpFFr~i~w~~L~~r~i~P 642 (694)
T KOG0694|consen 589 R-----FLSKEAIAIMRRLLRKNPEKRLGSGE-----RDAEDIKKHPFFRSIDWDDLLNRRIKP 642 (694)
T ss_pred C-----cccHHHHHHHHHHhccCcccccCCCC-----CCchhhhhCCccccCCHHHHhhccCCC
Confidence 4 34899999999999999999987631 111112347888999999987655543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=336.67 Aligned_cols=254 Identities=23% Similarity=0.281 Sum_probs=209.2
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeE-eeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKW-FGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~-~~~~~~~ 85 (468)
..-..+|++.++||.|+||+||++.++.+|..||.|.+.-. ........|+.+|++|+|+|+|..+.+ |..+.+.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 33345799999999999999999999999999999964422 233468899999999999887777774 4455666
Q ss_pred eEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCceeecccCCCCeEEEEe
Q 012192 86 NIMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHS--RG--FLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs--~g--iiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
.++||||| +|+|..+++. ..+.+++.+++.+..|++.||..+|+ .. |+||||||.||++ +.++.|||.|
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGD 171 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGD 171 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeecc
Confidence 89999999 8999998863 35679999999999999999999999 45 9999999999999 5899999999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
|||++.+....+ ....++|||.||+||.+.+.+|+.++||||+||++|||+.-..||.+. +-.+.-.+|.
T Consensus 172 fGL~r~l~s~~t-------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~ 241 (375)
T KOG0591|consen 172 FGLGRFLSSKTT-------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIE 241 (375)
T ss_pred chhHhHhcchhH-------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHH
Confidence 999998876543 345789999999999999999999999999999999999999999985 3334444455
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRL 280 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~ 280 (468)
...++ |.+. ..++..+..||..|+..|++.||+...++..
T Consensus 242 qgd~~-~~p~--~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 242 QGDYP-PLPD--EHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred cCCCC-CCcH--HHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 55443 2221 3458899999999999999999985433333
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=343.97 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=205.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEe-eEeCc-eeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWF-GVEGD-YNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~-~~~~~-~~~lv~ 90 (468)
-+|..++.||+|+||.||++.+..+|..+|||...... ....+..|+.+|..+. |++|+.+++. ..... .++++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEeee
Confidence 46899999999999999999999999999999754431 1345899999999999 5667666665 33333 678888
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC-CCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~-~~~vkL~DFGla~~~~~~~ 168 (468)
||+ +|+|.+++...+..|++..+..++.|++.||+|||++|||||||||+|||+ +. ++.+||+|||+++......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCcccccccccc
Confidence 888 999999999765589999999999999999999999999999999999999 45 6899999999998655311
Q ss_pred CcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. .........||+.|||||++..+ ...+++|||||||++.||+||..||... ......+..+......+ .
T Consensus 173 ~----~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P---~ 243 (313)
T KOG0198|consen 173 T----KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLP---E 243 (313)
T ss_pred c----cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCC---C
Confidence 1 11223467899999999999953 3456999999999999999999999874 22334444444444222 3
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
+...++++..+|+..|+..+|+.|||++ ++|++.|...
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~---eLL~hpf~~~ 281 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAE---ELLEHPFLKQ 281 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHH---HHhhChhhhc
Confidence 4455799999999999999999999999 4666666654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=347.31 Aligned_cols=263 Identities=24% Similarity=0.325 Sum_probs=214.4
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-c--hhHHHHHHHHHHhCCCCCceeeEeeEeCc-eeE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-P--QLHYESKLYMLLQGGTGIPHLKWFGVEGD-YNI 87 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-~--~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-~~~ 87 (468)
++.++|.++++||.|.||.||+|+.+.+++.||||.++.+... + .-.+|++.++++..|++|..+..+..+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 5668999999999999999999999999999999976655332 2 24679999999997788888877777766 999
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 88 lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+|||||..+|+++++.-++.|++..+..|+.||++||+|+|.+|+.|||+||+|||+. ....|||+|||||+.....
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccccccC
Confidence 9999999999999997788899999999999999999999999999999999999993 4889999999999976542
Q ss_pred cCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc-------
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK------- 239 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~------- 239 (468)
. || ...+-|..|.|||+++.- .|+.+.|+|++|||++|+.+=+..|+|....+..-++-.+...
T Consensus 164 p-----PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 164 P-----PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred C-----Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 2 33 356789999999999865 4899999999999999999999999985432222122111110
Q ss_pred ---------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 240 ---------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 240 ---------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
....+...+...++.++.++|..|+++||++||++++ .|+..|...
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~---al~~pffq~ 296 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ---ALQHPFFQV 296 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH---HhcCccccc
Confidence 0123344566778899999999999999999999995 555555443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=346.31 Aligned_cols=248 Identities=27% Similarity=0.348 Sum_probs=212.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-------CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-------TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
...++|.+++.||+|+||.|++|.+..+++.||||++... .....+.+|+.+++.+.+|++|..++.+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 5567999999999999999999999999999999975443 224456789999999997889999999888888
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCC-CeEEEEeCCccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDYGLAK 162 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~-~~vkL~DFGla~ 162 (468)
..|+||||+ ||.|.+.+.. .+++.+..+..++.|++.|++|||++||+||||||+|||+ +.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccc
Confidence 899999999 6799999997 7889999999999999999999999999999999999999 466 999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCC-CC-CcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s-~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
.... ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.+. +....+.+|....
T Consensus 170 ~~~~-------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~---~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 170 ISPG-------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS---NVPNLYRKIRKGE 239 (370)
T ss_pred ccCC-------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc---cHHHHHHHHhcCC
Confidence 7631 112346789999999999999988 84 8899999999999999999999873 3344455555555
Q ss_pred cCCCHHHhhccC-cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 241 VSTPIEVLCKSY-PSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 241 ~~~~~~~l~~~~-p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+..| ..+ ++++..++..|+..+|..|+++.+|.
T Consensus 240 ~~~p-----~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 FKIP-----SYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ccCC-----CCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 5544 233 88999999999999999999999765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=336.71 Aligned_cols=267 Identities=18% Similarity=0.275 Sum_probs=215.9
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc---CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK---TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
-.+..++|++.+.||.|.-+.||+|+...+++.||||++... ..-+.+.+|+..+..+.| |||..++..++.+...
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H-PNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH-PNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC-CCcceEEEEEEeccee
Confidence 346678999999999999999999999999999999985543 344678899999766555 7777888888899999
Q ss_pred EEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
++||.+| +|++.+++... ...|.+..+..|+++++.||.|||.+|.||||||+.|||| +.+|.|||+|||.+..+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASL 176 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeee
Confidence 9999999 99999998743 4569999999999999999999999999999999999999 58999999999998766
Q ss_pred ccccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
.+.. ....++. ..++||++|||||++.. ..|+.|+||||||++..||.+|..||..+.+..+ ....+ ....+
T Consensus 177 ~~~G--~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tL-qn~pp 250 (516)
T KOG0582|consen 177 FDSG--DRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTL-QNDPP 250 (516)
T ss_pred cccC--ceeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHh-cCCCC
Confidence 5533 2223333 78899999999999553 3599999999999999999999999998766432 12112 22222
Q ss_pred -----CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012192 243 -----TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 289 (468)
Q Consensus 243 -----~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~ 289 (468)
.......+.++.+|+.++..||..||.+||+++ ++|++.|.+..
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAs---kLlkh~FFk~~ 299 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTAS---KLLKHAFFKKA 299 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHH---HHhccHHHhhc
Confidence 112233466788999999999999999999999 45666665543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.39 Aligned_cols=255 Identities=24% Similarity=0.305 Sum_probs=211.8
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCc----hhHHHHHHHHHHhCCCCCceeeEeeEe-CceeE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP----QLHYESKLYMLLQGGTGIPHLKWFGVE-GDYNI 87 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~l~~~~~~-~~~~~ 87 (468)
..+.|+.+++||+|.||.||+|++..+|+.||+|.+......+ -..+|+.||++|.|+++|.....+... ....|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 4568999999999999999999999999999999876665443 468899999999986555544444443 46899
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 88 lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||+|||.-+|.-++....-.|++.++..|+.|++.||+|||++||+|||||..|||| |.++.+||+|||||+.|...
T Consensus 195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeeccCC
Confidence 999999999999998656689999999999999999999999999999999999999 78999999999999988754
Q ss_pred cCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc------
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK------ 240 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 240 (468)
.. . ...+.+-|..|.|||+++|.. |+..+|+||.||||.||+.|+..|++....+...++.++....
T Consensus 272 ~~---~---~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 272 GS---A---PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CC---c---ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 32 1 245778899999999999875 9999999999999999999999999976655555555543211
Q ss_pred ---c------------CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012192 241 ---V------------STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSY 276 (468)
Q Consensus 241 ---~------------~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~ 276 (468)
+ ..-+.+.++.+|.+..+|+..+|.+||++|.++.+
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~ 396 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS 396 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence 0 00112345778899999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=342.16 Aligned_cols=261 Identities=18% Similarity=0.313 Sum_probs=203.9
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeE-e
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGV-E 82 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~-~ 82 (468)
+-.++|++.++||+|+||.||+|.+. .++..||||++..... ...+..|+.++..+.+|++|+.+++++. .
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 44578999999999999999999753 3456899998654322 2357889999999966677777776554 3
Q ss_pred CceeEEEEecc-CCCHHHHHHHcC--------------------------------------------------------
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCN-------------------------------------------------------- 105 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~-------------------------------------------------------- 105 (468)
....+++|||+ +|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 45678899998 899999987421
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCC
Q 012192 106 -----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180 (468)
Q Consensus 106 -----~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 180 (468)
..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++....... +.....
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~ 235 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPD-----YVRKGS 235 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcc-----hhcccC
Confidence 247888999999999999999999999999999999999 4788999999999986533211 112234
Q ss_pred ccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHH
Q 012192 181 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSY 259 (468)
Q Consensus 181 ~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~l 259 (468)
..++..|+|||++.+..++.++|||||||+||||++ |..||.+..... .....+... .... ....+++++.++
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~-~~~~---~~~~~~~~l~~l 309 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDG-TRMR---APENATPEIYRI 309 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcC-CCCC---CCCCCCHHHHHH
Confidence 456788999999999999999999999999999997 999998754321 111112221 1111 123558899999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 260 FHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 260 i~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
|..||+.+|++||++.+|++.|+.++.
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=352.77 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=216.4
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCC----cEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTG----EEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~----~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
.+..++-.+.++||+|+||+||+|.....+ ..||||..... ....+++.|.++|+.++| ++|+.+++++.
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H-~NVVr~yGVa~ 231 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH-PNVVRFYGVAV 231 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEc
Confidence 344566677899999999999999976542 23899986542 234578999999988665 78899999999
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
..++.++|||+| ||+|.+++......++..+.+.++.++|.||+|||++++|||||.++|||++ .++.+||+||||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGL 308 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGL 308 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCcccc
Confidence 999999999999 8899999997666799999999999999999999999999999999999995 667789999999
Q ss_pred ccccccccCcccccccCCC-CccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhh
Q 012192 161 AKKYRDLQTHKHIPYRENK-NLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~-~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
++... .|.... ...-+++|+|||++....|+.++|||||||++||+++ |..||.+++... ...++..
T Consensus 309 s~~~~--------~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~~ 377 (474)
T KOG0194|consen 309 SRAGS--------QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIVK 377 (474)
T ss_pred ccCCc--------ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHHh
Confidence 87533 122233 3346789999999999999999999999999999998 899999987653 3344445
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
..++.+.+. ..|.++..++..||..+|++||+|.++.+.|+.+....
T Consensus 378 ~~~r~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 378 NGYRMPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred cCccCCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 555555444 44999999999999999999999999999999987643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=349.07 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=209.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
..|...++||+|+.|.||.|....+++.||||.+.... ..+-+..|+.+|+..+|.+.|..+..|.+. +..++||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEee
Confidence 57999999999999999999999999999999865543 344578899999988887777766666555 778999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ ||+|.|++.. -.+++.++..|+++++.||+|||.+||||||||.+|||++ .++.|||+|||+|..+.....
T Consensus 352 m~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred cCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeeeeccccccC--
Confidence 9 8999999984 4599999999999999999999999999999999999995 788899999999998766443
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
...+.+||++|||||++....|++|+||||||++++||+-|+.||-..+. .+.+..|..... |.-.....
T Consensus 425 -----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lrAlyLIa~ng~--P~lk~~~k 494 (550)
T KOG0578|consen 425 -----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATNGT--PKLKNPEK 494 (550)
T ss_pred -----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HHHHHHHhhcCC--CCcCCccc
Confidence 34678999999999999999999999999999999999999999986332 333333333222 22223345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
++++|++|+.+||..|++.|+++.+ +|++.|..
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~e---LL~HpFl~ 527 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKE---LLEHPFLK 527 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHH---HhcChhhh
Confidence 6899999999999999999999995 56666553
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=322.81 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=203.0
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCc----hhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP----QLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|+.+.++|+|+||.||+|+++.||+.||||......+.+ -.++|++++++|.|++.|..+. ++......+||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiE-VFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIE-VFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHH-HHHhcceeEEEe
Confidence 57999999999999999999999999999999866555433 4688999999999866655444 446677789999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|||.-++.+.+....+.++.+.+..++.|++.|+.|+|+++||||||||+|||++ ..+.+||||||+|+.+..+..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCCcc-
Confidence 9999888888887788899999999999999999999999999999999999996 789999999999997764221
Q ss_pred ccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc---------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--------- 240 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 240 (468)
.....+.|..|.|||.+.| ..|+..+|||++||++.||++|...|++..+- ++.+.....-.
T Consensus 157 ------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi--DQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 157 ------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI--DQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred ------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH--HHHHHHHHHHcccCHHHHHH
Confidence 2245678999999999998 56999999999999999999999999986543 33332111111
Q ss_pred ---------cCC-------CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 241 ---------VST-------PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 241 ---------~~~-------~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+.. |.+.-..++..-+.+|++.||..||++|++-+++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 111 11112233445688999999999999999998764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=329.46 Aligned_cols=263 Identities=26% Similarity=0.480 Sum_probs=196.4
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccCCCchhHHHHHH------------HHHH--hC
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKTKHPQLHYESKL------------YMLL--QG 69 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~~~~~~~~E~~~------------l~~l--~~ 69 (468)
..+.++.+++|++.++||+|+||.||+|.+..+ +..+|+|+...... .+..|... +..+ ..
T Consensus 4 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~--~~~~e~~~~~~~~~~~~~~~~~~~~~~~ 81 (294)
T PHA02882 4 IPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE--TIVMETLVYNNIYDIDKIALWKNIHNID 81 (294)
T ss_pred eeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCC--chhhHHHHHHhhhhHHHHHHHHHhccCC
Confidence 456788999999999999999999999998777 67888886443322 12222211 1111 13
Q ss_pred CCCCceeeEeeEeCc----eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeec
Q 012192 70 GTGIPHLKWFGVEGD----YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG 145 (468)
Q Consensus 70 ~~~i~~l~~~~~~~~----~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~ 145 (468)
|.+++.+++++.... +.+++++.+..++.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 82 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill- 159 (294)
T PHA02882 82 HLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV- 159 (294)
T ss_pred CCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence 456666666554433 5578889888899888875 3456788899999999999999999999999999999999
Q ss_pred ccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 012192 146 LGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLK 225 (468)
Q Consensus 146 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~ 225 (468)
+..+.++|+|||+|+.+..................||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 160 --~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 160 --DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred --cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 467899999999998764322211111112234579999999999999999999999999999999999999998764
Q ss_pred cccHHH------HHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 226 AGTKKQ------KYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 226 ~~~~~~------~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
...... .+..+...+. ....+|+++.+++..||.++|++||+|.+|.+.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLHEGKI------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cchHHHHHhHHHHHHHhhhhhh------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 322111 1111222111 2345689999999999999999999999998876
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.47 Aligned_cols=261 Identities=20% Similarity=0.300 Sum_probs=209.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
..-++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.+..++...+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH-PFIVNMMCSFQDENRV 93 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEcCCEE
Confidence 33478999999999999999999999999999999865432 23457889999999876 5666777777888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
+++||++ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcC
Confidence 9999997 8899998875 5578999999999999999999999999999999999999 578899999999997653
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+.......|
T Consensus 170 ~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~p- 235 (329)
T PTZ00263 170 DR----------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEKILAGRLKFP- 235 (329)
T ss_pred CC----------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCcCCC-
Confidence 31 124579999999999999999999999999999999999999997643 2344444544443332
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCccccccccc
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
..++.++.++|..||+.||.+||+.. .+.+++. +++....+|..+.
T Consensus 236 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~-------hp~f~~~~~~~~~ 283 (329)
T PTZ00263 236 ----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN-------HPYFHGANWDKLY 283 (329)
T ss_pred ----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc-------CCccCCCCHHHHH
Confidence 33588999999999999999999731 1222332 3445556677654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=360.43 Aligned_cols=266 Identities=23% Similarity=0.345 Sum_probs=222.4
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeE
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKW 78 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~ 78 (468)
....++-..+.++.+.||+|+||+||+|+... ....||||.++.... ..+|.+|++++..|+| +||+.+.+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H-~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH-PNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC-CCeEEEEE
Confidence 45566677788899999999999999998543 346799997665543 3579999999999887 67888899
Q ss_pred eeEeCceeEEEEecc-CCCHHHHHHHcC---------CC----CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceee
Q 012192 79 FGVEGDYNIMVIDLL-GPSLEDLFNYCN---------RK----FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144 (468)
Q Consensus 79 ~~~~~~~~~lv~el~-ggsL~~ll~~~~---------~~----ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl 144 (468)
++.+++..+||+||+ .|+|..++.... .. |+..+.+.||.|||.||+||-++.+|||||..+||||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 999999999999999 999999998542 23 8889999999999999999999999999999999999
Q ss_pred cccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 012192 145 GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 223 (468)
Q Consensus 145 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~ 223 (468)
+ ++..|||+||||++..-.... |+......-.++||+||.+..+.|+.++|||||||+|||+++ |..||.+
T Consensus 637 g---e~l~VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g 708 (774)
T KOG1026|consen 637 G---ENLVVKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG 708 (774)
T ss_pred c---cceEEEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence 6 899999999999986433222 233335556899999999999999999999999999999999 9999999
Q ss_pred CCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 224 LKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 224 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
+.+. +.++.|..... .+.+..| |.++.+||..||+.+|.+||+|.+|...|++.....
T Consensus 709 lSn~---EVIe~i~~g~l-L~~Pe~C---P~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 709 LSNQ---EVIECIRAGQL-LSCPENC---PTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred cchH---HHHHHHHcCCc-ccCCCCC---CHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 8764 34444444444 5555444 999999999999999999999999999999987653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=327.28 Aligned_cols=263 Identities=19% Similarity=0.231 Sum_probs=204.8
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.|++.+.||+|+||+||+|.+..+++.||||...... ....+..|+.++..+.| +++..+..++.+.+..+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCC-CcEEEEEEEEccCCeEEEEE
Confidence 3889999999999999999999999999999754322 12246779999988876 56666777777788899999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+++ +++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||+ ++++.++|+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 988 78998877643 3468999999999999999999999999999999999999 578899999999997653211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+..... ......
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~ 224 (285)
T cd05631 157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----EDQEEY 224 (285)
T ss_pred e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh----cccccC
Confidence 1 1245789999999999999999999999999999999999999987554322222222111 111223
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCcccccccccCC
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGFQFDYVFDWTVLKYP 304 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 304 (468)
...+++++.+||..||+.||++||+ +++| ++ +++...++|..+...
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~---~~-------h~~~~~~~~~~~~~~ 275 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV---KQ-------HPIFKNINFKRLEAN 275 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH---hc-------CHhhcCCCHHHHHhC
Confidence 3457899999999999999999997 4433 33 344455667766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=330.56 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=211.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+|++++.||+|+||.||+|.+..+++.||||++... .....+..|.+++..+.++++|+.++.++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999986542 223356778888888888888999998888899999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCC
Confidence 998 8899988874 4578999999999999999999999999999999999999 4788999999999874322111
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+.......+
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~~----- 221 (324)
T cd05587 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSIMEHNVSYP----- 221 (324)
T ss_pred -------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCC-----
Confidence 12345799999999999999999999999999999999999999986543 334444444333222
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
..+++++.+++..||..+|.+|++.... ..+++ ..+++....+|....
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~--~~~~~---~~hp~~~~~~~~~~~ 269 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGPT--GERDI---REHAFFRRIDWEKLE 269 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCC--CHHHH---hcCCCcCCCCHHHHH
Confidence 3568999999999999999999976310 01111 235566667887654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=326.29 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=207.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|..++.+..+....+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH-PFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCC-CcHhhhHhhhccCCeEEEE
Confidence 47999999999999999999999899999999865432 23457789999888876 5666777777888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC-
Confidence 9988 7899999875 5579999999999999999999999999999999999999 57889999999998765321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+..+.......+
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~---- 218 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYEKILAGKLEFP---- 218 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCcCCC----
Confidence 1245789999999999999999999999999999999999999986432 334444444443332
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
..+++.+.++|.+||+.||.+||+ ++++ + .+++...++|....
T Consensus 219 -~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~---l-------~h~~~~~~~~~~~~ 266 (291)
T cd05612 219 -RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDV---K-------NHRWFKSVDWDDVP 266 (291)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHH---h-------cCccccCCCHHHHh
Confidence 345889999999999999999995 4432 2 34555667776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=326.79 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=200.3
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcC----------------CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQ----------------TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTG 72 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~----------------~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~ 72 (468)
+..++|++.++||+|+||.||+|.+.. ++..||||+...... ...+..|++++..+.| ++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKD-PN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCC-CC
Confidence 456799999999999999999997532 345799998654322 2357889999998876 66
Q ss_pred CceeeEeeEeCceeEEEEecc-CCCHHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 012192 73 IPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCN------------------RKFSLKTVLMLADQLINRVEYMHSRGFL 133 (468)
Q Consensus 73 i~~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~------------------~~ls~~~~~~ia~qia~gL~yLHs~gii 133 (468)
|+.+.+++.+.+..+++||++ +++|.+++.... ..+++..++.++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 777777777888899999998 889999886421 2467889999999999999999999999
Q ss_pred eccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHH
Q 012192 134 HRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY 213 (468)
Q Consensus 134 HrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~e 213 (468)
||||||+|||+ +.++.+||+|||+++....... +.......++..|+|||++.+..++.++||||||+++||
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 99999999999 4788999999999976533211 112234456889999999998899999999999999999
Q ss_pred HHc--CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 214 FLR--GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 214 llt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
|++ +..||.+............................+|..+.++|.+||+.+|++||++.+|.+.|+
T Consensus 233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 986 678888765433222221111111000001112345899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=327.34 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=211.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+|.+.+.||+|+||.||+|.+..++..||||++.... ....+..|..++..+.++++|..+..++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999865432 12245667778777888899999999989999999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCC
Confidence 998 7899988874 4579999999999999999999999999999999999999 5788999999999875332111
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+.......|
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~~p----- 221 (323)
T cd05616 157 -------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVAYP----- 221 (323)
T ss_pred -------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC-----
Confidence 12356799999999999999999999999999999999999999986433 344444544443333
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
..++.++.+++..|++.+|++|++.... ..+++ ..+++....+|.....
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~~--~~~~i---~~h~~~~~~~~~~~~~ 270 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGPE--GERDI---KEHAFFRYIDWEKLER 270 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCCC--CHHHH---hcCCCcCCCCHHHHHh
Confidence 3468999999999999999999985210 01111 2345556678877653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=336.89 Aligned_cols=259 Identities=19% Similarity=0.322 Sum_probs=205.7
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCC-----CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQT-----GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~-----~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
-.++|++++.||+|+||.||+|.+... +..||||++..... ...+..|+.++..+..|++|+.+.+++....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 346899999999999999999986543 35799998754332 2357789999999966788888888888888
Q ss_pred eeEEEEecc-CCCHHHHHHHcC----------------------------------------------------------
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCN---------------------------------------------------------- 105 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~---------------------------------------------------------- 105 (468)
..+++|||+ +|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999998 889999886421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 106 -----------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 106 -----------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
..+++..++.++.||+.||+|||++||+||||||+|||+ ++++.++|+|||+++.......
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~----- 267 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSN----- 267 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcc-----
Confidence 247888999999999999999999999999999999999 4788999999999976543211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCc
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP 253 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 253 (468)
........++..|+|||++.+..++.++|||||||++|+|++ |..||....... .+............ ...+|
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~~~---~~~~~ 341 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQMSR---PDFAP 341 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCccC---CCCCC
Confidence 111223446678999999999999999999999999999997 999998754322 22222222222211 12358
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 254 SEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 254 ~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
+++.++|..||+.+|++||++.+|+++|++++
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=327.37 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=201.9
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|..+..++...+..++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999865432 22356778888888876 56777777778888999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~------ 149 (323)
T cd05571 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCC------
Confidence 899888874 5679999999999999999999999999999999999999 578899999999987532211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+.......+ ..+++
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~~~p-----~~~~~ 220 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIRFP-----RTLSP 220 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCCCC-----CCCCH
Confidence 11235679999999999999999999999999999999999999997643 2333333333333222 45689
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||+.||++|| ++.+|+ .+++....+|....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll----------~h~~f~~~~~~~~~ 263 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIM----------EHRFFASINWQDVV 263 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHH----------cCCCcCCCCHHHHH
Confidence 999999999999999999 566543 24556667777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.86 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=200.4
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++.++||.|+||.||+|.+..++..||||+..... ....+..|+.++..+.| ++|..+..++...+..+++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH-ANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEEe
Confidence 57999999999999999999999999999999865332 23457789999998876 667778777788888999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
++.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~--- 157 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT--- 157 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC---
Confidence 99999999988766678999999999999999999999999999999999999 578899999999987543211
Q ss_pred cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc---------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV--------- 241 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 241 (468)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+.....
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 158 ----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred ----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 11234578999999999876 4589999999999999999999999987543222222211110000
Q ss_pred -------------CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 242 -------------STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 242 -------------~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..+.......+++++.++|..||+.||.+||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0011112234578899999999999999999999765
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=306.55 Aligned_cols=251 Identities=20% Similarity=0.237 Sum_probs=205.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.+|...++||+|.||.||+|++..+|+.||||.+...... ....+|++.++.++| ++|..+.+++...+..-+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h-~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKH-PNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccC-cchhhhhhhccCCCceEEEE
Confidence 5789999999999999999999999999999987765443 367899999999986 56666666667777888999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|++..+|+.+++.....|+...+..|+.+++.||+|||++.|+||||||.|+|++ .++.+||+|||+|+.+.....
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p~~- 156 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSPNR- 156 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCCCc-
Confidence 9999999999998888899999999999999999999999999999999999995 899999999999998875432
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc---------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--------- 240 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 240 (468)
.....+-|..|.|||.+.|.. |+..+|+||.||++.||+.|.+-|+|.++-+...++..+....
T Consensus 157 ------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 157 ------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred ------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 112236788999999999875 8999999999999999999998888865533333332221110
Q ss_pred ----------cC-CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012192 241 ----------VS-TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSY 276 (468)
Q Consensus 241 ----------~~-~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~ 276 (468)
++ .+...++...+....+|+..+|..||.+|+++.+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ 277 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence 11 1112244556678899999999999999999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=331.14 Aligned_cols=247 Identities=20% Similarity=0.333 Sum_probs=200.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+. |++|+.+..++...+..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999865432 2345778899988887 56777777788888999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--
Confidence 9998 8899999975 5578999999999999999999999999999999999999 5788999999999976433
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc--cCCCH-
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--VSTPI- 245 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~--~~~~~- 245 (468)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+.... ...+.
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWENLKYWKETLQRPVY 222 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HHHHHHHhccccccCCCC
Confidence 123567999999999999999999999999999999999999999865432 2222222211 11111
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
......+++++.++|..||..+|++||++.+|.+
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 1111245889999999999999999999876543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=335.31 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=211.8
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
-...|...+.||.|+||.||+|.+..+++.||||++..... ...+..|+.++..+.+ ++|..+++....+...+++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-PNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-chHHhhhhheeecccHHHH
Confidence 34578888999999999999999999999999998766543 3467889999988887 6777777777889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ ||++.++++. +..+.+..+..++++++.||.|||..+.+|||||+.|||+. ..+.|||+|||.+.......
T Consensus 90 Mey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechh
Confidence 9999 8899999984 55568889999999999999999999999999999999995 66999999999998765533
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. ...+++||+.|||||++.+..|+.|+||||||++.|||++|.+||.++.++..... +.+ .+++.+
T Consensus 166 ~-------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----Ipk---~~PP~L 231 (467)
T KOG0201|consen 166 K-------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----IPK---SAPPRL 231 (467)
T ss_pred h-------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----ccC---CCCCcc
Confidence 2 23689999999999999988999999999999999999999999998766322211 111 223334
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
-..+.+.|++|+..||..||+.||++.+ +|.+-|++.
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~---LLKh~FIk~ 268 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKE---LLKHKFIKR 268 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHH---HhhhHHHHh
Confidence 4578899999999999999999999995 455555543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.60 Aligned_cols=254 Identities=19% Similarity=0.247 Sum_probs=197.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcC-CCcEEEEEEeeccCC----CchhHHHHHHHHHHh--CCCCCceeeEeeE-----e
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQ-TGEEIAVKLELVKTK----HPQLHYESKLYMLLQ--GGTGIPHLKWFGV-----E 82 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~-~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~--~~~~i~~l~~~~~-----~ 82 (468)
++|++.+.||+|+||.||+|.+.. ++..||||....... ...+..|+.++..+. .|++|+.+.+++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 468899997654322 234667888887775 3577777766553 3
Q ss_pred CceeEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 GDYNIMVIDLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 ~~~~~lv~el~ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
....+++||++.++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccce
Confidence 4568999999999999998754 3458999999999999999999999999999999999999 47889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh---
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE--- 238 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~--- 238 (468)
+.+.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.....
T Consensus 158 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 158 RIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred EeccCCc--------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 7654321 12356789999999999998999999999999999999999999987544322222211100
Q ss_pred ----------------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 239 ----------------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 239 ----------------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....+.+.+...+++.+.++|.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 01112223344567889999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=323.95 Aligned_cols=278 Identities=21% Similarity=0.288 Sum_probs=227.5
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
-+.+--..|++++.||.|.-|.||++....++..+|+|++... .+......|.+||..+.| |.++.++..++..
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH-PFlPTLYa~fet~ 149 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH-PFLPTLYASFETD 149 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC-Cccchhhheeecc
Confidence 3445557899999999999999999999999999999986543 334567789999887765 8999999999999
Q ss_pred ceeEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
++.+++|||| ||+|..+++.. ++.|++..+..++.+++.||+|||-.|||+|||||+|||| .++|+|.|+||.|+
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS 226 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLS 226 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeecccc
Confidence 9999999999 99999998753 5679999999999999999999999999999999999999 68999999999997
Q ss_pred cccccccCcc----------------------------c--------------------ccc-cCCCCcccccccccccc
Q 012192 162 KKYRDLQTHK----------------------------H--------------------IPY-RENKNLTGTARYASVNT 192 (468)
Q Consensus 162 ~~~~~~~~~~----------------------------~--------------------~~~-~~~~~~~Gt~~y~APE~ 192 (468)
.......+.. . .|. .....++||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 5442200000 0 000 11345789999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCC
Q 012192 193 HLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKP 272 (468)
Q Consensus 193 ~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RP 272 (468)
+.|...+.++|+|+|||+||||+.|..||.|... .+.+..|..+....|... .++...++||..+|..||.+|.
T Consensus 307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~---~~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN---KETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc---hhhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhhhh
Confidence 9999999999999999999999999999998644 466667777766665432 4468999999999999999998
Q ss_pred CHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 273 DYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 273 s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
.+. +.......++|+...+|..+.
T Consensus 381 g~~------rGA~eIK~HpFF~gVnWaLir 404 (459)
T KOG0610|consen 381 GSK------RGAAEIKRHPFFEGVNWALIR 404 (459)
T ss_pred ccc------cchHHhhcCccccCCChhhee
Confidence 743 233334568999999999754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=340.77 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=208.6
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
...-+|-.+++.+++.||+|.||+||+|.|.. +||||++....-. +.|..|+.+|++-+|. ||..+.+++..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~-NIlLFMG~~~~ 459 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHE-NILLFMGACMN 459 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchh-hheeeehhhcC
Confidence 34456677888999999999999999999853 5999997765433 3588899999998885 55566666666
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
..+ .||..+| |.+|+.+++-...+|...+.+.||.|+++||.|||.++|||||||..||++ .+++.|||.||||+
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLA 535 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccce
Confidence 666 7788888 778999998667789999999999999999999999999999999999999 57799999999998
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
..-..-... .......|.+.|||||++... +|++.+||||||+|+|||++|.+||... ...+.+.. +.
T Consensus 536 tvk~~w~g~-----~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~---~~dqIifm-VG 606 (678)
T KOG0193|consen 536 TVKTRWSGE-----QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ---NRDQIIFM-VG 606 (678)
T ss_pred eeeeeeccc-----cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC---ChhheEEE-ec
Confidence 643221111 112345688999999999844 5899999999999999999999999842 22333332 23
Q ss_pred cccCC-CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 239 KKVST-PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 239 ~~~~~-~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+.. ..-....++|.++.+|+..||..++++||.+.+|...|+++..
T Consensus 607 rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 607 RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 33333 3334456679999999999999999999999999998887764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=317.75 Aligned_cols=255 Identities=14% Similarity=0.227 Sum_probs=203.6
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
-.++|++.+.||+|+||.||+|.+. ..+..||||....... ...+..|+.++..+.| ++|+.+.+++...+..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH-SNIVRLEGVITRGNTM 81 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEecCCCc
Confidence 3567999999999999999999865 3567899998654432 2356778888888765 6777788888888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++||||+ +++|.+++......+++..++.++.|++.||+|||+++++||||||+|||+ +.++.++|+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCccccccc
Confidence 9999999 679999988656679999999999999999999999999999999999999 478899999999876432
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.... .......++..|+|||++.+..++.++|||||||++||+++ |..||.+..... .+..+. .....+
T Consensus 159 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~-~~~~~~ 228 (266)
T cd05064 159 SEAI------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVE-DGFRLP 228 (266)
T ss_pred ccch------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHH-CCCCCC
Confidence 2110 11123345678999999999999999999999999999775 999998764432 222222 222222
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
. ...+|..+.+++.+||+.+|++||++.+|.+.|..+
T Consensus 229 ~---~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 A---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C---CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 2 245689999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=321.87 Aligned_cols=292 Identities=42% Similarity=0.686 Sum_probs=244.2
Q ss_pred CCceecC-ceEEEceEeeeCCeEEEEEEEcCCC-cEEEEEEeeccCC--CchhHHHHHHHHHHh---CCCCCceeeEee-
Q 012192 9 MDHVIGG-KFKLGRKIGSGSFGELYLGVNVQTG-EEIAVKLELVKTK--HPQLHYESKLYMLLQ---GGTGIPHLKWFG- 80 (468)
Q Consensus 9 ~~~ii~~-~y~i~~~LG~G~fG~Vy~~~~~~~~-~~vAIK~~~~~~~--~~~~~~E~~~l~~l~---~~~~i~~l~~~~- 80 (468)
++..... +|++.++||+|+||.||+|.+..++ ..+|+|++..... ...+..|..++..+. +..+++.+.+.+
T Consensus 11 ~~~~~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 11 LDNDKVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred hhhcccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 3444445 8999999999999999999987764 6899998776533 337999999999998 467999999999
Q ss_pred EeCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC--CCCeEEEEe
Q 012192 81 VEGDYNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR--KANQVYIID 157 (468)
Q Consensus 81 ~~~~~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~--~~~~vkL~D 157 (468)
....+.+|||+++|.+|.++..... +.|+..+++.++.|++.+|++||+.|+|||||||.|+++|... +...++|+|
T Consensus 91 ~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 91 STEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred CCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 5888999999999999999997554 7899999999999999999999999999999999999998543 226799999
Q ss_pred CCccc--ccccccCcccccccC-CCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 012192 158 YGLAK--KYRDLQTHKHIPYRE-NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 158 FGla~--~~~~~~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 234 (468)
||+++ .+.........+.+. ...+.||.+|+++++|.+.++++++|+|||++++.+|+.|.+||.+.........+.
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99999 443322222344444 346779999999999999999999999999999999999999999877665566665
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
.......... .+...|.++..++..+-..++.++|+|..+..+|++.+...+.....++||+....
T Consensus 251 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~ 316 (322)
T KOG1164|consen 251 KDPRKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLR 316 (322)
T ss_pred HHhhhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccccc
Confidence 5544443332 44456899999999999999999999999999999999999999999999997653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=320.35 Aligned_cols=252 Identities=20% Similarity=0.258 Sum_probs=198.0
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.++|++.++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++|+.+..++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCC-CCcCeEEEEEecCCeEEEEE
Confidence 3689999999999999999999998999999998654322 2356789999988876 56777777778888999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|++.++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +..+.+||+|||++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCC--
Confidence 999999999888666779999999999999999999999999999999999999 578899999999987543211
Q ss_pred ccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST------ 243 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------ 243 (468)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... ...+..+.......
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 158 -----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred -----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhcc
Confidence 112345689999999998764 5889999999999999999999999875432 12221111100000
Q ss_pred -----------------C--HHHhh--ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 244 -----------------P--IEVLC--KSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 244 -----------------~--~~~l~--~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+ ..... ..+++++.+++..||+.||.+||++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 0 00000 12457889999999999999999988653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=336.88 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=213.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
|-|++++.||.|+.|.|-+|++..||+.+|||++.... ....+.+|+-+|+.+.| ++|..++.++....++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~H-pnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEH-PNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcC-CCeeeeeeeeccCceEEEE
Confidence 57999999999999999999999999999999866542 23457888888776666 6777888888888888888
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
.||+ +|.|.+++-. .+.|.+.++.+++.||+.|+.|+|..+|+||||||+|+|+ |..+++||+|||+|......
T Consensus 91 lEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCC-
Confidence 8888 8899988875 5689999999999999999999999999999999999999 67788999999999764432
Q ss_pred CcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
....+-||.+.|+|||++.|.+| +.++||||.|||||-||+|.+||.+ .+....+.++....+.+|
T Consensus 166 -------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~MP--- 232 (786)
T KOG0588|consen 166 -------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFEMP--- 232 (786)
T ss_pred -------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCcccCC---
Confidence 23467899999999999999997 7899999999999999999999985 456677778888888877
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.+++.+.++||.+++..||+.|.++++| |++.|.
T Consensus 233 --s~Is~eaQdLLr~ml~VDp~~RiT~~eI---~kHP~l 266 (786)
T KOG0588|consen 233 --SNISSEAQDLLRRMLDVDPSTRITTEEI---LKHPFL 266 (786)
T ss_pred --CcCCHHHHHHHHHHhccCccccccHHHH---hhCchh
Confidence 5669999999999999999999998865 445554
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=326.29 Aligned_cols=255 Identities=20% Similarity=0.261 Sum_probs=195.7
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEe-----Ccee
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVE-----GDYN 86 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-----~~~~ 86 (468)
+|++.++||+|+||.||+|.+..++..||||.+.... ....+..|++++..+.|+ +|..+..+... ....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHP-DIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCC-CEeeecceEeccCCCCCceE
Confidence 6999999999999999999999999999999765321 223577899999998765 55555444332 2347
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 87 IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 87 ~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+++||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 80 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCcccccccc
Confidence 99999999999999875 4579999999999999999999999999999999999999 5788999999999976432
Q ss_pred ccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH---------
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK--------- 235 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~--------- 235 (468)
..... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 156 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 156 DTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 21110 11234579999999999876 5789999999999999999999999986543211111100
Q ss_pred --------------HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 236 --------------ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 236 --------------i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
........+.......+++++.++|..||..+|++||++.+|++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 01111222233334567889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=338.57 Aligned_cols=237 Identities=20% Similarity=0.339 Sum_probs=198.7
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCCHH
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLE 98 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggsL~ 98 (468)
++.||+|+.|.||+|+. .++.||||.... .-.-+++-|++|.| ++|..+.+++.....++|+|||| .|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e-----lkETdIKHLRkLkH-~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE-----LKETDIKHLRKLKH-PNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhh-----hhhhhHHHHHhccC-cceeeEeeeecCCceeEEeeeccccccHH
Confidence 57799999999999986 678999995321 12346777788887 56677888888889999999999 89999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCC
Q 012192 99 DLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYREN 178 (468)
Q Consensus 99 ~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 178 (468)
.+++. ++.++......|..+||.||.|||.++|||||||.-||||+ .+..|||+|||.++...+..+ .
T Consensus 201 ~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~ST--------k 268 (904)
T KOG4721|consen 201 EVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKST--------K 268 (904)
T ss_pred HHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhh--------h
Confidence 99995 78899999999999999999999999999999999999996 678999999999987766443 3
Q ss_pred CCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHH
Q 012192 179 KNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVS 258 (468)
Q Consensus 179 ~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~ 258 (468)
-.++||+.|||||++.+.+.+.|+|||||||||||||||..||.+.... ..+.-+....+..|.+..| |+.|.-
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~LpvPstc---P~Gfkl 342 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHLPVPSTC---PDGFKL 342 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccccCcccC---chHHHH
Confidence 4689999999999999999999999999999999999999999875432 2221222334455655555 999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 259 YFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 259 li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
||++||+..|.+||+|.+|+..|+
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHh
Confidence 999999999999999998877654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.37 Aligned_cols=254 Identities=19% Similarity=0.213 Sum_probs=198.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|++.+.||+|+||.||+|.+..++..||||+..... ....+..|++++..+.| ++|..+..++...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ-ENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCC-ccccchhhhEecCCEEEEEE
Confidence 47999999999999999999999999999999865432 23456789999988876 45666777777888999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
||+.+.+.+.+......+++..+..++.|++.||.|||+.+|+||||||+|||+ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc-
Confidence 999777666666556679999999999999999999999999999999999999 4788999999999986543211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc-----------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK----------- 239 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 239 (468)
.......||..|+|||++.+..++.++|||||||++|||++|..||.+.........+..+...
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 156 -----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred -----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 1123457899999999999989999999999999999999999999875432221111111000
Q ss_pred -----ccCCCH--------HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 -----KVSTPI--------EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 -----~~~~~~--------~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+. ......++.++.+||.+||+.||++||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000 011123678899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=324.47 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=212.9
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+|++.+.||+|+||.||+|.+..++..||||++.... ....+..|..++..+.|+++|..+..++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999865431 22346678888888888899999988888889999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCC-
Confidence 999 7899988874 4579999999999999999999999999999999999999 578899999999987533211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+..+.......|
T Consensus 156 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~p----- 221 (323)
T cd05615 156 ------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIMEHNVSYP----- 221 (323)
T ss_pred ------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC-----
Confidence 112356799999999999999999999999999999999999999987533 344444444443333
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
..++.++.+++..||+.+|.+|++..+. ..+++ ..+++...++|.....
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~--~~~~i---~~h~~f~~~~~~~~~~ 270 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPE--GERDI---REHAFFRRIDWDKLEN 270 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCC--CHHHH---hcCcccCCCCHHHHhc
Confidence 3458899999999999999999975421 11111 2456677788877653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=321.60 Aligned_cols=254 Identities=21% Similarity=0.272 Sum_probs=202.5
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.+|++|+.+..++...+..++|||++ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999865432 22345667777777777889999888888889999999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~------ 150 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGE------ 150 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCC------
Confidence 899988875 4579999999999999999999999999999999999999 578899999999997543211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+....... ...++.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~-----~~~~~~ 221 (316)
T cd05592 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDRPHF-----PRWISK 221 (316)
T ss_pred -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCC-----CCCCCH
Confidence 122356799999999999999999999999999999999999999987543 33333333322222 234588
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||..+|++||++.+ +++ .+++....+|....
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~--~l~-------~h~~~~~~~~~~~~ 260 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDG--DIR-------QHPFFRGIDWERLE 260 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChH--HHH-------cCcccCCCCHHHHH
Confidence 9999999999999999998742 111 24555566776654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=325.20 Aligned_cols=262 Identities=22% Similarity=0.308 Sum_probs=210.8
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEEEcCCC-cEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTG-EEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~-~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
....+.-++|++.++||+|+||.||+|.+..++ ..||||..... .....+..|+.++..+.| ++|+.+..++.
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~ 101 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNLYGSFK 101 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCCcceEEEEE
Confidence 344556678999999999999999999876654 68999976432 223457789999888875 66777777888
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
+....+++|||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~ 177 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGF 177 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCC
Confidence 888999999998 8899999875 5579999999999999999999999999999999999999 5788999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+....
T Consensus 178 a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~i~~~~ 244 (340)
T PTZ00426 178 AKVVDTR----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKILEGI 244 (340)
T ss_pred CeecCCC----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHHHHHhcCC
Confidence 9764321 1345799999999999998999999999999999999999999986432 33344444443
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
...| ..+++++.++|.+||+.+|++|+ ++++|. .+++...++|....
T Consensus 245 ~~~p-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~----------~hp~f~~~~~~~~~ 296 (340)
T PTZ00426 245 IYFP-----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK----------EHPWFGNIDWVSLL 296 (340)
T ss_pred CCCC-----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH----------cCCCcCCCCHHHHH
Confidence 3333 34588999999999999999996 555432 35666677887644
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.32 Aligned_cols=257 Identities=19% Similarity=0.314 Sum_probs=204.0
Q ss_pred cCceEEEceEeeeCCeEEEEEEE-----cCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVN-----VQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~-----~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.++|++.++||+|+||.||+|.+ ..++..||||++.... ....+..|+.++..+.+|++|+.+.+++..+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45899999999999999999974 2456789999865432 223577899999999777899999988899999
Q ss_pred eEEEEecc-CCCHHHHHHHcC-----------------------------------------------------------
Q 012192 86 NIMVIDLL-GPSLEDLFNYCN----------------------------------------------------------- 105 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~----------------------------------------------------------- 105 (468)
.+++|||+ +|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999998 889998886421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 106 ---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 106 ---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
..+++..+..++.||+.||.|||+++|+||||||+|||+. .++.++|+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~- 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSN- 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCccc-
Confidence 2478888999999999999999999999999999999994 678899999999976543211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
+.......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+.+..........+
T Consensus 270 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~~~~--- 339 (375)
T cd05104 270 ----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMIKEGYRMLSP--- 339 (375)
T ss_pred ----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHHHhCccCCCC---
Confidence 111233456678999999999999999999999999999997 999998754322 122222222222211
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
...|.++.+||..||+.||++||++.+|++.|+..
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 23488999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=326.17 Aligned_cols=265 Identities=19% Similarity=0.273 Sum_probs=205.4
Q ss_pred ceEEEceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccC------CCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 16 KFKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKT------KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
+|+++++||+|+||.||++.+. .++..||||+..... ....+..|+.++..+.+|++|..+..++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 478999999865321 1234677999999998889999998888888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 9999999 7899988874 5579999999999999999999999999999999999999 478899999999997653
Q ss_pred cccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH-HHHHHhhcccCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYDKISEKKVST 243 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~~~ 243 (468)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.......... ....+......
T Consensus 157 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 229 (332)
T cd05614 157 SEEKE------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP- 229 (332)
T ss_pred ccCCC------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC-
Confidence 32111 123457999999999998754 7899999999999999999999997543322222 22222222221
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCccccccccc
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+...+++++.++|..||+.||++||++. .+.++++ +++....+|....
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~-------h~~~~~~~~~~~~ 279 (332)
T cd05614 230 ----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE-------HPFFKGLDWEALA 279 (332)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc-------CCCcCCCCHHHHH
Confidence 2234689999999999999999999543 2223332 3455556676653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=324.83 Aligned_cols=260 Identities=20% Similarity=0.249 Sum_probs=205.3
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..+++.||||++.... ....+..|.+++..+.+|++|..++.++...+..++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999865431 22346678888887878899999999999999999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV----- 151 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc-----
Confidence 899888874 5679999999999999999999999999999999999999 5788999999999875432111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+..+.......| ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~i~~~~~~~p-----~~~~~ 221 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESILHDDVLYP-----VWLSK 221 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCC-----CCCCH
Confidence 12346799999999999999999999999999999999999999986543 334444444333222 23588
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||+.+|++||+........+++ ..+++...++|..+.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~---~~hp~~~~~~~~~~~ 266 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAI---KQHPFFKEIDWVLLE 266 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHH---hcCCccCCCCHHHHH
Confidence 999999999999999999433211111111 135566777888654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=322.01 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=202.2
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..+++.||||++... .....+..|..++..+.+|++|..++.++...+..++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999986543 223456677888777777889999988888999999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC-----
Confidence 899988875 4579999999999999999999999999999999999999 5788999999999874321111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+....... ...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~~~~~-----~~~~~~ 221 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVDTPHY-----PRWITK 221 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCC-----CCCCCH
Confidence 12356799999999999999999999999999999999999999986433 23333332222212 234588
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||+.||++||++.+ ++ ..+++....+|..+.
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~--~~-------~~h~~f~~~~~~~~~ 260 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVG--NI-------RGHPFFKTINWTALE 260 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChH--HH-------HcCCCcCCCCHHHHH
Confidence 9999999999999999998742 11 124556666777554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=336.24 Aligned_cols=212 Identities=25% Similarity=0.343 Sum_probs=185.1
Q ss_pred CCCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHh-----CCCCCceee
Q 012192 4 DGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQ-----GGTGIPHLK 77 (468)
Q Consensus 4 ~~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~-----~~~~i~~l~ 77 (468)
++.+...+.++.+|++.+.||+|+||.|.+|.+.+|++.||||+++... ...+...|+.+|..|. +..++++++
T Consensus 175 dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 175 DYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred ceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 4567788999999999999999999999999999999999999876543 3567788999999998 346788999
Q ss_pred EeeEeCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 78 WFGVEGDYNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 78 ~~~~~~~~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
.++...++.+||+|++.-+|.++++.+. ..|++..+..|+.||+.||.+||+.+|||+||||+||||-.. ....|||+
T Consensus 255 d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVI 333 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVI 333 (586)
T ss_pred eccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEE
Confidence 9999999999999999999999999653 459999999999999999999999999999999999999533 34589999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 226 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~ 226 (468)
|||.+...... ......+..|.|||+++|.+|+.+.|+||||||++||++|.+.|+|...
T Consensus 334 DFGSSc~~~q~----------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 334 DFGSSCFESQR----------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ecccccccCCc----------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 99998754321 1245677889999999999999999999999999999999888887543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=332.19 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=210.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+.... ..+.+|++++..++|+++| .+...++.....++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv-~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIV-EMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchh-hHHHhhcccceEEEEe
Confidence 5789999999999999999999999999999986554332 2488999999999986555 4544456777889999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
||+-|+|..++.. +..++++.+..++.|++.||.|||+.+|+|||+||.|||+ +..+.+|++|||+|+.......
T Consensus 81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce-
Confidence 9998899999986 6789999999999999999999999999999999999999 5899999999999997664221
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
......||+.|||||+..+.+|+..+|+|||||++||++.|++||.. ....+.+..|.......|.
T Consensus 156 ------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p~----- 221 (808)
T KOG0597|consen 156 ------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPPS----- 221 (808)
T ss_pred ------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCcc-----
Confidence 23567899999999999999999999999999999999999999974 3455666666665555554
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.....|..|++-.|..||..|.+..+ ++.+.|.+
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~---Ll~HpF~k 255 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTD---LLGHPFWK 255 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHH---HhcChHHh
Confidence 34789999999999999999999774 55555543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=323.48 Aligned_cols=259 Identities=19% Similarity=0.252 Sum_probs=206.2
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..++..||||++... .....+..|..++..+.+|++|+.++.++...+..++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999986532 222346678888887777889999999889999999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~----- 151 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK----- 151 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC-----
Confidence 899988875 5679999999999999999999999999999999999999 5788999999999875322111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+.......+ ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~-----~~~~~ 221 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAILNDEVVYP-----TWLSQ 221 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCCCCC-----CCCCH
Confidence 12345799999999999999999999999999999999999999986433 334444443333222 34589
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||+.||++||++.++ ...-....+++...++|+.+.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~----~~~~~~~~h~~f~~~~~~~~~ 265 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTL----GGEEAILRHPFFKELDWEKLN 265 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCC----CCHHHHHcCCCcCCCCHHHHH
Confidence 99999999999999999998442 111111245666677887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=335.25 Aligned_cols=256 Identities=21% Similarity=0.284 Sum_probs=193.3
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeE-------eC
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGV-------EG 83 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-------~~ 83 (468)
....++|+++++||+|+||.||+|.+..+++.||||.+... ......|+.++..+.|++.|.....+.. ..
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 44567899999999999999999999999999999976433 2345579999999987555544333321 12
Q ss_pred ceeEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 84 DYNIMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 84 ~~~~lv~el~ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
.+.++||||+.++|.+++.. ....+++..+..++.||+.||.|||+++|+||||||+|||+. ...+.+||+|||+
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGl 217 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGS 217 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeecccc
Confidence 35679999999999887753 356799999999999999999999999999999999999994 2345799999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
|+.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+..+...
T Consensus 218 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 218 AKNLLAGQ--------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred chhccCCC--------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 98654321 12345789999999998865 5899999999999999999999999875433222222111100
Q ss_pred --------------ccCCC-------HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 --------------KVSTP-------IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 --------------~~~~~-------~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+ ...+....|+++.+||.+||..+|.+||++.++.
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00000 0112234678999999999999999999998653
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.34 Aligned_cols=239 Identities=22% Similarity=0.288 Sum_probs=194.5
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHh--CCCCCceeeEeeEeCceeEEE
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQ--GGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv 89 (468)
|++.+.||+|+||.||+|.+..+++.||||+..... ....+..|.+++..+. .|++|..+..++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999865331 2234666777665443 367888888888889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9998 778887776 4579999999999999999999999999999999999999 578899999999987533211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+.......+
T Consensus 156 -------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~~~p---- 221 (324)
T cd05589 156 -------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDSIVNDEVRYP---- 221 (324)
T ss_pred -------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC----
Confidence 112456799999999999999999999999999999999999999986432 333333444333322
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYS 275 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~ 275 (468)
..++.++.++|.+||+.+|.+||++.
T Consensus 222 -~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 222 -RFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred -CCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 34589999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=328.61 Aligned_cols=258 Identities=20% Similarity=0.338 Sum_probs=216.1
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
.+..+..+||-|.||+||.|.|++-.--||||.++.+.. ..+|+.|..+|+.+.|++.|. +.++|..+...||+.|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVq-LLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ-LLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHH-HhhhhccCCCeEEEEecc
Confidence 456677899999999999999999888999998665543 467999999999998865555 455555555566666665
Q ss_pred -CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 94 -GPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 94 -ggsL~~ll~~~~~~-ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+|+|.+++.+|++. ++.-..+.++.||..||+||..+++|||||.++|||+| ++..|||+||||++.+..+.
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDT--- 419 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDT--- 419 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCc---
Confidence 99999999998765 56667788999999999999999999999999999996 88999999999999877543
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
|.+.....-.+.|.|||.+....++.|+|||+|||+|||+.| |.-||++..- ..+..+.++.+.+..++-|
T Consensus 420 ---YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----SqVY~LLEkgyRM~~PeGC- 491 (1157)
T KOG4278|consen 420 ---YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYGLLEKGYRMDGPEGC- 491 (1157)
T ss_pred ---eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----HHHHHHHhccccccCCCCC-
Confidence 344445556789999999999999999999999999999999 9999998543 3444577888887766555
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 289 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~ 289 (468)
|+.+..||..||+++|.+||+|.+|.+.|+.+|....
T Consensus 492 --PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 492 --PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred --CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 9999999999999999999999999999999986543
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.65 Aligned_cols=265 Identities=20% Similarity=0.288 Sum_probs=206.1
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.+|++|+.+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999865432 12346678888888877888999998889999999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~----- 151 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC-----
Confidence 899888764 5679999999999999999999999999999999999999 5788999999999875322111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc------cHHHHHHHHhhcccCCCHHHh
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~l 248 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........+.......|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---- 225 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---- 225 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----
Confidence 123567999999999999999999999999999999999999999632111 11122223333333333
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
..++.++.++|..||+.||++||+..... .+.++ ..+++...++|......+
T Consensus 226 -~~~~~~~~~ll~~~L~~dP~~R~~~~~~~-~~~~i---~~hp~f~~~~~~~~~~~~ 277 (329)
T cd05618 226 -RSLSVKAASVLKSFLNKDPKERLGCHPQT-GFADI---QGHPFFRNVDWDLMEQKQ 277 (329)
T ss_pred -CCCCHHHHHHHHHHhcCCHHHcCCCCCCC-CHHHH---hcCCCCCCCCHHHHHcCC
Confidence 34588999999999999999999843110 01111 246777788898765433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.22 Aligned_cols=242 Identities=20% Similarity=0.269 Sum_probs=196.3
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCC
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPS 96 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggs 96 (468)
||+|+||.||+|.+..+++.||||++... .....+..|+.++..+.| ++|+.+..++...+..++||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC-PFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 79999999999999999999999986532 122356778889888865 56666666777888999999998 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccccc
Q 012192 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176 (468)
Q Consensus 97 L~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 176 (468)
|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence 9998875 5579999999999999999999999999999999999999 5788999999999875332111
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHH
Q 012192 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEF 256 (468)
Q Consensus 177 ~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~ 256 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+.......+ ..+++++
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~~~~~-----~~~~~~~ 220 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEPLRFP-----DGFDRDA 220 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCCCCC-----CcCCHHH
Confidence 1234679999999999999999999999999999999999999998643 2334444444333322 4568999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 257 VSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 257 ~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
.++|..||+.||++||++..+.++|.+.
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 9999999999999999876555666553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=326.30 Aligned_cols=266 Identities=20% Similarity=0.301 Sum_probs=204.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|+++++||+|+||+||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.++..+.+....+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~-~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS-LWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCeEEEE
Confidence 47999999999999999999999999999999865432 22356778888888865 6677777777888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccc
Confidence 9998 8899999875 5679999999999999999999999999999999999999 578899999999997543211
Q ss_pred Ccc-------c---------------------ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCC
Q 012192 169 THK-------H---------------------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP 220 (468)
Q Consensus 169 ~~~-------~---------------------~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~P 220 (468)
... . .........+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 000 0 000011245799999999999999999999999999999999999999
Q ss_pred CCCCCcccHHHHHHHHhhcc--cCCCHHHhhccCcHHHHHHHHHHhcCCCC---CCCCHHHHHHHHHHHHHHcCCCCCcc
Q 012192 221 WQGLKAGTKKQKYDKISEKK--VSTPIEVLCKSYPSEFVSYFHYCRSLRFE---DKPDYSYLKRLFRDLFIREGFQFDYV 295 (468)
Q Consensus 221 f~~~~~~~~~~~~~~i~~~~--~~~~~~~l~~~~p~~~~~li~~cl~~~p~---~RPs~~~l~~~L~~~~~~~~~~~~~~ 295 (468)
|.+... .+.+..+.... ...|.. ..+++++.++|..++. +|+ .||++++|+ .+++...
T Consensus 236 f~~~~~---~~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~----------~hp~f~~ 298 (363)
T cd05628 236 FCSETP---QETYKKVMNWKETLIFPPE---VPISEKAKDLILRFCC-EWEHRIGAPGVEEIK----------TNPFFEG 298 (363)
T ss_pred CCCCCH---HHHHHHHHcCcCcccCCCc---CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh----------CCCCCCC
Confidence 986433 33333343322 112211 1346889999987554 444 457877653 3577778
Q ss_pred ccccccc
Q 012192 296 FDWTVLK 302 (468)
Q Consensus 296 ~dw~~~~ 302 (468)
.+|..+.
T Consensus 299 ~~~~~~~ 305 (363)
T cd05628 299 VDWEHIR 305 (363)
T ss_pred CCHHHHH
Confidence 8888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=329.32 Aligned_cols=252 Identities=15% Similarity=0.187 Sum_probs=197.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+..++|+++++||+|+||.||+|.+..+++.||||... ...+..|++++..+.| ++|+.+..++......+++++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINH-PSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCC-CCCCCEeEEEEECCeeEEEEe
Confidence 44578999999999999999999999999999999632 3457889999999976 566677777788889999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+++++|..++.. ...+++..++.++.||+.||+|||++|||||||||+|||+ +..+.++|+|||+++.......
T Consensus 164 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~-- 237 (391)
T PHA03212 164 RYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINA-- 237 (391)
T ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCcccccccccc--
Confidence 999999988875 4578999999999999999999999999999999999999 4778999999999975332111
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc----cHHHHHHHHhhcc-------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYDKISEKK------- 240 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~----~~~~~~~~i~~~~------- 240 (468)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..+....
T Consensus 238 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 ----NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ----cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 1123467999999999999999999999999999999999999887643210 0001111111000
Q ss_pred -------------------cC----CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 241 -------------------VS----TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 241 -------------------~~----~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.. .+.......+|.++.+||.+||+.||++||++.+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 00 000111124577899999999999999999999654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.90 Aligned_cols=252 Identities=18% Similarity=0.236 Sum_probs=196.9
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHh--CCCCCceeeEeeEe-----Cc
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQ--GGTGIPHLKWFGVE-----GD 84 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~-----~~ 84 (468)
+|++.+.||+|+||+||+|.+..+++.||||....... ...+..|+.++..+. .|++|..+..++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999998654322 234667888888775 45777777665442 34
Q ss_pred eeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..+++||++.++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcccc
Confidence 578999999999999887543 458999999999999999999999999999999999999 4788999999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc----
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK---- 239 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~---- 239 (468)
..... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+......
T Consensus 158 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 158 YSCQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccCcc--------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 54211 123456899999999999999999999999999999999999999765432222222111100
Q ss_pred ---------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 ---------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 ---------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+.......+++++.++|.+||+.||++||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 001112233456788999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=338.04 Aligned_cols=255 Identities=18% Similarity=0.216 Sum_probs=190.6
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCC-----CCceeeEeeE-eCce
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGT-----GIPHLKWFGV-EGDY 85 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~-----~i~~l~~~~~-~~~~ 85 (468)
..++|+++++||+|+||.||+|.+..+++.||||++.... .......|++++..+.+.+ ++..+..++. +..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 3578999999999999999999999999999999875432 2334667888888776543 3444444443 4567
Q ss_pred eEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccC-------------CCC
Q 012192 86 NIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGR-------------KAN 151 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~-------------~~~ 151 (468)
.++||++++++|.+++.. .+.+++..+..|+.||+.||+|||+ .|||||||||+|||+...+ +..
T Consensus 207 ~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 899999999999998875 4679999999999999999999998 5999999999999995321 112
Q ss_pred eEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH
Q 012192 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 231 (468)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~ 231 (468)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+........
T Consensus 286 ~vkl~DfG~~~~~~~----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 286 RVRICDLGGCCDERH----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred eEEECCCCccccCcc----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 599999998754221 1235689999999999999999999999999999999999999998754322222
Q ss_pred HHHHHhhcc----------------------c--CCCHHHh---h-------ccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 232 KYDKISEKK----------------------V--STPIEVL---C-------KSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 232 ~~~~i~~~~----------------------~--~~~~~~l---~-------~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
.+..+.... . ......+ . ....+.+.+||..||..||++||++.++
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 221111000 0 0000000 0 0013567899999999999999999965
Q ss_pred H
Q 012192 278 K 278 (468)
Q Consensus 278 ~ 278 (468)
+
T Consensus 436 L 436 (467)
T PTZ00284 436 T 436 (467)
T ss_pred h
Confidence 4
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=323.92 Aligned_cols=263 Identities=21% Similarity=0.313 Sum_probs=205.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|.+.++||+|+||+||+|.+..++..||||++.... ....+..|+.++..+ +|++|+.+..++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence 47999999999999999999999999999999866432 223466677776655 457777787778888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||+ +..+.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9998 899999998766789999999999999999999999999999999999999 578999999999997654322
Q ss_pred CcccccccCCCCcccccccccccccc------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHL------GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~------~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
.. ......||+.|+|||++. +..++.++|||||||++|+|++|..||..... ...+..+......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~ 227 (330)
T cd05601 157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQRF 227 (330)
T ss_pred ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCCc
Confidence 10 123457899999999987 45678999999999999999999999986433 2333333322111
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
...+ ....+++++.++|..||. +|.+||++.++. .+++....+|....
T Consensus 228 ~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~----------~h~~~~~~~~~~~~ 275 (330)
T cd05601 228 LKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLC----------CHPFFSKIDWNNIR 275 (330)
T ss_pred cCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh----------CCCCcCCCCHHHHh
Confidence 1101 112468999999999998 999999988653 34555566777543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=328.90 Aligned_cols=266 Identities=24% Similarity=0.360 Sum_probs=209.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.++||+|+||.||+|.+..+++.||||++... .....+..|++++..+.| ++|+.+..++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCC-CCccchhhheecCCeEEEE
Confidence 4799999999999999999999999999999986543 223456778888887764 6777777777888999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccC
Confidence 9998 88999999853 679999999999999999999999999999999999999 578899999999998654322
Q ss_pred Cc----------------------ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc
Q 012192 169 TH----------------------KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 226 (468)
Q Consensus 169 ~~----------------------~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~ 226 (468)
.. ............||+.|+|||++.+..++.++|||||||+||||++|..||.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00 00000122345799999999999999999999999999999999999999987543
Q ss_pred ccHHHHHHHHhh--cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 227 GTKKQKYDKISE--KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPD-YSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 227 ~~~~~~~~~i~~--~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs-~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
...+..+.. .....+.. ..+++++.++|..|+. +|.+||+ +.+|++ +++...++|....
T Consensus 236 ---~~~~~~i~~~~~~~~~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~----------hp~~~~~~~~~~~ 297 (350)
T cd05573 236 ---QETYNKIINWKESLRFPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS----------HPFFKGIDWENLR 297 (350)
T ss_pred ---HHHHHHHhccCCcccCCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc----------CCCcCCCCHHHHh
Confidence 233333333 22222211 2368999999999997 9999999 886543 4555566776543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=323.98 Aligned_cols=265 Identities=20% Similarity=0.267 Sum_probs=208.5
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..++..||||++.... ....+..|..++..+.+|++|+.+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999876432 12346788889889988899999999999999999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGD----- 151 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCC-----
Confidence 899888874 4579999999999999999999999999999999999999 5788999999999875322111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc----cHHHHHHHHhhcccCCCHHHhhc
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+..+.......| .
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p-----~ 224 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP-----R 224 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC-----C
Confidence 123467999999999999999999999999999999999999999643221 11222323333322222 3
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
.++.++.++|..||+.||.+|+++... ..+++ ...++++..++|+.+...+
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~---i~~h~~f~~~~~~~~~~~~ 275 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQ-TGFSD---IKSHTFFRSIDWDLLEKKQ 275 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHH---HHcCCCCCCCCHHHHHhCC
Confidence 458899999999999999999985421 01111 1356777888898765333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=320.81 Aligned_cols=259 Identities=18% Similarity=0.290 Sum_probs=202.1
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
+..++|++.++||+|+||.||++.+..++..||+|+...... ...+..|++++..+.| ++|+.+..++...+..++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEE
Confidence 456899999999999999999999999999999998654422 2458889999999876 567777777778888999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
||||+ +++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCcccccccc
Confidence 99998 7899999875 45789999999999999999999986 69999999999999 4788999999999876533
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH-----------
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK----------- 235 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~----------- 235 (468)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+..
T Consensus 157 ~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 157 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred cc---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence 11 2345789999999999999999999999999999999999999975432111111000
Q ss_pred ----------------------------HhhcccCC-CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 236 ----------------------------ISEKKVST-PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 236 ----------------------------i~~~~~~~-~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
........ ........+++++.+||.+||+.||++||++.+| |++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el---l~h~~~ 304 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML---MNHTFI 304 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH---hcChHH
Confidence 00000000 0000012467899999999999999999999965 445554
Q ss_pred H
Q 012192 287 R 287 (468)
Q Consensus 287 ~ 287 (468)
.
T Consensus 305 ~ 305 (331)
T cd06649 305 K 305 (331)
T ss_pred h
Confidence 3
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=320.63 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=199.8
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||++.+..++..||||++.... ....+..|++++..+.| ++|+.+..++...+..++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCEEEEEEeCCCC
Confidence 47999999999999999999999999865432 22345678888888866 56777777778888999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCC-----
Confidence 899888874 5579999999999999999999999999999999999999 5788999999999875322111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+.......| ..+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~~~p-----~~~~~ 220 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEIRFP-----RTLSP 220 (323)
T ss_pred --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCC-----CCCCH
Confidence 12345799999999999999999999999999999999999999976432 233333333333332 35689
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||..+|++|| ++.++. + +++....+|....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l---~-------h~~~~~~~~~~~~ 263 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVM---E-------HRFFLSINWQDVV 263 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHH---c-------CCCcCCCCHHHHH
Confidence 999999999999999998 555432 2 4555566777543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.22 Aligned_cols=262 Identities=20% Similarity=0.283 Sum_probs=204.6
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..++..||||++.... ....+..|..++..+.+|++|+.++.++......+++|||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999876432 12346788889888888889999999888999999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC-----
Confidence 899888864 5679999999999999999999999999999999999999 5788999999999874221111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc------cHHHHHHHHhhcccCCCHHHh
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~l 248 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........+.......|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p---- 225 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP---- 225 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----
Confidence 123467999999999999999999999999999999999999999642211 11122223333333322
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
..++.++.++|..||+.||.+||++... ..++++ ..+++....+|....
T Consensus 226 -~~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i---~~hp~~~~~~~~~~~ 274 (329)
T cd05588 226 -RSLSVKASSVLKGFLNKDPKERLGCHPQ-TGFRDI---KSHPFFRNIDWDLLE 274 (329)
T ss_pred -CCCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHH---hcCCCCCCCCHHHHH
Confidence 3458899999999999999999984311 011111 235566667887654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=318.30 Aligned_cols=258 Identities=20% Similarity=0.301 Sum_probs=200.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcE----EEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEE----IAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~----vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
+-..+|++.+.||+|+||.||+|.+..++.. ||||+...... ...+..|+.++..+.| ++|..+.+++....
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~g~~~~~~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTST 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEcCCC
Confidence 4457899999999999999999998666554 89998653322 2457778888888866 55566666666555
Q ss_pred eeEEEEec-cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDL-LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el-~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
.. +++++ .+|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 ~~-~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 83 VQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (316)
T ss_pred ce-eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccc
Confidence 44 55555 4899999998766679999999999999999999999999999999999999 4778899999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
+....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... .+..+......
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~ 229 (316)
T cd05108 159 LGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEKGER 229 (316)
T ss_pred ccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHhCCCC
Confidence 64322110 1122345678999999999999999999999999999997 99999875432 22233333333
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.+.+ ..++.++.+++..||..+|++||++.+|...|..+..
T Consensus 230 ~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 LPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 3332 2347899999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=320.65 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=200.1
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||++.+..++..||||++.... ....+..|++++..+.| ++|+.+..++...+..++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999865432 22356778888887766 66777777778888999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc-----
Confidence 899888874 5679999999999999999999999999999999999999 5788999999999875322111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+....... ...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~~-----p~~~~~ 220 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDIKF-----PRTLSA 220 (328)
T ss_pred --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCCccC-----CCCCCH
Confidence 12345799999999999999999999999999999999999999976432 22333333222222 245689
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||..||++|| ++.+|.+ +++....+|....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~----------h~~~~~~~~~~~~ 263 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR----------HSFFTGVNWQDVY 263 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc----------CCCcCCCCHHHHH
Confidence 999999999999999997 6665432 3455566777554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=321.07 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=201.0
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||+||+|.+..++..||||++.... ....+..|...+.....|++|+.+..++...+..+++||++ +
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999865432 12234455554444345677888888888889999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~----- 151 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG----- 151 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC-----
Confidence 799988874 5678899999999999999999999999999999999999 5788999999999875432111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+....... ...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~-----~~~~~~ 221 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILNKPLQL-----KPNITN 221 (325)
T ss_pred --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHHHhCCcCC-----CCCCCH
Confidence 12356799999999999999999999999999999999999999986433 33333343332222 235689
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||+.+|.+||+..+... ++ .++.+...++|+.+.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~---~i---~~~~~~~~~~~~~~~ 263 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFM---EI---KNHIFFSPINWDDLI 263 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHH---HH---hcCcccCCCCHHHHH
Confidence 9999999999999999998764322 21 245566778898764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.87 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=202.2
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||+||+|.+..++..||||++... ........|..++..+.+|++|+.+..++...+..+++|||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999986543 223346667788777777889999988888999999999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDA----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCC-----
Confidence 899999875 4578999999999999999999999999999999999999 4788999999999875322111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.......+ ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~-----~~~~~ 221 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDNPCYP-----RWLTR 221 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC-----ccCCH
Confidence 12346799999999999999999999999999999999999999986543 233333332222222 23578
Q ss_pred HHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||+.+|++||++. +| ..+++....+|....
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l----------~~h~~~~~~~~~~~~ 260 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDI----------RQHPFFREIDWSALE 260 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHH----------HcCcccCCCCHHHHH
Confidence 999999999999999999986 32 234555666776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=314.63 Aligned_cols=261 Identities=20% Similarity=0.233 Sum_probs=204.2
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.|++.++||+|+||+||++.+..+++.||||++.... ....+..|+.++..+.| ++|+.+...+..++..+++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCC-CCEeeeeeeecCCCeEEEEE
Confidence 4899999999999999999998899999999865432 12345679999998876 56666777777788899999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||+ +++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||+ ++.+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 998 78999887643 3469999999999999999999999999999999999999 477899999999987653211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||.+.........+....... ....
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~ 224 (285)
T cd05605 157 T--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED----QEEY 224 (285)
T ss_pred c--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----cccc
Confidence 1 124578999999999999899999999999999999999999998754432222222211111 1112
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
...++..+.+||..||..||++|| ++++|. .+++....+|..++
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~----------~~~~~~~~~~~~~~ 273 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK----------AHPFFRTANFKRLE 273 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh----------cCcCccCCCHHHHh
Confidence 345689999999999999999999 555432 24555667777665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.81 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=206.9
Q ss_pred eEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccCCCHHH
Q 012192 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLED 99 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ggsL~~ 99 (468)
.||.|.||+||.|++..+...+|||-+..+. ....+..|+.+...|.|.++|.++..+...+.+.++.++..||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5899999999999999999999999755443 34568999999999999888877777666664444444455999999
Q ss_pred HHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccC
Q 012192 100 LFNYCNRKF--SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRE 177 (468)
Q Consensus 100 ll~~~~~~l--s~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 177 (468)
++....+++ .+.++-.+..||++||.|||++.|||||||-+|+|+. .-.|.+||+|||.++....-+ | +
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAgin-----P--~ 732 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGIN-----P--C 732 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCC-----c--c
Confidence 999888888 8899999999999999999999999999999999995 357899999999998765422 2 3
Q ss_pred CCCccccccccccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHH
Q 012192 178 NKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSE 255 (468)
Q Consensus 178 ~~~~~Gt~~y~APE~~~~~~--~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 255 (468)
..+++||..|||||++..++ |+.++|||||||++.||.||++||..+. +......+....+..+|++... +.+
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg--spqAAMFkVGmyKvHP~iPeel---sae 807 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG--SPQAAMFKVGMYKVHPPIPEEL---SAE 807 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC--ChhHhhhhhcceecCCCCcHHH---HHH
Confidence 56889999999999998764 8999999999999999999999998764 3344455666777777765433 789
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 256 FVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 256 ~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.+.||.+|+..+|.+||++. ++|.+.|..
T Consensus 808 ak~FilrcFepd~~~R~sA~---~LL~DpFlq 836 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAK---DLLQDPFLQ 836 (1226)
T ss_pred HHHHHHHHcCCCcccCccHH---HhccCcccc
Confidence 99999999999999999998 456665544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.97 Aligned_cols=272 Identities=19% Similarity=0.280 Sum_probs=209.4
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
+..++|++.++||+|+||.||+|.+..++..||+|+...... ...+..|++++..+.| ++|+.+.+++...+..++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CcccceeEEEEECCEEEE
Confidence 456899999999999999999999999999999998654422 2457889999999975 567777777788889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+|||+ +++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.++|+|||++..+..
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhh
Confidence 99999 7899999885 45689999999999999999999985 79999999999999 4678899999999876533
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH------------
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD------------ 234 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~------------ 234 (468)
.. .....||..|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 157 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (333)
T cd06650 157 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227 (333)
T ss_pred hc---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence 11 234578999999999999899999999999999999999999997543211111000
Q ss_pred -------------------------HHhhcccCCCHHHh-hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 235 -------------------------KISEKKVSTPIEVL-CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 235 -------------------------~i~~~~~~~~~~~l-~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
.+.......+.+.+ ...++.++.+||.+||+.||++||++.+| |.+.+.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el---l~h~~~~~ 304 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL---MVHAFIKR 304 (333)
T ss_pred CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH---hhCHHHhc
Confidence 00000000000011 12357899999999999999999999865 44555543
Q ss_pred -CCCCCccccccc
Q 012192 289 -GFQFDYVFDWTV 300 (468)
Q Consensus 289 -~~~~~~~~dw~~ 300 (468)
..+..+...|..
T Consensus 305 ~~~~~~~~~~~~~ 317 (333)
T cd06650 305 SEAEEVDFAGWLC 317 (333)
T ss_pred CccccccHHHHHH
Confidence 344556677763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=322.69 Aligned_cols=260 Identities=20% Similarity=0.307 Sum_probs=202.1
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEee-EeC
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFG-VEG 83 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~-~~~ 83 (468)
-+++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+..|+.++..+.+|++|+.+.+++ ..+
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 35689999999999999999997543 457899998654322 235678999999996666776666544 455
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------------------------------------------------------
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN--------------------------------------------------------- 105 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~--------------------------------------------------------- 105 (468)
...+++|+|+ +++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 6678889888 889999886421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCcc
Q 012192 106 ---RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 182 (468)
Q Consensus 106 ---~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 182 (468)
..+++..+..++.||+.||+|||++||+||||||.|||+ +.++.++|+|||++..+..... +.......
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~-----~~~~~~~~ 236 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPD-----YVRKGDAR 236 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcc-----hhhccCCC
Confidence 257899999999999999999999999999999999999 4688999999999986533211 11123445
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHH
Q 012192 183 GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFH 261 (468)
Q Consensus 183 Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~ 261 (468)
++..|+|||++.+..++.++|||||||+||||++ |..||.+..... .+............ ...+++++.+++.
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 310 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKEGTRMRA---PEYATPEIYSIML 310 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhccCCCCC---CccCCHHHHHHHH
Confidence 6788999999999999999999999999999997 999998643321 12122222221111 1345789999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 262 YCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 262 ~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
+||+.+|++||++.+|++.|++++.
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.37 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=200.4
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||+||+|.+..+++.||||++.... ....+..|...+....+|++|+.+...+...+..++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999865432 12344556555444445577778888888888999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~------ 150 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHS------ 150 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCC------
Confidence 899888874 5679999999999999999999999999999999999999 578899999999987532211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+....... ...++.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~-----~~~~~~ 221 (323)
T cd05575 151 -KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILNKPLRL-----KPNISV 221 (323)
T ss_pred -CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCCC-----CCCCCH
Confidence 11235679999999999999999999999999999999999999998643 234444444433322 234589
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||+.+|.+||+..+ .++++ ..+++...++|..+.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~---~~~~i---l~~~~~~~~~~~~~~ 263 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAKD---DFLEI---KNHVFFSSINWDDLV 263 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCCC---CHHHH---HcCCCcCCCCHHHHh
Confidence 9999999999999999998752 12222 135566667777654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.43 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=200.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCc-eeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD-YNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-~~~lv~e 91 (468)
+.|.-...||+|+||.||+|.. .++..||||....... ..+|..|+.++.+++ |+|++.+.+|+.+.+ ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEEEEE
Confidence 5788888999999999999985 4558999997665544 567999999999999 567777788888777 5999999
Q ss_pred cc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 92 LL-GPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMHSRG---FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~-~ls~~~~~~ia~qia~gL~yLHs~g---iiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
|+ +|+|++.+..... .++|..++.||.++|.||+|||... ||||||||.|||+ |++.++||+|||+|+....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence 99 8899999986544 8999999999999999999999854 9999999999999 7899999999999965443
Q ss_pred -ccCcccccccCCCCc-cccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc---cHHHHHHHHhhc-c
Q 012192 167 -LQTHKHIPYRENKNL-TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---TKKQKYDKISEK-K 240 (468)
Q Consensus 167 -~~~~~~~~~~~~~~~-~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~---~~~~~~~~i~~~-~ 240 (468)
... .... .||..|+|||++..+..+.|+|||||||+|+|+++|+.|....... ....+....... .
T Consensus 230 ~~~~--------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 230 GDTS--------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cccc--------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 111 1112 7999999999999989999999999999999999999888753311 112211111111 1
Q ss_pred cCCC-HHHhh-ccCc-----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 241 VSTP-IEVLC-KSYP-----SEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 241 ~~~~-~~~l~-~~~p-----~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
...- .+.+. ..++ ..+..+...|++.+|.+||+|.+|++.|+.+.
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1100 01111 2223 23667788999999999999999998885543
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=317.33 Aligned_cols=265 Identities=20% Similarity=0.257 Sum_probs=203.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++++.||+|+||.||++.+..++..||||++... .....+..|+.++..+ +|++|+.++.++...+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence 4799999999999999999999999999999986532 1223466777777666 457778888888888999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 9998 899999998666789999999999999999999999999999999999999 478899999999987654322
Q ss_pred CcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
. .......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+... .+.+..+.......
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~ 227 (331)
T cd05597 157 T------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHKEHF 227 (331)
T ss_pred C------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH---HHHHHHHHcCCCcc
Confidence 1 01123469999999999873 3478899999999999999999999986432 33344443332222
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFED--KPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~--RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+.+.....+++++.++|..|+..+++. ||++.++ |+ +++...++|....
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~---l~-------hp~~~~~~~~~~~ 278 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDF---KD-------HPFFEGIDWDNIR 278 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHH---hc-------CCCCCCCCHHHHh
Confidence 222233457899999999988653332 5665543 32 4566667787654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=351.70 Aligned_cols=260 Identities=19% Similarity=0.282 Sum_probs=207.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCC-----CcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQT-----GEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~-----~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+-...-++.+.||+|+||+||.|+.... ...||||.+.... +..+|..|..+|..+.|+ ||+.+.+++...
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~Hp-Niv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHP-NIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCc-ceeeEEEeecCC
Confidence 3446778999999999999999997652 2358888754432 344688999998888875 555555555557
Q ss_pred ceeEEEEecc-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYC------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
...++++||| ||+|..+++.. ...|+....+.++.|||+|++||+++++|||||.++|||+ +....|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence 7778888887 99999999987 6679999999999999999999999999999999999999 477999999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 235 (468)
|||||+.+-.... |+......-.++|||||.+....++.|+|||||||+|||+++ |..||.+..+......+
T Consensus 845 DFGlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~-- 917 (1025)
T KOG1095|consen 845 DFGLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV-- 917 (1025)
T ss_pred ccchhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH--
Confidence 9999994332221 333333355689999999999999999999999999999999 99999987654433323
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.... ..+.+. .+|+.+.++|..||+.+|++||+|..|++.+..+...
T Consensus 918 ~~gg--RL~~P~---~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 918 LEGG--RLDPPS---YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HhCC--ccCCCC---CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 2233 333343 4499999999999999999999999999988887664
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=305.85 Aligned_cols=258 Identities=20% Similarity=0.247 Sum_probs=207.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCc----hhHHHHHHHHHHhCCCCCceeeEee--EeCceeEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP----QLHYESKLYMLLQGGTGIPHLKWFG--VEGDYNIM 88 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~l~~~~--~~~~~~~l 88 (468)
+.|+.+.+|++|+||.||+|+++.|++.||+|.+....... -..+|+.++..++| ++|+.+.-+. ..-+..||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H-~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARH-PNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCC-CCeeeeEEEEeccccceeee
Confidence 67999999999999999999999999999999865544332 45889999999985 6666665443 35566899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 89 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 89 v~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||+|+.-+|..++..-.++|...++..++.|++.||+|||.+.|+||||||.|+|+. +.+.+||+|||||+.|..+
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLAREYGSP- 230 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhhhcCC-
Confidence 999999999999998788999999999999999999999999999999999999994 8999999999999988764
Q ss_pred CcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc-------
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK------- 240 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 240 (468)
.......+-|..|.|||.++|.. |+...|+||+|||+.||+++.+.|+|........++.++....
T Consensus 231 ------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 231 ------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred ------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 22345778899999999999876 9999999999999999999999999865544333433322111
Q ss_pred ------------cCCCHHHhhcc-----CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 241 ------------VSTPIEVLCKS-----YPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 241 ------------~~~~~~~l~~~-----~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
...|...+.+. +.+.-.+|++.+|.+||.+|.+++ +.|++-+.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~---~~L~h~~F 364 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE---DGLKHEYF 364 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH---Hhhccccc
Confidence 01111122222 336678999999999999999998 45555443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.29 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=205.5
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCC-----CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQT-----GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~-----~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.++|+++++||+|+||.||+|.+... +..||||++..... ...+..|++++..+..|++|+.+.+++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 57888999999999999999986432 35799998654322 24578899999999867888888888888889
Q ss_pred eEEEEecc-CCCHHHHHHHcC-----------------------------------------------------------
Q 012192 86 NIMVIDLL-GPSLEDLFNYCN----------------------------------------------------------- 105 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~----------------------------------------------------------- 105 (468)
.+|||||+ +|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999998 889998876421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC
Q 012192 106 ------------------------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 106 ------------------------------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~ 149 (468)
..+++..++.++.||+.||+|||+++|+||||||+|||+ +.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---AQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---eC
Confidence 247788889999999999999999999999999999999 46
Q ss_pred CCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCccc
Q 012192 150 ANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 228 (468)
Q Consensus 150 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~ 228 (468)
++.++|+|||+++.+..... +.......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 78899999999986543221 112234457788999999999899999999999999999997 999998754321
Q ss_pred HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 229 KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 229 ~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
..+..+ ......+. ...+|.++.++|.+||+.+|++||++.+|.+.|+.++
T Consensus 348 --~~~~~~-~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 --TFYNKI-KSGYRMAK---PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHH-hcCCCCCC---CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 112122 22222221 2356899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=325.96 Aligned_cols=269 Identities=20% Similarity=0.304 Sum_probs=205.0
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+. |++|+.++.++...+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999999999999999875432 2234677999988886 56777788888889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.+....
T Consensus 80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence 9998 8899999875 4579999999999999999999999999999999999999 578999999999987543211
Q ss_pred Ccccc-----------------c---------c-----cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcC
Q 012192 169 THKHI-----------------P---------Y-----RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG 217 (468)
Q Consensus 169 ~~~~~-----------------~---------~-----~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG 217 (468)
..... + + ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00000 0 0 001134699999999999999999999999999999999999
Q ss_pred CCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccc
Q 012192 218 SLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFD 297 (468)
Q Consensus 218 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~d 297 (468)
..||.+... .+.+..+.........+. ...+++++.++|..|+. +|.+|++...+.++|. +++...++
T Consensus 236 ~~Pf~~~~~---~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~-------h~~~~~~~ 303 (364)
T cd05599 236 YPPFCSDNP---QETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS-------HPFFKGVD 303 (364)
T ss_pred CCCCCCCCH---HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc-------CCCcCCCC
Confidence 999986543 233333332221111111 12458899999999996 9999998322223333 34555567
Q ss_pred ccc
Q 012192 298 WTV 300 (468)
Q Consensus 298 w~~ 300 (468)
|..
T Consensus 304 ~~~ 306 (364)
T cd05599 304 WEH 306 (364)
T ss_pred HHH
Confidence 764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=313.98 Aligned_cols=254 Identities=19% Similarity=0.250 Sum_probs=200.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|.+.++||+|+||.||+|.+..++..||||...... ....+..|+.++..+.| ++|..+..++...+..+++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCC-CCcceEEEEEeeCCeEEEEEe
Confidence 67999999999999999999999899999999765332 22356789999988876 667777777788889999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
++.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +..+.++|+|||++........
T Consensus 85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCcc--
Confidence 99999999988766678999999999999999999999999999999999999 5788999999999875432111
Q ss_pred cccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc----------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK---------- 240 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 240 (468)
......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.......
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 160 -----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred -----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 12344678999999998764 58999999999999999999999998754432222221111000
Q ss_pred ------c------CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 ------V------STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 ------~------~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
. ..+.......+++++.++|..||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 00111122456789999999999999999999886543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=317.01 Aligned_cols=258 Identities=22% Similarity=0.280 Sum_probs=204.4
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..++..||||++... .....+..|..++..+.+|++|+.++.++...+..++|||++ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999986643 223346678888888877889999999888999999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV----- 151 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC-----
Confidence 899888875 4579999999999999999999999999999999999999 5788999999999875322111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+..+.......+ ..++.
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i~~~~~~~~-----~~~~~ 221 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSILEDEVRYP-----RWLSK 221 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCCCCC-----CcCCH
Confidence 12345789999999999999999999999999999999999999976432 333333444333322 34689
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||..+|.+||++.+ ..+.++ ..+++....+|....
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~--~~~~~l---l~~~~~~~~~~~~~~ 264 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLP--TGEQDI---KGHPFFREIDWDKLE 264 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCC--CCHHHH---hcCCCcCCCCHHHHH
Confidence 9999999999999999999832 111111 124455556776543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.72 Aligned_cols=267 Identities=22% Similarity=0.260 Sum_probs=202.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
.+|+++++||+|+||.||+|.+..+++.||||++... .....+..|++++..+.| ++|+.++..+.+++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999986432 223457789999988876 5666777777888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+|..+....
T Consensus 80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccc
Confidence 9998 8899999875 4578999999999999999999999999999999999999 578899999999986432110
Q ss_pred Ccc------------------------------------cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHH
Q 012192 169 THK------------------------------------HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLM 212 (468)
Q Consensus 169 ~~~------------------------------------~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ 212 (468)
... ...........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000 00000112457999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHHHHcC
Q 012192 213 YFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKP---DYSYLKRLFRDLFIREG 289 (468)
Q Consensus 213 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RP---s~~~l~~~L~~~~~~~~ 289 (468)
||++|..||.+.... .....+.........+ ....+++++.++|.+|+ .+|.+|+ ++.+| +.
T Consensus 236 ell~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el---l~------- 300 (376)
T cd05598 236 EMLVGQPPFLADTPA---ETQLKVINWETTLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEI---KA------- 300 (376)
T ss_pred ehhhCCCCCCCCCHH---HHHHHHhccCccccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH---hC-------
Confidence 999999999875432 2222222211111111 11346889999999977 4999999 66644 32
Q ss_pred CCCCcccccccc
Q 012192 290 FQFDYVFDWTVL 301 (468)
Q Consensus 290 ~~~~~~~dw~~~ 301 (468)
+++...++|...
T Consensus 301 h~~~~~~~~~~~ 312 (376)
T cd05598 301 HPFFKGIDFASL 312 (376)
T ss_pred CCCcCCCCHHHH
Confidence 345555666554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.56 Aligned_cols=242 Identities=19% Similarity=0.208 Sum_probs=196.0
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-C----chhHHHHHHHHHHhCCCCCceeeEeeEe----CceeEEEEe
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-H----PQLHYESKLYMLLQGGTGIPHLKWFGVE----GDYNIMVID 91 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~----~~~~~lv~e 91 (468)
..||+|++|.||+|.+ +|+.||||....... . ..+..|+.++.++.|+ +|+.+++++.+ ....+++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCC-CEEEEeeeEEecccCCCceEEEEE
Confidence 5789999999999987 788999998654322 2 3456899999999875 66666666555 346789999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +|+|.+++.. .+.+++...+.++.|++.||.|||+. +++||||||+|||+ ++++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 103 YCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred eCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc-
Confidence 99 7899999985 56799999999999999999999985 99999999999999 578899999999987653311
Q ss_pred cccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||.+... .+.+..+.......+.+
T Consensus 178 ---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~- 244 (283)
T PHA02988 178 ---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLIINKNNSLKLP- 244 (283)
T ss_pred ---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCCCCC-
Confidence 23468899999999976 5799999999999999999999999987543 33344443333333322
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
..+|+++.++|.+||+.||++||++.+|++.|+.+.
T Consensus 245 --~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 245 --LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 245899999999999999999999999999998764
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=307.16 Aligned_cols=257 Identities=19% Similarity=0.330 Sum_probs=206.1
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+...+|.+.++||+|+||.||+|.+..++..||+|+...... ...+..|++++..+.| +++..+..++......+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCC-CChhheEEEEcCCCCcEEEE
Confidence 445679999999999999999999998999999998654322 3467889999999876 55666666667777889999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|++ +++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||+ ++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccce
Confidence 987 78999998754 3458999999999999999999999999999999999999 478899999999997654321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... ..+..+ ...... .
T Consensus 159 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~-~~~~~~---~ 225 (263)
T cd05052 159 Y------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL-EKGYRM---E 225 (263)
T ss_pred e------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-HCCCCC---C
Confidence 1 11123344678999999999999999999999999999998 99999864332 222222 222222 2
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
....+|.++.++|.+||..+|++||++.+|.+.|+.++
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 23567899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=311.90 Aligned_cols=254 Identities=20% Similarity=0.310 Sum_probs=202.0
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCC-----cEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTG-----EEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~-----~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.++|++.+.||+|+||.||+|.+...+ ..||+|....... ...+..|+.++..+.| ++|..+..++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH-PNIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCC-cccceEEEEEcCCCc
Confidence 458999999999999999999876554 6899997654332 2357789999888876 566667777777788
Q ss_pred eEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC
Q 012192 86 NIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~ 149 (468)
.+++||++ +++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+|||+ ++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---cC
Confidence 89999998 789999987531 458889999999999999999999999999999999999 47
Q ss_pred CCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCccc
Q 012192 150 ANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 228 (468)
Q Consensus 150 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~ 228 (468)
++.++|+|||+++....... +.......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~- 233 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ- 233 (283)
T ss_pred CCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 78999999999875432211 112234456889999999998899999999999999999998 99999875442
Q ss_pred HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 229 KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 229 ~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
+....+... ...+ ....+|.++.+|+..||+.+|.+||++.+|.+.|+.
T Consensus 234 --~~~~~i~~~-~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 --EVIEMIRSR-QLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHHcC-CcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 222222222 2122 234569999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.21 Aligned_cols=267 Identities=19% Similarity=0.246 Sum_probs=204.0
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.++||+|+||.||++.+..+++.||||+..... ....+..|..++..+ +|++|..+..++...++.++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 57999999999999999999999999999999865321 122355666666555 457888888888889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9998 899999998766789999999999999999999999999999999999999 578899999999997654322
Q ss_pred CcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
.. ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+... .+.+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~ 227 (331)
T cd05624 157 TV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHEERF 227 (331)
T ss_pred ce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH---HHHHHHHHcCCCcc
Confidence 10 1224579999999999876 4578899999999999999999999986432 33344443333222
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+.+.....+++++.++|.+|+..++ +|+....+.+.+ .+++...++|+...
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~-~~~~~~~~~~~~-------~h~~f~~~~~~~~~ 278 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRE-RRLGQNGIEDFK-------KHAFFEGIDWENIR 278 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCch-hhcCCCCHHHHh-------cCCCcCCCCHHHHh
Confidence 3233334568999999999998654 444322222222 34566677888654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.26 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=202.0
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.|+++++||+|+||+||+|.+..+++.||||++.... ....+..|++++..+.| ++|+.++.++.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCC-CCeeeeEEEEecCCEEEEEE
Confidence 6899999999999999999999999999999875432 22356789999888865 67777888888889999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+ +++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+|||+ +..+.++|+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 81 DYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCcccccccc
Confidence 999 8899999875 4578999999999999999999999999999999999999 5788999999999864321100
Q ss_pred ccc----------------------------------------ccccCCCCccccccccccccccCCCCCCcchHHHHHH
Q 012192 170 HKH----------------------------------------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGY 209 (468)
Q Consensus 170 ~~~----------------------------------------~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGv 209 (468)
... .........+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000112457999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCcccHHHHHHHHhh--cccCCCHHHhhccCcHHHHHHHHHHh--cCCCCCCCCHHHHHHHHHHHH
Q 012192 210 VLMYFLRGSLPWQGLKAGTKKQKYDKISE--KKVSTPIEVLCKSYPSEFVSYFHYCR--SLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 210 vl~elltG~~Pf~~~~~~~~~~~~~~i~~--~~~~~~~~~l~~~~p~~~~~li~~cl--~~~p~~RPs~~~l~~~L~~~~ 285 (468)
++|||++|..||...... .....+.. .....+.. ..+++++.++|.+++ ..++..||++.+|++
T Consensus 237 il~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~---~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~------ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPT---ETQLKVINWENTLHIPPQ---VKLSPEAVDLITKLCCSAEERLGRNGADDIKA------ 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHH---HHHHHHHccccccCCCCC---CCCCHHHHHHHHHHccCcccccCCCCHHHHhc------
Confidence 999999999999865432 22222222 11222211 245889999999844 455556999886543
Q ss_pred HHcCCCCCccccccc
Q 012192 286 IREGFQFDYVFDWTV 300 (468)
Q Consensus 286 ~~~~~~~~~~~dw~~ 300 (468)
+++...++|..
T Consensus 305 ----hp~f~~~~~~~ 315 (381)
T cd05626 305 ----HPFFSEVDFSS 315 (381)
T ss_pred ----CcccCCCChhH
Confidence 45556667764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=316.49 Aligned_cols=265 Identities=20% Similarity=0.255 Sum_probs=205.4
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.++||+|+||+||++.+..+++.||||++.... ....+..|+.++..+. |++|..+..++...+..++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEE
Confidence 47999999999999999999999999999999864321 1223566777766654 57788888888888999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.++|+|||++..+....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 9998 899999998666789999999999999999999999999999999999999 578899999999987543321
Q ss_pred CcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.. ..+.+..+.......
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (332)
T cd05623 157 T------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKERF 227 (332)
T ss_pred c------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC---HHHHHHHHhCCCccc
Confidence 1 11234579999999999873 457899999999999999999999998643 334444444433333
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFED--KPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~--RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+.+..+..+++++.++|.+|+..+++. |+++.++. .+++...++|+.+.
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~----------~h~~f~~~~~~~~~ 278 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFK----------QHPFFTGIDWDNIR 278 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHh----------CCCCcCCCCHHHHh
Confidence 333334567899999999999765443 45665433 35666677787654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=310.96 Aligned_cols=237 Identities=22% Similarity=0.257 Sum_probs=188.2
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCC
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPS 96 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggs 96 (468)
||+|+||+||+|.+..+++.||||.+..... ...+..|++++..+. |++|..+..++......+++|||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 6999999999999999999999998654321 234567888888885 467777777777888899999998 789
Q ss_pred HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 97 LEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 97 L~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
|.+++.. .+..+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.++|+|||++..+.....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc----
Confidence 9887743 24568999999999999999999999999999999999999 5788999999999976543221
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHH-HHHHHHhhcccCCCHHHhhccC
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
......||+.|+|||++.+..++.++|||||||++|||++|..||......... .....+..... .....+
T Consensus 153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 224 (280)
T cd05608 153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV-----TYPDKF 224 (280)
T ss_pred ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC-----CCcccC
Confidence 123457899999999999999999999999999999999999999864332221 11212211111 122456
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHH
Q 012192 253 PSEFVSYFHYCRSLRFEDKPDYS 275 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RPs~~ 275 (468)
++++.+++..||+.+|++||++.
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCC
Confidence 89999999999999999999553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.46 Aligned_cols=258 Identities=19% Similarity=0.211 Sum_probs=194.1
Q ss_pred CCCCCc---eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeE
Q 012192 6 KLRMDH---VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKW 78 (468)
Q Consensus 6 ~l~~~~---ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~ 78 (468)
.+.++. .+.++|++.+.||+|+||.||+|.+..++..||||++.... ....+..|+.++..+.|+ +|..+..
T Consensus 9 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~ 87 (359)
T cd07876 9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK-NIISLLN 87 (359)
T ss_pred eecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCC-CEeeeee
Confidence 344444 56689999999999999999999999999999999865432 234567889998888765 4444444
Q ss_pred eeEeC------ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCe
Q 012192 79 FGVEG------DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ 152 (468)
Q Consensus 79 ~~~~~------~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~ 152 (468)
++... ...+++|||++++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 88 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~ 161 (359)
T cd07876 88 VFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCT 161 (359)
T ss_pred eeccCCCccccceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCC
Confidence 43322 3579999999988887765 358899999999999999999999999999999999999 57889
Q ss_pred EEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH
Q 012192 153 VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 232 (468)
Q Consensus 153 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~ 232 (468)
+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+.........
T Consensus 162 ~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~ 233 (359)
T cd07876 162 LKILDFGLARTACTNF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK 233 (359)
T ss_pred EEEecCCCccccccCc--------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999997543211 12345789999999999999999999999999999999999999986543211111
Q ss_pred HHH-------------------HhhcccCC---CHHH------------hhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 233 YDK-------------------ISEKKVST---PIEV------------LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 233 ~~~-------------------i~~~~~~~---~~~~------------l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+.. ........ .... .....++++.+||.+||..||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 234 VIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred HHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 100 00000000 0000 0112357889999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.07 Aligned_cols=254 Identities=22% Similarity=0.246 Sum_probs=198.2
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeC---
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEG--- 83 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--- 83 (468)
...+++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+.|++.+.....+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 45568999999999999999999999999999999986554322 34567777777776654443333332211
Q ss_pred ----ceeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEE
Q 012192 84 ----DYNIMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYI 155 (468)
Q Consensus 84 ----~~~~lv~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL 155 (468)
...++||||+ +|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence 1367899998 78999988642 3568999999999999999999999999999999999999 47889999
Q ss_pred EeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 156 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..
T Consensus 185 ~DFGls~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSD-----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVMHK 256 (496)
T ss_pred EecccCeeccccccc-----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHH
Confidence 999999865432111 112456799999999999999999999999999999999999999986432 233333
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+...... .+...+++++.+++..||+.+|++||++.+|++
T Consensus 257 ~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 257 TLAGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HhcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 3332221 133456899999999999999999999998765
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=324.63 Aligned_cols=259 Identities=16% Similarity=0.168 Sum_probs=202.3
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEEEc--CCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNV--QTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~--~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
....++..+|+++++||.|+||.||+|... .++..||||..... .....|++++..+.| ++|+.+..++.....
T Consensus 85 ~~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 85 DPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISH-RAIINLIHAYRWKST 160 (392)
T ss_pred CcchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCC-CCccceeeeEeeCCE
Confidence 345667789999999999999999999754 35678999975432 345789999999987 556666666677788
Q ss_pred eEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 86 NIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
.+++|++++++|.+++. ....+++..++.++.||+.||.|||++|||||||||+|||+ +..+.++|+|||++....
T Consensus 161 ~~lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 161 VCMVMPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLD 236 (392)
T ss_pred EEEEehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccC
Confidence 99999999999999885 35679999999999999999999999999999999999999 578899999999997654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc----
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV---- 241 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---- 241 (468)
.... ........||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+..+.....
T Consensus 237 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~ 311 (392)
T PHA03207 237 AHPD-----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL 311 (392)
T ss_pred cccc-----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence 3221 1112356799999999999999999999999999999999999999987654433333222221100
Q ss_pred -------------------------CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 242 -------------------------STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 242 -------------------------~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..+.......++.++.++|.+||..+|++||++.+|+.
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000111245778999999999999999999996543
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=307.58 Aligned_cols=261 Identities=20% Similarity=0.282 Sum_probs=201.3
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCc----EEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGE----EIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~----~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
|+-+...+|++.++||+|+||.||+|.+..++. .||||+...... ...+..|+.++..+.| ++|..+.+++.
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~ 79 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVCRLLGICL 79 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCC-CCCceEEEEEc
Confidence 455677899999999999999999999877765 489997654322 2356678888777765 56666666665
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
... .+++++++ +|+|.+++......+++..++.++.|++.||+|||+++|+||||||+|||+. +++.+||+|||+
T Consensus 80 ~~~-~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~ 155 (279)
T cd05109 80 TST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGL 155 (279)
T ss_pred CCC-cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCc
Confidence 444 45666665 8899999886566799999999999999999999999999999999999994 678899999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... +......
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~~ 226 (279)
T cd05109 156 ARLLDIDETEY-----HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----IPDLLEK 226 (279)
T ss_pred eeeccccccee-----ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHC
Confidence 98664322111 1122345678999999999899999999999999999998 999997654322 2222222
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
....+.+ ..++.++.+++..||..||++||++.+|.+.|+.+..
T Consensus 227 ~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 227 GERLPQP---PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCcCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 2222222 3458999999999999999999999999988877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=315.97 Aligned_cols=256 Identities=22% Similarity=0.279 Sum_probs=198.4
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..+++.||||++.... ....+..|...+.+..+|++|+.+..++...+..++|||++ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999865332 12235555554444345577777888888888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~------ 150 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPE------ 150 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCC------
Confidence 899887764 5678999999999999999999999999999999999999 578899999999987532211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......+ ...+.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~-----~~~~~ 221 (321)
T cd05603 151 -ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKPLQLP-----GGKTV 221 (321)
T ss_pred -CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCCCCCC-----CCCCH
Confidence 11234679999999999999899999999999999999999999998643 3344444444333222 34578
Q ss_pred HHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..||+.+|.+||+.. ++.+. ..+.+....+|..+.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~~-------~~~~~~~~~~~~~~~ 263 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAKADFLEI-------KNHVFFSPINWDDLY 263 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCCCCHHHH-------hCCCCcCCCCHHHHh
Confidence 999999999999999999764 22222 245556667777654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.19 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=219.8
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
..-+...|++.+.||.|.||.||+|..+.+|..+|+|++..... ...+..|+.+|..+.+|++|+.+...++...
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 35566789999999999999999999999999999998765543 2478999999999998899999999999999
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC-CCeEEEEeCCccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDYGLAK 162 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~-~~~vkL~DFGla~ 162 (468)
..++|||++ ||.|.+.+... .+++..+..++.|++.++.|||+.|++||||||+|+|+...+. ++.++++|||++.
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999 89999988765 3999999999999999999999999999999999999975443 3589999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
.+... ......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+... ......+....+.
T Consensus 188 ~~~~~--------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~---~~~~~~i~~~~~~ 256 (382)
T KOG0032|consen 188 FIKPG--------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE---FEIFLAILRGDFD 256 (382)
T ss_pred EccCC--------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh---hHHHHHHHcCCCC
Confidence 76651 124567999999999999999999999999999999999999999987543 3444456666664
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+.+ ....++..+.++|..++..||..|+++.++++
T Consensus 257 f~~~-~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 257 FTSE-PWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCC-CccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 4433 34567899999999999999999999996555
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=307.92 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=210.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeE----eC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGV----EG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~ 83 (468)
.+..+|..++.||.|+||.|+.+.+..+|+.||||.+... .......+|+++++.++|.++|..+..+.. ..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3456777789999999999999999999999999976522 233467899999999997666555555443 34
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 84 DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 84 ~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
+-.|+|+++|+.+|..+++. ++.|+.+.+..++.|++.||+|+|+.+++||||||.|+|+ +.+..+||+|||||+.
T Consensus 99 ~DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 99 NDVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARY 174 (359)
T ss_pred ceeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceee
Confidence 45799999999999999994 5569999999999999999999999999999999999999 6888999999999998
Q ss_pred cccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH---------
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY--------- 233 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~--------- 233 (468)
.... .+ -...+..+.|..|.|||+++. ..|+...||||.||+|.||++|+..|.|.......+.+
T Consensus 175 ~~~~-~~----~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 175 LDKF-FE----DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cccc-Cc----ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 7542 11 112356788999999999875 46999999999999999999999999985542221111
Q ss_pred ---HHH-----------hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 234 ---DKI-----------SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 234 ---~~i-----------~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
..| .......|...++++..+...+|+.++|..||.+|+|++ +.|++.+...
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~---eAL~hPYl~~ 315 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE---EALAHPYLAP 315 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH---HHhcChhhhh
Confidence 111 112223444566778889999999999999999999988 5666666543
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=311.03 Aligned_cols=256 Identities=18% Similarity=0.281 Sum_probs=203.7
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCc--EEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGE--EIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~--~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.+.||+|+||.||+|....++. .++||...... ....+..|+.++.++.+|+++..+.+++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999876664 46888654322 1235788999999997778888888888888889999
Q ss_pred Eecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 90 IDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
++++ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeE
Confidence 9998 789999986422 358899999999999999999999999999999999999 468899
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 232 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~ 232 (468)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.+.... +.
T Consensus 159 kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~ 227 (297)
T cd05089 159 KIADFGLSRGEEVYV--------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---EL 227 (297)
T ss_pred EECCcCCCcccccee--------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence 999999986432110 0112233567999999998889999999999999999997 99999875432 22
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
+..+.. ....+. ...++.++.+||.+||..+|.+||++++|.+.|+.++...
T Consensus 228 ~~~~~~-~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 228 YEKLPQ-GYRMEK---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHhc-CCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 322222 121211 1346899999999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=310.97 Aligned_cols=263 Identities=18% Similarity=0.310 Sum_probs=207.4
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcC-------CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQ-------TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~-------~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
++..++|.+++.||+|+||.||+|.+.. +...||+|+...... ...+..|+.++..+..|++|+.+..++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4556899999999999999999998643 235799998654322 235777999999997678888888888
Q ss_pred EeCceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceee
Q 012192 81 VEGDYNIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144 (468)
Q Consensus 81 ~~~~~~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl 144 (468)
...+..+++||++ +++|.+++.... ..+++.+++.++.|++.||+|||++|++||||||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 8888999999998 779999997532 248899999999999999999999999999999999999
Q ss_pred cccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 012192 145 GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 223 (468)
Q Consensus 145 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~ 223 (468)
+.++.++|+|||++........ +.......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 174 ---~~~~~~kL~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 174 ---TEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred ---cCCCcEEECCCcccccccccch-----hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 4778999999999876532111 011122334578999999999889999999999999999998 8899976
Q ss_pred CCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 224 LKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 224 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
... .+....+.. ..... ....++.++.++|..||..+|++||++.+|++.|+.++...
T Consensus 246 ~~~---~~~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 246 VPV---EELFKLLKE-GHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CCH---HHHHHHHHc-CCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 432 222222222 22111 22345899999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.65 Aligned_cols=267 Identities=21% Similarity=0.300 Sum_probs=202.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|+++++||+|+||+||+|.+..+++.||||++.... ....+..|++++..+.| ++|+.++.++.+..+.++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS-PWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCeeEEE
Confidence 47999999999999999999999999999999865422 22356778998888765 6777888888889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccc
Confidence 9998 8899999874 5679999999999999999999999999999999999999 478899999999996432210
Q ss_pred Ccc-------cccc---------------------------------cCCCCccccccccccccccCCCCCCcchHHHHH
Q 012192 169 THK-------HIPY---------------------------------RENKNLTGTARYASVNTHLGVEQSRRDDLESLG 208 (468)
Q Consensus 169 ~~~-------~~~~---------------------------------~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlG 208 (468)
... .... ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 0000 001135799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHH
Q 012192 209 YVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKP---DYSYLKRLFRDLF 285 (468)
Q Consensus 209 vvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RP---s~~~l~~~L~~~~ 285 (468)
|++|||++|..||.+... ...+..+.........+. ...++.++.++|..|+. +|.+|+ ++.++. .
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l---~--- 304 (377)
T cd05629 236 AIMFECLIGWPPFCSENS---HETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK---S--- 304 (377)
T ss_pred hhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh---c---
Confidence 999999999999976433 233333332111111111 12357899999999997 777764 666433 2
Q ss_pred HHcCCCCCcccccccc
Q 012192 286 IREGFQFDYVFDWTVL 301 (468)
Q Consensus 286 ~~~~~~~~~~~dw~~~ 301 (468)
+++....+|+.+
T Consensus 305 ----hp~~~~~~~~~~ 316 (377)
T cd05629 305 ----HPFFRGVDWDTI 316 (377)
T ss_pred ----CCCcCCCCHHHH
Confidence 444555666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=302.40 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=203.0
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.+.||+|+||.||+|.+..++..||||....... ...+..|++++..+.| +++..+..++...+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH-PNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-cceeeeeeeEEECCeEEEE
Confidence 589999999999999999999999999999997543221 2346779999888876 5666677777778888999
Q ss_pred Eecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 90 IDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 90 ~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++++ +++|.+++.. ....+++..+..++.|++.||+|||+++++|+||||+|||+ +.++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 9998 6799988863 23458899999999999999999999999999999999999 467889999999987654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ........+..... .+.
T Consensus 158 ~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~ 228 (267)
T cd08228 158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDY-PPL 228 (267)
T ss_pred chhH-------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCC-CCC
Confidence 3211 11245688999999999988899999999999999999999999975432 22222222222221 111
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
....++..+.++|.+||..+|++||++.+|.+.|+.+
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1234578999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.43 Aligned_cols=246 Identities=21% Similarity=0.266 Sum_probs=192.0
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|++++..+.| ++|+.+..++...+..+++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH-PNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCC-CCcceeeeEeccCCeEEEEE
Confidence 4679999999999999999999999999999998654332 2457889999988876 66777777778888899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+ +++|.+. ..+.+..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 152 e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 152 EFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred ecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccccc
Confidence 999 6677542 245677888999999999999999999999999999999 5788999999999986543211
Q ss_pred cccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
......||..|+|||++.. ...+.++|||||||++|||++|..||..............+.... .
T Consensus 224 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~-- 293 (353)
T PLN00034 224 -------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-P-- 293 (353)
T ss_pred -------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-C--
Confidence 1234579999999998743 234679999999999999999999998543333332222222111 1
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
......++.++.+||..||+.+|++||++.+|++
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122456899999999999999999999986644
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=308.51 Aligned_cols=258 Identities=19% Similarity=0.211 Sum_probs=199.8
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCC
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPS 96 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggs 96 (468)
||+|+||.||++.+..+|..||+|.+.... ....+..|++++..+.| ++|..+..++..+...+++|||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCC-CcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999764321 22345668999998865 66777777777888999999998 889
Q ss_pred HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccc
Q 012192 97 LEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175 (468)
Q Consensus 97 L~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 175 (468)
|.+++... ...+++..+..++.|++.||+|||+.||+||||||+|||+ +.++.++|+|||++........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce------
Confidence 98887643 3458999999999999999999999999999999999999 4788999999999876543111
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhhcccCCCHHHhhccCcH
Q 012192 176 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 176 ~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||.+...... .+....+....... ....+++
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 224 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF----EHQNFTE 224 (277)
T ss_pred --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc----ccccCCH
Confidence 1234689999999999998999999999999999999999999986543222 12222222222211 1235689
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|.+||+.||++||++.++.+.+ . .++++..++|....
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~---~---~h~~f~~~~~~~~~ 266 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDP---R---KHEFFKTINFPRLE 266 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhh---h---cChhhcCCCHHHHh
Confidence 999999999999999999997654222 1 35566667776554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.91 Aligned_cols=257 Identities=21% Similarity=0.255 Sum_probs=199.0
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||+||+|.+..+++.||||+..... ....+..|..++....+|++|+.+...+...+..+++|||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999999999999999865431 22345556555545455677888888888888999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~----- 151 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD----- 151 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC-----
Confidence 889888764 5679999999999999999999999999999999999999 5788999999999875322111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+.+..+.......+ ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~~~~~~~~~~-----~~~~~ 221 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---AEMYDNILHKPLVLR-----PGASL 221 (325)
T ss_pred --CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---HHHHHHHHcCCccCC-----CCCCH
Confidence 12356799999999999999999999999999999999999999986432 333333433332222 34588
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
++.++|..|+..+|.+||++.+.. +++ ..+++....+|....
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~---~~i---~~h~~f~~~~~~~~~ 263 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDF---LEI---QEHPFFESLSWTDLE 263 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCH---HHH---hcCCCcCCCCHHHHH
Confidence 999999999999999999875322 221 134555566676543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.30 Aligned_cols=261 Identities=21% Similarity=0.281 Sum_probs=203.3
Q ss_pred CCCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEe
Q 012192 4 DGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 4 ~~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
++.+..+++..++|+++++||+|+||+||+|.+..++..||+|++.... ....+..|+.++..|.|+++|..+..|
T Consensus 2 p~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 2 PGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred CccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 3567778888899999999999999999999999999999999865432 234578899999999886555555444
Q ss_pred eE-eCceeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCceeeccc
Q 012192 80 GV-EGDYNIMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSR-------GFLHRDIKPDNFLMGLG 147 (468)
Q Consensus 80 ~~-~~~~~~lv~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~-------giiHrDIKp~NiLl~~~ 147 (468)
.. .....||||||+ +++|.+++... ...+++..++.|+.||+.||.|||+. +||||||||+||||...
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 33 346789999999 78999998743 35799999999999999999999984 49999999999999531
Q ss_pred --------------CCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHH
Q 012192 148 --------------RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVL 211 (468)
Q Consensus 148 --------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~s~ksDvwSlGvvl 211 (468)
+....+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+|
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL 233 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence 123458999999997654321 1235679999999999865 3488999999999999
Q ss_pred HHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 212 MYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 212 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
|+|++|..||..... ..+.+..+ ......+ ...++.++.+||..||..+|++||++.+++.
T Consensus 234 YELLTGk~PF~~~~~--~~qli~~l-k~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 234 YELCSGKTPFHKANN--FSQLISEL-KRGPDLP----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHCCCCCCcCCc--HHHHHHHH-hcCCCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999999999976432 22222222 2222222 1345899999999999999999999987653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=313.73 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=214.3
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
...+|++.+.||.|.||.|-+|+....|+.||||.+..... .-.+.+|++||..|.| ++|..++-+++..+..+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNH-PhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNH-PHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCC-CceeehhhhhcCCceEE
Confidence 45789999999999999999999989999999997554432 2247889999998887 56667777888899999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+||||. +|.|+|++.+ .+.|++.++..+.+||..|+.|+|.++++|||||.+|||+ |.++++||+||||+..|.+
T Consensus 130 ivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhcc
Confidence 999998 9999999997 5579999999999999999999999999999999999999 7899999999999988776
Q ss_pred ccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.. ..++++|.+-|++||.+-|.+| ++.+|-|||||+||-|+.|.+||.|. +.+..+.+|....+..|.
T Consensus 206 ~k--------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQIs~GaYrEP~ 274 (668)
T KOG0611|consen 206 KK--------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQISRGAYREPE 274 (668)
T ss_pred cc--------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHhhcccccCCC
Confidence 43 2468999999999999999998 78999999999999999999999985 345666777777776554
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRL 280 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~ 280 (468)
. |....-||.++|..||+.|.+..+|...
T Consensus 275 ~------PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 275 T------PSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred C------CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 3 7788999999999999999999877653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=317.02 Aligned_cols=256 Identities=20% Similarity=0.281 Sum_probs=203.2
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----------------CchhHHHHHHHHHHhCCCCC
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----------------HPQLHYESKLYMLLQGGTGI 73 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----------------~~~~~~E~~~l~~l~~~~~i 73 (468)
+...-++|++++.||+|.||.|-+|++..+++.||||++..+.. .+...+|+.+|++|.| +||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H-~nV 170 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH-PNV 170 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC-cCe
Confidence 44566899999999999999999999999999999998554321 1357899999999988 667
Q ss_pred ceeeEeeE--eCceeEEEEecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC
Q 012192 74 PHLKWFGV--EGDYNIMVIDLL-GPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 74 ~~l~~~~~--~~~~~~lv~el~-ggsL~~ll~~~~~~-ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~ 149 (468)
+.+.-+.. ..+..|||+||| .|.+. +.. +... |++.++..|+++++.||+|||.+|||||||||.|+|++ .
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~-w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~ 245 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVK-WCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---S 245 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccc-cCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---C
Confidence 77666654 456789999999 44332 111 2334 89999999999999999999999999999999999995 7
Q ss_pred CCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 012192 150 ANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE----QSRRDDLESLGYVLMYFLRGSLPWQGLK 225 (468)
Q Consensus 150 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~s~ksDvwSlGvvl~elltG~~Pf~~~~ 225 (468)
+++|||+|||.+............ ......+||+.|+|||...+.. .+.+.||||+||+||-|+.|+.||.+
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d--~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-- 321 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSD--DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-- 321 (576)
T ss_pred CCcEEeeccceeeecccCCccccH--HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc--
Confidence 899999999998765332111111 1123478999999999998732 36789999999999999999999986
Q ss_pred cccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 226 AGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 226 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+.+.+|....+.+|... .+.+.+.+||..+|..||+.|.+..+|+.
T Consensus 322 -~~~~~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 322 -DFELELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred -chHHHHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhhee
Confidence 355677888888777766542 34689999999999999999999876643
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=330.78 Aligned_cols=242 Identities=21% Similarity=0.296 Sum_probs=205.4
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+.|.-++.||.|+||.||.|++..+.+.||||.+.-. .++.++..|+..|.++.|++ +..+.+|.......+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPn-tieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPN-TIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCC-cccccceeeccchHHHH
Confidence 3467788999999999999999999999999985533 23457899999999999854 55566676777788999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 90 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 90 ~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||||-|+-.|++.-...+|.+..+..|+.+.+.||.|||+.+.||||||+.|||++ +.+.|||+|||.|.....
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCc---
Confidence 99999999999998888999999999999999999999999999999999999995 899999999999876543
Q ss_pred cccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
...++||++|||||+++. +.|+-++||||||++++|+.-.++|+.+++++ ..+..|.....++.
T Consensus 179 --------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM---SALYHIAQNesPtL-- 245 (948)
T KOG0577|consen 179 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPTL-- 245 (948)
T ss_pred --------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH---HHHHHHHhcCCCCC--
Confidence 457899999999999984 45999999999999999999999999987664 33444554433222
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
-...++..|..|+..||+.-|.+||+.+++
T Consensus 246 -qs~eWS~~F~~Fvd~CLqKipqeRptse~l 275 (948)
T KOG0577|consen 246 -QSNEWSDYFRNFVDSCLQKIPQERPTSEEL 275 (948)
T ss_pred -CCchhHHHHHHHHHHHHhhCcccCCcHHHH
Confidence 134568999999999999999999999854
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=308.17 Aligned_cols=244 Identities=22% Similarity=0.280 Sum_probs=193.6
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.|++.+.||+|+||+||+|.+..+++.||||...... ....+..|++++..+.| ++++.+.+++..++..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-QFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC-cCceeEEEEEecCCEEEEEE
Confidence 3788999999999999999999999999999864432 12346779999998876 55666666677788899999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+++ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||+ +..+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 988 77898887643 3469999999999999999999999999999999999999 467889999999987543211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.......+.+... ........
T Consensus 157 ~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~----~~~~~~~~ 224 (285)
T cd05632 157 S--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR----VLETEEVY 224 (285)
T ss_pred c--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh----hhcccccc
Confidence 1 12457899999999999989999999999999999999999999865432222222111 11111223
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYS 275 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~ 275 (468)
...+++++.+|+..||+.+|++||+..
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 355689999999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.24 Aligned_cols=256 Identities=16% Similarity=0.221 Sum_probs=196.8
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCc----EEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGE----EIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~----~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
.++|++.+.||.|+||+||+|.+..++. .|++|........ ..+..|+.++..+.| ++|..+.+++.... .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h-~~iv~~~~~~~~~~-~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH-AYIVRLLGICPGAS-L 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCC-CCcceEEEEECCCc-c
Confidence 4789999999999999999999877776 4667764332221 234445555556655 56777776665444 4
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
+++++++ +++|.+++......+++..+..++.|++.||+|||+++++||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceecc
Confidence 5556555 899999998767789999999999999999999999999999999999999 578899999999997654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
...... ......++..|+|||++.+..++.++|||||||++||+++ |..||.+... ..+..+.......+
T Consensus 161 ~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~ 231 (279)
T cd05111 161 PDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPDLLEKGERLA 231 (279)
T ss_pred CCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHCCCcCC
Confidence 321110 1224557788999999998899999999999999999998 9999987543 22233334333333
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.+.. ++..+..++..||..+|++||++.+|.+.|..+..
T Consensus 232 ~~~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 3333 47889999999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=305.09 Aligned_cols=254 Identities=20% Similarity=0.360 Sum_probs=202.8
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+-.++|++.++||+|+||.||+|.+. .+..||||...... ....+..|+.++..+.| +++..+..+....+..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQH-DKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCC-CCeeeEEEEEcCCCCcEEEE
Confidence 34578999999999999999999864 56789999755432 34567889999998876 56666666677788889999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|++ +++|.+++... ...+++..++.++.|++.||+|||+.+++||||||+|||+ +.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCc
Confidence 998 78999998643 4568999999999999999999999999999999999999 478899999999998654321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+.. ....+
T Consensus 158 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~-~~~~~--- 224 (261)
T cd05072 158 Y------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQR-GYRMP--- 224 (261)
T ss_pred e------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHc-CCCCC---
Confidence 1 11223456778999999998889999999999999999998 999998654322 2222222 22222
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
....+|.++.+++.+||..+|++||++++|.++|++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 123568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=303.39 Aligned_cols=255 Identities=16% Similarity=0.292 Sum_probs=204.7
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
.++|++.+.||+|+||.||+|.+... ...||||+...... ...+..|+.++..+.| ++|..+..+....+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH-PNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCcceEeEEEecCCceE
Confidence 46899999999999999999997643 46899998654332 2356779999888876 57777777778888899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
++||++ +++|.+++......+++..+..++.|++.||+|||+++|+|+||||+|||+ +.++.++|+|||++..+..
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcccc
Confidence 999998 789999998666689999999999999999999999999999999999999 4788999999999987642
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... + ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +....+.. ....+.
T Consensus 159 ~~~~----~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~-~~~~~~ 229 (266)
T cd05033 159 SEAT----Y-TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVED-GYRLPP 229 (266)
T ss_pred cccc----e-eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHc-CCCCCC
Confidence 1111 0 1112345678999999999899999999999999999998 99999765432 22222322 222222
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+ ..+|+.+.+++..||+.+|++||++.+|.+.|+++
T Consensus 230 ~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 P---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2 34589999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=303.68 Aligned_cols=255 Identities=20% Similarity=0.356 Sum_probs=201.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+..++|++.++||+|+||.||+|.+..+ ..||||....... ...+..|++++..+.| +++..+..+. .....+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~-~~~~~~lv~ 79 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQLYAVV-SEEPIYIVT 79 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCC-CCcceEEEEE-CCCCcEEEE
Confidence 4568899999999999999999987655 4699998654332 3467889999999876 5566665554 345578999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+++ +++|.+++... ...+++..+..++.|++.||+|||+++++|+||||+|||++ .++.++|+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeeccccc
Confidence 998 67999998753 34689999999999999999999999999999999999994 68889999999997654321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... +.+..+.. ....+.
T Consensus 157 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~~~~-~~~~~~-- 224 (262)
T cd05071 157 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVER-GYRMPC-- 224 (262)
T ss_pred c------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHHHhc-CCCCCC--
Confidence 1 11223456778999999998899999999999999999999 89999765432 22322222 222221
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
...+|..+.++|.+||+.+|++||++.++.+.|++.|
T Consensus 225 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 2346899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=321.37 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=199.1
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+-.++|++.++||+|+||.||+|.+..++..||||++... .....+..|+.++..+.| ++|+.+..++.+...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h-~~iv~~~~~~~~~~~ 117 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS-EWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCE
Confidence 34457899999999999999999999999999999986532 122345678888777765 677777778888899
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++||||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeec
Confidence 99999998 8899999873 468999999999999999999999999999999999999 57899999999999765
Q ss_pred ccccCcccccccCCCCccccccccccccccCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGV----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~----~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ...+..+....
T Consensus 193 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~ 263 (370)
T cd05596 193 DANGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMDHK 263 (370)
T ss_pred cCCCc------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCC
Confidence 43211 112346799999999998754 378999999999999999999999986432 33444444332
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCC--CCCHHHH
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFED--KPDYSYL 277 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~--RPs~~~l 277 (468)
.....+. ...++.++.++|..||..+|++ ||++++|
T Consensus 264 ~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 264 NSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred CcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 2111111 1246899999999999998987 9998865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.98 Aligned_cols=269 Identities=20% Similarity=0.296 Sum_probs=206.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.+.||+|+||.||+|.+..+++.||||++... .....+..|+.++..+.| ++++.+...+...+..++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999986532 223456778888888866 6677777777888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccc
Confidence 9999 7899999875 5679999999999999999999999999999999999999 578999999999987543211
Q ss_pred Cccc----------------------------ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCC
Q 012192 169 THKH----------------------------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP 220 (468)
Q Consensus 169 ~~~~----------------------------~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~P 220 (468)
.... .........+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0000 000011245799999999999999999999999999999999999999
Q ss_pred CCCCCcccHHHHHHHHhhcc--cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccc
Q 012192 221 WQGLKAGTKKQKYDKISEKK--VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDW 298 (468)
Q Consensus 221 f~~~~~~~~~~~~~~i~~~~--~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw 298 (468)
|.+.... ..+..+.... ...|.. ..+++++.++|.+++ .+|.+|++...+.+++ .+++....+|
T Consensus 236 f~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~-------~hp~f~~~~~ 301 (360)
T cd05627 236 FCSETPQ---ETYRKVMNWKETLVFPPE---VPISEKAKDLILRFC-TDSENRIGSNGVEEIK-------SHPFFEGVDW 301 (360)
T ss_pred CCCCCHH---HHHHHHHcCCCceecCCC---CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh-------cCCCCCCCCH
Confidence 9865432 3333333211 112211 124789999999876 4999999753333333 4667777889
Q ss_pred cccc
Q 012192 299 TVLK 302 (468)
Q Consensus 299 ~~~~ 302 (468)
..+.
T Consensus 302 ~~~~ 305 (360)
T cd05627 302 GHIR 305 (360)
T ss_pred HHHh
Confidence 8764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.68 Aligned_cols=251 Identities=20% Similarity=0.290 Sum_probs=197.5
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..++..||||++.... ....+..|++++..+.| ++|+.+..++...+..++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999865432 12345677887777765 67777777778888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
++|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc----
Confidence 889888774 5579999999999999999999997 799999999999999 5788999999999875322111
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCc
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP 253 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 253 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......+.......+ ..++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~~~p-----~~~~ 220 (325)
T cd05594 152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEIRFP-----RTLS 220 (325)
T ss_pred ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCCCCC-----CCCC
Confidence 12345799999999999999999999999999999999999999976432 233333333332222 3468
Q ss_pred HHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012192 254 SEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVL 301 (468)
Q Consensus 254 ~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 301 (468)
+++.++|..||+.||++|+ ++.+|.+ +++....+|...
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~----------h~~~~~~~~~~~ 263 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ----------HKFFAGIVWQDV 263 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc----------CCCcCCCCHHHH
Confidence 9999999999999999997 6665432 345555566644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=316.77 Aligned_cols=260 Identities=20% Similarity=0.297 Sum_probs=202.3
Q ss_pred cCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEee-EeCc
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFG-VEGD 84 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~-~~~~ 84 (468)
.++|++++.||.|+||.||+|.+. .+++.||||++..... ...+..|+.++..+.+|++|+.+..++ ..+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 478999999999999999999843 4678999998765432 235778999999998777777776544 4556
Q ss_pred eeEEEEecc-CCCHHHHHHHcC----------------------------------------------------------
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCN---------------------------------------------------------- 105 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~---------------------------------------------------------- 105 (468)
..+++|||+ +++|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 778999998 889999886421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccC
Q 012192 106 --------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRE 177 (468)
Q Consensus 106 --------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 177 (468)
..+++..+..++.|++.||+|||+++|+||||||.|||+ +.++.++|+|||++........ +..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~-----~~~ 237 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPD-----YVR 237 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcc-----hhh
Confidence 236788889999999999999999999999999999999 4788999999999876532211 111
Q ss_pred CCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHH
Q 012192 178 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEF 256 (468)
Q Consensus 178 ~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~ 256 (468)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||.+..... ... .........+.+ ..+++++
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~-~~~~~~~~~~~~---~~~~~~~ 311 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC-RRLKEGTRMRAP---DYTTPEM 311 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH-HHHhccCCCCCC---CCCCHHH
Confidence 223456678999999999899999999999999999996 999998654321 111 112222212211 2347899
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 257 VSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 257 ~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.+++..||+.+|++||++.+|++.|+.++..
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=302.30 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=198.6
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
..+|++.+.||+|+||.||+|.. .+..||+|..........+..|+.++..+.|++.+..+..+.......+++||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35899999999999999999976 4778999987655555678899999999987655554444455667789999998
Q ss_pred -CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 94 -GPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 94 -ggsL~~ll~~~~~-~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||++ ++++.++|+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccC---
Confidence 6799999875433 48899999999999999999999999999999999999 478899999999987543211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
....++..|+|||++.+..++.++|||||||++|+|++ |..||..... .+....+ ....... ...
T Consensus 157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~-~~~~~~~---~~~ 222 (256)
T cd05082 157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV-EKGYKMD---APD 222 (256)
T ss_pred -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH-hcCCCCC---CCC
Confidence 23345678999999998889999999999999999997 9999976432 2222222 2222111 224
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
.+|+++.++|.+||+.+|++||++.+|.+.|++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 568999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=323.77 Aligned_cols=268 Identities=22% Similarity=0.257 Sum_probs=201.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.++.++.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h-~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCC-CcCCeEEEEEEeCCEEEEEE
Confidence 6999999999999999999999999999999865432 23457789999888865 67777777788889999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+|..+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 81 DYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCcccccccc
Confidence 998 7899999875 4578999999999999999999999999999999999999 5789999999999864321000
Q ss_pred ccc----------------------------------------ccccCCCCccccccccccccccCCCCCCcchHHHHHH
Q 012192 170 HKH----------------------------------------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGY 209 (468)
Q Consensus 170 ~~~----------------------------------------~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGv 209 (468)
... .........+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000 0000112457999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012192 210 VLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 289 (468)
Q Consensus 210 vl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~ 289 (468)
++|||++|..||.+.... +....+.........+ ....+++++.++|.+++ .+|++|++...+.+++ .
T Consensus 237 il~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~-------~ 304 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPL---ETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK-------A 304 (382)
T ss_pred HHHHHHhCCCCCCCCCHH---HHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh-------c
Confidence 999999999999875432 2222232211111111 11345788999998876 5999999722222333 2
Q ss_pred CCCCccccccc
Q 012192 290 FQFDYVFDWTV 300 (468)
Q Consensus 290 ~~~~~~~dw~~ 300 (468)
+++...++|..
T Consensus 305 hp~f~~~~~~~ 315 (382)
T cd05625 305 HPFFKTIDFSS 315 (382)
T ss_pred CCCcCCcChHH
Confidence 45555566654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=317.17 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=202.6
Q ss_pred ceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 21 RKIGSGSFGELYLGVNV---QTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
+.||+|+||.||++.+. .++..||||++.... ....+..|++++..+.| ++|+.++.++......++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH-PFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCC-CCcccEEEEEEcCCEEEEEEcCC
Confidence 68999999999998763 478999999865432 22346678889888876 56667777778888999999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 94 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 94 -ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++......
T Consensus 81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~---- 152 (318)
T cd05582 81 RGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHE---- 152 (318)
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCC----
Confidence 7899998874 5579999999999999999999999999999999999999 578899999999987543321
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccC
Q 012192 173 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......+ ..+
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~~~~p-----~~~ 221 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAKLGMP-----QFL 221 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCCCCCC-----CCC
Confidence 11234679999999999999889999999999999999999999998643 2333444444333332 345
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCcccccccccC
Q 012192 253 PSEFVSYFHYCRSLRFEDKPDYSY--LKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RPs~~~--l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
++++.++|..||+.||++||++.+ +.+++. +++...++|..+..
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~-------~~~~~~~~~~~~~~ 267 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGPDGVEEIKR-------HPFFSTIDWNKLYR 267 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhC-------CCCcCCCCHHHHHh
Confidence 899999999999999999999766 444443 44555567776543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=323.40 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=205.7
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
.|-+..|+++++||.||.+.||++..-.. ..+|+|....... ..-+..|+.+|.+|+++..|+.+++|...+.+.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 45678899999999999999999986544 4455554222222 235889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 87 IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 87 ~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
|||||+-..+|..++......+..-.+..+..||+.++.++|+.||||-||||.|||+ -.|.+||+|||.|..+..
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCc
Confidence 9999999999999999765555544788899999999999999999999999999999 689999999999998876
Q ss_pred ccCcccccccCCCCccccccccccccccCCC-----------CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVE-----------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-----------~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
+.+.. .....+||+.||+||.+.... .++++|||||||+||+|+.|+.||.... +...++..
T Consensus 512 DTTsI-----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~a 584 (677)
T KOG0596|consen 512 DTTSI-----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHA 584 (677)
T ss_pred cccce-----eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHh
Confidence 65533 234668999999999987543 4689999999999999999999998654 23455555
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
|......++.+.... +.++.++|+.||..||.+||+..+|+
T Consensus 585 I~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred hcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHh
Confidence 655544444444432 23499999999999999999988653
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=305.35 Aligned_cols=255 Identities=19% Similarity=0.268 Sum_probs=200.0
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
..-.++|+++++||+|+||.||+|.+..++..||||+...... ...+..|+.++..+.|+ ++..+.+++...+..++
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~-~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC-NIVAYFGSYLSREKLWI 83 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCC-CeeeeeEEEEeCCEEEE
Confidence 3445789999999999999999999989999999998654432 23467788888888775 55566666778888999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|||++ +++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 84 CMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeeccc
Confidence 99998 6799998874 4578999999999999999999999999999999999999 47788999999999865421
Q ss_pred cCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.. ......|+..|+|||.+. ...++.++|||||||++|||++|..||...... .....+.......+
T Consensus 160 ~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~ 229 (267)
T cd06646 160 IA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RALFLMSKSNFQPP 229 (267)
T ss_pred cc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---hhheeeecCCCCCC
Confidence 11 123456889999999885 344788999999999999999999999754322 11111222222222
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRL 280 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~ 280 (468)
.......++.++.++|..||..+|++||++++|++.
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 222234568999999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=301.82 Aligned_cols=254 Identities=20% Similarity=0.336 Sum_probs=203.8
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+..++|++.+.||+|+||.||+|.+. .+..||||...... ...++..|+.++..+.| +++..+..++...+..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRH-PKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCC-CCccceeEEEecCCCeeeee
Confidence 45678999999999999999999864 45789999865433 23468889999999986 56777777778888899999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|++ +++|.+++... +..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||+++.+....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCCc
Confidence 999 89999998753 3568999999999999999999999999999999999999 478899999999998765321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. ........+..|+|||++.+..++.++||||||+++|+|++ |..||.+.... ..+..+.. ....+.+
T Consensus 158 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~-~~~~~~~- 226 (261)
T cd05068 158 Y------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQVDQ-GYRMPCP- 226 (261)
T ss_pred c------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc-CCCCCCC-
Confidence 1 11122233568999999999899999999999999999999 99999875432 22222322 2222222
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
..++..+.+++.+||+.+|++||++.+|.+.|++
T Consensus 227 --~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 --PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 3458999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=293.36 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=215.3
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
....--++|++++.||.|-||.||+|+.++++-.||+|++... ....++.+|+++...|.| ++|..++.++.+.
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~h-pnilrlY~~fhd~ 94 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRH-PNILRLYGYFHDS 94 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCC-ccHHhhhhheecc
Confidence 3445558999999999999999999999999999999985443 344578889999888887 5677788888888
Q ss_pred ceeEEEEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~-~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
...||++||. .|.|...+.. ....+++.....++.|+|.||.|+|.+++|||||||+|+|+| ..+.+||+|||.+
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGws 171 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWS 171 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCce
Confidence 8899999998 7888877763 355699999999999999999999999999999999999996 7899999999987
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
..-. .....+++||..|.+||+..+..++..+|+|++|+++|||+.|..||.... ..+.|.+|.....
T Consensus 172 V~~p---------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~ 239 (281)
T KOG0580|consen 172 VHAP---------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDL 239 (281)
T ss_pred eecC---------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccc
Confidence 6432 234578999999999999999999999999999999999999999998643 5677777777777
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..| ..++.+.+++|.+|+..+|.+|....++ +++.++
T Consensus 240 ~~p-----~~is~~a~dlI~~ll~~~p~~r~~l~~v---~~hpwI 276 (281)
T KOG0580|consen 240 KFP-----STISGGAADLISRLLVKNPIERLALTEV---MDHPWI 276 (281)
T ss_pred cCC-----cccChhHHHHHHHHhccCccccccHHHH---hhhHHH
Confidence 666 4568999999999999999999987754 444444
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.56 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=216.5
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeec----cCCCch-hHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV----KTKHPQ-LHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~----~~~~~~-~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+-.++|.+++.||.|+||+|.+++++.++..||+|++.. +..... |..|..+ +...+..-|+.+++.+.+..+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDi-mv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDI-MVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHH-HHcCCcHHHHHHHHHhcCccc
Confidence 3456899999999999999999999999999999997543 233333 4445555 455557788888888899999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.||||+|+ ||+|..++.... .++++.+.+|+..|+.||.-||+.|+|||||||+|||| |..|++||+|||.|-.+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKM 225 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhc
Confidence 99999998 999999999756 89999999999999999999999999999999999999 68999999999999887
Q ss_pred ccccCcccccccCCCCcccccccccccccc----C-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHL----G-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~----~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
....+.. ....+|||.|++||++. + +.|++.+|+||+||++|||+.|..||.. ......|.+|...
T Consensus 226 ~~dG~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~h 296 (1317)
T KOG0612|consen 226 DADGTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNH 296 (1317)
T ss_pred CCCCcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhch
Confidence 6543322 34679999999999987 3 4689999999999999999999999985 3556777777665
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPD---YSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs---~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+-....|.. ..++++..+||...+. +|+.|.. +++| ..++|+...||..+.
T Consensus 297 k~~l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedi----------k~HpFF~g~~W~~iR 350 (1317)
T KOG0612|consen 297 KESLSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDI----------KNHPFFEGIDWDNIR 350 (1317)
T ss_pred hhhcCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHH----------HhCccccCCChhhhh
Confidence 333222211 2379999999999886 7888876 4433 357899999996643
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=307.27 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=203.0
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.++|.+.+.||+|+||.||+|.+.. ++..||||........ ..+..|++++..+.| +++..+..++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH-ENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCC-CCchheeeEEecCCC
Confidence 4679999999999999999998643 4578999986554332 468889999999876 567777777788888
Q ss_pred eEEEEecc-CCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC
Q 012192 86 NIMVIDLL-GPSLEDLFNYCN-------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~-------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~ 151 (468)
.+++|+++ +++|.+++...+ ..+++..+..++.|++.||.|||++|++||||||+|||+ +.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCCC
Confidence 99999988 899999987532 347888999999999999999999999999999999999 4789
Q ss_pred eEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHH
Q 012192 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 230 (468)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~ 230 (468)
.++|+|||++........ +.......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 160 ~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--- 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--- 231 (280)
T ss_pred eEEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 999999999875432111 111234456789999999999999999999999999999998 99999765432
Q ss_pred HHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 231 QKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 231 ~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
..+..+.......+ ...+|.++.+++..||..+|++||++.+|.+.|+
T Consensus 232 ~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECITQGRLLQR----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 23333333222221 1356899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=321.91 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=205.8
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+-.++|.++++||+|+||.||+|.+. .++..||||++...... ..+..|++++..+..|++|+.+.+++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33467889999999999999999864 34568999987644322 35778999999998678888888888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------------------------------------------------------
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN--------------------------------------------------------- 105 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~--------------------------------------------------------- 105 (468)
...++||||+ +|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 8899999998 889999986432
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeec
Q 012192 106 ----------------------------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG 145 (468)
Q Consensus 106 ----------------------------------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~ 145 (468)
..+++..++.++.||+.||+|||+++++||||||.|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl- 272 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI- 272 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence 136777889999999999999999999999999999999
Q ss_pred ccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCC
Q 012192 146 LGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGL 224 (468)
Q Consensus 146 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~ 224 (468)
++.+.++|+|||+++.+..... ........+++.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 273 --~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 273 --CEGKLVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred --eCCCEEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 4688999999999986533211 111234467889999999999889999999999999999998 89999765
Q ss_pred CcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 225 KAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 225 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
... +............+.+ ..++.++.+|+..||..+|++||++.+|++.|+.++
T Consensus 346 ~~~---~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 346 PMN---EQFYNAIKRGYRMAKP---AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred Cch---HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 432 2222222222222222 345899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=306.67 Aligned_cols=253 Identities=20% Similarity=0.292 Sum_probs=199.7
Q ss_pred CceEEEceEeeeCCeEEEEEEEc----CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNV----QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~----~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
.+|++.++||+|+||.||+|.+. ..+..||||....... ...+..|+.++..+.| ++|+.+.++...++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH-PNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCCceE
Confidence 57999999999999999999853 3557899998654322 2357789999998875 66777777778888899
Q ss_pred EEEecc-CCCHHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCC
Q 012192 88 MVIDLL-GPSLEDLFNYC----------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKA 150 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~----------------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~ 150 (468)
++||++ +++|.+++... ...+++..++.++.|++.||+|||+++++||||||+|||+ +.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cCC
Confidence 999998 68999988532 1247888999999999999999999999999999999999 477
Q ss_pred CeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccH
Q 012192 151 NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 229 (468)
Q Consensus 151 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~ 229 (468)
+.++|+|||+++....... +.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-- 233 (283)
T cd05090 161 LHVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-- 233 (283)
T ss_pred CcEEeccccccccccCCcc-----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 8899999999976533211 112234456788999999998889999999999999999998 99999875432
Q ss_pred HHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 230 KQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 230 ~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
.... ........+ ....+|+++.++|.+||+.+|++||++.+|.+.|+.
T Consensus 234 -~~~~-~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 -EVIE-MVRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHH-HHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2222 222222222 234568999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.41 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=207.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
|-..+|.+.+.||+|+||.||++... .++..||||...... ....+..|+.++..+.| ++++.+..++...+
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 80 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEGD 80 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCC
Confidence 44678999999999999999999752 345679999754432 23457889999999976 67778888888888
Q ss_pred eeEEEEecc-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCN------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~ 151 (468)
..+++||++ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||+ ++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence 999999998 789999987432 248999999999999999999999999999999999999 5788
Q ss_pred eEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHH
Q 012192 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 230 (468)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~ 230 (468)
.++|+|||+++....... +.......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 158 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--- 229 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--- 229 (288)
T ss_pred cEEeccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 999999999975432211 111233456788999999999889999999999999999998 99999765432
Q ss_pred HHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 231 QKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 231 ~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+..+...... + ....++.++.+++.+||+.+|.+||++.+|.+.|+++...
T Consensus 230 ~~~~~i~~~~~~-~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 EVIECITQGRVL-Q---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHHcCCcC-C---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 233333332221 1 2234689999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=300.82 Aligned_cols=249 Identities=18% Similarity=0.257 Sum_probs=199.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
++|++.+.||+|+||.||+|.+. .+..+|+|...... ...++..|+.++..+.| +++..+++++......+++|+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH-PKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCC-CCceeEEEEEccCCCEEEEEEcC
Confidence 57999999999999999999864 45689999754332 23578889999998876 66777777778888899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 94 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 94 -ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
+++|.+++......+++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCce---
Confidence 789999987555578999999999999999999999999999999999999 4788999999999876432211
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 173 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||..... .+.+..+..... ...+ ..
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~~-~~~~---~~ 225 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGFR-LYRP---KL 225 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCC-CCCC---CC
Confidence 11223346678999999998889999999999999999999 9999976433 233333333221 1111 23
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
.+.++.+++.+||+.+|++||++.+|.+.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 478999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=306.94 Aligned_cols=256 Identities=15% Similarity=0.298 Sum_probs=201.4
Q ss_pred ceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
+|++.+.||+|+||.||+|.+.. ....||+|....... ...+..|+.++..+.| ++|+.+.+++...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH-PHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCCcE
Confidence 58899999999999999998653 235788987654332 2357789999988876 56666777777788889
Q ss_pred EEEecc-CCCHHHHHHHc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcee
Q 012192 88 MVIDLL-GPSLEDLFNYC-----------------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL 143 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~-----------------------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiL 143 (468)
++++++ +++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999998 78999988642 134788999999999999999999999999999999999
Q ss_pred ecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCC
Q 012192 144 MGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQ 222 (468)
Q Consensus 144 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~ 222 (468)
+ ++++.++|+|||+++....... +.......++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 160 l---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 160 V---AEGRKMKISDFGLSRDVYEEDS-----YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred E---cCCCcEEeccccccccccCccc-----hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9 4788999999999876433211 111223345678999999998889999999999999999998 999997
Q ss_pred CCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 223 GLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 223 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+.... .+..........+. ...++.++.+++..||+.+|++||++.+|.+.|++++.+
T Consensus 232 ~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 232 GIAPE----RLFNLLKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCHH----HHHHHHhCCCCCCC---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 65432 22222232222222 245689999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=305.21 Aligned_cols=255 Identities=19% Similarity=0.308 Sum_probs=199.1
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+..++|++.+.||+|+||.||+|.+.. ++..||||....... ...+..|+.++..+.| ++|+.+..++.++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC
Confidence 567899999999999999999998642 456899997543221 2357788888888765 5667777777788
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN---------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~---------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
...+++||++ +++|.+++.... ..+++..++.++.|++.||+|||+.+++|+||||+|||+ +.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCCE
Confidence 8899999987 789999987432 235788899999999999999999999999999999999 478899
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 232 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~ 232 (468)
+|+|||+++....... +.......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... ..
T Consensus 159 ~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QV 230 (277)
T ss_pred EECCCCCccccCCcce-----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence 9999999875432211 111223355788999999999899999999999999999999 78999875432 22
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
+..+..... .+ ....++.++.+++.+||+.+|++||++.++++.|+
T Consensus 231 ~~~~~~~~~-~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGL-LD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCc-CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 222222222 11 22345899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=308.18 Aligned_cols=260 Identities=18% Similarity=0.292 Sum_probs=206.6
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
.+..++|.+.+.||+|+||.||+|.+. .++..||||+...... ...+..|++++.++.+|++|+.+..++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 355578999999999999999999753 3456899997554322 23577899999999767888888888888
Q ss_pred CceeEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
.+..+++||++ +++|.+++.... ..+++.++..++.|++.||+|||+++|+|+||||+|||+ +.++.++|+|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCcc
Confidence 88899999998 789999987533 348999999999999999999999999999999999999 4778899999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
++....... +.......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... ..+......
T Consensus 188 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~---~~~~~~~~~ 259 (302)
T cd05055 188 ARDIMNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD---SKFYKLIKE 259 (302)
T ss_pred cccccCCCc-----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch---HHHHHHHHc
Confidence 976543211 111223456788999999999999999999999999999998 99999875432 222222222
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
....+ .....++++.+++.+||..+|++||++.+|.+.|+++
T Consensus 260 ~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GYRMA---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCcCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 22221 1234588999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=310.19 Aligned_cols=257 Identities=18% Similarity=0.262 Sum_probs=203.7
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcE--EEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEE--IAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~--vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
-++|++.+.||+|+||.||+|.+..++.. +|+|...... ....+..|+.++.++.+|++|+.+.+++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 36899999999999999999998777754 5666543221 223577899999999777899999988888899999
Q ss_pred EEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCe
Q 012192 89 VIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ 152 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~ 152 (468)
+|||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||+ +.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCCc
Confidence 99998 789999987432 257899999999999999999999999999999999999 47889
Q ss_pred EEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHH
Q 012192 153 VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 231 (468)
Q Consensus 153 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~ 231 (468)
++|+|||++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... +
T Consensus 163 ~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 231 (303)
T cd05088 163 AKIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E 231 (303)
T ss_pred EEeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---H
Confidence 999999998632210 01112234678999999988889999999999999999998 99999865432 2
Q ss_pred HHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 232 KYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 232 ~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
.+..+.. ..... ....+++++.++|.+||+.+|++||+++++++.|..++...
T Consensus 232 ~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 232 LYEKLPQ-GYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHHhc-CCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 2222211 11111 11345889999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=317.49 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=192.8
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeE------
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGV------ 81 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~------ 81 (468)
.+.++|++++.||.|+||.||+|.+..++..||||...... ....+..|++++..+.|++.+ .+..++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI-GLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchh-hhhhhhccccccc
Confidence 35689999999999999999999999999999999865432 123567899999999875544 4443332
Q ss_pred eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 82 EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 82 ~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
.....++++++++++|.+++. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~ 165 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLA 165 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCccc
Confidence 224468999999999998886 4579999999999999999999999999999999999999 47889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc-
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK- 239 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~- 239 (468)
+..... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 166 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 166 RQADDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred eecCCC----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 865431 234578999999999987 46899999999999999999999999764322111111110000
Q ss_pred -------------------ccCCC---HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 -------------------KVSTP---IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 -------------------~~~~~---~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+ ........++.+.+||..||..||++||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00000 1112234567789999999999999999998654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=317.04 Aligned_cols=254 Identities=18% Similarity=0.198 Sum_probs=191.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEe-----
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVE----- 82 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----- 82 (468)
.+.++|++.+.||+|+||.||+|.+..++..||||.+..... ...+..|+.+++.+.|++.+..+..+...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 356899999999999999999999988999999998654322 23567789898888775555444433322
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 83 GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 83 ~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
....+++||++.++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 167 (355)
T ss_pred cceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcccc
Confidence 235699999999888877753 58899999999999999999999999999999999999 478899999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH-------
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK------- 235 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~------- 235 (468)
...... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+............
T Consensus 168 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 168 TAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred cCCCcc--------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 543211 12345789999999999999999999999999999999999999986442211111100
Q ss_pred ------------HhhcccC-----CC----------HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 236 ------------ISEKKVS-----TP----------IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 236 ------------i~~~~~~-----~~----------~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....... .+ ........+.++.+||.+||..||++||++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000000 00 00001123567899999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=302.00 Aligned_cols=248 Identities=19% Similarity=0.327 Sum_probs=192.7
Q ss_pred eEeeeCCeEEEEEEEc--CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CC
Q 012192 22 KIGSGSFGELYLGVNV--QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GP 95 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~~--~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-gg 95 (468)
.||+|+||.||+|.+. ..+..||||+...... ...+..|+.++..+.|+ ++..+.+++. .+..++|||++ ++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~-~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP-YIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCC-CeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999765 3556799998654432 24578899999998765 4555555543 45678899988 88
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccc
Q 012192 96 SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175 (468)
Q Consensus 96 sL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 175 (468)
+|.+++......+++..++.++.|++.||+|||++|++||||||+|||+ +.++.++|+|||++..+...... +
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~----~ 152 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSY----Y 152 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccc----e
Confidence 9999987656689999999999999999999999999999999999999 47889999999999755432111 1
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 176 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 176 ~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
.......++..|+|||++.+..++.++|||||||++|++++ |..||.+....+.... + ......+. ...+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~-~~~~~~~~---~~~~~~ 225 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF---I-EQGKRLDC---PAECPP 225 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---H-HCCCCCCC---CCCCCH
Confidence 11122334678999999998889999999999999999996 9999987654332222 2 22222222 234589
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
++.++|..||..+|++||++.+|.+.|+.++
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=302.56 Aligned_cols=252 Identities=19% Similarity=0.254 Sum_probs=204.1
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCc------
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD------ 84 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~------ 84 (468)
..|+.+++||+|+||+||+|+.+.+|..||+|.+....+ .....+|+-+++.|.|.++|+.+..+....+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 458888999999999999999999999999998665544 3356899999999999887888888877766
Q ss_pred eeEEEEeccCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 85 YNIMVIDLLGPSLEDLFNYCN---RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 85 ~~~lv~el~ggsL~~ll~~~~---~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
..+||+|++.-+|..++.... ..++...+..++.||+.||+|||+++|+||||||.|||+ ++.+.+||+|||+|
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLA 167 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeeccchH
Confidence 789999999999999999776 468889999999999999999999999999999999999 47999999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
+.+.. |-+.....++|..|.|||+++|. .|+...||||+||+++||++++..|++.........+..+....
T Consensus 168 ra~~i-------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 168 RAFSI-------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred HHhcC-------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 86543 22334567889999999999998 59999999999999999999999999876533222222221110
Q ss_pred ---------------cCCC----HHHhh---ccCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012192 241 ---------------VSTP----IEVLC---KSYPSEFVSYFHYCRSLRFEDKPDYSY 276 (468)
Q Consensus 241 ---------------~~~~----~~~l~---~~~p~~~~~li~~cl~~~p~~RPs~~~ 276 (468)
...+ ...++ +...+...+++.+|++.+|.+|.++..
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 0000 01111 222247889999999999999999884
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.67 Aligned_cols=262 Identities=16% Similarity=0.298 Sum_probs=208.4
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEc-------CCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNV-------QTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~-------~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
++..++|.+.+.||+|+||.||+|.+. ..+..||||...... ....+..|+.++..+.+|++|..+.+++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 566789999999999999999999753 234579999765332 2346788999999996678888888888
Q ss_pred EeCceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceee
Q 012192 81 VEGDYNIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144 (468)
Q Consensus 81 ~~~~~~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl 144 (468)
......+++||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 8888899999998 779999987531 347888999999999999999999999999999999999
Q ss_pred cccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 012192 145 GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 223 (468)
Q Consensus 145 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~ 223 (468)
+.++.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 171 ---~~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 171 ---TENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred ---cCCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 47789999999999865432211 11223346678999999999889999999999999999998 8889976
Q ss_pred CCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 224 LKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 224 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
... .+.+..+.... ... ....++.++.+++..||..+|++||++.+|++.|+.++.-
T Consensus 243 ~~~---~~~~~~~~~~~-~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 243 IPV---EELFKLLKEGH-RMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCH---HHHHHHHHcCC-cCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 532 23333332221 111 1235689999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=305.18 Aligned_cols=267 Identities=19% Similarity=0.283 Sum_probs=205.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+..++|++.++||+|+||.||+|.+.. .+..||||........ ..+..|+.++..+.| ++|..+..++...
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC-HHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC
Confidence 456899999999999999999997542 3458999975433322 245678888887765 6788888877888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN---------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~---------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
+..+++|||+ +++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcE
Confidence 8899999998 899999997432 2356778899999999999999999999999999999994 78899
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 232 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~ 232 (468)
+|+|||+++....... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... +.
T Consensus 159 ~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QV 230 (288)
T ss_pred EECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence 9999999875432211 111223345778999999999899999999999999999998 88999764332 22
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccc
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDW 298 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw 298 (468)
+..+...... + ....+++++.+++..||+.+|++||++.++++.|++.+ ++.....||
T Consensus 231 ~~~~~~~~~~-~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~----~~~~~~~~~ 288 (288)
T cd05061 231 LKFVMDGGYL-D---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL----HPSFPEVSF 288 (288)
T ss_pred HHHHHcCCCC-C---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc----CCCCCCCCC
Confidence 2222222111 1 12345899999999999999999999999998888764 345555565
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=317.55 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=197.8
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHh--CCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQ--GGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
||+|+||+||+|.+..++..||||++.... .......|..++..+. +|++|+.++.++......+++|||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999865432 1123445666666554 7788999988888899999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~------ 150 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDN------ 150 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCC------
Confidence 899888874 5679999999999999999999999999999999999999 578899999999987532211
Q ss_pred ccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCc
Q 012192 175 YRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP 253 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 253 (468)
.......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.. ..+.+..+.......+. ..++
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~----~~~~ 222 (330)
T cd05586 151 -KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIAFGKVRFPK----NVLS 222 (330)
T ss_pred -CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHHcCCCCCCC----ccCC
Confidence 112356799999999999765 48999999999999999999999997643 23344444444333332 2358
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHH-HHHHHHHHHHHcCCCCCccccccccc
Q 012192 254 SEFVSYFHYCRSLRFEDKPDYSY-LKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 254 ~~~~~li~~cl~~~p~~RPs~~~-l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+++.++|..||..+|++||+... +.++++ +++....+|....
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~-------h~~~~~~~~~~~~ 265 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE-------HPFFADIDWDLLS 265 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc-------CccccCCCHHHHH
Confidence 89999999999999999995432 223332 4445556676654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=306.56 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=201.8
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCc----e
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD----Y 85 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~----~ 85 (468)
+..+.-.|+-.+.+|.|+||.||.|....+++.||||....+.. ---+|.++|..+.|+|+|..++.|....+ +
T Consensus 19 ~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 19 GKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred CcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 33445579999999999999999999999999999997554433 34579999998888766666666654322 4
Q ss_pred eEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 86 NIMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
..+||||+..+|..+++. .+..++.-.+.-++.||+.||.|||+.||+||||||.|+|+. .+.+.+||||||.|+
T Consensus 97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcce
Confidence 578999999999999884 367888889999999999999999999999999999999994 456999999999999
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc--
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-- 239 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 239 (468)
....... +.....|..|.|||.+.|.. |+.+.||||.|||+.||+-|..-|+|.........+.++...
T Consensus 175 ~L~~~ep--------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 175 VLVKGEP--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred eeccCCC--------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 8765322 34567788999999999875 999999999999999999999999996554333332222111
Q ss_pred -------ccC---C--------C-HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 240 -------KVS---T--------P-IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 240 -------~~~---~--------~-~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
+.. . + ...+.+..+++..+|+.+++..+|.+|.++.++
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~ 303 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA 303 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH
Confidence 000 0 0 011345678999999999999999999998854
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=312.90 Aligned_cols=238 Identities=21% Similarity=0.300 Sum_probs=190.0
Q ss_pred EceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccC------CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 20 GRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKT------KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+++||+|+||.||++.+. .+++.||||++.... ....+..|+.++..+.| ++|+.+..++..++..+++|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH-PFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCC-CchhceeeEEecCCeEEEEE
Confidence 368999999999999864 478899999865321 12345678999988876 56666666677788899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+ +++|.+++.. ...+.+..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 998 7899998875 5578899999999999999999999999999999999999 5788999999999875332111
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+.......+
T Consensus 156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~~~~~~~~~~~~~~~----- 220 (323)
T cd05584 156 -------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---KKTIDKILKGKLNLP----- 220 (323)
T ss_pred -------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCC-----
Confidence 12345799999999999998999999999999999999999999986432 233444444333222
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCC-----CHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKP-----DYSYL 277 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RP-----s~~~l 277 (468)
..+++++.++|..||+.+|++|| ++.++
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 253 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEV 253 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHH
Confidence 34588999999999999999999 56644
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.05 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=206.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCCC--chhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTKH--PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
.++|.+.+.||+|+||.||+|.+.. ++..|++|........ ..+..|+.++..+.| ++|..+.+++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-EHIVKFYGVCGDGDPL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCce
Confidence 4679999999999999999998542 4567899975544322 457889999888876 6777788888888899
Q ss_pred EEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCC
Q 012192 87 IMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKA 150 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~ 150 (468)
++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 9999998 899999987432 348899999999999999999999999999999999999 578
Q ss_pred CeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccH
Q 012192 151 NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 229 (468)
Q Consensus 151 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~ 229 (468)
+.++|+|||++........ ........++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 160 ~~~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 232 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-- 232 (291)
T ss_pred CcEEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 8999999999975433211 111234567889999999999899999999999999999998 99999765432
Q ss_pred HHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 230 KQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 230 ~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+..+....... ....+|.++.+++.+||+.+|++||++.+|.+.|+++...
T Consensus 233 -~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 -EVIECITQGRVLE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHHHHhCCCCCC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 2232232222211 1234589999999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.62 Aligned_cols=249 Identities=18% Similarity=0.211 Sum_probs=192.8
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
...|++++.||+|+||.||+|.+..++..||+|+... .....|+.++..+.| ++|+.+..++......++||+++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~----~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----GTTLIEAMLLQNVNH-PSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc----cccHHHHHHHHhCCC-CCCcChhheEEeCCeeEEEEEcc
Confidence 4579999999999999999999998999999997322 234678999988876 56777777778888999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
.++|.+++......+++..+..|+.||+.||.|||++|||||||||+|||+ +..+.++|+|||+++......
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~----- 211 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP----- 211 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc-----
Confidence 999999988667789999999999999999999999999999999999999 578899999999987432211
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-------HHHHHHHhhc-ccC---
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-------KQKYDKISEK-KVS--- 242 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~-------~~~~~~i~~~-~~~--- 242 (468)
......||..|+|||++.+..++.++|||||||++|||+++..|+........ ...+..+... ...
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred ---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 12346799999999999999999999999999999999986555433222110 0111111110 000
Q ss_pred CC---H----------------------HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 243 TP---I----------------------EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 243 ~~---~----------------------~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+ . ......++.++.++|.+||+.||.+||++.+|+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l 349 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence 00 0 000124567788899999999999999998654
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.13 Aligned_cols=256 Identities=17% Similarity=0.290 Sum_probs=204.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCC---cEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTG---EEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~---~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
.++|++.+.||+|+||.||+|.+..++ ..||||....... ...+..|+.++..+.| ++|..+..++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCccE
Confidence 468999999999999999999876443 3799997654322 2357888888888865 67778888888888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
++||++ +++|.+++......+++.+++.++.|++.||.|||+++++||||||+|||+ +.++.++|+|||++..+..
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCccccccc
Confidence 999999 789999998766678999999999999999999999999999999999999 4788999999999987643
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
..... .......++..|+|||++.+..++.++|+||||+++|++++ |..||.+.... +.+..+... ...+.
T Consensus 159 ~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~-~~~~~ 230 (267)
T cd05066 159 DPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEG-YRLPA 230 (267)
T ss_pred cccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCC-CcCCC
Confidence 22111 01112234568999999999899999999999999999886 99999875432 222223222 22222
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
...+|+.+.+++.+||+.+|++||++.+|.+.|+++
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 ---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 234689999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.76 Aligned_cols=258 Identities=18% Similarity=0.314 Sum_probs=204.4
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCC-----CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQT-----GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~-----~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
-.++|++.+.||+|+||.||+|.+... ...||+|....... ...+..|+.++..+..|++|..+..++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 347899999999999999999987643 36899997654322 2347789999989866788888888888888
Q ss_pred eeEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC
Q 012192 85 YNIMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR 148 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~---------------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~ 148 (468)
..+++||++ +++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||+ +
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---T 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---c
Confidence 899999987 88999998632 3468899999999999999999999999999999999999 4
Q ss_pred CCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcc
Q 012192 149 KANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 227 (468)
Q Consensus 149 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~ 227 (468)
.++.++|+|||+++.+..... +.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDY-----YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred CCCeEEeCccccccccccccc-----eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 788999999999986543221 111223345678999999998899999999999999999997 99999865432
Q ss_pred cHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 228 TKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 228 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
+.+..+.. ...... ...++.++.+++..||..+|++||++.+|++.|+++.
T Consensus 242 ---~~~~~~~~-~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ---ELFKLLKE-GYRMEK---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HHHHHHHc-CCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 22222222 221111 1345789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=309.28 Aligned_cols=264 Identities=17% Similarity=0.304 Sum_probs=207.5
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcC-------CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQ-------TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~-------~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
++...+|++++.||+|+||.||+|.+.. ....||||+...... ...+..|++++.++..|++|..+..++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3455689999999999999999998643 234789997654332 246788999999997678888888888
Q ss_pred EeCceeEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceee
Q 012192 81 VEGDYNIMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144 (468)
Q Consensus 81 ~~~~~~~lv~el~-ggsL~~ll~~~---------------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl 144 (468)
......++++|++ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 8888889999998 77999998742 1347889999999999999999999999999999999999
Q ss_pred cccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 012192 145 GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 223 (468)
Q Consensus 145 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~ 223 (468)
+.++.++|+|||+++....... +.......++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 168 ---~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 168 ---TEDNVMKIADFGLARDVHNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred ---cCCCcEEECCcccceecccccc-----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 4778999999999976543211 111223344578999999999999999999999999999998 8999986
Q ss_pred CCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012192 224 LKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 289 (468)
Q Consensus 224 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~ 289 (468)
... ...+..+... ...+ ....++.++.++|..||+.+|++||++.+|++.|+.++....
T Consensus 240 ~~~---~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 240 IPV---EELFKLLKEG-HRMD---KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred CCH---HHHHHHHHcC-CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 543 2222222222 2112 123458899999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.40 Aligned_cols=258 Identities=16% Similarity=0.273 Sum_probs=202.6
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCc---EEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGE---EIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
.++|++.+.||+|+||.||+|.+..++. .||||+...... ...+..|+.++..+.| +++..+..++..+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-cCcceEEEEECCCCceE
Confidence 4579999999999999999999876654 699998654322 2467889999888865 56777777778888899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
++||++ +++|.+++......+++..++.++.|++.||+|||++|++|+||||+|||+ +.++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence 999998 679999998666779999999999999999999999999999999999999 5778999999999876543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... ..+........+..|+|||++.+..++.++|||||||++|||++ |..||.+.... .....+ ......+.
T Consensus 159 ~~~~--~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i-~~~~~~~~ 232 (269)
T cd05065 159 DTSD--PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI-EQDYRLPP 232 (269)
T ss_pred Cccc--cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH-HcCCcCCC
Confidence 2110 01111111223467999999999899999999999999999886 99999765432 222222 22222222
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+ ..+|.++.+++..||+.+|++||++.+|...|+.+
T Consensus 233 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 P---MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred c---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2 34589999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.65 Aligned_cols=249 Identities=18% Similarity=0.226 Sum_probs=191.2
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeE-----eC
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGV-----EG 83 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~~ 83 (468)
+.++|++.+.||+|+||.||+|.+..++..||||++.... ....+..|+.++..+.|++.+..+..+.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4689999999999999999999999999999999865432 23456788899888877555544433322 22
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 84 DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 84 ~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
...++||||+.++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccc
Confidence 45799999999999887753 58899999999999999999999999999999999999 4788999999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
..... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+..... .+.++....-..
T Consensus 176 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~ 244 (364)
T cd07875 176 AGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTP 244 (364)
T ss_pred cCCCC--------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCC
Confidence 43211 1234578999999999999999999999999999999999999998754322 121111110000
Q ss_pred C-------------------------HHH------------hhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 244 P-------------------------IEV------------LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 244 ~-------------------------~~~------------l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
. ... .....+.++.++|.+||+.||.+||++.+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0 000 0011245789999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=302.65 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=194.3
Q ss_pred EEEceEeeeCCeEEEEEEEc----CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 18 KLGRKIGSGSFGELYLGVNV----QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 18 ~i~~~LG~G~fG~Vy~~~~~----~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.+.+.||.|.||.||+|.+. ..+..|+||+...... ...+..|++.+..+ .|++|..+.+++...+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccccccccccc
Confidence 57899999999999999987 3567899998754332 35788899999999 5577888888888777789999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|++ +++|.+++... ...+++..+..|+.|++.||.|||+++++|+||+++|||+ +.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 998 68999999975 5679999999999999999999999999999999999999 478899999999998652211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. +.......+...|+|||.+.+..++.++||||||+++|||++ |..||.+... .+....+..... .+.+
T Consensus 158 ~-----~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~~~~-~~~~- 227 (259)
T PF07714_consen 158 K-----YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQGQR-LPIP- 227 (259)
T ss_dssp S-----EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHTTEE-TTSB-
T ss_pred c-----ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccc-ceec-
Confidence 1 112334567789999999999889999999999999999999 7899987643 233333323222 2222
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
..+|..+.++|..||..+|++||++.+|.+.|
T Consensus 228 --~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 --DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 34599999999999999999999999998865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.78 Aligned_cols=261 Identities=19% Similarity=0.275 Sum_probs=199.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCC----------------cEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCC
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTG----------------EEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGI 73 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~----------------~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i 73 (468)
..++|+++++||+|+||.||+|.+...+ ..||+|+...... ...+..|++++..+.| +++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD-PNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCC-CCE
Confidence 3478999999999999999999876543 5689998654432 3457789999999976 566
Q ss_pred ceeeEeeEeCceeEEEEecc-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCce
Q 012192 74 PHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCN----------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNF 142 (468)
Q Consensus 74 ~~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~----------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~Ni 142 (468)
..+..++......+++|+++ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 67777777778889999988 789999987533 2689999999999999999999999999999999999
Q ss_pred eecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc--CCCC
Q 012192 143 LMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR--GSLP 220 (468)
Q Consensus 143 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt--G~~P 220 (468)
|++ .++.++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 162 li~---~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 162 LVG---KNYTIKIADFGMSRNLYSSDY-----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred eec---CCCceEEccccceeecccCcc-----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 994 678999999999875433211 111234456789999999998889999999999999999998 7788
Q ss_pred CCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 221 WQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 221 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
|..............................+|.++.+++..||+.+|++||++.+|.+.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 234 YEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 87654322211111110000000111112345799999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.88 Aligned_cols=257 Identities=20% Similarity=0.307 Sum_probs=197.8
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcC----------------CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCc
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQ----------------TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIP 74 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~----------------~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~ 74 (468)
.++|++.++||+|+||.||++.+.. ++..||||+...... ...+..|+.++..+.| ++|.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKD-PNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcc
Confidence 4689999999999999999986432 345799998654322 2457889999998865 6777
Q ss_pred eeeEeeEeCceeEEEEecc-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcee
Q 012192 75 HLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCN----------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL 143 (468)
Q Consensus 75 ~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~----------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiL 143 (468)
.+.+++...+..+++||++ +++|.+++.... ..+++.++..++.|++.||+|||++||+|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 7887888888899999998 789999987532 24778899999999999999999999999999999999
Q ss_pred ecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc--CCCCC
Q 012192 144 MGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR--GSLPW 221 (468)
Q Consensus 144 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt--G~~Pf 221 (468)
++ .++.++|+|||+++.+..... ........++..|++||++.+..++.++|||||||++|||++ |..||
T Consensus 163 i~---~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 163 VG---KNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred Ec---CCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 94 688999999999876533211 111223345678999999998899999999999999999998 78899
Q ss_pred CCCCcccHHHHHHHHhh---cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 222 QGLKAGTKKQKYDKISE---KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 222 ~~~~~~~~~~~~~~i~~---~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
................. .....+.+ ..+|+.+.++|..||+.+|++||++.+|.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 235 SQLSDEQVIENTGEFFRDQGRQVYLPKP---ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cccChHHHHHHHHHHHhhccccccCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 76544322221111110 11111111 345899999999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.99 Aligned_cols=254 Identities=20% Similarity=0.379 Sum_probs=201.5
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+|..++|+++++||+|+||.||+|.. .++..||||...... ....+..|+.++..+.| +++..+..+. ..+..+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~-~~~~~~~v 78 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH-PRLVRLYAVV-TQEPIYII 78 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCC-cCeeeEEEEE-ccCCcEEE
Confidence 35678999999999999999999985 467889999765433 23468889999999876 5566666654 44567889
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|+++ +++|.+++... +..+++..+..++.|++.||+|||+.|++||||||+||++ +.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCC
Confidence 9988 78999988643 4568999999999999999999999999999999999999 47889999999998765421
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
. +.......++..|+|||++.+..++.++||||||+++|++++ |..||.+..... .+..+. .....+.
T Consensus 156 ~------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~-~~~~~~~- 224 (260)
T cd05067 156 E------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNLE-RGYRMPR- 224 (260)
T ss_pred C------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHH-cCCCCCC-
Confidence 1 111233456788999999998889999999999999999998 999998754322 222222 2222222
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
...+|.++.++|.+||..+|++||++++|...|++
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 --PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 23468999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=303.43 Aligned_cols=258 Identities=20% Similarity=0.314 Sum_probs=200.8
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+-.+.|.+.+.||+|+||.||+|.+.. ++..||+|....... ...+..|+.++..+.| ++|..+.+++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH-QNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccC
Confidence 345789999999999999999999876 678899997543322 2357888999888876 5777777777777
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
...+++||++ +++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||+........++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 8889999998 889999987543 258999999999999999999999999999999999999533334579999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 235 (468)
|||+++....... +........+..|+|||++.+..++.++|||||||++|+|++ |..||.+..... ....
T Consensus 162 dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~ 233 (277)
T cd05036 162 DFGMARDIYRASY-----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEF 233 (277)
T ss_pred cCccccccCCccc-----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 9999986532111 011122234568999999999899999999999999999997 999998654322 2222
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
+... ... .....+|.++.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~~~-~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGG-GRL---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcC-CcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2211 111 122456899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=302.43 Aligned_cols=259 Identities=20% Similarity=0.333 Sum_probs=202.1
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcC----CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEe-eEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQ----TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWF-GVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~----~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~-~~~~ 83 (468)
+-+++|++.+.||+|+||.||+|.+.. ++..|++|.+..... ...+..|+.++..+.|+ ++..+.++ ....
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ-NILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEecCC
Confidence 567899999999999999999999865 358899997653322 23467888888888665 55555554 4446
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEE
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN-------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYI 155 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~-------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL 155 (468)
...+++++++ +++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+|||++ +++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEE
Confidence 7788888887 789999987532 4589999999999999999999999999999999999994 7789999
Q ss_pred EeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHH
Q 012192 156 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~ 234 (468)
+|||+++.+.....+. ......++..|+|||++.+..++.++||||||+++|++++ |..||...... ....
T Consensus 159 ~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~ 230 (280)
T cd05043 159 TDNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAA 230 (280)
T ss_pred CCCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHH
Confidence 9999998654322211 1123356778999999999899999999999999999998 99999865432 2222
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.+ ......+.. ..+|+++.+++.+||..+|++||++.+|.+.|+++..
T Consensus 231 ~~-~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 231 YL-KDGYRLAQP---INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HH-HcCCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22 222222211 2358999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=318.87 Aligned_cols=257 Identities=18% Similarity=0.243 Sum_probs=195.8
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCc-----ee
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD-----YN 86 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-----~~ 86 (468)
+|+++++||+|+||.||+|.+..+++.||||.+.... ....+..|+.++..++|+ +|..+..+....+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHD-NVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCC-CcCCHhheecCCCccccceE
Confidence 5889999999999999999998899999999764322 224577899999988765 5555555555444 78
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 87 IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 87 ~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+++|||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 80 ~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeeccc
Confidence 99999999999888863 5679999999999999999999999999999999999999 5788999999999976433
Q ss_pred ccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH---------
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI--------- 236 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i--------- 236 (468)
... .......+|..|+|||++.+. .++.++|||||||++|||++|..||.+.........+...
T Consensus 156 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 156 DES------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred Ccc------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 211 112234678999999999875 4799999999999999999999999875433222211111
Q ss_pred -----------hhcccCCCH-H---HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 237 -----------SEKKVSTPI-E---VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 237 -----------~~~~~~~~~-~---~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.......+. . .+....++++.+||..||+.||++||++.++ |++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~---l~hp~~ 291 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA---LAHPYL 291 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH---hcCHhh
Confidence 000111110 1 1123457899999999999999999999854 444443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=301.20 Aligned_cols=250 Identities=17% Similarity=0.280 Sum_probs=200.4
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
.++|++.+.||+|+||.||+|.+.. +..||||...... ....+..|+.++..+.| ++|+.+++++......+++||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSH-EKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCC-CCeeeEEEEEccCCCcEEEEEc
Confidence 3679999999999999999998643 4569999755432 23568889999988875 6777888888888888999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +++|.+++......+++..++.++.|++.||.|||++|++|+||||.|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCce--
Confidence 8 789999988655679999999999999999999999999999999999999 4778999999999876533211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
.......++..|++||++.+..++.++|||||||++|+|++ |..||...... .....+.... ..+.+ .
T Consensus 156 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~-~~~~~---~ 224 (256)
T cd05113 156 ----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKVSQGL-RLYRP---H 224 (256)
T ss_pred ----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHhcCC-CCCCC---C
Confidence 11223456778999999998889999999999999999998 99999765432 2222332222 12211 2
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
..++++.+++..||+.+|++||++.+|++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 3478999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.40 Aligned_cols=255 Identities=20% Similarity=0.228 Sum_probs=197.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+.+..|.+.+.||+|+||.||+|.+..+++.||||... ...+..|++++..+.| ++|+.+..++..+...+++|+
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~H-pnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSH-PAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEEE
Confidence 45678999999999999999999999999999999532 2346789999999976 566677777788889999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
++.++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||+ +..+.++|+|||+++........
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceeccccccc-
Confidence 99999999887656679999999999999999999999999999999999999 47788999999999765432110
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-----cHHHHHHHHhhcccCC---
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYDKISEKKVST--- 243 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~~~--- 243 (468)
.......||..|+|||++.+..++.++|||||||+||||++|..|+...... ...+....+.......
T Consensus 317 ----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 317 ----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 1123467999999999999999999999999999999999987765432211 1111111111111100
Q ss_pred CH------------------------H--HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 244 PI------------------------E--VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 244 ~~------------------------~--~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+. . .....++.++.+||..||+.||.+||++.+|++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 0 000134567899999999999999999997644
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=304.70 Aligned_cols=254 Identities=19% Similarity=0.231 Sum_probs=199.4
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++.++||.|+||.||+|.+..++..||||...... ....+..|+.++..+.| ++|..+..++...+..+++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCC-CCcceEEEEEecCCeEEEEEe
Confidence 57999999999999999999998899999999765332 22356789999998876 567777777788889999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
++.++|.+++......+++..+..++.|++.||+|||+.||+|+||||+|||+ +.++.++|+|||++.......
T Consensus 85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~--- 158 (301)
T cd07873 85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT--- 158 (301)
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC---
Confidence 99999999988666779999999999999999999999999999999999999 578899999999987543211
Q ss_pred cccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc----------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK---------- 240 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 240 (468)
.......++..|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..+....
T Consensus 159 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 ----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred ----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 112334678899999998764 47899999999999999999999998654322211111111000
Q ss_pred ------cCC------CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 ------VST------PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 ------~~~------~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
... ........+++++.++|.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 011222456889999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=297.80 Aligned_cols=246 Identities=18% Similarity=0.293 Sum_probs=194.4
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCC
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPS 96 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggs 96 (468)
+.||+|+||.||+|.+..++..||||....... ...+..|++++..+.| ++|..+.+++......++|||++ +++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 479999999999999988999999997543221 2457889999888865 66777777778888899999988 789
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccccc
Q 012192 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176 (468)
Q Consensus 97 L~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 176 (468)
|.+++......+++..++.++.|++.||+|||++|++||||||+|||+ +.++.++|+|||++........ ..
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~-----~~ 151 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVY-----AS 151 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccc-----cc
Confidence 999987655678999999999999999999999999999999999999 4778899999999875432110 00
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHH
Q 012192 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSE 255 (468)
Q Consensus 177 ~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 255 (468)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...........+. ...+|.+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~ 224 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----TREAIEQGVRLPC---PELCPDA 224 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----HHHHHHcCCCCCC---cccCCHH
Confidence 0111223567999999998889999999999999999997 999997654322 1112222222222 2345899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 256 FVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 256 ~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
+.+++.+||+.+|++||++.+|.+.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=303.23 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=195.4
Q ss_pred Cce-EEEceEeeeCCeEEEEEEE----cCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe--Cc
Q 012192 15 GKF-KLGRKIGSGSFGELYLGVN----VQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE--GD 84 (468)
Q Consensus 15 ~~y-~i~~~LG~G~fG~Vy~~~~----~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~ 84 (468)
++| ++.+.||+|+||+||++.. ..++..||||+...... ...+..|++++..+.| ++|..+..++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH-ENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCc
Confidence 455 9999999999999988653 34678999998655432 3457789999999876 555556555443 34
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..+++||++ +++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+|||+ +.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKA 156 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccccc
Confidence 678999988 7899999874 469999999999999999999999999999999999999 4678999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-----------HHH
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-----------KQK 232 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~-----------~~~ 232 (468)
+..... .+.......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 157 VPEGHE----YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cCCcch----hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 543211 01112233456779999999988899999999999999999999999865332100 001
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+..........+. ...+|.++.+++..||+.+|++||++++|++.|+++
T Consensus 233 ~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 233 LIELLERGMRLPC---PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhcCCCCCC---CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111111111 234689999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=304.28 Aligned_cols=242 Identities=21% Similarity=0.256 Sum_probs=191.8
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.|++.+.||+|+||.||+|.+..+++.||||....... ...+..|+.++..+.|+ ++..+...+...+..+++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~-~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCC-CeeeeeEEEecCCEEEEEE
Confidence 47889999999999999999999999999997554321 13456799999888765 5555666667778899999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+++ +++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+|||+ +..+.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 988 78999888643 3468999999999999999999999999999999999999 478889999999986543211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||..............+.... ....
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~ 224 (285)
T cd05630 157 T--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----QEEY 224 (285)
T ss_pred c--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----hhhc
Confidence 1 123478999999999999999999999999999999999999998754322222222211111 1122
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCC
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPD 273 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs 273 (468)
...+++++.+|+..||+.||++||+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccC
Confidence 3456889999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=299.55 Aligned_cols=247 Identities=19% Similarity=0.337 Sum_probs=191.9
Q ss_pred ceEeeeCCeEEEEEEE--cCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 21 RKIGSGSFGELYLGVN--VQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~--~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
++||+|+||.||+|.+ ..++..||||+....... ..+..|+.++..+.| ++|..+.+++. .+..+++|+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN-PYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCC-CCcceEEEEEc-CCCcEEEEecCC
Confidence 3689999999999965 457789999986544322 357788888888866 55666665554 45668899988
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
+++|.+++.. ...+++..+..++.|++.||+|||++||+||||||.|||+ +.++.++|+|||++.........
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~--- 151 (257)
T cd05116 79 LGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENY--- 151 (257)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCe---
Confidence 6789999874 4579999999999999999999999999999999999999 46788999999999765432211
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccC
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
+.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... .....+.... ..+ ....+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~~~~-~~~---~~~~~ 223 (257)
T cd05116 152 -YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIESGE-RME---CPQRC 223 (257)
T ss_pred -eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHCCC-CCC---CCCCC
Confidence 111223345678999999988889999999999999999997 99999865432 2222232222 122 22356
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 253 PSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
|+++.++|.+||+.+|++||++++|.+.|++.
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 89999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=300.03 Aligned_cols=258 Identities=16% Similarity=0.274 Sum_probs=204.0
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCc---EEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGE---EIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
|...+|+..+.||+|+||.||+|.+..++. .||||....... ...+..|++++..+.| +++..+.+++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH-HNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEccCCC
Confidence 556789999999999999999999875554 799997654322 2357788888888876 567777778788888
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.+++||++ +++|.+++......+++..+..++.|++.||+|||+.|++|+||||+|||+ +.++.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 99999988 679999998666789999999999999999999999999999999999999 47889999999998765
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
....... ........+..|+|||++.+..++.++|||||||++|||++ |..||..... ......+.. ....
T Consensus 158 ~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~-~~~~ 229 (268)
T cd05063 158 EDDPEGT----YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAIND-GFRL 229 (268)
T ss_pred ccccccc----eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhc-CCCC
Confidence 4321110 01112233567999999998889999999999999999997 9999976443 222222322 2222
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+.. ..+|.++.+++.+||+.+|++||++.+|.+.|+++
T Consensus 230 ~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PAP---MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 221 24589999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.81 Aligned_cols=260 Identities=20% Similarity=0.282 Sum_probs=197.5
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCC--------------CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCcee
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQT--------------GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHL 76 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~--------------~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l 76 (468)
.++|++.++||+|+||.||+|.+..+ ...||||....... ...+..|++++..+.| +++..+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKN-PNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCcCeE
Confidence 46899999999999999999986543 23589998654322 2357789999999876 567777
Q ss_pred eEeeEeCceeEEEEecc-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceee
Q 012192 77 KWFGVEGDYNIMVIDLL-GPSLEDLFNYCN-----------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144 (468)
Q Consensus 77 ~~~~~~~~~~~lv~el~-ggsL~~ll~~~~-----------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl 144 (468)
.+++......+++||++ +++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+|||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 77777888899999998 789999886421 236888999999999999999999999999999999999
Q ss_pred cccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc--CCCCCC
Q 012192 145 GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR--GSLPWQ 222 (468)
Q Consensus 145 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt--G~~Pf~ 222 (468)
++++.+||+|||++........ +.......++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 163 ---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 163 ---GNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred ---cCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 4678899999999876432211 112233456788999999998899999999999999999987 678887
Q ss_pred CCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 223 GLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 223 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
.............................+|+.+.+||.+||+.+|++||++++|.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 654332222211111111000001112345899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.62 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=199.8
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
..+|++.+.||+|+||.||+|.+. ++..+|||+...... ...+..|++++..+.| +++..+.+++....+.+++||+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH-PNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCceEEEEec
Confidence 357999999999999999999875 566899998654332 3467789999988876 5677777777888889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +++|.+++......+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+|||+++...+...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~-- 155 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQY-- 155 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecccccc--
Confidence 8 889999987655678999999999999999999999999999999999999 5788999999999876432111
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +....+.. ....+.+ .
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~-~~~~~~~---~ 224 (256)
T cd05059 156 ----TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESVSA-GYRLYRP---K 224 (256)
T ss_pred ----cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHHHc-CCcCCCC---C
Confidence 11122334568999999999899999999999999999998 89999765432 22222322 2222211 3
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
.+|.++.+++.+||..+|++||++.+|.+.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 4589999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=298.82 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=213.9
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
...+.+.|++.+.||+|.|+.||++.+..+|+.+|+|++..+ ...+++.+|+.|-..|+| |+|+.+........+
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH-P~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESF 84 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC-CcEeehhhhhcccce
Confidence 346778999999999999999999999999999999975433 345678999999888887 566677776678889
Q ss_pred eEEEEecc-CCCHHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 86 NIMVIDLL-GPSLED-LFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 86 ~~lv~el~-ggsL~~-ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
.|||+|++ |+.|.. ++. ...+++..+-.+++||+.+|.|+|.+||||||+||.|+|+...+...-|||+|||+|..
T Consensus 85 ~ylvFe~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred eEEEEecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999 666643 333 24578889999999999999999999999999999999998777788899999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
..+. .....++||+.|||||++...+|+..+|||+.||+||.++.|.+||.+. +....|+.|....+..
T Consensus 163 l~~g--------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rlye~I~~g~yd~ 231 (355)
T KOG0033|consen 163 VNDG--------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYEQIKAGAYDY 231 (355)
T ss_pred eCCc--------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhccccCC
Confidence 7632 2356789999999999999999999999999999999999999999874 4456778888888877
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSY 276 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~ 276 (468)
+.+. ...+.++.++|+.++|..||.+|.++.+
T Consensus 232 ~~~~-w~~is~~Ak~LvrrML~~dP~kRIta~E 263 (355)
T KOG0033|consen 232 PSPE-WDTVTPEAKSLIRRMLTVNPKKRITADE 263 (355)
T ss_pred CCcc-cCcCCHHHHHHHHHHhccChhhhccHHH
Confidence 6543 3567899999999999999999999874
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.14 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=198.7
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCch----hHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQ----LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~----~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
|+++++||+|+||.||++.+..+++.||+|+......... ...|+.++..+. |++|..+..+.......+++|++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc-ccccccccccccccccccccccc
Confidence 8999999999999999999999999999998766644332 244889999995 56777778888889999999999
Q ss_pred cCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 LGP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~gg-sL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+.+ +|.+++. ....+++..+..++.||+.||+|||+++|+|+||||+|||+ +.++.++|+|||.+.......
T Consensus 80 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~--- 152 (260)
T PF00069_consen 80 CPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENN--- 152 (260)
T ss_dssp ETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTT---
T ss_pred ccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc---
Confidence 966 9999998 35689999999999999999999999999999999999999 588999999999987541111
Q ss_pred cccccCCCCcccccccccccccc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 172 HIPYRENKNLTGTARYASVNTHL-GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~-~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
.......++..|+|||++. +..++.++||||||+++|+|++|..||...........+............ ....
T Consensus 153 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 227 (260)
T PF00069_consen 153 ----ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-QQSR 227 (260)
T ss_dssp ----SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-TSHT
T ss_pred ----cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-cccc
Confidence 1234567899999999998 788999999999999999999999999876322223333222221110000 0001
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..++++.++|..||+.+|++||++.+|++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12489999999999999999999997653
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=324.96 Aligned_cols=250 Identities=18% Similarity=0.221 Sum_probs=201.1
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCC-CcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQT-GEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~-~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
...|.+.+.||.|+||.||+|....+ +..||+|....... ...+..|+.++..+.| ++|+.++.++...+..+|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDH-FGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEEECCEEEEEE
Confidence 34599999999999999999998777 78899997543322 2346678888888865 67777777888889999999
Q ss_pred ecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 91 DLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 91 el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
||+ +++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||+ +..+.+||+|||+++.+..
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCC
Confidence 999 89999887532 3468999999999999999999999999999999999999 4788999999999987643
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+...... +
T Consensus 222 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~~~~~~~~-~-- 290 (478)
T PTZ00267 222 SVS-----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQVLYGKYD-P-- 290 (478)
T ss_pred ccc-----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC-C--
Confidence 211 1123456799999999999999999999999999999999999999976432 3333333333322 1
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....++.++.++|..||..+|++||++.+++.
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11345889999999999999999999998754
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.09 Aligned_cols=262 Identities=19% Similarity=0.250 Sum_probs=209.1
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC--chhHHHHHHHHHHhCCCCCceeeE-eeE-----e-Cc
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH--PQLHYESKLYMLLQGGTGIPHLKW-FGV-----E-GD 84 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~-~~~-----~-~~ 84 (468)
..+++|.+.|.+|||+.||+|.+...+.+||+|.+....+. ..+..|+.+|+.|.+|++|+.+.+ ... . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 36788999999999999999999888899999987666433 357899999999999999888877 222 1 23
Q ss_pred eeEEEEeccC-CCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 85 YNIMVIDLLG-PSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 85 ~~~lv~el~g-gsL~~ll~-~~~~~ls~~~~~~ia~qia~gL~yLHs~g--iiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
..+|+||||. |.|-|+++ +....|++.+++.|+.|+++|+.+||..+ |||||||.+||||+ .+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCcccc
Confidence 5688999994 89999987 34556999999999999999999999987 99999999999994 788999999999
Q ss_pred cccccc-ccCcccccccC-CCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 161 AKKYRD-LQTHKHIPYRE-NKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 161 a~~~~~-~~~~~~~~~~~-~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
|.-... ........+.. .-...-|+.|.|||++. +.+.+.|+|||+|||+||.|+....||.+.-. ..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------la 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LA 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------ee
Confidence 863221 11111111110 11234589999999875 66789999999999999999999999986411 23
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
|...++.+|.. ..|+..|.+||..||+.||++||++-++...+..+....
T Consensus 266 Ilng~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 ILNGNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred EEeccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 66777777753 467899999999999999999999988888777766554
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=318.95 Aligned_cols=250 Identities=22% Similarity=0.256 Sum_probs=212.4
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
.+.|.+++++|.|+||.+++++++..+..|++|.+..... ......|+.++.+++|+++|-+...|..++.+.+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 4689999999999999999999999999999998665432 235788999999988866666666665666669999
Q ss_pred Eecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|+|| ||+|.+.+.... ..|+++.+..|+.||+.||.|||++.|+|||||+.||+++ .++.|+|.|||+|+.....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCCc
Confidence 9999 999999988654 5699999999999999999999999999999999999996 7788899999999987653
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
.. ...+..||+.|++||.+.+.+|+.|+|||||||++|||++=+.+|.+. +....+.+|....+ .|
T Consensus 160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---~m~~Li~ki~~~~~-~P--- 225 (426)
T KOG0589|consen 160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---NMSELILKINRGLY-SP--- 225 (426)
T ss_pred hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---chHHHHHHHhhccC-CC---
Confidence 31 356789999999999999999999999999999999999999999864 45566666666653 22
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRL 280 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~ 280 (468)
+...+..++..+|..|+..+|+.||++.+|+..
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 335668999999999999999999999987664
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=306.69 Aligned_cols=254 Identities=19% Similarity=0.244 Sum_probs=199.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCC-----CcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQT-----GEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~-----~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
..+|++.++||.|+||.||+|.+..+ +..||||+....... ..+..|+.++..+.| ++|..+..++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~ 82 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH-PNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEcCCCc
Confidence 35688999999999999999987543 578999987644332 346678888777776 567777777777788
Q ss_pred eEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC
Q 012192 86 NIMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~---------------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~ 149 (468)
.+++++++ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||.|||+ ++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cC
Confidence 88999987 78899887521 2347888999999999999999999999999999999999 46
Q ss_pred CCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCccc
Q 012192 150 ANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 228 (468)
Q Consensus 150 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~ 228 (468)
++.+||+|||+++....... +.......+++.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 232 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-- 232 (283)
T ss_pred CCceEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 78899999999876533211 111234456789999999998889999999999999999998 8889987543
Q ss_pred HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 229 KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 229 ~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
.+.+..+..... .+ ....+|.++.+++..||+.+|++||++.+|...|+.
T Consensus 233 -~~~~~~i~~~~~-~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -QDVIEMIRNRQV-LP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHHHcCCc-CC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 233333333322 12 234569999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.22 Aligned_cols=252 Identities=18% Similarity=0.341 Sum_probs=192.8
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCc--EEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEe------Cc
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGE--EIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVE------GD 84 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~--~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------~~ 84 (468)
|.++++||+|+||.||+|.+..++. .||||...... ....+..|++++..+.| ++|..+..++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH-PNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEccCCcccCCC
Confidence 4578999999999999999876664 68999754432 23457788999988876 555555544321 12
Q ss_pred eeEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeC
Q 012192 85 YNIMVIDLL-GPSLEDLFNYC-----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDY 158 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~-----~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DF 158 (468)
..+++|+|+ +++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.++|+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCC
Confidence 457888887 78998887432 2358899999999999999999999999999999999999 47889999999
Q ss_pred CcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHh
Q 012192 159 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~ 237 (468)
|+++.+..... +.......+++.|++||++.+..++.++|||||||++|||++ |..||.+... .+.+..+.
T Consensus 157 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 228 (272)
T cd05075 157 GLSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLR 228 (272)
T ss_pred CcccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence 99986543211 111223456778999999999999999999999999999999 8999986433 23333333
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
.... .+ ....++..+.++|.+||+.+|++||++.+|.+.|+++
T Consensus 229 ~~~~-~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNR-LK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCC-CC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2221 11 1235689999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=305.75 Aligned_cols=261 Identities=19% Similarity=0.316 Sum_probs=206.1
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcC-------CCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQ-------TGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~-------~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
+-.++|.++++||+|+||.||+|.+.. ....||+|+....... ..+..|+.++..+.+|++|+.+..++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 445799999999999999999997632 3457999986543222 356789999988877788888888888
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeec
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG 145 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~ 145 (468)
.....+++||++ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 167 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV- 167 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE-
Confidence 888899999998 789999987531 358899999999999999999999999999999999999
Q ss_pred ccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCC
Q 012192 146 LGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGL 224 (468)
Q Consensus 146 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~ 224 (468)
+.++.++|+|||+++....... +.......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDY-----YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred --cCCCcEEEcccccccccccccc-----ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 4678999999999986543211 111122234567999999999889999999999999999999 89999765
Q ss_pred CcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 225 KAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 225 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.. ...+..+... .... ....++.++.+++..||..+|++||++.+|.+.|+++...
T Consensus 241 ~~---~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 241 PV---EELFKLLREG-HRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred CH---HHHHHHHHcC-CCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 43 2222222222 1111 1235588999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=300.74 Aligned_cols=252 Identities=20% Similarity=0.374 Sum_probs=195.4
Q ss_pred eEEEceEeeeCCeEEEEEEEcC---CCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCc-----
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQ---TGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD----- 84 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~---~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~----- 84 (468)
|++++.||+|+||.||+|.... ++..||||....... ...+..|+.++..+.| ++|..+.++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH-PNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCC-CCeeeEEeeeccCCccccC
Confidence 6788999999999999998754 347899998654322 2357789998888876 45556655544333
Q ss_pred -eeEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEe
Q 012192 85 -YNIMVIDLL-GPSLEDLFNYC-----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 85 -~~~lv~el~-ggsL~~ll~~~-----~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
..+++|+++ +++|..++... ...+++..+..++.|++.||+|||+++++||||||+|||+ ++++.++|+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECC
Confidence 368888887 88999887532 2368999999999999999999999999999999999999 5788999999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHH
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i 236 (468)
||+++....... +.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... +.+..+
T Consensus 157 fg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL 228 (273)
T ss_pred ccceeecccccc-----ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 999986543221 111222345678999999998889999999999999999999 99999765432 233323
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
.... ... ....++.++.++|.+||+.+|++||++.+|.+.|+++
T Consensus 229 ~~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGN-RLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCC-CCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2221 111 2245689999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=298.35 Aligned_cols=253 Identities=20% Similarity=0.379 Sum_probs=198.4
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+..++|++.++||+|+||.||+|.+..+ ..||||....... ...+..|++++..+.|++.+. +..+. ..+..+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~-~~~~~-~~~~~~~v~ 79 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP-LYAVV-SEEPIYIVT 79 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeee-EEEEE-cCCCcEEEE
Confidence 4567899999999999999999987554 4699997554332 346788999999998766555 44443 345678999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+++ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+|||+ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCc
Confidence 998 67999998753 3458999999999999999999999999999999999999 478899999999997653211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.... .....+.. ....+
T Consensus 157 ------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~-~~~~~--- 223 (260)
T cd05069 157 ------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVER-GYRMP--- 223 (260)
T ss_pred ------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-CCCCC---
Confidence 111223456778999999998889999999999999999999 99999875432 22222222 22222
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
....+|..+.+++.+||..+|++||++++|.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 123568999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=300.81 Aligned_cols=260 Identities=19% Similarity=0.283 Sum_probs=203.8
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCc----EEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGE----EIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~----~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
.+..++|++.+.||+|+||.||+|.+..++. .||+|....... ...+..|+.++..+.|+ ++..+.+++..
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~- 80 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHP-HVVRLLGICLS- 80 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCC-CcceEEEEEec-
Confidence 4556899999999999999999999876654 589997554432 23577889999888764 55555555555
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...+++|+++ +++|.+++......+++..++.++.|++.||+|||+.+++||||||+|||+ +.++.++|+|||+++
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~ 157 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcccc
Confidence 6677888877 889999998766679999999999999999999999999999999999999 578899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
......... ......++..|+|||.+....++.++||||||+++||+++ |..||.+.......+. + ....
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~-~~~~ 228 (279)
T cd05057 158 LLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL---L-EKGE 228 (279)
T ss_pred cccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---H-hCCC
Confidence 654321110 1112334678999999988889999999999999999998 9999987543322222 2 2222
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+.+. .++..+.+++.+||..+|.+||++.+|.+.|+.+...
T Consensus 229 ~~~~~~---~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 RLPQPP---ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCC---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 223222 2478899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=312.18 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=217.4
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
+..|++=|.+.+.||+|.|+.|-+|++.-||+.||||++.+... ...++.|++.|+.++| ++|+.+|-+...+..
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQH-pNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQH-PNIVRLYEVIDTQTK 91 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcC-cCeeeeeehhcccce
Confidence 44567889999999999999999999999999999998765433 3478999999888877 677788888888889
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.||++|+- +|+|.|++-.....+.++.+..+..||+.|+.|+|+..+|||||||+|+.+. .+-+.|||.|||++..+
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccC
Confidence 99999998 7799999998888999999999999999999999999999999999999886 57899999999998776
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s-~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
.... ...+.+|...|-|||+++|..|+ +++|||||||+||.|++|+.||+.-++. +.+..|..-++..
T Consensus 170 ~PG~--------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---ETLTmImDCKYtv 238 (864)
T KOG4717|consen 170 QPGK--------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---ETLTMIMDCKYTV 238 (864)
T ss_pred CCcc--------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---hhhhhhhcccccC
Confidence 5432 35678999999999999999985 7899999999999999999999975443 4445566777777
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
|.. ++.+.++||..||..||.+|.+.++|+.
T Consensus 239 Psh-----vS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 239 PSH-----VSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred chh-----hhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 643 3789999999999999999999987753
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=299.36 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=203.0
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.+.||.|+||.||+|.+..++..||||...... ....+..|+.++..+.| ++++.+..++...+..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccC-CchhhhhheeEeCCeEEEE
Confidence 47899999999999999999998899999999754321 12357788999888865 5666677777778888999
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 90 IDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
|+++ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 9998 67999988642 3468999999999999999999999999999999999999 478899999999987654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.+.... .......+..... .+.
T Consensus 158 ~~~~-------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~ 228 (267)
T cd08229 158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDY-PPL 228 (267)
T ss_pred cCCc-------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhcCCC-CCC
Confidence 3211 112456889999999999988999999999999999999999999764321 1222222222111 111
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
....+++++.+++.+||..+|++||++.+|++.++++
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1134688999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=319.37 Aligned_cols=259 Identities=22% Similarity=0.337 Sum_probs=211.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcC----CCcEEEEEEeecc---CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQ----TGEEIAVKLELVK---TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~----~~~~vAIK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
+..++.++||.|-||.||.|.+.. ...-||||..+.+ ...+.|+.|.-+|+.+.|++ |..+.+++. ....+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHph-IikLIGv~~-e~P~W 466 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPH-IIKLIGVCV-EQPMW 466 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcc-hhheeeeee-cccee
Confidence 445567889999999999998653 2346888875442 23457899999988888754 555555443 45678
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+|||++ .|.|..++......|+..+...++.||..+|.|||++++|||||.++|||+. ....|||+||||++.+.+
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccc
Confidence 999998 8999999998777899999999999999999999999999999999999995 778999999999998766
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.. |.......-++.|||||.+-...++.++|||-|||++||++. |..||++.++.++.-.+ +...+.|.
T Consensus 544 ~~------yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i----EnGeRlP~ 613 (974)
T KOG4257|consen 544 DA------YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI----ENGERLPC 613 (974)
T ss_pred cc------hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe----cCCCCCCC
Confidence 43 233334556788999999999999999999999999999887 99999998876544333 45555665
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQ 291 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~ 291 (468)
+..| |+.+..++.+||..+|.+||.+.+|+..|.++++.+..+
T Consensus 614 P~nC---Pp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~ 656 (974)
T KOG4257|consen 614 PPNC---PPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN 656 (974)
T ss_pred CCCC---ChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence 5555 999999999999999999999999999999998854443
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.12 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=196.0
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.++..+.| ++|+.+..++..+..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~ 117 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFCAFQDDKY 117 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCE
Confidence 445689999999999999999999999999999999865321 12345677777766654 677778888888899
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+|...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceec
Confidence 99999998 8899999873 468999999999999999999999999999999999999 57899999999999865
Q ss_pred ccccCcccccccCCCCccccccccccccccCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. ....+..+....
T Consensus 193 ~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~~i~~~~ 263 (370)
T cd05621 193 DETGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYSKIMDHK 263 (370)
T ss_pred ccCCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC
Confidence 43211 1123567999999999997643 7899999999999999999999998643 233444444332
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCC--CCCHHHHH
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFED--KPDYSYLK 278 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~--RPs~~~l~ 278 (468)
.....+. ...++..+.+++..|+..++.. |+++.+++
T Consensus 264 ~~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l 302 (370)
T cd05621 264 NSLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIK 302 (370)
T ss_pred cccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHh
Confidence 2111111 1235788999999999854433 77777543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.61 Aligned_cols=253 Identities=22% Similarity=0.271 Sum_probs=196.3
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
...+..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.++..+. |++|+.+..++...
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~ 115 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDD 115 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcC
Confidence 34556689999999999999999999999999999999865321 1223556777766655 56777777788888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...++||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCcee
Confidence 9999999999 8899999874 468999999999999999999999999999999999999 478899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
....... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.. ....+..+..
T Consensus 191 ~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~ 261 (371)
T cd05622 191 KMNKEGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMN 261 (371)
T ss_pred EcCcCCc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHc
Confidence 6543211 1123567999999999997643 7899999999999999999999998643 2344444443
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCC---CCCHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFED---KPDYSYLK 278 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~---RPs~~~l~ 278 (468)
.......+. ...++.++.++|..|+. +|.. |+++.+|.
T Consensus 262 ~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~ 302 (371)
T cd05622 262 HKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIK 302 (371)
T ss_pred CCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHh
Confidence 322211111 13568999999999998 5555 55655443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=299.84 Aligned_cols=250 Identities=19% Similarity=0.338 Sum_probs=197.5
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEe------Ccee
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVE------GDYN 86 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------~~~~ 86 (468)
.+.|++.+.||+|+||+||+|.+..+++.||||+..... ....+..|+.++..+.+|+++..+..++.. ....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 578999999999999999999999999999999865443 234678899999988777777777766553 2467
Q ss_pred EEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
+++||++ +++|.+++... ...+++..+..++.|++.||.|||+++|+|+||||+||++ +.++.++|+|||++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCceec
Confidence 8999999 67999998853 3568999999999999999999999999999999999999 57888999999998764
Q ss_pred ccccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
.... .......|+..|+|||++. +..++.++|||||||++|||++|..||...... .....+...
T Consensus 162 ~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~~~~~~ 231 (272)
T cd06637 162 DRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPRN 231 (272)
T ss_pred cccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhcC
Confidence 3211 1123467899999999986 335888999999999999999999999764332 111111111
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
... ......++.++.+||.+||..+|.+||++.+|++
T Consensus 232 ~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 1112346889999999999999999999987643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=302.62 Aligned_cols=248 Identities=19% Similarity=0.339 Sum_probs=197.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++.+.||+|+||.||+|.+..+|+.||||....... ...+..|..++.+..+|++++.+..++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999998654432 23466677776777788888888888888888999999
Q ss_pred ccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 92 LLGPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 92 l~ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
++.++|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||+ +.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 9999999888642 34689999999999999999999997 99999999999999 57889999999998765321
Q ss_pred cCcccccccCCCCccccccccccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc-ccC
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLG----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-KVS 242 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~----~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~~ 242 (468)
. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...... .+.+..+... ...
T Consensus 158 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 227 (283)
T cd06617 158 V--------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQ 227 (283)
T ss_pred c--------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHhcCCCC
Confidence 1 1123468889999998865 44689999999999999999999999754321 1222222221 111
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+ ...+|+++.++|..||..+|++||++.+|++
T Consensus 228 ~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1346899999999999999999999987644
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.69 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=204.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.+.||+|+||.||+|.+..++..||||..... .....+..|++++..+.| +++..+..++...+..+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~-~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-PNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCeeeeeeeeecCCeEEEE
Confidence 5899999999999999999999889999999975432 123467889999998866 5666777777778889999
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 90 IDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
|||+ +++|.+++... ...+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 9998 68999988642 3458999999999999999999999999999999999999 478899999999987654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... ......++..|+|||++.+..++.++|||||||++|+|++|..||..... ........+..... .+.
T Consensus 158 ~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~ 228 (267)
T cd08224 158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDY-PPL 228 (267)
T ss_pred CCCc-------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCC-CCC
Confidence 3211 12235688899999999988899999999999999999999999975432 22222222222211 111
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+ ...++.++.++|.+||..+|++||++.+|.+.|+++
T Consensus 229 ~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 P--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 124588999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=294.61 Aligned_cols=246 Identities=23% Similarity=0.288 Sum_probs=200.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|.+.+.||+|+||.||+|.+..++..|++|..... .....+..|++++..+.| +++..+..++.+....+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS-SYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCC-CCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999976532 223457778888888875 566667777778888999999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++ .++.++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCccc
Confidence 88 88999998764 46789999999999999999999999999999999999994 678999999999886543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ......+...... +. .
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~-~~---~ 222 (256)
T cd08529 157 -------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKIIRGVFP-PV---S 222 (256)
T ss_pred -------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCC-CC---c
Confidence 12345688999999999999999999999999999999999999976542 2233333332221 11 1
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..++.++.++|.+||+.+|++||++.+|++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 256899999999999999999999997754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=301.41 Aligned_cols=251 Identities=20% Similarity=0.346 Sum_probs=204.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
..+|++.++||.|+||.||+|.+.. +..||+|+...... ...+..|+.++..+.| +++..+..++...+..+++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRH-KHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCC-cchhheeeeEecCCCeEEEEe
Confidence 4679999999999999999999876 88999998665443 4568889999888875 666677777788888999999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+|||+ +.++.++|+|||++..+.....
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCccc
Confidence 98 77999998753 4568999999999999999999999999999999999999 4788999999999976543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
......++..|++||++.+..++.++||||||+++|+|++ |..||.+... .+.+..+. .....+.+
T Consensus 160 -------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~-~~~~~~~~-- 226 (261)
T cd05148 160 -------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT-AGYRMPCP-- 226 (261)
T ss_pred -------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH-hCCcCCCC--
Confidence 1123456778999999998889999999999999999998 8999976543 22333232 22222222
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
..+|+++.++|.+||+.+|++||++.+|.+.|+.
T Consensus 227 -~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 -AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 3558999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=301.06 Aligned_cols=255 Identities=18% Similarity=0.307 Sum_probs=201.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCC-----CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQT-----GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~-----~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+-.++|++.+.||+|+||.||+|.+... +..||||....... ...+..|+.++..+.| +++..+++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~ 81 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSTG 81 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEcCC
Confidence 4457899999999999999999987643 37899998544322 2356778888888765 6777888888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN---------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~---------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
...+++||++ +++|.+++.... ..+++..++.++.|++.||.|||+++++||||||+|||+ +.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence 8999999998 789999986421 246888999999999999999999999999999999999 478899
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 232 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~ 232 (468)
+|+|||+++....... +.......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.... +.
T Consensus 159 kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~ 230 (277)
T cd05032 159 KIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EV 230 (277)
T ss_pred EECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HH
Confidence 9999999876543211 112234457889999999998889999999999999999998 99999764432 22
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
...+.... ..+. ...+|.++.++|..||+.+|++||++.+|.+.|+
T Consensus 231 ~~~~~~~~-~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 LKFVIDGG-HLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHhcCC-CCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 22232221 1111 2345899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=295.26 Aligned_cols=251 Identities=20% Similarity=0.310 Sum_probs=202.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
++|++.+.||.|+||.||+|.+..++..++||+..... ....+..|+.++..+.| +++..++++.......+++||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH-PNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCC-CChhceEEEEEeCCEEEEEEeC
Confidence 68999999999999999999998889999999866443 23568889999888866 5666677777888899999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +++|.+++......+++..+..++.|++.||.|||+.+|+|+||+|+||++ ++++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhh--
Confidence 8 679999888655789999999999999999999999999999999999999 5788999999999876543211
Q ss_pred cccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~---~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.... +....+....+..+....
T Consensus 157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~ 228 (262)
T cd06613 157 -----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RALFLISKSNFPPPKLKD 228 (262)
T ss_pred -----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCccccc
Confidence 12345788999999999877 7899999999999999999999999865432 222222222222222122
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...++.++.++|.+||..+|.+||++.+|+.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3456789999999999999999999987753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=299.32 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=196.6
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|++.++||+|+||.||+|.+..++..||||....... ...+..|+.++..+.| +++..+..++..+...++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH-PNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCC-CCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999988999999997654322 2457789999988875 677778888888889999999
Q ss_pred ccCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LLGPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~ggsL~~ll~~~~--~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++.++|.+++.... ..+++..+..++.|++.||+|||+++++|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCc-
Confidence 99889988886433 568999999999999999999999999999999999999 578899999999987543211
Q ss_pred cccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh-----------
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS----------- 237 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~----------- 237 (468)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+..............
T Consensus 156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 156 ------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred ------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 112234678899999998764 47899999999999999999999998643211111110000
Q ss_pred ----------hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 238 ----------EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 238 ----------~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..............+++++.++|.+||..||++||++.+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000111122456889999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=296.11 Aligned_cols=246 Identities=21% Similarity=0.252 Sum_probs=199.7
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
+|++.++||.|+||.||++.+..++..||+|...... ....+..|+.++..+.| +++..+..++......+++|++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH-PNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEee
Confidence 5899999999999999999999999999999764332 23456778888888876 5677777777888999999999
Q ss_pred c-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 93 L-GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 93 ~-ggsL~~ll~~-~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
+ +++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+|||+ ++++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc-
Confidence 8 7899988864 34568999999999999999999999999999999999999 5788999999999876543211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ...+..+..... .+ +..
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~~~~~~~~~-~~---~~~ 222 (255)
T cd08219 156 ------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLILKVCQGSY-KP---LPS 222 (255)
T ss_pred ------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHHHHHhcCCC-CC---CCc
Confidence 12345788999999999998899999999999999999999999976432 222323322222 11 123
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.++..+.++|.+||+.+|++||++.+|..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 45889999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=303.79 Aligned_cols=256 Identities=18% Similarity=0.211 Sum_probs=187.7
Q ss_pred EceEeeeCCeEEEEEEEc--CCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeE-eCceeEEEEeccCCC
Q 012192 20 GRKIGSGSFGELYLGVNV--QTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGV-EGDYNIMVIDLLGPS 96 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~--~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-~~~~~~lv~el~ggs 96 (468)
+++||+|+||+||+|.+. .++..||||..........+..|+.++..+.|++.+..+..+.. .....+++|++++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 468999999999999965 36789999987665555678899999999987655544444432 345678999999999
Q ss_pred HHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc-CCCCeEEEEeCCcccccccc
Q 012192 97 LEDLFNYCN--------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 97 L~~ll~~~~--------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~-~~~~~vkL~DFGla~~~~~~ 167 (468)
|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+++.+...
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 999886431 248899999999999999999999999999999999999432 34578999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCccc------HHHHHHHHhhcc
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYDKISEKK 240 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~------~~~~~~~i~~~~ 240 (468)
.. +........||+.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+..+....
T Consensus 166 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 166 LK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred Cc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 11 11123456789999999999875 58999999999999999999999997533210 011111111000
Q ss_pred -------------cCC--------------------CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 -------------VST--------------------PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 -------------~~~--------------------~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+.. ..+......+.++.++|..||+.||++||+++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000122456889999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=297.97 Aligned_cols=253 Identities=21% Similarity=0.364 Sum_probs=198.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+..++|++.++||+|+||.||+|.+. .+..||+|...... ....+..|+.++..+.|+ ++..+..+.. ....+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD-KLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCC-ceEEEEeEEC-CCCcEEEE
Confidence 45678999999999999999999864 56679999765432 234688999999999875 4445555543 45578999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+++ +++|.+++... ...+++..+..++.|++.||.|||+++++||||||+|||++ +++.++|+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeeccCcc
Confidence 988 78999998753 34689999999999999999999999999999999999994 67899999999997654311
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.... .....+.. ....+.
T Consensus 157 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~-~~~~~~-- 224 (260)
T cd05070 157 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVER-GYRMPC-- 224 (260)
T ss_pred c------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc-CCCCCC--
Confidence 1 11223345678999999998889999999999999999999 99999875432 22222222 222222
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
...++.++.+++.+||..+|++||++.+|.+.|++
T Consensus 225 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 -PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 24568999999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=300.14 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=197.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCce-----
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY----- 85 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~----- 85 (468)
++|++.+.||+|+||.||+|.+..++..||||...... ....+..|+.++..+.+|++|+.+..++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999999999999999754432 224678899999999888888888877766554
Q ss_pred eEEEEeccCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 86 NIMVIDLLGPSLEDLFNYC----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~~----~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
.+++||++.++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||++. ..++.++|+|||++
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~ 158 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG 158 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence 7999999988999887643 24589999999999999999999999999999999999994 22789999999998
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
..+.... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.........+.......
T Consensus 159 ~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 159 RAFSIPV-------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred eecCCCc-------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 7653311 111233568889999988754 57999999999999999999999998754322221111100000
Q ss_pred --------------------cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 241 --------------------VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 241 --------------------~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...........+++++.++|..||..+|.+||++.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 00011122245789999999999999999999998664
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=309.01 Aligned_cols=253 Identities=19% Similarity=0.312 Sum_probs=208.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
+.|.++++||+|+||.||+|.++.+|..||||...+...-.++..|+.++.++..+..|.++..|+ ....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-K~sDLWIVMEYCG 111 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYF-KHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhc-cCCceEeehhhcC
Confidence 457899999999999999999999999999999999888899999999999988754444444444 444578999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
.|++.|+++.-+..|+++++..++...+.||+|||...-||||||+.|||+ +.++..||+|||.|-.+.+.-.
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMA---- 184 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMA---- 184 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHH----
Confidence 689999999878899999999999999999999999999999999999999 5889999999999977655221
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh--hcc
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL--CKS 251 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l--~~~ 251 (468)
...++.||+.|||||++....|+.++||||||++..||..|++||.+.-+... +.-|.. .|++.+ ...
T Consensus 185 ---KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT----~PPPTF~KPE~ 254 (502)
T KOG0574|consen 185 ---KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPT----KPPPTFKKPEE 254 (502)
T ss_pred ---hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccC----CCCCCCCChHh
Confidence 23567899999999999999999999999999999999999999987554321 111111 111111 122
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
++.+|.+|+..||-.+|++|-++. +++++.|++.
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~---~L~~H~Fikn 288 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTAL---RLCEHTFIKN 288 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHH---HHhhhhhhcC
Confidence 478899999999999999999887 4566666553
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=300.19 Aligned_cols=244 Identities=20% Similarity=0.299 Sum_probs=192.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++++.||+|+||.||+|.+..++..||||+...... ...+..|++++..+.| +++..+.+++...+..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEECCEEEEEEe
Confidence 478999999999999999999999999999998654322 2357789999888865 667777777778888899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|+ +++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||+ +.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc---
Confidence 99 6666433 257888999999999999999999999999999999999 47889999999999765432
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH----HHHHHHHhhcccCCCHH
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK----KQKYDKISEKKVSTPIE 246 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~----~~~~~~i~~~~~~~~~~ 246 (468)
......||..|+|||++.+..++.++||||||+++|+|++|..||........ ......+..... ..
T Consensus 149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~ 219 (279)
T cd06619 149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP---PV 219 (279)
T ss_pred ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC---CC
Confidence 12345789999999999999999999999999999999999999975432211 111111111111 11
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....+++++.++|.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 112346789999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=299.11 Aligned_cols=247 Identities=18% Similarity=0.275 Sum_probs=195.4
Q ss_pred ceEeeeCCeEEEEEEEcCCCc--EEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGE--EIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~--~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..++. .+++|...... ....+..|++++.++.+|++|..+.+++......+++||++ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999887765 46888654322 22457789999999988888989988888888899999998 7
Q ss_pred CCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 95 PSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 95 gsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||+ +.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCC
Confidence 89999987422 247899999999999999999999999999999999999 478899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhh
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.+.... ..+..+..
T Consensus 158 l~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~ 226 (270)
T cd05047 158 LSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLPQ 226 (270)
T ss_pred Cccccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHHhC
Confidence 98632210 01112234567999999988889999999999999999997 99999765432 22222222
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
. .... ....++.++.+++.+||..+|.+||++.+|.+.|+.++
T Consensus 227 ~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 G-YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C-CCCC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1 1111 11335789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=300.86 Aligned_cols=252 Identities=19% Similarity=0.343 Sum_probs=200.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeE------eCc
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGV------EGD 84 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~------~~~ 84 (468)
.-.+.|++.+.||.|+||.||+|.+..+++.||+|+..... ....+..|+.++.++.+|+++..+.+++. ...
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 34589999999999999999999999999999999865442 34567888999999987888888877764 356
Q ss_pred eeEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
..+++||++ +++|.+++... ...+++..+..++.|++.||.|||+.+|+|+||+|+||++ ++++.++|+|||++.
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~ 169 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchh
Confidence 789999999 66999998753 3458889999999999999999999999999999999999 478889999999987
Q ss_pred ccccccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
....... ......|+..|+|||++. +..++.++|||||||++|+|++|..||...... ..+..+.
T Consensus 170 ~~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~~~ 239 (282)
T cd06636 170 QLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM---RALFLIP 239 (282)
T ss_pred hhhcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---hhhhhHh
Confidence 5432111 123457899999999986 345888999999999999999999999764322 1121111
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.. .+.......++.++.++|.+||+.+|.+||++.+|++
T Consensus 240 ~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 RN---PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hC---CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11 1111223457899999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=333.48 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=203.7
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|++++..+.| ++|+.++.++.+.+..+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~H-PNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-PGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCC-cCcCeEEEEEeeCCEEEEE
Confidence 689999999999999999999999999999998654322 2357889999988876 5667777777888899999
Q ss_pred Eecc-CCCHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeC
Q 012192 90 IDLL-GPSLEDLFNYC----------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDY 158 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~----------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DF 158 (468)
|+++ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9998 88999988642 1245677889999999999999999999999999999999 47889999999
Q ss_pred CcccccccccCc-----------ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc
Q 012192 159 GLAKKYRDLQTH-----------KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 227 (468)
Q Consensus 159 Gla~~~~~~~~~-----------~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~ 227 (468)
|+++........ ...........+||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 999865211100 000111123457999999999999999999999999999999999999999764322
Q ss_pred cHHHHHHHHhhcccCCCHH-HhhccCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 012192 228 TKKQKYDKISEKKVSTPIE-VLCKSYPSEFVSYFHYCRSLRFEDKP-DYSYLKRLFRDLFI 286 (468)
Q Consensus 228 ~~~~~~~~i~~~~~~~~~~-~l~~~~p~~~~~li~~cl~~~p~~RP-s~~~l~~~L~~~~~ 286 (468)
.. .. ......+.. .....+|+.+.+++.+||..+|++|| +++++.+.|+..+.
T Consensus 238 ki--~~----~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KI--SY----RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh--hh----hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 11 111111111 11245789999999999999999996 66778888877665
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=298.66 Aligned_cols=251 Identities=19% Similarity=0.283 Sum_probs=197.9
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC--chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH--PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.++|++.++||+|+||.||+|.+..++..||||+....... ..+..|+.++..+.| +++..+..++...+..+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h-~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH-SNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCEEEEEEe
Confidence 36899999999999999999999999999999986554322 346678888887765 666677777788889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++ +++|.+++.. ...+++.+++.++.|++.||.|||+.|++|+||||+||++ +..+.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 87 FCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc--
Confidence 98 6799998874 5579999999999999999999999999999999999999 477889999999987553211
Q ss_pred ccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 171 KHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
.......|+..|+|||++. ...++.++|||||||++|+|++|..||....... .+..........+...
T Consensus 161 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 161 -----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKLK 232 (267)
T ss_pred -----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhccCCCCCccc
Confidence 1223557899999999974 4558899999999999999999999997644321 1111222222222111
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....++..+.++|.+||+.+|++||++++|++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 12246789999999999999999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.15 Aligned_cols=262 Identities=16% Similarity=0.260 Sum_probs=223.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCC---cEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTG---EEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~---~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
|-.....|.+.||.|-||+||.|+.+..+ ..||||.++... ...+|+.|..||-++.| |||.++.++......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH-PNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIRLEGVVTKSKP 704 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC-CcEEEEEEEEecCce
Confidence 33456788999999999999999977654 579999876543 34579999999988887 677788888888899
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.+++.||| +|+|+.+++...+.|++-++..+++.|+.||+||-+.++|||||.++|||+ +.+-.+|++||||++.+
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeec
Confidence 99999999 999999999888889999999999999999999999999999999999999 67888999999999977
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
.++.. .+.....-.-+++|.|||.+....++.++|||||||++||.+. |..||-++.+. .+.+.++..+..
T Consensus 782 edd~~----~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----dVIkaIe~gyRL 853 (996)
T KOG0196|consen 782 EDDPE----AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVIKAIEQGYRL 853 (996)
T ss_pred ccCCC----ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----HHHHHHHhccCC
Confidence 55431 1111222334689999999999999999999999999999887 99999988764 444455778888
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
|.+..| |..+..||..||+.|-.+||.|.+|+..|++++.+.
T Consensus 854 PpPmDC---P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 854 PPPMDC---PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCCCCC---cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 888766 999999999999999999999999999999987653
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=293.47 Aligned_cols=247 Identities=20% Similarity=0.263 Sum_probs=195.9
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.|++.+.||.|+||.||++.+..+++.||||.+..... ...+..|++++..+.|++.+..+..+.......+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48999999999999999999988999999998654322 23567788888888775544433333334556789999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++... ...+++.++..++.|++.||+|||++||+|+||||+||++ +..+.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCC
Confidence 98 78999988753 4468999999999999999999999999999999999999 4788999999999976543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......+++.|+|||++.+..++.++||||||+++|+|++|..||..... ......+...... ...
T Consensus 158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~~~~----~~~ 223 (257)
T cd08223 158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLVYRIIEGKLP----PMP 223 (257)
T ss_pred -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCC----CCc
Confidence 22355789999999999999999999999999999999999999975432 2222223332221 122
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..+++++.+++.+||+.+|++||++.+|++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 456899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=298.57 Aligned_cols=251 Identities=20% Similarity=0.226 Sum_probs=196.6
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|++.+.||+|+||.||+|.+..+|..||+|....... ...+..|++++..+.| +++..+..+..+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCC-CCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999998654322 2456789999988876 567777777778889999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+++++|.+++......+++..+..++.||+.||.|||+++|+||||||+||++ +.++.++|+|||++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~--- 153 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPV--- 153 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCC---
Confidence 99999999887666779999999999999999999999999999999999999 578899999999997643321
Q ss_pred cccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc----------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK---------- 240 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 240 (468)
.......++..|+|||++.+.. ++.++|||||||++|+|++|..||..... ....+..+....
T Consensus 154 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 154 ----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred ----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHH
Confidence 1122346788999999987754 78999999999999999999888654322 112221111100
Q ss_pred ---------cCC-----CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 ---------VST-----PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 ---------~~~-----~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
... ........+++++.++|.+||+.||.+||++.+|.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 001122356789999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=296.32 Aligned_cols=251 Identities=20% Similarity=0.221 Sum_probs=195.6
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC--ceeEEEEe
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG--DYNIMVID 91 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~~lv~e 91 (468)
|++.++||+|+||.||+|.+..++..||||....... ......|+.++..+.+|+++..+..++.+. +..+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999998999999998654321 223456888888888778888888877766 78999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
++.++|.+++......+++..+..++.|++.||+|||++|++||||+|+||++. . +.++|+|||++........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCCC--
Confidence 999999998876556799999999999999999999999999999999999994 5 9999999999976543211
Q ss_pred cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc-----------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK----------- 239 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 239 (468)
.....++..|+|||++.. ..++.++|||||||++|||++|..||.+................
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 155 ------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred ------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 123457889999997654 45789999999999999999999999865432211111111000
Q ss_pred ----ccC------CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 ----KVS------TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 ----~~~------~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
... .....+...++.++.++|.+||..+|++||++.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000 0112223456899999999999999999999987654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=295.41 Aligned_cols=254 Identities=22% Similarity=0.393 Sum_probs=204.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+..++|++.++||.|+||.||+|.+. .+..||||...... ....+..|+.++..+.| +++..+..++......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRH-DKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCC-CCEeeeeeeeecCCceEEEE
Confidence 56789999999999999999999865 55789999765433 34568889999998886 66777777777778889999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+++ +++|.+++... +..+++..+..++.|++.||.|||+++++|+||||+||++ +.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceeccchh
Confidence 998 78999998753 3579999999999999999999999999999999999999 478999999999987654311
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
+.......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... ...+..+.. ....+.+
T Consensus 158 ------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~-~~~~~~~- 226 (261)
T cd05034 158 ------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVER-GYRMPRP- 226 (261)
T ss_pred ------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc-CCCCCCC-
Confidence 111223345678999999998889999999999999999998 9999976543 223333322 2222222
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
..+|.++.+++.+||..+|++||++.+|.+.|+.
T Consensus 227 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 --PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2348999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=295.23 Aligned_cols=249 Identities=20% Similarity=0.332 Sum_probs=202.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
++|++.++||+|+||.||+|.+..++..|++|..........+..|++++..+. |+++..+.+++......++++|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEEEEecCC
Confidence 689999999999999999999988899999998765544667889999999885 467777777777888899999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
+++|.+++......+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~---- 154 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMA---- 154 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCcc----
Confidence 679999998667789999999999999999999999999999999999999 4788999999999886543211
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCc
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP 253 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 253 (468)
......++..|+|||++.+..++.++||||||+++|+|++|..||........ ...+.. .. .+.......++
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~~~~~-~~-~~~~~~~~~~~ 226 (256)
T cd06612 155 ---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IFMIPN-KP-PPTLSDPEKWS 226 (256)
T ss_pred ---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hhhhcc-CC-CCCCCchhhcC
Confidence 12345588899999999998999999999999999999999999986443211 111111 11 11111123457
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 254 SEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 254 ~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.++.++|..||+.+|++||++.+|++
T Consensus 227 ~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 227 PEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 89999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=301.04 Aligned_cols=251 Identities=19% Similarity=0.282 Sum_probs=197.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
...+.|+++++||.|+||.||+|.+..++..|++|+...... ...+..|+.++..+.| +++..+..++......+++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH-PYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CcEeeeEEEEEeCCeEEEE
Confidence 345789999999999999999999999999999998654432 2356778888888876 5666777776777888999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||++ +++|..++......+++..+..++.|++.+|.|||+.+++||||||+||++ +.++.++|+|||++.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccccc
Confidence 9998 778888776656779999999999999999999999999999999999999 468899999999986533211
Q ss_pred CcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
.......++..|+|||++. ...++.++|||||||++|+|++|..||..... ...+..+.... .
T Consensus 165 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~--~ 232 (292)
T cd06644 165 -------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSE--P 232 (292)
T ss_pred -------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCC--C
Confidence 1123456888999999985 34478899999999999999999999976432 22222222211 1
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+.......++.++.++|.+||..+|++||++.+|+
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 267 (292)
T cd06644 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267 (292)
T ss_pred ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 11112245678999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=294.10 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=200.7
Q ss_pred ceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 21 RKIGSGSFGELYLGVNVQT---GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
+.||+|+||.||+|.+... +..|+||+...... ...+..|++++..+. |+++..+..+.......+++|+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEecc
Confidence 4799999999999998765 88999998665543 357788999999988 567777777777788899999999
Q ss_pred CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 94 GPSLEDLFNYC--------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 94 ggsL~~ll~~~--------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
+++|.+++... ...+++..+..++.|++.||+|||+++++|+||||+||++ +.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccc
Confidence 99999999865 4779999999999999999999999999999999999999 477999999999998755
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.... +.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +....+.. .....
T Consensus 157 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~-~~~~~ 227 (262)
T cd00192 157 DDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLRK-GYRLP 227 (262)
T ss_pred cccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc-CCCCC
Confidence 4221 122345567889999999998889999999999999999998 69999876432 22333322 21122
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
. ...+|.++.+++..||..+|++||++.+|.+.|
T Consensus 228 ~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 228 K---PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred C---CccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 234589999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=299.34 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=200.0
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
-..+|++.++||+|+||.||+|... .++..||+|...... ....+..|++++..+.| ++|..+.+++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 81 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH-QHIVRFYGVCTEGRP 81 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCC-CCCceEEEEEecCCc
Confidence 4568899999999999999999642 356789999754332 23468889999998866 567777777888888
Q ss_pred eEEEEecc-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCC
Q 012192 86 NIMVIDLL-GPSLEDLFNYCN--------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKA 150 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~--------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~ 150 (468)
.+++|+++ +++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+|||+ +++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cCC
Confidence 99999988 789999987532 248899999999999999999999999999999999999 478
Q ss_pred CeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccH
Q 012192 151 NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 229 (468)
Q Consensus 151 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~ 229 (468)
+.++|+|||++....... .+.......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 159 ~~~kL~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 231 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTD-----YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-- 231 (280)
T ss_pred CCEEECCCCceeEcCCCc-----eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--
Confidence 899999999987543211 1122234456788999999999999999999999999999998 99999764432
Q ss_pred HHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 230 KQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 230 ~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
..+..+..... .. ....+|+.+.++|.+||+.+|++||++.+|.+.|+
T Consensus 232 -~~~~~~~~~~~-~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 -EAIECITQGRE-LE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHHHHHcCcc-CC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 22222222211 11 11356899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=294.68 Aligned_cols=253 Identities=18% Similarity=0.255 Sum_probs=190.5
Q ss_pred ceEeeeCCeEEEEEEEcC---CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 21 RKIGSGSFGELYLGVNVQ---TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~---~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
+.||+|+||.||+|.+.. .+..||||....... ...+..|+.++..+.|++.+..+..+...+...+++|+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 346799997543222 2456778888888876554444443444566678899887
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
+++|.+++......+++..++.++.|++.||.|||+.+++||||||+|||+ +.++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~---~ 154 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEY---Y 154 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcc---e
Confidence 789999998655667888899999999999999999999999999999999 4778999999999975433111 0
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccC
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
.........++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+... ...+.+ ..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~---~~~ 227 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLLQG-RRLLQP---EYC 227 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhcC-CCCCCC---CcC
Confidence 1111224456778999999998899999999999999999999 56667654322 222222222 111111 345
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 253 PSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
|+.+.+++..||..+|++||++.+|.+.|++++.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 8899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=302.61 Aligned_cols=252 Identities=18% Similarity=0.282 Sum_probs=197.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.+|+..++||+|+||.||++.+..++..||||...... ....+..|+.++.++..|++|+.+.+++......+++|+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46778899999999999999999999999999765432 223577888888888867788888888888888999999
Q ss_pred ccCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 92 LLGPSLEDLFNY----CNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 92 l~ggsL~~ll~~----~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+++.+|.++... ....+++..+..++.|++.||+|||+. +++||||||+|||+ +..+.++|+|||++.....
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhcc
Confidence 999888876542 245799999999999999999999975 99999999999999 4678899999999976543
Q ss_pred ccCcccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
... .....|+..|+|||++.+. .++.++|||||||++|+|++|..||.... ...+.+..+.......
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~ 230 (288)
T cd06616 161 SIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPI 230 (288)
T ss_pred CCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCc
Confidence 211 1234688899999999876 68999999999999999999999997643 1222222222111111
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
........++.++.+||..||+.+|++||++.+|..
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111112346899999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.71 Aligned_cols=252 Identities=19% Similarity=0.303 Sum_probs=196.9
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeE-----eCcee
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGV-----EGDYN 86 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~~~~~ 86 (468)
..++|++.+.||+|+||.||+|.+..++..||||+..... ....+..|+.++..+..|++++.+..++. .++..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 4579999999999999999999999999999999754432 23467889999999976677877776653 34678
Q ss_pred EEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 87 IMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+++||++ +++|.+++.. ....+++..+..++.|++.||.|||+.+|+||||||+||++. ..+.++|+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~ 172 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEEccCCcee
Confidence 9999998 8899988753 245688999999999999999999999999999999999994 67889999999987
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
....... ......|+..|+|||++.. ..++.++|||||||++|+|++|..||....... .+..+.
T Consensus 173 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---~~~~~~ 242 (286)
T cd06638 173 QLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---ALFKIP 242 (286)
T ss_pred ecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---HHhhcc
Confidence 6543211 1234468999999999753 447889999999999999999999998654321 111111
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.. . .+.......++.++.++|.+||+.+|++||++.+|++
T Consensus 243 ~~-~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 243 RN-P-PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred cc-C-CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11 1 1111122345789999999999999999999998765
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=292.54 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=199.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-------CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-------KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
+.|++.+.||+|+||.||.|.+..++..||||...... ....+..|++++..+.| ++|..+..++...+..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH-ERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEccCCeEE
Confidence 56999999999999999999998899999999755332 12356778888888865 66777888888888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+++|++ +++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||++ ++++.++|+|||+++....
T Consensus 81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccc
Confidence 999998 7899998875 4578999999999999999999999999999999999999 4778999999999876533
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
..... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...... ..+..+.......
T Consensus 157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~--- 226 (263)
T cd06625 157 ICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTNP--- 226 (263)
T ss_pred ccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHHHhccCCCC---
Confidence 21100 0012356788999999999999999999999999999999999999764322 2222222222211
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+...++.++.++|..||..+|++||++.+|++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 223456899999999999999999999987764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=298.94 Aligned_cols=247 Identities=19% Similarity=0.285 Sum_probs=194.8
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
-|++.+.||+|+||.||+|.+..++..+++|...... ....+..|++++..+.| +++..+..++......++++||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCC-CCeeeEEEEEeeCCEEEEEEEec
Confidence 3688999999999999999999899999999864432 23356778998888875 56667777777888899999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 94 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 94 -ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
+++|..++......+++..+..++.|++.||.|||+.|++||||||+|||+ +.++.++|+|||++........
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccccccc---
Confidence 778888776556679999999999999999999999999999999999999 5788999999999875432111
Q ss_pred ccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 173 IPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
......++..|+|||++. +..++.++|||||||++|+|++|..||..... .+.+..+..... +...
T Consensus 159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~--~~~~ 229 (282)
T cd06643 159 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEP--PTLA 229 (282)
T ss_pred ----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCC--CCCC
Confidence 123456899999999984 44578899999999999999999999986542 222222222111 1111
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....++.++.++|..||+.+|++||++.+|+
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1234689999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=301.53 Aligned_cols=259 Identities=19% Similarity=0.288 Sum_probs=200.0
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCc----EEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGE----EIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~----~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
+-.++|+..+.||+|+||.||+|.+..++. .||+|........ ..+..|+.++..+.| ++|..+.+++....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH-PHLVRLLGVCLSPT 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEcCCC
Confidence 445789999999999999999999877775 4688875543322 256778888888865 55666666554443
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
.+++++++ +++|.+++......+++..++.++.|++.||+|||+++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 -~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 83 -IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (303)
T ss_pred -ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccccc
Confidence 45666666 789999988666678999999999999999999999999999999999999 4678899999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... +..+......
T Consensus 159 ~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~ 229 (303)
T cd05110 159 LEGDEKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLEKGER 229 (303)
T ss_pred ccCcccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCCC
Confidence 5432110 01123345778999999999899999999999999999997 999998754322 2223333332
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.+.+ ..++..+.+++..||..+|++||++.+|++.|+.+...
T Consensus 230 ~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 LPQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3322 23478999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=294.24 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=199.6
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----------chhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----------PQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
+|.+.+.||+|+||.||+|.+..++..||||........ ..+..|+.++..+.| ++|..+.+++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH-ENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCC
Confidence 588899999999999999999888999999975443221 346778888888876 66777777888888
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..+++||++ +++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+|||+ ++++.++|+|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK 155 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcc
Confidence 999999998 7799999975 4578999999999999999999999999999999999999 4788999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
........ ..........|+..|+|||.+.+..++.++|||||||++|+|++|..||.+... ...+..+... ..
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-~~- 229 (267)
T cd06628 156 LEANSLST-KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGEN-AS- 229 (267)
T ss_pred cccccccC-CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHhcc-CC-
Confidence 65321111 111122345688999999999998899999999999999999999999986532 2222222221 11
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+.+...++.++.++|.+||+.+|++||++.+|++
T Consensus 230 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 --PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1223456899999999999999999999987754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=294.18 Aligned_cols=254 Identities=19% Similarity=0.270 Sum_probs=196.1
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|++.+.||+|+||.||+|.+..+++.||||...... ....+..|++++..+.| +++..+..++......+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH-PNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCC-CCEeeeeeEEeeCCEEEEEE
Confidence 57999999999999999999998899999999765332 12346789999998876 56667777778888899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|++.+.+.+.+......+++..++.++.|++.||+|||+.+++|+||||+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc-
Confidence 999555444443345579999999999999999999999999999999999999 4778999999999986543221
Q ss_pred ccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc----------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK---------- 239 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 239 (468)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+......
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 156 ------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred ------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 1123457889999999876 45789999999999999999999999875543222211111000
Q ss_pred ------cc-------CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 ------KV-------STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 ------~~-------~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.. ..+.......++..+.+||.+||+.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 01112234567899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.98 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=189.5
Q ss_pred ceEeeeCCeEEEEEEEcC--CCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQ--TGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~--~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.... ++..+|+|........ ..+..|+.++..+.| ++|+.+.+++.+....++||||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQH-SNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCCCCcEEEEECCCC
Confidence 468999999999998643 5568999975543322 357779999998876 55666677777778889999998 7
Q ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 95 PSLEDLFNYCN----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 95 gsL~~ll~~~~----~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+|||+ +..+.++|+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~- 155 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDY- 155 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcce-
Confidence 89999987432 245677888999999999999999999999999999999 4688999999999865332111
Q ss_pred ccccccCCCCccccccccccccccCC-------CCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGV-------EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~-------~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
+.......++..|+|||++.+. .++.++||||||+++|||++ |..||........ ....+......
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~ 229 (269)
T cd05087 156 ----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTVREQQLK 229 (269)
T ss_pred ----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHhhcccCC
Confidence 1122345678899999998643 35789999999999999996 9999986543321 11122233333
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
.+.+.+...+++.+.++|..|| .+|++||++++|...|.
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 3444444556889999999999 68999999999988764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.69 Aligned_cols=260 Identities=22% Similarity=0.256 Sum_probs=196.7
Q ss_pred cCceEEEceEeeeCCeEEEEEEE----cCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEee--EeCce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVN----VQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFG--VEGDY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~----~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~--~~~~~ 85 (468)
..+|++.+.||+|+||.||+|.. ..++..||||....... ...+..|++++..+.|+ +++.+.+++ .....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD-NIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCC-CeeEEEEEEccCCCCc
Confidence 46899999999999999999974 45788999998654332 23678899999998764 555555543 23456
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++++|++ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccccc
Confidence 78999988 899999998656679999999999999999999999999999999999999 47889999999999865
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc------------HHHH
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------KKQK 232 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~------------~~~~ 232 (468)
...... +.......++..|+|||++.+..++.++||||||+++|||++|..|+......- ....
T Consensus 159 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 159 PQDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cCCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 432210 111112234456999999998899999999999999999999887765432110 0000
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+..+.......+ ....+|.++.++|.+||..+|++||++.+|++.|+.+
T Consensus 235 ~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111111111 1235689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=292.28 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=193.7
Q ss_pred ceEeeeCCeEEEEEEEcCCC---cEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 21 RKIGSGSFGELYLGVNVQTG---EEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~---~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
++||+|+||.||+|.+..++ ..||||....... ...+..|++++..+.| ++++.+..+.. .+..+++|+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH-PCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEc-CCceEEEEEeCC
Confidence 57999999999999876654 7899998654433 3467789999988876 56666666554 45578888887
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
+++|.+++.. ...+++..+..++.|++.||+|||..+++|+||||+|||+ +.++.++|+|||+++.......
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~---- 150 (257)
T cd05060 79 LGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSD---- 150 (257)
T ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCc----
Confidence 7899999985 4479999999999999999999999999999999999999 4788999999999986543221
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccC
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
.+.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... +....+.... ..+ ....+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~~-~~~---~~~~~ 223 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESGE-RLP---RPEEC 223 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCC-cCC---CCCCC
Confidence 1222223345678999999998899999999999999999998 99999765432 2222232221 112 12345
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 253 PSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+.++.++|.+||..+|++||++.+|.+.|+++
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 89999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=296.23 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=208.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.+.||+|+||.||++.+..+++.||||+..... ....+..|++++..+. |++|+.+..++..+...+++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEE
Confidence 47999999999999999999999899999999865422 2345778999999888 56777788888888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||++ +++|.+++.. ...+++..+..++.|++.||+|||++|++|+||+|+|||+ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 80 MEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC-
Confidence 9999 9999999875 4679999999999999999999999999999999999999 57789999999998765432
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .......+.......+
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~---- 218 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKVRFP---- 218 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCccCC----
Confidence 234568899999999998889999999999999999999999997644 2233333333322222
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
..++..+.++|.+||..+|.+|++.. ...++++ ..+++....+|..+.
T Consensus 219 -~~~~~~l~~li~~~l~~~p~~R~~~~--~~~~~~l---~~~~~~~~~~~~~~~ 266 (290)
T cd05580 219 -SFFSPDAKDLIRNLLQVDLTKRLGNL--KNGVNDI---KNHPWFAGIDWIALL 266 (290)
T ss_pred -ccCCHHHHHHHHHHccCCHHHccCcc--cCCHHHH---HcCcccccCCHHHHh
Confidence 34589999999999999999998321 0111111 125666777888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=299.11 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=201.1
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
+..+... .+|++.+.||+|+||.||+|.+..++..||||....... ...+..|+.++..+.| +++..+..++..+.
T Consensus 13 ~~~~~~~-~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~v~~~~~~~~~~~ 90 (296)
T cd06654 13 VSVGDPK-KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGD 90 (296)
T ss_pred cccCCcc-cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCC-CCEeeEEEEEEeCC
Confidence 3445555 699999999999999999999988999999997654332 3457778888887765 56667777777788
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++||+++ +++|.+++. ...+++..+..++.|++.||+|||+.||+||||||+|||+ +.++.++|+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EEEEeecccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchh
Confidence 999999998 789999886 3468999999999999999999999999999999999999 4778999999999876
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
...... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||...... ...+. +.... .
T Consensus 166 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~-~~~~~--~ 233 (296)
T cd06654 166 ITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL-IATNG--T 233 (296)
T ss_pred cccccc-------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHH-HhcCC--C
Confidence 433211 122456889999999999888999999999999999999999999764331 11111 11111 1
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+.......++..+.++|.+||..+|++||++.+|++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 111122456889999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=299.69 Aligned_cols=249 Identities=19% Similarity=0.299 Sum_probs=199.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
++|++.++||.|+||.||+|.+..++..||+|+..... ....+..|++++..+. |+++..+...+......++|||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEEEeec
Confidence 57999999999999999999998889999999865432 2235778999999998 56788888888888899999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +++|.+++......+++..+..++.|++.||.|||+++|+|+||||+||++ +.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccccc--
Confidence 9 779999988766789999999999999999999999999999999999999 5788999999999865432111
Q ss_pred cccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 172 HIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
......+++.|+|||++. +..++.++||||||+++|+|++|..||.+.... +.+..+..... +..
T Consensus 159 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~~ 228 (280)
T cd06611 159 -----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLKILKSEP--PTL 228 (280)
T ss_pred -----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHHHhcCCC--CCc
Confidence 123456899999999975 345788999999999999999999999865432 22222222211 111
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....++.++.++|..||+.+|++||++.+|++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 112346889999999999999999999986633
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=320.66 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=206.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcC---CCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQ---TGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~---~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
++.++.++||+|.||.|++|.|.. +-..||||.+.... ...+|.+|+.+|..|+| +++..+|++..+ ....|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H-~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQH-PHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccC-cceeEEeeeecc-chhhH
Confidence 677889999999999999999875 34689999865443 34689999999999998 566667776555 77899
Q ss_pred EEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 89 VIDLL-GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 89 v~el~-ggsL~~ll~~-~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
|+|++ .|+|.+.+.. ....|-......|+.|||.||.||.++++|||||.++|+|+. ....|||+||||.+-+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceeccCC
Confidence 99999 8999999886 455688899999999999999999999999999999999995 578999999999987664
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
... -|.......-...|.|||.+....++.++|||+|||++|||++ |..||.|.... +.+..|. .+...+.
T Consensus 265 ned----~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qIL~~iD-~~erLpR 336 (1039)
T KOG0199|consen 265 NED----MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QILKNID-AGERLPR 336 (1039)
T ss_pred CCc----ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HHHHhcc-ccccCCC
Confidence 332 2344455566788999999999999999999999999999999 99999987653 3333333 5555555
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+..| |+.+.+++..||..+|+|||+|..|.+
T Consensus 337 Pk~c---sedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 337 PKYC---SEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCC---hHHHHHHHHHhccCCccccccHHHHHH
Confidence 5444 999999999999999999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.11 Aligned_cols=257 Identities=19% Similarity=0.209 Sum_probs=195.2
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeC-----c
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEG-----D 84 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~-----~ 84 (468)
++++|++.++||+|+||.||+|.+..++..||||+..... ....+..|+.++..+.|+ +++.+..+.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE-NIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCC-CcCchhheeecccccccc
Confidence 5689999999999999999999999999999999864322 223467799999999864 455555443322 3
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 85 YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 85 ~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
..++++++++++|.+++. ...+++..+..++.|++.||+|||+.||+||||||+|||+ +..+.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 82 DVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIA 156 (336)
T ss_pred eEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeec
Confidence 578999999999988886 4679999999999999999999999999999999999999 57889999999999765
Q ss_pred ccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH--------
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK-------- 235 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~-------- 235 (468)
....... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 157 DPEHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccc----CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 4322111 11234578999999998765 4589999999999999999999999976432111111100
Q ss_pred ----Hhh-----------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 236 ----ISE-----------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 236 ----i~~-----------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+.. .....+.......+++++.++|.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00111222234456788999999999999999999986544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=293.20 Aligned_cols=254 Identities=20% Similarity=0.357 Sum_probs=199.8
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
.+..++|++.++||+|+||.||+|.+. .+..||||...... ....+..|++++..+.| +++..+..+... ...+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH-DKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCC-CCcceEEEEEcC-CCeEEE
Confidence 367789999999999999999999854 55679999755433 23467889999998876 455555555555 667899
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|+++ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||++ +..+.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeeccCC
Confidence 9998 68999998753 4568889999999999999999999999999999999999 47889999999998765431
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
.. .......++..|+|||++.+..++.++|+|||||++|++++ |..||.+...... ...+. .....+
T Consensus 156 ~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~-~~~~~~-- 223 (260)
T cd05073 156 EY------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRALE-RGYRMP-- 223 (260)
T ss_pred Cc------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHh-CCCCCC--
Confidence 11 11223456678999999998889999999999999999998 9999987543222 22222 222222
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
....+|.++.+++.+||..+|++||++.+|.+.|+.
T Consensus 224 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 224568999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=299.33 Aligned_cols=258 Identities=22% Similarity=0.289 Sum_probs=196.1
Q ss_pred ceEEEceEeeeCCeEEEEEEE----cCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEe--Ccee
Q 012192 16 KFKLGRKIGSGSFGELYLGVN----VQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVE--GDYN 86 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~----~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~~ 86 (468)
-|++++.||+|+||.||+|.+ ..++..||||...... ....+..|+.++..+.|+ ++..+.+++.. ....
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE-NIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCC-CeeeeeeEEecCCCCce
Confidence 468999999999999999974 3468899999865332 224578899999998774 55555555544 3567
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
+++||++ +++|.+++......+++..++.++.|++.||+|||++|++||||||+|||+ +.++.++|+|||++..+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccccc
Confidence 8999998 899999987655578999999999999999999999999999999999999 467889999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc-----------ccHHHHHH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----------GTKKQKYD 234 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~-----------~~~~~~~~ 234 (468)
..... +.......++..|+|||++.+..++.++|||||||++|+|+++..|+..... ........
T Consensus 161 ~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 161 TDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 32211 1122345677889999999988899999999999999999998766532110 00001111
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
.........+. ...++.++.+|+.+||+.+|++||++.+|++.|+++
T Consensus 237 ~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLPR---PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111221 234689999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=288.83 Aligned_cols=265 Identities=18% Similarity=0.220 Sum_probs=202.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeE-----eCc
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGV-----EGD 84 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~~~ 84 (468)
|.+++|++.++||+|||+.||++++..++..+|+|.+.... .....++|++.++++.+++ |..+..+.. ...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~-vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPN-VLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcc-hHHHHHHHHHhhccCce
Confidence 45689999999999999999999999999999999866554 3456889999999998854 444433332 334
Q ss_pred eeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceeecccCCCCeEEEEeC
Q 012192 85 YNIMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDY 158 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~g--iiHrDIKp~NiLl~~~~~~~~vkL~DF 158 (468)
..|++++|. .|+|.+.+... +..+++..++.|+.+++.||++||+.. ++||||||.|||++ +.+.++|.||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~ 173 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDL 173 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEec
Confidence 578888877 89999988753 447999999999999999999999998 99999999999996 5899999999
Q ss_pred Ccccccccc--cCcccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH
Q 012192 159 GLAKKYRDL--QTHKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 233 (468)
Q Consensus 159 Gla~~~~~~--~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 233 (468)
|.+...... .............-..|..|.|||.+.- ...+.++|||||||+||.|+.|.-||...... -....
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSla 252 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSLA 252 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeEE
Confidence 998754321 1111111222334467899999998863 34689999999999999999999999632110 00000
Q ss_pred HHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 234 DKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 234 ~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
..+....+..|... .+++.+.++|..|++.||.+||+..+|...++++
T Consensus 253 LAv~n~q~s~P~~~---~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 LAVQNAQISIPNSS---RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EeeeccccccCCCC---CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11223334444332 3789999999999999999999999999888775
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=293.70 Aligned_cols=246 Identities=20% Similarity=0.288 Sum_probs=195.6
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
.++|++.+.||+|+||.||+|.. ++..||||..........+..|+.++..+.|++ +..+..++... ..+++|+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKN-LVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCC-cCeEEEEEcCC-CcEEEEECC
Confidence 36899999999999999999864 778899998766555567888999998887754 45555554443 468899988
Q ss_pred -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 94 -GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 94 -ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceeccccC---
Confidence 789999987543 358999999999999999999999999999999999999 467899999999987543211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
.....+..|+|||++.+..++.++|+|||||++|+|++ |..||...... .....+ ....... ...
T Consensus 155 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~-~~~~~~~---~~~ 220 (254)
T cd05083 155 -------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECV-EKGYRME---PPE 220 (254)
T ss_pred -------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHH-hCCCCCC---CCC
Confidence 12234567999999998899999999999999999997 99999865432 222222 2222222 124
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
.+|+++.+++.+||+.+|++||++++|.+.|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 568999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=293.13 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=198.5
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--------CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--------KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
.|+..+.||+|+||.||+|.+..++..||||++.... ....+..|++++..++| ++++.+.+++.+.+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH-PHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCC-CceehhhceeccCCeEE
Confidence 4888999999999999999999999999999865432 13467889999999877 55666666667777888
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
++++++ +++|.+++.. ...+++..+..++.|++.||+|||++|++|+||+|+||++. .....++|+|||++..+..
T Consensus 80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccccccccccc
Confidence 888887 7899999875 45789999999999999999999999999999999999994 2234699999999977654
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
...... .......|+..|+|||++.+..++.++||||||+++|+|++|..||..............+...... .
T Consensus 157 ~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 230 (268)
T cd06630 157 KGTGAG---EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---P 230 (268)
T ss_pred ccccCC---ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC---C
Confidence 321111 1123456889999999999888999999999999999999999999754433323333222221111 1
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....+++++.+++.+||..+|++||++.+|++
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 222345889999999999999999999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=291.04 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=200.4
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
..++|++.+.||.|+||.||+|.. .+..||||....... ...+..|+.++..+.| +++..+.++.......+++||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH-PNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCC-cceeeeEEEEcCCCCeEEEEE
Confidence 467899999999999999999986 478999998665543 4578889999999976 556666666666888899999
Q ss_pred cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||.||++ +.++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccccc-
Confidence 98 579999987543 268999999999999999999999999999999999999 478899999999997653211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
....++..|+|||++.+..++.++||||||+++|+|++ |..||...... .....+ ....... .
T Consensus 157 ---------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~-~~~~~~~---~ 220 (256)
T cd05039 157 ---------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHV-EKGYRME---A 220 (256)
T ss_pred ---------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH-hcCCCCC---C
Confidence 12344678999999998889999999999999999997 99999765322 222222 2221111 2
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
...+|+++.++|.+||..+|++||++.+|.+.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 24568999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=295.92 Aligned_cols=260 Identities=22% Similarity=0.306 Sum_probs=202.9
Q ss_pred cCceEEEceEeeeCCeEEEEEEEc----CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe--Cc
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNV----QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE--GD 84 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~----~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~ 84 (468)
.++|++.++||+|+||.||+|.+. .++..||||+...... ...+..|++++..+.| +++..+..++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~-~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH-ENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCC-CChheEEeeeecCCCC
Confidence 467889999999999999999864 3478999998665543 3568889999998866 566666666655 56
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..+++||++ +++|.+++......+++..+..++.|++.||+|||++|++|+||||+|||+ +.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccccccc
Confidence 789999998 789999998655579999999999999999999999999999999999999 4779999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc-----------HHHH
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-----------KKQK 232 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~-----------~~~~ 232 (468)
...... .+.......++..|++||.+.+..++.++||||||+++|||++|..||....... ....
T Consensus 159 ~~~~~~----~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 159 LPEDKD----YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccCCc----ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 653211 1111222345667999999998899999999999999999999999987543221 0111
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+..........+.+ ..+|.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 235 ~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRP---PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCC---ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22222222222222 34588999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.80 Aligned_cols=251 Identities=19% Similarity=0.286 Sum_probs=195.7
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++.++||+|+||.||+|.+..++..||+|....... ..++..|++++..+.| ++|+.+..++..++..+++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS-PYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCEEEEEee
Confidence 479999999999999999999999999999998654422 2357789999999965 567777777788889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|+ +++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCcccccccc-
Confidence 98 7899999985 4678999999999999999999998 589999999999999 467889999999986543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh------------
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS------------ 237 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~------------ 237 (468)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||...........+....
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 234578999999999998889999999999999999999999997543221111110000
Q ss_pred -----------------hcccCCCHHHh-hccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 238 -----------------EKKVSTPIEVL-CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 238 -----------------~~~~~~~~~~l-~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
........+.+ ...++.++.++|.+||..+|++||++.+|.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000000 0125788999999999999999999885533
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=293.66 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=200.7
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|++.+.||+|+||.||+|.+..++..||||+..... ....+..|+.++..+.| +++..+..++..+...++|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-PYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCC-CCCcceeeEEecCCeeEEEec
Confidence 5899999999999999999998899999999865443 23467889999998874 677777777788889999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+++++|.+++......+++..+..++.|++.||+|||+.|++|+||||+||++ +..+.++|+|||++........
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC--
Confidence 99999999998667789999999999999999999999999999999999999 4688999999999876543211
Q ss_pred cccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc-----------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK----------- 239 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 239 (468)
.......|+..|+|||++.+.. ++.++||||||+++|+|++|..||.+................
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 ----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred ----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 1123456899999999987654 689999999999999999998888764432211111110000
Q ss_pred -----------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 -----------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 -----------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+........+.++.++|..||..+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0001122233456799999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=294.01 Aligned_cols=250 Identities=18% Similarity=0.256 Sum_probs=187.9
Q ss_pred ceEeeeCCeEEEEEEEcC--CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQ--TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~--~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.... ....+|||....... ...+..|+.++..+.| ++|..+.+.+......+++||++ +
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH-PNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCC-CCcceEEEEECCCCceEEEEEeCCC
Confidence 469999999999997533 345788886543322 2346778888887765 66777777777888899999999 7
Q ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 95 PSLEDLFNYCN----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 95 gsL~~ll~~~~----~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.++|+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~- 155 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDY- 155 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchh-
Confidence 89999987532 235678889999999999999999999999999999999 5788999999999865332111
Q ss_pred ccccccCCCCccccccccccccccC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLG-------VEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~-------~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
+.......++..|+|||++.. ..++.++|||||||++|||++ |..||........ ....+......
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~~~~~ 229 (269)
T cd05042 156 ----YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVREQDIK 229 (269)
T ss_pred ----eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhhccCcc
Confidence 111223456778999998753 356889999999999999998 8899986543221 11112333333
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
.+.+.+...+++.+..++..|| .+|++||++++|.++|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 4444555678899999999999 59999999999988863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=298.14 Aligned_cols=253 Identities=20% Similarity=0.320 Sum_probs=199.8
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.++|++.+.||+|+||.||+|.+.. ++..||||+...... ...+..|+.++..+.| +++..+.+++..++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH-PNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCCc
Confidence 4689999999999999999998743 678999998654432 2457789999888876 677777777778888
Q ss_pred eEEEEecc-CCCHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcee
Q 012192 86 NIMVIDLL-GPSLEDLFNYCN---------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL 143 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~---------------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiL 143 (468)
.+++||++ +++|.+++.... ..+++..++.++.|++.||+|||+++++||||||.|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 89999998 679999987421 24778889999999999999999999999999999999
Q ss_pred ecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCC
Q 012192 144 MGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQ 222 (468)
Q Consensus 144 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~ 222 (468)
+ +.++.++|+|||++..+..... +.......++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 163 ~---~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 163 V---GENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred e---cCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9 4788999999999875432111 111223345678999999999899999999999999999997 889997
Q ss_pred CCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 223 GLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 223 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
+.... +.+..+...... + ....+|.++.+||.+||+.+|++||++.+|.+.|+
T Consensus 235 ~~~~~---~~~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 235 GMAHE---EVIYYVRDGNVL-S---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCHH---HHHHHHhcCCCC-C---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 65432 333333322221 1 12346899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.20 Aligned_cols=254 Identities=18% Similarity=0.278 Sum_probs=199.7
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
-..+|++.++||+|+||+||+|.+..++..||+|+...... ...+..|++++..+.| +++..+..++......++|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS-PYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCC-CCcceEeeeEecCCEEEEE
Confidence 34689999999999999999999998999999997654322 3467889999888864 6777777777888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|||+ +++|.+++.. .+.+++..+..++.|++.+|.|||+ .+++||||||+||++ ++++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh
Confidence 9999 7799988875 4579999999999999999999997 589999999999999 47889999999998654321
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc----cHHHHHHHHhhcccCC
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYDKISEKKVST 243 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~~~ 243 (468)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+..+.......
T Consensus 158 ~---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 158 I---------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred c---------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 1 12457899999999999889999999999999999999999999864431 0011111111111111
Q ss_pred CHHHhh-ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012192 244 PIEVLC-KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRL 280 (468)
Q Consensus 244 ~~~~l~-~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~ 280 (468)
..+.+. ..+|.++.+++.+||+.+|++||++.+|.+.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111111 1258899999999999999999999977654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=294.46 Aligned_cols=252 Identities=21% Similarity=0.262 Sum_probs=196.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++.+.||+|+||.||+|.+..+++.||||....... ...+..|++++..+.| ++|..+..++...+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH-ANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCC-cceeeEEEEEecCCeEEEEEe
Confidence 689999999999999999999988999999998654322 2346779999999865 677788888888899999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
++.++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.++|+|||+++......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~--- 157 (291)
T cd07844 84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS--- 157 (291)
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC---
Confidence 99989999988766788999999999999999999999999999999999999 578899999999986532211
Q ss_pred cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc----------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK---------- 240 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 240 (468)
.......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.... .+.+..+....
T Consensus 158 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 158 ----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred ----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhh
Confidence 11123356889999999876 45899999999999999999999999764421 11111111000
Q ss_pred ---------------cCCCHHHhhccCc--HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 ---------------VSTPIEVLCKSYP--SEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 ---------------~~~~~~~l~~~~p--~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...+.......+. .++.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0011111112333 78889999999999999999987643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.64 Aligned_cols=248 Identities=17% Similarity=0.259 Sum_probs=195.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++++.||+|+||.||+|.+..++..||+|....... ...+..|+.++..+.| +++..+..++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCC-CcHHhhhhheecCCeEEEEEe
Confidence 478999999999999999999988999999997654322 2467789999988865 566667767777888999999
Q ss_pred cc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 92 LL-GPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 92 l~-ggsL~~ll~~~--~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
++ +++|..++... ...+++..+..++.|++.||.|||+ .+|+|+||||+|||+. ..+.++|+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccCC
Confidence 99 77998888743 2378999999999999999999997 5999999999999994 6889999999998765322
Q ss_pred cCcccccccCCCCccccccccccccccCC------CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGV------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~------~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
. .....++..|+|||++.+. .++.++|||||||++|+|++|..||...........+..+.....
T Consensus 157 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 157 L---------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred c---------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 1 1234678899999998654 358899999999999999999999976443322222222222211
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..+...+++++.++|.+||..+|++||++.+|.+
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1122346899999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=298.66 Aligned_cols=252 Identities=19% Similarity=0.325 Sum_probs=201.1
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
..++|++.+.||+|+||+||+|.+..++..||||....... ...+..|+.++..+..|++|+.+.+++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 44789999999999999999999988899999998654332 234566777777777788899999888899999999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|++++++|.+++......+++..+..++.|++.||.|||+ .+|+||||+|+||++ ++++.++|+|||++..+....
T Consensus 93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCCC
Confidence 9999999999988766789999999999999999999997 599999999999999 578899999999987654322
Q ss_pred CcccccccCCCCccccccccccccccCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
. .....++..|+|||++.+.. ++.++||||||+++|+|++|..||..... ..+.+..+........
T Consensus 170 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 170 A--------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPSL 239 (296)
T ss_pred c--------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCCC
Confidence 1 12235788999999987654 78999999999999999999999975322 1222222222221111
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+ ....++.++.++|.+||..+|++||++.+|++
T Consensus 240 -~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 240 -P-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred -C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 11246899999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=292.55 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=200.9
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
+-..+|.+.++||+|+||.||+|.+... ...||||...... ....+..|+.++..+.|+ ++..+.+++.. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~-~i~~~~~~~~~-~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHP-HIVKLIGVITE-NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCC-chhceeEEEcC-CC
Confidence 3456799999999999999999987543 4578999755433 233678899999888764 55556555544 44
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.+++||++ +++|.+++......+++..++.++.|++.||+|||+.+++|+||||+|||++ ..+.++|+|||+++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeec
Confidence 67888887 8899999986566799999999999999999999999999999999999994 6789999999998765
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
..... + ......++..|+|||.+.+..++.++||||||+++||+++ |..||.+.... +....+.... ..
T Consensus 158 ~~~~~-----~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~-~~ 227 (270)
T cd05056 158 EDESY-----Y-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENGE-RL 227 (270)
T ss_pred ccccc-----e-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCC-cC
Confidence 43211 1 1122334568999999988889999999999999999886 99999875433 2222222221 11
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+ ....+|.++.++|.+||..+|++||++.++.+.|+++..+
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 P---MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 2 2245689999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=296.32 Aligned_cols=246 Identities=22% Similarity=0.323 Sum_probs=197.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
.+|++.++||.|+||.||+|.+..+++.||||...... ....+..|+.++..+.| ++++.+..++...+..++++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN-PNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCC-CceeeeeeeEecCceEEEEEEe
Confidence 57999999999999999999999999999999765432 23457778898888876 5566677777788889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 98 LAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred cCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhcccccc--
Confidence 8 8899998873 468999999999999999999999999999999999999 4788999999999876443211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
......++..|+|||.+.+..++.++|||||||++|+|++|..||.+..... ....+.... .+.......
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~---~~~~~~~~~--~~~~~~~~~ 240 (296)
T cd06655 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNG--TPELQNPEK 240 (296)
T ss_pred -----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcC--CcccCCccc
Confidence 1234568899999999998889999999999999999999999997644321 111121111 111112345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+++.+.++|.+||..+|++||++.+|+
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 688999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=294.19 Aligned_cols=251 Identities=18% Similarity=0.284 Sum_probs=196.5
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeC-----ceeE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEG-----DYNI 87 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~-----~~~~ 87 (468)
.++|.+.+.||+|+||.||+|.+..+++.+|||+..... ....+..|+.++..+.+|+++..+..++... ...+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 478999999999999999999999999999999865432 2345678899988887778888877766543 3578
Q ss_pred EEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 88 MVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
++|||+ +++|.+++.. ....+++..+..++.|++.||+|||+.+++|+||||+||++ +.++.++|+|||++..
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchh
Confidence 999998 7899998763 34578999999999999999999999999999999999999 4778899999999876
Q ss_pred cccccCcccccccCCCCccccccccccccccCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
...... ......|+..|+|||++... .++.++|||||||++|+|++|..||...... ..+..+..
T Consensus 178 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~~~~ 247 (291)
T cd06639 178 LTSTRL-------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFKIPR 247 (291)
T ss_pred cccccc-------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHHHhc
Confidence 543211 11234688999999997643 3688999999999999999999999865432 22222222
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.... . ......++.++.++|.+||+.+|++||++.+|.+
T Consensus 248 ~~~~-~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 248 NPPP-T-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCC-C-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1110 0 0112335678999999999999999999997654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=297.87 Aligned_cols=260 Identities=18% Similarity=0.258 Sum_probs=203.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.+.||+|+||.||++.+..++..||||.+.... ....+..|++++..+.| ++|+.+++.+....+.+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN-PFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEecCCEEEEE
Confidence 47999999999999999999999999999999865432 12356678888888765 6777777877888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||++ +++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||.|||+ +..+.++|+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCc
Confidence 9998 7899999975 4578999999999999999999999999999999999999 478899999999987422111
Q ss_pred Ccc--------cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 169 THK--------HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 169 ~~~--------~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
... ...........++..|+|||.+.+..++.++|+|||||++|+|++|..||.+... .+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc
Confidence 000 0000112235678899999999988899999999999999999999999986433 23333333322
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
...+.. ...+|.++.++|.+||+.+|++||+...+.++|++.
T Consensus 233 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 233 IEWPEG--DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred cCCCCc--cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 222211 124689999999999999999999987777777664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=295.39 Aligned_cols=253 Identities=18% Similarity=0.217 Sum_probs=196.3
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-------chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-------PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-------~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
+|++.+.||.|+||.||+|.+..++..||||........ ..+..|++++..+.| ++|..+..++.+.+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH-PNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCC-CCChhhhheeecCCEEEE
Confidence 589999999999999999999889999999986544322 245678899888885 566667777777889999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 89 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 89 v~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+++++|.+++......+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCCC
Confidence 99999999999998544479999999999999999999999999999999999999 478899999999997654321
Q ss_pred CcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh---------
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE--------- 238 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~--------- 238 (468)
. ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+...............
T Consensus 157 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 157 R-------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred c-------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 1 1123356788999999865 4578999999999999999999888876443221111111000
Q ss_pred -----------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 239 -----------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 239 -----------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....+........+.++.++|..||+.+|++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00011122233456789999999999999999999986654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=300.55 Aligned_cols=255 Identities=19% Similarity=0.213 Sum_probs=185.4
Q ss_pred EceEeeeCCeEEEEEEEcC--CCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEee-EeCceeEEEEeccCCC
Q 012192 20 GRKIGSGSFGELYLGVNVQ--TGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFG-VEGDYNIMVIDLLGPS 96 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~--~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~-~~~~~~~lv~el~ggs 96 (468)
+.+||+|+||.||+|.+.. ++..||+|.+........+..|++++..+.|++.+..+..+. ......+++|++++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 4689999999999998654 668999998766555567888999999998755444444333 2456779999999999
Q ss_pred HHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc-CCCCeEEEEeCCcccccccc
Q 012192 97 LEDLFNYC--------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 97 L~~ll~~~--------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~-~~~~~vkL~DFGla~~~~~~ 167 (468)
|.+++... ...+++..+..++.||+.||.|||+.+|+||||||+|||+... +..+.+||+|||+++.+...
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 99887632 1247889999999999999999999999999999999999422 34678999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH------HHHHHHHhhcc
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYDKISEKK 240 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~------~~~~~~i~~~~ 240 (468)
.. +........||+.|+|||++.+. .++.++|||||||++|||++|..||........ ...+..+....
T Consensus 166 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 166 LK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cc----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 21 11122356789999999999874 489999999999999999999999975322100 00111000000
Q ss_pred c--------------------------CC---CH----HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 241 V--------------------------ST---PI----EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 241 ~--------------------------~~---~~----~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
. .. .. +......+..+.++|.+||..||.+||++.++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l 312 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL 312 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence 0 00 00 000012345688999999999999999999765
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=296.61 Aligned_cols=254 Identities=20% Similarity=0.229 Sum_probs=195.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeC--ceeE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEG--DYNI 87 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~~ 87 (468)
.++|++.++||.|+||.||+|.+..+++.||||+....... ..+..|+.++..+.|++ +..+..+..+. +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN-IVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCC-CcceEEEEecCCCCeEE
Confidence 46899999999999999999999999999999986543322 24567999999998755 55555554433 5689
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 88 lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+|||+++++|.+++......+++..+..++.||+.||.|||+.|++||||||+||++ +..+.++|+|||++......
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCCc
Confidence 999999999999998766789999999999999999999999999999999999999 47889999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc-------
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK------- 239 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~------- 239 (468)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 162 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 162 AK-------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred cC-------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 11 1122345788999999876 45899999999999999999999999865433222222111100
Q ss_pred ---------ccCC------CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 ---------KVST------PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 ---------~~~~------~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.... ........+++++.++|..||+.||++||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 0000 00111123578899999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=286.71 Aligned_cols=247 Identities=23% Similarity=0.273 Sum_probs=203.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|++.+.||.|+||.||.+.+..++..|++|...... ....+..|++++.++.| ++|..+..++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-PNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCC-CCeeEEEeEEecCCeEEEEEE
Confidence 5999999999999999999999999999999754432 23457889999998865 677778878888899999999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccc
Confidence 98 78999998754 4568999999999999999999999999999999999999 4778899999999986543221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.... ..+.+..+........ .
T Consensus 157 -------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~----~ 222 (256)
T cd08221 157 -------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTPV----V 222 (256)
T ss_pred -------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCC----c
Confidence 1234568999999999998889999999999999999999999997533 3334444433332221 1
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRL 280 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~ 280 (468)
..++.++.++|.+||..+|++||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 4568999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=291.69 Aligned_cols=251 Identities=20% Similarity=0.337 Sum_probs=198.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEe------Ccee
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVE------GDYN 86 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------~~~~ 86 (468)
.++|++.+.||+|+||.||+|.+..+++.|++|+...... ...+..|+.++..+..|++++.+..++.. +...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 3789999999999999999999988899999998654432 35678899999999777888888877754 3457
Q ss_pred EEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 87 IMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+++|+++ +++|.+++... +..+++..+..++.|++.||+|||+.+++|+||+|+||++ +.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccce
Confidence 8999998 67999988643 4679999999999999999999999999999999999999 478899999999987
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
....... ......|+..|+|||++.. ..++.++|||||||++|+|++|..||...... ..+..+.
T Consensus 162 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~ 231 (275)
T cd06608 162 QLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFKIP 231 (275)
T ss_pred ecccchh-------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHHhh
Confidence 6543211 1234568999999998764 24678999999999999999999999754322 2222222
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...... -.....++.++.++|.+||..||++||++.+|++
T Consensus 232 ~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 221111 0111236789999999999999999999998754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=287.30 Aligned_cols=244 Identities=18% Similarity=0.288 Sum_probs=192.1
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCC
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPS 96 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggs 96 (468)
+.||+|+||.||+|.. .++..||+|+...... ...+..|++++..+.| +++..+..++......+++||++ +++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDH-PNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCC-CCcCeEEEEEecCCccEEEEECCCCCc
Confidence 4789999999999985 4678999998654322 2246789999888865 66777777777888899999998 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccccc
Q 012192 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176 (468)
Q Consensus 97 L~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 176 (468)
|.+++......+++..+..++.|++.+|.|||++|++|+||||+||++ +.++.++|+|||++........ .
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~------~ 149 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIY------S 149 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceecccccc------c
Confidence 999887656678999999999999999999999999999999999999 4788999999999875332111 1
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHH
Q 012192 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSE 255 (468)
Q Consensus 177 ~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 255 (468)
......++..|+|||++.+..++.++||||||+++|++++ |..||.+...... ...+. ...... ....+|..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~~~-~~~~~~---~~~~~~~~ 222 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQVE-KGYRMS---CPQKCPDD 222 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHH-cCCCCC---CCCCCCHH
Confidence 1122344678999999998889999999999999999998 9999987543222 22222 222111 12346899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 256 FVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 256 ~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
+.+++.+||+.+|++||++.+|.+.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=289.16 Aligned_cols=255 Identities=20% Similarity=0.281 Sum_probs=201.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++.+.||.|+||+||+|.+..++..||||+..... ....+..|++++..+.| +++..+.......+..+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-PNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCC-CCEEEEEEEEeeCCEEEEEEe
Confidence 47999999999999999999988899999999865432 23567889998888866 566777777788889999999
Q ss_pred cc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 92 LL-GPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 92 l~-ggsL~~ll~~~--~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
++ +++|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|+||++ ++++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence 99 78999998754 2468999999999999999999999999999999999999 467889999999998765433
Q ss_pred CcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC-CCHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS-TPIE 246 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~ 246 (468)
... ........|+..|+|||++... .++.++|+|||||++|+|++|..||...... +.+..+...... .+..
T Consensus 157 ~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (267)
T cd06610 157 DRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETG 230 (267)
T ss_pred ccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCc
Confidence 211 0123455789999999998877 7899999999999999999999999865432 222222222111 1111
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....+++++.+++..||..+|++||++.+|++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111356899999999999999999999987654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=292.39 Aligned_cols=246 Identities=20% Similarity=0.332 Sum_probs=199.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++.+.||.|+||.||+|.+..++..||||+...... ...+..|++++..+.| +++..+..++.++...++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS-PYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCC-CCeeeeeEEEEECCeEEEEEE
Confidence 479999999999999999999998999999998654432 2357788999888885 566667777778889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++ +++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||+++.......
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc-
Confidence 98 7799999884 389999999999999999999999999999999999999 5788999999999987654321
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
......++..|+|||++.+..++.++||||||+++|+|++|..||...... .....+...... .. ...
T Consensus 154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~-~~--~~~ 221 (274)
T cd06609 154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLFLIPKNNPP-SL--EGN 221 (274)
T ss_pred ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHHHhhhcCCC-CC--ccc
Confidence 123457888999999999988999999999999999999999999764422 222222222111 11 112
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+++++.+++..||..+|++||++.+|++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 27899999999999999999999987644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=289.87 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=195.4
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++.+.||+|+||.||+|.+..++..||||+....... ..+..|+.++..+.| +++..+..++..++..+++||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCC-CCEeEEEEEEecCCeEEEEEe
Confidence 6899999999999999999999889999999986543322 246789999888876 667788888888889999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+++++|.+++......+.+..+..++.|++.||+|||+.||+|+||||+|||+ +.++.++|+|||+++.......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~-- 158 (291)
T cd07870 84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQ-- 158 (291)
T ss_pred cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCC--
Confidence 99999988876555668889999999999999999999999999999999999 4788999999999875432111
Q ss_pred cccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc---------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV--------- 241 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 241 (468)
......++..|+|||++.+. .++.++|||||||++|+|++|..||.+.... .+.+..+.....
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 159 -----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred -----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhh
Confidence 12234578999999998764 4788999999999999999999999865431 122221111000
Q ss_pred ----------------CCCHHHhh--ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 242 ----------------STPIEVLC--KSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 242 ----------------~~~~~~l~--~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
........ -..+.++.+++.+|+..+|.+||++.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 00000000 11357899999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=302.65 Aligned_cols=254 Identities=17% Similarity=0.207 Sum_probs=189.1
Q ss_pred EEceEeee--CCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 19 LGRKIGSG--SFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 19 i~~~LG~G--~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
++++||+| +|++||++.+..+|+.||||.+..... ...+..|+.+++.+.| ++|+.+..++...+..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCEEEEEEec
Confidence 56889999 789999999999999999998654422 2346678888877765 6777777888888899999999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 93 L-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 93 ~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
+ +++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||+ +.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccccccc
Confidence 8 78999998743 3468999999999999999999999999999999999999 47789999999876543221110
Q ss_pred ccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS------ 242 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~--~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------ 242 (468)
............++..|+|||++.+ ..++.++|||||||++|||++|..||........ +.........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCcccccccc
Confidence 0000001123456788999999986 3589999999999999999999999986543211 1111100000
Q ss_pred -CCH----------------------------------HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 243 -TPI----------------------------------EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 243 -~~~----------------------------------~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+. ......+++++.+||..||+.||++||++++|.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 0011235678999999999999999999996653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=287.52 Aligned_cols=245 Identities=21% Similarity=0.332 Sum_probs=194.9
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCC
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPS 96 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggs 96 (468)
++||+|+||.||+|.+.. +..||+|....... ...+..|++++..+.| ++|..+..++......+++|+++ +++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH-PNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 479999999999999876 89999997554332 2467889999888875 56777777778888899999998 789
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccccc
Q 012192 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176 (468)
Q Consensus 97 L~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 176 (468)
|.+++......+++..++.++.|++.+|.|||+++++||||||+|||+ +.++.++|+|||++......... .
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~-----~ 150 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYT-----V 150 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcce-----e
Confidence 999987656678999999999999999999999999999999999999 57889999999998754321110 0
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHH
Q 012192 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSE 255 (468)
Q Consensus 177 ~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 255 (468)
......++..|+|||++.+..++.++||||||+++|+|++ |..||........... + ......+. ...+|.+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~-~~~~~~~~---~~~~~~~ 223 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---I-ESGYRMPA---PQLCPEE 223 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---H-hcCCCCCC---CccCCHH
Confidence 0112234667999999998889999999999999999998 8999987653222222 1 22222222 2345899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 256 FVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 256 ~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
+.++|.+||..+|++||++.+|.+.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=288.82 Aligned_cols=252 Identities=20% Similarity=0.333 Sum_probs=198.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--------CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--------HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
+|++.+.||.|+||+||+|.. .++..+|||....... ...+..|+.++..+.| ++++.+.+++.+.+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH-VNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCC-CCEeeEeeEeecCCeEE
Confidence 588999999999999999985 5788999997554321 1347778999888876 56777777778889999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+++|++ +++|.+++.. ...+++..+..++.|++.||+|||+.+|+|+||+|+||++ +.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence 999998 8899999875 4578999999999999999999999999999999999999 5788999999999876532
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
...... .........|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....+.... ...+
T Consensus 155 ~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~~~--~~~~ 228 (265)
T cd06631 155 VGLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYIGAHR--GLMP 228 (265)
T ss_pred cccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH---HHHHhhhcc--CCCC
Confidence 111100 0111234568999999999999889999999999999999999999997643221 111121111 1122
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+...++.++.++|.+||+.+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 234567899999999999999999999987653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.86 Aligned_cols=262 Identities=18% Similarity=0.204 Sum_probs=188.8
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCC-CcEEEEE------------------Ee-eccCCCchhHHHHHHHHH
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQT-GEEIAVK------------------LE-LVKTKHPQLHYESKLYML 66 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~-~~~vAIK------------------~~-~~~~~~~~~~~E~~~l~~ 66 (468)
+..+..+.++|+++++||+|+||+||+|..... ++.+++| .. ........+..|+.++..
T Consensus 140 ~~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~ 219 (501)
T PHA03210 140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGR 219 (501)
T ss_pred cccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHh
Confidence 344556678999999999999999999875432 2222222 00 011112356789999988
Q ss_pred HhCCCCCceeeEeeEeCceeEEEEeccCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCce
Q 012192 67 LQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYC----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNF 142 (468)
Q Consensus 67 l~~~~~i~~l~~~~~~~~~~~lv~el~ggsL~~ll~~~----~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~Ni 142 (468)
+.| ++|+.+..++...+..|+++++++++|.+++... ........+..|+.||+.||+|||++|||||||||+||
T Consensus 220 l~H-pnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI 298 (501)
T PHA03210 220 LNH-ENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298 (501)
T ss_pred CCC-CCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 876 5677778888888899999999998888876532 12244667888999999999999999999999999999
Q ss_pred eecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCC-C
Q 012192 143 LMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP-W 221 (468)
Q Consensus 143 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~P-f 221 (468)
|+ +.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ |
T Consensus 299 Ll---~~~~~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 299 FL---NCDGKIVLGDFGTAMPFEKERE------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred EE---CCCCCEEEEeCCCceecCcccc------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 99 4788999999999986643211 112346799999999999999999999999999999999998764 4
Q ss_pred CCCCcccHHHHHHHHhhcc------cC-------------------CCHHHh--hccCcHHHHHHHHHHhcCCCCCCCCH
Q 012192 222 QGLKAGTKKQKYDKISEKK------VS-------------------TPIEVL--CKSYPSEFVSYFHYCRSLRFEDKPDY 274 (468)
Q Consensus 222 ~~~~~~~~~~~~~~i~~~~------~~-------------------~~~~~l--~~~~p~~~~~li~~cl~~~p~~RPs~ 274 (468)
.+... .....+.++.... +. ...+.+ ...++..+.++|.+||+.||.+||++
T Consensus 370 ~~~~~-~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa 448 (501)
T PHA03210 370 GDGGG-KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA 448 (501)
T ss_pred cCCCC-CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH
Confidence 43222 2212221111100 00 001111 12467788899999999999999999
Q ss_pred HHHHH
Q 012192 275 SYLKR 279 (468)
Q Consensus 275 ~~l~~ 279 (468)
.+++.
T Consensus 449 ~elL~ 453 (501)
T PHA03210 449 AELLA 453 (501)
T ss_pred HHHhh
Confidence 97643
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=291.83 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=198.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|++.++||+|+||.||+|.+..+++.||||..... .....+..|+++++.+.| ++|..+..++...+..+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-ENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCC-CCeeehhheEEECCEEEEEE
Confidence 4799999999999999999999989999999975432 223567889999999985 56777777778888999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|++.+++.+.+......+++..+..++.|++.||.|||+.+++|+||+|+||++ ++++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcc-
Confidence 999777766655456679999999999999999999999999999999999999 5789999999999876543221
Q ss_pred ccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc----------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK---------- 239 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 239 (468)
.......++..|+|||++.+. .++.++||||||+++|+|++|..||.+............+...
T Consensus 156 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 -----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred -----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 012345678899999999988 7899999999999999999999999864332111111111000
Q ss_pred --------cc---CCC--HHH-hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 --------KV---STP--IEV-LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 --------~~---~~~--~~~-l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+ ..+ .+. ....++.++.++|..||..+|++||++++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 000 011 11234889999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=295.09 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=198.7
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
....|++.++||+|+||.||+|.+..+++.||||....... ...+..|++++..+.| +++..+.+++...+..+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH-PNTIEYKGCYLREHTAW 91 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEEeCCeEE
Confidence 34679999999999999999999988999999997653322 1357789999888865 67777888888888999
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 88 lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+|+|++.++|.+++......+++..+..++.|++.||.|||+.+|+|+||+|+||++ ++++.++|+|||++.....
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~- 167 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP- 167 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCC-
Confidence 999999999999887666789999999999999999999999999999999999999 4788999999999865432
Q ss_pred cCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.....++..|+|||++. ...++.++||||||+++|||++|..||.+.... .....+........
T Consensus 168 ----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~ 234 (307)
T cd06607 168 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNDSPTL 234 (307)
T ss_pred ----------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HHHHHHhcCCCCCC
Confidence 22456788999999985 345889999999999999999999999764322 11222222111111
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....++.++.++|..||+.+|++||++.+|+.
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 235 ---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred ---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11235789999999999999999999997754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=295.65 Aligned_cols=269 Identities=21% Similarity=0.302 Sum_probs=216.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+--++|..++.||+|.||.|-+++.+.+++.+|||++.+. .....-.-|.+++....| |.+..+...+...+.
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H-PFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRH-PFLTSLKYSFQTQDR 242 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccC-cHHHHhhhhhccCce
Confidence 34457899999999999999999999999999999975433 233345668888887776 566667777788889
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++||||. ||.|.-.+.. .+.|+++....+..+|+.||.|||+++||.||||.+|+|+ |+++++||+|||||+.-
T Consensus 243 lCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhc
Confidence 99999999 7888777775 5689999999999999999999999999999999999999 79999999999999853
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
-... ...++++||+.|+|||++....|++.+|+|.+||++|||++|++||..... ...+.-|....+..|
T Consensus 319 I~~g-------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 319 IKYG-------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDLKFP 388 (516)
T ss_pred cccc-------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhccCC
Confidence 2211 135789999999999999999999999999999999999999999986433 334444555555555
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCC--CHHHHHHHHHHHHHHcCCCCCcccccccccCCCc
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKP--DYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQI 306 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RP--s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~ 306 (468)
..+.++...|+.-+|..+|.+|. ..++..+..++ .++..++|+......+
T Consensus 389 -----r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h-------~FF~~v~W~~~~~Kki 440 (516)
T KOG0690|consen 389 -----RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH-------RFFASVDWEATYRKKI 440 (516)
T ss_pred -----ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh-------hhhccCCHHHHHHhcc
Confidence 34589999999999999999996 33444444443 4566788988654333
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=289.19 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=193.6
Q ss_pred ceEeeeCCeEEEEEEEcC-CC--cEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 21 RKIGSGSFGELYLGVNVQ-TG--EEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~-~~--~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
+.||+|+||.||+|.+.. .+ ..||||....... ...+..|+.++..+.|+ ++..+..++.. ...+++||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE-NLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCC-CccceeEEEcC-CeEEEEEEecC
Confidence 478999999999998765 33 3699998655433 34678899999999875 45555555555 7889999998
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 94 GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 94 ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
+++|.+++.... ..+++..+..++.|++.||+|||+++++|+||||+|||+ +.++.++|+|||++..+.....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~--- 152 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNED--- 152 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEecccccccccccccc---
Confidence 889999987544 568999999999999999999999999999999999999 4679999999999987644221
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 173 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
.+.......++..|+|||++.+..++.++|||||||++|+|++ |..||...... +.+..+.......+ ....
T Consensus 153 -~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~---~~~~ 225 (257)
T cd05040 153 -HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDKEGERLE---RPEA 225 (257)
T ss_pred -ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCcCC---CCcc
Confidence 1222234567889999999998899999999999999999998 99999765432 22222222111111 1234
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
+|..+.+++..||+.+|++||++.+|++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 6899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=293.59 Aligned_cols=246 Identities=20% Similarity=0.323 Sum_probs=199.0
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.+.|+..++||.|+||.||+|.+..++..||||+...... ...+..|++++..+.| ++++.+.+++......++||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEEEE
Confidence 3568899999999999999999988999999998654322 2357778888888865 67777888888889999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|++ +++|.+++. ...+++..+..++.|++.||+|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 82 EYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence 998 789999887 3578999999999999999999999999999999999999 4788899999999876543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......++..|+|||++.+..++.++|+|||||++|||++|..||....... ....+... . .+.+.
T Consensus 157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~-~---~~~~~ 222 (277)
T cd06640 157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLFLIPKN-N---PPTLT 222 (277)
T ss_pred -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---HhhhhhcC-C---CCCCc
Confidence 1233468889999999998889999999999999999999999998654321 11111111 1 12233
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..+|..+.++|..||+.+|++||++.+|++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 445889999999999999999999997744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=291.71 Aligned_cols=253 Identities=19% Similarity=0.312 Sum_probs=201.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.++|++.++||.|+||.||+|.... ....|++|........ ..+..|++++..+.| ++++.+..++.+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCC-cceeeeEEEECCCCc
Confidence 4789999999999999999999654 3467999976543332 467889999999965 667778878888888
Q ss_pred eEEEEecc-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 86 NIMVIDLL-GPSLEDLFNYCN--------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~--------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
.++|||++ +++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +..+.++|+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEEc
Confidence 99999999 689999987533 158999999999999999999999999999999999999 478899999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 235 (468)
|||++...... .+.......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... ...+..
T Consensus 160 ~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~ 230 (275)
T cd05046 160 LLSLSKDVYNS------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR 230 (275)
T ss_pred ccccccccCcc------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH
Confidence 99998643221 1112234467788999999998889999999999999999998 8999976433 223333
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
+.......+. ...+|..+.+++.+||+.+|++||++.+|.+.|.
T Consensus 231 ~~~~~~~~~~---~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPV---PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 3323322221 2346899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=296.58 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=198.7
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
++.. ++|++.+.||+|+||.||+|.+..++..||||....... ...+..|+.++..+.| +++..+..++...+..+
T Consensus 15 ~~~~-~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 15 GDPK-KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELW 92 (297)
T ss_pred CChh-hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCEEE
Confidence 4444 789999999999999999999988999999998654332 2356678888777755 67777777778888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
++||++ +++|.+++. ...+++..+..++.|++.||.|||+.|++||||||+|||+ +.++.++|+|||++.....
T Consensus 93 lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 93 VVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EeecccCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccC
Confidence 999998 889999887 3568999999999999999999999999999999999999 4788999999999876443
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
... ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+..... ..+ .+.... .+..
T Consensus 168 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~~-~~~~~~--~~~~ 235 (297)
T cd06656 168 EQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY-LIATNG--TPEL 235 (297)
T ss_pred Ccc-------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--hee-eeccCC--CCCC
Confidence 211 1224568899999999999889999999999999999999999997643211 111 111111 1111
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....++..+.+++.+||..+|++||++.+|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122346889999999999999999999986554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=302.16 Aligned_cols=255 Identities=21% Similarity=0.266 Sum_probs=195.1
Q ss_pred CCCCc---eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEe
Q 012192 7 LRMDH---VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 7 l~~~~---ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
++++. .+.++|++.+.||+|+||.||+|.+..++..||||...... ....+..|+.++..+.|++.+..+..+
T Consensus 5 ~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 5 VEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred ecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 45555 56799999999999999999999999999999999864322 223567799999988775554444433
Q ss_pred eE-----eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEE
Q 012192 80 GV-----EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVY 154 (468)
Q Consensus 80 ~~-----~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vk 154 (468)
.. +....++|||++.++|.+.+.. .++...+..++.|++.||+|||++||+||||||+|||+ +.++.++
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~k 158 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLK 158 (353)
T ss_pred ccCCCccccCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEE
Confidence 32 2235799999999999988863 28999999999999999999999999999999999999 5788999
Q ss_pred EEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 012192 155 IIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 234 (468)
|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||....... .+.
T Consensus 159 L~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~---~~~ 227 (353)
T cd07850 159 ILDFGLARTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID---QWN 227 (353)
T ss_pred EccCccceeCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence 99999997653311 1233467899999999999999999999999999999999999998653221 111
Q ss_pred HHhhcccC-------------------------CCHHHh-------------hccCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012192 235 KISEKKVS-------------------------TPIEVL-------------CKSYPSEFVSYFHYCRSLRFEDKPDYSY 276 (468)
Q Consensus 235 ~i~~~~~~-------------------------~~~~~l-------------~~~~p~~~~~li~~cl~~~p~~RPs~~~ 276 (468)
.+...... .+...+ ....++++.++|..||+.||++||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 307 (353)
T cd07850 228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307 (353)
T ss_pred HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence 11110000 000000 1134677899999999999999999986
Q ss_pred HH
Q 012192 277 LK 278 (468)
Q Consensus 277 l~ 278 (468)
++
T Consensus 308 iL 309 (353)
T cd07850 308 AL 309 (353)
T ss_pred Hh
Confidence 54
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=301.65 Aligned_cols=263 Identities=19% Similarity=0.264 Sum_probs=202.1
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEe--C
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVE--G 83 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~ 83 (468)
+..+.++|++.+.||+|+||.||+|.+..++..||||..... .....+..|+.++..+.+|++|..+.+++.. .
T Consensus 2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred CchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 456788999999999999999999999889999999975432 2234567799999999555667676665543 4
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 84 DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 84 ~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
...+++||++.++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARS 156 (337)
T ss_pred ceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhc
Confidence 46799999999999988874 378899999999999999999999999999999999999 5789999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh-----
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS----- 237 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~----- 237 (468)
........ .........|+..|+|||++.+. .++.++||||||+++|+|++|..||.+.........+....
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 157 LSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred cccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 54322211 01122345689999999988754 57899999999999999999999997644322211111110
Q ss_pred ------------------hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 238 ------------------EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 238 ------------------~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
......+.....+.++.++.++|..||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 001112233444557899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=286.72 Aligned_cols=249 Identities=21% Similarity=0.313 Sum_probs=197.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
.+|++.+.||+|+||.||+|.+. .+..+|||....... ...+..|++++..+.| +++..+.+++......+++|+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSH-PKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCC-CCeeeEEEEEccCCceEEEEEcC
Confidence 57999999999999999999875 467899997654332 3568889999999876 55667777777778889999988
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 94 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 94 -ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
+++|.+++......++++.+..++.|++.+|+|||+.+++|+||||.||++ +.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~---- 154 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ---- 154 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCc----
Confidence 789999988656678999999999999999999999999999999999999 467899999999987543211
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 173 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
+.......++..|+|||++.+..++.++||||||+++|||++ |..||..... ...+..+... .....+ ..
T Consensus 155 --~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~-~~~~~~---~~ 225 (256)
T cd05112 155 --YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAG-FRLYKP---RL 225 (256)
T ss_pred --ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCC-CCCCCC---CC
Confidence 111223345678999999998889999999999999999998 9999975432 2222222221 111111 22
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
.+.++.+|+.+||+.+|++||++.++.+.|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 489999999999999999999999988776
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=290.06 Aligned_cols=234 Identities=26% Similarity=0.317 Sum_probs=181.3
Q ss_pred eEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----chhHHHHHHHHHHh--CCCCCceeeEeeEeCceeEEEEecc-
Q 012192 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----PQLHYESKLYMLLQ--GGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
.||+|+||.||++.+..++..||||........ ..+..|..++..+. +++++..+..++...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999889999999976543211 12334444433332 4677888887777888899999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
+++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~----- 151 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK----- 151 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-----
Confidence 7899888874 4579999999999999999999999999999999999999 578899999999987543211
Q ss_pred cccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccC
Q 012192 174 PYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... .+.... ...+ ..+...+
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~---~~~~-~~~~~~~ 222 (279)
T cd05633 152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT---LTVN-VELPDSF 222 (279)
T ss_pred ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh---hcCC-cCCcccc
Confidence 123468999999999874 56899999999999999999999999865433222 221111 1111 1233456
Q ss_pred cHHHHHHHHHHhcCCCCCCCC
Q 012192 253 PSEFVSYFHYCRSLRFEDKPD 273 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RPs 273 (468)
+.++.++|..||..||.+||+
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcC
Confidence 899999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.29 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=198.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.+.||+|+||.||+|.+..++..||||....... ...+..|++++..+.| ++|+.+.+++......+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH-PFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCC-CCchhheeeeecCCEEEEE
Confidence 479999999999999999999988999999998655432 2357788898888875 6777777777888899999
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||++ +++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence 9987 78999998753 3578999999999999999999999999999999999999 46789999999998765332
Q ss_pred cCcccc----------------------cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 012192 168 QTHKHI----------------------PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLK 225 (468)
Q Consensus 168 ~~~~~~----------------------~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~ 225 (468)
...... .........||..|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110000 0001224578999999999999899999999999999999999999998654
Q ss_pred cccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHH
Q 012192 226 AGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYS 275 (468)
Q Consensus 226 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~ 275 (468)
. ...+..+.......+.. ..++.++.++|.+||..+|++||+..
T Consensus 237 ~---~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~ 280 (316)
T cd05574 237 R---DETFSNILKKEVTFPGS---PPVSSSARDLIRKLLVKDPSKRLGSK 280 (316)
T ss_pred h---HHHHHHHhcCCccCCCc---cccCHHHHHHHHHHccCCHhHCCCch
Confidence 3 23333333333322221 22589999999999999999999943
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=317.31 Aligned_cols=249 Identities=18% Similarity=0.320 Sum_probs=198.4
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
+.|.|+..||.|+||.||+|.++.++...|-|++..+. .-.+++-|++||..+.|+.++..+..|..++. ++|+.|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-LwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-LWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-eEEEEee
Confidence 45788999999999999999999898888889755443 34578889999999986554444444544554 4555555
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
| ||..+.++-..++.|++..+..++.|++.||.|||+++|||||||+.|||++ -+|.++|+|||.+..... +
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~--t-- 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKS--T-- 183 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchh--H--
Confidence 5 8889888888899999999999999999999999999999999999999997 689999999999754322 1
Q ss_pred cccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 172 HIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
......+.||++|||||+.. ..+|++++||||||++|+||.-+.+|-+..+++.+.-++ .... +|.-
T Consensus 184 ---~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi---aKSe--PPTL 255 (1187)
T KOG0579|consen 184 ---RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSE--PPTL 255 (1187)
T ss_pred ---HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH---hhcC--CCcc
Confidence 11245789999999999865 567999999999999999999999999887665433333 2221 2222
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.-...+...|.+|+..||..||+.||++.+|++
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 223567889999999999999999999997753
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=294.42 Aligned_cols=261 Identities=23% Similarity=0.251 Sum_probs=196.1
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEe-------
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVE------- 82 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------- 82 (468)
.++|++.++||+|+||.||+|.+..++..||||....... ...+..|++++..+.|+ +|..+..+..+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP-NVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCC-Cccchhhheecccccccc
Confidence 5899999999999999999999999999999997654322 23567899999999875 45555444322
Q ss_pred -CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 -GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 -~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
....+++|+++.++|..++......+++..+..++.|++.||.|||++||+|+||||+|||+ +.++.++|+|||++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccc
Confidence 33569999999999988887656679999999999999999999999999999999999999 57889999999999
Q ss_pred cccccccCcccc----cccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 012192 162 KKYRDLQTHKHI----PYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 162 ~~~~~~~~~~~~----~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 236 (468)
............ .........++..|+|||++.+. .++.++|||||||++|+|++|..||.+.......+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 765432211100 01112345678899999988764 4789999999999999999999999865443322222211
Q ss_pred hhc----------------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 237 SEK----------------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 237 ~~~----------------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
... ............+.+++.++|.+||+.+|++||++.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 100 000011112234557899999999999999999988764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.69 Aligned_cols=246 Identities=21% Similarity=0.274 Sum_probs=198.4
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|++.+.||+|+||.||+|.+..++..||||...... ....+..|+++++.+.| +++..+.......+..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-PNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCC-CchhheeeeEecCCEEEEEEe
Confidence 5899999999999999999999999999999865432 23457789999988876 566666666777888999999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++... ...+++..+..++.|++.+|+|||++|++|+||+|+||++. ++++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCc-
Confidence 98 78999998754 34589999999999999999999999999999999999994 345678999999998654321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+... ...+..+...... + +.
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~-~---~~ 222 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTFA-P---IS 222 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCCC-C---CC
Confidence 12345688999999999988899999999999999999999999976433 2223223222211 1 22
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..++.++.+++..||..+|++||++.+|++
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 346899999999999999999999997754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=293.22 Aligned_cols=247 Identities=19% Similarity=0.304 Sum_probs=199.4
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|++.++||.|+||.||+|.+..+++.||||.+..... ...+..|++++..+. |+++..+..++......+++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEEE
Confidence 478999999999999999999998999999998655432 245788999988888 5667777777777889999999
Q ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LLG-PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~g-gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++. ++|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++ .++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHHHh
Confidence 994 89999998655789999999999999999999999 9999999999999994 688999999999876543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc--ccHHHHHHHHhhcccCCCHHH
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~~ 247 (468)
....++..|+|||++.+..++.++||||||+++|+|++|..||..... ....+....+..... +.
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 223 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP----PR 223 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC----CC
Confidence 126788999999999998999999999999999999999999976421 122222222222211 11
Q ss_pred hhcc-CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 248 LCKS-YPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 248 l~~~-~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+... ++.++.++|..||..+|++||++.+|+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 1112 688999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=299.59 Aligned_cols=280 Identities=22% Similarity=0.264 Sum_probs=231.5
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
+.+.|-..+|.++..||.|+||.|.+|..+.+.+.+|||++... ...+--+.|-++|.....++.+..++.++..
T Consensus 342 ~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 342 KRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred cccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 34567778999999999999999999999999999999975443 3333456677787777778889999999999
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
-+.+|+||||+ ||+|.-.+.. -+++.+..+..+|.+||-||-|||++|||.||||.+|+|+ |..+++||+|||+|
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMC 497 (683)
T ss_pred hhheeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccc
Confidence 99999999999 8888887875 5579999999999999999999999999999999999999 78999999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
+.-... -...++++||+.|+|||.+...+|+..+|+|||||+||||+.|+.||.+. +..+.+..|.+.+.
T Consensus 498 KEni~~-------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe---DE~elF~aI~ehnv 567 (683)
T KOG0696|consen 498 KENIFD-------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQAIMEHNV 567 (683)
T ss_pred cccccC-------CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHccC
Confidence 853221 12357899999999999999999999999999999999999999999884 44567777888877
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCCccCCCC
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGSSSK 311 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 311 (468)
..| ++++.|..++..-.+...|.+|....---+ ++ ...+.++.-+||+.+...++...-.
T Consensus 568 syP-----KslSkEAv~ickg~ltK~P~kRLGcg~~ge--~d---i~~H~FFR~iDWek~E~~eiqPPfk 627 (683)
T KOG0696|consen 568 SYP-----KSLSKEAVAICKGLLTKHPGKRLGCGPEGE--RD---IREHPFFRRIDWEKLERREIQPPFK 627 (683)
T ss_pred cCc-----ccccHHHHHHHHHHhhcCCccccCCCCccc--cc---hhhCcchhhccHHHHhhccCCCCCC
Confidence 666 556899999999999999999964321000 11 1336778889999988777655443
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=292.11 Aligned_cols=253 Identities=20% Similarity=0.268 Sum_probs=194.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|++.++||+|+||.||+|.+..+++.||||+...... ...+..|++++..+.| ++|..+..++..+...++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH-ENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCC-cchhhHHHhcccCCeEEEEE
Confidence 479999999999999999999988899999997543322 3357789999888865 66777777778888999999
Q ss_pred eccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLLG-PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~g-gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+. +.|..+.. ....+++..++.++.|++.||.|||+.+++|+||+|+||++ ++++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 80 EFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred ecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence 9995 45555554 34569999999999999999999999999999999999999 5788999999999876543211
Q ss_pred cccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc---------
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK--------- 239 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 239 (468)
......++..|+|||++.+. .++.++||||||+++|||++|..||...........+..+...
T Consensus 156 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 156 -------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred -------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 12335678999999998764 4788999999999999999999999764322111111111000
Q ss_pred -------cc-------CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 -------KV-------STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 -------~~-------~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+ ..+.....+.++..+.+++..||..+|++||++.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 01111234567899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.16 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=198.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC------------CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK------------HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+|.+.+.||.|+||.||+|.+..+++.||||....... .+.+..|+.++..+.| ++++.+.+++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH-LNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCC-CCcceEEEEeccC
Confidence 58999999999999999999888999999997543211 1246678888888865 6677777888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+..++|||++ +++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISK 156 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccc
Confidence 8999999998 88999998854 578999999999999999999999999999999999999 578999999999987
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
........ .......|+..|+|||++.... ++.++|+||||+++|++++|..||..... ...+..+....
T Consensus 157 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~ 228 (272)
T cd06629 157 KSDDIYDN-----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKR 228 (272)
T ss_pred cccccccc-----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHHHhhccc
Confidence 54321111 1123456889999999988755 78999999999999999999999975332 22222222221
Q ss_pred cC-CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 VS-TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 ~~-~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.. .........++.++.++|..||..+|++||++.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11 1122344567899999999999999999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=293.38 Aligned_cols=259 Identities=21% Similarity=0.250 Sum_probs=195.6
Q ss_pred ceEEEceEeeeCCeEEEEEEEcC--CCcEEEEEEeec-----cCCCchhHHHHHHHHHHhCCCCCceeeEeeEeC--cee
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQ--TGEEIAVKLELV-----KTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEG--DYN 86 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~--~~~~vAIK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~ 86 (468)
+|++.++||+|+||.||+|.+.. ++..||||.... ......+..|+.++..+.| +++..+..++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH-ENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCC-CCccceEEEEeCCCCceE
Confidence 58999999999999999999988 889999998665 2234567789999998876 5666666666666 789
Q ss_pred EEEEeccCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecc-cCCCCeEEEEeCCcc
Q 012192 87 IMVIDLLGPSLEDLFNYCN----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDYGLA 161 (468)
Q Consensus 87 ~lv~el~ggsL~~ll~~~~----~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~-~~~~~~vkL~DFGla 161 (468)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||+.. ++..+.+||+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999999999988876432 36889999999999999999999999999999999999952 112789999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCccc------HHHHHH
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYD 234 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~------~~~~~~ 234 (468)
........ .........++..|+|||++.+. .++.++|||||||++|+|++|..||.+..... ....+.
T Consensus 160 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 160 RLFNAPLK----PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred cccCCCcc----cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 86543221 11223445788999999998774 47899999999999999999999998654322 000111
Q ss_pred HHhhc--------------------------ccCCC---HHH-hh--ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 235 KISEK--------------------------KVSTP---IEV-LC--KSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 235 ~i~~~--------------------------~~~~~---~~~-l~--~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+... ....+ ... .. ...+.++.++|..||+.+|++||++.+|.+
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11000 00000 000 00 145678999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=290.30 Aligned_cols=255 Identities=20% Similarity=0.222 Sum_probs=196.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|++.++||.|+||.||+|.+..+++.||||...... ....+..|+++++.+.| ++++.+..++......++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccC-CCEeeEEEEEecCCeEEEEE
Confidence 57999999999999999999998899999999754432 22457789999999866 67778888888889999999
Q ss_pred eccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||++++|.+++.... ..+++..+..++.||+.||+|||+++++|+||+|+||++. ..++.+||+|||++.......
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCc-
Confidence 999989988876433 2367888999999999999999999999999999999994 245679999999997543211
Q ss_pred cccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc--------
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK-------- 240 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------- 240 (468)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||...................
T Consensus 158 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 158 ------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred ------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 112234678899999998764 57899999999999999999999998643321111111110000
Q ss_pred -------------cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 -------------VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 -------------~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...........+++++.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111223456889999999999999999999997654
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.68 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=198.3
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCC----cEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTG----EEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~----~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
|++.+.||.|+||.||+|.+...+ ..||+|....... ...+..|+.++..+ +|+++..+..++.+....+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEE
Confidence 467899999999999999988766 8999998654432 34678899999988 557778888777777889999
Q ss_pred Eecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~-ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|+++ +++|.+++...... +++..+..++.|++.||.|||+.+++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecccc
Confidence 9998 78999998754434 9999999999999999999999999999999999999 47789999999999866543
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
.. +. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...+..+..... .+.
T Consensus 157 ~~-----~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~-~~~- 225 (258)
T smart00219 157 DY-----YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKKGYR-LPK- 225 (258)
T ss_pred cc-----cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCC-CCC-
Confidence 21 11 112337789999999988889999999999999999998 8899976433 222322322222 221
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
...+|.++.+++.+||..+|++||++.+|.+.|
T Consensus 226 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 --PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 233689999999999999999999999887653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=290.34 Aligned_cols=240 Identities=15% Similarity=0.177 Sum_probs=181.5
Q ss_pred ceEeeeCCeEEEEEEEcC------------CCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 21 RKIGSGSFGELYLGVNVQ------------TGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~------------~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
+.||+|+||.||+|.... ....|++|+...... ...+..|+.++..+.| ++|+.+.+++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~h-p~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH-KHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCC
Confidence 468999999999998532 234688887544322 2245667777777765 6777788888888888
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC----CCCeEEEEeCCcc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR----KANQVYIIDYGLA 161 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~----~~~~vkL~DFGla 161 (468)
+++||++ +++|..++......+++..++.++.||+.||+|||+++|+||||||+|||+.... ....++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999998 6788888776566799999999999999999999999999999999999995211 1123899999998
Q ss_pred cccccccCcccccccCCCCcccccccccccccc-CCCCCCcchHHHHHHHHHHHH-cCCCCCCCCCcccHHHHHHHHhhc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHL-GVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~s~ksDvwSlGvvl~ell-tG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
..... .....++..|+|||.+. +..++.++|||||||++|||+ .|..||......... .....
T Consensus 160 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~ 224 (262)
T cd05077 160 ITVLS-----------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RFYEG 224 (262)
T ss_pred ccccC-----------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HHHhc
Confidence 65432 12346788999999887 456899999999999999998 589998764332211 11121
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
.... ....++++.+||.+||+.+|++||++.+|++.|
T Consensus 225 ~~~~-----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QCML-----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CccC-----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111 122367899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=288.53 Aligned_cols=253 Identities=22% Similarity=0.270 Sum_probs=198.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
+|++.++||.|+||.||+|.+..++..||||...... ....+..|+.++..+.| +++..+..++...+..+++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC-CCEeeeeeeEeeCCcEEEEEec
Confidence 5899999999999999999998899999999865442 23456789999999865 7788888888888899999999
Q ss_pred cCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 93 LGPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 93 ~ggsL~~ll~~~~--~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
+.++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ ++++.++|+|||++.......
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCc--
Confidence 9989999887543 468999999999999999999999999999999999999 578899999999997543211
Q ss_pred ccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc---------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--------- 240 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 240 (468)
.......++..|++||++.+. .++.++|||||||++|+|++|..||.+.........+.......
T Consensus 155 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 155 -----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred -----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 112234578899999998764 47899999999999999999999998754332222211110000
Q ss_pred ---------cC---CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 ---------VS---TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 ---------~~---~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.. .....+...++.++.++|..||+.+|++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0011122345788999999999999999999987653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=300.04 Aligned_cols=259 Identities=18% Similarity=0.248 Sum_probs=198.9
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeE----eCc
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGV----EGD 84 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~ 84 (468)
++.+|++.+.||.|+||.||+|.+..++..||||.+.... ....+..|+.++..+.| ++|+.+..++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH-DNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCC-CCccCHHHhccccCCCCc
Confidence 4589999999999999999999999999999999865432 23456779999999985 55555544332 345
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 85 YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 85 ~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
..+++|++++++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceee
Confidence 6899999999999998874 4569999999999999999999999999999999999999 47899999999999765
Q ss_pred ccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH--------
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK-------- 235 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~-------- 235 (468)
...... .........|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 158 ~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 158 SSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred cccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 432211 1111234578899999999876 4589999999999999999999999976543211111100
Q ss_pred ---------------HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 236 ---------------ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 236 ---------------i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
........+...+....++++.++|..||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00111112223344667899999999999999999999986443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.48 Aligned_cols=240 Identities=18% Similarity=0.247 Sum_probs=182.7
Q ss_pred ceEeeeCCeEEEEEEEcCCCc-------EEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 21 RKIGSGSFGELYLGVNVQTGE-------EIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~-------~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+.||.|+||.||+|.+...+. .||+|....... ...+..|+.++..+.| ++++.+..++..++..+++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH-KHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCC-CChhheeeEEEeCCCcEEEEe
Confidence 479999999999998765443 488887543322 2356778888777765 666677777777788899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC-----CCeEEEEeCCcccccc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK-----ANQVYIIDYGLAKKYR 165 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~-----~~~vkL~DFGla~~~~ 165 (468)
|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++..+. ...++++|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 98 78999999865667899999999999999999999999999999999999962211 1237999999986433
Q ss_pred cccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCC-CCCCCCCcccHHHHHHHHhhcccCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
. .....++..|+|||++.+. .++.++||||||+++|+|++|. .||........ . .........
T Consensus 160 ~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~-~~~~~~~~~ 224 (258)
T cd05078 160 P-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L-QFYEDRHQL 224 (258)
T ss_pred C-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H-HHHHccccC
Confidence 2 2245678899999999874 4799999999999999999984 66654332111 1 111222222
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
+ .....++.++|..||+.+|++||++++|++.|
T Consensus 225 ~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 225 P-----APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred C-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2 22357899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=287.62 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=196.2
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHh--CCCCCceeeEeeEeCce-----
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQ--GGTGIPHLKWFGVEGDY----- 85 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~----- 85 (468)
|++.+.||+|+||.||+|.+..++..||||........ ..+..|+.++..+. .|+++..+..++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999888999999986543322 24567888887775 36777788777776665
Q ss_pred eEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.+++|+++.++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++..+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceec
Confidence 89999999889999887643 368999999999999999999999999999999999999 46799999999999775
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh------
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE------ 238 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~------ 238 (468)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 158 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 158 SFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred cCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 43211 1233578899999999999999999999999999999999999987543322222211100
Q ss_pred -------------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 239 -------------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 239 -------------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.....+.......+++.+.++|..||+.+|.+||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 0001111222334568889999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=290.91 Aligned_cols=245 Identities=20% Similarity=0.329 Sum_probs=197.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHh--CCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQ--GGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.|++.+.||+|+||.||+|.+..++..||||...... ....+..|+.++..+. .|+++..+..++..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5888999999999999999998999999999865432 2345778999998887 3677777887888888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|++ +++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++ ..+.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCcc
Confidence 998 7899998873 4799999999999999999999999999999999999994 688999999999986654221
Q ss_pred cccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
......|+..|+|||++.+. .++.++|+||||+++|+|++|..||.+.... ..+..+... .+ +.+
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~---~~-~~~ 222 (277)
T cd06917 157 -------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF---RAMMLIPKS---KP-PRL 222 (277)
T ss_pred -------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---hhhhccccC---CC-CCC
Confidence 12344688999999998754 4789999999999999999999999764321 111111111 11 112
Q ss_pred h-ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 249 C-KSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 249 ~-~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
. ..++.++.++|..||+.+|++||++.++..
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 237899999999999999999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=292.94 Aligned_cols=254 Identities=21% Similarity=0.249 Sum_probs=197.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeC--ceeEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEG--DYNIM 88 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~~l 88 (468)
++|++.+.||.|+||.||+|.+..++..||||........ ..+..|+.++..+.| ++|..+..++... ...++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCC-CCEEEEEEEEEecCCCcEEE
Confidence 5799999999999999999999889999999986544322 245679999999985 6677777666665 88999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 89 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 89 v~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
++|++.++|.+++......+++..++.++.|++.||+|||+++++|+||||+|||+ +..+.++|+|||++.......
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccCCc
Confidence 99999999999998766679999999999999999999999999999999999999 578899999999988655421
Q ss_pred CcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc--------
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-------- 239 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~-------- 239 (468)
. ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+......
T Consensus 161 ~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 161 K-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred c-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 1 122345788999999987654 689999999999999999999999865443222222111100
Q ss_pred ----------cc-CC---CHHHhhcc--CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 ----------KV-ST---PIEVLCKS--YPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 ----------~~-~~---~~~~l~~~--~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.. .. ........ +++.+.++|..||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00 00011111 4788999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=289.08 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=198.2
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
+.||+|+||.||+|.+..+++.||||+...... ...+..|..++....+|+++..+..++...+..++++||+ +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999988999999998654321 1234455555555556788888888888889999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++ +..+.++|+|||++.....
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~-------- 149 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE-------- 149 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc--------
Confidence 899999985 4578999999999999999999999999999999999999 4678999999999875322
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... .+.+..+.......+ ......+++
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~ 222 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRINWP-EEVKEFCSP 222 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccCCC-CcccccCCH
Confidence 2345688899999999988899999999999999999999999976433 233333333322221 222335689
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
++.++|.+||+.+|++||++..+.++|.+.+.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 99999999999999999988877787777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=292.30 Aligned_cols=266 Identities=21% Similarity=0.244 Sum_probs=196.5
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
-+.+.+.++ +|++.++||+|+||.||+|.+..++..||||....... ...+..|++++..+.|++.+ .+..++.
T Consensus 4 ~~~~~~~~~-~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~ 81 (310)
T cd07865 4 EFPFCDEVS-KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVV-NLIEICR 81 (310)
T ss_pred cCcccchhh-heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCcc-ceEEEEe
Confidence 345556664 69999999999999999999999999999997654322 22456799999999775544 4444443
Q ss_pred eC--------ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 82 EG--------DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 82 ~~--------~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
.. ...+++||+++++|.+++......+++..+..++.|++.||+|||++|++|+||||+|||+ +.++.+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~ 158 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGIL 158 (310)
T ss_pred cccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcE
Confidence 32 3459999999999999888655579999999999999999999999999999999999999 478899
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 232 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~ 232 (468)
+|+|||++..+....... ........++..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.........
T Consensus 159 kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~ 235 (310)
T cd07865 159 KLADFGLARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235 (310)
T ss_pred EECcCCCcccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999998654322111 01123446788999999987654 78899999999999999999999986543222222
Q ss_pred HHHHhhcc----------------cCCCH-------HHh-hccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 233 YDKISEKK----------------VSTPI-------EVL-CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 233 ~~~i~~~~----------------~~~~~-------~~l-~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+..+.... ...+. ..+ .......+.++|..||..||++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 22211100 00000 000 0112467789999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=287.28 Aligned_cols=236 Identities=18% Similarity=0.256 Sum_probs=184.4
Q ss_pred ceEeeeCCeEEEEEEEcCCC----------cEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 21 RKIGSGSFGELYLGVNVQTG----------EEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~----------~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+.||+|+||.||+|.+..++ ..|++|....... ...+..|+.++..+.| ++|..+.+++.. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH-KHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCC-cchhheeeEEec-CCcEEE
Confidence 47999999999999987766 4588886544433 4567788888888876 566666665555 667899
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC-------eEEEEeCCcc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-------QVYIIDYGLA 161 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~-------~vkL~DFGla 161 (468)
||++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ ..+ .++|+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~---~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA---RYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEe---cCccccCCceeEEeCCCCcc
Confidence 9998 7899999886555799999999999999999999999999999999999995 333 7999999998
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC--CCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhh
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV--EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...........+.
T Consensus 156 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 156 ITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred ccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 75432 1234567789999999877 78999999999999999999 688887764322222221
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
.....+.+. ...+.++|.+||..+|++||++.+|++.|
T Consensus 221 ~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 DQHRLPMPD-----CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred cCCCCCCCC-----chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 111111111 37899999999999999999999988766
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=290.68 Aligned_cols=249 Identities=19% Similarity=0.318 Sum_probs=190.7
Q ss_pred ceEeeeCCeEEEEEEEcCCC------cEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 21 RKIGSGSFGELYLGVNVQTG------EEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~------~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+.||+|+||.||+|.+.... ..||||...... ....+..|+.++..+.| ++|..+.+++...+..+++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH-PNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCC-CCeeeEeeeecCCCCeEEEEe
Confidence 46899999999999876443 689999754332 23467889999888876 566667777777788899999
Q ss_pred cc-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC--CCCeEEEEeCCccc
Q 012192 92 LL-GPSLEDLFNYC------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDYGLAK 162 (468)
Q Consensus 92 l~-ggsL~~ll~~~------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~--~~~~vkL~DFGla~ 162 (468)
++ +++|.+++... ...+++..++.++.|++.||+|||+++++|+||||+|||+...+ ....++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 87 78999988642 23478899999999999999999999999999999999995211 12379999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
....... +.......++..|+|||++.+..++.++|||||||++|+|++ |..||...... +....+....
T Consensus 160 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~~~- 230 (269)
T cd05044 160 DIYKSDY-----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVTAGG- 230 (269)
T ss_pred ccccccc-----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHHhcCC-
Confidence 6543211 111223456788999999999999999999999999999998 99999764432 2222222211
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
... ....+|+.+.++|.+||..+|++||++.+|.+.|+
T Consensus 231 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RLQ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ccC---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111 12345899999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=292.45 Aligned_cols=239 Identities=16% Similarity=0.229 Sum_probs=182.1
Q ss_pred eEeeeCCeEEEEEEEcCC------------------------CcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCce
Q 012192 22 KIGSGSFGELYLGVNVQT------------------------GEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPH 75 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~~~~------------------------~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~ 75 (468)
+||+|+||.||+|....+ ...||||+...... ...+..|+.++..+.| ++|+.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h-~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH-IHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC-CCeee
Confidence 699999999999975321 24588887543221 2345667777766665 77888
Q ss_pred eeEeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc----CCC
Q 012192 76 LKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG----RKA 150 (468)
Q Consensus 76 l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~----~~~ 150 (468)
+++++......++||||+ +++|..++......+++..++.++.|++.||+|||+++|+||||||+|||+... ...
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 888888888999999999 788988887666789999999999999999999999999999999999999521 112
Q ss_pred CeEEEEeCCcccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHH-cCCCCCCCCCccc
Q 012192 151 NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGT 228 (468)
Q Consensus 151 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~ell-tG~~Pf~~~~~~~ 228 (468)
..++|+|||++..... .....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.+.....
T Consensus 161 ~~~kl~d~g~~~~~~~-----------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 161 PFIKLSDPGVSFTALS-----------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ceeeecCCcccccccc-----------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3589999998764321 122357788999998876 56899999999999999985 6999998654332
Q ss_pred HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 229 KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 229 ~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
... ........+ ...++++.++|.+||+.+|++||++.+|++.|
T Consensus 230 ~~~----~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KER----FYEKKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH----HHHhccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 222 112222222 12357899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=283.58 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=204.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.+|++.+.||.|+||.||+|.+..++..|+||+...... ...+..|+..+..+. |+++..+..++......+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEEE
Confidence 468999999999999999999998999999998665533 456888999988888 4677778888888899999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 98 5999999985 3679999999999999999999999 999999999999999 5789999999999876543221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.........+....+..... ....
T Consensus 156 -------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 224 (264)
T cd06623 156 -------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSLP 224 (264)
T ss_pred -------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----CCCC
Confidence 11245688999999999998899999999999999999999999987643233344433332221 1222
Q ss_pred cc-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 250 KS-YPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 250 ~~-~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.. ++..+.++|..||..+|++||++.+|++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 33 6899999999999999999999987655
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=293.28 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=200.6
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
+..+...|...+.||+|+||.||+|.+..++..||||....... ...+..|++++..+.| ++++.+..++...+
T Consensus 20 ~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 98 (317)
T cd06635 20 KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH-PNSIEYKGCYLREH 98 (317)
T ss_pred CCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCC
Confidence 34455668999999999999999999988999999998653322 2357778999888875 56777777778888
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 85 YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 85 ~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
..+++|||+.++|.+++......+++..+..++.|++.||.|||+++|+||||+|+||++ +.++.++|+|||++...
T Consensus 99 ~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 99 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIA 175 (317)
T ss_pred eEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCcccc
Confidence 999999999999999887667779999999999999999999999999999999999999 57889999999998653
Q ss_pred ccccCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
.. .....|+..|+|||++. +..++.++|||||||++|+|++|..||..... ...+..+.....
T Consensus 176 ~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~ 241 (317)
T cd06635 176 SP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNES 241 (317)
T ss_pred CC-----------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhccC
Confidence 32 22456888999999984 34688999999999999999999999976432 222222322222
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRL 280 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~ 280 (468)
... ....+++.+.++|.+||+.+|.+||++.+|.+.
T Consensus 242 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 242 PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 111 123457899999999999999999999977653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=288.59 Aligned_cols=253 Identities=19% Similarity=0.213 Sum_probs=196.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.|++++.||.|+||.||+|.+..++..||||....... ...+..|++++..+.| +++..+..++...+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCC-CCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999988999999997654322 2357889999999976 567777777778889999999
Q ss_pred ccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++.++|.+++... ...+++..+..++.|++.||+|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc-
Confidence 9988999888753 3568999999999999999999999999999999999999 5788999999999875432111
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc----------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK---------- 239 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 239 (468)
......++..|+|||++.+.. ++.++||||||+++|+|++|..||.+.........+......
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 122335688999999987654 688999999999999999999999764332111111100000
Q ss_pred -----------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 -----------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 -----------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
............+++++.++|.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0001111223456788999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=295.77 Aligned_cols=256 Identities=18% Similarity=0.233 Sum_probs=195.8
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCC--CcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEe----Cce
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQT--GEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVE----GDY 85 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~--~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----~~~ 85 (468)
+|++.+.||+|+||.||+|.+..+ +..||||.+.... ....+..|+.++..+.+|++|+.+..+... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 8899999754322 134567899999999877788887765432 245
Q ss_pred eEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 86 NIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
.++++++++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.+.
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecc
Confidence 789999999999998874 5679999999999999999999999999999999999999 578899999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH----------
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD---------- 234 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~---------- 234 (468)
..... .........||..|+|||++.+ ..++.++|||||||++|+|++|..||.+...........
T Consensus 157 ~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 32211 0111234578999999998876 458999999999999999999999997643211111110
Q ss_pred --HHh-----------hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 235 --KIS-----------EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 235 --~i~-----------~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+. ......+.......++.++.+++.+||+.+|++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000 00011122233345678999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=283.96 Aligned_cols=245 Identities=26% Similarity=0.374 Sum_probs=198.0
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-------CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-------KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
+|+..+.||+|+||.||+|.+..++..|+||...... ....+..|+.++..+.| +++..+.+++......++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCC-CCchheeeeEecCCeEEE
Confidence 5888899999999999999998899999999865433 22457889999888865 677777778788888999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
++|++ +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 80 FLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceecccc
Confidence 99998 7799999875 4468999999999999999999999999999999999999 47889999999998765432
Q ss_pred cCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
. ......|+..|++||.+.... ++.++|+||||+++|+|++|..||..... ......+..... .+
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~---~~ 221 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRSKE---LP 221 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHHhccc---CC
Confidence 1 123456889999999998776 89999999999999999999999976542 222222222111 11
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....+++++.++|.+||+.+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 223456899999999999999999999997653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=286.72 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=211.9
Q ss_pred ceEEE-ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC--chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 16 KFKLG-RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH--PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 16 ~y~i~-~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
-|++. +.||+|+|+.|--+....++.++|||++.+...+ ....+|++++..+++|++|..+..|+++++..|||||-
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 34443 5689999999999999999999999987666544 46899999999999999999999999999999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ ||.|...+.. ...|++.++..++.+|+.||.|||.+||.||||||+|||....+.-.-|||+||.|...+.....-.
T Consensus 158 m~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 158 MRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred ccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9 8888888874 6689999999999999999999999999999999999999765555668999999976433211111
Q ss_pred cccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc------------cHHHHHH
Q 012192 172 HIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------------TKKQKYD 234 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~-----~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~------------~~~~~~~ 234 (468)
...--...+.+|+..|||||+..- ..|+.++|+||||||||.|+.|++||.|.-.. -....+.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 111112345689999999998752 24899999999999999999999999875432 1345677
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
.|.+.++.+|... ...++.+..++|..++..++.+|.++.++
T Consensus 317 sIQEGkYeFPdkd-WahIS~eakdlisnLlvrda~~rlsa~~v 358 (463)
T KOG0607|consen 317 SIQEGKYEFPDKD-WAHISSEAKDLISNLLVRDAKQRLSAAQV 358 (463)
T ss_pred HHhccCCcCChhh-hHHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence 7888888887553 45778999999999999999999887744
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=288.38 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=191.1
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-------CchhHHHHHHHHHHhCCCCCceeeEeeEe--Cce
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-------HPQLHYESKLYMLLQGGTGIPHLKWFGVE--GDY 85 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~ 85 (468)
..|++.+.||+|+||.||+|.+..++..||+|....... ...+..|+.++..+.| ++|..+..+... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH-ERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCC-CCeeeEEEEEEcCCCCE
Confidence 368999999999999999999999999999997543321 1346778999999976 555555555443 467
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.+++++++ +++|.+++.. ...+++..++.++.|++.||+|||+.+|+|+||||+||++ +.++.++|+|||++...
T Consensus 81 ~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcccc
Confidence 78899988 7799999875 4568999999999999999999999999999999999999 57889999999998765
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..||..... .+.+..+.....
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~~~~~~~~--- 226 (266)
T cd06651 157 QTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPT--- 226 (266)
T ss_pred ccccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHHHHhcCCC---
Confidence 3211100 111234688999999999998899999999999999999999999986532 222222221111
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+.+...+++.+.+++ .||..+|++||++.+|+
T Consensus 227 ~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 227 NPQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 1122234578888998 68889999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=295.97 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=196.6
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEee-EeCceeE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFG-VEGDYNI 87 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~-~~~~~~~ 87 (468)
+.++|++.+.||.|+||.||+|.+..++..||||..... .....+..|++++..+.|++ ++.+..++ ......+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHEN-IISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCC-eeeEeeeEecCCCcEE
Confidence 678999999999999999999999999999999975432 12346778999999998755 44555544 4466788
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 88 lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+++++++++|.+++. ...+++..+..++.|++.||.|||+++|+||||+|.|||+ +..+.++|+|||++.....
T Consensus 87 lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 87 FVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP- 160 (328)
T ss_pred EEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCC-
Confidence 999999999998887 4568889999999999999999999999999999999999 5788999999999875322
Q ss_pred cCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH----------
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI---------- 236 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i---------- 236 (468)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+..+
T Consensus 161 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 161 ---------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ---------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 1123467889999999876 56899999999999999999999999764431111111000
Q ss_pred -------------hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 237 -------------SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 237 -------------~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.......+....+..+++++.++|.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0111122334455667899999999999999999999986533
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=286.97 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=198.5
Q ss_pred ceEEEceEeeeCCeEEEEEEEcC-CCcEEEEEEeeccCC------------CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQ-TGEEIAVKLELVKTK------------HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~-~~~~vAIK~~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
.|++.+.||+|+||.||+|.+.. .+..+|||....... ...+..|+.++.....|+++..+..++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999877 678999997543211 12355677777665567788888888888
Q ss_pred CceeEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEe
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
.+..+++|||+ +++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||+|+|||+ +.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 89999999998 7799988753 34568999999999999999999996 789999999999999 4788999999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
||++....... ......|+..|++||++.+..++.++||||||+++|+|++|..||...... .....+.
T Consensus 158 fg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~ 226 (269)
T cd08528 158 FGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKIV 226 (269)
T ss_pred ccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHHHh
Confidence 99997644321 123457889999999999888999999999999999999999999754322 2222233
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
..... +.. ...+++++.++|.+||+.||++||++.++...+.
T Consensus 227 ~~~~~-~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYE-PLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCC-cCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 32222 111 1245899999999999999999999999988775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=282.96 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=192.0
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-------CchhHHHHHHHHHHhCCCCCceeeEeeEe--Cce
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-------HPQLHYESKLYMLLQGGTGIPHLKWFGVE--GDY 85 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~ 85 (468)
.+|++.+.||+|+||.||+|.+..++..||||....... ...+..|+.++..+.| ++|+.+.+++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH-ERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCC-CCeeeEEeEeccCCCce
Confidence 579999999999999999999999999999997543221 1246778999888866 555566665544 356
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.+++||++ +++|.+++.. ...+++..++.++.|++.||+|||+++++|+||||+|||+ +.++.++|+|||++...
T Consensus 81 ~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCcccccc
Confidence 77899998 7899999875 3568999999999999999999999999999999999999 47889999999998764
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
..... .........|+..|+|||++.+..++.++|||||||++|+|++|..||...... ..+..+......
T Consensus 157 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~-- 227 (265)
T cd06652 157 QTICL----SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTN-- 227 (265)
T ss_pred ccccc----cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHHHHhcCCCC--
Confidence 32111 001123456889999999999888999999999999999999999999864322 222222221111
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+.....++..+.++|..||. +|++||++++|++
T Consensus 228 -~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 -PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11223446789999999994 9999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=284.19 Aligned_cols=246 Identities=21% Similarity=0.244 Sum_probs=200.4
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|++.++||+|+||.||++.+..++..||||...... ....+..|+.+++.+.| +++..+..++...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH-PNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCC-CCeeeeEeeecCCCeEEEEEe
Confidence 5999999999999999999999899999999765332 23467889999988876 567777777788889999999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++... ...+++..++.++.|++.||.|||+++++|+||+|+|||+ +.++.++|+|||++..+.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchh
Confidence 98 78999988753 3468899999999999999999999999999999999999 4678899999999976543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||.... ....+..+...... + ..
T Consensus 157 -------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~~~~~~~-~---~~ 222 (256)
T cd08218 157 -------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN---MKNLVLKIIRGSYP-P---VS 222 (256)
T ss_pred -------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC---HHHHHHHHhcCCCC-C---Cc
Confidence 1123468889999999999889999999999999999999999997532 23333333333221 1 22
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..++.++.++|.+||+.+|++||++.+|++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 456899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=286.51 Aligned_cols=253 Identities=25% Similarity=0.284 Sum_probs=193.2
Q ss_pred eEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----chhHHHHHHHHHH--hCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----PQLHYESKLYMLL--QGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----~~~~~E~~~l~~l--~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
.||+|+||.||+|.+..+++.||||........ ..+..|..++..+ .+++++..+.+++...+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999889999999976543211 1233444444433 35678888888888888999999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
|++|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+|||+ +.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~----- 151 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK----- 151 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-----
Confidence 8899988874 5579999999999999999999999999999999999999 478899999999987543211
Q ss_pred cccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccC
Q 012192 174 PYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
.....|+..|+|||++.+. .++.++|||||||++|+|++|..||.+............+..... .+...+
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 222 (278)
T cd05606 152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-----ELPDSF 222 (278)
T ss_pred ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC-----CCCCcC
Confidence 1245789999999999854 689999999999999999999999987533222222111111111 122345
Q ss_pred cHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 253 PSEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+.++.+++.+||..+|.+|| ++.++.+ +++...++|....
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~----------~~~~~~~~~~~~~ 267 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE----------HPFFRSLDWQMVF 267 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh----------CccccCCCchHhh
Confidence 89999999999999999999 7776542 4555556676654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=283.77 Aligned_cols=268 Identities=19% Similarity=0.321 Sum_probs=212.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++.+++..||+|+-|.||+++...+|..+|||.+...... ..+...+.++......+.|+..++|+......++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3456778899999999999999999999999987665443 3456667777677778999999999999988999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++..-++.++....+++++..+-.+...++.||.||-++ +|||||+||.|||+ |+.+++||||||.+-.+.+...
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc-
Confidence 999889999998888999999999999999999999865 89999999999999 7999999999999977665433
Q ss_pred ccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~---~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
...-.|.+.|||||.+.-. .|+.++||||||++|+||.||..||.+.+.. -+.+.++..... |.-.
T Consensus 248 -------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln~eP--P~L~ 316 (391)
T KOG0983|consen 248 -------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLNEEP--PLLP 316 (391)
T ss_pred -------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHhcCC--CCCC
Confidence 3345788999999998743 4899999999999999999999999985432 233333443221 2111
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc-CCCCCccccccc
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE-GFQFDYVFDWTV 300 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~-~~~~~~~~dw~~ 300 (468)
-..++++.|.+|+..||..|+.+||.|.+ +|++.|... ..-..++.+|=.
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~---Ll~h~Fi~~ye~a~~dVa~WF~ 367 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNK---LLEHPFIKRYETAEVDVASWFK 367 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcchHH---HhcCcceeecchhhccHHHHHH
Confidence 12347999999999999999999999994 555555432 111234455543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=296.58 Aligned_cols=247 Identities=19% Similarity=0.291 Sum_probs=194.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
+.|.....||+|+||.||++.+..++..||||...... ....+..|+.++..+.| +++..+..++..++..+++||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH-ENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCC-CcHHHHHHheecCCeEEEEEeC
Confidence 45666788999999999999998899999999764332 23457788888888865 5666666666778899999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +++|.+++. ...+++..+..++.||+.||+|||+++|+||||||+||++ +.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc--
Confidence 9 778988876 3468999999999999999999999999999999999999 4778999999999875432111
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
......|+..|+|||++.+..++.++||||||+++|||++|..||.+.... ..+..+.. ..... ......
T Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~-~~~~~-~~~~~~ 243 (292)
T cd06658 174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRIRD-NLPPR-VKDSHK 243 (292)
T ss_pred -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh-cCCCc-cccccc
Confidence 123456899999999999888999999999999999999999999864332 22222211 11111 111234
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
++..+.++|..||..+|.+||++.+|++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 5789999999999999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=285.53 Aligned_cols=241 Identities=20% Similarity=0.253 Sum_probs=190.5
Q ss_pred CceEEEceE--eeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKI--GSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~L--G~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
++|++.+.+ |+|+||.||++....++..+|+|........ ..|......+.+|++++.+..++...+..++|||+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 567777777 9999999999999999999999986543211 12344444455678888888888888899999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC-eEEEEeCCcccccccccCc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~-~vkL~DFGla~~~~~~~~~ 170 (468)
+ +++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++. .++ .++|+|||++......
T Consensus 91 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 91 IKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCC---
Confidence 8 88999999853 4899999999999999999999999999999999999994 455 8999999998754321
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhhcccCCCHHHhh
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~ 249 (468)
....++..|+|||++.+..++.++||||||+++|+|++|..||........ ...+....... ....
T Consensus 164 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~ 230 (267)
T PHA03390 164 --------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK-----LPFI 230 (267)
T ss_pred --------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc-----CCcc
Confidence 234688999999999998999999999999999999999999985433221 11121111111 1222
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCC-HHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPD-YSYLK 278 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs-~~~l~ 278 (468)
+.+++.+.++|..||+.+|++||+ +++|+
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 457899999999999999999995 57554
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=293.59 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=197.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+.|++.+.||+|+||.||+|.+..++..||||+...... ...+..|++++..+.| ++|+.+.+++......++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCC-CccHhhhcccccCCceEEEEE
Confidence 457788999999999999999988999999998653322 2357788998888865 677777777778888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++ +++|.+++. ...+++..+..++.|++.||.|||+++++|+||+|+||++. +++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 83 YLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred ccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCcch-
Confidence 99 678988886 45789999999999999999999999999999999999994 678999999999876543211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
......|+..|+|||++.+..++.++|||||||++|||++|..||......... ..+.... .+.+..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~----~~~~~~ 223 (277)
T cd06642 157 ------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLIPKNS----PPTLEG 223 (277)
T ss_pred ------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhhhcCC----CCCCCc
Confidence 112346888999999999989999999999999999999999999765432211 1111111 112234
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.++.++.++|..||+.+|++||++.+|++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 56889999999999999999999998765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=282.94 Aligned_cols=247 Identities=22% Similarity=0.252 Sum_probs=207.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC------C----chhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK------H----PQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~------~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
..|.-.+.||.|..+.|-++.++.++.++|+|++..... . +.-..|+.+++++.+||+|..+.++.+...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 467778899999999999999999999999998543211 1 234678999999999999999999999999
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
+.++|++++ .|.|.|++.. .-.++++....|++|+..|++|||.++||||||||+|||+ +++.+++|+|||++..
T Consensus 97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceeec
Confidence 999999999 8899999985 4479999999999999999999999999999999999999 7899999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCC------CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGV------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~------~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
+.... ....++||++|+|||.+.-. .|+..+|+|++||++|-++.|..||..-+ ....+..|.
T Consensus 173 l~~Ge--------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlMLR~Im 241 (411)
T KOG0599|consen 173 LEPGE--------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLMLRMIM 241 (411)
T ss_pred cCCch--------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHHHHHH
Confidence 65422 24578999999999988632 48999999999999999999999997532 223344466
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
+.++....++ ..+++.+..+||.+||+.||.+|.+..+.
T Consensus 242 eGkyqF~spe-Wadis~~~KdLIsrlLqVdp~~Ritake~ 280 (411)
T KOG0599|consen 242 EGKYQFRSPE-WADISATVKDLISRLLQVDPTKRITAKEA 280 (411)
T ss_pred hcccccCCcc-hhhccccHHHHHHHHHeeCchhcccHHHH
Confidence 6666554332 35678899999999999999999999854
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=297.21 Aligned_cols=256 Identities=20% Similarity=0.227 Sum_probs=193.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeE----------
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGV---------- 81 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~---------- 81 (468)
+++|++.+.||.|+||.||+|.+..++..||||.+..... ...+..|++++..+.|++ +..+..+..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~-i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN-IVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCc-chhhHhhhccccccccccc
Confidence 5899999999999999999999999999999998655432 345778999999997754 444443222
Q ss_pred ----eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEe
Q 012192 82 ----EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 82 ----~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
+....+++||++.++|.+++. ...+++..+..++.||+.||+|||+.||+||||||+|||+. ..+..++|+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence 124578999999999988886 35799999999999999999999999999999999999995 3456789999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 236 (468)
||++.......... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.............
T Consensus 159 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 159 FGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred cccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99987643211111 01123457889999998765 45889999999999999999999999765432211111000
Q ss_pred ----------------------hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 237 ----------------------SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 237 ----------------------~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.......+...+...++.++.++|..||+.+|++||++.+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 001111222333456788999999999999999999998664
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=291.15 Aligned_cols=260 Identities=21% Similarity=0.262 Sum_probs=199.1
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeC--
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEG-- 83 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~-- 83 (468)
+++..++|++.++||+|+||.||+|.+..+++.||||+...... ...+..|++++..+.|+ ++..+..++.+.
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~-~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR-NIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCC-CeeeeeheecCcch
Confidence 34566899999999999999999999998999999998654322 23466789999888764 555555554433
Q ss_pred --------ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEE
Q 012192 84 --------DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYI 155 (468)
Q Consensus 84 --------~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL 155 (468)
...++++|++.++|.+++......+++..+..++.|++.||.|||+.||+|+||||+||++ ++.+.+||
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl 157 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKL 157 (302)
T ss_pred hhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEe
Confidence 3789999999889988887555579999999999999999999999999999999999999 57889999
Q ss_pred EeCCcccccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 012192 156 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 234 (468)
+|||++..+..... .+ .....++..|+|||++.+. .++.++|||||||++|+|++|..||...........+.
T Consensus 158 ~dfg~~~~~~~~~~---~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 158 ADFGLARLYNSEES---RP---YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred CcccccccccCCcc---cc---cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999986543221 11 1233567889999988754 47899999999999999999999998644322222222
Q ss_pred HHhhcccC----------------------CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 235 KISEKKVS----------------------TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 235 ~i~~~~~~----------------------~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
........ ......+..+|.++.+++..||+.+|.+||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22111100 0011223457899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=284.15 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=191.4
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
+.....||+|+||.||+|.+..++..||+|...... ....+..|+.++..++| ++|..+.+++..++..++++|++
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH-RNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCC-CCeeeeeeeeccCCEEEEEEecCC
Confidence 334458999999999999998899999999755443 23467889999888876 56667777778888899999988
Q ss_pred CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 94 GPSLEDLFNYCNRKF--SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 94 ggsL~~ll~~~~~~l--s~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+++|.+++......+ ++..+..++.|++.||+|||++||+||||||.||++. ...+.++|+|||++........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~-- 164 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP-- 164 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC--
Confidence 789999987544455 8888999999999999999999999999999999994 2367899999999875432111
Q ss_pred cccccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~--~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......|+..|+|||++.+.. ++.++||||||+++|+|++|..||....... ............ +.+.
T Consensus 165 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~---~~~~ 234 (268)
T cd06624 165 -----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMFKIH---PEIP 234 (268)
T ss_pred -----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhhhccC---CCCC
Confidence 122346889999999987654 7899999999999999999999997643211 111111111111 1122
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..+++++.+++.+||+.+|++||++.+|+.
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 446889999999999999999999997654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=286.88 Aligned_cols=244 Identities=20% Similarity=0.322 Sum_probs=197.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
-|++.++||.|+||.||+|.+..++..||||+..... ....+..|+.++..+.| +++..+.+++..++..++|||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCEeEEEEEEEeCCeEEEEEEe
Confidence 4788999999999999999988899999999754332 22457788888888876 5677777778888999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +++|.+++. ...+++..+..++.|++.+|.|||++|++|+||+|.||++ +.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 84 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh--
Confidence 9 678988886 4578999999999999999999999999999999999999 4778899999999876543111
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... .....+.... .+.+...
T Consensus 157 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~----~~~~~~~ 224 (277)
T cd06641 157 -----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLFLIPKNN----PPTLEGN 224 (277)
T ss_pred -----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHHHHhcCC----CCCCCcc
Confidence 122356888999999999888999999999999999999999999764332 2222222211 1223345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
++.++.++|..||+.+|++||++.++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 6899999999999999999999998766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=283.39 Aligned_cols=246 Identities=23% Similarity=0.262 Sum_probs=196.0
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeE--eCceeEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGV--EGDYNIMV 89 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~--~~~~~~lv 89 (468)
+|++.+.||.|+||.||+|.+..++..||+|....... ...+..|++++..+.|++ +..+..+.. .+...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN-IVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCc-cceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999998654322 235677889988888754 554444332 45567899
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 90 IDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMH-----SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLH-----s~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
||++ +++|.+++... ...+++..++.++.||+.||.||| +.+++|+||+|+||++ +..+.++|+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEecccc
Confidence 9998 78999998754 467999999999999999999999 8999999999999999 4789999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
+........ ......++..|+|||++.+..++.++|+||||+++|+|++|..||..... ......+....
T Consensus 157 ~~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~ 226 (265)
T cd08217 157 AKILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIKEGK 226 (265)
T ss_pred cccccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHhcCC
Confidence 986543221 12244689999999999998899999999999999999999999986542 22222222222
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
. ..+...++.++.+++.+||+.+|++||++.+|++
T Consensus 227 ~----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 F----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred C----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1 1233456899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=286.43 Aligned_cols=252 Identities=19% Similarity=0.237 Sum_probs=193.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe--CceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE--GDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~~~lv 89 (468)
++|+..++||.|+||.||+|.+..+++.||+|....... ...+..|++++..+.| ++|..+..++.. ....+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS-PYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEccCCCeEEEE
Confidence 479999999999999999999988999999998654322 3467889999988875 556666554433 3467899
Q ss_pred Eecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 90 IDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 90 ~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
||++ +++|.+++.. ....+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccc
Confidence 9998 7899888653 24568999999999999999999999999999999999999 477889999999987543
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc--ccHHHHHHHHhhcccCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYDKISEKKVST 243 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~ 243 (468)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....+....+.......
T Consensus 157 ~~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd06621 157 NSL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227 (287)
T ss_pred ccc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh
Confidence 211 1234678899999999998999999999999999999999999986532 12222222222211110
Q ss_pred CHH--HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 244 PIE--VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 244 ~~~--~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
... .....+++++.++|.+||..+|.+||++.+|.+
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 001235688999999999999999999986544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.82 Aligned_cols=255 Identities=18% Similarity=0.207 Sum_probs=195.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeC-----
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEG----- 83 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~----- 83 (468)
+..+|.+.+.||.|+||.||+|.+..++..||||..... .....+..|+.++..+.| +++..+.+++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDH-ENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCC-CCccchHHheeccccccc
Confidence 467899999999999999999999999999999975432 123356779999888876 5555555444322
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 84 DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 84 ~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
...++++++++++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+|||+ +.++.++|+|||++..
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCccccc
Confidence 35799999999999998874 5679999999999999999999999999999999999999 4778999999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh-----
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS----- 237 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~----- 237 (468)
...... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+....
T Consensus 158 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 158 TSEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred cCCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 543211 1234567889999999875 458999999999999999999999997643211111111000
Q ss_pred ------------------hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 238 ------------------EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 238 ------------------~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
......+.......+++++.++|.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 000111122233567899999999999999999999886544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.83 Aligned_cols=242 Identities=24% Similarity=0.304 Sum_probs=197.8
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.|++.+.||.|+||.||+|.+..++..||+|+..... ....+..|++++..+.| +++..+..++......++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH-PFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCC-CChHHHHHhhcCCCeEEEEE
Confidence 4899999999999999999998899999999865432 23467888999888866 56777777777888899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
+++ +++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||++ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCc-
Confidence 998 88999998853 579999999999999999999999999999999999999 578899999999987654321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||.........+........ .....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~ 222 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA-----DVLYP 222 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc-----cccCc
Confidence 123456888999999999888999999999999999999999999876543222222222211 12222
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYS 275 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~ 275 (468)
..+|..+.++|.+||+.+|++||++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCcc
Confidence 45689999999999999999999984
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=286.54 Aligned_cols=252 Identities=19% Similarity=0.227 Sum_probs=195.5
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
|++.++||.|++|.||+|.+..+|..||||+...... ...+..|++++..+.| ++++.+..++.++...+++|++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH-PNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCC-CCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999988999999998654322 2357789999888876 5666677777788999999999
Q ss_pred cCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 LGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
++++|.+++.... ..+++..++.++.|++.||+|||+++++|+||+|+||++. .++.++|+|||++.......
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPV--- 153 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCc---
Confidence 9999999887533 3689999999999999999999999999999999999994 68899999999987543211
Q ss_pred cccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH--------------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI-------------- 236 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i-------------- 236 (468)
.......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+.+.
T Consensus 154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 154 ----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred ----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 111233568899999988764 4789999999999999999999999764332111111000
Q ss_pred -------hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 237 -------SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 237 -------~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...............++.++.++|.+||+.+|++||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000011222234567789999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=284.93 Aligned_cols=248 Identities=19% Similarity=0.261 Sum_probs=184.0
Q ss_pred ceEeeeCCeEEEEEEEcCC--CcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 21 RKIGSGSFGELYLGVNVQT--GEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~--~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
++||+|+||.||+|..... ...+++|...... ....+..|+.++..+.| ++++.+.+++......+++|||+ +
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH-PNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCC-cchhheEEEecCCCccEEEEecCCC
Confidence 3699999999999975432 3456677544332 23467788888887765 66666666777788899999999 6
Q ss_pred CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 95 PSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 95 gsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
++|.+++... ...+.+..+..++.||+.||+|||+++++||||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh--
Confidence 8999998753 2346677888999999999999999999999999999999 5788999999999754221100
Q ss_pred cccccCCCCccccccccccccccC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHH-hhcccC
Q 012192 172 HIPYRENKNLTGTARYASVNTHLG-------VEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKI-SEKKVS 242 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~-------~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i-~~~~~~ 242 (468)
........++..|+|||++.. ..++.++|||||||++|||++ |..||...... ..+..+ ......
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~~ 228 (268)
T cd05086 155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHVIKDQQVK 228 (268)
T ss_pred ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhhcccc
Confidence 011234578899999999753 246789999999999999996 67788764432 222222 222222
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L 281 (468)
.+.+.+...+++.+.+++..|| .+|++||++.+|.+.|
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 3334444557899999999999 6899999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=288.08 Aligned_cols=265 Identities=20% Similarity=0.294 Sum_probs=206.6
Q ss_pred ceEEEceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccC------CCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 16 KFKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKT------KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
+|++.+.||+|+||.||++.+. .++..||||+..... ....+..|++++..+.+|++++.+...+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999854 367889999865321 2235678999999998888998888888888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++|||++ +++|.+++.. ...+++..+..++.|++.+|.|||+.+++|+||+|.||++ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 9999998 6799888874 4578999999999999999999999999999999999999 467889999999987644
Q ss_pred cccCcccccccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH-HHHhhcccC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-DKISEKKVS 242 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~ 242 (468)
.... .......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...........+ ..+.....
T Consensus 157 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 229 (288)
T cd05583 157 AEEE------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP- 229 (288)
T ss_pred cccc------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC-
Confidence 3211 1122456889999999987765 788999999999999999999999643222211222 12222211
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+ ....++.++.++|.+||+.+|++||++.++.++|++. +....+|..+.
T Consensus 230 -~---~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~-------~~~~~~~~~~~ 278 (288)
T cd05583 230 -P---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP-------FFQGIDWDDLA 278 (288)
T ss_pred -C---CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc-------ccccCCHHHHh
Confidence 1 1234588999999999999999999998888877664 44556776543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.82 Aligned_cols=268 Identities=17% Similarity=0.238 Sum_probs=211.0
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
..+.++-.....+.++||+|-||+|.+|.- ..+..||||.+.... ....|..|+++|.+|+| |+|+.+.+.+..+
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkh-PNIveLvGVC~~D 607 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKH-PNIVELLGVCVQD 607 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCC-CCeeEEEeeeecC
Confidence 345566667888999999999999999984 446899999865432 23579999999999965 6778888888899
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~-ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
+.++|++||+ +|+|.+++.....+ +.-+....|+.||+.||+||.+.+||||||.++|||+ +.++++||+|||++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgms 684 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMS 684 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccc
Confidence 9999999998 89999999875433 3556678899999999999999999999999999999 58999999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHH--cCCCCCCCCCcccHHHHHHHHhhc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL--RGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ell--tG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
+.+-.... |+.....+-+++|||+|.++.+.++.++|+|+||+++||++ +...||..+.+....+........
T Consensus 685 R~lysg~y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~ 759 (807)
T KOG1094|consen 685 RNLYSGDY-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRD 759 (807)
T ss_pred cccccCCc-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCC
Confidence 85432221 34445567789999999999999999999999999999866 489999876553222222111111
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
.-..-......-+|.++.++|..||..+-++||++++|...|++.
T Consensus 760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111111112234599999999999999999999999999888764
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.09 Aligned_cols=247 Identities=18% Similarity=0.299 Sum_probs=196.7
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
..|....+||+|+||.||+|.+..++..||||+..... ....+..|+.++..+.| +++..+..++..++..++++|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-QNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCC-CchhhhhhheeeCCeEEEEEec
Confidence 44566778999999999999998899999999865432 23457788888888865 6677777777788889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +++|.+++. ...+++..+..++.|++.||+|||+.|++||||||.|||+ +.++.++|+|||++..+.....
T Consensus 100 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 100 LQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc--
Confidence 8 778988776 3568999999999999999999999999999999999999 5788999999999875433211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
......|+..|+|||++.+..++.++|||||||++|||++|..||..... ...+..+..... +.......
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~--~~~~~~~~ 242 (297)
T cd06659 173 -----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPP--PKLKNAHK 242 (297)
T ss_pred -----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCC--CCccccCC
Confidence 12345789999999999988999999999999999999999999976432 222222222111 11122345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
++.++.++|..||+.+|++||++.+|++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 6889999999999999999999987655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=279.56 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=198.7
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|.+.+.||+|+||.||+|.+..++..||||....... ...+..|+.++..+.| ++|..+..+....+..++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-PNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCC-CChhheeeeEecCCEEEEEEe
Confidence 68999999999999999999988999999998665433 3467889999888876 567777777778888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++ +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ ..+.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCCCCCc
Confidence 98 7899999885 45689999999999999999999999999999999999994 6889999999998876543221
Q ss_pred ccccccCCCCccccccccccccccCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~---~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
... ......++..|++||++.+.. ++.++||||||+++|++++|..||..... .......+.. ......+
T Consensus 156 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~-~~~~~~~- 228 (264)
T cd06626 156 MGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGA-GHKPPIP- 228 (264)
T ss_pred ccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhc-CCCCCCC-
Confidence 100 012356889999999998776 88999999999999999999999976532 1122222222 1111111
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....++..+.++|..||+.+|++||++.+|..
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11234889999999999999999999997643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=277.66 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=200.5
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
+|++.+.||+|+||.||+|.+..++..|++|+..... ....+..|++++..+. ++++..+..++......+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEEecC
Confidence 5889999999999999999998889999999865554 4457888999988888 467777777778888899999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 94 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 94 -ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
+++|.+++......+++..+..++.|++.+|.|||++|++|+||+|+||++ ++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc---
Confidence 599999988655689999999999999999999999999999999999999 4688999999999876543211
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccC
Q 012192 173 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
.....++..|++||.+.+..++.++||||||+++|+|++|..||...... .....+..... +.......+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~~~~~~~~ 223 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIATNGP--PGLRNPEKW 223 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHhcCC--CCcCccccc
Confidence 23457889999999999888999999999999999999999999865322 22211221111 111111224
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 253 PSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+.++.++|..||+.+|++||++.+|.+
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 789999999999999999999987654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=298.22 Aligned_cols=274 Identities=22% Similarity=0.239 Sum_probs=218.8
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+..+-.+.|..-+.||.|+||+||-+....||+-+|+|.+..+ ....-...|..++.++..+ .|+.+...+...
T Consensus 179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~-FiVslaYAfeTk 257 (591)
T KOG0986|consen 179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSP-FIVSLAYAFETK 257 (591)
T ss_pred hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccC-cEEEEeeeecCC
Confidence 3455668899999999999999999999999999999964332 2333467788888888764 777777777888
Q ss_pred ceeEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
+-.++|+.+| ||+|.-.|-.. +..|++..++.++.+|+.||++||..+||.|||||+|||+ |+.++|+|+|+|||
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLA 334 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLA 334 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceE
Confidence 8999999999 88887666543 3579999999999999999999999999999999999999 79999999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
..+..... ....+||.+|||||++.+..|+...|+|||||+||||+.|.-||...+.....+.+++ ..
T Consensus 335 vei~~g~~--------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr----r~ 402 (591)
T KOG0986|consen 335 VEIPEGKP--------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR----RT 402 (591)
T ss_pred EecCCCCc--------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH----HH
Confidence 98776443 2345899999999999999999999999999999999999999987554333333322 22
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
....+.+..+++++..+|....|+.||.+|.....- ..-....++++..++|..+..
T Consensus 403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~-----ga~evk~HpfFk~lnw~rlea 459 (591)
T KOG0986|consen 403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGE-----GAQEVKEHPFFKDLNWRRLEA 459 (591)
T ss_pred hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCc-----CcchhhhCcccccCCHhHHhc
Confidence 233345557789999999999999999999765411 111223467777788887643
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=281.93 Aligned_cols=247 Identities=22% Similarity=0.283 Sum_probs=197.5
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|.+.+.||.|+||.||+|.+..++..||+|..... .....+..|+.++..+.| +++..+.+++......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH-PNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCC-CChhhhhheeccCCeEEEEEe
Confidence 589999999999999999999999999999986543 233467789999888876 566666677778888999999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++... ...+++..+..++.|++.||.|||+.+++|+||||+||+++ ++...++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence 98 88999988753 33589999999999999999999999999999999999995 2335679999999876543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... .+.+..+...... ...
T Consensus 158 -------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 223 (257)
T cd08225 158 -------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---HQLVLKICQGYFA----PIS 223 (257)
T ss_pred -------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhcccCC----CCC
Confidence 11234688999999999888899999999999999999999999975432 2223222222211 122
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..++.++.++|.+||..+|++||++.+|.+
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 456889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=286.11 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=199.4
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
|++.+.||+|++|.||+|.+..+++.++||....... ...+..|++++..+.| +++..+..+...+...++++|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH-PNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcC-CCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999988999999997554332 2457788999888874 6777777777788899999999
Q ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 93 LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 93 ~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
+.++|.+++......+++..+..++.|++.||.|||+.+|+|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~---- 152 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPV---- 152 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCc----
Confidence 9999999988766789999999999999999999999999999999999999 477899999999987654422
Q ss_pred ccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh-------------
Q 012192 173 IPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE------------- 238 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~------------- 238 (468)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+....+..........
T Consensus 153 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 ---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 112234678899999999877 689999999999999999999999976443221111111000
Q ss_pred ---------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 239 ---------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 239 ---------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.........+...++.++.++|..||+.+|.+||++.+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00111122233456889999999999999999999997754
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=289.72 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=199.8
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
+.++.. .++|++.+.||+|+||.||+|.+..++..||||...... ....+..|+.++..+.| +++..+..++...+
T Consensus 12 ~~~~~~-~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~ 89 (293)
T cd06647 12 VSVGDP-KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH-PNIVNYLDSYLVGD 89 (293)
T ss_pred eeccCc-hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCC-CCeeehhheeeeCC
Confidence 334444 379999999999999999999988889999999864332 23457778888888875 67777877778888
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++|+|++ +++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ 164 (293)
T ss_pred cEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceec
Confidence 899999998 8899998873 468899999999999999999999999999999999999 4678999999999876
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
...... ......|++.|++||++.+..++.++|+||||+++|++++|..||...... ..+..+.... .
T Consensus 165 ~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~---~~~~~~~~~~--~ 232 (293)
T cd06647 165 ITPEQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNG--T 232 (293)
T ss_pred cccccc-------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---hheeehhcCC--C
Confidence 543221 123456889999999999888999999999999999999999999764321 1111111111 1
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+.......++..+.++|..||..+|++||++.+|+
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11111234578899999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=281.75 Aligned_cols=234 Identities=21% Similarity=0.272 Sum_probs=188.4
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCC
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPS 96 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggs 96 (468)
||.|+||.||+|.+..++..||||+..... ....+..|++++..+.| ++|..+..++.++...++++|++ +++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNH-PFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCC-CCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999998889999999865432 22457889999888865 66777777778888899999997 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccccc
Q 012192 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176 (468)
Q Consensus 97 L~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 176 (468)
|.+++.. ...+++..+..++.|++.||+|||+++++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~-------- 147 (262)
T cd05572 80 LWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQ-------- 147 (262)
T ss_pred HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCccc--------
Confidence 9999875 4568999999999999999999999999999999999999 478899999999997654321
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHH
Q 012192 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEF 256 (468)
Q Consensus 177 ~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~ 256 (468)
......++..|++||++.+..++.++|+||||+++|+|++|..||..... .....+..+.........+ ...++++
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~ 223 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKLEFP---NYIDKAA 223 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCCCCC---cccCHHH
Confidence 12234688899999999888899999999999999999999999987542 1223333333211111211 2237899
Q ss_pred HHHHHHHhcCCCCCCCC
Q 012192 257 VSYFHYCRSLRFEDKPD 273 (468)
Q Consensus 257 ~~li~~cl~~~p~~RPs 273 (468)
.++|..||+.+|++||+
T Consensus 224 ~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 224 KDLIKQLLRRNPEERLG 240 (262)
T ss_pred HHHHHHHccCChhhCcC
Confidence 99999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=284.30 Aligned_cols=252 Identities=17% Similarity=0.300 Sum_probs=191.4
Q ss_pred eEEEceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCc-----
Q 012192 17 FKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD----- 84 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~----- 84 (468)
|++.+.||+|+||.||+|.+. .++..||||+...... ..++..|++++..+.| +++..+.+++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH-PNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 3578999998654432 2357789999888876 56666666554321
Q ss_pred -eeEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEe
Q 012192 85 -YNIMVIDLL-GPSLEDLFNYC-----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 85 -~~~lv~el~-ggsL~~ll~~~-----~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
..+++++++ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.++|+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECc
Confidence 235677776 78998876422 1247889999999999999999999999999999999999 4788999999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHH
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i 236 (468)
||+++....... +.......++..|++||.+.+..++.++||||||+++|+|++ |..||.+.... ..+..+
T Consensus 157 fg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL 228 (273)
T ss_pred ccccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH
Confidence 999886532111 111223455678999999998889999999999999999999 89999765432 222222
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
..... .. ....++..+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 229 ~~~~~-~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGNR-LK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCc-CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22211 11 1134578999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=289.00 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=197.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
+.+.|...++||+|+||.||+|.+..++..|+||....... ...+..|+.++..+.| ++++.+..++.+.+..+
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH-PNTIEYKGCYLKEHTAW 97 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEE
Confidence 34557888899999999999999988999999998654322 1356788999888875 66777777888889999
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 88 lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
++||++.++|.+++......+++..+..++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC-
Confidence 999999999999988666789999999999999999999999999999999999999 4778999999999854221
Q ss_pred cCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||....... ....+......
T Consensus 174 ----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~~~~~-- 238 (313)
T cd06633 174 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNDSP-- 238 (313)
T ss_pred ----------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCC--
Confidence 23457889999999985 3558889999999999999999999998754322 22222221111
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
......++..+.+++.+||+.+|++||++.++..
T Consensus 239 -~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 239 -TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122346788999999999999999999986653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=285.28 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=202.0
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|.+.+.||+|+||.||+|.+..++..||||+.... .....+..|.+++..+..+++|..+..++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999999889999999986542 22345778889988888578888888888888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|+++ +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccccccCCcc
Confidence 9999 9999999985 45799999999999999999999999999999999999994 77899999999987654322
Q ss_pred Ccccc-------------cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 169 THKHI-------------PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 169 ~~~~~-------------~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
..... .........++..|+|||++.+..++.++|+||||+++|++++|..||..... .+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHH
Confidence 11100 01223445688999999999988899999999999999999999999986432 233333
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDY 274 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~ 274 (468)
+.......+ ..+++.+.++|..||+.+|++||++
T Consensus 234 ~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 234 ILKLEYSFP-----PNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHhcCCCCC-----CccCHHHHHHHHHHhcCCHhhCCCc
Confidence 333322222 3458999999999999999999999
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=304.51 Aligned_cols=275 Identities=20% Similarity=0.271 Sum_probs=221.8
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
-.+++++..||-|+||.|-++.......-+|+|++.+. .+.+.+..|..+|+.+. .+.|+.++-.+.+..+.||
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhh
Confidence 35677888999999999999887555555788864432 23446788999998887 5788888888889999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+||.| ||.|+.++.. .+.|+..++..++.++++|++|||++|||+|||||+|+|+ +..+-+||.|||+|+.+...
T Consensus 498 LmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 498 LMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccC
Confidence 99987 9999999985 6789999999999999999999999999999999999999 68999999999999987753
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. ...+++||+.|.|||++++...+..+|.||||+++|||++|.+||.+.++. ..|..|....-.. .
T Consensus 574 ~--------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm---ktYn~ILkGid~i---~ 639 (732)
T KOG0614|consen 574 R--------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM---KTYNLILKGIDKI---E 639 (732)
T ss_pred C--------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHhhhhhh---h
Confidence 2 356899999999999999999999999999999999999999999986554 4444443322111 2
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCCccCCCCC
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGSSSKG 312 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~~ 312 (468)
+.+.++....++|..+...+|.+|..+. ...+-....+.|+..|||+.+....+.++...
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~-----~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~ 699 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQ-----KGGINDIKKHRWFEGFDWEGLRSRTLPPPIIP 699 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccc-----cCChHHHHhhhhhhcCChhhhhhccCCCCccc
Confidence 2356688999999999999999997643 12222234577899999999887666554443
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=283.26 Aligned_cols=266 Identities=18% Similarity=0.282 Sum_probs=202.0
Q ss_pred ceEEEceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccC------CCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 16 KFKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKT------KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
.|++.+.||.|+||.||+|.+. .+|..||+|+..... ....+..|++++..+.+|++|+.++.++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999874 478999999865321 2245677999999998889999998888888889
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++++|++ +++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+|||+ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 9999999 7899998875 4578999999999999999999999999999999999999 478899999999987654
Q ss_pred cccCcccccccCCCCccccccccccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGV--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
.... .......|+..|+|||++.+. .++.++||||||+++|+|++|..||...........+........ .
T Consensus 157 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 229 (290)
T cd05613 157 EDEV------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-P 229 (290)
T ss_pred cccc------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-C
Confidence 3211 112245688999999998764 467899999999999999999999974322222222211111111 1
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCccccccccc
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+ ....+++.+.+++.+||+.+|++||+.. .+.+++ .+++...+.|+...
T Consensus 230 ~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~-------~~~~~~~~~~~~~~ 280 (290)
T cd05613 230 P---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK-------KHPFFQKINWDDLA 280 (290)
T ss_pred C---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH-------cCcccccCCHHHHh
Confidence 1 1234688999999999999999998321 111222 24455566777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=283.77 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=194.8
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeC--ceeEEEE
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEG--DYNIMVI 90 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~~lv~ 90 (468)
|++.++||+|+||.||+|.+..++..||||...... ....+..|++++..+.| +++..+..+.... ...++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccC-CCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999998899999999876543 22357789999998886 5555566555555 7899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
+++.++|.+++......+++..++.++.|++.||+|||+.|++|+||+|.|||+ ++++.++|+|||++........
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCc-
Confidence 999989999987555679999999999999999999999999999999999999 4788999999999986654321
Q ss_pred ccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc---------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--------- 240 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 240 (468)
.......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.......
T Consensus 156 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 156 -----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred -----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 011234567889999988754 57899999999999999999999998654322111111110000
Q ss_pred ---------c----CCCHHHhhcc-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 ---------V----STPIEVLCKS-YPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 ---------~----~~~~~~l~~~-~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
. .......... +++++.+++..||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0000111222 3889999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=291.83 Aligned_cols=251 Identities=19% Similarity=0.260 Sum_probs=190.9
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEe-----
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVE----- 82 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----- 82 (468)
.+.++|.+.+.||+|+||.||+|.+..++..||||....... ...+..|+.++..+.|++ |..+..+...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~-iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN-VIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCc-ccceeeeeeeccccc
Confidence 356899999999999999999999988999999998654321 235677999999888755 4444444332
Q ss_pred -CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 -GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 -~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
....++++++++++|.+++. ...+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEeccccc
Confidence 23468899999999999887 3469999999999999999999999999999999999999 47889999999998
Q ss_pred cccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh---
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS--- 237 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~--- 237 (468)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 168 ~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 168 RHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred ccccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 75432 1234567889999999877 468899999999999999999999997643321111110000
Q ss_pred --------------------hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 238 --------------------EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 238 --------------------~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...............++++.++|..|++.+|++||++.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 00000111112234578899999999999999999988543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=292.78 Aligned_cols=255 Identities=19% Similarity=0.231 Sum_probs=198.0
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCc-----ee
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD-----YN 86 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-----~~ 86 (468)
+|++.+.||.|+||.||+|.+..++..||||...... ....+..|+.++..+.| ++|..+.+++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH-ENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCC-cchhhhhhhhcccCcccccce
Confidence 6899999999999999999998889999999765432 34568889999998875 56666665555443 67
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 87 IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 87 ~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+++|++++++|.+++.. ...+++..+..++.||+.||+|||++||+|+||||.|||+ +.++.++|+|||++.....
T Consensus 80 ~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecc
Confidence 99999999899988874 4489999999999999999999999999999999999999 4679999999999987654
Q ss_pred ccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc------
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK------ 239 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~------ 239 (468)
.... ........++..|+|||++.+. .++.++|+||||+++|+|++|..||.+.........+......
T Consensus 156 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 156 DEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 3210 0112345678899999999988 7899999999999999999999999875432221111111000
Q ss_pred -----------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 -----------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 -----------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+.......++.++.++|..||+.+|++||++.+|..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0001111223456889999999999999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=283.95 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=195.9
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
|++.+.||+|+||+||+|....+++.|+||....... ......|+..+..+.+|+++..+..++..++..+++||++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999988899999997544322 1234568888888885678888887778889999999999
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 94 GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 94 ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
+++|.+++.... ..+++..+..++.|++.+|.|||+++++|+||+|+||++ +..+.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC---
Confidence 999999887543 478999999999999999999999999999999999999 4789999999999876543211
Q ss_pred ccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc------------
Q 012192 173 IPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK------------ 239 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~------------ 239 (468)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||..............+...
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 -----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 123567889999998864 45789999999999999999999999765432222111111000
Q ss_pred ----------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 ----------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 ----------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.............+..+.++|..||+.+|++||++.+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0001111222334688999999999999999999987653
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=291.08 Aligned_cols=265 Identities=18% Similarity=0.258 Sum_probs=199.2
Q ss_pred CCceecCceEE-EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----------------chhHHHHHHHHHHhCCC
Q 012192 9 MDHVIGGKFKL-GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----------------PQLHYESKLYMLLQGGT 71 (468)
Q Consensus 9 ~~~ii~~~y~i-~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----------------~~~~~E~~~l~~l~~~~ 71 (468)
|..-+.++|.. .+.||.|+||+||+|.+..+++.||||+....... ..+..|++++..+.| +
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ 80 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH-E 80 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC-c
Confidence 44556788875 57799999999999999889999999975433221 146789999998876 5
Q ss_pred CCceeeEeeEeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC
Q 012192 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151 (468)
Q Consensus 72 ~i~~l~~~~~~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~ 151 (468)
+++.+..++..+++.+++||++.++|.+++.. ...+++..+..++.|++.||+|||++|++|+||+|+||++ +..+
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~ 156 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG 156 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence 66667777788889999999999999999874 5579999999999999999999999999999999999999 4778
Q ss_pred eEEEEeCCcccccccccCccc-------ccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCC
Q 012192 152 QVYIIDYGLAKKYRDLQTHKH-------IPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQG 223 (468)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~-------~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~ 223 (468)
.++|+|||++..+........ ..........++..|+|||++.+.. ++.++|||||||++|+|++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999976542110000 0000112335688899999998754 68999999999999999999999987
Q ss_pred CCcccHHHHHHHHhhcc--------------------cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 224 LKAGTKKQKYDKISEKK--------------------VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 224 ~~~~~~~~~~~~i~~~~--------------------~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.........+....... ...........++.++.++|..||+.+|++||++++++
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 54322221111111000 00011122345678899999999999999999988654
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=283.22 Aligned_cols=257 Identities=21% Similarity=0.241 Sum_probs=196.2
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCC
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPS 96 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggs 96 (468)
||+|+||+||+|.+..+++.||||+..... ....+..|++++..+. |+++..+...+...+..+++|||+ +++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 689999999999998899999999865422 1234567899998887 567777777777778889999998 689
Q ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccc
Q 012192 97 LEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175 (468)
Q Consensus 97 L~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 175 (468)
|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~------- 149 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGK------- 149 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCC-------
Confidence 999887533 369999999999999999999999999999999999999 578899999999987543211
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHH
Q 012192 176 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSE 255 (468)
Q Consensus 176 ~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 255 (468)
......++..|++||++.+..++.++||||||+++|+|++|..||...........+. ......+ ......++++
T Consensus 150 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~ 224 (277)
T cd05577 150 -KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTLEMA-VEYPDKFSPE 224 (277)
T ss_pred -ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hcccccc-ccCCccCCHH
Confidence 1234567889999999998889999999999999999999999997654422222221 1111111 1223456899
Q ss_pred HHHHHHHHhcCCCCCCCCHHH-HHH-HHHHHHHHcCCCCCccccccccc
Q 012192 256 FVSYFHYCRSLRFEDKPDYSY-LKR-LFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 256 ~~~li~~cl~~~p~~RPs~~~-l~~-~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+.++|.+||+.+|++||++.+ ... ++. +++...++|....
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~-------h~~~~~~~~~~~~ 266 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE-------HPLFKDLNWRRLE 266 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh-------ChhhhcCChhhhh
Confidence 999999999999999995544 222 222 4444556776553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=291.31 Aligned_cols=250 Identities=19% Similarity=0.284 Sum_probs=192.2
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeC-----
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEG----- 83 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~----- 83 (468)
+.++|++.+.||+|+||.||+|.+..++..||||....... ...+..|+.++..+.|++.+ .+..++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVI-GLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcc-ceeeeecCCccccc
Confidence 57889999999999999999999999999999998643222 23577899999999775544 454444322
Q ss_pred -ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 -DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 -~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...+++|++++++|.+++. ...+++..+..++.|++.||+|||+.||+||||||.|||++ .++.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~dfg~~~ 166 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 166 (343)
T ss_pred cceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeccccc
Confidence 2458999999999998887 45799999999999999999999999999999999999994 68889999999987
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc--
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-- 239 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 239 (468)
..... .....++..|+|||++.+ ..++.++|+|||||++|++++|..||.+.........+..+...
T Consensus 167 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 167 QTDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred ccccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 54321 123467889999999876 35889999999999999999999999865432111111110000
Q ss_pred ---------------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 ---------------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 ---------------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
........+...++.++.++|..|++.||++||++.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000011122345678899999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=284.61 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=202.6
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
..+.|++.+.||+|+||.||+|.+..++..|++|+...... ...+..|++++..+.| +++..+..++......+++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH-PNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCC-CCeeEEEEEEEECCEEEEEEe
Confidence 44679999999999999999999988899999998655433 4567889999888876 677788888888899999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++ +++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchh-
Confidence 99 589999998644489999999999999999999999999999999999999 4788999999999865443211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
......++..|++||++.+..++.++|+||||+++|+|++|..||...... .....+...... +.. ...
T Consensus 172 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~~~-~~~ 240 (286)
T cd06614 172 ------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLITTKGIP-PLK-NPE 240 (286)
T ss_pred ------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCC-CCc-chh
Confidence 123345788999999999888999999999999999999999999764332 222222222221 111 123
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+|.++.++|.+||+.+|.+||++.+|+.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 36899999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.14 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=193.1
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-------CCchhHHHHHHHHHHhCCCCCceeeEeeEe--Cce
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-------KHPQLHYESKLYMLLQGGTGIPHLKWFGVE--GDY 85 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~ 85 (468)
.+|++.+.||+|+||.||+|.+..++..||||...... ....+..|++++..+.|. ++..+.++... +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~-~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD-RIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCC-CcceEEEEEEcCCCCE
Confidence 57999999999999999999999999999999754321 123567799999999765 55555555543 356
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++++|++ +++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||||+||++ +.++.++|+|||+++..
T Consensus 81 ~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcccccccc
Confidence 77888888 7899999874 3468999999999999999999999999999999999999 47788999999999865
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
...... ........++..|+|||++.+..++.++|+|||||++|+|++|..||.+... ...+.++... ..
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~---~~ 226 (264)
T cd06653 157 QTICMS----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQ---PT 226 (264)
T ss_pred cccccc----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHcC---CC
Confidence 321110 0112345689999999999998899999999999999999999999986432 2222222211 11
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+.++..+++++.++|.+||. ++..||+..++.
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 223445678999999999999 579999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=275.01 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=200.9
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeC--ceeEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEG--DYNIMV 89 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~~~~lv 89 (468)
+|.+.+.||+|+||.||+|.+..++..|+||+...... ...+..|++++..+.| +++..+..+.... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-PNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCC-CCEeeEEEEEecCCCCeEEEE
Confidence 58899999999999999999988999999998655442 4567889999999885 5666666666666 788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+|++ +++|.+++... ..+++..+..++.|++.+|+|||+.+++|+||+|+||++. .++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence 9999 89999998854 3899999999999999999999999999999999999994 67899999999988765432
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.. .......++..|++||.+.+..++.++||||||+++|+|++|..||.... ........+...... ..+
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~---~~~ 225 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEP---PEI 225 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCC---cCC
Confidence 11 01234568899999999998889999999999999999999999998754 222222222221111 122
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...++.++.++|.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 2345899999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=277.51 Aligned_cols=246 Identities=24% Similarity=0.294 Sum_probs=200.2
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|.+.+.||.|+||.||++.+..++..||||...... ....+..|++++..+.| +++..+..........+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-PNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCC-CChhheEEEEecCCEEEEEEE
Confidence 5899999999999999999998899999999866543 23457889999888885 566666666677788999999
Q ss_pred cc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 92 LL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 92 l~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
++ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeecccC
Confidence 98 67999998764 3679999999999999999999999999999999999999 46789999999999765442
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
.. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .+....+..... ..
T Consensus 157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~ 222 (258)
T cd08215 157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELALKILKGQY----PP 222 (258)
T ss_pred cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---HHHHHHHhcCCC----CC
Confidence 21 12345788999999999988899999999999999999999999976432 222322222221 12
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+...++.++.+++.+||..+|++||++.+|++
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22356899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.99 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=211.5
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCc----hhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP----QLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
-+...-+-|.+.+.||+|.|++|.+|++..++.+||||++....... .+.+|+++|+.|.| |+|++++.+.....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~H-PnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNH-PNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCC-cceeeeeeeeeecc
Confidence 34445578999999999999999999999999999999876554332 46899999988887 67777888888888
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..|+||||+ +|.+.+++... ..+.+..+..+..|++.+++|||+++|||||||++|+|| +.+.++||+|||++..
T Consensus 129 ~lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTF 204 (596)
T ss_pred eeEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeecccccee
Confidence 999999998 99999999864 456669999999999999999999999999999999999 6788899999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
+.... ...+.+|++.|+|||++.+..| ++.+|+||+|++||-|+.|.+||.+..- +..-.+....++.
T Consensus 205 ~~~~~--------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---k~Lr~rvl~gk~r 273 (596)
T KOG0586|consen 205 FDYGL--------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---KELRPRVLRGKYR 273 (596)
T ss_pred ecccc--------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---ccccchheeeeec
Confidence 76422 3567899999999999999886 7899999999999999999999987433 3333445667777
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+|... ..+..++|.+.+-++|..|++.++|.+
T Consensus 274 Ip~~m-----s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 274 IPFYM-----SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cccee-----echhHHHHHHhhccCccccCCHHHhhh
Confidence 76544 678999999999999999999987643
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=284.37 Aligned_cols=247 Identities=20% Similarity=0.287 Sum_probs=195.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
..|...++||+|+||.||+|.+..++..|+||...... ....+..|+.++..+.| +++..+..++...+..++++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h-~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH-PNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCC-CChheEEEEEEcCCeEEEEEec
Confidence 35666789999999999999998899999999764332 23356788888888765 6777777777788889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|.||++ +.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc--
Confidence 8 8899999885 578999999999999999999999999999999999999 5788999999998865432111
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.+... ...+..+..... +.......
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~--~~~~~~~~ 240 (285)
T cd06648 171 -----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDNLP--PKLKNLHK 240 (285)
T ss_pred -----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhcCC--CCCccccc
Confidence 12345688999999999988899999999999999999999999976432 222222222211 11111223
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
++.++.++|.+||+.+|++||++.+|++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 6889999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=290.43 Aligned_cols=250 Identities=19% Similarity=0.270 Sum_probs=189.6
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeC-----
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEG----- 83 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~----- 83 (468)
+.++|.+.+.||+|+||.||+|.+..+++.||||...... ....+..|+.++..+.|+ +|..+..++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE-NVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCC-CccchhheecccccCCC
Confidence 3579999999999999999999998899999999865432 123577899999988765 455555444322
Q ss_pred -ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 -DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 -~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...+++++++..+|..++ +..+++..+..++.|++.||+|||+.+++||||||.|||+ +.++.++|+|||+++
T Consensus 92 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCc
Confidence 345899999988877665 3468999999999999999999999999999999999999 478899999999987
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh---
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE--- 238 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~--- 238 (468)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..+..
T Consensus 166 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 166 HADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred CCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 54321 124567889999999876 4589999999999999999999999986432211111100000
Q ss_pred -----------------cc---cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 239 -----------------KK---VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 239 -----------------~~---~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.. ...........++.++.++|..||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 001111222356788999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.59 Aligned_cols=247 Identities=19% Similarity=0.280 Sum_probs=196.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
.....|...+.||+|+||.||+|.+..++..||||....... ...+..|++++..+.| +++..+..++......
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 90 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTA 90 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCcccEEEEEEcCCee
Confidence 345668889999999999999999988999999997643211 2346778999888876 5566666777778889
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 87 IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 87 ~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
++|||++.++|.+++......+++..+..++.|++.||.|||+.+++||||+|.|||+ +.++.++|+|||++.....
T Consensus 91 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence 9999999999998887666679999999999999999999999999999999999999 4678999999999875432
Q ss_pred ccCcccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.......
T Consensus 168 -----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~ 233 (308)
T cd06634 168 -----------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPA 233 (308)
T ss_pred -----------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHHhhcCCCC
Confidence 224568889999999853 457889999999999999999999997654322 222222222111
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
. ....++.++.++|.+||..+|++||++.+|.+
T Consensus 234 ~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 234 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 1 12346889999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.04 Aligned_cols=247 Identities=19% Similarity=0.285 Sum_probs=192.7
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCc----
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD---- 84 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~---- 84 (468)
+.++|++.+.||+|+||.||+|.+..++..||||+..... ....+..|+.++..+.|++ +..+..+....+
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN-VIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCC-HHHHHHHhhccccccc
Confidence 5789999999999999999999999999999999865321 2245667999998887654 444443333333
Q ss_pred --eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 85 --YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 85 --~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
..++|+++++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~ 166 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLAR 166 (343)
T ss_pred cccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEccccccc
Confidence 3899999999999999873 579999999999999999999999999999999999999 468899999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
..... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.... ..+..+.....
T Consensus 167 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~ 233 (343)
T cd07851 167 HTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVG 233 (343)
T ss_pred ccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcC
Confidence 65321 2344678899999998763 5789999999999999999999999864432 22222211110
Q ss_pred C--------------------------CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 242 S--------------------------TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 242 ~--------------------------~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
. .........+++++.++|..||+.+|++||++.+|.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 0 011122234688999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.63 Aligned_cols=269 Identities=20% Similarity=0.284 Sum_probs=203.3
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeec---cCCCchhHHHHHHHHHHhCCCCCceeeEeeEeC----
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV---KTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEG---- 83 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~---- 83 (468)
.-..+-|...+.||+|+||.||+|+++.+|+.||||.... ....+.+..|++++++|. |+||+.+.+...+.
T Consensus 9 ~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 9 SGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGL 87 (732)
T ss_pred cCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCc
Confidence 3344778899999999999999999999999999997554 344567899999999999 56666665554433
Q ss_pred --ceeEEEEecc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCC-CeEEEEe
Q 012192 84 --DYNIMVIDLL-GPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKA-NQVYIID 157 (468)
Q Consensus 84 --~~~~lv~el~-ggsL~~ll~~~--~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~-~~vkL~D 157 (468)
...+++|||| +|+|..++... ...|++..++.++.++..||.|||++|||||||||.||++-.+.+. -.-||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 3458899998 99999999843 3469999999999999999999999999999999999998543322 3458999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-cHHHHHHH
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYDK 235 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~-~~~~~~~~ 235 (468)
||.|+...+.. ....++||..|++||+... +.|+.-+|+|||||++|+.+||.+||-..... ...+....
T Consensus 168 fG~Arel~d~s--------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 168 FGAARELDDNS--------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred ccccccCCCCC--------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 99999877643 2467899999999999995 78999999999999999999999999643322 11222222
Q ss_pred Hhhccc-------------------CCC-HHHhhccCcHHHHHHHHHHhcCCCCCCC--CHHHHHHHHHHHHHHc
Q 012192 236 ISEKKV-------------------STP-IEVLCKSYPSEFVSYFHYCRSLRFEDKP--DYSYLKRLFRDLFIRE 288 (468)
Q Consensus 236 i~~~~~-------------------~~~-~~~l~~~~p~~~~~li~~cl~~~p~~RP--s~~~l~~~L~~~~~~~ 288 (468)
+..++. ..| ...++..+-..+..++..++..+|++|- .+.+....+.+++...
T Consensus 240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 222210 011 1123333334555677777778888887 7777777778777653
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=281.28 Aligned_cols=252 Identities=20% Similarity=0.219 Sum_probs=197.8
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
|++.++||+|+||.||+|.+..+++.||||+..... ....+..|+.++..+.| +++..+..++...+..++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCC-CCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999899999999866532 23456788999888874 6677777777778899999999
Q ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 93 LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 93 ~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
++++|.+++......+++..+..++.|++.||+|||+.||+|+||+|+||++ ++++.++|+|||++........
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~--- 153 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLR--- 153 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCcc---
Confidence 9999999998655679999999999999999999999999999999999999 4689999999999876543211
Q ss_pred ccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh-------------
Q 012192 173 IPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE------------- 238 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~------------- 238 (468)
......++..|+|||.+.+. .++.++|||||||++|||++|..||.+.........+.....
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 ----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred ----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 11234567789999999877 789999999999999999999999976443221111111100
Q ss_pred --------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 239 --------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 239 --------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.............++..+.++|..||..+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00001111223445789999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.65 Aligned_cols=261 Identities=20% Similarity=0.314 Sum_probs=210.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcC-------CCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQ-------TGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~-------~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
+-.+...+.+.||+|.||.|++|.... ....||||...... +...+..|+++|..+.+|++|..+.+++.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 334555677899999999999997432 14689999855443 34678999999999999999999888888
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeec
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG 145 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~ 145 (468)
.....++++||+ .|+|.+++..+. ..++....+.++.|||.|++||+++++|||||.++|||++
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 888888888888 899999998765 3489999999999999999999999999999999999995
Q ss_pred ccCCCCeEEEEeCCcccccccccCcccccccCCCCcc--ccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCC
Q 012192 146 LGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQ 222 (468)
Q Consensus 146 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~--Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~ 222 (468)
.+..+||+|||+|+....... |. .+... -.+.|||||.+....|+.++|||||||+|||+++ |..||.
T Consensus 453 ---~~~~~kIaDFGlar~~~~~~~-----y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 453 ---KNKVIKIADFGLARDHYNKDY-----YR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred ---CCCEEEEccccceeccCCCCc-----eE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 778999999999986443221 22 12222 3566999999999999999999999999999999 999999
Q ss_pred CCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 223 GLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 223 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+..... ..+. ..........+..| ++++.++|..||+.+|++||++.++.+.|...+..
T Consensus 524 ~~~~~~--~l~~-~l~~G~r~~~P~~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 524 GIPPTE--ELLE-FLKEGNRMEQPEHC---SDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred CCCcHH--HHHH-HHhcCCCCCCCCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 854221 2232 34444455555545 99999999999999999999999999999996553
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=271.93 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=199.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|++.+.||+|+||.||+|.+..++..|+||...... ....+..|++++..+.| +++..+..+.......+++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-PNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCC-CCccEEEEEEEeCCEEEEEEe
Confidence 5899999999999999999998899999999865443 23467889999888876 566677777777888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++ +++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||++. .++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCcc-
Confidence 98 67999998853 6799999999999999999999999999999999999994 678999999999986543221
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
......++..|+|||.+.+..++.++|||+||+++|+|++|..||...... .....+...... .+..
T Consensus 155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~----~~~~ 221 (254)
T cd06627 155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AALFRIVQDDHP----PLPE 221 (254)
T ss_pred ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHhccCCC----CCCC
Confidence 123456889999999998888899999999999999999999999865421 222222222211 1224
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+++++.++|..||..+|++||++.+++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 56899999999999999999999987653
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=275.98 Aligned_cols=244 Identities=20% Similarity=0.271 Sum_probs=198.2
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+|++.++||.|+||.||++.+..+++.+|||...... ....+..|++++..+.| ++|+.+..++.+....+++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC-CCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999865432 23356778888888885 677777777777889999999
Q ss_pred cc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 92 LL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 92 l~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
++ +++|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|.||+++ ..+.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC
Confidence 88 88999988642 35689999999999999999999999999999999999995 6788999999999765432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
......++..|++||.+.+..++.++|+||||+++|+|++|..||...... .....+..... .+
T Consensus 157 ---------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~~--- 220 (256)
T cd08530 157 ---------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKVQRGKY-PP--- 220 (256)
T ss_pred ---------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCC-CC---
Confidence 122346788999999999988999999999999999999999999865432 22222222222 11
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+...++.++.+++.+||+.+|++||++.+|.+
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 22356899999999999999999999997754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=278.03 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=196.7
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCC
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPS 96 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggs 96 (468)
||.|+||.||+|.+..+++.|+||+..... ....+..|++++..+.| +++..+..+...+...+++++++ +++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCC-cchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999998889999999865432 23457778888888875 66666777777888899999999 779
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc-ccccc
Q 012192 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH-KHIPY 175 (468)
Q Consensus 97 L~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~-~~~~~ 175 (468)
|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||++ +.++.++|+|||++......... .....
T Consensus 80 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCccccccccc
Confidence 99999864 479999999999999999999999999999999999999 57889999999998754322110 00001
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHH
Q 012192 176 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSE 255 (468)
Q Consensus 176 ~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 255 (468)
.......++..|++||++.+..++.++||||||+++|++++|..||..... ...+..+.......+.. ..++..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~---~~~~~~ 229 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEIFQNILNGKIEWPED---VEVSDE 229 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCcCCCcc---ccCCHH
Confidence 122345678899999999988899999999999999999999999976442 23333333323222211 124899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 256 FVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 256 ~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+.+++..||+.+|++||++..+.++|++.
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 99999999999999999998777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=287.91 Aligned_cols=252 Identities=17% Similarity=0.207 Sum_probs=184.9
Q ss_pred EceEeee--CCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 20 GRKIGSG--SFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 20 ~~~LG~G--~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
...||.| +||+||+|.+..+++.||||+....... ..+..|+.++..+.| ++|..++.++..++..+++|+++
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRH-PNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcceEeeeEecCCceEEEEecc
Confidence 3466666 9999999999999999999986543322 346667777666665 67888888888888999999998
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 94 -GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 94 -ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccc
Confidence 67999988753 3458999999999999999999999999999999999999 467899999998764332211111
Q ss_pred cccccCCCCccccccccccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC-----
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGV--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP----- 244 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~--~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~----- 244 (468)
...+.......++..|+|||++.+. .++.++|||||||++|+|++|..||.+..... .+..........+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---MLLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH---HHHHHhcCCCCCCccccc
Confidence 1111112223456789999999874 47899999999999999999999998653221 1111110000000
Q ss_pred -------------------------------------HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 245 -------------------------------------IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 245 -------------------------------------~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.......+++++.+||..||+.||++||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0001123567899999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=277.70 Aligned_cols=254 Identities=18% Similarity=0.211 Sum_probs=208.4
Q ss_pred eecCceEEEc-eEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeE----eCcee
Q 012192 12 VIGGKFKLGR-KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGV----EGDYN 86 (468)
Q Consensus 12 ii~~~y~i~~-~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~~~ 86 (468)
-|.++|.+-. +||-|-.|.|-.+.++.|++.+|+|++.. .+...+|+++..+..+|++|+.+..+.. ....+
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 3567787764 57999999999999999999999997543 4567889999999999999988776543 34567
Q ss_pred EEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
++|||++ ||.|.+.+... ...|++.++..|+.||..|+.|||+.+|.||||||+|+|+.....+..+||+|||+|+.-
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 8999999 88999888754 346999999999999999999999999999999999999987777888999999999864
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhhcccCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISEKKVST 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~ 243 (468)
.... ...+.+-|+.|.|||++-...|+..+|+||+||++|.|++|..||........ ...-.+|....+.+
T Consensus 215 ~~~~--------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 215 QEPG--------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred CCCc--------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 3211 13456789999999999988899999999999999999999999986544221 22234466666666
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
|.++ ...+++...++|..+|..+|.+|.+..++
T Consensus 287 P~pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 287 PEPE-WSCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred CChh-HhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 6543 34568899999999999999999998753
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=283.47 Aligned_cols=244 Identities=18% Similarity=0.268 Sum_probs=192.7
Q ss_pred EEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-C
Q 012192 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-G 94 (468)
Q Consensus 18 ~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-g 94 (468)
....+||+|+||.||+|.+..++..||||...... ....+..|+.++..+.| ++++.+..++...+..+++||++ +
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCC-cchhheeeEEEeCCEEEEEEecCCC
Confidence 33468999999999999998999999999754332 23457788888888876 67777777778889999999998 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++|.+++. ...+++..+..++.|++.||+|||+.|++|+||+|.||++ +.++.++|+|||++........
T Consensus 102 ~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~----- 171 (292)
T cd06657 102 GALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP----- 171 (292)
T ss_pred CcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc-----
Confidence 78888775 4568999999999999999999999999999999999999 4778899999999875433111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
......|+..|++||++.+..++.++|+||||+++|+|++|..||.+.... ..+..+. ........ ....++.
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~-~~~~~~~~-~~~~~~~ 244 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIR-DNLPPKLK-NLHKVSP 244 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-hhCCcccC-CcccCCH
Confidence 123456889999999998888999999999999999999999999764332 2221121 11111111 1234688
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+.++|.+||..+|.+||++.+|..
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 9999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=294.96 Aligned_cols=270 Identities=21% Similarity=0.316 Sum_probs=215.3
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccCC
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGP 95 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~gg 95 (468)
.+.||+|.||+||-|.+.++|+.||||++.+. ....++..|+.||..+.| ++|+.+...++..+..|+|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~H-PGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHH-PGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCC-CCeeEEEEeecCCceEEEEehhhcc
Confidence 36899999999999999999999999986543 334678999999988765 8999999999999999999999987
Q ss_pred CHHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 96 SLEDL-FNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 96 sL~~l-l~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
++.+. +....++|++.....++.||+.||.|||.++|+|.||||+|+|+...+.-.++||||||+|+.+.....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence 76665 455567899999999999999999999999999999999999998776778999999999998776432
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
....+||+.|+|||++.++.|++.-|+||.||++|--+.|..||....+ .-++|....+..|.. -.+.+.+
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQNAaFMyPp~-PW~eis~ 793 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQNAAFMYPPN-PWSEISP 793 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhccccccCCC-chhhcCH
Confidence 4678999999999999999999999999999999999999999975322 222333333333322 2356688
Q ss_pred HHHHHHHHHhcCCCCCCCCHHH-----------HHHHHHHHHHHcCCC----CCcccccccccCC
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSY-----------LKRLFRDLFIREGFQ----FDYVFDWTVLKYP 304 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~-----------l~~~L~~~~~~~~~~----~~~~~dw~~~~~~ 304 (468)
+..+||..+|+..-.+|-+.+. ++..|+++-.+.+-. ..+...|+...++
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThesDD~~~~~~~~~ 858 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHESDDARWEQLANE 858 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCcchhhhhhhhcCc
Confidence 9999999999999999987762 344455555544421 2334456655433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=284.01 Aligned_cols=272 Identities=23% Similarity=0.297 Sum_probs=209.5
Q ss_pred CCCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHH--HHhCCCCCceeeEeeE
Q 012192 4 DGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYM--LLQGGTGIPHLKWFGV 81 (468)
Q Consensus 4 ~~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~--~l~~~~~i~~l~~~~~ 81 (468)
+.++-+++.|+.+..+++.||+|.||+||+|.+ .|+.||||+... .+...+.+|.+||+ .|+|.|++-.+..--.
T Consensus 200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s-rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS-RDERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred CchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecc-cchhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 456889999999999999999999999999988 788999998544 45677889999987 4566554433322111
Q ss_pred eC---ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCceeecccCC
Q 012192 82 EG---DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR--------GFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 82 ~~---~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~--------giiHrDIKp~NiLl~~~~~ 149 (468)
+. ...+||.+|- .|+|.|++.. ..++.+..+.++..+|.||++||.. .|.|||||..|||+ .+
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kk 351 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KK 351 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---cc
Confidence 11 2357777776 9999999994 6899999999999999999999952 49999999999999 58
Q ss_pred CCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCC------CCCcchHHHHHHHHHHHHcC------
Q 012192 150 ANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE------QSRRDDLESLGYVLMYFLRG------ 217 (468)
Q Consensus 150 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~------~s~ksDvwSlGvvl~elltG------ 217 (468)
++...|+|+|||..+........++ ....+||.+|||||++...- .-..+||||||.|+||++..
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 9999999999998877654433333 45678999999999987542 12468999999999999853
Q ss_pred ----CCCCCCCCcccH-HHHHHH-HhhcccCCCHHHhhccCc--HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 218 ----SLPWQGLKAGTK-KQKYDK-ISEKKVSTPIEVLCKSYP--SEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 218 ----~~Pf~~~~~~~~-~~~~~~-i~~~~~~~~~~~l~~~~p--~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.+||.++.+.+. .+...+ +...++.++++...++.| ..+.++|..||..||.-|.++-.|++.|.++..
T Consensus 429 ~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 679987655421 122212 334445555554444444 578899999999999999999999999988763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.79 Aligned_cols=279 Identities=22% Similarity=0.275 Sum_probs=215.1
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
|+...+-..-|..++.||-|+||+|.++....|...+|+|.+.+. +.......|..||....+ +-|+.+++.+.
T Consensus 621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn-~WVVrLyySFQ 699 (1034)
T KOG0608|consen 621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADN-EWVVRLYYSFQ 699 (1034)
T ss_pred HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCC-cceEEEEEEec
Confidence 555666677899999999999999999998889999999964433 233456678888766554 78888999999
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
+.+.+|+||+|+ ||++..||.. -+-|.++.+.++++++..|++++|..|+|||||||+|||| |.++++||.||||
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGL 775 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccc
Confidence 999999999998 9999999885 4579999999999999999999999999999999999999 7899999999999
Q ss_pred ccccccc--------cCcccc-------------------ccc--------CCCCccccccccccccccCCCCCCcchHH
Q 012192 161 AKKYRDL--------QTHKHI-------------------PYR--------ENKNLTGTARYASVNTHLGVEQSRRDDLE 205 (468)
Q Consensus 161 a~~~~~~--------~~~~~~-------------------~~~--------~~~~~~Gt~~y~APE~~~~~~~s~ksDvw 205 (468)
|.-++.. .+|... ..+ ..-.++||+.|+|||++....|+..+|+|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 9765431 000000 000 02246899999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 206 SLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 206 SlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
|.|||||||+.|+.||..........++..+ +..+.++ .|.+++.+..++|.+++. .+++|..-. -.+
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw-~~~l~~~---~~~~ls~e~~~li~kLc~-sad~RLGkn-----g~d-- 923 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQYKVINW-RNFLHIP---YQGNLSKEALDLIQKLCC-SADSRLGKN-----GAD-- 923 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcceeeeeeh-hhccccc---cccccCHHHHHHHHHHhc-Chhhhhccc-----chh--
Confidence 9999999999999999987766544444221 2223333 345668888888886553 567775322 111
Q ss_pred HHcCCCCCccccccccc
Q 012192 286 IREGFQFDYVFDWTVLK 302 (468)
Q Consensus 286 ~~~~~~~~~~~dw~~~~ 302 (468)
....++|+..+||..+.
T Consensus 924 ~vKaHpfFkgIDfsslR 940 (1034)
T KOG0608|consen 924 QVKAHPFFKGIDFSSLR 940 (1034)
T ss_pred hhhcCccccccchHhhh
Confidence 22458899999998753
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=277.63 Aligned_cols=245 Identities=23% Similarity=0.273 Sum_probs=190.8
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeec-------cCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV-------KTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~-------~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
+|.+.++||+|+||.||++.+..++..+++|+... .....++..|+.++..+.| +++..+..++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH-PAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCC-CcHHHHHHHHhcCCceEE
Confidence 68999999999999999999887777777775332 1122345668888888765 566666666677778899
Q ss_pred EEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 89 VIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 89 v~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
++|++ +++|.+++.. ....+++..++.++.|++.||.|||++|++|+||+|+||++. ++.++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 99988 7899988764 245799999999999999999999999999999999999993 467999999998765
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
..... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+....
T Consensus 156 ~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~---- 221 (260)
T cd08222 156 MGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEGP---- 221 (260)
T ss_pred CCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCC----
Confidence 43221 1234567889999999988889999999999999999999999996532 222222222211
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+.....++.++.++|.+||..+|++||++.+|.+
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11223456899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=298.54 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=202.7
Q ss_pred CCceecCce-EEEceEeeeCCeEEEEEEEcCCCcEEE---EEEeec---cCCCchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 9 MDHVIGGKF-KLGRKIGSGSFGELYLGVNVQTGEEIA---VKLELV---KTKHPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 9 ~~~ii~~~y-~i~~~LG~G~fG~Vy~~~~~~~~~~vA---IK~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
++.--.++| ++..+||+|+|-+||+|.+..+|.+|| ||+... ...-..|..|+.+|+.|+|+ +|..++..+.
T Consensus 33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~-NIirfy~SW~ 111 (632)
T KOG0584|consen 33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHP-NIIRFYDSWV 111 (632)
T ss_pred cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCC-ceeeeeehee
Confidence 333334444 566789999999999999999999998 333222 22235688899999999985 4555555554
Q ss_pred e--CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCceeecccCCCCeEEEE
Q 012192 82 E--GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR--GFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 82 ~--~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~--giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
+ .....++.|++ .|+|..++++ .+.++.+.+..|++||+.||.|||++ .|||||||.+||+|. ...|.|||.
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIG 188 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIG 188 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeec
Confidence 3 34467788888 9999999986 56899999999999999999999987 599999999999996 567999999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 236 (468)
|+|||....... .+.+.|||.|||||+.. ..|+..+||||||++++||+|+..||.... ...+.|.++
T Consensus 189 DLGLAtl~r~s~---------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV 256 (632)
T KOG0584|consen 189 DLGLATLLRKSH---------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKV 256 (632)
T ss_pred chhHHHHhhccc---------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHH
Confidence 999998766432 34589999999999987 679999999999999999999999998754 456777776
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..... +..+.+--.+++++||.+|+.. ..+||++.+ +|.+.|..
T Consensus 257 ~SGiK---P~sl~kV~dPevr~fIekCl~~-~~~R~sa~e---LL~d~Ff~ 300 (632)
T KOG0584|consen 257 TSGIK---PAALSKVKDPEVREFIEKCLAT-KSERLSAKE---LLKDPFFD 300 (632)
T ss_pred HcCCC---HHHhhccCCHHHHHHHHHHhcC-chhccCHHH---HhhChhhc
Confidence 66543 3334344478999999999998 999999885 55565544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=278.17 Aligned_cols=253 Identities=19% Similarity=0.294 Sum_probs=205.3
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
..+.+-+..||.|+||.|++-.++.+|+.+|||.+..... ..++..|.+..++-...++|+.+++..-.+...+|.|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 3455566789999999999999999999999998765544 3568889999999999999999888776777789999
Q ss_pred eccCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 91 DLLGPSLEDLFNYC----NRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 91 el~ggsL~~ll~~~----~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
|+|.-+|+.+.++. ...+++..+-.|+...+.||.||-. .+||||||||.|||+ +..+.|||||||.|-.+.
T Consensus 143 ELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHH
Confidence 99999999887643 5578899999999999999999985 589999999999999 689999999999987654
Q ss_pred cccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
++- +...-.|...|||||.+.. ..|+.++||||||++|||+.||..||.++.. ..+.+..+.....+.
T Consensus 220 ~Si--------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~ 289 (361)
T KOG1006|consen 220 DSI--------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPI 289 (361)
T ss_pred HHH--------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCe
Confidence 421 2334578889999999874 3589999999999999999999999998754 334444444433322
Q ss_pred C-HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 244 P-IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 244 ~-~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
. .+.-|-.+...+..+|..|+..|-.+||.|.+|++
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1 12234557889999999999999999999997654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=304.78 Aligned_cols=143 Identities=26% Similarity=0.462 Sum_probs=124.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|.++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++|+.++.++......+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS-PFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCC-CCcCeEEEEEEECCEEEEE
Confidence 689999999999999999999998999999998654322 2456778888777765 6677777777888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
|||+ +++|.+++.. ...+++..++.|+.||+.||+|||.++||||||||+|||+ +.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9998 8999999875 4568999999999999999999999999999999999999 477899999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=299.38 Aligned_cols=248 Identities=20% Similarity=0.336 Sum_probs=208.5
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeE-----eCceeE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGV-----EGDYNI 87 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~~~~~~ 87 (468)
.+.|+|++.||.|.+|.||+++++.+++.+|||+..... ..+++..|..+++.+.+|+|++.+++++. .++.++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 478999999999999999999999999999999855443 44578889999999999999999998875 466789
Q ss_pred EEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 88 MVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
|||||| +|+.-|+++.. +..+.|+.+..|+..++.||.+||.+.+||||||-.|||++ .++.|||+|||++...+
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeeeeeeeee
Confidence 999999 88999998843 67899999999999999999999999999999999999996 88999999999998765
Q ss_pred cccCcccccccCCCCccccccccccccccCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGV-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
..- ....+++||+.|||||++... .|+.++|+||||++.+||.-|.+|+.++-+.. .+. ..
T Consensus 175 sT~-------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF----~I 240 (953)
T KOG0587|consen 175 STV-------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALF----LI 240 (953)
T ss_pred ccc-------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhc----cC
Confidence 421 234678999999999999754 37789999999999999999999998875432 111 22
Q ss_pred cCCCHHHh--hccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 241 VSTPIEVL--CKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 241 ~~~~~~~l--~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+.|++.+ ...+..+|.+||..||..|.+.||.+.+++
T Consensus 241 pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 241 PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 22333332 356789999999999999999999988653
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.49 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=208.2
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeec----cCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV----KTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
|.-+|.-+.+||.|.||.||-|.+..+|+..|||.+.- ...-+.+..|.+++..+.| ++++.++++.++.+..+|
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnH-pNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNH-PNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccC-ccccccCceeecHHHHHH
Confidence 44578888999999999999999999999999995332 2234567889999988887 567778888889999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
.|||| +|+|.+++.. ++..++.....+..|++.||.|||+.|||||||||.||++ +.++.+|++|||.|..+...
T Consensus 1312 FMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCc
Confidence 99999 9999999984 6678888888999999999999999999999999999999 67889999999999877653
Q ss_pred cCcccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.. ..| ...+...||+.|||||++.+. ....++||||||||+.||+||+.||..+.+. -+...++.....+ +
T Consensus 1388 ~~--~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh~P-q 1461 (1509)
T KOG4645|consen 1388 AQ--TMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGHKP-Q 1461 (1509)
T ss_pred hh--cCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccCCC-C
Confidence 21 111 334577899999999999864 3678999999999999999999999987542 2333333333322 2
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.+. .++.+-++||..||..||+.|.++. ++|++.|.+
T Consensus 1462 ~P~---~ls~~g~dFle~Cl~~dP~~Rw~~~---qlle~~f~~ 1498 (1509)
T KOG4645|consen 1462 IPE---RLSSEGRDFLEHCLEQDPKMRWTAS---QLLEHAFGK 1498 (1509)
T ss_pred Cch---hhhHhHHHHHHHHHhcCchhhhHHH---HHHHhhccc
Confidence 222 2588999999999999999997665 566666654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=272.39 Aligned_cols=277 Identities=19% Similarity=0.251 Sum_probs=224.8
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
+--++|.+++.||.|+|++|.++++++|.+.+|+|++++. ...+-.+.|-.++.+..++|.++-++.|+..+...
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3347899999999999999999999999999999975432 33344677888889999999999999999999999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++|.||. ||+|.-.+.. .++|+++.+..+..+|..||.|||++|||.||||.+|+|+ |..+++||.|+|+|+.--
T Consensus 327 ffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l 402 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCC
Confidence 9999998 8888766664 6789999999999999999999999999999999999999 789999999999998533
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCC--CCc---ccHHHHHHHHhhcc
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG--LKA---GTKKQKYDKISEKK 240 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~--~~~---~~~~~~~~~i~~~~ 240 (468)
.+. ....+++||+.|.|||.+.|.+|+..+|+|+|||+++||+.|+-||.- +.+ ++..-.+.-|.++.
T Consensus 403 ~~g-------d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 403 GPG-------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred CCC-------cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 222 235689999999999999999999999999999999999999999962 222 23333455567777
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCCccC
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~ 308 (468)
+.+|. +++-....+++--|+.||.+|..-.- ..-|. ...+++++..+||+.+...++..
T Consensus 476 iripr-----slsvkas~vlkgflnkdp~erlgc~~-~~g~~---dik~h~ffr~idwd~leqk~v~p 534 (593)
T KOG0695|consen 476 IRIPR-----SLSVKASHVLKGFLNKDPKERLGCRP-QTGFS---DIKSHAFFRSIDWDLLEQKQVLP 534 (593)
T ss_pred ccccc-----eeehhhHHHHHHhhcCCcHHhcCCCc-ccchh---hhhcchhhhhCCHHHHhhcccCC
Confidence 77774 34677888999999999999854220 00111 22567888899999988666543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=292.72 Aligned_cols=241 Identities=21% Similarity=0.265 Sum_probs=199.8
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
+.+.|.+...+|.|+|+.|-.+.+..++...++|++... ..+...|+.++....+|+++..+.....++...++|||+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 467899999999999999999999999999999986555 455667888999999999999999999999999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ |+-|.+.+.+ .+.+. .++..|+++|+.++.|||++|+|||||||+|||+. +..++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchh----
Confidence 9 4444444442 33344 77778999999999999999999999999999993 37899999999999865542
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
...-+-|..|.|||++...+|+.++||||||++||+|++|+.||...... .+...++...... ..
T Consensus 470 ------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~~ 534 (612)
T KOG0603|consen 470 ------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS-------EC 534 (612)
T ss_pred ------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc-------cc
Confidence 12335688999999999999999999999999999999999999876554 2333333332222 45
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
++++.++|+.+||+.+|.+||++.++.
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhc
Confidence 689999999999999999999999653
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=279.36 Aligned_cols=254 Identities=17% Similarity=0.202 Sum_probs=183.3
Q ss_pred EEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 18 ~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
.+++.+|.| |.||.+....++..||||+.... .....+..|++++..++| ++|..+..++...+..+++|+++
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH-PNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCC-cchhhhhheeecCCeEEEEEecc
Confidence 344444444 44555555668999999986543 223468889999999886 56666666777888899999998
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 94 -GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 94 -ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||+ +.++.++|+|||.+..+.......
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccccccc
Confidence 68999998753 4568999999999999999999999999999999999999 467899999999987654322111
Q ss_pred cccccCCCCccccccccccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc---------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGV--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--------- 240 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~--~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 240 (468)
...........++..|+|||++... .++.++|||||||++|+|++|..||....... ..+..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence 1111122345678899999998763 58899999999999999999999998643221 1111111000
Q ss_pred ------cC-------------CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 241 ------VS-------------TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 241 ------~~-------------~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+. .........++.++.++|..||..+|++||++++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00 0000111234568899999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=278.36 Aligned_cols=268 Identities=17% Similarity=0.243 Sum_probs=205.9
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-CCCchhHHHHHHHHHHhCC-----CCCceeeEe
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-TKHPQLHYESKLYMLLQGG-----TGIPHLKWF 79 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-~~~~~~~~E~~~l~~l~~~-----~~i~~l~~~ 79 (468)
.+..++++.++|.+.+.+|+|.||.|-.+.+..++..||||++..- ...+....|++++.++..+ .-++.+..+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3567899999999999999999999999999999999999975543 3345677899999988543 223344445
Q ss_pred eEeCceeEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC----------
Q 012192 80 GVEGDYNIMVIDLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR---------- 148 (468)
Q Consensus 80 ~~~~~~~~lv~el~ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~---------- 148 (468)
+....+.++|+|++|.++.|++..+ -.+++.+.+..|+.|++.+++|||+.+++|-||||+|||+...+
T Consensus 160 FdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 160 FDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 6677788999999999999999863 34689999999999999999999999999999999999995311
Q ss_pred -------CCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCC
Q 012192 149 -------KANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 221 (468)
Q Consensus 149 -------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf 221 (468)
+...|+|+|||.|+..... ....+.|..|.|||++++.+++..+||||+||||+|+.+|...|
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~----------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH----------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC----------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 2446899999999864321 24678899999999999999999999999999999999999999
Q ss_pred CCCCcccHHHHHHHHhhccc-----------------------------------CCCHHHhhcc---CcHHHHHHHHHH
Q 012192 222 QGLKAGTKKQKYDKISEKKV-----------------------------------STPIEVLCKS---YPSEFVSYFHYC 263 (468)
Q Consensus 222 ~~~~~~~~~~~~~~i~~~~~-----------------------------------~~~~~~l~~~---~p~~~~~li~~c 263 (468)
+...+.+.....+.|..... ..|....... .-.++.+||..+
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 97665443333333322100 0000000000 113588999999
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHH
Q 012192 264 RSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 264 l~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
|..||.+|+++.| .|.+.|.
T Consensus 390 L~fDP~~RiTl~E---AL~HpFF 409 (415)
T KOG0671|consen 390 LEFDPARRITLRE---ALSHPFF 409 (415)
T ss_pred HccCccccccHHH---HhcCHHh
Confidence 9999999999885 4444443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=284.82 Aligned_cols=267 Identities=21% Similarity=0.304 Sum_probs=207.4
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEee---------ccCCCchhHHHHHHHHHHhCCCCCceee
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLEL---------VKTKHPQLHYESKLYMLLQGGTGIPHLK 77 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~---------~~~~~~~~~~E~~~l~~l~~~~~i~~l~ 77 (468)
|+-..++.++|-++..||.|||++||+|.+...++.||||+-. ..+.+....+|..|.+.|.|+.+|..+.
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 5556778899999999999999999999999999999999722 2233456788999999998877777667
Q ss_pred EeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCceeecccCCCCeEE
Q 012192 78 WFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR--GFLHRDIKPDNFLMGLGRKANQVY 154 (468)
Q Consensus 78 ~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~--giiHrDIKp~NiLl~~~~~~~~vk 154 (468)
.|..+.+..+-|+||| |.+|+.+++. .+-++++++..|+.||+.||.||.+. .|||-||||.|||+-.+...+.+|
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 7777888899999999 5567766764 67899999999999999999999976 599999999999997667789999
Q ss_pred EEeCCcccccccccCcccccccCCCCccccccccccccccCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHH
Q 012192 155 IIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 230 (468)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~----~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~ 230 (468)
|.||||++.+.+.......-........||..|++||.+.-. ..+.|+||||.||++|..+.|+.||.........
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 999999998876554322222234557899999999987643 2688999999999999999999999753221111
Q ss_pred HHHHHHhhc-ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 231 QKYDKISEK-KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 231 ~~~~~i~~~-~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
-.+.-|... .+.+|.. +-+..+..+||.+||++.-++|.+..+|
T Consensus 694 LqeNTIlkAtEVqFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 694 LQENTILKATEVQFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred HhhhchhcceeccCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 111112211 1222221 2346899999999999999999877654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=263.60 Aligned_cols=234 Identities=24% Similarity=0.325 Sum_probs=190.5
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCC
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPS 96 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggs 96 (468)
||.|+||.||++.+..+++.||||+...... ...+..|++++..+.| +++..+...+..+...+++|+++ +++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH-PFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCC-CcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6999999999999988899999998654332 2367888898888875 56666777777888999999999 999
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccccc
Q 012192 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176 (468)
Q Consensus 97 L~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 176 (468)
|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++ +..+.++|+|||++........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~------- 148 (250)
T cd05123 80 LFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGS------- 148 (250)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCC-------
Confidence 9999985 4478999999999999999999999999999999999999 4778999999999876543210
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHH
Q 012192 177 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEF 256 (468)
Q Consensus 177 ~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~ 256 (468)
......++..|++||.+.+..++.++|+||||+++|++++|..||..... .+.+..+.......+ ..++.++
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-----~~~~~~l 220 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPLRFP-----EFLSPEA 220 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCCCCC-----CCCCHHH
Confidence 12345688899999999988899999999999999999999999975432 233333333222222 3348999
Q ss_pred HHHHHHHhcCCCCCCCCHHH
Q 012192 257 VSYFHYCRSLRFEDKPDYSY 276 (468)
Q Consensus 257 ~~li~~cl~~~p~~RPs~~~ 276 (468)
.++|..||..+|++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 99999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=294.64 Aligned_cols=255 Identities=20% Similarity=0.308 Sum_probs=207.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCc----EEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGE----EIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~----~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
..+..++||+|+||+||+|.+...|+ +||||++..... ..++..|+-+|..+.|++ +.++.+++.... ..|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpn-l~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPN-LLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCch-HHHHhhhcccch-HHH
Confidence 45567899999999999999887654 688887655433 357888888888888754 445555554444 566
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|.+|+ .|.|.|+++.....+-.+..+.|..|||+||.|||.++++||||.++|+|+ ...++|||.|||+++.....
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCcc
Confidence 67776 999999999888899999999999999999999999999999999999999 58899999999999987654
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
...- .. ....-.+.|||-|.+....|+.++|||||||++||++| |..||.++...+... +.++..+.+.+
T Consensus 852 ~~ey----~~-~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d----lle~geRLsqP 922 (1177)
T KOG1025|consen 852 EKEY----SA-PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD----LLEKGERLSQP 922 (1177)
T ss_pred cccc----cc-cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH----HHhccccCCCC
Confidence 4322 21 23345678999999999999999999999999999999 999999987654433 44554445555
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..| +-.+..+|.+||..|++.||.|.++...|......
T Consensus 923 piC---tiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 923 PIC---TIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCc---cHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 555 88999999999999999999999999988887654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=243.42 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=201.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.+|...++||+|.||+||+|++..+++.||+|........ ....+|+-+++.+.|. +|+.++.........-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhk-nivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK-NIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhc-ceeehhhhhccCceeEEeH
Confidence 3577789999999999999999999999999986554433 3688999999999985 5666777777778889999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++|..+|..++..+++.++.+.+..++.|++.||.|+|+++++|||+||.|.|+ +.++.+||+|||+++-+.
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafg----- 152 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFG----- 152 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcC-----
Confidence 999999999999999999999999999999999999999999999999999999 689999999999998654
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccC---CCH
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVS---TPI 245 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~---~~~ 245 (468)
+|.++...-+-|..|.+|.++.|.. |+...|+||.||++.|+.. |.+.|++.........+.+....... +..
T Consensus 153 --ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 153 --IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred --CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 3445556678899999999999877 8999999999999999998 88888875433333333222211100 000
Q ss_pred ------------------HHhhccCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012192 246 ------------------EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSY 276 (468)
Q Consensus 246 ------------------~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~ 276 (468)
..+.+.+...=+++++..+.-+|..|.++++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaea 279 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEA 279 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHH
Confidence 0111223334568999999999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=267.84 Aligned_cols=140 Identities=28% Similarity=0.490 Sum_probs=119.7
Q ss_pred CCCCCceec-CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCC-------CCCcee
Q 012192 6 KLRMDHVIG-GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGG-------TGIPHL 76 (468)
Q Consensus 6 ~l~~~~ii~-~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~-------~~i~~l 76 (468)
++.+|+++. ++|.+.++||.|.|++||+|.+..+.+.||+|+.+.... .+....|+++|+++..+ .+|+.+
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 378899998 999999999999999999999999999999998665443 34578899999988754 345555
Q ss_pred eEee----EeCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeec
Q 012192 77 KWFG----VEGDYNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMG 145 (468)
Q Consensus 77 ~~~~----~~~~~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~ 145 (468)
.+.+ ..+.+.+||+|++|.+|..+|.+.+ +.+++..+..|+.||+.||.|||.+ ||||-||||+|||+.
T Consensus 148 lD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 5444 3677889999999999999998764 5699999999999999999999965 899999999999994
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.82 Aligned_cols=252 Identities=18% Similarity=0.180 Sum_probs=164.9
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCC----CcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEe-----eEeC
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQT----GEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWF-----GVEG 83 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~----~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~-----~~~~ 83 (468)
-.++|++.++||+|+||.||+|.+..+ +..||||.............| .+ ....+......+..+ ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l-~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RV-RRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HH-HhhchhhHHHHHHhhhcccccccC
Confidence 347899999999999999999999888 899999975433222111111 11 111111111111111 2455
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCC-------------------CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcee
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKF-------------------SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL 143 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~l-------------------s~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiL 143 (468)
...+++++|+ +++|.+++....... ....+..++.||+.||+|||+++||||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 6788999998 778998887432111 12345679999999999999999999999999999
Q ss_pred ecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCC----------------------CCCc
Q 012192 144 MGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE----------------------QSRR 201 (468)
Q Consensus 144 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----------------------~s~k 201 (468)
+. ++.+.+||+|||+++....... .......+++.|+|||.+.... ++.+
T Consensus 288 l~--~~~~~~KL~DFGlA~~l~~~~~------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 288 FS--EGSGSFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred Ee--CCCCcEEEEeCCCccccccccc------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 94 2457899999999986543211 1234568899999999764322 3456
Q ss_pred chHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC-----------CCHH-----HhhccCcHHHHHHHHHHhc
Q 012192 202 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS-----------TPIE-----VLCKSYPSEFVSYFHYCRS 265 (468)
Q Consensus 202 sDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-----------~~~~-----~l~~~~p~~~~~li~~cl~ 265 (468)
+|||||||+||||+++..|+... ..+....+...... ...+ ...........+||..||+
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 79999999999999987775431 11111111111000 0000 0011112345689999999
Q ss_pred CCCCCCCCHHHHH
Q 012192 266 LRFEDKPDYSYLK 278 (468)
Q Consensus 266 ~~p~~RPs~~~l~ 278 (468)
.||++||++.++.
T Consensus 436 ~dP~kR~ta~e~L 448 (566)
T PLN03225 436 FKGRQRISAKAAL 448 (566)
T ss_pred CCcccCCCHHHHh
Confidence 9999999998543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=310.52 Aligned_cols=249 Identities=13% Similarity=0.152 Sum_probs=188.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
..|...+.||+|+||.||+|.+..++..||||....... ....|++++.++.| ++|+.+++++...+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~H-pnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQH-PNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCC-CCcceEEEEEEcCCCCEEEEeCCC
Confidence 356777899999999999999988999999997543322 23456788888865 67778888888888899999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH---SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLH---s~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
+++|.+++. .+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+++. |+.......
T Consensus 767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccccccc----
Confidence 899999986 4899999999999999999999 6799999999999999 455666654 665433211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc--cHHHHHHHHhh---------c
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYDKISE---------K 239 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~--~~~~~~~~i~~---------~ 239 (468)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+....... .
T Consensus 835 -------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 835 -------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred -------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 12346889999999999999999999999999999999999999643221 11111111100 0
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
...... ........++.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 908 ~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 908 SIRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 000000 0001113467889999999999999999999999988754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=300.41 Aligned_cols=257 Identities=21% Similarity=0.246 Sum_probs=188.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEe--------
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVE-------- 82 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-------- 82 (468)
..+|+.++.||+||||.||+++++-+|++||||.+.... ....+.+|++++.+|.|++.|.++....+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 367999999999999999999999999999999866553 234578899999999986666554211000
Q ss_pred --------------------------------------------------------------------------------
Q 012192 83 -------------------------------------------------------------------------------- 82 (468)
Q Consensus 83 -------------------------------------------------------------------------------- 82 (468)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------ceeEEEEeccCCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 012192 83 ----------------------G--------DYNIMVIDLLGPSLEDLFNYCNRKF-SLKTVLMLADQLINRVEYMHSRG 131 (468)
Q Consensus 83 ----------------------~--------~~~~lv~el~ggsL~~ll~~~~~~l-s~~~~~~ia~qia~gL~yLHs~g 131 (468)
. .+.||-||||..+|...+...+... .....+++.+||+.||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 2458889999665555444323333 47788999999999999999999
Q ss_pred ceeccCCCCceeecccCCCCeEEEEeCCcccccc----c----cc--Cc-ccccccCCCCccccccccccccccCCC---
Q 012192 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR----D----LQ--TH-KHIPYRENKNLTGTARYASVNTHLGVE--- 197 (468)
Q Consensus 132 iiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~----~----~~--~~-~~~~~~~~~~~~Gt~~y~APE~~~~~~--- 197 (468)
||||||||.||++ +..+.|||+|||+|+... . .. +. ...........+||.-|+|||++.+..
T Consensus 718 iIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred eeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999 689999999999998722 0 00 11 111111345678999999999998765
Q ss_pred CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 198 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 198 ~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
|+.|+|+|||||||+||+. ||. +.++....+..+.....+.+ ..+...--+.-..+|+++++.||.+||++.+|
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFG--TSMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCC--chHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 9999999999999999985 464 22333344444433333333 22233333566789999999999999999987
Q ss_pred HH
Q 012192 278 KR 279 (468)
Q Consensus 278 ~~ 279 (468)
++
T Consensus 869 L~ 870 (1351)
T KOG1035|consen 869 LN 870 (1351)
T ss_pred hh
Confidence 54
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=259.40 Aligned_cols=220 Identities=15% Similarity=0.158 Sum_probs=173.8
Q ss_pred eCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCCHHHHHHHc
Q 012192 26 GSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYC 104 (468)
Q Consensus 26 G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~ 104 (468)
|.||.||++.+..+++.||+|.+.... ....|...+... .+++++.+..++...+..+++||++ +++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK- 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence 899999999999999999999865543 223343333333 3578888888888889999999998 7899998875
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCcccc
Q 012192 105 NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGT 184 (468)
Q Consensus 105 ~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt 184 (468)
...+++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||++...... .....++
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~----------~~~~~~~ 145 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS----------CDGEAVE 145 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc----------cccCCcC
Confidence 4469999999999999999999999999999999999999 47888999999987654321 1233456
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHh
Q 012192 185 ARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCR 264 (468)
Q Consensus 185 ~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl 264 (468)
..|+|||.+.+..++.++||||||+++|||++|..||...... + ....... +...+++.+.++|.+||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~-~~~~~~~---~~~~~~~~~~~li~~~l 213 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------I-NTHTTLN---IPEWVSEEARSLLQQLL 213 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------c-ccccccC---CcccCCHHHHHHHHHHc
Confidence 7899999998888999999999999999999999887642211 0 0001111 12345889999999999
Q ss_pred cCCCCCCCCHH
Q 012192 265 SLRFEDKPDYS 275 (468)
Q Consensus 265 ~~~p~~RPs~~ 275 (468)
+.||++||++.
T Consensus 214 ~~dp~~R~~~~ 224 (237)
T cd05576 214 QFNPTERLGAG 224 (237)
T ss_pred cCCHHHhcCCC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=260.37 Aligned_cols=267 Identities=20% Similarity=0.250 Sum_probs=202.1
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCC----cEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTG----EEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~----~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
..|+++.+||+|.||.||+|....++ .++|||.+... .......+|+.+++.++|++.|.....|.......
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46999999999999999999655543 37899976554 23346889999999999987777766666668889
Q ss_pred EEEEeccCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecc-cCCCCeEEEEeCCcc
Q 012192 87 IMVIDLLGPSLEDLFNYCN----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDYGLA 161 (468)
Q Consensus 87 ~lv~el~ggsL~~ll~~~~----~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~-~~~~~~vkL~DFGla 161 (468)
+|+++|..-+|..+++... +.++...+..|+.||+.|+.|||++=|+||||||.|||+.- ..+.+.|||+|||++
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9999999999999998653 45888899999999999999999999999999999999942 234599999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCccc------HHHHHH
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYD 234 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~------~~~~~~ 234 (468)
+.+.++-. |......++-|+.|.|||.++|.. |+.+.|||+.||++.||++-.+.|.+..... ....+.
T Consensus 184 R~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 184 RLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred HHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 98876432 333345678899999999999875 9999999999999999999888887632210 011112
Q ss_pred HHhhcc-------------cC--------------CC--HH---HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012192 235 KISEKK-------------VS--------------TP--IE---VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282 (468)
Q Consensus 235 ~i~~~~-------------~~--------------~~--~~---~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~ 282 (468)
+|.+-. ++ .+ .. ...+.-++...+|+.++|+.||-+|.+++ +.|+
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~---qAle 336 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAE---QALE 336 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHH---HHhc
Confidence 221100 00 00 00 00012234477899999999999999988 5777
Q ss_pred HHHHHc
Q 012192 283 DLFIRE 288 (468)
Q Consensus 283 ~~~~~~ 288 (468)
+.+..+
T Consensus 337 h~yF~~ 342 (438)
T KOG0666|consen 337 HPYFTE 342 (438)
T ss_pred cccccc
Confidence 766554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-34 Score=260.77 Aligned_cols=259 Identities=22% Similarity=0.260 Sum_probs=197.4
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeE-------
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGV------- 81 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~------- 81 (468)
..+.|+-..+||+|.||+||+|+...+|+.||+|..... .......+|++++..|.|.+.+..+..|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 346788899999999999999999999999999963322 223457889999999998766655443321
Q ss_pred eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 82 EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 82 ~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
+....||||.+|.-+|.-++.....+|++.++..++.+++.||.|+|...|+|||+||.|+|| +.++.+||+|||++
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeeccccc
Confidence 223479999999999999998656789999999999999999999999999999999999999 47899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
+.+.......... ..+.+.|..|..||.++|. .|++..|||..||++.||++|.+.+++.........+..+....
T Consensus 172 r~fs~~~n~~kpr---ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 172 RAFSTSKNVVKPR---YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred cceecccccCCCC---cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 8776544433222 3456779999999999986 49999999999999999999999998754432222222221111
Q ss_pred ----------------c-CCCHH--------Hhhc--cCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 241 ----------------V-STPIE--------VLCK--SYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 241 ----------------~-~~~~~--------~l~~--~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
+ ..|.+ ...+ .-.++..+++.+++.+||.+|+++++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~a 312 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQA 312 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhh
Confidence 0 00000 0000 012467899999999999999999853
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=274.70 Aligned_cols=215 Identities=21% Similarity=0.300 Sum_probs=180.4
Q ss_pred CCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCC-----CCCceeeE
Q 012192 5 GKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGG-----TGIPHLKW 78 (468)
Q Consensus 5 ~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~-----~~i~~l~~ 78 (468)
+.+.+++++.++|.+....|+|-|++|..|.+...|..||||++.... .+..=+.|+++|++|... .|+..++-
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 457899999999999999999999999999999999999999876543 345567899999999742 33444444
Q ss_pred eeEeCceeEEEEeccCCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 79 FGVEGDYNIMVIDLLGPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 79 ~~~~~~~~~lv~el~ggsL~~ll~~~~~--~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
.+...++++||+|.+..+|.++++..+. .|.+..+..|+.|+..||..|-..||+|.||||+|||+. ...+.+|||
T Consensus 502 ~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLC 579 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLC 579 (752)
T ss_pred HhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeec
Confidence 5567889999999999999999987655 478899999999999999999999999999999999995 456788999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 230 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~ 230 (468)
|||.|..... ....|| ..+-.|.|||+++|.+|+...|+||.||+|||+.||+..|+|.++..+.
T Consensus 580 DfGSA~~~~e---neitPY------LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 580 DFGSASFASE---NEITPY------LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred cCcccccccc---ccccHH------HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 9999976543 122333 3345799999999999999999999999999999999999997665433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=261.63 Aligned_cols=267 Identities=19% Similarity=0.268 Sum_probs=201.7
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCC-----CcEEEEEEeeccCCCc---hhHHHHHHHHHHhCCCCCceee
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQT-----GEEIAVKLELVKTKHP---QLHYESKLYMLLQGGTGIPHLK 77 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~-----~~~vAIK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~l~ 77 (468)
++.--.+-..++++...+-+|.||.||.|.+... .++|.+|........- .+..|.-++..+.|++......
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3344455667899999999999999999976542 2456666533332222 2444554545555555555555
Q ss_pred EeeEeCceeEEEEecc-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC
Q 012192 78 WFGVEGDYNIMVIDLL-GPSLEDLFNYCN-------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 78 ~~~~~~~~~~lv~el~-ggsL~~ll~~~~-------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~ 149 (468)
....+.+..++++.+. -|+|..++..|. +.++-.+...++.|++.|++|||+.++||.||.++||+| |+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hh
Confidence 5556677777777777 689999988552 346677888999999999999999999999999999999 68
Q ss_pred CCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCccc
Q 012192 150 ANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 228 (468)
Q Consensus 150 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~ 228 (468)
.-+|||+|=.+++.......+.- ..+-..+..||+||.+.+..|+..+|||||||+||||++ |+.||...++.+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcL-----GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCL-----GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred heeEEeccchhccccCccccccc-----CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 89999999999997665443321 123345678999999999999999999999999999999 999998876543
Q ss_pred HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 229 KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 229 ~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+.. .....++...+. ++|+++..+|..||...|++||++++++..|.++...
T Consensus 507 m~~----ylkdGyRlaQP~---NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 MEH----YLKDGYRLAQPF---NCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHH----HHhccceecCCC---CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 332 233344433333 4499999999999999999999999999999987654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=245.19 Aligned_cols=236 Identities=25% Similarity=0.323 Sum_probs=188.6
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccCC-CHHHHHH
Q 012192 27 SFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGP-SLEDLFN 102 (468)
Q Consensus 27 ~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~gg-sL~~ll~ 102 (468)
+||.||+|.+..+++.||+|+...... ...+..|++.+..+ .++++..+..++......+++++++++ +|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 689999999988899999998665543 46788899998888 556777777777778889999999955 9999988
Q ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCcc
Q 012192 103 YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 182 (468)
Q Consensus 103 ~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 182 (468)
... .+++..+..++.+++.+|.|||+.+++|+||+|.||++ +.++.++|+|||++....... ......
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeecccc--------cccccc
Confidence 533 38999999999999999999999999999999999999 467899999999998655421 123556
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHH
Q 012192 183 GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHY 262 (468)
Q Consensus 183 Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~ 262 (468)
++..|++||.+.+..++.++|||+||+++|++++|..||...... ...+..+......... ....++.++.+++.+
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~ 223 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKPPFPP--PEWKISPEAKDLIRK 223 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCCCCcc--ccccCCHHHHHHHHH
Confidence 888999999999888999999999999999999999999763221 2222222222221111 111168999999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 012192 263 CRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 263 cl~~~p~~RPs~~~l~~ 279 (468)
||..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999998765
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=261.20 Aligned_cols=258 Identities=20% Similarity=0.261 Sum_probs=191.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHh-CCCCCceeeEeeEeCc----eeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ-GGTGIPHLKWFGVEGD----YNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~-~~~~i~~l~~~~~~~~----~~~lv 89 (468)
...++.+.||+|.||.||+|.. +++.||||+... ..+..+..|..|+.... .|++|..+......+. .++||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCH-HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 4567888999999999999986 568999997543 44667888999887532 3455655555444333 56777
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS---------RGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs---------~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
++|. .|+|.++++ ...++|....+|+.-|+.||+|||+ ..|+|||||..|||+ ..+....|+|||
T Consensus 287 t~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccc
Confidence 7776 999999999 5689999999999999999999996 369999999999999 689999999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCC-CC-----CcchHHHHHHHHHHHHcC------------CCCC
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QS-----RRDDLESLGYVLMYFLRG------------SLPW 221 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s-----~ksDvwSlGvvl~elltG------------~~Pf 221 (468)
||..+..... ....-+-+||.+|||||++.+.. +. .+.||||+|.|||||++. ++||
T Consensus 362 LAl~~~p~~~-----~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 362 LALRLEPGKP-----QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeEEecCCCC-----CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9988764222 22233478999999999998754 22 367999999999999974 2344
Q ss_pred CCC--CcccHHHHHHHHhhcccCCCH--HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 222 QGL--KAGTKKQKYDKISEKKVSTPI--EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 222 ~~~--~~~~~~~~~~~i~~~~~~~~~--~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
... ...+..+.....+.++.++.. ...+.....-+.+.+..||..|++.|.|+.=+.+.+.++.
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 310 111223333334455544433 3334445577889999999999999999987777776654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=281.17 Aligned_cols=244 Identities=21% Similarity=0.260 Sum_probs=190.2
Q ss_pred EceEeeeCCe-EEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccCCCHH
Q 012192 20 GRKIGSGSFG-ELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLE 98 (468)
Q Consensus 20 ~~~LG~G~fG-~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ggsL~ 98 (468)
.+.+|.|+-| .||+|.. .|++||||.+ .........+|+..++....|+||+.+++...+..+.|+..|+|..+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrl-l~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~ 590 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRL-LEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQ 590 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHH-hhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHH
Confidence 3457899987 5799987 7889999963 3334556789999999999999999999998999999999999999999
Q ss_pred HHHHHcCCCC---CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC--CCCeEEEEeCCcccccccccCcccc
Q 012192 99 DLFNYCNRKF---SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 99 ~ll~~~~~~l---s~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~--~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
|++......+ ..-....++.|++.||++||+.+||||||||.||||...+ ....++|+|||+|+.+.....
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s---- 666 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS---- 666 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc----
Confidence 9998531111 1134567889999999999999999999999999997543 335789999999998765433
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCC-CHHHhhcc
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVST-PIEVLCKS 251 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~~l~~~ 251 (468)
.+....+..||-+|+|||++.....+..+|||||||++|+.++ |.+||.+.... -..|....... ....+.
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-----~~NIl~~~~~L~~L~~~~-- 739 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-----QANILTGNYTLVHLEPLP-- 739 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-----hhhhhcCccceeeeccCc--
Confidence 2334667899999999999999988999999999999999999 59999763321 11232222211 111110
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..+..+||..+++.+|..||++.+|.
T Consensus 740 -d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 740 -DCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -hHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 12889999999999999999999663
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=235.79 Aligned_cols=213 Identities=20% Similarity=0.268 Sum_probs=173.9
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.++..-+..||+|+||.|-+-++..+|...|+|.+...- ...++..|+.+.++...++.++++++--......++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 345556788999999999999999999999999765443 23467788888888888888888887555666678999
Q ss_pred eccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 91 DLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 91 el~ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
|.+..+|..+... .+..+++..+-+||..++.||+|||++ .+||||+||.|||+ +.+++||+||||.+-.+.+
T Consensus 125 E~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehh
Confidence 9999999988763 377899999999999999999999986 89999999999999 6899999999999876554
Q ss_pred ccCcccccccCCCCccccccccccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLG----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~----~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
+- +.....|...|||||.+.. ..|+.++||||||++++||.+++.||..+. +.-+.+.++.+.
T Consensus 202 Si--------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~qLkqvVee 268 (282)
T KOG0984|consen 202 SI--------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQQLKQVVEE 268 (282)
T ss_pred hh--------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHHHHHHHhcC
Confidence 22 1223578889999998763 368999999999999999999999998764 334455444443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=242.51 Aligned_cols=259 Identities=20% Similarity=0.316 Sum_probs=198.7
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceee-EeeEeCceeEEEEe
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLK-WFGVEGDYNIMVID 91 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~-~~~~~~~~~~lv~e 91 (468)
.+.|.|.+.||+|.||.+.++++.+++..+++|...... ...+|.+|...--.|.+|.||..-+ ..+...+++++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 478999999999999999999999999999999755443 3457888887766777776665543 44566778889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++ .|+|.+-+. ...+-+.....++.|++.||+|||++++||||||.+|||+-.. +...|||||||+.+.....
T Consensus 103 ~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k~g~t--- 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRKVGTT--- 176 (378)
T ss_pred cCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccccCce---
Confidence 98 788887666 3568888999999999999999999999999999999999533 4568999999998654321
Q ss_pred ccccccCCCCccccccccccccccCCC-----CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH---HHHHHhhcccC
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ---KYDKISEKKVS 242 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~-----~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~---~~~~i~~~~~~ 242 (468)
-.....+..|.+||+..... ..+.+|+|.||+++|..++|.+||+. +....+ .+.+....+ .
T Consensus 177 -------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk--a~~~d~~Y~~~~~w~~rk-~ 246 (378)
T KOG1345|consen 177 -------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK--ASIMDKPYWEWEQWLKRK-N 246 (378)
T ss_pred -------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh--hhccCchHHHHHHHhccc-C
Confidence 01223456789999876432 46789999999999999999999983 222222 222232332 2
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
+-.+..++-+.+.+..++.+-|..+|++|--..+..+...+.+.+.
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 3445566777899999999999999999977777777777776654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-29 Score=261.04 Aligned_cols=255 Identities=17% Similarity=0.170 Sum_probs=173.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEc----------------CCCcEEEEEEeeccCC----------------CchhH
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNV----------------QTGEEIAVKLELVKTK----------------HPQLH 58 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~----------------~~~~~vAIK~~~~~~~----------------~~~~~ 58 (468)
.+..++|++.++||+|+||.||+|... ..++.||||.+..... .....
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 355789999999999999999999752 2346799998643321 11233
Q ss_pred HHHHHHHHHhCCCCC----ceeeEeeE--------eCceeEEEEecc-CCCHHHHHHHcC--------------------
Q 012192 59 YESKLYMLLQGGTGI----PHLKWFGV--------EGDYNIMVIDLL-GPSLEDLFNYCN-------------------- 105 (468)
Q Consensus 59 ~E~~~l~~l~~~~~i----~~l~~~~~--------~~~~~~lv~el~-ggsL~~ll~~~~-------------------- 105 (468)
.|+..+.++.+++.+ ..+.+++. .....+||++|+ +++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 456666667665432 22222221 234578999998 789998886321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCcc
Q 012192 106 ---RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 182 (468)
Q Consensus 106 ---~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 182 (468)
..+++..+..++.|++.+|.|||+.+|+||||||+|||+ +.++.++|+|||++........ .......
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~------~~~~~g~ 371 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGIN------FNPLYGM 371 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCc------cCccccC
Confidence 124567888999999999999999999999999999999 4678999999999975432111 0111234
Q ss_pred ccccccccccccCCCC----------------------CCcchHHHHHHHHHHHHcCCC-CCCCCCcccH--------HH
Q 012192 183 GTARYASVNTHLGVEQ----------------------SRRDDLESLGYVLMYFLRGSL-PWQGLKAGTK--------KQ 231 (468)
Q Consensus 183 Gt~~y~APE~~~~~~~----------------------s~ksDvwSlGvvl~elltG~~-Pf~~~~~~~~--------~~ 231 (468)
+|+.|+|||++..... ..+.||||+||++|+|++|.+ ||.+...... ..
T Consensus 372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~ 451 (507)
T PLN03224 372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN 451 (507)
T ss_pred CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH
Confidence 5789999998864321 234799999999999999886 7754322111 11
Q ss_pred HHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCC---CCCCCHHHH
Q 012192 232 KYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRF---EDKPDYSYL 277 (468)
Q Consensus 232 ~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p---~~RPs~~~l 277 (468)
.+..+....+..+ .....++...+++..++..+| .+|++++++
T Consensus 452 ~~r~~~~~~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ea 497 (507)
T PLN03224 452 RWRMYKGQKYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQA 497 (507)
T ss_pred HHHhhcccCCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHH
Confidence 1111112222222 234457899999999999766 689999854
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=229.56 Aligned_cols=248 Identities=18% Similarity=0.319 Sum_probs=188.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCc--eeEEEEe
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD--YNIMVID 91 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~--~~~lv~e 91 (468)
.++|++++++|.|-|++||.|.+..+++.++||+++ .-+...+.+|++++..|.++++|..+.....+.. ..-|++|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 478999999999999999999999999999999753 3455678999999999999999999887765443 4567777
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
+. +.+...+. +.|+.-.+..++.|++.||.|+|+.||+|||+||.|+++. .....++|+|+|||..+.....
T Consensus 116 ~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 116 YVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred hhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCce-
Confidence 77 44444333 3688889999999999999999999999999999999995 4567899999999988764332
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcc-cHHHHHHH----------Hhh
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYDK----------ISE 238 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~-~~~~~~~~----------i~~ 238 (468)
....+.+..|--||.+.... |+..-|+|||||+|..|+..+.||.....+ +..-++.+ +..
T Consensus 189 -------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 189 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred -------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 22334566678899987654 899999999999999999999998643332 21112211 111
Q ss_pred cccCCCHH--Hhh-----------------ccCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012192 239 KKVSTPIE--VLC-----------------KSYPSEFVSYFHYCRSLRFEDKPDYSY 276 (468)
Q Consensus 239 ~~~~~~~~--~l~-----------------~~~p~~~~~li~~cl~~~p~~RPs~~~ 276 (468)
..+..++. .+. .-..++..+|+..+|..|-++|||+.+
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE 318 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE 318 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence 11211111 100 113488999999999999999999985
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=253.27 Aligned_cols=195 Identities=22% Similarity=0.385 Sum_probs=169.0
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----------CCCchhHHHHHHHHHHh--CCCCCceeeEeeEeC
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----------TKHPQLHYESKLYMLLQ--GGTGIPHLKWFGVEG 83 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----------~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~ 83 (468)
+|..++.||+|+||.|++|.++.+..+|+||.+.+. .+-...-.|++||..|. .|++|.++..|+++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 599999999999999999999999999999975433 22334678999999887 357788888899999
Q ss_pred ceeEEEEecc--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 84 DYNIMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 84 ~~~~lv~el~--ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
+++||+||-- |-+|.+++.. ...+++.++..|..|++.|+++||+.||||||||-+|+++ +.++.+||+|||.+
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 9999999998 4567777875 5679999999999999999999999999999999999999 68999999999998
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCC
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQG 223 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~ 223 (468)
...... | ...++||..|+|||++.|..| +..-|||+||++||-++....||.+
T Consensus 718 a~~ksg------p---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSG------P---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCC------C---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 754432 2 357899999999999999887 6778999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-28 Score=221.22 Aligned_cols=208 Identities=27% Similarity=0.415 Sum_probs=179.0
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccC-CCHH
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLG-PSLE 98 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~g-gsL~ 98 (468)
||+|++|.||++....+++.++||+....... ..+..|++++..+.+ +++..+..++......+++++++. ++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 68999999999998878999999987665543 678999999999987 778888888888788999999996 9999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC-CCeEEEEeCCcccccccccCcccccccC
Q 012192 99 DLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDYGLAKKYRDLQTHKHIPYRE 177 (468)
Q Consensus 99 ~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~ 177 (468)
+++......+++..+..++.+++.+|.+||+.|++|+||+|.||++. . .+.++|+|||.+........ .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcc-------h
Confidence 99986445789999999999999999999999999999999999994 5 68999999999976543211 1
Q ss_pred CCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHH
Q 012192 178 NKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEF 256 (468)
Q Consensus 178 ~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~ 256 (468)
.....+...|++||.+... .++.+.|+|+||++++++ .++
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~ 190 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL 190 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence 2335678889999999887 788999999999999998 578
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHH
Q 012192 257 VSYFHYCRSLRFEDKPDYSYLKRL 280 (468)
Q Consensus 257 ~~li~~cl~~~p~~RPs~~~l~~~ 280 (468)
.+++..|+..+|++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 899999999999999999987653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-30 Score=239.02 Aligned_cols=200 Identities=20% Similarity=0.318 Sum_probs=160.0
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeE----eCceeEE
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGV----EGDYNIM 88 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~~~~l 88 (468)
.+-.+-||.|+||.||.+++..+|+.||+|.+..- .....+.+|++.+..++|.+.+..+..... .-+..|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999999999999999964322 224568889999988887655544433221 1123577
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 89 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 89 v~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+.|++..+|..++-. .+.|+.+.+.-++.||+.||+|||+.+|+||||||.|+|+ +.+..+||+|||+++......
T Consensus 135 ~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchhh
Confidence 888999999888773 6789999999999999999999999999999999999999 578889999999998765432
Q ss_pred CcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCc
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKA 226 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~ 226 (468)
.. ....-+-|..|.|||.+.|.. |+...||||.||++.|++..+..|+...+
T Consensus 211 ~~------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 211 RL------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred hh------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 21 122345688999999999875 99999999999999999999999986544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=237.84 Aligned_cols=207 Identities=26% Similarity=0.435 Sum_probs=173.0
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcC---CCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQ---TGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~---~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+.+.|.++++||+|.|+.||++.+.. ..+.||+|.+........+..|++.+..+.+..+|..+..+...++...+|
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 45789999999999999999999877 788999999888888888999999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
++|+ .....+++. .++...+..++..++.||.++|.+|||||||||.|||.. ...+.-.|+|||||..+...+
T Consensus 114 lp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred ecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHhhh
Confidence 9998 556666665 577899999999999999999999999999999999996 456777899999997321110
Q ss_pred ------C----c---------------------------ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHH
Q 012192 169 ------T----H---------------------------KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYV 210 (468)
Q Consensus 169 ------~----~---------------------------~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvv 210 (468)
. + ........-+..||++|.|||++...+ ++.++||||.||+
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 0 000011123457999999999999776 8999999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 012192 211 LMYFLRGSLPWQGLK 225 (468)
Q Consensus 211 l~elltG~~Pf~~~~ 225 (468)
+.-++++..||..-.
T Consensus 268 ~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAK 282 (418)
T ss_pred eehhhccccccccCc
Confidence 999999999997533
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-29 Score=254.91 Aligned_cols=249 Identities=18% Similarity=0.284 Sum_probs=199.2
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.++|+++.++|+|.||.||+++++.+++..|||+++... ...-+..|+-+++-+.|+++|.++..| ...+..+++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-lr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-LRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-hhhcCcEEEEE
Confidence 378999999999999999999999999999999865443 334567788888888887777766655 34556799999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|| +|+|+|+..- -+.+++.++..+++..+.||+|||++|-+|||||-.|||++ +.+.||++|||.+..+...
T Consensus 93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqitat--- 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITAT--- 165 (829)
T ss_pred ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhhh---
Confidence 99 7899998773 56899999999999999999999999999999999999995 7899999999998766532
Q ss_pred ccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 171 KHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
....+.+.||+.|||||+.. .+.|...+|||++|++..|+.--..|..+.-.. +...-.....+..|.-.
T Consensus 166 ----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 166 ----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMTKSGFQPPTLK 238 (829)
T ss_pred ----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhhccCCCCCccc
Confidence 12356889999999999764 567999999999999999998877776554322 22211222333333333
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
....+.+-|.+|++.|+..+|.+||+++.+
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaekl 268 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKL 268 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhh
Confidence 344578899999999999999999999855
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=213.23 Aligned_cols=197 Identities=28% Similarity=0.424 Sum_probs=164.6
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
|.+.+.||+|+||.||+|.+..++..+|||...... ....+..|++.+..+.+ +++..+..+.......+++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKH-PNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CChhhheeeeecCCceEEEEecc
Confidence 678899999999999999998889999999866543 34567889999888865 56777777777778888999998
Q ss_pred CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 94 GP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 94 gg-sL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
.+ +|.+++......+++..+..++.+++.+|.|||+.+++|+||+|.||++ +..+.++|+|||++..+.....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~--- 153 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLA--- 153 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCccc---
Confidence 44 9999998543338999999999999999999999999999999999999 4669999999999887654320
Q ss_pred ccccCCCCccccccccccccc-cCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 012192 173 IPYRENKNLTGTARYASVNTH-LGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~-~~~~~s~ksDvwSlGvvl~elltG~~Pf~~ 223 (468)
.......++..|++||.+ ....++.++|+|+||+++|+|++|..||..
T Consensus 154 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ---ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 012345678889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=209.32 Aligned_cols=167 Identities=16% Similarity=0.174 Sum_probs=128.1
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
|+|.+++...+..+++..++.|+.|++.||.|||+.+ ||+|||+ +.++.+++ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc-------
Confidence 6899999865667999999999999999999999998 9999999 47788888 9998765431
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH--HhhccC
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE--VLCKSY 252 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--~l~~~~ 252 (468)
...||+.|+|||++.+..++.++|||||||++|||++|..||....... ..+..+.......... .....+
T Consensus 63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHH
Confidence 2268899999999999999999999999999999999999997543221 1222222111111000 001122
Q ss_pred cH--HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 253 PS--EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 253 p~--~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
+. ++.++|..||..+|++||++.+|.+.+.....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 33 79999999999999999999998887766543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=222.71 Aligned_cols=198 Identities=21% Similarity=0.293 Sum_probs=165.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEe-----
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVE----- 82 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----- 82 (468)
++..+|.-.+.+|.|+- .|..+-+.-++..||||..... ...+...+|..++..+.|.+.|..+..|...
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 56678999999999999 7888888889999999974433 2345678899999889887776666555432
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 83 GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 83 ~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
....|+|||++..+|..++. -.++-+++..+..|++.|++|||+.||+||||||+||++ +.+..+||.|||+|+
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLAR 166 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhc
Confidence 23468999999999998887 367888999999999999999999999999999999999 688999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL 224 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~ 224 (468)
.-... . ...-.+.|..|.|||++.+..|...+||||+||++.||++|...|.|.
T Consensus 167 ~e~~~--~------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 167 TEDTD--F------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred ccCcc--c------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 64331 1 233457888999999999999999999999999999999999999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=261.53 Aligned_cols=188 Identities=15% Similarity=0.204 Sum_probs=133.6
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecc----------------
Q 012192 83 GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL---------------- 146 (468)
Q Consensus 83 ~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~---------------- 146 (468)
.+..+++||+++++|.+++......+++..++.++.||+.||+|||++|||||||||+||||..
T Consensus 52 ~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 52 DDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred cchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 3456788899999999999865667999999999999999999999999999999999999941
Q ss_pred cCCCCeEEEEeCCccccccccc--------Cccccccc-CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcC
Q 012192 147 GRKANQVYIIDYGLAKKYRDLQ--------THKHIPYR-ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG 217 (468)
Q Consensus 147 ~~~~~~vkL~DFGla~~~~~~~--------~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG 217 (468)
.+.++.+||+|||+++...... .....++. ......||+.|+|||++.+..|+.++|||||||+||||++|
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence 0223456666666665321100 00000100 01124689999999999999999999999999999999999
Q ss_pred CCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 218 SLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 218 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..|+.... ..+..+..... +.. .... .++...++..||+.+|.+||++.+|++
T Consensus 212 ~~~~~~~~-----~~~~~~~~~~~--~~~-~~~~-~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 212 VSSREEKS-----RTMSSLRHRVL--PPQ-ILLN-WPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCchhhHH-----HHHHHHHHhhc--Chh-hhhc-CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88875321 11111211111 111 1111 345678899999999999999998754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=213.98 Aligned_cols=175 Identities=19% Similarity=0.214 Sum_probs=133.1
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEEEcC-CCcEEEEEEeeccC-------CCchhHHHHHHHHHHhCCCCCceeeEe
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQ-TGEEIAVKLELVKT-------KHPQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~-~~~~vAIK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
.....+.++|.+.+.||+|+||+||+|.+.. +++.||||+..... ....+..|++++..+.|+++++.+..+
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 3567788999999999999999999998876 67788999754221 123478999999999998888766653
Q ss_pred eEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCceeecccCCCCeEEEEe
Q 012192 80 GVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI-KPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 80 ~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDI-Kp~NiLl~~~~~~~~vkL~D 157 (468)
...++||||+ |++|.. +. ... ...++.|++.+|.|||++||+|||| ||.|||++ .++.++|+|
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiD 155 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVID 155 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEE
Confidence 3468999998 667752 21 111 1467889999999999999999999 99999994 667899999
Q ss_pred CCcccccccccCccccc-ccCCCCccccccccccccccCCC
Q 012192 158 YGLAKKYRDLQTHKHIP-YRENKNLTGTARYASVNTHLGVE 197 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~-~~~~~~~~Gt~~y~APE~~~~~~ 197 (468)
||+|+.+....+...+. +..-.+..++..|+|||++....
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 99999776543322211 11224678899999999987543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-22 Score=197.33 Aligned_cols=256 Identities=29% Similarity=0.398 Sum_probs=191.1
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
|.+.+.||.|+||.||++.+. ..+++|.+..... ...+..|..++..+.+++++..+..++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999976 7788997655433 34588899999999988767777777776666788888
Q ss_pred cc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC-eEEEEeCCcccccccc
Q 012192 92 LL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKYRDL 167 (468)
Q Consensus 92 l~-ggsL~~ll~~~~--~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~-~vkL~DFGla~~~~~~ 167 (468)
++ +++|.+++.... ..+.......++.|++.+|+|+|+.+++||||||+|||+. ... .++++|||+++.+...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCC
Confidence 88 788887776433 2799999999999999999999999999999999999994 555 7999999999855432
Q ss_pred cCcccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-cHHHHHHHHhhcccCC
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYDKISEKKVST 243 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~ 243 (468)
....... .......||..|++||.+.+ ..++...|+||+|++++++++|..||...... ...+....+.......
T Consensus 156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 2211000 12457789999999999998 57899999999999999999999998765431 1122222222222110
Q ss_pred CHHHhhcc----CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 244 PIEVLCKS----YPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 244 ~~~~l~~~----~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
........ ....+.+++..|+..+|..|.+......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 00011111 1257899999999999999998876544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-22 Score=190.58 Aligned_cols=231 Identities=23% Similarity=0.288 Sum_probs=147.6
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----chhHHHHHHHHHHhC---------C-CCCceeeEe-
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----PQLHYESKLYMLLQG---------G-TGIPHLKWF- 79 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----~~~~~E~~~l~~l~~---------~-~~i~~l~~~- 79 (468)
.+..++.||.|+|+.||.+++..|++++|||+....... +++..|.-.+..+.+ + ..+.-+...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456788999999999999999999999999985544422 123323211111111 0 111111111
Q ss_pred -------eEeC---ce-----eEEEEeccCCCHHHHHHHc---CCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 012192 80 -------GVEG---DY-----NIMVIDLLGPSLEDLFNYC---NRK---FSLKTVLMLADQLINRVEYMHSRGFLHRDIK 138 (468)
Q Consensus 80 -------~~~~---~~-----~~lv~el~ggsL~~ll~~~---~~~---ls~~~~~~ia~qia~gL~yLHs~giiHrDIK 138 (468)
.... .. .+++|+.+.++|.+++... ... +.....+.+..|++..+++||..|++|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1111 11 3678888899999987642 222 2334456677899999999999999999999
Q ss_pred CCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccC--------CCCCCcchHHHHHHH
Q 012192 139 PDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG--------VEQSRRDDLESLGYV 210 (468)
Q Consensus 139 p~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--------~~~s~ksDvwSlGvv 210 (468)
|+||++ +.++.++|.||+.......... . ...+..|.+||.... ..++.+.|.|+||++
T Consensus 173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~-------~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 173 PENFLL---DQDGGVFLGDFSSLVRAGTRYR-------C---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp GGGEEE----TTS-EEE--GGGEEETTEEEE-------G---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eeeEEE---cCCCCEEEcChHHHeecCceee-------c---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999 5899999999998765443111 1 233467899987643 247889999999999
Q ss_pred HHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCC
Q 012192 211 LMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDK 271 (468)
Q Consensus 211 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~R 271 (468)
+|.|++|.+||.......... +.-..|..+|+.++.||..+|+.||++|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~------------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPE------------WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSG------------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCcccccc------------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999999998654321111 0234677889999999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-22 Score=215.17 Aligned_cols=254 Identities=21% Similarity=0.248 Sum_probs=177.5
Q ss_pred EEEceEeeeCCeEEEEEEEcCCCcEEEEEEeec---cCCCc-h----hHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV---KTKHP-Q----LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 18 ~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~---~~~~~-~----~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
.....+|.|+||.|+.+......+.++.|.... ..... . +..|..+-..+.|.+.+..+..+..... .+-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence 467789999999888877665555555553321 11111 1 2223223233455444443333322222 2233
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 90 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 90 ~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||||..+|..++.. ...++...+..+..|++.||+|||+.||.|||||++|+|+. ..+.+||+|||.+..+..+-.
T Consensus 400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcceeeccCcc
Confidence 89986688888874 34789999999999999999999999999999999999994 778999999999977654322
Q ss_pred cccccccCCCCccccccccccccccCCCCCC-cchHHHHHHHHHHHHcCCCCCCCCCcccHHH-HHHHHhhcccCCCHHH
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYDKISEKKVSTPIEV 247 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~-ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~~~~~~~ 247 (468)
.. .......+|...|+|||++.+.+|.+ ..||||.|++++-|++|+.||.--....... ......+.........
T Consensus 476 ~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 476 KN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 11 12456789999999999999999865 5799999999999999999997543322110 1111122223334445
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+...+|.+.+.+|..+|+++|..|.++++|.+
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 55667999999999999999999999986543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=211.02 Aligned_cols=261 Identities=22% Similarity=0.301 Sum_probs=190.8
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHh--CCCCCceeeEeeEeCc
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ--GGTGIPHLKWFGVEGD 84 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~ 84 (468)
.+--.+-+++|.|.+.||+|+||.||+|.... |+.||+|++.....++ ++.=.+++.+|. --+.|.++...-...+
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 33445667899999999999999999999765 9999999876555433 333334444444 1133444444445566
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc----CCCCeEEEEeCC
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG----RKANQVYIIDYG 159 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~----~~~~~vkL~DFG 159 (468)
-.+||++|. .|+|.++++ ..+.+++..+..++.||+.-++.||..+|||+||||+|+||... .+...++|+|||
T Consensus 768 ~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred cceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 678888887 999999999 67889999999999999999999999999999999999999742 234568999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
.+..+...... ...+..++|-.+-++|+..|.++++..|.|-|+-+++-||.|+..= ..++... ..
T Consensus 847 ~siDm~lfp~~-----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~~~-------~~ 912 (974)
T KOG1166|consen 847 RSIDMKLFPDG-----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGSSW-------MV 912 (974)
T ss_pred cceeeeEcCCC-----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCcce-------ec
Confidence 99876544332 1234567888999999999999999999999999999999985421 1111000 00
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
......+.+ -+-+.+|+..+|+.+-..=|...+|...|+..+.+.
T Consensus 913 --~~~~~Ry~~--~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 913 --KTNFPRYWK--RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred --cccchhhhh--HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 000000000 134668888888866666689999999999888754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.9e-22 Score=211.30 Aligned_cols=236 Identities=22% Similarity=0.366 Sum_probs=163.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
...+|..++.|-.|+||.||+++++.+.+.+|+|+- .++. +.+. ++.. -+ ..++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l---ilRn--ilt~-a~---------------npfvv--- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL---ILRN--ILTF-AG---------------NPFVV--- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccc-ccch---hhhc--cccc-cC---------------Cccee---
Confidence 347899999999999999999999999999999752 1110 1110 1110 01 11112
Q ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc--
Q 012192 93 LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH-- 170 (468)
Q Consensus 93 ~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~-- 170 (468)
|+-..+++. -+.+.. +++.+++|||+.||+|||+||+|.||+ .-+++|+.|||+.+......+.
T Consensus 136 --gDc~tllk~-~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 --GDCATLLKN-IGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred --chhhhhccc-CCCCcc--------hhhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchh
Confidence 334444442 223433 237899999999999999999999995 7899999999998753221110
Q ss_pred --ccc----cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 171 --KHI----PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 171 --~~~----~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.++ .-...+..+||+.|.|||+++...|+.-+|+|++|+++||++.|..||.+..+.+ .+...+......+
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~visd~i~wp 278 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVISDDIEWP 278 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhhhhcccc
Confidence 000 1112466799999999999999999999999999999999999999999865543 3333333333233
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccc
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 299 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~ 299 (468)
.. ...+|+|.+++|.++|..+|-+|--.. ..+....+.++...||.
T Consensus 279 E~--dea~p~Ea~dli~~LL~qnp~~Rlgt~-------ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 279 EE--DEALPPEAQDLIEQLLRQNPLCRLGTG-------GALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cc--CcCCCHHHHHHHHHHHHhChHhhcccc-------hhhhhhhccceeecccc
Confidence 22 244689999999999999999995322 12233445667778888
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=177.68 Aligned_cols=136 Identities=20% Similarity=0.239 Sum_probs=102.3
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----------Cch-----------------hHHHHHHHHHHhCCC
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----------HPQ-----------------LHYESKLYMLLQGGT 71 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----------~~~-----------------~~~E~~~l~~l~~~~ 71 (468)
...||+|+||.||+|.+. +|+.||||+...... ... ...|.+++..+.+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~- 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA- 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC-
Confidence 468999999999999976 899999998654311 111 13488888888763
Q ss_pred CCceeeEeeEeCceeEEEEeccCCC-HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCceeecccCC
Q 012192 72 GIPHLKWFGVEGDYNIMVIDLLGPS-LEDLFNYCNRKFSLKTVLMLADQLINRVEYM-HSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 72 ~i~~l~~~~~~~~~~~lv~el~ggs-L~~ll~~~~~~ls~~~~~~ia~qia~gL~yL-Hs~giiHrDIKp~NiLl~~~~~ 149 (468)
+++....+.. ...+||||+++|. +..... ....++...+..++.|++.+|.|| |+.||+||||||+|||+.
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 3332222222 2248999999654 433322 246799999999999999999999 799999999999999993
Q ss_pred CCeEEEEeCCccccc
Q 012192 150 ANQVYIIDYGLAKKY 164 (468)
Q Consensus 150 ~~~vkL~DFGla~~~ 164 (468)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=181.12 Aligned_cols=173 Identities=18% Similarity=0.218 Sum_probs=127.8
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCch-----------hHHHHHHHHHHhCCCCCcee
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQ-----------LHYESKLYMLLQGGTGIPHL 76 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~-----------~~~E~~~l~~l~~~~~i~~l 76 (468)
-+++++.++|++++.||.|+||.||+... ++..+|||+........+ +..|++.+.++.| ++++.+
T Consensus 24 ~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~-~GI~~~ 100 (232)
T PRK10359 24 IFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS-EGLASL 100 (232)
T ss_pred HHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH-CCCCcc
Confidence 35678899999999999999999999654 466899998654432222 4678888888866 567766
Q ss_pred eEeeEeC--------ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc
Q 012192 77 KWFGVEG--------DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 147 (468)
Q Consensus 77 ~~~~~~~--------~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~ 147 (468)
..+.... ...+|+|||+ |.+|.++.. ++. ....+++.+|..||..|++||||||.|||+.
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~-- 169 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS-- 169 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe--
Confidence 6664432 3478999999 557877632 232 2456999999999999999999999999994
Q ss_pred CCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHH
Q 012192 148 RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL 215 (468)
Q Consensus 148 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ell 215 (468)
.++ ++|+|||.......... .-.+.+...|..++|+|+|||++..+.
T Consensus 170 -~~g-i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 -KNG-LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -CCC-EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 455 99999998765432111 011444555778999999999987653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-21 Score=201.57 Aligned_cols=250 Identities=20% Similarity=0.277 Sum_probs=190.7
Q ss_pred eEeeeCCeEEEEEEE---cCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 22 KIGSGSFGELYLGVN---VQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~---~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
.+|+|+||.|+++.- ...+.-+|+|+..... .......|..++..++.++.++.++..+......++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998642 2356678888744332 12255678888888887888888887777777777777777
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
|+.|...+. ....+.+.....+...++.+++++|+.+|+|||+|++||++ +..|++++.|||+++......
T Consensus 81 gg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 81 GGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred cchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhh-----
Confidence 666665555 25567888888899999999999999999999999999999 789999999999998755422
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCc
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP 253 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 253 (468)
..+||..|||||++. ......|+||||+++++|++|..||.+ +....|.......|.+. .
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~p~~l-----~ 211 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEMPREL-----S 211 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCCchhh-----h
Confidence 228999999999998 567789999999999999999999986 33344555555555443 6
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 254 SEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 254 ~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
....+++.+++..+|..|.... -+.......+.+...+||..+...+
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~-----~~~~~eik~h~f~~~i~~~~l~~r~ 258 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAG-----PDGVDEIKQHEFFQSIDWNELEARS 258 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccC-----cchhHHHhccchheeeeHhhHhhcC
Confidence 7888999999999999986442 0111222346678889999776444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=169.27 Aligned_cols=136 Identities=21% Similarity=0.291 Sum_probs=103.4
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----------------------------chhHHHHHHHHHHhCCC
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----------------------------PQLHYESKLYMLLQGGT 71 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----------------------------~~~~~E~~~l~~l~~~~ 71 (468)
.+.||+|+||.||+|.+. +|+.||||+....... ..+..|.+.+.++.+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~- 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA- 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 578999999999999976 8999999986543210 0124678888888764
Q ss_pred CCceeeEeeEeCceeEEEEeccCCC-HH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccC
Q 012192 72 GIPHLKWFGVEGDYNIMVIDLLGPS-LE-DLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGR 148 (468)
Q Consensus 72 ~i~~l~~~~~~~~~~~lv~el~ggs-L~-~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~ 148 (468)
++.....+... ..+||||+++|. +. ..+. ...++...+..++.|++.+|.+||+ .||+||||||+|||+.
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--- 152 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--- 152 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---
Confidence 33333332222 248999999654 33 2333 3467889999999999999999999 9999999999999993
Q ss_pred CCCeEEEEeCCcccccc
Q 012192 149 KANQVYIIDYGLAKKYR 165 (468)
Q Consensus 149 ~~~~vkL~DFGla~~~~ 165 (468)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 6889999999997644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.4e-20 Score=169.48 Aligned_cols=191 Identities=15% Similarity=0.083 Sum_probs=134.2
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCc------hhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP------QLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~------~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+.+...|++|+||+||++.. .+..++.+-........ -+..|+++|.+|.++++++.+..+ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34667899999999998764 56677766433332211 367899999999998889988765 3468999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI-KPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDI-Kp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+|+ |.+|...... ....++.|++.+|+++|++||+|||| ||.|||++ .++.++|+|||+|.......
T Consensus 78 eyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcc
Confidence 997 6667543321 12357789999999999999999999 79999994 67889999999998543211
Q ss_pred Cc------ccccccCCCCccccccccccccccCC-CCC-CcchHHHHHHHHHHHHcCCCCCCCC
Q 012192 169 TH------KHIPYRENKNLTGTARYASVNTHLGV-EQS-RRDDLESLGYVLMYFLRGSLPWQGL 224 (468)
Q Consensus 169 ~~------~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s-~ksDvwSlGvvl~elltG~~Pf~~~ 224 (468)
.. .............++.|++|+...-. ..+ .+.++++.|+.+|.|+|+.++..+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 00000000112357778888765433 233 5668889999999999998887653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-20 Score=199.08 Aligned_cols=252 Identities=17% Similarity=0.140 Sum_probs=176.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC------chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH------PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~------~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+|...+.||++.|=+|.+|++ ..|. |+||+....... .+...|++ ..+..++|+..+....+.....|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHH
Confidence 789999999999999999985 3444 889986554321 23334444 2333344444444445566667888
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc-cccc
Q 012192 90 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY-RDLQ 168 (468)
Q Consensus 90 ~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~-~~~~ 168 (468)
=+|..-+|.|.+. ...-|..-+...|+.|++.||.-+|..||+|+|||.+|||++ .-+-++|+||..-+.. -...
T Consensus 100 RqyvkhnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence 8899999999988 355577788889999999999999999999999999999996 5677899999877642 1111
Q ss_pred CcccccccCCCCccccccccccccccCC----------C-CCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGV----------E-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~----------~-~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i 236 (468)
......|..... ..-.+|+|||-+-.. . .+++-||||+||++.|+++ |++||. .-|.+..-
T Consensus 176 NPadf~fFFDTS-rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~------LSQL~aYr 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTS-RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT------LSQLLAYR 248 (1431)
T ss_pred CcccceEEEecC-CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc------HHHHHhHh
Confidence 111122222222 233579999976542 2 5678899999999999998 788884 22333222
Q ss_pred hhcccCCCHHHhhccC-cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 237 SEKKVSTPIEVLCKSY-PSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~-p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
... ....+.+...+ ...++.+|..|++.+|..|.++++.++..+..
T Consensus 249 ~~~--~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 SGN--ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ccC--ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111 23333333333 35799999999999999999999877765544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6e-20 Score=171.06 Aligned_cols=245 Identities=13% Similarity=0.164 Sum_probs=178.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+...++.+|.+...|+.|+|++. |..+++|++.+.. ...+|..|.-.++.+.|+++++.+..|....+...+..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 45667889999999999999985 4466778755443 33467778888888888877777777765555444444
Q ss_pred eccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceeecccCCCCeEEE--EeCCcccccc
Q 012192 91 DLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYI--IDYGLAKKYR 165 (468)
Q Consensus 91 el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~g--iiHrDIKp~NiLl~~~~~~~~vkL--~DFGla~~~~ 165 (468)
.+..|+|..++.... -..+-.++..++.+|+.|+.|||+.. |..--|....+++ |++.+.+| +|--++..
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq-- 342 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ-- 342 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee--
Confidence 455999999998532 23667789999999999999999874 3344577778888 55555554 33222211
Q ss_pred cccCcccccccCCCCccccccccccccccCCCC---CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~---s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
.....-.+.||+||.+...+- -+.+|+|||++++||+.|...||.+..+.+-..++. +...+..
T Consensus 343 ------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-leglrv~ 409 (448)
T KOG0195|consen 343 ------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-LEGLRVH 409 (448)
T ss_pred ------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-hcccccc
Confidence 123344678999999987763 357899999999999999999999988765444431 2222223
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+| ++++..+..+|..|.+.||.+||.++.|+-.|+.+
T Consensus 410 ip-----pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 IP-----PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CC-----CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 33 45678999999999999999999999999988875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=167.61 Aligned_cols=181 Identities=19% Similarity=0.252 Sum_probs=134.7
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC-CCeEEEEeCCccc
Q 012192 84 DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~-~~~vkL~DFGla~ 162 (468)
...|+||.-+..+|..++- .+..+..+...|+.|+++|+.|||.+||.|||+|.+|||+-++|+ ...+.|+|||.|-
T Consensus 316 ~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 3468999999999999887 567788888999999999999999999999999999999977543 4567899999874
Q ss_pred ccccccCcccccccCC-CCccccccccccccccCCCC------CCcchHHHHHHHHHHHHcCCCCCCCCCcccHH-HHHH
Q 012192 163 KYRDLQTHKHIPYREN-KNLTGTARYASVNTHLGVEQ------SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYD 234 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~-~~~~Gt~~y~APE~~~~~~~------s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~-~~~~ 234 (468)
--.. ..-..||... ...-|....||||+....+- -.|+|.|+.|-+.||++....||.+.-..... ..|
T Consensus 394 Ad~~--hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y- 470 (598)
T KOG4158|consen 394 ADDN--HGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY- 470 (598)
T ss_pred eccc--cccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh-
Confidence 3221 1222344332 23457788999998875431 24889999999999999999999862211111 111
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYS 275 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~ 275 (468)
+.. ..+.+...+|+.+++++...|+.||.+|++..
T Consensus 471 ---qe~---qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 471 ---QES---QLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ---hhh---hCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 111 12334456699999999999999999998875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-18 Score=163.48 Aligned_cols=140 Identities=20% Similarity=0.236 Sum_probs=106.7
Q ss_pred ceEEEceEeeeCCeEEEEEE-EcCCCcEEEEEEeeccCCC--------------------------chhHHHHHHHHHHh
Q 012192 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKH--------------------------PQLHYESKLYMLLQ 68 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~-~~~~~~~vAIK~~~~~~~~--------------------------~~~~~E~~~l~~l~ 68 (468)
-|.+.+.||+|+||.||+|. +..+|+.||||+....... ..+..|..++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 6679999999986543210 12457999999987
Q ss_pred CC-CCCceeeEeeEeCceeEEEEeccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCceeec
Q 012192 69 GG-TGIPHLKWFGVEGDYNIMVIDLLGP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG-FLHRDIKPDNFLMG 145 (468)
Q Consensus 69 ~~-~~i~~l~~~~~~~~~~~lv~el~gg-sL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~g-iiHrDIKp~NiLl~ 145 (468)
+. ..++.+..+ ...++|||++++ +|..+.. ....+....+..++.|++.+|.+||+.| |+||||||+|||+.
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 52 223333322 234799999965 5554432 2345666677899999999999999999 99999999999993
Q ss_pred ccCCCCeEEEEeCCccccc
Q 012192 146 LGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 146 ~~~~~~~vkL~DFGla~~~ 164 (468)
.+.++|+|||++...
T Consensus 184 ----~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 ----DGKVVIIDVSQSVEL 198 (237)
T ss_pred ----CCCEEEEEChhhhcc
Confidence 678999999998643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-17 Score=156.03 Aligned_cols=136 Identities=17% Similarity=0.238 Sum_probs=103.6
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc--CCCchhHHHHHHHHHHhC----CCCCceeeEeeEeCc---e-eEE
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK--TKHPQLHYESKLYMLLQG----GTGIPHLKWFGVEGD---Y-NIM 88 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~--~~~~~~~~E~~~l~~l~~----~~~i~~l~~~~~~~~---~-~~l 88 (468)
-.+.||+|+||.||. +..++.. +||+.... .....+.+|+.++..+.+ +++|+.++++..... + ..+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999996 6666665 68976543 234568999999999964 677888888776653 3 347
Q ss_pred EEeccC---CCHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCceeecccC-CCCeEEEEeCCcc
Q 012192 89 VIDLLG---PSLEDLFNYCNRKFSLKTVLMLADQLINRV-EYMHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDYGLA 161 (468)
Q Consensus 89 v~el~g---gsL~~ll~~~~~~ls~~~~~~ia~qia~gL-~yLHs~giiHrDIKp~NiLl~~~~-~~~~vkL~DFGla 161 (468)
++++.| ++|.+++.. ..+++. ..++.|++.++ +|||+++||||||||+|||++..+ ....++|+||+-+
T Consensus 83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 899865 899999974 346655 36678888888 999999999999999999996432 3458999995544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=170.53 Aligned_cols=209 Identities=15% Similarity=0.226 Sum_probs=158.2
Q ss_pred CCCCceeeEeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCCceeeccc
Q 012192 70 GTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF-LHRDIKPDNFLMGLG 147 (468)
Q Consensus 70 ~~~i~~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~gi-iHrDIKp~NiLl~~~ 147 (468)
|.++..+.+.+.++...+++-++| .|+|.|++......+++--...++++++.||+|||.-.| .|+.++..||++
T Consensus 6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv--- 82 (484)
T KOG1023|consen 6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV--- 82 (484)
T ss_pred hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee---
Confidence 467777888888888888888888 899999999767788888899999999999999998766 999999999999
Q ss_pred CCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCC-------CCCcchHHHHHHHHHHHHcCCCC
Q 012192 148 RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-------QSRRDDLESLGYVLMYFLRGSLP 220 (468)
Q Consensus 148 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-------~s~ksDvwSlGvvl~elltG~~P 220 (468)
+....+||.|||+......... +.......-..-|.|||.+.+.. .+.+.|+||||++++|+++...|
T Consensus 83 d~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 83 DSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 6899999999999866532000 01111222345699999998742 36679999999999999999999
Q ss_pred CCCCCccc-HHHHHHHHhhccc---CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 221 WQGLKAGT-KKQKYDKISEKKV---STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 221 f~~~~~~~-~~~~~~~i~~~~~---~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
|....... ..+.+.++..... .+..... ...++++..++..||..+|++||++++|...++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 98633322 2334433333122 2222211 25677899999999999999999999998888777653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=4e-17 Score=153.03 Aligned_cols=131 Identities=27% Similarity=0.470 Sum_probs=103.1
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-C---------chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-H---------PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~---------~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+.||+|++|.||+|.+ .+..|+||+...... . ..+..|+.++..+.+. +++....++...+..+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKA-GVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHC-CCCCCeEEEEeCCCCEEEE
Confidence 5799999999999986 677899997443221 1 2366788888888764 3444444444566778999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
+++ |++|.+++.... . ....++.+++.+|.+||+.+++|+|++|.|||+. .+.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 998 789999887422 2 7889999999999999999999999999999993 67899999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.6e-18 Score=172.86 Aligned_cols=242 Identities=21% Similarity=0.260 Sum_probs=156.1
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceee-----E-ee---
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLK-----W-FG--- 80 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~-----~-~~--- 80 (468)
..+.+.+..+..+++.++...-... .+.+.-+...... ......+++..+.-..+++...... . ..
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~ 323 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRN 323 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccc
Confidence 3445555666666666665442221 2333333222211 1122334444444445555444332 0 00
Q ss_pred --EeCceeEEEEecc-CCCHHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEE
Q 012192 81 --VEGDYNIMVIDLL-GPSLEDLFN--YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYI 155 (468)
Q Consensus 81 --~~~~~~~lv~el~-ggsL~~ll~--~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL 155 (468)
....+.|+.|++| ..+|.+++. ......++...+.++.|++.|++| ++.+|||+||.||.+. .+.++||
T Consensus 324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kI 397 (516)
T KOG1033|consen 324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKI 397 (516)
T ss_pred ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhh
Confidence 0134678999999 789999996 234457788999999999999999 9999999999999994 5668999
Q ss_pred EeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHH
Q 012192 156 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~ 234 (468)
.|||+........+ ...++......+||..||+||.+.+..|+.++||||||++|+|++. -..++.-. ....
T Consensus 398 gDFgl~ts~~~~~~-~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------~t~~ 470 (516)
T KOG1033|consen 398 GDFGLVTSQDKDET-VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------ATLT 470 (516)
T ss_pred hhhhheeecccCCc-ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------Hhhh
Confidence 99999876654331 1112333456689999999999999999999999999999999987 33333211 1111
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCC
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPD 273 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs 273 (468)
.+....+ | +....++| +-..|+.+++..+|.+||+
T Consensus 471 d~r~g~i--p-~~~~~d~p-~e~~ll~~lls~~p~~RP~ 505 (516)
T KOG1033|consen 471 DIRDGII--P-PEFLQDYP-EEYTLLQQLLSPSPEERPS 505 (516)
T ss_pred hhhcCCC--C-hHHhhcCc-HHHHHHHHhcCCCcccCch
Confidence 1222211 1 22223333 4458999999999999993
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=146.98 Aligned_cols=127 Identities=24% Similarity=0.426 Sum_probs=98.0
Q ss_pred eEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CC---------chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KH---------PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~---------~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.||+|+||.||+|.+ ++..|+||+..... .. ..+..|++++..+.+.. ++....+....+..+++|+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG-VNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEECCCCEEEEE
Confidence 379999999999984 67789999744321 11 33567899988888643 3333334445666789999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
++ |++|.+++.... . .++.|++.+|.+||+.|++|+|++|.|||+. ++.++|+|||++..
T Consensus 78 ~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence 98 788988876321 1 7899999999999999999999999999993 78899999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=147.17 Aligned_cols=134 Identities=20% Similarity=0.312 Sum_probs=100.8
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC------------------------CchhHHHHHHHHHHhCCC-
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK------------------------HPQLHYESKLYMLLQGGT- 71 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~------------------------~~~~~~E~~~l~~l~~~~- 71 (468)
|.+.+.||+|+||.||+|.+ .+|+.||||+...... ......|..++..+.+..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88899999999999999986 4799999997543220 012456777777776642
Q ss_pred CCceeeEeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCC
Q 012192 72 GIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKA 150 (468)
Q Consensus 72 ~i~~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~ 150 (468)
.++.... ....+++||++ |++|.++.. ......++.+++.++.++|+.||+||||||.|||+ +.+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~ 161 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDD 161 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCC
Confidence 2333322 23458899998 566665432 13456788999999999999999999999999999 468
Q ss_pred CeEEEEeCCcccccc
Q 012192 151 NQVYIIDYGLAKKYR 165 (468)
Q Consensus 151 ~~vkL~DFGla~~~~ 165 (468)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.6e-16 Score=166.30 Aligned_cols=135 Identities=21% Similarity=0.406 Sum_probs=103.7
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-C---------CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-K---------HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~---------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
....|...+.||+|+||+||+|.+... .+++|+...+. . ...+..|++++..+.++. ++....+...
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~ 407 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG-VPTPVIYDVD 407 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccC-CCeeEEEEEe
Confidence 344556788999999999999987443 44455322111 1 124678999999988754 5555555566
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
....+++|||+ |++|.+++. ....++.|++.+|.|||+.|++||||||+|||+ +++.++|+|||++
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla 474 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLG 474 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccc
Confidence 66778999998 889988875 346789999999999999999999999999999 4678999999998
Q ss_pred cc
Q 012192 162 KK 163 (468)
Q Consensus 162 ~~ 163 (468)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 64
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=137.96 Aligned_cols=134 Identities=23% Similarity=0.370 Sum_probs=93.7
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----Cch----------------------hHHHHHHHHHHhCC-CC
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQ----------------------LHYESKLYMLLQGG-TG 72 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~----------------------~~~E~~~l~~l~~~-~~ 72 (468)
.+.||+|+||.||+|.+. +++.||||+...... ... ...|...+..+.+. ..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999875 889999997543211 011 13455555555543 22
Q ss_pred CceeeEeeEeCceeEEEEeccCC-CHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCC
Q 012192 73 IPHLKWFGVEGDYNIMVIDLLGP-SLE-DLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 73 i~~l~~~~~~~~~~~lv~el~gg-sL~-~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~ 149 (468)
++....+ ...+++|+++.+ .+. ..+.... . ...+..++.+++.++.++|. .+|+|+||||+||++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~---- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD---- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----
Confidence 4433332 235899999954 211 1122111 1 16678899999999999999 9999999999999993
Q ss_pred CCeEEEEeCCcccccc
Q 012192 150 ANQVYIIDYGLAKKYR 165 (468)
Q Consensus 150 ~~~vkL~DFGla~~~~ 165 (468)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 7889999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.5e-14 Score=126.57 Aligned_cols=132 Identities=20% Similarity=0.288 Sum_probs=106.0
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCC-CCCceeeEeeEeCceeEEEEeccCC-C
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG-TGIPHLKWFGVEGDYNIMVIDLLGP-S 96 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~-~~i~~l~~~~~~~~~~~lv~el~gg-s 96 (468)
+++.||.|.++.||++... +..++||..........+..|..++..+.++ ..++.+..+....+..+++|+++.+ .
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4578999999999999874 3689999754433345788999999999876 6677777776666788999999854 3
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 97 L~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~---giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
+..+ +......++.+++.+|++||.. +++|+||+|.|||+. ..+.++++|||++..
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 4332 5566778899999999999985 799999999999994 568999999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-13 Score=132.63 Aligned_cols=132 Identities=16% Similarity=0.215 Sum_probs=94.7
Q ss_pred ceEe-eeCCeEEEEEEEcCCCcEEEEEEeecc---------------CCCchhHHHHHHHHHHhCCCC-CceeeEeeEe-
Q 012192 21 RKIG-SGSFGELYLGVNVQTGEEIAVKLELVK---------------TKHPQLHYESKLYMLLQGGTG-IPHLKWFGVE- 82 (468)
Q Consensus 21 ~~LG-~G~fG~Vy~~~~~~~~~~vAIK~~~~~---------------~~~~~~~~E~~~l~~l~~~~~-i~~l~~~~~~- 82 (468)
..|| .|+.|+||.+.. .+..++||..... .....+..|..++..|.+... ++....+...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888765 4678899864321 112346779999999986432 3444443322
Q ss_pred Cce---eEEEEeccC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEe
Q 012192 83 GDY---NIMVIDLLG--PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 83 ~~~---~~lv~el~g--gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
... .+++|+++. .+|.+++.. ..++... +.|++.+|.+||++||+||||||.|||+. .++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence 222 248899884 489888863 3555543 56899999999999999999999999994 567899999
Q ss_pred CCcccc
Q 012192 158 YGLAKK 163 (468)
Q Consensus 158 FGla~~ 163 (468)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.4e-16 Score=166.89 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=184.7
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcC-CCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQ-TGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~-~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
...|.+.+.||+|+|+.|-+..... ....+|+|....... ......|..+-..+..|.++.++.......++.++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4578899999999999999877543 334556664333321 12233466666666667888888888888899999
Q ss_pred EEecc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCceeecccCCCC-eEEEEeCCccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMH-SRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKY 164 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~-~ls~~~~~~ia~qia~gL~yLH-s~giiHrDIKp~NiLl~~~~~~~-~vkL~DFGla~~~ 164 (468)
.+++. |+++.+.+..... ..+......+..|+..+|.|+| ..++.||||||+|.++ +..+ .++++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhccc
Confidence 99987 7777776622232 5677788899999999999999 9999999999999999 4566 8999999999987
Q ss_pred ccccCcccccccCCCCccc-cccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 165 RDLQTHKHIPYRENKNLTG-TARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~G-t~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
....... +.....+| ++.|+|||...+. ......|+||.|+++.-+++|..||....... ..+......+..
T Consensus 176 ~~~~g~~----~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~~ 249 (601)
T KOG0590|consen 176 RNKNGAE----RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKGR 249 (601)
T ss_pred cccCCcc----eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccccc
Confidence 7622211 12234466 9999999999985 45788999999999999999999997533221 222222222211
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
.-.....++.....+++..++..+|..|.+..++
T Consensus 250 -~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 250 -FTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred -cccCccccCChhhhhcccccccCCchhccccccc
Confidence 1122335667888999999999999999887754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-14 Score=149.45 Aligned_cols=257 Identities=17% Similarity=0.137 Sum_probs=195.1
Q ss_pred CCCceecCceEEEceEee--eCCeEEEEEEE--cCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEe
Q 012192 8 RMDHVIGGKFKLGRKIGS--GSFGELYLGVN--VQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~--G~fG~Vy~~~~--~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
.....+...|.+.+.+|. |.+|.||.+.. ..++..+|+|.-.... ....-.+|..-.+++.-|.+.+..+..
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 456677788999999999 99999999887 6788899999622221 122334566666667667777777777
Q ss_pred eEeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCceeecccCCC-CeEE
Q 012192 80 GVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLIN----RVEYMHSRGFLHRDIKPDNFLMGLGRKA-NQVY 154 (468)
Q Consensus 80 ~~~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~----gL~yLHs~giiHrDIKp~NiLl~~~~~~-~~vk 154 (468)
+...+..++-.|+++.+|.++......-+....++.+..+... ||.++|+.+++|-|+||.||++. .+ ...+
T Consensus 187 ~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~ 263 (524)
T KOG0601|consen 187 WEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCK 263 (524)
T ss_pred cccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceee
Confidence 8899999999999999999998866666888888888888888 99999999999999999999996 44 7889
Q ss_pred EEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 012192 155 IIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 234 (468)
+.|||+...+.+.... ..+.......|...|++||+..+ -++..+|+|+||.++.+..++..+....+.....
T Consensus 264 ~~df~~v~~i~~~~~~--~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~---- 336 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFS--SVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWS---- 336 (524)
T ss_pred cCCcceeEEccCCccc--cceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcc----
Confidence 9999999887764422 12222334467788999998765 5788999999999999999988776543322111
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
+.....-...+|.....++...+..++..++..|++.+.+
T Consensus 337 ---~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~ 376 (524)
T KOG0601|consen 337 ---QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQIL 376 (524)
T ss_pred ---ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHH
Confidence 1111112345666777788888889999888888877644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-12 Score=135.43 Aligned_cols=137 Identities=18% Similarity=0.300 Sum_probs=95.4
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCc-------------------------------------------hh
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP-------------------------------------------QL 57 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~-------------------------------------------~~ 57 (468)
+.||.|++|.||+|+. .+|+.||||+..... .. ++
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i-~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGI-EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCc-HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 5699999999999985 589999999843211 00 23
Q ss_pred HHHHHHHHHHh----CCCCCceeeEeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 012192 58 HYESKLYMLLQ----GGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLIN-RVEYMHSRG 131 (468)
Q Consensus 58 ~~E~~~l~~l~----~~~~i~~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~-gL~yLHs~g 131 (468)
..|.+.+.++. +.+.+.....+.......+|||||+ |.+|.++.......+. ...++.+++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 44554444443 3444444444444445679999999 7788877653222232 3345556655 477899999
Q ss_pred ceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 132 iiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++|+|++|.||++ +.++.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 9999999999999 467899999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.1e-12 Score=112.97 Aligned_cols=126 Identities=17% Similarity=0.217 Sum_probs=94.4
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccCC-CH
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGP-SL 97 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~gg-sL 97 (468)
++.|+.|.++.||++.. .+..|++|+..... ....+..|.+++..+.+...++.+..+.. ...++||+++.| ++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 46789999999999886 47789999854432 23457889999999887666777766543 345789999844 44
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 98 EDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF-----LHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 98 ~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~gi-----iHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
.+. . .....++.+++.+|..||..++ +|+|++|.|||+. ++.++|+||+.+.
T Consensus 79 ~~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAG 135 (170)
T ss_pred ccc------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEeccccc
Confidence 322 0 1123456899999999999885 9999999999993 5689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-11 Score=114.40 Aligned_cols=135 Identities=14% Similarity=0.170 Sum_probs=97.2
Q ss_pred ceEeeeCCeEEEEEEEcC------CCcEEEEEEeecc-----------------------CC-Cch----hHHHHHHHHH
Q 012192 21 RKIGSGSFGELYLGVNVQ------TGEEIAVKLELVK-----------------------TK-HPQ----LHYESKLYML 66 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~------~~~~vAIK~~~~~-----------------------~~-~~~----~~~E~~~l~~ 66 (468)
..||.|-=+.||.|.... .+..+|||+-... .. ... ...|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999997543 3579999972110 00 011 2378888888
Q ss_pred HhCC-CCCceeeEeeEeCceeEEEEeccCCC-H-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCce
Q 012192 67 LQGG-TGIPHLKWFGVEGDYNIMVIDLLGPS-L-EDLFNYCNRKFSLKTVLMLADQLINRVEYM-HSRGFLHRDIKPDNF 142 (468)
Q Consensus 67 l~~~-~~i~~l~~~~~~~~~~~lv~el~ggs-L-~~ll~~~~~~ls~~~~~~ia~qia~gL~yL-Hs~giiHrDIKp~Ni 142 (468)
+... -.+|....+ ...++|||++++. + ...+. ...++.+....+..|++.+|..| |..|+||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8753 456665543 5678999999763 2 11222 22455566778889999999999 899999999999999
Q ss_pred eecccCCCCeEEEEeCCcccccc
Q 012192 143 LMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 143 Ll~~~~~~~~vkL~DFGla~~~~ 165 (468)
|+. ++.++|+|||.+....
T Consensus 157 L~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE----CCcEEEEECCCceeCC
Confidence 993 5789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.4e-10 Score=122.40 Aligned_cols=139 Identities=17% Similarity=0.268 Sum_probs=90.7
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC------------------------------------C-----
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK------------------------------------H----- 54 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~------------------------------------~----- 54 (468)
.|+. +.||+|++|.||+|+...+|++||||+...... .
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 5776 789999999999999877799999998542210 0
Q ss_pred -chhHHHHHHHHHHh----CCCCCceeeEeeEeCceeEEEEecc-CCCHHHHHHHcCCC-----CCHHHHHHHHHHHHHH
Q 012192 55 -PQLHYESKLYMLLQ----GGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRK-----FSLKTVLMLADQLINR 123 (468)
Q Consensus 55 -~~~~~E~~~l~~l~----~~~~i~~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~-----ls~~~~~~ia~qia~g 123 (468)
-++..|...+.++. +.+.+.....|.......+||||++ |+.|.++-...... +....+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---- 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---- 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH----
Confidence 12344555544444 3333333333434456689999999 67887653211122 222223333333
Q ss_pred HHHHHhCCceeccCCCCceeecccCCCC----eEEEEeCCcccccc
Q 012192 124 VEYMHSRGFLHRDIKPDNFLMGLGRKAN----QVYIIDYGLAKKYR 165 (468)
Q Consensus 124 L~yLHs~giiHrDIKp~NiLl~~~~~~~----~vkL~DFGla~~~~ 165 (468)
++..|++|+|+||.||++. .++ .++++|||++..+.
T Consensus 276 ---if~~GffHaDpHPGNIlv~---~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ---VFRDGFFHADMHPGNIFVS---YDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ---HHhCCeeeCCCChHHeEEe---cCCCCCCeEEEEecceEEECC
Confidence 3468999999999999995 444 89999999987553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.3e-12 Score=141.60 Aligned_cols=276 Identities=17% Similarity=0.150 Sum_probs=189.5
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
.+.--+.|.+++-+-+|+|+.++.+.-..++...++|+.... ...+....+..++. .-+++.++....-+....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i-~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI-TPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccc-cCCCCceecccCCCCCCC
Confidence 345567888999999999999999876666655666642221 11222222222211 011122221111234566
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..+|+++++ +++|...++. ....+.+-...+...+...++|||...++|||++|.|+|. ...++.++.||++...
T Consensus 878 P~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CcchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccc
Confidence 789999998 6677777774 4467777777788889999999999999999999999999 4789999999984432
Q ss_pred cccc--cC----------------------cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCC
Q 012192 164 YRDL--QT----------------------HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSL 219 (468)
Q Consensus 164 ~~~~--~~----------------------~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~ 219 (468)
...- .+ ......+......||+.|.+||..++......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2110 00 00001123455689999999999999999999999999999999999999
Q ss_pred CCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccc
Q 012192 220 PWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 299 (468)
Q Consensus 220 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~ 299 (468)
||.... ..+.+..|....+..+. .....+.+.++++...+..++..|..+.. .....++.++...+|+
T Consensus 1034 p~na~t---pq~~f~ni~~~~~~~p~--g~~~~s~~aq~~~~~ll~~~~~qr~~a~~-------~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1034 PFNAET---PQQIFENILNRDIPWPE--GPEEGSYEAQDLINRLLTEEPTQRLGAKG-------AAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred CCCCcc---hhhhhhccccCCCCCCC--CccccChhhhhhhhhhhccCchhccCccc-------ccccccCCccCCCCcc
Confidence 997643 34455445444443332 22334789999999999999999976541 1234678889999999
Q ss_pred ccc
Q 012192 300 VLK 302 (468)
Q Consensus 300 ~~~ 302 (468)
.+.
T Consensus 1102 ~l~ 1104 (1205)
T KOG0606|consen 1102 NLA 1104 (1205)
T ss_pred ccc
Confidence 864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.1e-10 Score=102.70 Aligned_cols=142 Identities=19% Similarity=0.272 Sum_probs=107.3
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-CCCc---------hhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-TKHP---------QLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-~~~~---------~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
....|-+|+-+.|+++.+ .|+.+.||.-..+ -.++ ....|++++.++.-- +|.....++.+.....+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence 567888999999999986 7888889953222 2233 346788888877653 56656666677788899
Q ss_pred EEeccCC--CHHHHHHHcCCCCCH-HHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 89 VIDLLGP--SLEDLFNYCNRKFSL-KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 89 v~el~gg--sL~~ll~~~~~~ls~-~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
+||+..| ++.+++......-.. +....++.++-..|.-||..+|||+||...|||+-.++....+.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999977 888887654333333 33478889999999999999999999999999997544555669999999753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.5e-10 Score=101.60 Aligned_cols=128 Identities=23% Similarity=0.406 Sum_probs=95.4
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-CCCc---------hhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVK-TKHP---------QLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-~~~~---------~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
..+++|+-+.||.+.+ -|..+++|.-..+ -.++ ....|.+++.++.. .+|+....+..+.+...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEcCCCCEEEE
Confidence 4578999999999876 4445788863332 2233 24568888877765 36777777777888889999
Q ss_pred eccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 91 DLLGP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 91 el~gg-sL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
|+.+| .|.+.+... ...++..+=.-+.-||..||||+||.+.||+++ ...++++||||+..
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccc
Confidence 99955 555577642 245666677777889999999999999999994 55699999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.3e-11 Score=122.12 Aligned_cols=240 Identities=16% Similarity=0.088 Sum_probs=164.7
Q ss_pred cCceEEEceEeeeCCeEEEEEEEc-CCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNV-QTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~-~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
..+|.++.+||.|.|+.||..... .++..+++|..... .....-..|+-+...+.-+.+++.+...+...+..|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 468999999999999999987644 46778888853222 1222335566666666666666665555556666678
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
-.|++ ++++...+ .....+++...+.+..|++.++.++|++.++|+|+||.||++.. ..+..++.|||.+..+...
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~--~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN--DGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc--chhhhhcccccccccccee
Confidence 88998 55555444 45667888999999999999999999999999999999999952 1277789999998642211
Q ss_pred cCcccccccCCCCcccccccc--ccccccCCCCCCcchHHHHHHHHHHHHcCCC-CCCCCCcccHHHHHHHHhhcccCCC
Q 012192 168 QTHKHIPYRENKNLTGTARYA--SVNTHLGVEQSRRDDLESLGYVLMYFLRGSL-PWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~--APE~~~~~~~s~ksDvwSlGvvl~elltG~~-Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
. ....+.-++. +++......+..+.|++|||..+.+.++|.. ++.+.. . ..|......
T Consensus 421 ~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------~-~~i~~~~~p-- 481 (524)
T KOG0601|consen 421 S----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------S-LTIRSGDTP-- 481 (524)
T ss_pred c----------ccccccccccccchhhccccccccccccccccccccccccCcccCccccc------c-eeeeccccc--
Confidence 1 1222333333 5556666678999999999999999998754 333211 1 112222111
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+......++..+.......++..||.+.++.
T Consensus 482 ---~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 482 ---NLPGLKLQLQVLLKVMINPDRKRRPSAVELS 512 (524)
T ss_pred ---CCCchHHhhhhhhhhhcCCccccchhhhhhc
Confidence 1122246778888888888998888776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.9e-09 Score=99.94 Aligned_cols=136 Identities=21% Similarity=0.295 Sum_probs=96.1
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCC-CCceeeEeeEeC---ceeEEEEecc
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGT-GIPHLKWFGVEG---DYNIMVIDLL 93 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~-~i~~l~~~~~~~---~~~~lv~el~ 93 (468)
+.|+.|.++.||++... +|..+++|+..... ....+..|.+++..+.+.. .++.+..+.... +..+++|+++
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 57899999999999863 35789999855433 2457899999999987742 356565555443 2557899998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 012192 94 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS------------------------------------------- 129 (468)
Q Consensus 94 -ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs------------------------------------------- 129 (468)
|.++.+.+. ...++......++.+++..|.+||+
T Consensus 83 ~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 444544332 1345666666667777777777763
Q ss_pred -------------CCceeccCCCCceeecccCC--CCeEEEEeCCccc
Q 012192 130 -------------RGFLHRDIKPDNFLMGLGRK--ANQVYIIDYGLAK 162 (468)
Q Consensus 130 -------------~giiHrDIKp~NiLl~~~~~--~~~vkL~DFGla~ 162 (468)
..++|+|+.|.|||+. . .+.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFH---PDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEc---CCCCcEEEEEeccccc
Confidence 2469999999999994 4 4568999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.5e-09 Score=104.65 Aligned_cols=189 Identities=11% Similarity=0.150 Sum_probs=121.8
Q ss_pred CCceeeEeeEeCce-----eEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCC
Q 012192 72 GIPHLKWFGVEGDY-----NIMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSR--GFLHRDIKPD 140 (468)
Q Consensus 72 ~i~~l~~~~~~~~~-----~~lv~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~--giiHrDIKp~ 140 (468)
+++.++.|+.+..+ .+++.+|+ -|+|..++++ +...+......+|+.||+.||.|||+. .|+|+++..+
T Consensus 128 nlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~ 207 (458)
T KOG1266|consen 128 NLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCD 207 (458)
T ss_pred HHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchh
Confidence 36666666554333 34455555 8999999874 456788999999999999999999986 5999999999
Q ss_pred ceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCC
Q 012192 141 NFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP 220 (468)
Q Consensus 141 NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~P 220 (468)
-|++. .++.+|+. ....-..........-.......+.++|.+||.-.....+-.+|||+||+...+|..+..-
T Consensus 208 tifiq---~ngLIkig---~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 208 TIFIQ---HNGLIKIG---SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred heeec---CCceEEec---ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 99994 56666653 2111000000000001112334567889999987777778899999999999999987654
Q ss_pred C-CCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 221 W-QGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 221 f-~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
- .+.......+.+... . +..+ ..-=+.++..|++-.|..||++..+
T Consensus 282 ~tnseS~~~~ee~ia~~---i--~~le------n~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 282 STNSESKVEVEENIANV---I--IGLE------NGLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred cCCCcceeehhhhhhhh---e--eecc------CccccCcCcccccCCCCCCcchhhh
Confidence 2 221111111111110 0 0000 1223468899999999999999854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.8e-08 Score=99.06 Aligned_cols=260 Identities=14% Similarity=0.195 Sum_probs=159.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCce-eeE------eeEeCc
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH-LKW------FGVEGD 84 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~-l~~------~~~~~~ 84 (468)
.-++-...++-||+|+-+.+|-.- .-...+-|+.....-.-+ ...+..|...-.++.+.. +.| -...+.
T Consensus 8 ~~ge~i~~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 8 VYGEPIPPGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred ccCcccCCCccccCCccceeeecc---hhhchhheeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 334444577889999999999632 222233465443322111 111222222222333332 221 122334
Q ss_pred eeEEEEeccCC--CHHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEe
Q 012192 85 YNIMVIDLLGP--SLEDLFNY-----CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 85 ~~~lv~el~gg--sL~~ll~~-----~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
..-++|..+-| -+.++++- .-..+.|+..++.++.++.+.+.||..|.+-+|+.++|+|++ ++..|.|+|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEc
Confidence 45667776633 23333321 122478999999999999999999999999999999999996 788899987
Q ss_pred CCcccccccccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCccc---
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGT--- 228 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG-~~Pf~~~~~~~--- 228 (468)
-..-....+. +. ...-+|...|..||.-. +.+-+...|.|-||+++++++.| +.||.|.....
T Consensus 161 sDsfqi~~ng-----~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 161 SDSFQINANG-----TL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred ccceeeccCC-----ce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 5433222111 11 12347889999999754 34457789999999999999985 99998754321
Q ss_pred -HHH-HHH--------HHhhcccCCCHHHhhccCcHHHHHHHHHHhcC--CCCCCCCHHHHHHHHHHHHH
Q 012192 229 -KKQ-KYD--------KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSL--RFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 229 -~~~-~~~--------~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~--~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+ .+. +........|...-..-+|+.+..++.+|+.. ++.-||+.+..+..|..+-.
T Consensus 233 ~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 233 NPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred CcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 111 000 00011112222222344689999999999975 35689999988777766543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.2e-08 Score=93.76 Aligned_cols=132 Identities=21% Similarity=0.177 Sum_probs=91.4
Q ss_pred eEEEEEEEcCCCcEEEEEEeeccC-----------CCc--hhHHHHHHHHHHhCC-CCCceeeEeeEe-----CceeEEE
Q 012192 29 GELYLGVNVQTGEEIAVKLELVKT-----------KHP--QLHYESKLYMLLQGG-TGIPHLKWFGVE-----GDYNIMV 89 (468)
Q Consensus 29 G~Vy~~~~~~~~~~vAIK~~~~~~-----------~~~--~~~~E~~~l~~l~~~-~~i~~l~~~~~~-----~~~~~lv 89 (468)
..|+.+.. .|+.|.||.-.... ..+ .+..|...+.+|... -.++....+++. ....++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34555543 56678888532211 011 367888888877532 223333334432 2346899
Q ss_pred EeccCC--CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecc----cCCCCeEEEEeCCccc
Q 012192 90 IDLLGP--SLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL----GRKANQVYIIDYGLAK 162 (468)
Q Consensus 90 ~el~gg--sL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~----~~~~~~vkL~DFGla~ 162 (468)
+|++++ +|.+++... ....+......++.+++..+.-||..||+|+|+++.|||+.. .+.+..+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 998865 699998632 345566778899999999999999999999999999999952 1235789999999875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.3e-08 Score=102.96 Aligned_cols=184 Identities=15% Similarity=0.140 Sum_probs=124.5
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccC
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLG 94 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~g 94 (468)
|.+ ...+-++.+..-.|..+.++.+|.|........ .....+-++.++.++|++++.++.. .+.....|+|.|-+.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-~e~~~~~ylvTErV~ 92 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-TEEEGTLYLVTERVR 92 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-hcccCceEEEeeccc
Confidence 444 344444443222456667888888887655554 3445666778888888655555544 455557889998886
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH-SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLH-s~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
+ |..+++. +....+...+.||+.||.||| +.+++|++|--+-+++ +..+.+||.+|.++........
T Consensus 93 P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~---- 160 (690)
T KOG1243|consen 93 P-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNA---- 160 (690)
T ss_pred c-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCc----
Confidence 4 5556663 235666677899999999998 6689999999999999 5899999999999865443221
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCC
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSL 219 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~ 219 (468)
......--..|..|+.+.... ...|.|-|||++||++.|..
T Consensus 161 ---~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 161 ---PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred ---ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 011112223456666544322 34699999999999999933
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.5e-09 Score=96.08 Aligned_cols=124 Identities=23% Similarity=0.363 Sum_probs=78.4
Q ss_pred EEEEEEEcCCCcEEEEEEeecc---------------C--------CC-----chhHHHHHHHHHHhCCC-CCceeeEee
Q 012192 30 ELYLGVNVQTGEEIAVKLELVK---------------T--------KH-----PQLHYESKLYMLLQGGT-GIPHLKWFG 80 (468)
Q Consensus 30 ~Vy~~~~~~~~~~vAIK~~~~~---------------~--------~~-----~~~~~E~~~l~~l~~~~-~i~~l~~~~ 80 (468)
.||.|.. ..|.+||||+-... . .. .....|.+.|.++.... .+|.+..+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899985 57789999972110 0 00 12467888888887653 46766544
Q ss_pred EeCceeEEEEeccC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCceeecccCCCCeEEEEe
Q 012192 81 VEGDYNIMVIDLLG--PSLEDLFNYCNRKFSLKTVLMLADQLINRVEY-MHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 81 ~~~~~~~lv~el~g--gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~y-LHs~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
...+||||+++ |.....+... .++.+....++.+++..+.. +|..||+|+||.+.|||+. .+.++|+|
T Consensus 79 ---~~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID 149 (188)
T PF01163_consen 79 ---NRNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID 149 (188)
T ss_dssp ---ETTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred ---eCCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence 24689999997 5433333321 12234556677788885555 5799999999999999994 44999999
Q ss_pred CCccccc
Q 012192 158 YGLAKKY 164 (468)
Q Consensus 158 FGla~~~ 164 (468)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9998653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.4e-09 Score=108.96 Aligned_cols=153 Identities=12% Similarity=0.171 Sum_probs=105.0
Q ss_pred HHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCC--CCcccccccccccccc
Q 012192 118 DQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYREN--KNLTGTARYASVNTHL 194 (468)
Q Consensus 118 ~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~--~~~~Gt~~y~APE~~~ 194 (468)
.+++.||.|+|. .++||++|.|++|.+ +..+.+||+.|+.+.............|... ....-...|.|||++.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345599999996 589999999999999 6889999999999876544322111112111 1223456799999999
Q ss_pred CCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCC
Q 012192 195 GVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPD 273 (468)
Q Consensus 195 ~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs 273 (468)
+...+.++|++|||+.+|.+.. |+.-+..... .... ................++|.|+.+-+.+.+..+..-||+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~---~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSY---SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCC-cchh---hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 9888999999999999998885 4444433221 1111 111111111222223678999999999999999999997
Q ss_pred HHHH
Q 012192 274 YSYL 277 (468)
Q Consensus 274 ~~~l 277 (468)
+..+
T Consensus 259 ~~~l 262 (700)
T KOG2137|consen 259 LDLL 262 (700)
T ss_pred hhhh
Confidence 7644
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=6.4e-07 Score=83.91 Aligned_cols=109 Identities=19% Similarity=0.287 Sum_probs=80.6
Q ss_pred CchhHHHHHHHHHHhC-CCCCceeeEeeEeC----ceeEEEEeccCC--CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 012192 54 HPQLHYESKLYMLLQG-GTGIPHLKWFGVEG----DYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEY 126 (468)
Q Consensus 54 ~~~~~~E~~~l~~l~~-~~~i~~l~~~~~~~----~~~~lv~el~gg--sL~~ll~~~~~~ls~~~~~~ia~qia~gL~y 126 (468)
......|...+..|.. +-.++....++... ...+++++.+.+ +|.+++.... .++......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence 4467888888777764 22344444454432 234788888744 6899888533 36777888999999999999
Q ss_pred HHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 127 MHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 127 LHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
||..||+|+|+++.|||+...+....+.|+||+.++.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999995333334899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=3e-06 Score=78.85 Aligned_cols=137 Identities=12% Similarity=0.094 Sum_probs=98.4
Q ss_pred eEeeeCCeEEEEEEEcCCCcEEEEEEee--------ccCCCchhHHHHHHHHHHhCC-CCCceeeEeeEe----CceeEE
Q 012192 22 KIGSGSFGELYLGVNVQTGEEIAVKLEL--------VKTKHPQLHYESKLYMLLQGG-TGIPHLKWFGVE----GDYNIM 88 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~~~~~~~vAIK~~~--------~~~~~~~~~~E~~~l~~l~~~-~~i~~l~~~~~~----~~~~~l 88 (468)
--|.||.+-|+.-.. .|..+-+|.-. .....+-+..|...+..|... -.++....+... .-..+|
T Consensus 25 N~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence 346689999998664 33467788521 133456789999999888743 225555443332 223578
Q ss_pred EEeccC--CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCe--EEEEeCCcccc
Q 012192 89 VIDLLG--PSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDYGLAKK 163 (468)
Q Consensus 89 v~el~g--gsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~--vkL~DFGla~~ 163 (468)
|.+-++ .+|.+++... -...+......+..+++..|.-||+.|+.|+|+-+.|||+. ..+. |.++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~---~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVK---TEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeec---CCCCeeEEEEEhhccch
Confidence 888776 6899888632 23457777889999999999999999999999999999993 3344 99999987653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.4e-06 Score=78.09 Aligned_cols=128 Identities=23% Similarity=0.404 Sum_probs=95.3
Q ss_pred EEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccC-CC
Q 012192 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLG-PS 96 (468)
Q Consensus 18 ~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~g-gs 96 (468)
+..+.||.|.+|.||+|.+ .|.++|+|+-..+.....+..|.+++..+.+...-+.+++++.+. +.|++.. ..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcc
Confidence 3456799999999999987 667999999888888889999999999999988899998886543 4499984 48
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CC-ceeecccCCCCeEEEEeCCcccc
Q 012192 97 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIK-PD-NFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 97 L~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIK-p~-NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
|.++.... +.+.++. +++.---|-..||-|..|. |. |+++ .++.++|+||..|+.
T Consensus 99 L~~~~~~~----~rk~l~~----vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG----DRKHLLR----VLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc----cHHHHHH----HHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 87766521 3333333 3344334556789898884 43 5555 456999999999863
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.6e-06 Score=78.68 Aligned_cols=71 Identities=17% Similarity=0.072 Sum_probs=54.8
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCC-CceeeEeeEeCceeEEEEeccCC
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTG-IPHLKWFGVEGDYNIMVIDLLGP 95 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~l~~~~~~~~~~~lv~el~gg 95 (468)
..||+|..+.||+. .+..+++|+............|.+++..+..... ++....++...+...++|+++.|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2446778976554445568899999999876544 78888888777778889999966
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2e-06 Score=82.08 Aligned_cols=133 Identities=20% Similarity=0.317 Sum_probs=93.1
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEee----------c------cCCC--------chhHHHHHHHHHHhCC-C
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLEL----------V------KTKH--------PQLHYESKLYMLLQGG-T 71 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~----------~------~~~~--------~~~~~E~~~l~~l~~~-~ 71 (468)
+.++.+||-|--+.||.|.+ ..|.++|||.=. . ...+ ....+|.++|.+|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45788999999999999985 478999999610 0 0011 1357788888888764 3
Q ss_pred CCceeeEeeEeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC
Q 012192 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151 (468)
Q Consensus 72 ~i~~l~~~~~~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~ 151 (468)
.||... ..+...+|||+..|....-+ +++.+..-.++..|+.-+.-+-..||||+|+.+=|||++ +++
T Consensus 172 ~VP~P~----~~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~dg 239 (304)
T COG0478 172 KVPKPI----AWNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---EDG 239 (304)
T ss_pred CCCCcc----ccccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---cCC
Confidence 454443 34678999999966322111 123444455566666666666689999999999999994 788
Q ss_pred eEEEEeCCccc
Q 012192 152 QVYIIDYGLAK 162 (468)
Q Consensus 152 ~vkL~DFGla~ 162 (468)
.++++||=.+.
T Consensus 240 ~~~vIDwPQ~v 250 (304)
T COG0478 240 DIVVIDWPQAV 250 (304)
T ss_pred CEEEEeCcccc
Confidence 99999997664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.3e-06 Score=90.25 Aligned_cols=139 Identities=19% Similarity=0.296 Sum_probs=90.4
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeecc------------------------C----CC--------------chhH
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVK------------------------T----KH--------------PQLH 58 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~------------------------~----~~--------------~~~~ 58 (468)
+-|+.++-|.||+|+. .+|+.||||+.... . .. -++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5688999999999995 46999999972110 0 00 0234
Q ss_pred HHHHHHHHHh----CCCCCceeeEeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 012192 59 YESKLYMLLQ----GGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 133 (468)
Q Consensus 59 ~E~~~l~~l~----~~~~i~~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~gii 133 (468)
.|...+.++. +.+.+.....|..-....+|+|||+ |-.+.++..-....++.+.+.....++. +..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 4544444433 4455555555555667789999999 5466666432234566444433333322 2233347999
Q ss_pred eccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 134 HRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 134 HrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
|.|..|.||++ +.++.+.+.|||+...+.
T Consensus 288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 288 HADPHPGNILV---RSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccCCCccceEE---ecCCcEEEEcCcceecCC
Confidence 99999999999 578999999999986554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.4e-06 Score=76.56 Aligned_cols=139 Identities=18% Similarity=0.266 Sum_probs=88.7
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCc-----------hhHHHHHHHHHHh--CCCCCce
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP-----------QLHYESKLYMLLQ--GGTGIPH 75 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~-----------~~~~E~~~l~~l~--~~~~i~~ 75 (468)
.+.++.++|.+.+.+-......|.+-.- .|..+.+|......... ....++.....+. +......
T Consensus 25 ~~~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 25 GEKILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred HHHHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 3567788999999998888777777553 66788899644332211 1122233223332 2222222
Q ss_pred eeEeeE-----eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC
Q 012192 76 LKWFGV-----EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 76 l~~~~~-----~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~ 149 (468)
++.... .....+|+|||+ |..|.++.. +++ .++..++..|.-||+.|++|+|+.|.|+++.
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~---- 169 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS---- 169 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----
Confidence 222222 223457899999 445554432 222 3456677889999999999999999999994
Q ss_pred CCeEEEEeCCccc
Q 012192 150 ANQVYIIDYGLAK 162 (468)
Q Consensus 150 ~~~vkL~DFGla~ 162 (468)
++.++++||+..+
T Consensus 170 ~~~i~iID~~~k~ 182 (229)
T PF06176_consen 170 NNGIRIIDTQGKR 182 (229)
T ss_pred CCcEEEEECcccc
Confidence 6669999998754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.20 E-value=0.0002 Score=73.81 Aligned_cols=208 Identities=16% Similarity=0.188 Sum_probs=133.2
Q ss_pred CeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeE----eCceeEEEEecc--CCCHHH
Q 012192 28 FGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGV----EGDYNIMVIDLL--GPSLED 99 (468)
Q Consensus 28 fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~~~~lv~el~--ggsL~~ 99 (468)
-.+.|++....+|..|++|.+..... ......-++..+++.|.+.|+. ..++. ..--.++|++|. -++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~f-revf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPF-REVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeeh-hhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34679999888999999998733221 1123445677788888655544 33322 334468888887 567877
Q ss_pred HHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 100 LFNYC--------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 100 ll~~~--------------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
+.-.. +...++..++.++.|+..||.++|+.|+.-+-|.|.+||+. .+.+++|..-|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeeec
Confidence 64321 23467889999999999999999999999999999999994 34477776555433221
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCC-CCCCCcccHHHHHHHHhhcccCCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
... . +.+. .-.+.|.=-||.++.-|.+|..- |... ..+.. -
T Consensus 445 ~d~-------------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d----~~~~s----------~ 486 (655)
T KOG3741|consen 445 EDP-------------------T--EPLE---SQQQNDLRDLGLLLLALATGTENSNRTD----STQSS----------H 486 (655)
T ss_pred CCC-------------------C--cchh---HHhhhhHHHHHHHHHHHhhccccccccc----chHHH----------H
Confidence 110 0 1111 12366999999999999998543 2211 11111 0
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...+...+..++++++.+....++++ -+..+|.
T Consensus 487 ~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 487 LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 11122344677888888888888876 3454443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.7e-05 Score=73.25 Aligned_cols=139 Identities=17% Similarity=0.235 Sum_probs=79.0
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCC-CceeeEeeE---eCceeEEEEecc-C
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTG-IPHLKWFGV---EGDYNIMVIDLL-G 94 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~l~~~~~---~~~~~~lv~el~-g 94 (468)
++.|+.|..+.||+..... ..+++|+.........+..|..++..+..... ++.+..+.. .....+++|+++ |
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4689999999999988643 48899985444344578889999988876544 666665433 334568888888 4
Q ss_pred CCHHH----------------HHHHc--C--C--CCCHHH---------HHHH------------HHHHHH-HHHHHH--
Q 012192 95 PSLED----------------LFNYC--N--R--KFSLKT---------VLML------------ADQLIN-RVEYMH-- 128 (468)
Q Consensus 95 gsL~~----------------ll~~~--~--~--~ls~~~---------~~~i------------a~qia~-gL~yLH-- 128 (468)
..+.. .+... . . .+.... .... ...+.. .++.++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 44444 11110 0 0 011000 0000 011222 233333
Q ss_pred -----hCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 129 -----SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 129 -----s~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...++|+|+.|.|||+. +.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceee--eccceeEEEecccce
Confidence 24699999999999994 356777899998864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.12 E-value=9e-05 Score=68.79 Aligned_cols=129 Identities=19% Similarity=0.270 Sum_probs=92.6
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC------------------CCchhHHHHHHHHHHh-C----CCCCcee
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT------------------KHPQLHYESKLYMLLQ-G----GTGIPHL 76 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~------------------~~~~~~~E~~~l~~l~-~----~~~i~~l 76 (468)
...||+|+.-.||. .......+||+..... ...+...|+..+..+. . ..+++.+
T Consensus 6 ~~~i~~G~~R~cy~---HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ---HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE---CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35689999999997 3345566789855443 2456788888887776 2 3667778
Q ss_pred eEeeEeCceeEEEEecc-------CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC
Q 012192 77 KWFGVEGDYNIMVIDLL-------GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 77 ~~~~~~~~~~~lv~el~-------ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~ 149 (468)
+++.....-.-+|+|.. ..+|.+++. ...++. .... .+-.-.+||-+.+|+.+|++|.||+++..++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 88877777778888877 457888886 344555 3333 3334456788999999999999999987665
Q ss_pred CC-eEEEEe
Q 012192 150 AN-QVYIID 157 (468)
Q Consensus 150 ~~-~vkL~D 157 (468)
.. .+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 55 788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.3e-05 Score=72.04 Aligned_cols=74 Identities=14% Similarity=0.210 Sum_probs=51.7
Q ss_pred eEeeeCC-eEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCCHH
Q 012192 22 KIGSGSF-GELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLE 98 (468)
Q Consensus 22 ~LG~G~f-G~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggsL~ 98 (468)
.|-.|.+ ..||+... .+..+.||+..... ...+..|++++..+...-.++.+..+....+..+++|+++ |.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444555 78999864 34678888754332 4567889999999886666777777776666778899988 44444
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.9e-05 Score=71.42 Aligned_cols=133 Identities=20% Similarity=0.284 Sum_probs=89.8
Q ss_pred eEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---------------------Cc-----hhHHHHHHHHHHhCC-CCCc
Q 012192 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---------------------HP-----QLHYESKLYMLLQGG-TGIP 74 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---------------------~~-----~~~~E~~~l~~l~~~-~~i~ 74 (468)
.|.+|-=+.||+|.. ..+..||||+...... .. -...|...|.++... -.+|
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 566667779999873 5788999997332110 00 135577777766542 3333
Q ss_pred eeeEeeEeCceeEEEEeccCCCHH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCC
Q 012192 75 HLKWFGVEGDYNIMVIDLLGPSLE--DLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKAN 151 (468)
Q Consensus 75 ~l~~~~~~~~~~~lv~el~ggsL~--~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~ 151 (468)
....+ ..++|+||++|.... =.++ .-.+..+....+..+++..+.-|-. .++||+||..=|||+ .++
T Consensus 134 ~Pi~~----~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~----~~~ 203 (268)
T COG1718 134 EPIAF----RNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV----HDG 203 (268)
T ss_pred Cceee----cCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE----ECC
Confidence 33332 457899999975410 0111 1123344677888899999998876 899999999999999 388
Q ss_pred eEEEEeCCcccccc
Q 012192 152 QVYIIDYGLAKKYR 165 (468)
Q Consensus 152 ~vkL~DFGla~~~~ 165 (468)
.++|+||+-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999986543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00012 Score=67.66 Aligned_cols=124 Identities=18% Similarity=0.277 Sum_probs=85.6
Q ss_pred CceEEEceEeeeCC-eEEEEEEEcCCCcEEEEEEeec-------------c----------CCCchhHHHHHHHHHHhCC
Q 012192 15 GKFKLGRKIGSGSF-GELYLGVNVQTGEEIAVKLELV-------------K----------TKHPQLHYESKLYMLLQGG 70 (468)
Q Consensus 15 ~~y~i~~~LG~G~f-G~Vy~~~~~~~~~~vAIK~~~~-------------~----------~~~~~~~~E~~~l~~l~~~ 70 (468)
.+++.++.||.|.- |.||++.. .|..+|+|+... . .....|..|.+.+.+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 79999999999999 99999986 677999998110 0 1123578899999888854
Q ss_pred CC--C--ceeeEeeE-eC-----------------ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 012192 71 TG--I--PHLKWFGV-EG-----------------DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128 (468)
Q Consensus 71 ~~--i--~~l~~~~~-~~-----------------~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLH 128 (468)
.. + +.++++.. .. ....||.|+....- .+ ...-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence 33 2 44444432 10 11245555542211 12 2334567888899999
Q ss_pred hCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 129 s~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
..||+-+|+++.|..=| +|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~G--------~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRGG--------KLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccCC--------EEEecccC
Confidence 99999999999998743 79999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.6e-06 Score=90.84 Aligned_cols=186 Identities=11% Similarity=0.007 Sum_probs=131.7
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccCCC
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPS 96 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ggs 96 (468)
|...+.+++|+++.+++.+...+...+ .+++... ....-++++|.++++++-+.....-...+++.+++++++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 445566788999999998765554444 5543333 456668889999998773444434445667788899998443
Q ss_pred --HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccccc
Q 012192 97 --LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174 (468)
Q Consensus 97 --L~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 174 (468)
-........-.+..-....+.+.-+.+|+|||+.--+|+| |||. ....+++.||+....+....
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~------ 385 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM------ 385 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc------
Confidence 1111111111233334555677778899999998888999 8887 46888999999887654421
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 012192 175 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQ 222 (468)
Q Consensus 175 ~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~ 222 (468)
......+|+.|+|||+..+..+....|+|++|+-..++.-|..|-.
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2457789999999999999999999999999998888887776643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=8e-05 Score=78.57 Aligned_cols=141 Identities=19% Similarity=0.281 Sum_probs=89.1
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---------------------------------------CCchhHHHH
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---------------------------------------KHPQLHYES 61 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---------------------------------------~~~~~~~E~ 61 (468)
+-||.-+.|.||+|+.+ .|+.||||+-...- ..-+|..|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 56899999999999954 59999999721110 001234444
Q ss_pred HHHHHHh----CCC-----CCceeeEeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012192 62 KLYMLLQ----GGT-----GIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131 (468)
Q Consensus 62 ~~l~~l~----~~~-----~i~~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~g 131 (468)
+...++. +-. .||.+++ ......+|+|||+ |.-+.|+-.-....++...+..-+.++..-+-+ ..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf--~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF--KTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH--hcC
Confidence 4333322 222 1444444 3455679999999 545555533224567777665555554433333 457
Q ss_pred ceeccCCCCceeeccc-CCCCeEEEEeCCccccccc
Q 012192 132 FLHRDIKPDNFLMGLG-RKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 132 iiHrDIKp~NiLl~~~-~~~~~vkL~DFGla~~~~~ 166 (468)
++|.|=.|.||++... ..+..+.+.|||+......
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 9999999999999632 2467889999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00047 Score=77.82 Aligned_cols=78 Identities=12% Similarity=0.149 Sum_probs=51.4
Q ss_pred EEceEeeeCCeEEEEEEEcCCC--cEEEEEEeeccC---CCchhHHHHHHHHHHhCCCC--CceeeEeeEeC---ceeEE
Q 012192 19 LGRKIGSGSFGELYLGVNVQTG--EEIAVKLELVKT---KHPQLHYESKLYMLLQGGTG--IPHLKWFGVEG---DYNIM 88 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~--~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~--i~~l~~~~~~~---~~~~l 88 (468)
-+++|+.|.+..+|+......+ ..+++|+..... ....+.+|.+++..+..+.. ++.+++++.+. ...|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3578899999999998754322 366777643322 22368899999999974343 45555555443 34689
Q ss_pred EEeccCCC
Q 012192 89 VIDLLGPS 96 (468)
Q Consensus 89 v~el~ggs 96 (468)
|||++.|.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99998553
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00031 Score=67.00 Aligned_cols=68 Identities=18% Similarity=0.158 Sum_probs=42.6
Q ss_pred ceEeeeCCe-EEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCC--CCCceeeEeeEeC---ceeEEEEecc
Q 012192 21 RKIGSGSFG-ELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG--TGIPHLKWFGVEG---DYNIMVIDLL 93 (468)
Q Consensus 21 ~~LG~G~fG-~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~~---~~~~lv~el~ 93 (468)
+.|+.|+.. .||+.. ..+++|+.........+..|.+++..+... -.++.+...+... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777776 489742 356788744433445788999999888753 2345554444332 2347788887
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0061 Score=61.51 Aligned_cols=70 Identities=16% Similarity=0.233 Sum_probs=48.1
Q ss_pred eEeeeCCeEEEEEEEcCCCcEEEEEEe----ec-----cCCCchhHHHHHHHHHHhC--CCCCceeeEeeEeCceeEEEE
Q 012192 22 KIGSGSFGELYLGVNVQTGEEIAVKLE----LV-----KTKHPQLHYESKLYMLLQG--GTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~~~~~~~vAIK~~----~~-----~~~~~~~~~E~~~l~~l~~--~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.||.|....||++.+...+..|+||.- .+ .........|...|..... +..+|.++.| +.+..+++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997433368999961 11 1223356778888876554 3457776665 666778888
Q ss_pred ecc
Q 012192 91 DLL 93 (468)
Q Consensus 91 el~ 93 (468)
|++
T Consensus 80 EdL 82 (370)
T TIGR01767 80 EDL 82 (370)
T ss_pred hhC
Confidence 887
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0028 Score=60.12 Aligned_cols=71 Identities=17% Similarity=0.088 Sum_probs=46.2
Q ss_pred EceEeeeCCeEEEEEEEcC-CCcEEEEEEeeccCCC-chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccC
Q 012192 20 GRKIGSGSFGELYLGVNVQ-TGEEIAVKLELVKTKH-PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLG 94 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~-~~~~vAIK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~g 94 (468)
++.|..|-...+|+..... .+..|++|+....... .....|..++..+.....++.+..+.. ..++|+++.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeC
Confidence 4567778888999986432 2567889964432221 234578889888876666777655432 247888873
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00091 Score=66.75 Aligned_cols=138 Identities=19% Similarity=0.224 Sum_probs=94.6
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----------------------CCCc-----hhHHHHHHHHHHhCC
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----------------------TKHP-----QLHYESKLYMLLQGG 70 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----------------------~~~~-----~~~~E~~~l~~l~~~ 70 (468)
|-.+|..|--+.||.|. ...|..+|||+.... .... -...|.+-|.++...
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 55678889999999998 567888999972211 0011 146678888887653
Q ss_pred CCCceeeEeeEeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCceeecccCC
Q 012192 71 TGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH-SRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 71 ~~i~~l~~~~~~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLH-s~giiHrDIKp~NiLl~~~~~ 149 (468)
+|+...-.. -...+|||+++|..-+-.=.-..-.++...+..+-.|++.-|.-|- ..++||.||.-=|+|+ .
T Consensus 227 -GIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----h 299 (520)
T KOG2270|consen 227 -GIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----H 299 (520)
T ss_pred -CCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----E
Confidence 344322221 1335899999975432211111345777777778788888888775 5689999999999999 6
Q ss_pred CCeEEEEeCCccccc
Q 012192 150 ANQVYIIDYGLAKKY 164 (468)
Q Consensus 150 ~~~vkL~DFGla~~~ 164 (468)
++.++|+|-+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 899999999877543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0036 Score=64.29 Aligned_cols=73 Identities=16% Similarity=0.318 Sum_probs=51.3
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeec---------cCCCchhHHHHHHHHHHhC--CCCCceeeEeeEeCceeEE
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELV---------KTKHPQLHYESKLYMLLQG--GTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~---------~~~~~~~~~E~~~l~~l~~--~~~i~~l~~~~~~~~~~~l 88 (468)
.+.||.|.+..||++.....++.|+||.... .........|.+.|..+.. +..+|.++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4678999999999998754335899997321 1123356778888877653 3567877777 4466789
Q ss_pred EEeccC
Q 012192 89 VIDLLG 94 (468)
Q Consensus 89 v~el~g 94 (468)
|||++.
T Consensus 109 VME~L~ 114 (401)
T PRK09550 109 VMEDLS 114 (401)
T ss_pred EEecCC
Confidence 999984
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0023 Score=71.97 Aligned_cols=201 Identities=18% Similarity=0.185 Sum_probs=122.9
Q ss_pred hHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe----cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012192 57 LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID----LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131 (468)
Q Consensus 57 ~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e----l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~g 131 (468)
...|...+..+.|.+ +..+..+..+....-++++ ++ .-++.+++.. -...+..+.+.+..+++.||+|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n-~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDN-LGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhcccc-ccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 344555556666644 4444444443332223322 22 5566666663 557889999999999999999999986
Q ss_pred ceeccCCCCceeecccCCCCeEEEE--eCCcccccccccCcccccccCCCCccccccccccccccCCCCC--CcchHHHH
Q 012192 132 FLHRDIKPDNFLMGLGRKANQVYII--DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS--RRDDLESL 207 (468)
Q Consensus 132 iiHrDIKp~NiLl~~~~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s--~ksDvwSl 207 (468)
..|.-+...-..-...+..+.+.+. ||+..+.+.+... .-...-+.-|.++|......+. ...|+|.+
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--------SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCccc--------chhhcCccccccccccccccchhhhhhHHHHH
Confidence 6665554442222112345666665 8888776554321 1122334557788887766654 44799999
Q ss_pred HHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 208 GYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 208 Gvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
|..+..+..|..+-... ..+...++.....+..+....|+..+.++|+...++ +.+.|.+
T Consensus 379 gll~~~~~~~~~i~~~~-----------------~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l---l~~~f~~ 438 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKS-----------------AVPVSLLDVLSTSELLDALPKCLDEDSEERLSALEL---LTHPFLR 438 (1351)
T ss_pred HHHHhhhhhcCcccccc-----------------cchhhhhccccchhhhhhhhhhcchhhhhccchhhh---hhchhcc
Confidence 99999888875442210 011112222223477888999999999999998854 4444443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0029 Score=61.05 Aligned_cols=130 Identities=15% Similarity=0.156 Sum_probs=74.5
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC--chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccCC-CHH-
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKTKH--PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGP-SLE- 98 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~--~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~gg-sL~- 98 (468)
+..|-.+.+|+.. ..+..+++|+....... .....|.+++..+......+.+.++.. .++||+++.| .+.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 4557788999876 35667888974332222 246789999998887655666655432 3678888743 221
Q ss_pred -------------HHHHHcC------CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceeccCCCCc
Q 012192 99 -------------DLFNYCN------RKFSLK-TVLMLADQL---------INRVEYMHS--------RGFLHRDIKPDN 141 (468)
Q Consensus 99 -------------~ll~~~~------~~ls~~-~~~~ia~qi---------a~gL~yLHs--------~giiHrDIKp~N 141 (468)
.++.... ..++.. .+..+..++ ...++.+-. ..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1111111 112221 111211111 111222221 258999999999
Q ss_pred eeecccCCCCeEEEEeCCccc
Q 012192 142 FLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 142 iLl~~~~~~~~vkL~DFGla~ 162 (468)
||++ +++ +.|+||+.|.
T Consensus 158 il~~---~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVT---PQG-LKLIDWEYAS 174 (256)
T ss_pred EEEe---CCC-CEEEeccccC
Confidence 9995 333 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0029 Score=58.25 Aligned_cols=97 Identities=26% Similarity=0.282 Sum_probs=72.1
Q ss_pred HHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccC-CCHHHH----HHHcCCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 012192 59 YESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLG-PSLEDL----FNYCNRKFSLKTVLMLADQLINRVEYMHS---R 130 (468)
Q Consensus 59 ~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~g-gsL~~l----l~~~~~~ls~~~~~~ia~qia~gL~yLHs---~ 130 (468)
.|.-+++.+++..+++.+.+.+ + .+++.|+.+ +++... .. --..+|..+..||.+++..+++|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C--G--~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC--G--RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC--C--CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3677778888877888877664 2 245666664 444321 11 1246899999999999999999997 3
Q ss_pred CceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 131 giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.+.-.|++|+||-+. +++.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN---DDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEe---CCCcEEEEechhcchh
Confidence 477899999999994 7789999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.016 Score=57.83 Aligned_cols=73 Identities=15% Similarity=0.135 Sum_probs=43.1
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCC-CCCceeeE------eeEeCceeEEEEec
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG-TGIPHLKW------FGVEGDYNIMVIDL 92 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~-~~i~~l~~------~~~~~~~~~lv~el 92 (468)
.+.|+.|....+|+... ..| .+++|+.. ......+..|..++..|... -.++.+.. +....+..++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 35567777789999763 333 67888754 33345566777777777532 11333221 12234556788888
Q ss_pred cCC
Q 012192 93 LGP 95 (468)
Q Consensus 93 ~gg 95 (468)
+.|
T Consensus 104 l~G 106 (319)
T PRK05231 104 LEG 106 (319)
T ss_pred cCC
Confidence 744
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0088 Score=59.41 Aligned_cols=139 Identities=19% Similarity=0.288 Sum_probs=77.2
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCC-CCceeeE------eeEeCceeEEEEe
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGT-GIPHLKW------FGVEGDYNIMVID 91 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~-~i~~l~~------~~~~~~~~~lv~e 91 (468)
-++.++.|....+|+... .++ .+++|+.........+..|.+++..|.... .++.+.. +....+..+++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 356677777789998763 344 567887544333456677888887775422 1333322 1122445678888
Q ss_pred ccCC------CHH------HHHHH---cCCCC--------C---HHHHH------------HHHHHHHHHHHHHHh----
Q 012192 92 LLGP------SLE------DLFNY---CNRKF--------S---LKTVL------------MLADQLINRVEYMHS---- 129 (468)
Q Consensus 92 l~gg------sL~------~ll~~---~~~~l--------s---~~~~~------------~ia~qia~gL~yLHs---- 129 (468)
++.| +.. ..+.. ....+ . |.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 8743 111 11110 01111 0 11000 011123344555542
Q ss_pred ---CCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 130 ---RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 130 ---~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
.++||+|+.+.|+++. .++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 5899999999999994 45556899999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.017 Score=57.05 Aligned_cols=69 Identities=12% Similarity=0.005 Sum_probs=45.1
Q ss_pred ceEeeeCCeEEEEEEEcC------CCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 21 RKIGSGSFGELYLGVNVQ------TGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~------~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
+.|..|-...||+..... .+..+++|+..... .......|.+++..+......+.+.++... .++++++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 456667777899887432 25789999854432 224678899999888766566666665432 3466665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.012 Score=60.05 Aligned_cols=72 Identities=19% Similarity=0.285 Sum_probs=50.3
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEE----eeccC----CCchhHHHHHHHHHHhC--CCCCceeeEeeEeCceeEEE
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKT----KHPQLHYESKLYMLLQG--GTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~----~~~~~----~~~~~~~E~~~l~~l~~--~~~i~~l~~~~~~~~~~~lv 89 (468)
.+.||.|.-..||++.+...+.-|+||. ..+.. .......|.+.|+.+.. +..+|.++.| +.+..++|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5688999999999998743356799996 22211 22356778888876653 4568877776 56667778
Q ss_pred Eecc
Q 012192 90 IDLL 93 (468)
Q Consensus 90 ~el~ 93 (468)
||++
T Consensus 112 MEdL 115 (409)
T PRK12396 112 MEDL 115 (409)
T ss_pred HHhC
Confidence 8777
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.02 Score=56.37 Aligned_cols=137 Identities=16% Similarity=0.156 Sum_probs=77.5
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCC-CCceeeE------eeEeCceeEEEEec
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGT-GIPHLKW------FGVEGDYNIMVIDL 92 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~-~i~~l~~------~~~~~~~~~lv~el 92 (468)
++.|..|....+|+... .+..+++|+... .....+..|..++..+.... .++.+.. +....+..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 55677787789998763 334688897543 34456778888888886532 2333322 11233456788888
Q ss_pred cCC-CHH-----------HHHHH---cCCCC----------CHHHH----------HHHHHHHHHHHHHHHh-------C
Q 012192 93 LGP-SLE-----------DLFNY---CNRKF----------SLKTV----------LMLADQLINRVEYMHS-------R 130 (468)
Q Consensus 93 ~gg-sL~-----------~ll~~---~~~~l----------s~~~~----------~~ia~qia~gL~yLHs-------~ 130 (468)
+.| .+. ..+.. ....+ .+... ......+...+.++.. .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 733 221 11110 00011 11100 0011123334444443 4
Q ss_pred CceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 131 giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
++||+|+.|.|||+. +++.+.|+||+.|.
T Consensus 176 ~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFD---GDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence 799999999999993 45556899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.01 Score=58.08 Aligned_cols=46 Identities=11% Similarity=0.062 Sum_probs=29.0
Q ss_pred eeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCC
Q 012192 24 GSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG 70 (468)
Q Consensus 24 G~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~ 70 (468)
++|-...||... ...|..+++|.-........+.+|.+++..+..+
T Consensus 20 ~~g~~~~v~~i~-~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 20 ESGLDFQVVFAK-DTDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceeEEEEEE-cCCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence 333334555542 2357788889754333345688999999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.046 Score=55.34 Aligned_cols=140 Identities=14% Similarity=0.172 Sum_probs=79.3
Q ss_pred ceEEEceEeeeCCeEEEEEEEcC----CCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQ----TGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~----~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
...+. .|-.|-.-.+|++.... .+..|++|+...... .-....|..++..+.....-+.+.+++..+ .++
T Consensus 38 ~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 38 ALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred cEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 44444 55448888999987432 246788997543321 223477999999888877777776665433 356
Q ss_pred ecc-CCCHH--------------HHHHHc---C---CC-CC-HHHHHHHHHHH-----------------HHHHHHH---
Q 012192 91 DLL-GPSLE--------------DLFNYC---N---RK-FS-LKTVLMLADQL-----------------INRVEYM--- 127 (468)
Q Consensus 91 el~-ggsL~--------------~ll~~~---~---~~-ls-~~~~~~ia~qi-----------------a~gL~yL--- 127 (468)
+|+ +.+|. ..+... . .. .. ++.+..+..++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 665 22322 111110 0 00 11 22232332111 1111112
Q ss_pred -H----hCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 128 -H----SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 128 -H----s~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
. ...++|+|+++.|||+. +.++.++|+||..|.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 1 23589999999999995 234679999999874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0018 Score=63.66 Aligned_cols=133 Identities=20% Similarity=0.330 Sum_probs=88.8
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEe--------eccCC----------------CchhHHHHHHHHHHhCC-
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLE--------LVKTK----------------HPQLHYESKLYMLLQGG- 70 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~--------~~~~~----------------~~~~~~E~~~l~~l~~~- 70 (468)
-+.++.+||-|--+.||.+.+ ..|.+.++|+= .++.. .-...+|...|+.|..+
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 356889999999999999985 56788899950 00100 01246688888888753
Q ss_pred CCCceeeEeeEeCceeEEEEeccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC
Q 012192 71 TGIPHLKWFGVEGDYNIMVIDLLG-PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 71 ~~i~~l~~~~~~~~~~~lv~el~g-gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~ 149 (468)
--||... +....++||++.. -.|..+.. ..+..++ ...+..-+.-|-..|+||+|..-=||++ ++
T Consensus 172 fpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~----v~d~~~l---y~~lm~~Iv~la~~GlIHgDFNEFNimv---~d 237 (465)
T KOG2268|consen 172 FPVPKPI----DHNRHCVVMELVDGYPLRQVRH----VEDPPTL---YDDLMGLIVRLANHGLIHGDFNEFNIMV---KD 237 (465)
T ss_pred CCCCCcc----cccceeeHHHhhcccceeeeee----cCChHHH---HHHHHHHHHHHHHcCceecccchheeEE---ec
Confidence 2233332 3456788999883 34433222 2233333 3344444556778999999999999999 47
Q ss_pred CCeEEEEeCCcccc
Q 012192 150 ANQVYIIDYGLAKK 163 (468)
Q Consensus 150 ~~~vkL~DFGla~~ 163 (468)
+..++++||=-+..
T Consensus 238 d~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVS 251 (465)
T ss_pred CCCEEEeechHhhc
Confidence 88999999976653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.0067 Score=63.10 Aligned_cols=163 Identities=21% Similarity=0.202 Sum_probs=89.9
Q ss_pred CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 012192 53 KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 132 (468)
Q Consensus 53 ~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~gi 132 (468)
...++.-..+.++.++|.+.-.++..........++|||+++.+|+|++.... +-..... .+++
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~--------------~~~~ 88 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL--------------AHGV 88 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc--------------cccc
Confidence 34456666777777877544444433333344578999999999999988422 2111111 1222
Q ss_pred eeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHH
Q 012192 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLM 212 (468)
Q Consensus 133 iHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ 212 (468)
.| - +..+.+| .++..+ ... ..+|+||||+|.++.
T Consensus 89 ~~-----~----------~~~~~td-~~~t~~--------------~~~----------------~~pKsdVwsl~~i~~ 122 (725)
T KOG1093|consen 89 LH-----L----------NIIYITD-HFLTKY--------------PSP----------------IGPKSDVWSLGFIIL 122 (725)
T ss_pred ce-----e----------hhhhccc-cccccC--------------CCC----------------CCcchhhhhHHHHHH
Confidence 22 1 2223333 111100 001 114999999999999
Q ss_pred HHHcCCCCCCCCCcccHHHHHHHHhhccc---CCCHH-HhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 213 YFLRGSLPWQGLKAGTKKQKYDKISEKKV---STPIE-VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 213 elltG~~Pf~~~~~~~~~~~~~~i~~~~~---~~~~~-~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
++..|..-|......+....+.+...... ....+ ..-..++..+..+...|+...|..||...++
T Consensus 123 el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 123 ELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 99999888876543322222211110000 00000 1123357888899999999999988866543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.04 Score=55.40 Aligned_cols=74 Identities=18% Similarity=0.058 Sum_probs=45.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+..++....| |=...+|+...... +..|++|+...... .-....|..++..+.....-+.+.++...+ ++.
T Consensus 15 ~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~ 89 (330)
T PLN02421 15 SDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQ 89 (330)
T ss_pred CceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eee
Confidence 3455544434 77778998864332 23788997543322 224467889999888776667766654322 356
Q ss_pred ecc
Q 012192 91 DLL 93 (468)
Q Consensus 91 el~ 93 (468)
+++
T Consensus 90 ~fi 92 (330)
T PLN02421 90 SFI 92 (330)
T ss_pred hhh
Confidence 655
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.061 Score=53.26 Aligned_cols=107 Identities=13% Similarity=0.094 Sum_probs=73.5
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCC--CCCceeeEeeEe---CceeEEEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG--TGIPHLKWFGVE---GDYNIMVI 90 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~---~~~~~lv~ 90 (468)
.-.-.+.||.|..++||.... ..+ .+.+|+.........+..|...+..+... -.||.+..++.. .+..+|||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344567899999999999753 233 46778743322445889999999999764 357777765543 35579999
Q ss_pred eccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 012192 91 DLLG-PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130 (468)
Q Consensus 91 el~g-gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~ 130 (468)
|++. .++.+. ..+......++.+++.+|.-||..
T Consensus 93 E~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 93 ERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9984 445431 123445566778889999999975
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.24 Score=51.11 Aligned_cols=73 Identities=15% Similarity=0.299 Sum_probs=49.2
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEee-----ccC----CCchhHHHHHHHHHHhC--CCCCceeeEeeEeCceeE
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLEL-----VKT----KHPQLHYESKLYMLLQG--GTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~-----~~~----~~~~~~~E~~~l~~l~~--~~~i~~l~~~~~~~~~~~ 87 (468)
..+.||.|.-..||+..+ .+..|+||.-. ... .......|...|..+.. +..+|.++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467889999999999876 34468899732 111 23445667777766542 346777777755 5578
Q ss_pred EEEeccCC
Q 012192 88 MVIDLLGP 95 (468)
Q Consensus 88 lv~el~gg 95 (468)
++||++.+
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88998844
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.29 Score=50.32 Aligned_cols=73 Identities=11% Similarity=0.105 Sum_probs=44.9
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCC-CcE-----EEEEEeecc-CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQT-GEE-----IAVKLELVK-TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~-~~~-----vAIK~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
.+.+ +.|..|-...+|++..... +.. |++.+.... ..--.-..|.+++..+.....-+.+++.+. .++
T Consensus 52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~ 126 (383)
T PTZ00384 52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFT 126 (383)
T ss_pred cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEE
Confidence 3444 4555588899999874332 122 444431111 111234678999999998888888877754 357
Q ss_pred EEecc
Q 012192 89 VIDLL 93 (468)
Q Consensus 89 v~el~ 93 (468)
+++++
T Consensus 127 l~efI 131 (383)
T PTZ00384 127 IQEWV 131 (383)
T ss_pred EEEEe
Confidence 77777
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.046 Score=54.90 Aligned_cols=74 Identities=20% Similarity=0.261 Sum_probs=59.3
Q ss_pred EeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 81 VEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 81 ~~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
.++.|.|++|++-|+.|.-+- ...+++++.++.+.+.-|.-+..+ .+=|||+.-+|||| + .|+|.|+||-
T Consensus 296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfk 366 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFK 366 (488)
T ss_pred CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEee
Confidence 467788999999998876322 245778888888887777666654 68899999999999 4 8999999999
Q ss_pred cccc
Q 012192 160 LAKK 163 (468)
Q Consensus 160 la~~ 163 (468)
+|+.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.16 Score=49.97 Aligned_cols=74 Identities=16% Similarity=0.211 Sum_probs=51.2
Q ss_pred EEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHh--CCCCCceeeEeeEeCceeEEEEeccC
Q 012192 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ--GGTGIPHLKWFGVEGDYNIMVIDLLG 94 (468)
Q Consensus 18 ~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~lv~el~g 94 (468)
+-.+.|+-|....+|+.. .++..+.||+-. ......+..|.+-|..|. ..-.+|.+..++...+..+|+||++.
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445668889999999876 577889999755 445667899999999883 56678888888887778899999983
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.076 Score=54.10 Aligned_cols=60 Identities=22% Similarity=0.254 Sum_probs=41.3
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCceeecc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH-SRGFLHRDIKPDNFLMGL 146 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLH-s~giiHrDIKp~NiLl~~ 146 (468)
..+|++++. |-++..+++.. ..+++.+..++.-.+.||--+- --+++|.|+.|.||++-.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 356777777 66777777743 3444556666665566654333 458999999999999953
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.0035 Score=72.31 Aligned_cols=128 Identities=10% Similarity=-0.055 Sum_probs=92.4
Q ss_pred eeEEEEecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC-----CceeccCCCCceeecccCCCCeEEE
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCN---RKFSLKTVLMLADQLINRVEYMHSR-----GFLHRDIKPDNFLMGLGRKANQVYI 155 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~---~~ls~~~~~~ia~qia~gL~yLHs~-----giiHrDIKp~NiLl~~~~~~~~vkL 155 (468)
..+..+.++ +|.+.+.+-..- ..+...-+.....+.+.+..-+|+. --+|+++|+-|.++ ..+..||+
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~ 1381 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYNVKL 1381 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCcccc
Confidence 345666666 788888776432 2233334444444546777777754 26899999999999 57888999
Q ss_pred EeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 012192 156 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQ 222 (468)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~ 222 (468)
.++|+.+...... ...+...+++.|++++..-...++.++|+|..++.+|....|..+|-
T Consensus 1382 gk~gLdKIknp~~-------sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1382 GKGGLDKIKNPVL-------SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred cccccccccCchH-------hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999998322211 12345678888999998888889999999999999999988888774
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.92 Score=45.45 Aligned_cols=69 Identities=12% Similarity=0.091 Sum_probs=38.8
Q ss_pred eCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCC--CCCcee--eE--eeEeCceeEEEEeccCC
Q 012192 26 GSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGG--TGIPHL--KW--FGVEGDYNIMVIDLLGP 95 (468)
Q Consensus 26 G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~--~~i~~l--~~--~~~~~~~~~lv~el~gg 95 (468)
+.-..||+.. ..++..+++|+..... ...++..|.+.+..|... +.+..+ .+ +...+.+.+.++++++|
T Consensus 36 s~eN~vy~v~-~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFG-DEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEe-cCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 3445788876 3456679999753222 345677888888877642 111111 11 12234566777877743
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.45 Score=47.47 Aligned_cols=31 Identities=23% Similarity=0.446 Sum_probs=25.6
Q ss_pred CceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 131 giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++|+|+.+.|+|+. ...-+=|+||+++..-
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEeccccccC
Confidence 589999999999994 4555789999998653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.15 Score=50.34 Aligned_cols=29 Identities=41% Similarity=0.810 Sum_probs=24.6
Q ss_pred CCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 130 ~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
.++||+|+.+.|||+. . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 5789999999999994 3 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.99 E-value=1.5 Score=51.03 Aligned_cols=47 Identities=9% Similarity=0.092 Sum_probs=31.3
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhC
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQG 69 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~ 69 (468)
+.|+ |..-.+|+.. ..++..+++|+.........+..|.+++..|..
T Consensus 31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~ 77 (1013)
T PRK06148 31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSEPRVESDFQTAALDHLAA 77 (1013)
T ss_pred eecC-CcCCceEEEE-eCCCCeEEEEEcCCccchhHHHHHHHHHHHHHh
Confidence 4564 4567788876 346778999986655445566677777776654
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.79 E-value=0.66 Score=46.25 Aligned_cols=61 Identities=25% Similarity=0.236 Sum_probs=39.0
Q ss_pred eeEEEEeccCCCHHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHh----CCceeccCCCCceeec
Q 012192 85 YNIMVIDLLGPSLEDLFN----YCNRKFSLKTVLMLADQLINRVEYMHS----RGFLHRDIKPDNFLMG 145 (468)
Q Consensus 85 ~~~lv~el~ggsL~~ll~----~~~~~ls~~~~~~ia~qia~gL~yLHs----~giiHrDIKp~NiLl~ 145 (468)
-.++++.+.-++-+.+-. +.+-.--.+.+..+..||+.-.-.+-. .+++|-||||+|||+-
T Consensus 249 GnIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 317 (444)
T PHA03111 249 GNIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF 317 (444)
T ss_pred CcEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence 357888887554433321 112222345677788888766544533 3599999999999996
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.13 E-value=3.3 Score=43.40 Aligned_cols=72 Identities=13% Similarity=-0.057 Sum_probs=45.3
Q ss_pred EEceEeeeCCeEEEEEEEcC--------CCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 19 LGRKIGSGSFGELYLGVNVQ--------TGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~--------~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
-++.|..|=.-.+|++.... .+..|++++..... .-.....|..++..+.....-+.+.+.+. .+.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 44566667788899987432 14578888744332 12245678888888887666666665432 3445
Q ss_pred EeccC
Q 012192 90 IDLLG 94 (468)
Q Consensus 90 ~el~g 94 (468)
.+|+.
T Consensus 185 ~efi~ 189 (442)
T PTZ00296 185 EEWLY 189 (442)
T ss_pred EEeeC
Confidence 66663
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=90.17 E-value=1.3 Score=41.97 Aligned_cols=68 Identities=18% Similarity=0.242 Sum_probs=44.7
Q ss_pred EeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCC--CCCceeeEeeEeCceeEEEEecc
Q 012192 23 IGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG--TGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 23 LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
+--|.--+.|...+ ....+.||+ ........+..|+.-|..+... -.|+.+...+....+.|+||+++
T Consensus 24 v~gG~inea~~v~d--g~~~~FvK~-n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 24 VSGGDINEAWRLRD--GTDPFFVKC-NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cCCccccceeEeec--CCcceEEEe-cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 33344444444332 334688885 2333345678888877776644 46778888888999999999998
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=89.65 E-value=0.5 Score=46.88 Aligned_cols=29 Identities=21% Similarity=0.418 Sum_probs=25.5
Q ss_pred CceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 131 giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
++||+|+.++|+|+ +.++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhcc
Confidence 79999999999999 466789999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=89.64 E-value=0.54 Score=47.02 Aligned_cols=78 Identities=22% Similarity=0.269 Sum_probs=46.2
Q ss_pred eEEEEeccCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh----CCceeccCCCCceeecccCC--------
Q 012192 86 NIMVIDLLGPSLEDLFNY----CNRKFSLKTVLMLADQLINRVEYMHS----RGFLHRDIKPDNFLMGLGRK-------- 149 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~----~~~~ls~~~~~~ia~qia~gL~yLHs----~giiHrDIKp~NiLl~~~~~-------- 149 (468)
.++++.+.-++-+.+-.. .+-..-.+.+..+..|||.-.--+-+ .+++|-||||+|||+-..+.
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 478888886555443221 12222345566777777653321322 36999999999999963222
Q ss_pred -------CCeEEEEeCCcccc
Q 012192 150 -------ANQVYIIDYGLAKK 163 (468)
Q Consensus 150 -------~~~vkL~DFGla~~ 163 (468)
.-.++|-||.++..
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred eEEEecccceeeecccCHHHh
Confidence 22346777777654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 468 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-157 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-140 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-140 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-139 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-100 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-100 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-100 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-100 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-98 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 4e-95 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 4e-95 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 7e-29 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 1e-28 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 1e-28 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 9e-28 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 2e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 468 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 0.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 0.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 0.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 0.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-180 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-171 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-165 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 5e-24 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-23 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-23 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-23 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-23 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-22 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-22 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-22 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-22 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-22 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 6e-21 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-20 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-20 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-19 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-19 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-19 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-19 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 8e-19 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 9e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 9e-19 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-18 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-18 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-18 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-18 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-18 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-18 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-18 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-18 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-18 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-18 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-18 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-18 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-18 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 8e-18 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 9e-18 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 9e-18 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-17 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-17 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-17 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-17 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-17 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-17 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-17 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-17 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 6e-17 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-17 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-17 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 9e-17 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-16 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-16 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-16 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-16 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-16 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-16 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-16 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-16 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-16 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 6e-16 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-16 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 8e-16 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 8e-16 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 9e-16 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-15 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-15 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-15 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-15 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-15 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-15 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 9e-15 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-14 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-14 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-14 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-14 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-14 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-14 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-14 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-14 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 6e-14 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 8e-14 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 9e-14 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-13 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-13 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-13 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-13 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-13 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-13 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-13 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-13 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-13 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-13 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-13 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 7e-13 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 7e-13 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-13 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-12 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-12 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-12 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-12 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-12 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-12 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-12 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-12 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-12 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-12 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-12 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-12 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-12 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-12 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-12 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-11 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-11 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-11 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-11 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-11 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-11 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-11 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-11 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 6e-11 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 8e-11 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-10 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-10 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-10 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-10 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-10 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-10 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-10 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-10 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 5e-10 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-10 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-09 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-09 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-09 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-09 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-09 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-09 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 5e-09 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-09 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-09 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-09 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 9e-09 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 9e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-08 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-08 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-08 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-08 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-08 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-08 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-08 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-08 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-08 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-08 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 5e-08 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-08 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 7e-08 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 7e-08 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 8e-08 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-08 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-07 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-07 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-07 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-07 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-07 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-07 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-07 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-07 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-07 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-07 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-07 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-07 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-07 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-07 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-07 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 8e-07 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 8e-07 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-06 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-06 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-06 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-06 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-06 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-06 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-06 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-06 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-06 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-06 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-06 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-06 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-06 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-06 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-06 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-06 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-06 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-05 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-05 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-05 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-05 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-05 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-05 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-05 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-05 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-05 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-05 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-05 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-04 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-04 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-04 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 9e-04 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 590 bits (1521), Expect = 0.0
Identities = 274/465 (58%), Positives = 333/465 (71%), Gaps = 8/465 (1%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G KF+LGRKIGSGSFGE+YLG N+QT EE+A+KLE VKTKHPQL YESK+Y +LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GGTGIP+++WFGVEGDYN++V+DLLGPSLEDLFN+C+RK SLKTVLMLADQ+INRVE++H
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ FLHRDIKPDNFLMGLGR+ANQVYIID+GLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
SVNTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY+KISEKKV+T IE L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGS 308
C+ YP+EF SYFHYCRSLRF+DKPDYSYLKRLFRDLFIREGFQFDYVFDWT+LKY Q
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 309 SSKGRHSSGKVGLTPGPSAERPERGSVGKEIRDKLSGAVEAFSRKNAAG-TPHRDHPRHK 367
+S + G G + + + SG R+ + K
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASVGTLAKQK 360
Query: 368 SSDDGPSSKHVNPDSEKGRSFSRYGSTSRKAVIASTK---PGSSGEFSECRSSRLV-SSS 423
+ +S P R +SR+ ++S++ P + E S R++ +
Sbjct: 361 APVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDASPGAF 420
Query: 424 GRLSTTQRLQ--SGYDSRQSSFNRTAGGRICTRDDPIRSFEMLSI 466
R S Q+ + + + SS R + + ++ E L+
Sbjct: 421 RRTSGPQKSSPVNSAEPKHSSSARHSSNVK-NYESALKGIEGLNF 464
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 553 bits (1428), Expect = 0.0
Identities = 171/302 (56%), Positives = 229/302 (75%), Gaps = 3/302 (0%)
Query: 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGT 71
++G F++G+KIG G+FGEL LG N+ T E +A+KLE +K++ PQLH E + Y L G
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
GIP + +FG G YN MV++LLGPSLEDLF+ C+R FSLKTVLM+A QLI+R+EY+HS+
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 132 FLHRDIKPDNFLMGLG--RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
++RD+KP+NFL+G + ++IID+ LAK+Y D +T KHIPYRE+K+LTGTARY S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 190 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249
+NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T K++Y KI + K +TPIEVLC
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245
Query: 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGSS 309
+++P E +Y Y R L F +KPDY YL++LF DLF R+G+ FDY +DW + P +
Sbjct: 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGA 304
Query: 310 SK 311
+
Sbjct: 305 VQ 306
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 550 bits (1418), Expect = 0.0
Identities = 219/294 (74%), Positives = 268/294 (91%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G +++LGRKIGSGSFG++YLG ++ GEE+A+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP ++W G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 550 bits (1418), Expect = 0.0
Identities = 162/295 (54%), Positives = 214/295 (72%), Gaps = 2/295 (0%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
++V+G +K+GR+IG GSFG ++ G N+ +++A+K E ++ PQL E + Y LL
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
G TGIP++ +FG EG +N++VIDLLGPSLEDL + C RKFS+KTV M A Q++ RV+ +H
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 129 SRGFLHRDIKPDNFLMGL--GRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 186
+ ++RDIKPDNFL+G + AN +Y++D+G+ K YRD T +HIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 187 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246
Y S+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKY++I EKK STP+
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVL 301
LC +P EF Y HY R+L F+ PDY YL+ LF + R D FDW +L
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 507 bits (1308), Expect = e-180
Identities = 88/334 (26%), Positives = 148/334 (44%), Gaps = 29/334 (8%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGV-----NVQTGEEIAVKLELVKTKHPQLHYESKL 63
+ + +K+G IG G FG +YL +V + VK+E + + L E K
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE--PSDNGPLFTELKF 86
Query: 64 YMLLQ--------------GGTGIPHLKWFGVEG----DYNIMVIDLLGPSLEDLFNYCN 105
Y G+P G+ Y M++D G L+ ++
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 106 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165
++FS KTVL L+ ++++ +EY+H ++H DIK N L+ +QVY++DYGLA +Y
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLAYRYC 205
Query: 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLK 225
HK + GT + S++ H GV SRR DLE LGY ++ +L G LPW+
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265
Query: 226 AGTKKQKYDKISEKKVSTPIEVLC---KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFR 282
K + KI ++ + C + P E Y + L + +KP Y L+ +
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325
Query: 283 DLFIREGFQFDYVFDWTVLKYPQIGSSSKGRHSS 316
G + D D +V++ + + + + +
Sbjct: 326 QGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRA 359
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 484 bits (1248), Expect = e-171
Identities = 91/313 (29%), Positives = 141/313 (45%), Gaps = 29/313 (9%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-TKHPQLHYESKLYMLL 67
+D + G ++ LG+KIGSG FG +YL E+ A + V+ ++ L E K Y +
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 68 QGGT--------------GIPHLKWFGV----EGDYNIMVIDLLGPSLEDLFNYCNRKFS 109
GIP G+ Y MV++ LG L+ + N F
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTFK 149
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169
TVL L ++++ +EY+H ++H DIK N L+G +QVY+ DYGL+ +Y
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQVYLADYGLSYRYCPNGN 208
Query: 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL---KA 226
HK K GT + S++ H GV SRR D+E LGY ++ +L G LPW+
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268
Query: 227 GTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286
+ K + + E S S E + SL +++KP+Y LK++ I
Sbjct: 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328
Query: 287 REGFQFDYVFDWT 299
G D++
Sbjct: 329 PLGP-----LDFS 336
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 468 bits (1205), Expect = e-165
Identities = 74/317 (23%), Positives = 126/317 (39%), Gaps = 33/317 (10%)
Query: 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTG--------EEIAVKLELVKT----------- 52
G ++KL + G LY T ++ ++KL+
Sbjct: 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR 98
Query: 53 --KHPQLHYESKLYMLLQGGTGIPHLKWFGV-EGDYNIMVIDLLGPSLEDLFNYCNRK-F 108
K Q++ KLY IP FGV + Y +V+ LG SL+ + +
Sbjct: 99 AAKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVL 156
Query: 109 SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168
S ++VL +A +L++ +E++H ++H ++ +N + + +QV + YG A +Y
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCP-- 213
Query: 169 THKHIPYRENKN--LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 226
+ KH+ Y E G + S++ H G SRR DL+SLGY ++ +L G LPW
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273
Query: 227 GTKKQKYDKISEKKVSTPIEVLCKSY---PSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283
T+ K P C + Y +L +E+KP Y+ L+
Sbjct: 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333
Query: 284 LFIREGFQFDYVFDWTV 300
L +
Sbjct: 334 LLQDLRVSPYDPIGLPM 350
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 37/281 (13%), Positives = 77/281 (27%), Gaps = 53/281 (18%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK--------------------LELVKTKHP 55
K KL + G ++L +V+ E+ A+K +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 56 ---QLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI-------MVIDLLGPSLEDLFNYCN 105
+ +L + + + + +++ LE LF+ +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 R------KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159
+ + +L QLI + S+G +H PDN + ++ + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVS 239
Query: 160 LAKKYRDLQTHKHIPYRENKNLTGTARYAS--VNTHLGVEQSRRDDLESLGYVLMY-FLR 216
K + YA + + LG + +Y
Sbjct: 240 ALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLG-LSIYRVWC 288
Query: 217 GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFV 257
LP+ + G K + + + +FV
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFV 329
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 58/315 (18%), Positives = 105/315 (33%), Gaps = 63/315 (20%)
Query: 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLLQ 68
+ L +G G+ ++ G + +TG+ A+K+ E ++ L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 69 GGTGIPH---LKWFGVEGDYNIMVIDLLGPSLE-----DLFNYCNRK-----FSLKTVLM 115
H +K F +E + L+ +E L+ L+
Sbjct: 66 ------HKNIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 116 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDYGLAKKYRDLQTHKHIP 174
+ ++ + ++ G +HR+IKP N + +G VY + D+G A++ D
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-------- 168
Query: 175 YRENKNLT---GTARYAS--------VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQ 222
++ GT Y + + DL S+G V Y GSLP++
Sbjct: 169 ---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFR 224
Query: 223 GLKAG-TKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281
+ K+ KI K S I + K+ D P L R
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRGL 275
Query: 282 RDL---FIREGFQFD 293
+ L + + D
Sbjct: 276 QVLLTPVLANILEAD 290
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 59/323 (18%), Positives = 106/323 (32%), Gaps = 63/323 (19%)
Query: 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLL 67
+ L +G G+ ++ G + +TG+ A+K+ E ++ L
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 68 QGGTGIPH---LKWFGVEGDYNIMVIDLLGPSLE-----DLFNYCNRK-----FSLKTVL 114
H +K F +E + L+ +E L+ L
Sbjct: 65 N------HKNIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 115 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDYGLAKKYRDLQTHKHI 173
++ ++ + ++ G +HR+IKP N + +G VY + D+G A++ D
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED------- 168
Query: 174 PYRENKNLT---GTARYAS--------VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPW 221
++ GT Y + + DL S+G V Y GSLP+
Sbjct: 169 ----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPF 223
Query: 222 QGLKAG-TKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRL 280
+ + K+ KI K S I + K+ D P L R
Sbjct: 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRG 274
Query: 281 FRDL---FIREGFQFDYVFDWTV 300
+ L + + D W
Sbjct: 275 LQVLLTPVLANILEADQEKCWGF 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 53/255 (20%), Positives = 102/255 (40%), Gaps = 57/255 (22%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYM------ 65
+++LG +G G FG ++ G + ++A+K+ + + + L +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKV-IPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 66 LLQGGTGIPH----LKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVL--MLADQ 119
+ G G P L WF + + ++V++ P+ +DLF+Y K L Q
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGF-MLVLERPLPA-QDLFDYITEKGPLGEGPSRCFFGQ 147
Query: 120 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD--LQTHKHIPYRE 177
++ +++ HSRG +HRDIK +N L + + +ID+G D
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHDEPYTD-------- 197
Query: 178 NKNLTGTARYAS---VNTHL--GVEQSRRDDLESLG---YVLMYFLRGSLPWQGLKAGTK 229
GT Y+ ++ H + + SLG Y ++ G +P++
Sbjct: 198 ---FDGTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVC---GDIPFER------ 241
Query: 230 KQKYDKISEKKVSTP 244
+I E ++ P
Sbjct: 242 ---DQEILEAELHFP 253
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 39/285 (13%), Positives = 80/285 (28%), Gaps = 48/285 (16%)
Query: 4 DGKLRMDHVIGGK---FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL------------- 47
R++ +G + G +G + +TGE V +
Sbjct: 59 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 48 ----------ELVKTKHP---QLHYESKLYMLLQGGTGIPHL-KWFGVEGDYNIMVIDLL 93
L K+ ++H L + + E D ++ L
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 94 GPS--------LEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL 143
P E L ++ ++ L L Q+I + +H G +H ++P + +
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238
Query: 144 MGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDD 203
+ + V++ + + E L S + + D
Sbjct: 239 LD---QRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295
Query: 204 LESLGYVLMY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
+LG +++Y LP + I + P V
Sbjct: 296 AWALG-LVIYWIWCADLPITK---DAALGGSEWIFRSCKNIPQPV 336
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 50/260 (19%), Positives = 92/260 (35%), Gaps = 49/260 (18%)
Query: 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLL 67
V G + + ++IGSG +++ +N + + A+K E E L
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 83
Query: 68 QGGTGIPH---LKWFGVEGDYN-IMVIDLLGPSLE----DLFNYCNRK--FSLKTVLMLA 117
Q ++ + E I ++ +E DL ++ +K
Sbjct: 84 QQ----HSDKIIRLYDYEITDQYIYMV------MECGNIDLNSWLKKKKSIDPWERKSYW 133
Query: 118 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRE 177
++ V +H G +H D+KP NFL+ G + +ID+G+A + + T
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK---- 185
Query: 178 NKNLTGTARYAS-----------VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLK 225
+ GT Y N + S + D+ SLG ++Y G P+Q +
Sbjct: 186 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQII 243
Query: 226 AGTKKQKYDKISEKKVSTPI 245
+ K I +
Sbjct: 244 --NQISKLHAIIDPNHEIEF 261
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 50/262 (19%), Positives = 91/262 (34%), Gaps = 53/262 (20%)
Query: 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLL 67
V G + + ++IGSG +++ +N + + A+K E E L
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 64
Query: 68 QGGTGIPH---LKWFGVEGDYN-IMVIDLLGPSLE----DLFNYCNRK--FSLKTVLMLA 117
Q ++ + E I ++ +E DL ++ +K
Sbjct: 65 QQ----HSDKIIRLYDYEITDQYIYMV------MECGNIDLNSWLKKKKSIDPWERKSYW 114
Query: 118 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRE 177
++ V +H G +H D+KP NFL+ + +ID+G+A + + T
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK---- 166
Query: 178 NKNLTGTARYAS-----------VNTHLGVEQSRRDDLESLG---YVLMYFLRGSLPWQG 223
+ GT Y N + S + D+ SLG Y + Y G P+Q
Sbjct: 167 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQ 222
Query: 224 LKAGTKKQKYDKISEKKVSTPI 245
+ + K I +
Sbjct: 223 II--NQISKLHAIIDPNHEIEF 242
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 4e-22
Identities = 53/326 (16%), Positives = 111/326 (34%), Gaps = 61/326 (18%)
Query: 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYES--- 61
+ G +++ ++G+G FG + ++ TGE++A+K EL + E
Sbjct: 7 SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM 66
Query: 62 ---------KLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRK----- 107
+ G + D ++ ++ DL Y N+
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLA-------PNDLPLLAMEYC--EGGDLRKYLNQFENCCG 117
Query: 108 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167
+ L + + + Y+H +HRD+KP+N ++ G + IID G AK+
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ- 176
Query: 168 QTHKHIPYRENKNLT---GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL 224
+ T GT +Y + + + D S G + + G P+
Sbjct: 177 ----------GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP- 225
Query: 225 KAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDK-PDYSYLKRLFRD 283
+ ++ +K + I V Y +++F P ++L +
Sbjct: 226 --NWQPVQWHGKVREKSNEHIVV-----------YDDLTGAVKFSSVLPTPNHLSGILAG 272
Query: 284 L---FIREGFQFDYVFDWTVLKYPQI 306
+++ + T + P +
Sbjct: 273 KLERWLQCMLMWHQRQRGTDPQNPNV 298
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 36/292 (12%), Positives = 78/292 (26%), Gaps = 61/292 (20%)
Query: 3 ADGKLRMDHVIGGK---FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL------------ 47
R++ +G + G +G + +TGE V +
Sbjct: 63 TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI 122
Query: 48 -----------ELVKTKHPQLHYESKLYMLLQGGTGIPHLKWF----GVEGDYNIMVIDL 92
L K+ + ++ P K E D ++
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182
Query: 93 LGP----SLEDLFNYC------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNF 142
L P +L+ ++ L L Q+I + +H G +H ++P +
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242
Query: 143 LMGLGRKANQVYIIDYGLAKKY-RDLQTHKHIPYRENKNLTGTARYAS-----VNTHLGV 196
++ + V++ + + + + + H
Sbjct: 243 VLD---QRGGVFLTGFEHLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPT 292
Query: 197 EQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
+ D +LG + +Y+ LP + I + P V
Sbjct: 293 LMTFAFDTWTLG-LAIYWIWCADLPNTD---DAALGGSEWIFRSCKNIPQPV 340
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 52/257 (20%), Positives = 90/257 (35%), Gaps = 41/257 (15%)
Query: 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYML 66
V G + + ++IGSG +++ +N + + A+K E E
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 67 LQG-GTGIPHLKWFGVEGDYNIMVIDLLGPSLE----DLFNYCNRK--FSLKTVLMLADQ 119
LQ I L + + Y MV +E DL ++ +K
Sbjct: 111 LQQHSDKIIRLYDYEITDQYIYMV-------MECGNIDLNSWLKKKKSIDPWERKSYWKN 163
Query: 120 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENK 179
++ V +H G +H D+KP NFL+ + +ID+G+A + + T
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK-----D 214
Query: 180 NLTGTARYAS-----------VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 228
+ G Y N + S + D+ SLG +L Y G P+Q +
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--N 272
Query: 229 KKQKYDKISEKKVSTPI 245
+ K I +
Sbjct: 273 QISKLHAIIDPNHEIEF 289
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 42/195 (21%), Positives = 72/195 (36%), Gaps = 24/195 (12%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYE------------SK 62
F+ +G G+FG++ N A+K + + K + E +
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 63 LYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLI 121
Y + + ++ +L DL + N L Q++
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD----LQTHKHIPYRE 177
+ Y+HS+G +HRD+KP N + ++ V I D+GLAK L+
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 178 NKNLT---GTARYAS 189
+ NLT GTA Y +
Sbjct: 184 SDNLTSAIGTAMYVA 198
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 52/236 (22%), Positives = 101/236 (42%), Gaps = 46/236 (19%)
Query: 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYM-- 65
+ ++++G +GSG FG +Y G+ V +A+K + K + +L +++ M
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH-VEKDRISDWGELPNGTRVPMEV 97
Query: 66 --LLQGGTGIPH----LKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVL--MLA 117
L + +G L WF + +++++ P +DLF++ + +L+ L
Sbjct: 98 VLLKKVSSGFSGVIRLLDWFERPDSF-VLILERPEPV-QDLFDFITERGALQEELARSFF 155
Query: 118 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD--LQTHKHIPY 175
Q++ V + H+ G LHRDIK +N L + ++ +ID+G +D
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYTDF----- 208
Query: 176 RENKNLTGTARYAS---VNTHL--GVEQSRRDDLESLG---YVLMYFLRGSLPWQG 223
GT Y+ + H G + SLG Y ++ G +P++
Sbjct: 209 ------DGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVC---GDIPFEH 251
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 69/245 (28%), Positives = 109/245 (44%), Gaps = 41/245 (16%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTK-HPQLHYESKLYMLLQG 69
F++GR +G G FG +YL Q+ +A+K+ +L K QL E ++ L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 70 GTGIPH-LKWFGV-EGDYNIMVIDLLGPSLE-----DLFNYCNR--KFSLKTVLMLADQL 120
P+ L+ +G + +I LE ++ + KF + +L
Sbjct: 69 ----PNILRLYGYFHDATRVYLI------LEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180
N + Y HS+ +HRDIKP+N L+G A ++ I D+G + H P +
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTD 166
Query: 181 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYDKISEK 239
L GT Y G + DL SLG VL Y FL G P++ A T ++ Y +IS
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQETYKRISRV 222
Query: 240 KVSTP 244
+ + P
Sbjct: 223 EFTFP 227
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 43/218 (19%), Positives = 87/218 (39%), Gaps = 20/218 (9%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
F +G G+ G + + ++AVK ++ E +L L+ P+
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVK-RILPECFSFADREVQL---LRESDEHPN 79
Query: 76 -LKWFGVEGDYNI--MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 132
+++F E D + I+L +L++ + + L Q + + ++HS
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNI 139
Query: 133 LHRDIKPDNFLMGLGRKANQ--VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS- 189
+HRD+KP N L+ + + I D+GL KK + + + GT + +
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTEGWIAP 195
Query: 190 --VNTHLGVEQSRRDDLESLGYVLMYFL--RGSLPWQG 223
++ + D+ S G + Y++ GS P+
Sbjct: 196 EMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 56/263 (21%), Positives = 95/263 (36%), Gaps = 77/263 (29%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTK----------------H 54
F +GR +G G FG +YL Q +A+K+ +L K H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 55 P---QLHY----ESKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYC 104
P +++ ++Y++L G +L+
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRG----------------------------ELYKEL 105
Query: 105 NR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+ +F + ++L + + Y H R +HRDIKP+N LMG ++ I D+G +
Sbjct: 106 QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWS- 161
Query: 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPW 221
H P + + GT Y G + DL G VL Y FL G P+
Sbjct: 162 --------VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAG-VLCYEFLVGMPPF 212
Query: 222 QGLKAGTKKQKYDKISEKKVSTP 244
+ + + + +I + P
Sbjct: 213 D---SPSHTETHRRIVNVDLKFP 232
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 50/236 (21%), Positives = 91/236 (38%), Gaps = 37/236 (15%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTG 72
+ + +G GS G + G +AVK ++ E KL L
Sbjct: 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVK-RMLIDFCDIALMEIKL---LTESDD 67
Query: 73 IPH-LKWFGVEGDYN--IMVIDLLGPSLEDL------FNYCNRKFSLKTVLMLADQLINR 123
P+ ++++ E + ++L +L+DL + + + L Q+ +
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 124 VEYMHSRGFLHRDIKPDNFL----------MGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173
V ++HS +HRD+KP N L G + ++ I D+GL KK Q+
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 174 PYRENKNLTGTARYA-------SVNTHLGVEQSRRDDLESLGYVLMYFL--RGSLP 220
N +GT+ + S N +R D+ S+G + Y++ +G P
Sbjct: 188 NL---NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 64/272 (23%), Positives = 90/272 (33%), Gaps = 79/272 (29%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK----------LELVKT------ 52
M + L + +G G++GE+ L VN T E +AVK E +K
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 60
Query: 53 --KHP---QLHYE-----SKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLED 99
H + Y + Y+ L GG +
Sbjct: 61 MLNHENVVKF-YGHRREGNIQYLFLEYCSGG----------------------------E 91
Query: 100 LFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157
LF+ + QL+ V Y+H G HRDIKP+N L L + N + I D
Sbjct: 92 LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISD 148
Query: 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYA-----SVNTHLGVEQSRRDDLESLGYVLM 212
+GLA +R + + + GT Y D+ S G VL
Sbjct: 149 FGLATVFRYNNRERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLT 199
Query: 213 YFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
L G LPW Q+Y EKK
Sbjct: 200 AMLAGELPWDQ--PSDSCQEYSDWKEKKTYLN 229
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 62/249 (24%), Positives = 106/249 (42%), Gaps = 38/249 (15%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTG 72
++K R +G GSFGE+ L + TG+E AVK+ + K + Q + L +Q
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKV-ISKRQVKQKTDKESLLREVQLLKQ 82
Query: 73 IPH---LKWFGV-EGDYNI-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLINR 123
+ H +K + E +V ++ G +LF+ + FS + Q+++
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 183
+ YMH +HRD+KP+N L+ K + IID+GL+ + + K G
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--------IG 190
Query: 184 TARYASVNTHLGVEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYDKIS 237
TA Y + E D+ S G V++Y L G P+ G + K+
Sbjct: 191 TAYYIA------PEVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDILKKVE 240
Query: 238 EKKVSTPIE 246
+ K + +
Sbjct: 241 KGKYTFELP 249
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 36/163 (22%), Positives = 62/163 (38%), Gaps = 15/163 (9%)
Query: 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKL---Y 64
R + F+ ++G GS+GE++ + + G AVK + KL
Sbjct: 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVG 108
Query: 65 MLLQGGTGIPH-----LKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ 119
+ G H L+ EG + +L GPSL+ V
Sbjct: 109 SHEKVG---QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRD 165
Query: 120 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+ + ++HS+G +H D+KP N +G + + D+GL
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLV 205
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 59/256 (23%), Positives = 96/256 (37%), Gaps = 51/256 (19%)
Query: 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQG 69
D ++ GR +G G F + + + T E A K+ + K+ + H K+ M +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKI-VPKSLLLKPHQREKMSMEIS- 67
Query: 70 GTGI------PH-LKWFGV-EGDYNIMVIDLLGPSLE-----DLFNYC--NRKFSLKTVL 114
I H + + G E + + V+ LE L + +
Sbjct: 68 ---IHRSLAHQHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEAR 118
Query: 115 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174
Q++ +Y+H +HRD+K N L V I D+GLA K + +
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATKV-EYDGERK-- 172
Query: 175 YRENKNLTGTARYA-----SVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGT 228
K L GT Y S H S D+ S+G +MY L G P++
Sbjct: 173 ----KVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSC 219
Query: 229 KKQKYDKISEKKVSTP 244
K+ Y +I + + S P
Sbjct: 220 LKETYLRIKKNEYSIP 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 52/257 (20%), Positives = 97/257 (37%), Gaps = 63/257 (24%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----------HPQLHYESKL 63
K+ +GSG+FG ++ V+ + +E+ VK + K K ++ E +
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF-IKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 64 YMLLQGGTGIPH-LKWFGV-EGDYNI-MVIDLLGPSLEDLFNYCNRKFSLKTVL--MLAD 118
++ + +K + E +V++ G L+ LF + +R L L +
Sbjct: 83 LSRVEH----ANIIKVLDIFENQGFFQLVMEKHGSGLD-LFAFIDRHPRLDEPLASYIFR 137
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD---LQTHKHIPY 175
QL++ V Y+ + +HRDIK +N + + + +ID+G A T
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLERGKLFYTF----- 189
Query: 176 RENKNLTGTARYA-----SVNTHLGVEQSRRDDLESLG---YVLMYFLRGSLPWQGLKAG 227
GT Y N + G E ++ SLG Y L++ P+
Sbjct: 190 ------CGTIEYCAPEVLMGNPYRGPEL----EMWSLGVTLYTLVF---EENPFCE---- 232
Query: 228 TKKQKYDKISEKKVSTP 244
++ E + P
Sbjct: 233 -----LEETVEAAIHPP 244
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 57/283 (20%), Positives = 106/283 (37%), Gaps = 57/283 (20%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK--------------LELVKT------ 52
+ K+ L IG GS+G + + + QT A+K +E +KT
Sbjct: 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 53 --KHP---QLH--YESK--LYM---LLQGG--------------TGIPHLKWFGVEGDYN 86
HP +L+ YE + + + L GG
Sbjct: 84 KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 87 IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 146
+ + S+ + K + + Q+ + + Y+H++G HRDIKP+NFL
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF-S 202
Query: 147 GRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS--VNTHLGVEQSRRDDL 204
K+ ++ ++D+GL+K++ L ++ GT + + V + D
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 205 ESLGYVLMYF-LRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246
S G VL++ L G++P+ G ++ KK+
Sbjct: 260 WSAG-VLLHLLLMGAVPFPG---VNDADTISQVLNKKLCFENP 298
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 39/180 (21%), Positives = 74/180 (41%), Gaps = 25/180 (13%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKH-PQLHYESKLYMLLQGGTG 72
+ +G G++G +Y G ++ IA+K + +++ LH E L+ L+
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK---- 77
Query: 73 IPH---LKWFGVEGDYNIMVIDL---LGPSLEDLFNYCNRKFSLK--TVLMLADQLINRV 124
H +++ G + + I + G SL L T+ Q++ +
Sbjct: 78 --HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 125 EYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGT 184
+Y+H +HRDIK DN L + + + I D+G +K+ + + TGT
Sbjct: 136 KYLHDNQIVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPC-------TETFTGT 186
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 58/251 (23%), Positives = 113/251 (45%), Gaps = 43/251 (17%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK----LELVKTKHPQLHYESKLYMLLQ 68
+ ++ +K+GSG++GE+ L + T E A+K + + + +L E + LL
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 69 GGTGIPH-LKWFGV-EGDYNI-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLI 121
P+ +K + E N +V++ G +LF+ + F+ ++ Q++
Sbjct: 95 H----PNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIKQVL 146
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181
+ V Y+H +HRD+KP+N L+ K + I+D+GL+ + + + K
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER-------- 198
Query: 182 TGTARYASVNTHLGVEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYDK 235
GTA Y + E R+ D+ S+G V+++ L G P+ G T ++ K
Sbjct: 199 LGTAYYIA------PEVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILRK 248
Query: 236 ISEKKVSTPIE 246
+ + K +
Sbjct: 249 VEKGKYTFDSP 259
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 64/272 (23%), Positives = 90/272 (33%), Gaps = 79/272 (29%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK----------LELVKT------ 52
M + L + +G G++GE+ L VN T E +AVK E +K
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 60
Query: 53 --KHP---QLHYE-----SKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLED 99
H + Y + Y+ L GG +
Sbjct: 61 MLNHENVVKF-YGHRREGNIQYLFLEYCSGG----------------------------E 91
Query: 100 LFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157
LF+ + QL+ V Y+H G HRDIKP+N L L + N + I D
Sbjct: 92 LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISD 148
Query: 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYA-----SVNTHLGVEQSRRDDLESLGYVLM 212
+GLA +R + + + GT Y D+ S G VL
Sbjct: 149 FGLATVFRYNNRERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLT 199
Query: 213 YFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
L G LPW Q+Y EKK
Sbjct: 200 AMLAGELPWDQ--PSDSCQEYSDWKEKKTYLN 229
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 61/272 (22%), Positives = 105/272 (38%), Gaps = 82/272 (30%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK----------LELVKT--------KH 54
I F RK+GSG+FG+++L +G E +K +E ++ H
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 55 P---QLH--YESKLYM-----LLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLF--- 101
P ++ +E M +GG +L
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGG----------------------------ELLERI 111
Query: 102 ---NYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDY 158
+ S V L Q++N + Y HS+ +H+D+KP+N L + + IID+
Sbjct: 112 VSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF 171
Query: 159 GLAKKYRDLQTHKHIPYRENKNLTGTARYAS---VNTHLGVEQSRRDDLESLGYVLMYF- 214
GLA+ ++ + N GTA Y + + + D+ S G V+MYF
Sbjct: 172 GLAELFKSDEHS--------TNAAGTALYMAPEVFKRDVTFKC----DIWSAG-VVMYFL 218
Query: 215 LRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246
L G LP+ G + ++ K + K+ + +E
Sbjct: 219 LTGCLPFTG---TSLEEVQQKATYKEPNYAVE 247
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 53/252 (21%), Positives = 103/252 (40%), Gaps = 45/252 (17%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-------HPQLHYESKLYMLL 67
GK+ +G +G GS+G++ ++ +T AVK+ L K K + E +L L
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKI-LKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 68 QGGTGIPHLK-----WFGVEGDYNIMVIDLLGPSLEDLFNY-CNRKFSLKTVLMLADQLI 121
+ ++ + E MV++ ++++ + ++F + QLI
Sbjct: 64 RH----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181
+ +EY+HS+G +H+DIKP N L L + I G+A+ P+ +
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVAEALH--------PFAADDTC 168
Query: 182 T---GTARYAS------VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 232
G+ + ++T G + D+ S G L G P++G +
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAGVTLYNITTGLYPFEG---DNIYKL 221
Query: 233 YDKISEKKVSTP 244
++ I + + P
Sbjct: 222 FENIGKGSYAIP 233
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 3e-18
Identities = 58/245 (23%), Positives = 96/245 (39%), Gaps = 38/245 (15%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTK-HPQLHYESKLYMLLQG 69
FK+G +G GSF +Y ++ TG E+A+K+ + K ++ E K++ L+
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 70 GTGIPH-LKWFGV-EGDYNI-MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVE 125
P L+ + E + +V+++ + + FS Q+I +
Sbjct: 71 ----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 126 YMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT--G 183
Y+HS G LHRD+ N L+ + + I D+GLA + K+ T G
Sbjct: 127 YLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLA---------TQLKMPHEKHYTLCG 174
Query: 184 TARYAS---VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYDKISEK 239
T Y S D+ SLG + Y L G P+ T K +K+
Sbjct: 175 TPNYISPEIAT---RSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVVLA 227
Query: 240 KVSTP 244
P
Sbjct: 228 DYEMP 232
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 58/258 (22%), Positives = 95/258 (36%), Gaps = 55/258 (21%)
Query: 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQG 69
D ++ GR +G G F + + + T E A K+ + K+ + H K+ M +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKI-VPKSLLLKPHQREKMSMEIS- 93
Query: 70 GTGI------PH-LKWFGV-EGDYNIMVIDLLGPSLE-----DLFNYC--NRKFSLKTVL 114
I H + + G E + + V+ LE L + +
Sbjct: 94 ---IHRSLAHQHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEAR 144
Query: 115 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIP 174
Q++ +Y+H +HRD+K N L V I D+GLA K +
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATK---------VE 192
Query: 175 YRENKNLT--GTARYA-----SVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA 226
Y + GT Y S H S D+ S+G +MY L G P++
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---T 243
Query: 227 GTKKQKYDKISEKKVSTP 244
K+ Y +I + + S P
Sbjct: 244 SCLKETYLRIKKNEYSIP 261
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 60/247 (24%), Positives = 110/247 (44%), Gaps = 44/247 (17%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGG 70
G ++L + IG G+F ++ L ++ TG E+A+K+ +L T +L E ++ +L
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH- 73
Query: 71 TGIPH-LKWFGV-EGDYNIMVIDLLGPSLE-----DLFNY--CNRKFSLKTVLMLADQLI 121
P+ +K F V E + + +I +E ++F+Y + + K Q++
Sbjct: 74 ---PNIVKLFEVIETEKTLYLI------MEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD---LQTHKHIPYREN 178
+ V+Y H + +HRD+K +N L L N + I D+G + ++ L
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTVGGKLDAF-------- 173
Query: 179 KNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237
G YA+ G + D+ SLG +L + GSLP+ G K+ +++
Sbjct: 174 ---CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---QNLKELRERVL 227
Query: 238 EKKVSTP 244
K P
Sbjct: 228 RGKYRIP 234
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 33/203 (16%), Positives = 73/203 (35%), Gaps = 60/203 (29%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL--------ELVKT--------KHP- 55
+ K+ + +G G FG ++ V + + K LVK +H
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN 62
Query: 56 --QLH--YESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL--GPSLEDLFNYC---NR 106
LH +ES + +M+ + + D+F
Sbjct: 63 ILHLHESFESMEEL---------------------VMIFEFISGL----DIFERINTSAF 97
Query: 107 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+ + + ++ Q+ ++++HS H DI+P+N + R+++ + II++G A++ +
Sbjct: 98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKP 156
Query: 167 LQTHKHIPYRENKNLTGTARYAS 189
+ L Y +
Sbjct: 157 GDNF--------RLLFTAPEYYA 171
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 40/222 (18%), Positives = 81/222 (36%), Gaps = 23/222 (10%)
Query: 12 VIGG-KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHY---ESKLYMLL 67
+I + +K+G G F + L + G A+K ++ + E+ ++ L
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALK-RILCHEQQDREEAQREADMHRLF 83
Query: 68 QGGTGIPHLKWFGVEGDYNIMVIDLL----GPSLEDLFNYC---NRKFSLKTVLMLADQL 120
+ + + E LL +L + + +L L +
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL--QTHKHIPYREN 178
+E +H++G+ HRD+KP N L+G Q ++D G + + + + ++
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 179 KNLTGTARYAS---VNTHLGVEQSRRDDLESLG---YVLMYF 214
T Y + + R D+ SLG Y +M+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 5e-18
Identities = 41/204 (20%), Positives = 78/204 (38%), Gaps = 61/204 (29%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---------ELVKT--------KHP 55
+ + + ++G+G+FG ++ TG A K E V+ +HP
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 56 ---QLH--YESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRK- 107
LH +E M +M+ + + G +LF +
Sbjct: 215 TLVNLHDAFEDDNEM---------------------VMIYEFMSGG----ELFEKVADEH 249
Query: 108 --FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165
S + Q+ + +MH ++H D+KP+N + +++N++ +ID+GL
Sbjct: 250 NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD 308
Query: 166 DLQTHKHIPYRENKNLTGTARYAS 189
P + K TGTA +A+
Sbjct: 309 --------PKQSVKVTTGTAEFAA 324
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 28/178 (15%), Positives = 64/178 (35%), Gaps = 19/178 (10%)
Query: 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY------ 64
+ + +G G+F ++Y + + ++K + P +E +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER 120
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFN----YCNRKFSLKTVLMLADQ 119
+ + + +++V +L +L + N + V+ A +
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 120 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ--------VYIIDYGLAKKYRDLQT 169
++ +E +H +H DIKPDNF++G G + +ID G + +
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 50/262 (19%), Positives = 89/262 (33%), Gaps = 46/262 (17%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGG 70
++ L +IG GS+G + L N A+K+ +L++ + GG
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 71 TGIPHLKWFGVEGDYNIM-------------VIDLLGPS-----LE-----DLFNYCNR- 106
P V + I+ V+D E +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 107 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
S LI +EY+H + +HRDIKP N L+G + + I D+G++ +++
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKG 189
Query: 167 LQTHKHIPYRENKNLTGTARYAS----VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQ 222
N GT + + T + D+ ++G L F+ G P+
Sbjct: 190 SDALLS-------NTVGTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQCPFM 241
Query: 223 GLKAGTKKQKYDKISEKKVSTP 244
+ KI + + P
Sbjct: 242 D---ERIMCLHSKIKSQALEFP 260
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 9e-18
Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 61/204 (29%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---------ELVKT--------KHP 55
+ + + ++GSG+FG ++ V TG K VK HP
Sbjct: 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 56 ---QLH--YESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRK- 107
LH +E K M +++++ L G +LF+ +
Sbjct: 109 KLINLHDAFEDKYEM---------------------VLILEFLSGG----ELFDRIAAED 143
Query: 108 --FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165
S V+ Q +++MH +H DIKP+N + +KA+ V IID+GLA K
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLN 202
Query: 166 DLQTHKHIPYRENKNLTGTARYAS 189
P K T TA +A+
Sbjct: 203 --------PDEIVKVTTATAEFAA 218
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 59/251 (23%), Positives = 102/251 (40%), Gaps = 43/251 (17%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK----LELVKTKHPQLHYESKLYMLLQ 68
++ + +G GSFGE+ + T +E AVK + E +L L
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 69 GGTGIPH-LKWFGV-EGDYNI-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLI 121
P+ +K F + E + +V +L G +LF+ ++ FS + Q+
Sbjct: 80 H----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181
+ + YMH +HRD+KP+N L+ K + IID+GL+ ++ K
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-------- 183
Query: 182 TGTARYASVNTHLGVEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYDK 235
GTA Y + E R D+ S G V++Y L G+ P+ G + +
Sbjct: 184 IGTAYYIA------PEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDILKR 233
Query: 236 ISEKKVSTPIE 246
+ K + +
Sbjct: 234 VETGKYAFDLP 244
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 39/181 (21%), Positives = 63/181 (34%), Gaps = 59/181 (32%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTK------------HP--- 55
++ + IGSG+FG L + T E +AVK + HP
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 56 QLHYE-----SKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY--CN 105
+ E + L +++ GG +L+
Sbjct: 80 RF-KEVILTPTHLAIIMEYASGG----------------------------ELYERICNA 110
Query: 106 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165
+FS QL++ V Y HS HRD+K +N L+ G A ++ I D+G +K
Sbjct: 111 GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSV 169
Query: 166 D 166
Sbjct: 170 L 170
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 35/169 (20%), Positives = 75/169 (44%), Gaps = 22/169 (13%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYML----- 66
+ ++ + + +GSG+ GE+ L +T +++A+K + K +
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 67 -LQGGTGIPH---LKWFGVEGDYNI-MVIDLL--GPSLEDLFNY-CNR-KFSLKTVLMLA 117
L+ + H +K + +V++L+ G +LF+ + T +
Sbjct: 68 ILKK---LNHPCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYF 120
Query: 118 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
Q++ V+Y+H G +HRD+KP+N L+ + + I D+G +K +
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 40/174 (22%), Positives = 66/174 (37%), Gaps = 20/174 (11%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH- 75
++G GSFGE++ + QTG + AVK ++ + E L
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---ELVACAGLS------SP 110
Query: 76 --LKWFGVEGDYNIMVIDL---LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130
+ +G + + I + G SL L L Q + +EY+H+R
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTR 169
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGT 184
LH D+K DN L L ++ + D+G A + K + + GT
Sbjct: 170 RILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 36/186 (19%), Positives = 79/186 (42%), Gaps = 28/186 (15%)
Query: 1 MFADGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK----------LELV 50
+ D + + ++ + + +GSG+ GE+ L +T +++A++
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180
Query: 51 KTKHPQLHYESKLYMLLQGGTGIPH---LKWFGVEGDYNI-MVIDLL--GPSLEDLFNY- 103
+ E ++ L H +K + +V++L+ G +LF+
Sbjct: 181 ADPALNVETEIEILKKLN------HPCIIKIKNFFDAEDYYIVLELMEGG----ELFDKV 230
Query: 104 -CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
N++ T + Q++ V+Y+H G +HRD+KP+N L+ + + I D+G +K
Sbjct: 231 VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 163 KYRDLQ 168
+
Sbjct: 291 ILGETS 296
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 47/224 (20%), Positives = 81/224 (36%), Gaps = 37/224 (16%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----------LELVKTKHPQLHYES 61
++ +G G + ++ T +E AVK E V+ E
Sbjct: 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 62 KLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLA 117
+ + G I LK + +V DL+ G +LF+Y K S K +
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKETRKIM 130
Query: 118 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRE 177
L+ + +H +HRD+KP+N L L N + + D+G + + +
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDPGEKL------- 180
Query: 178 NKNLTGTARYAS--VNTHLGVEQSRRDDLE----SLGYVLMYFL 215
+ + GT Y + + + E S G V+MY L
Sbjct: 181 -REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTL 222
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 40/245 (16%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY-----M-LLQ 68
G + + +G GSFG++ L + +T +++A+K + + + ++ + LL+
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKF-ISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 69 GGTGIPH-LKWFGV-EGDYNI-MVIDLLGPSLEDLFNYC--NRKFSLKTVLMLADQLINR 123
PH +K + V +I MVI+ G +LF+Y ++ + Q+I
Sbjct: 68 H----PHIIKLYDVITTPTDIVMVIEYAG---GELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD---LQTHKHIPYRENKN 180
+EY H +HRD+KP+N L L N V I D+GL+ D L+T
Sbjct: 121 IEYCHRHKIVHRDLKPENLL--LDDNLN-VKIADFGLSNIMTDGNFLKT----------- 166
Query: 181 LTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239
G+ YA+ G D+ S G VL L G LP+ + K++
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD---EFIPNLFKKVNSC 223
Query: 240 KVSTP 244
P
Sbjct: 224 VYVMP 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 61/267 (22%), Positives = 94/267 (35%), Gaps = 77/267 (28%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---------LELVKT--------KHP 55
I + L IG GS+GE+ + V T A K ++ K HP
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 56 ---QLH--YESK--LYM---LLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCN 105
+L+ +E +Y+ L GG +LF
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGG----------------------------ELFERVV 98
Query: 106 RK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
K F + +++ V Y H HRD+KP+NFL + + +ID+GLA +
Sbjct: 99 HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 164 YRDLQTHKHIPYRENKNLTGTARYAS---VNTHLGVEQSRRDDLESLGYVLMYF-LRGSL 219
++ + + GT Y S + G E D S G V+MY L G
Sbjct: 159 FKPGKMM--------RTKVGTPYYVSPQVLEGLYGPEC----DEWSAG-VMMYVLLCGYP 205
Query: 220 PWQGLKAGTKKQKYDKISEKKVSTPIE 246
P+ T + KI E + P +
Sbjct: 206 PFSA---PTDSEVMLKIREGTFTFPEK 229
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 19/170 (11%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQ 68
++ + +G GSFGE+ + T +E AVK+ + E +L L
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 69 GGTGIPH-LKWFGV-EGDYNI-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLI 121
P+ +K F + E + +V +L G +LF+ ++ FS + Q+
Sbjct: 80 H----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171
+ + YMH +HRD+KP+N L+ K + IID+GL+ ++ K
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 7e-17
Identities = 42/208 (20%), Positives = 76/208 (36%), Gaps = 72/208 (34%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---------------LELVKT-------- 52
+++G ++GSG F + TG+E A K E ++
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 53 KHP---QLH--YESKLYM-----LLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFN 102
+HP LH +E+K + L+ GG +LF+
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGG----------------------------ELFD 97
Query: 103 YCNRK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDYG 159
+ K + Q+++ V Y+HS+ H D+KP+N ++ ++ +ID+G
Sbjct: 98 FLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157
Query: 160 LAKKYRDLQTHKHIPYRENKNLTGTARY 187
+A K KN+ GT +
Sbjct: 158 IAHKIEAGNEF--------KNIFGTPEF 177
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 43/211 (20%), Positives = 76/211 (36%), Gaps = 72/211 (34%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---------------LELVKT----- 52
+ + +G ++GSG F + TG E A K E ++
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 53 ---KHP---QLH--YESKLYM-----LLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLED 99
H LH YE++ + L+ GG +
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSGG----------------------------E 101
Query: 100 LFNYCNRKFSL--KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM-GLGRKANQVYII 156
LF++ +K SL + Q+++ V Y+H++ H D+KP+N ++ + +I
Sbjct: 102 LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161
Query: 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARY 187
D+GLA + D KN+ GT +
Sbjct: 162 DFGLAHEIEDGVEF--------KNIFGTPEF 184
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-17
Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 32/173 (18%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY-----M-LLQ 68
G + LG +G G+FG++ +G + TG ++AVK+ L + K L K+ + L +
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKI-LNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 69 GGTGIPH-LKWFGV-EGDYNIMVIDLLGPSLE-----DLFNYC--NRKFSLKTVLMLADQ 119
PH +K + V + ++ +E +LF+Y + + L Q
Sbjct: 70 H----PHIIKLYQVISTPTDFFMV------MEYVSGGELFDYICKHGRVEEMEARRLFQQ 119
Query: 120 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD---LQT 169
+++ V+Y H +HRD+KP+N L L N I D+GL+ D L+T
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSDGEFLRT 169
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 41/202 (20%), Positives = 69/202 (34%), Gaps = 30/202 (14%)
Query: 5 GKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE----------LVK 51
G +D G FK IGSG FG+++ + G+ +K L K
Sbjct: 1 GAHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAK 60
Query: 52 TKHPQL--HYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRK- 107
H + + + + + ++ +LE +
Sbjct: 61 LDHVNIVHYNGC--WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 108 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167
L L +Q+ V+Y+HS+ ++RD+KP N + QV I D+GL ++
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKND 175
Query: 168 QTHKHIPYRENKNLTGTARYAS 189
GT RY S
Sbjct: 176 GKRTRS--------KGTLRYMS 189
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 62/277 (22%), Positives = 100/277 (36%), Gaps = 81/277 (29%)
Query: 4 DGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---------------- 47
+ + DH F++ R IG GSFG++ + T + A+K
Sbjct: 9 NEDVNFDH-----FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF 63
Query: 48 -E---LVKTKHP---QLHY----ESKLYM---LLQGGTGIPHLKWFGVEGDYNIMVIDLL 93
E + +HP L Y E ++M LL GG
Sbjct: 64 KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG----------------------- 100
Query: 94 GPSLEDLFN--YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151
DL N F +TV + +L+ ++Y+ ++ +HRD+KPDN L+ +
Sbjct: 101 -----DLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHG 152
Query: 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS---VNTHLGVEQSRRDDLESLG 208
V+I D+ +A + GT Y + ++ G S D SLG
Sbjct: 153 HVHITDFNIAAMLPRETQI--------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG 204
Query: 209 YVLMY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
V Y LRG P+ + + K+ V+ P
Sbjct: 205 -VTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 16 KFKLGRK-IGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYML--LQGGTG 72
++L +G G+ + +N+ T +E AVK+ + H + ++ ML QG
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 73 IPHLKWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMH 128
+ L F E D +V + + G + ++ +++ F+ ++ + + ++++H
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
++G HRD+KP+N L + + V I D+ L + I E G+A Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 189 S--VNTHLGVEQSRRD---DLESLGYVLMYFL 215
+ V E S D DL SLG V++Y L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 19/165 (11%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQ 68
+ + ++G G+F + V+ TG E A K+ +L +L E+++ LQ
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 69 GGTGIPH---LKWFGVEGDYNIMVIDLL--GPSLEDLFNY-CNR-KFSLKTVLMLADQLI 121
P+ L E ++ +V DL+ G +LF R +S Q++
Sbjct: 64 H----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQIL 115
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+ Y HS G +HR++KP+N L+ K V + D+GLA + D
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 45/208 (21%), Positives = 78/208 (37%), Gaps = 66/208 (31%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---------------LELVKT----- 52
+ + G ++GSG F + TG + A K E ++
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 53 ---KHP---QLH--YESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL--GPSLEDLFN 102
+HP LH YE+K + I++++L+ G +LF+
Sbjct: 69 KEIQHPNVITLHEVYENKTDV---------------------ILILELVAGG----ELFD 103
Query: 103 YCNRK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDYG 159
+ K + + Q++N V Y+HS H D+KP+N ++ ++ IID+G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 160 LAKKYRDLQTHKHIPYRENKNLTGTARY 187
LA K KN+ GT +
Sbjct: 164 LAHKIDFGNEF--------KNIFGTPEF 183
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 58/261 (22%), Positives = 99/261 (37%), Gaps = 73/261 (27%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LE-------------------LVKTKHP- 55
FK G+ +G GSF + L + T E A+K LE + + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 56 --QLHY----ESKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR 106
+L++ + KLY L + G +L Y +
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNG----------------------------ELLKYIRK 123
Query: 107 --KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
F ++++ +EY+H +G +HRD+KP+N L+ + + I D+G AK
Sbjct: 124 IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVL 180
Query: 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 223
+ GTA+Y S + DL +LG ++Y + G P+
Sbjct: 181 SPESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF-- 232
Query: 224 LKAGTKKQKYDKISEKKVSTP 244
+AG + + KI + + P
Sbjct: 233 -RAGNEYLIFQKIIKLEYDFP 252
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 43/205 (20%), Positives = 80/205 (39%), Gaps = 66/205 (32%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---------------LELVKT-------- 52
+ +G ++GSG F + TG E A K E ++
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 53 KHP---QLH--YESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL--GPSLEDLFNYCN 105
HP LH YE++ + +++++L+ G +LF++
Sbjct: 73 LHPNIITLHDVYENRTDV---------------------VLILELVSGG----ELFDFLA 107
Query: 106 RKFSL--KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDYGLAK 162
+K SL + Q+++ V Y+H++ H D+KP+N ++ + +ID+GLA
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 163 KYRDLQTHKHIPYRENKNLTGTARY 187
+ D KN+ GT +
Sbjct: 168 EIEDGVEF--------KNIFGTPEF 184
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 33/209 (15%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKW 78
+ +G GSF V+ ++ + AVK+ + K E L +G I L
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKI-ISKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 79 FGVEGDYNIMVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGFLH 134
+ + +V++LL G +LF +K FS + +L++ V +MH G +H
Sbjct: 74 VFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 135 RDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT---GTARYAS-- 189
RD+KP+N L ++ IID+G A+ +N+ L T YA+
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPCFTLHYAAPE 179
Query: 190 VNTHLGVEQSRRD---DLESLGYVLMYFL 215
+ + Q+ D DL SLG V++Y +
Sbjct: 180 L-----LNQNGYDESCDLWSLG-VILYTM 202
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 42/221 (19%), Positives = 68/221 (30%), Gaps = 73/221 (33%)
Query: 5 GKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK--------------LELV 50
D + ++L IG G F + +N +TG++ AVK E +
Sbjct: 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 51 KT--------KHP---QLH--YESK--LYM---LLQGGTGIPHLKWFGVEGDYNIMVIDL 92
K KHP +L Y S LYM + G
Sbjct: 74 KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA---------------------- 111
Query: 93 LGPSLEDLFNYCNRKFSLKTVLMLAD------QLINRVEYMHSRGFLHRDIKPDNFLMGL 146
DL ++ V A Q++ + Y H +HRD+KP L+
Sbjct: 112 ------DLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLAS 165
Query: 147 GRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 187
+ V + +G+A + + GT +
Sbjct: 166 KENSAPVKLGGFGVAIQLGE-------SGLVAGGRVGTPHF 199
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 35/179 (19%), Positives = 73/179 (40%), Gaps = 22/179 (12%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGTGIP 74
+++G G F + ++ TG+E A K + ++ +E + L + +
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 75 HLKWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRK----FSLKTVLMLADQLINRVEYMH 128
+L I++++ G ++F+ C + S V+ L Q++ V Y+H
Sbjct: 93 NLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 187
+H D+KP N L+ + I+D+G+++K + + GT Y
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--------REIMGTPEY 199
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 57/257 (22%), Positives = 98/257 (38%), Gaps = 52/257 (20%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------LELVKTKHPQLHYESKLYML 66
IG + RK+GSG++GE+ L E A+K + + + E +
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 67 ------LQGGTGIPH---LKWFGV-EGDYNI-MVIDLL--GPSLEDLFNYCNRK--FSLK 111
L+ + H +K F V E +V + G +LF + F
Sbjct: 94 YNEISLLKS---LDHPNIIKLFDVFEDKKYFYLVTEFYEGG----ELFEQIINRHKFDEC 146
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171
+ Q+++ + Y+H +HRDIKP+N L+ + I+D+GL+ + +
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLK 225
GTA Y + E ++ D+ S G V+MY L G P+ G
Sbjct: 207 DR--------LGTAYYIA------PEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG-- 249
Query: 226 AGTKKQKYDKISEKKVS 242
+ K+ + K
Sbjct: 250 -QNDQDIIKKVEKGKYY 265
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 21/168 (12%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYML----- 66
K+ IG G + V+ TG E AVK +E+ + E
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 67 -LQGGTGIPH-LKWFGV-EGDYNI-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLAD 118
L+ G PH + E + +V DL+ G +LF+Y K S K +
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
L+ V ++H+ +HRD+KP+N L L + + D+G +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEP 252
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 62/241 (25%), Positives = 101/241 (41%), Gaps = 36/241 (14%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+++ IG GS+ ++ T E AVK+ + E ++ + I
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI--IDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 76 LKWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRG 131
LK +G Y +V +L+ G +L + R+ FS + + + VEY+H++G
Sbjct: 81 LKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 132 FLHRDIKPDNFLM-GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT---GTARY 187
+HRD+KP N L + I D+G AK+ R EN L TA +
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLLMTPCYTANF 186
Query: 188 AS--VNTHLGVEQSRRD---DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYDKISEKKV 241
+ V +E+ D D+ SLG VL+Y L G P+ T ++ +I K
Sbjct: 187 VAPEV-----LERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGKF 240
Query: 242 S 242
S
Sbjct: 241 S 241
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 38/185 (20%), Positives = 68/185 (36%), Gaps = 59/185 (31%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----------LELVKT--------K 53
+ + ++G G+F + V+ TG E A K + ++ +
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 54 HP---QLH--YESK--LYM---LLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY 103
HP +LH + + Y+ L+ GG +LF
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVTGG----------------------------ELFED 118
Query: 104 CNRK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
+ +S Q++ + Y HS G +HR++KP+N L+ K V + D+GLA
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 162 KKYRD 166
+ D
Sbjct: 179 IEVND 183
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 41/228 (17%), Positives = 79/228 (34%), Gaps = 29/228 (12%)
Query: 13 IGG-KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH--PQLHYESKLYMLLQG 69
+G + ++ R + G F +Y +V +G E A+K L + + E L G
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG 84
Query: 70 --------GTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFN--YCNRKFSLKTVLMLADQ 119
+ +++ +L L + S TVL + Q
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 120 LINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD-----LQTHKH 172
V++MH + +HRD+K +N L+ + + D+G A +
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 173 IPYRENKNLTGTARYAS---VNTHLGVEQSRRDDLESLG---YVLMYF 214
E T Y + ++ + + D+ +LG Y+L +
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 45/201 (22%), Positives = 82/201 (40%), Gaps = 63/201 (31%)
Query: 16 KFKLGRK--IGSGSFGELYLGVNVQTGEEIAVKL---------ELVKT--------KHP- 55
+ + + +G G FG+++ TG ++A K+ E VK H
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 56 --QLH--YESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRK-- 107
QL+ +ESK + ++V++ + G +LF+ +
Sbjct: 148 LIQLYDAFESKNDI---------------------VLVMEYVDGG----ELFDRIIDESY 182
Query: 108 -FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+ ++ Q+ + +MH LH D+KP+N L + R A Q+ IID+GLA++Y+
Sbjct: 183 NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK- 240
Query: 167 LQTHKHIPYRENKNLTGTARY 187
P + K GT +
Sbjct: 241 -------PREKLKVNFGTPEF 254
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 57/183 (31%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------LE-----LVKTKHP 55
I F +GSG+F E++L TG+ A+K LE L K KH
Sbjct: 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 56 ---QLH--YESK--LYM---LLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY-C 104
L YES Y+ L+ GG +LF+
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGG----------------------------ELFDRIL 98
Query: 105 NR-KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
R ++ K ++ Q+++ V+Y+H G +HRD+KP+N L + +++ I D+GL+K
Sbjct: 99 ERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158
Query: 164 YRD 166
++
Sbjct: 159 EQN 161
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 63/267 (23%), Positives = 102/267 (38%), Gaps = 83/267 (31%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--------------------- 53
G + LG +G G+FG++ +G + TG ++AVK+ L + K
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKI-LNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 54 HP---QLH--YESK--LYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY 103
HP +L+ + ++M++ GG +LF+Y
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGG----------------------------ELFDY 106
Query: 104 C--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
N + K L Q+++ V+Y H +HRD+KP+N L L N I D+GL+
Sbjct: 107 ICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLS 163
Query: 162 KKYRD---LQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRG 217
D L+T G+ YA+ G D+ S G +L L G
Sbjct: 164 NMMSDGEFLRT-----------SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212
Query: 218 SLPWQGLKAGTKKQKYDKISEKKVSTP 244
+LP+ + KI + TP
Sbjct: 213 TLPFDD---DHVPTLFKKICDGIFYTP 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 43/202 (21%), Positives = 68/202 (33%), Gaps = 43/202 (21%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKL---YMLLQGGTG 72
+F KIGSG FG ++ V G A+K K + ++ L Y G
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAVLG-- 68
Query: 73 IPH---LKWFG--VEGDYNIMVIDLL-GPSLEDLFNYCNRK---FSLKTVLMLADQLINR 123
H +++F E D+ ++ + G SL D + R F + L Q+
Sbjct: 69 -QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 124 VEYMHSRGFLHRDIKPDN-FLMGLGRKANQVYII---------------DYGLAKKYRDL 167
+ Y+HS +H DIKP N F+ D G +
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 168 QTHKHIPYRENKNLTGTARYAS 189
Q G +R+ +
Sbjct: 188 QV-----------EEGDSRFLA 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 38/185 (20%), Positives = 66/185 (35%), Gaps = 59/185 (31%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----------LELVKT--------K 53
+++L ++G G+F + V V G+E A + ++ K
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 54 HP---QLH--YESK--LYM---LLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY 103
HP +LH + Y+ L+ GG +LF
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGG----------------------------ELFED 100
Query: 104 -CNR-KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
R +S Q++ V + H G +HR++KP+N L+ K V + D+GLA
Sbjct: 101 IVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
Query: 162 KKYRD 166
+
Sbjct: 161 IEVEG 165
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 32/150 (21%), Positives = 64/150 (42%), Gaps = 9/150 (6%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKW 78
+ +G G G++ N +T E+ A+K + P+ E +L+ I +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 79 F---GVEGDYNI-MVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 132
G + +V++ L G + + ++ F+ + + + ++Y+HS
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
HRD+KP+N L R + + D+G AK
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 42/290 (14%), Positives = 94/290 (32%), Gaps = 53/290 (18%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIP 74
+++ R + G F ++ L + A+K K+ + +K
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKK-YEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 75 H-----------------LKWFGV-EGDYNI-MVIDLLGPSLEDLFNY----------CN 105
L G+ + ++ + + + + +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM--ENDSILKFDEYFFVLDKNYT 145
Query: 106 RKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
++ + + ++N Y+H+ + HRD+KP N LM K +V + D+G ++
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESEYM 202
Query: 165 RDLQTHKHIPYRENKNLTGTARYAS--VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPW 221
D + GT + ++ + D+ SLG + +Y +P+
Sbjct: 203 VDKKIKG---------SRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNVVPF 252
Query: 222 QGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDK 271
+ + ++ I K + P++ YP L ED
Sbjct: 253 SL--KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 30/158 (18%), Positives = 69/158 (43%), Gaps = 10/158 (6%)
Query: 16 KFKLGRK-IGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIP 74
++L ++ +G G G++ + +TG++ A+K + P+ E + GG I
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGGPHIV 85
Query: 75 HLKWF---GVEGDYNI-MVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
+ G + ++++ + G + ++ F+ + + + ++++H
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
S HRD+KP+N L K + + D+G AK+
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 44/188 (23%), Positives = 71/188 (37%), Gaps = 33/188 (17%)
Query: 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH-- 75
L IG G FGE++ G GEE+AVK+ + E+++Y + + H
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKI-FSSREERSWFREAEIYQTVM----LRHEN 97
Query: 76 -LKWFGVEGDYNIMVIDLL-------GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 127
L + + N L SL D N +++ ++ LA + + ++
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHL 155
Query: 128 HSR--------GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENK 179
H HRD+K N L+ +K I D GLA ++ I
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA---PN 209
Query: 180 NLTGTARY 187
+ GT RY
Sbjct: 210 HRVGTKRY 217
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 31/183 (16%), Positives = 69/183 (37%), Gaps = 21/183 (11%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGT---G 72
+ + ++IG G FG ++ G V+ +A+K ++ + K +
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 73 IPH---LKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
+ H +K +G+ + MV++ + L L L + +EYM
Sbjct: 80 LNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 129 SRG--FLHRDIKPDNFLMGLGRKANQVY--IIDYGLAKKYRDLQTHKHIPYRENKNLTGT 184
++ +HRD++ N + + V + D+GL+++ + L G
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS----------GLLGN 189
Query: 185 ARY 187
++
Sbjct: 190 FQW 192
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 32/154 (20%), Positives = 65/154 (42%), Gaps = 9/154 (5%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKW 78
+ +G G G++ N +T E+ A+K + P+ E +L+ I +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVD 122
Query: 79 F---GVEGDYNI-MVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 132
G + +V++ L G + + ++ F+ + + + ++Y+HS
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
HRD+KP+N L R + + D+G AK+
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 60/285 (21%), Positives = 116/285 (40%), Gaps = 39/285 (13%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYE--------SKLY--- 64
+ +G++IGSGSFG +Y G ++AVK+ V PQ K
Sbjct: 25 QITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 65 -MLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLIN 122
+L G + P L +V G SL + KF +K ++ +A Q
Sbjct: 82 ILLFMGYSTAPQL----------AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 123 RVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 182
++Y+H++ +HRD+K +N + + N V I D+GLA + + + + L+
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT-----EKSRWSGSHQFEQLS 183
Query: 183 GTARYAS---VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239
G+ + + + S + D+ + G VL + G LP+ + + Q + +
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRG 241
Query: 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284
+S + + + P C + +++P + + +L
Sbjct: 242 SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 49/235 (20%), Positives = 99/235 (42%), Gaps = 45/235 (19%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQL----HYESKLY 64
+ +I ++K+ K+G G +YL + ++A+K + +
Sbjct: 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-I----FIPPREKEETLKRFE 59
Query: 65 MLLQGGTGIPHLKW-----FGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLAD 118
+ + + H E D +V++ + GP+L + + S+ T + +
Sbjct: 60 REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTN 118
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL---QTHKHIPY 175
Q+++ +++ H +HRDIKP N L+ + I D+G+AK + QT+
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQTN----- 170
Query: 176 RENKNLTGTARYASVNTHLGVEQSR------RDDLESLGYVLMY-FLRGSLPWQG 223
++ GT +Y S EQ++ D+ S+G +++Y L G P+ G
Sbjct: 171 ----HVLGTVQYFS------PEQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 36/185 (19%), Positives = 78/185 (42%), Gaps = 22/185 (11%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH- 75
G +G G FG+ + +TGE + +K + + Q + ++ ++ + H
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC----LEHP 67
Query: 76 --LKWFGV---EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
LK+ GV + N + + + G +L + + ++ + A + + + Y+HS
Sbjct: 68 NVLKFIGVLYKDKRLNF-ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD-------LQTHKHIPYRENKNLT 182
+HRD+ N L+ + V + D+GLA+ D L++ K ++ +
Sbjct: 127 MNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 183 GTARY 187
G +
Sbjct: 184 GNPYW 188
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 29/187 (15%)
Query: 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYML 66
+ ++ L RK+G G F ++L ++ +A+K +V+ E KL
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK--IVRGDKVYTEAAEDEIKLLQR 71
Query: 67 L----------QGGTGIPHLK-WF---GVEGDYNIMVIDLLGPSLEDLF-NYCNRKFSLK 111
+ G I L F G G + +MV ++LG +L L Y +R L
Sbjct: 72 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 131
Query: 112 TVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRK---ANQVYIIDYGLA-----K 162
V ++ QL+ ++YMH R G +H DIKP+N LM + Q+ I D G A
Sbjct: 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 163 KYRDLQT 169
+QT
Sbjct: 192 YTNSIQT 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 5e-14
Identities = 35/176 (19%), Positives = 64/176 (36%), Gaps = 52/176 (29%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE----------------LVKTKHPQ 56
K++ KIG GS+G ++ N TG+ +A+K L + KHP
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 57 L-------HYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFS 109
L + +L++ V + ++ + R
Sbjct: 64 LVNLLEVFRRKRRLHL-----------------------VFEYCDHTVLHELDRYQRGVP 100
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165
V + Q + V + H +HRD+KP+N L+ K + + + D+G A+
Sbjct: 101 EHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLT 153
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 30/170 (17%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
++L RK+G G + E++ +N+ E++ VK L+ VK K ++ E K+ L+GG I
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKREIKILENLRGGPNII 94
Query: 75 HLKWFGVEGDYNIMVIDLLGPSLED----LFNYCN--------RKFSLKTVLMLADQLIN 122
L D++ + +F + N + + + +++
Sbjct: 95 TL-------------ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 141
Query: 123 RVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172
++Y HS G +HRD+KP N + + + ++ +ID+GLA+ Y Q +
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNV 189
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 8e-14
Identities = 42/248 (16%), Positives = 84/248 (33%), Gaps = 70/248 (28%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQ-TGEEIAVKL---------------E- 48
+L ++ G++++ I G G +YL ++ G + +K E
Sbjct: 71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER 130
Query: 49 --LVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI-----MVIDLL-GPSLEDL 100
L + HP I + F D + +V++ + G SL+
Sbjct: 131 QFLAEVVHP----------------SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRS 174
Query: 101 FNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160
+K + + +++ + Y+HS G ++ D+KP+N ++ Q+ +ID G
Sbjct: 175 KG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGA 227
Query: 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSR-----RDDLESLGYVLMYFL 215
+ Y GT + + E R D+ ++G L
Sbjct: 228 VSR----INSFGYLY-------GTPGFQA------PEIVRTGPTVATDIYTVGRTLAALT 270
Query: 216 RGSLPWQG 223
G
Sbjct: 271 LDLPTRNG 278
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 36/174 (20%), Positives = 77/174 (44%), Gaps = 30/174 (17%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESK 62
+ ++++ + IG GSFG++ + + + +A+K+ V+ + H Q E +
Sbjct: 88 VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM--VRNEKRFHRQAAEEIR 145
Query: 63 LYMLLQGGTGIPHLKWFGVEGDYNI--------------MVIDLLGPSLEDLFNYCN-RK 107
+ L+ HL+ + N+ M +LL +L +L +
Sbjct: 146 I---LE------HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG 196
Query: 108 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
FSL V A ++ ++ +H +H D+KP+N L+ + + + +ID+G +
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSS 249
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 38/181 (20%), Positives = 73/181 (40%), Gaps = 29/181 (16%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+ ++ +G G+FG + +++A+K +++ E + + H
Sbjct: 9 EIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAFIVELRQLSRVN------H 60
Query: 76 ---LKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHS 129
+K +G + +V++ G SL ++ + ++ + Q V Y+HS
Sbjct: 61 PNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 130 R---GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 186
+HRD+KP N L L + I D+G A D+QTH N G+A
Sbjct: 121 MQPKALIHRDLKPPNLL--LVAGGTVLKICDFGTA---CDIQTHM-------TNNKGSAA 168
Query: 187 Y 187
+
Sbjct: 169 W 169
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 36/181 (19%), Positives = 69/181 (38%), Gaps = 55/181 (30%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL-------ELVKT--------KHP-- 55
+ F++ ++G G+ +Y T + A+K+ ++V+T HP
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNI 110
Query: 56 -QLH--YESK--LYM---LLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY-CNR 106
+L +E+ + + L+ GG +LF+ +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGG----------------------------ELFDRIVEK 142
Query: 107 -KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165
+S + Q++ V Y+H G +HRD+KP+N L + I D+GL+K
Sbjct: 143 GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
Query: 166 D 166
Sbjct: 203 H 203
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 26/162 (16%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP-----QLHYESKLYMLLQGG 70
K+ +KIG GSFG+ L + + G + +K E+ ++ + E + ++
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIK-EINISRMSSKEREESRREVAVLANMKHP 83
Query: 71 TGIPHLKWFGVEGDYNIMVIDLLGPSLE-----DLFNYCNRK----FSLKTVLMLADQLI 121
+ + + F G I+ ++ DLF N + F +L Q+
Sbjct: 84 NIVQYRESFEENGSLYIV--------MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
++++H R LHRDIK N + K V + D+G+A+
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARV 174
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 42/165 (25%), Positives = 68/165 (41%), Gaps = 27/165 (16%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHP----QLHYESKLYMLLQG 69
F++ +KIG G F E+Y + G +A+K +++ E L L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN- 90
Query: 70 GTGIPH------LKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRK---FSLKTVLMLADQ 119
H F + + NI V++L L + + ++ +TV Q
Sbjct: 91 -----HPNVIKYYASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 120 LINRVEYMHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDYGLAKK 163
L + +E+MHSR +HRDIKP N F+ V + D GL +
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRF 185
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 33/190 (17%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+ ++ ++IG G +GE+++G GE++AVK+ T+ E+++Y + H
Sbjct: 38 QIQMVKQIGKGRYGEVWMGKW--RGEKVAVKV-FFTTEEASWFRETEIYQT----VLMRH 90
Query: 76 ---LKWFGVEGDYNIMVIDLL-------GPSLEDLFNYCNRKFSLKTVLMLADQLINRVE 125
L + + L SL D + K++L LA ++ +
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLC 148
Query: 126 YMHSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRE 177
++H+ F HRD+K N L+ +K I D GLA K+ IP
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIP--- 202
Query: 178 NKNLTGTARY 187
GT RY
Sbjct: 203 PNTRVGTKRY 212
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 37/196 (18%), Positives = 69/196 (35%), Gaps = 25/196 (12%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTG 72
F+ + +G G FG ++ N A+K L + ++ E K L+
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 73 IPHLKWFGVEGDYNIMVIDLLGPSL---------EDLFNYCNRK-----FSLKTVLMLAD 118
+ + + + + L E+L ++ N + L +
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYREN 178
Q+ VE++HS+G +HRD+KP N + V + D+GL + + +
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 179 KNLT-----GTARYAS 189
GT Y S
Sbjct: 183 AYARHTGQVGTKLYMS 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 52/175 (29%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE----------------LVKTKHPQ 56
K++ KIG G++G ++ N +T E +A+K L+ L + KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 57 -------LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFS 109
LH + KL + V + L+ F+ CN
Sbjct: 63 IVRLHDVLHSDKKLTL-----------------------VFEFCDQDLKKYFDSCNGDLD 99
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
+ V QL+ + + HSR LHRD+KP N L+ + ++ + ++GLA+ +
Sbjct: 100 PEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAF 151
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 52/247 (21%), Positives = 97/247 (39%), Gaps = 55/247 (22%)
Query: 5 GKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQL------- 57
+ + +++LG +G G E++L +++ ++AVK+ L L
Sbjct: 2 SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV-L----RADLARDPSFY 56
Query: 58 ---HYESKLYMLL----------QGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNY 103
E++ L G G +V++ + G +L D+ +
Sbjct: 57 LRFRREAQNAAALNHPAIVAVYDTGEAE-------TPAGPLPYIVMEYVDGVTLRDIVHT 109
Query: 104 CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+ K + + + + H G +HRD+KP N ++ N V ++D+G+A+
Sbjct: 110 -EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARA 165
Query: 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSR------RDDLESLGYVLMY-FLR 216
D + + GTA+Y S EQ+R R D+ SLG ++Y L
Sbjct: 166 IADSGN----SVTQTAAVIGTAQYLS------PEQARGDSVDARSDVYSLG-CVLYEVLT 214
Query: 217 GSLPWQG 223
G P+ G
Sbjct: 215 GEPPFTG 221
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 37/174 (21%), Positives = 64/174 (36%), Gaps = 51/174 (29%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE---------------LVKTKHPQ- 56
+ K+G G++ +Y G + T +A+K LE L KH
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 57 ------LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSL 110
+H E L + V + L L+ + C ++
Sbjct: 63 VTLHDIIHTEKSLTL-----------------------VFEYLDKDLKQYLDDCGNIINM 99
Query: 111 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
V + QL+ + Y H + LHRD+KP N L+ + ++ + D+GLA+
Sbjct: 100 HNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAK 150
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 34/177 (19%), Positives = 62/177 (35%), Gaps = 52/177 (29%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE----------------LVKTKHPQ 56
K++ +G GS+G + N TG +A+K L + +H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 57 L-------HYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFS 109
L + + Y+ V + + ++ D
Sbjct: 86 LVNLLEVCKKKKRWYL-----------------------VFEFVDHTILDDLELFPNGLD 122
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+ V Q+IN + + HS +HRDIKP+N L+ ++ V + D+G A+
Sbjct: 123 YQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAA 176
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 44/238 (18%), Positives = 82/238 (34%), Gaps = 58/238 (24%)
Query: 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKL----------------E---LVKTKHPQLH 58
++G IG G FG++Y G E+A++L E +T+H +
Sbjct: 36 EIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV- 91
Query: 59 YESKLYMLLQGG-TGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLML 116
+L G PHL ++ L G +L + + +
Sbjct: 92 ------VLFMGACMSPPHL----------AIITSLCKGRTLYSVVRDAKIVLDVNKTRQI 135
Query: 117 ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK-KYRDLQTHKHIPY 175
A +++ + Y+H++G LH+D+K N G+ V I D+GL +
Sbjct: 136 AQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKL 191
Query: 176 RENKNLTGTARY---------ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL 224
R G + + + S+ D+ +LG + P++
Sbjct: 192 RIQ---NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 41/194 (21%), Positives = 74/194 (38%), Gaps = 60/194 (30%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIA---VKLE----------------LVKTKHP- 55
K++ KIG G+FGE++ + +TG+++A V +E L KH
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 56 --------------QLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLF 101
+ +Y++ D+ DL G L
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVF----------------DF--CEHDLAG-----LL 114
Query: 102 NYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
+ KF+L + + L+N + Y+H LHRD+K N L+ + + + D+GLA
Sbjct: 115 SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLA 171
Query: 162 KKYRDLQTHKHIPY 175
+ + + + Y
Sbjct: 172 RAFSLAKNSQPNRY 185
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 7e-13
Identities = 53/232 (22%), Positives = 90/232 (38%), Gaps = 51/232 (21%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQL----------HYESKLY 64
G ++L R +G G G++Y + +A+KL + L E++
Sbjct: 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKL-M----SETLSSDPVFRTRMQREARTA 88
Query: 65 MLLQGGTGIPHLKW---FGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQL 120
LQ PH+ FG + + L+ G L + + + + Q+
Sbjct: 89 GRLQE----PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQI 143
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL---QTHKHIPYRE 177
+ ++ H+ G HRD+KP+N L+ + Y++D+G+A D Q
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLG------- 193
Query: 178 NKNLTGTARYASVNTHLGVEQSR------RDDLESLGYVLMYFLRGSLPWQG 223
N GT Y + E+ R D+ +L VL L GS P+QG
Sbjct: 194 --NTVGTLYYMA------PERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 65/265 (24%), Positives = 91/265 (34%), Gaps = 78/265 (29%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK----------------------LELVKT-K 53
F + R IG G FGE+Y TG+ A+K L LV T
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 54 HP---QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFN- 102
P + Y KL +L GG DL
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGG----------------------------DLHYH 282
Query: 103 -YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
+ FS + A ++I +E+MH+R ++RD+KP N L+ + V I D GLA
Sbjct: 283 LSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLA 339
Query: 162 KKYRDLQTHKHIPYRENKNLTGTARY-ASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSL 219
+ + H GT Y A GV D SLG +++ LRG
Sbjct: 340 CDFSKKKPH---------ASVGTHGYMAPEVLQKGVAYDSSADWFSLG-CMLFKLLRGHS 389
Query: 220 PWQGLKAGTKKQKYDKISEKKVSTP 244
P++ K K + V P
Sbjct: 390 PFRQHKTKDKHEIDRMTLTMAVELP 414
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 38/193 (19%), Positives = 69/193 (35%), Gaps = 60/193 (31%)
Query: 1 MFADGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIA---VKLE--------- 48
M D K R +++ +G G F +Y + T + +A +KL
Sbjct: 1 MALDVKSRAK-----RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI 55
Query: 49 ----------LVKTKHP---QL----HYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91
L + HP L ++S + ++ D+ M D
Sbjct: 56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF----------------DF--METD 97
Query: 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151
L E + + + + + +EY+H LHRD+KP+N L+ +
Sbjct: 98 L-----EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENG 149
Query: 152 QVYIIDYGLAKKY 164
+ + D+GLAK +
Sbjct: 150 VLKLADFGLAKSF 162
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 58/285 (20%), Positives = 100/285 (35%), Gaps = 86/285 (30%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL-----------------E---LVKTKHP- 55
F++ + IG G+F E+ + QTG+ A+K+ E LV
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 56 --QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY--- 103
QLH+ E+ LY++++ GG DL
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGG----------------------------DLLTLLSK 154
Query: 104 CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+ + +++ ++ +H G++HRDIKPDN L+ + + + D+G
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCL- 210
Query: 164 YRDLQTHKHIPYRENKNLT--GTARYAS--VNTHLGVEQSRRD-----DLESLGYVLMY- 213
K ++L GT Y S + +G D +LG V Y
Sbjct: 211 -------KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG-VFAYE 262
Query: 214 FLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVS 258
G P+ A + + Y KI K + ++ + P E
Sbjct: 263 MFYGQTPFY---ADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 42/180 (23%), Positives = 66/180 (36%), Gaps = 54/180 (30%)
Query: 18 KLGRKIGSGSFGELYLGVN--VQTGEEIAVK------------------LELVKTKHP-- 55
G K+G G++G +Y + ++ A+K EL KHP
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL---KHPNV 80
Query: 56 -------QLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLG---PSLEDLFNYCN 105
H + K+++L DY DL N
Sbjct: 81 ISLQKVFLSHADRKVWLLF----------------DY--AEHDLWHIIKFHRASKANKKP 122
Query: 106 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDYGLAKKY 164
+ V L Q+++ + Y+H+ LHRD+KP N L MG G + +V I D G A+ +
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 41/188 (21%), Positives = 65/188 (34%), Gaps = 33/188 (17%)
Query: 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH-- 75
L +G G +GE++ G GE +AVK+ E++LY + + H
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKI-FSSRDEKSWFRETELYNTVM----LRHEN 63
Query: 76 -LKWFGVEGDYNIMVIDLL-------GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 127
L + + L SL D + L + + + + ++
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHL 121
Query: 128 HSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENK 179
H F HRD+K N L+ +K Q I D GLA + + N
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVG---NN 175
Query: 180 NLTGTARY 187
GT RY
Sbjct: 176 PRVGTKRY 183
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 38/230 (16%), Positives = 76/230 (33%), Gaps = 52/230 (22%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----------------ELVKTKHPQLHY 59
KL IG G +G +Y G +AVK+ + +H +
Sbjct: 14 NLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI-- 69
Query: 60 ESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLAD 118
++ + + T +++ +V++ SL + + LA
Sbjct: 70 -ARFIVGDERVTADGRMEYL--------LVMEYYPNGSLXKYLS--LHTSDWVSSCRLAH 118
Query: 119 QLINRVEYMHS---------RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169
+ + Y+H+ HRD+ N L+ + I D+GL+ + +
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRL 175
Query: 170 HKHIPY-RENKNLTGTARY-------ASVNTHLGVEQSRRDDLESLGYVL 211
+ + GT RY +VN ++ D+ +LG +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 60/265 (22%), Positives = 94/265 (35%), Gaps = 77/265 (29%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL-----------------E---LVKTKHP- 55
+++ + IG G+FGE+ L + T + A+KL E + P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 56 --QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR 106
QL Y + LYM+++ GG DL N +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGG----------------------------DLVNLMSN 162
Query: 107 -KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165
K +++ ++ +HS GF+HRD+KPDN L+ K+ + + D+G K
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMN 219
Query: 166 DLQTHKHIPYRENKNLTGTARYAS----VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLP 220
+ GT Y S + R D S+G V +Y L G P
Sbjct: 220 KEGMVR------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTP 272
Query: 221 WQGLKAGTKKQKYDKISEKKVSTPI 245
+ A + Y KI K S
Sbjct: 273 F---YADSLVGTYSKIMNHKNSLTF 294
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 52/177 (29%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE----------------LVKTKHPQ 56
+++ K+G G++GE+Y ++ T E +A+K LE L + +H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 57 -------LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFS 109
+H+ +L++ + + L+ + S
Sbjct: 95 IIELKSVIHHNHRLHL-----------------------IFEYAENDLKKYMDKN-PDVS 130
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN--QVYIIDYGLAKKY 164
++ + QLIN V + HSR LHRD+KP N L+ + + + I D+GLA+ +
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 42/176 (23%), Positives = 67/176 (38%), Gaps = 53/176 (30%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE----------------LVKTKHPQ 56
F+ KIG G++G +Y N TGE +A+K L+ L + HP
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 57 -------LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCN-RKF 108
+H E+KLY+ V + L L+ +
Sbjct: 64 IVKLLDVIHTENKLYL-----------------------VFEFLHQDLKKFMDASALTGI 100
Query: 109 SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
L + QL+ + + HS LHRD+KP N L+ + + D+GLA+ +
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF 153
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 32/169 (18%), Positives = 59/169 (34%), Gaps = 29/169 (17%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKH-PQLHYESKLYMLLQGGT 71
+++ IG+GS+G G+ + K + L E L L+
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLE-----DLFNY------CNRKFSLKTVLMLADQL 120
+ + + + ++ +E DL + + + VL + QL
Sbjct: 67 IVRYYDRIIDRTNTTLYIV------MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 121 INRVEYMHSRGF-----LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
++ H R LHRD+KP N + V + D+GLA+
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARIL 166
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 50/234 (21%), Positives = 79/234 (33%), Gaps = 44/234 (18%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+L G FG ++ E +AVK+ E ++Y L G+ H
Sbjct: 25 PLQLLEVKARGRFGCVWKA--QLLNEYVAVKI-FPIQDKQSWQNEYEVYSL----PGMKH 77
Query: 76 ---LKWFGVEGDYNIMVIDLL-------GPSLEDLFNYCNRKFSLKTVLMLADQLINRVE 125
L++ G E + +DL SL D S + +A+ + +
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAETMARGLA 135
Query: 126 YMHSRGF----------LHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKYRDLQTHKHIP 174
Y+H HRDIK N L+ K N I D+GLA K+ ++
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLL----KNNLTACIADFGLALKFEAGKSAG--- 188
Query: 175 YRENKNLTGTARY-----ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
+ GT RY + + R D+ ++G VL G
Sbjct: 189 --DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 3e-12
Identities = 44/175 (25%), Positives = 67/175 (38%), Gaps = 53/175 (30%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE----------------LVKTKHPQ 56
K+ KIG G++G +Y N GE A+K LE L + KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 57 -------LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFS 109
+H + +L + V + L L+ L + C
Sbjct: 62 IVKLYDVIHTKKRLVL-----------------------VFEHLDQDLKKLLDVCEGGLE 98
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
T QL+N + Y H R LHRD+KP N L+ + ++ I D+GLA+ +
Sbjct: 99 SVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAF 150
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 42/174 (24%), Positives = 70/174 (40%), Gaps = 46/174 (26%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE---------------LVKTKHPQ- 56
+FK K+G+G++ +Y G+N TG +A+K L+ + + KH
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 57 ------LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSL 110
+H E+KL ++ ++ M DL R L
Sbjct: 66 VRLYDVIHTENKLTLVF----------------EF--MDNDLKKYMDSRTVGNTPRGLEL 107
Query: 111 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
V QL+ + + H LHRD+KP N L+ K Q+ + D+GLA+ +
Sbjct: 108 NLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAF 158
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 39/171 (22%), Positives = 75/171 (43%), Gaps = 27/171 (15%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK----LELVKTKHPQLHYESKLYMLLQGGTG 72
K +IG GSF +Y G++ +T E+A +L K++ + E+++ LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ---- 83
Query: 73 IPH---LKWFGVEGDYN------IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLIN 122
H ++++ ++V +L+ +L+ + +K + Q++
Sbjct: 84 --HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILK 140
Query: 123 RVEYMHSRG--FLHRDIKPDN-FLMGLGRKANQVYIIDYGLAKKYRDLQTH 170
++++H+R +HRD+K DN F+ G V I D GLA R
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFAK 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 55/283 (19%), Positives = 92/283 (32%), Gaps = 84/283 (29%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL-----------------E---LVKTKHP- 55
F++ + IG G+FGE+ + + A+K+ E LV
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 56 --QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR 106
LHY ++ LY+++ GG DL ++
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGG----------------------------DLLTLLSK 167
Query: 107 ---KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+ + +++ ++ +H ++HRDIKPDN LM + + D+G
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCL- 223
Query: 164 YRDLQTHKHIPYRENKNLT--GTARYAS---VNTHLGVEQ--SRRDDLESLGYVLMY-FL 215
K + ++ GT Y S + G + D SLG V MY L
Sbjct: 224 -------KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG-VCMYEML 275
Query: 216 RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVS 258
G P+ A + + Y KI K
Sbjct: 276 YGETPFY---AESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 36/213 (16%), Positives = 82/213 (38%), Gaps = 14/213 (6%)
Query: 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYML 66
++ + G++ + RK+G G F ++L ++Q + +A+K ++ + E +L
Sbjct: 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKS 89
Query: 67 LQ-------GGTGIPHLK-WF---GVEGDYNIMVIDLLGPSLEDL-FNYCNRKFSLKTVL 114
++ + L F GV G + MV ++LG L + L V
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 115 MLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173
+ Q++ ++Y+H++ +H DIKP+N L+ + + + + ++
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLES 206
+ + + DL +
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 34/175 (19%), Positives = 63/175 (36%), Gaps = 53/175 (30%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE----------------LVKTKHPQ 56
K++ K+G G++G +Y + G +A+K L+ L + HP
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 57 -------LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFS 109
+H E L + V + + L+ + +
Sbjct: 81 IVSLIDVIHSERCLTL-----------------------VFEFMEKDLKKVLDENKTGLQ 117
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
+ + QL+ V + H LHRD+KP N L+ + + D+GLA+ +
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAF 169
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 12/104 (11%)
Query: 94 GPSLEDLFNYCNRKFSL--KTVLMLADQLINRVEYMHSRGFLHRDIKPDN-FLMGLGRKA 150
+L+D N L + Q+ VE++HS+G +HRD+KP N F
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MD 200
Query: 151 NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT-----GTARYAS 189
+ V + D+GL + + + T GT Y S
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 32/177 (18%), Positives = 66/177 (37%), Gaps = 44/177 (24%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+++ +IG G++G +Y + +G +A+K + + GG G+P
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALK----SVR---VPNGG------GGGGGLPI 56
Query: 76 --------LKWFGVEGDYNI-----MVIDLLGPSLEDL---FNYC------------NRK 107
L+ N+ + + F +
Sbjct: 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116
Query: 108 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
+T+ L Q + ++++H+ +HRD+KP+N L+ V + D+GLA+ Y
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIY 170
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 39/176 (22%), Positives = 73/176 (41%), Gaps = 32/176 (18%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESK 62
++ ++++ IG GSFG++ + E +A+K ++K K Q E +
Sbjct: 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK--IIKNKKAFLNQAQIEVR 102
Query: 63 LYMLLQGGTGIPHLKWFGVEGDYNI--------------MVIDLLGPSLEDLF-NYCNRK 107
LL+ + E Y I +V ++L +L DL N R
Sbjct: 103 ---LLE------LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG 153
Query: 108 FSLKTVLMLADQLINRVEYMHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
SL A Q+ + ++ + +H D+KP+N L+ K + + I+D+G +
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSS 208
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 33/155 (21%), Positives = 61/155 (39%), Gaps = 17/155 (10%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGI-- 73
F R+IG GSFG +Y +V+ E +A+K K ++ +
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-----DIIKEVRFLQ 109
Query: 74 ----PHL-KWFG--VEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 126
P+ ++ G + +V++ S DL + + + + + Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 127 MHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
+HS +HRD+K N L+ + V + D+G A
Sbjct: 170 LHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 42/188 (22%), Positives = 66/188 (35%), Gaps = 60/188 (31%)
Query: 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------LELVKT-KHP- 55
D + + IG+GSFG +Y +GE +A+K L++++ H
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 108
Query: 56 --QLHY----------ESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY 103
+L Y E L + V+D + E ++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNL-----------------------VLDYVP---ETVYRV 142
Query: 104 CNRKFSLKTVLMLAD------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157
K L + QL + Y+HS G HRDIKP N L L + + D
Sbjct: 143 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCD 200
Query: 158 YGLAKKYR 165
+G AK+
Sbjct: 201 FGSAKQLV 208
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 30/151 (19%), Positives = 62/151 (41%), Gaps = 18/151 (11%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESK 62
+ ++ F + RK+G G+FG + L ++ + AVK+ V+ E+
Sbjct: 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKV--VRNIKKYTRSAKIEAD 83
Query: 63 LYMLLQ----GGTGIPHLK-WFGVEGDYN---IMVIDLLGPSLEDLF-NYCNRKFSLKTV 113
+ +Q I F Y ++ + LGPSL ++ F ++ +
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKF----MYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDI 139
Query: 114 LMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144
+ +++ + Y+ H D+KP+N L+
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILL 170
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 60/271 (22%), Positives = 92/271 (33%), Gaps = 75/271 (27%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LE-------------------LVKTKHP- 55
F+ R +G G FGE+ TG+ A K LE L K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 56 --QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR 106
L Y + L ++L GG LK+ +++
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGG----DLKF--------------------HIYHMGQA 281
Query: 107 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
F + A ++ +E +H ++RD+KP+N L+ + I D GLA +
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPE 338
Query: 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLK 225
QT K GT Y + + D +LG L+Y + G P+Q K
Sbjct: 339 GQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALG-CLLYEMIAGQSPFQQRK 389
Query: 226 AGTKKQKYDKISEKKVSTPIEVLCKSYPSEF 256
KK K +++ P E Y F
Sbjct: 390 ---KKIKREEVERLVKEVPEE-----YSERF 412
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 40/187 (21%), Positives = 66/187 (35%), Gaps = 40/187 (21%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------LELVKT-KHPQ----LH 58
K+ LG+ +G+GSFG + ++++G+ A+K L+++K H +
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVD 67
Query: 59 YESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCN------------- 105
Y P + + Y N
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 106 -RKFSLKTVLMLAD-------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157
+ F + + QL V ++HS G HRDIKP N L + K N + + D
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNSKDNTLKLCD 185
Query: 158 YGLAKKY 164
+G AKK
Sbjct: 186 FGSAKKL 192
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 78/261 (29%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTK----------------HP- 55
F + +G+GSFG + L + ++G A+K+ ++VK K P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 56 --QLHY----ESKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY--C 104
+L + S LYM++ GG ++F++
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGG----------------------------EMFSHLRR 134
Query: 105 NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
+FS A Q++ EY+HS ++RD+KP+N L+ + + + D+G AK+
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRV 191
Query: 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 223
+ +T L GT + L ++ D +LG VL+Y G P+
Sbjct: 192 KG-RTW---------TLCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF-- 238
Query: 224 LKAGTKKQKYDKISEKKVSTP 244
A Q Y+KI KV P
Sbjct: 239 -FADQPIQIYEKIVSGKVRFP 258
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 53/262 (20%), Positives = 92/262 (35%), Gaps = 69/262 (26%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LE-------------------LVKTKHP- 55
F R +G G FGE++ TG+ A K L L K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 56 --QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR 106
L Y ++ L +++ GG H+ + N
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED----------------------NP 284
Query: 107 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
F + Q+++ +E++H R ++RD+KP+N L+ V I D GLA
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLA----- 336
Query: 167 LQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 223
+ + K GT + + LG E D +LG V +Y + P++
Sbjct: 337 ----VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYEMIAARGPFRA 391
Query: 224 LKAGTKKQK-YDKISEKKVSTP 244
+ ++ ++ E+ V+ P
Sbjct: 392 RGEKVENKELKQRVLEQAVTYP 413
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 39/179 (21%), Positives = 71/179 (39%), Gaps = 41/179 (22%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------LELVKT-KHP---QLHY 59
+ + IG+GSFG ++ V++ E +A+K L++++ KHP L
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 60 ESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDL------FNYCNRKFSLKTV 113
E N+ V++ + E + + + + +
Sbjct: 100 F------------FYSNGDKKDEVFLNL-VLEYVP---ETVYRASRHYAKLKQTMPMLLI 143
Query: 114 LMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172
+ QL+ + Y+HS G HRDIKP N L L + + +ID+G AK + +
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAKILIAGEPNVS 200
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 32/162 (19%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTG 72
G F+L +G+G++G++Y G +V+TG+ A+K +++ + ++ E +L+ +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE---INMLKKYSH 79
Query: 73 IPH--------LKWFGVEGDYNI-MVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLI 121
+ +K D + +V++ S+ DL + + + +++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+ ++H +HRDIK N L+ + +V ++D+G++ +
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQ 178
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 40/191 (20%), Positives = 77/191 (40%), Gaps = 42/191 (21%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYE--------SKLYML 66
+ KIG+GSFG ++ + G ++AVK+ + + H + E +L
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-- 92
Query: 67 LQGGTGIPH---LKWFGV--EGDYNIMVIDLL-GPSLEDLF--NYCNRKFSLKTVLMLAD 118
H + + G + +V + L SL L + + + L +A
Sbjct: 93 --------HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144
Query: 119 QLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176
+ + Y+H+R +HR++K N L+ K V + D+GL++ K +
Sbjct: 145 DVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRL-------KASTFL 194
Query: 177 ENKNLTGTARY 187
+K+ GT +
Sbjct: 195 SSKSAAGTPEW 205
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 35/176 (19%), Positives = 60/176 (34%), Gaps = 52/176 (29%)
Query: 18 KLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
L IG G FG++Y G+E+AVK +H S+ +
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI---GDEVAVK----AARHDPDEDISQT------------I 50
Query: 77 KWFGVEGDYNIM-------VIDLLGPSLE--------------DLFNY-CNRKFSLKTVL 114
+ E + +I L G L+ L ++ ++
Sbjct: 51 ENVRQEA--KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILV 108
Query: 115 MLADQLINRVEYMHSRG---FLHRDIKPDNFLMGLGRKANQVY-----IIDYGLAK 162
A Q+ + Y+H +HRD+K N L+ + + I D+GLA+
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 35/164 (21%), Positives = 69/164 (42%), Gaps = 37/164 (22%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE--------------LVKTKHPQLH 58
+++ ++G G+FG++Y N +TG A K + L HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP--- 76
Query: 59 YESKLY-MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLA 117
Y KL G L W +E + G +++ + +R + + ++
Sbjct: 77 YIVKLLGAYYHDG----KL-WIMIE--F------CPGGAVDAIMLELDRGLTEPQIQVVC 123
Query: 118 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
Q++ + ++HS+ +HRD+K N LM L + + D+G++
Sbjct: 124 RQMLEALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVS 164
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 34/170 (20%), Positives = 65/170 (38%), Gaps = 47/170 (27%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LE------------LVKTKHPQL--- 57
F + K+G GS+G +Y ++ +TG+ +A+K +E + + P +
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 58 ----HYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTV 113
+ L W +E Y S+ D+ N+ + +
Sbjct: 90 YGSYFKNTDL--------------WIVME--Y------CGAGSVSDIIRLRNKTLTEDEI 127
Query: 114 LMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+ + +EY+H +HRDIK N L L + + D+G+A +
Sbjct: 128 ATILQSTLKGLEYLHFMRKIHRDIKAGNIL--LNTEG-HAKLADFGVAGQ 174
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 25/161 (15%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTGI 73
++L IGSG+ + E++A+K LE +T +L E +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH----- 71
Query: 74 PH---LKWFG--VEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQL--INR-- 123
H + ++ V D +V+ LL G S+ D+ + K K+ ++ + I R
Sbjct: 72 -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 124 ---VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
+EY+H G +HRD+K N L+G + V I D+G++
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVS 168
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 5e-10
Identities = 55/271 (20%), Positives = 99/271 (36%), Gaps = 98/271 (36%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL-----------------E---LVKTKHP- 55
F++ R +G+GSFG ++L + G A+K+ E L HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 56 --QLHY----ESKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR 106
++ +++M++ +GG +LF+ +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGG----------------------------ELFSLLRK 99
Query: 107 --KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
+F A ++ +EY+HS+ ++RD+KP+N L+ K + I D+G AK
Sbjct: 100 SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYV 156
Query: 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGY----------VLMY- 213
D T+ L GT Y + E + + Y +L+Y
Sbjct: 157 PD-VTY---------TLCGTPDY------IAPEV-----VSTKPYNKSIDWWSFGILIYE 195
Query: 214 FLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
L G P+ + Y+KI ++ P
Sbjct: 196 MLAGYTPFY---DSNTMKTYEKILNAELRFP 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 35/153 (22%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH- 75
F KIG GSFGE++ G++ +T + +A+K+ ++ ++ + +L
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS---QCDSP 80
Query: 76 --LKWFG--VEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130
K++G ++ ++++ L G S DL + + +++ ++Y+HS
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDL--LEPGPLDETQIATILREILKGLDYLHSE 138
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+HRDIK N L+ + +V + D+G+A +
Sbjct: 139 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQ 168
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 37/201 (18%), Positives = 74/201 (36%), Gaps = 68/201 (33%)
Query: 1 MFADGKLR-MDHVIGGKFKLGRKIGSGSFGELYLGVNVQ-TGEEIAVK------------ 46
M DG R +++ +IG G++G+++ +++ G +A+K
Sbjct: 1 MEKDGLCRADQ-----QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP 55
Query: 47 ----------LELVKTKHP------------QLHYESKLYMLLQGGTGIPHLKWFGVEGD 84
L +HP + E+KL +
Sbjct: 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL------------------- 96
Query: 85 YNIMVIDLLGPSLEDLFNYCNRKF-SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL 143
V + + L + +T+ + QL+ ++++HS +HRD+KP N L
Sbjct: 97 ----VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 152
Query: 144 MGLGRKANQVYIIDYGLAKKY 164
+ + Q+ + D+GLA+ Y
Sbjct: 153 VT---SSGQIKLADFGLARIY 170
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 25/153 (16%), Positives = 64/153 (41%), Gaps = 20/153 (13%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTK---HPQLHYES 61
R+ + ++++ +G G+FG++ + + + ++A+K+ ++ E
Sbjct: 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKI--IRNVGKYREAARLEI 67
Query: 62 KLYMLLQ-----GGTGIPHLK-WFGVEGDYN---IMVIDLLGPSLEDLF-NYCNRKFSLK 111
+ ++ + WF +++ + +LLG + + + + L
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWF----NFHGHMCIAFELLGKNTFEFLKENNFQPYPLP 123
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144
V +A QL + + ++H H D+KP+N L
Sbjct: 124 HVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 59/277 (21%), Positives = 105/277 (37%), Gaps = 84/277 (30%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL-----------------E 48
K+ M+ F + +G G+FG++ L TG A+K+ E
Sbjct: 1 KVTMND-----FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 49 ---LVKTKHP---QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGP 95
L T+HP L Y +L +++ GG
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG------------------------- 90
Query: 96 SLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153
+LF + +R F+ + ++++ +EY+HSR ++RDIK +N ++ K +
Sbjct: 91 ---ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHI 144
Query: 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVL 211
I D+GL K + I T GT Y + + R D LG V+
Sbjct: 145 KITDFGLCK--------EGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VV 194
Query: 212 MY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
MY + G LP+ ++ ++ I +++ P +
Sbjct: 195 MYEMMCGRLPFYN---QDHERLFELILMEEIRFPRTL 228
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 34/153 (22%), Positives = 63/153 (41%), Gaps = 20/153 (13%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEI-AVKLELVKTK---HPQLHYES 61
+ V+ ++++ +G G+FG++ ++ + G AVK+ VK E
Sbjct: 5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKI--VKNVDRYCEAARSEI 62
Query: 62 KLYMLLQ-----GGTGIPHLK-WFGVEGDYN---IMVIDLLGPSLEDLFNYCNRK-FSLK 111
++ L + WF +++ +V +LLG S D F L
Sbjct: 63 QVLEHLNTTDPNSTFRCVQMLEWF----EHHGHICIVFELLGLSTYDFIKENGFLPFRLD 118
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144
+ +A Q+ V ++HS H D+KP+N L
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 41/167 (24%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---------LELV--------KTKHPQL- 57
K+ KIG G+ G +Y ++V TG+E+A++ EL+ + K+P +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 58 -HYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLML 116
+ +S L G L W +E Y L G SL D+ + +
Sbjct: 81 NYLDS----YLVGD----EL-WVVME--Y------LAGGSLTDV--VTETCMDEGQIAAV 121
Query: 117 ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+ + +E++HS +HRDIK DN L+G+ V + D+G +
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQ 165
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 41/176 (23%), Positives = 66/176 (37%), Gaps = 44/176 (25%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------LELVK----TKHP---Q 56
+F++ R G G+FG + LG TG +A+K L++++ HP Q
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQ 83
Query: 57 LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLML 116
L Y G + Y +V++ + + L C + +
Sbjct: 84 LQS----YFYTLGERDRRDI--------YLNVVMEYVP---DTLHRCCRNYYRRQVAPPP 128
Query: 117 AD------QLINRVEYMH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
QLI + +H S HRDIKP N L + + + D+G AKK
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAKKL 182
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 40/191 (20%), Positives = 66/191 (34%), Gaps = 71/191 (37%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------------- 46
L + F L R IG GS+ ++ L +T A+K
Sbjct: 5 PLGLQD-----FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 59
Query: 47 ---LELVKTKHP---QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLL 93
E + HP LH ES+L+ +++ GG
Sbjct: 60 KHVFEQA-SNHPFLVGLHSCFQTESRLFFVIEYVNGG----------------------- 95
Query: 94 GPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151
DL + R K + + ++ + Y+H RG ++RD+K DN L+
Sbjct: 96 -----DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEG 147
Query: 152 QVYIIDYGLAK 162
+ + DYG+ K
Sbjct: 148 HIKLTDYGMCK 158
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 36/168 (21%), Positives = 70/168 (41%), Gaps = 43/168 (25%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---------LELVKT--------KHPQL- 57
KIG GS G + L +G ++AVK EL+ +H +
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVV 105
Query: 58 -HYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLM 115
Y+S L G+ ++++ L G +L D+ + + + +
Sbjct: 106 EMYKSYLV------------------GEELWVLMEFLQGGALTDI--VSQVRLNEEQIAT 145
Query: 116 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+ + ++ + Y+H++G +HRDIK D+ L+ L +V + D+G +
Sbjct: 146 VCEAVLQALAYLHAQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQ 190
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 56/279 (20%), Positives = 98/279 (35%), Gaps = 91/279 (32%)
Query: 5 GKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------------ 46
++++ F +G GSFG++ L T E AVK
Sbjct: 15 DRMKLTD-----FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV 69
Query: 47 ----LELVKTKHP---QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDL 92
L L K P QLH +LY +++ GG
Sbjct: 70 EKRVLALP-GKPPFLTQLHSCFQTMDRLYFVMEYVNGG---------------------- 106
Query: 93 LGPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKA 150
DL + + +F + A ++ + ++ S+G ++RD+K DN ++
Sbjct: 107 ------DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SE 157
Query: 151 NQVYIIDYGLAKK--YRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLES 206
+ I D+G+ K+ + + T T GT Y + + D +
Sbjct: 158 GHIKIADFGMCKENIWDGVTTK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWA 206
Query: 207 LGYVLMY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
G VL+Y L G P++G + + + I E V+ P
Sbjct: 207 FG-VLLYEMLAGQAPFEG---EDEDELFQSIMEHNVAYP 241
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 45/177 (25%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHY-ESKLYMLLQGG 70
+G ++ + +G G G ++ V+ + +A+K + L + + E K+
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKI------- 61
Query: 71 TGIPHLKWFGVEGDYNIM-VIDLLGPSLEDLFNYCNRKFSLKTV-----LMLAD------ 118
++ + NI+ V ++LGPS L + L +V M D
Sbjct: 62 -----IRRLDHD---NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 119 --------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161
QL+ ++Y+HS LHRD+KP N + + + I D+GLA
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLA 168
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 60/279 (21%), Positives = 107/279 (38%), Gaps = 87/279 (31%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------------- 46
KL+++ F L + +G GSFG+++L +T + A+K
Sbjct: 13 KLKIED-----FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 47 ---LELVKTKHP---QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLL 93
L L +HP + + L+ +++ GG
Sbjct: 68 KRVLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGG----------------------- 103
Query: 94 GPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151
DL + KF L A ++I ++++HS+G ++RD+K DN L+ K
Sbjct: 104 -----DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDG 155
Query: 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGY 209
+ I D+G+ K +++ + K T GT Y + LG + + D S G
Sbjct: 156 HIKIADFGMCK--------ENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFG- 205
Query: 210 VLMY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
VL+Y L G P+ G +++ + I P +
Sbjct: 206 VLLYEMLIGQSPFHG---QDEEELFHSIRMDNPFYPRWL 241
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 57/285 (20%), Positives = 100/285 (35%), Gaps = 90/285 (31%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------------- 46
L + F L R IG GS+ ++ L +T A++
Sbjct: 48 SLGLQD-----FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE 102
Query: 47 ---LELVKTKHP---QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLL 93
E + HP LH ES+L+ +++ GG
Sbjct: 103 KHVFEQA-SNHPFLVGLHSCFQTESRLFFVIEYVNGG----------------------- 138
Query: 94 GPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151
DL + R K + + ++ + Y+H RG ++RD+K DN L+
Sbjct: 139 -----DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEG 190
Query: 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGY 209
+ + DYG+ K + + + T GT Y + G + D +LG
Sbjct: 191 HIKLTDYGMCK--------EGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG- 240
Query: 210 VLMY-FLRGSLPWQGLKAG------TKKQKYDKISEKKVSTPIEV 247
VLM+ + G P+ + + T+ + I EK++ P +
Sbjct: 241 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 42/204 (20%), Positives = 75/204 (36%), Gaps = 64/204 (31%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLY------- 64
I F+L +G G++G + + TGE +A+K K P ++ L+
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEP---FDKPLFALRTLRE 59
Query: 65 -MLLQGGTGIPHLKWFGVEGDYNIM-VIDLLGPSLEDLFN--YCNRKFSLKTVLMLAD-- 118
+L+ H K NI+ + ++ P + FN Y + LM D
Sbjct: 60 IKILK------HFK------HENIITIFNIQRPDSFENFNEVY------IIQELMQTDLH 101
Query: 119 ------------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYG 159
Q + V+ +H +HRD+KP N L+ +N + + D+G
Sbjct: 102 RVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFG 157
Query: 160 LAKKYRDLQTHKHIPYRENKNLTG 183
LA+ + P + +
Sbjct: 158 LARIIDESAADNSEPTGQQSGMVE 181
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 37/185 (20%), Positives = 77/185 (41%), Gaps = 53/185 (28%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY-------- 64
+ + +GSG++G + ++ ++GE++A+K K P ++S+++
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK----KLSRP---FQSEIFAKRAYREL 74
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 118
+LL+ H++ V G ++ + D + L M D
Sbjct: 75 LLLK------HMQHENVIGLLDVFTPASSLRNFYDFY--------LVMPFMQTDLQKIMG 120
Query: 119 -------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKY 164
Q++ ++Y+HS G +HRD+KP N + + ++ I+D+GLA+
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHA 176
Query: 165 RDLQT 169
T
Sbjct: 177 DAEMT 181
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 39/176 (22%), Positives = 79/176 (44%), Gaps = 23/176 (13%)
Query: 4 DGKLRMDHVIGGK--------FKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKT 52
GK IGG+ + ++GSG+ G+++ +TG IAVK K
Sbjct: 6 SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 53 KHPQLHYESKLYMLLQGGTGIPHL-KWFG---VEGDYNIMVIDLLGPSLEDLFNYCNRKF 108
++ ++ + L ++L+ P++ + FG D I ++L+G E L
Sbjct: 66 ENKRILMD--LDVVLKSHDC-PYIVQCFGTFITNTDVFI-AMELMGTCAEKLKKRMQGPI 121
Query: 109 SLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163
+ + + ++ + Y+ G +HRD+KP N L+ + Q+ + D+G++ +
Sbjct: 122 PERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGR 174
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 86/276 (31%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYL---GVNVQTGEEIAVKL--------------- 47
K F+L + +G GSFG+++L + A+K+
Sbjct: 20 KADPSQ-----FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK 74
Query: 48 -E---LVKTKHP---QLHY----ESKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLL 93
E LV+ HP +LHY E KLY++L +GG
Sbjct: 75 MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG----------------------- 111
Query: 94 GPSLEDLFN--YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151
DLF F+ + V +L ++++HS G ++RD+KP+N L+ +
Sbjct: 112 -----DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEG 163
Query: 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGY 209
+ + D+GL+K + I + E K + GT Y + ++ D S G
Sbjct: 164 HIKLTDFGLSK--------ESIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG- 213
Query: 210 VLMY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
VLM+ L G+LP+QG +K+ I + K+ P
Sbjct: 214 VLMFEMLTGTLPFQG---KDRKETMTMILKAKLGMP 246
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 56/279 (20%), Positives = 100/279 (35%), Gaps = 87/279 (31%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK------------------- 46
+L +D+ F+ R +G GSFG++ L +TG+ AVK
Sbjct: 19 RLGIDN-----FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE 73
Query: 47 ---LELVKTKHP---QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLL 93
L L HP QL +L+ +++ GG
Sbjct: 74 KRILSLA-RNHPFLTQLFCCFQTPDRLFFVMEFVNGG----------------------- 109
Query: 94 GPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151
DL + + +F A ++I+ + ++H +G ++RD+K DN L+
Sbjct: 110 -----DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEG 161
Query: 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGY 209
+ D+G+ K + I T GT Y + + D ++G
Sbjct: 162 HCKLADFGMCK--------EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMG- 211
Query: 210 VLMY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
VL+Y L G P++ + ++ I +V P +
Sbjct: 212 VLLYEMLCGHAPFEA---ENEDDLFEAILNDEVVYPTWL 247
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 55/278 (19%), Positives = 104/278 (37%), Gaps = 85/278 (30%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL-----------------E 48
++ M+ F+ + +G G+FG++ L TG A+K+ E
Sbjct: 144 RVTMNE-----FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 49 ---LVKTKHP---QLHY----ESKLYMLL---QGGTGIPHLKWFGVEGDYNIMVIDLLGP 95
L ++HP L Y +L ++ GG
Sbjct: 199 NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG------------------------- 233
Query: 96 SLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQ 152
+LF + +R FS ++++ ++Y+HS + ++RD+K +N ++ K
Sbjct: 234 ---ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGH 287
Query: 153 VYIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYV 210
+ I D+GL K + I T GT Y + + R D LG V
Sbjct: 288 IKITDFGLCK--------EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG-V 337
Query: 211 LMY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
+MY + G LP+ ++ ++ I +++ P +
Sbjct: 338 VMYEMMCGRLPFYN---QDHEKLFELILMEEIRFPRTL 372
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 56/268 (20%), Positives = 94/268 (35%), Gaps = 82/268 (30%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK----------------------LELVKTKH 54
F +G GSFG++ L T E AVK L L K
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKP 401
Query: 55 P---QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYC 104
P QLH +LY +++ GG DL +
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGG----------------------------DLMYHI 433
Query: 105 NR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+ +F + A ++ + ++ S+G ++RD+K DN ++ + I D+G+ K
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCK 490
Query: 163 KYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSL 219
++I T GT Y + + D + G VL+Y L G
Sbjct: 491 --------ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQA 540
Query: 220 PWQGLKAGTKKQKYDKISEKKVSTPIEV 247
P++G + + + I E V+ P +
Sbjct: 541 PFEG---EDEDELFQSIMEHNVAYPKSM 565
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 66/283 (23%), Positives = 108/283 (38%), Gaps = 92/283 (32%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYL---GVNVQTGEEIAVKL--------------- 47
K+R + F+L R +G G +G+++ TG+ A+K+
Sbjct: 13 KIRPEC-----FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 48 ---E---LVKTKHP---QLHY----ESKLYMLL---QGGTGIPHLKWFGVEGDYNIMVID 91
E L + KHP L Y KLY++L GG
Sbjct: 68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG--------------------- 106
Query: 92 LLGPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149
+LF R F T ++ + ++H +G ++RD+KP+N ++
Sbjct: 107 -------ELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---H 156
Query: 150 ANQVYIIDYGLAKK--YRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLE 205
V + D+GL K+ + TH T GT Y + + +R D
Sbjct: 157 QGHVKLTDFGLCKESIHDGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWW 205
Query: 206 SLGYVLMY-FLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
SLG LMY L G+ P+ G +K+ DKI + K++ P +
Sbjct: 206 SLG-ALMYDMLTGAPPFTG---ENRKKTIDKILKCKLNLPPYL 244
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 20/192 (10%), Positives = 48/192 (25%), Gaps = 48/192 (25%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYE--------SKLYML 66
+ K+ GEL+ G G +I VK+ V+ + +
Sbjct: 11 QLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-- 65
Query: 67 LQGGTGIPH---LKWFGV----EGDYNIMVIDLL-GPSLED-LFNYCNRKFSLKTVLMLA 117
H L G + ++ + SL + L N + A
Sbjct: 66 --------HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 118 DQLINRVEYMHSRGF--LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175
+ + ++H+ + + ++ + I +
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKF------------S 162
Query: 176 RENKNLTGTARY 187
++ +
Sbjct: 163 FQSPGRMYAPAW 174
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 58/268 (21%), Positives = 90/268 (33%), Gaps = 82/268 (30%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK----------------------LELVKTKH 54
F + IG GSFG++ L + AVK L KH
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-NVKH 98
Query: 55 P---QLHY----ESKLYMLLQ---GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYC 104
P LH+ KLY +L GG +LF +
Sbjct: 99 PFLVGLHFSFQTADKLYFVLDYINGG----------------------------ELFYHL 130
Query: 105 NR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
R F A ++ + + Y+HS ++RD+KP+N L+ + + D+GL K
Sbjct: 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCK 187
Query: 163 KYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSL 219
++I + + T GT Y + R D LG ++Y L G
Sbjct: 188 --------ENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEMLYGLP 237
Query: 220 PWQGLKAGTKKQKYDKISEKKVSTPIEV 247
P+ + YD I K + +
Sbjct: 238 PFYS---RNTAEMYDNILNKPLQLKPNI 262
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 24/222 (10%), Positives = 52/222 (23%), Gaps = 55/222 (24%)
Query: 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGT 71
+ G+++L G + + ++ ++A+ PQ + T
Sbjct: 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTF-----VDPQGVLPDDVLQETLSRT 82
Query: 72 ---------GIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLI 121
G+ + ++V + + G SL+++ + S + L
Sbjct: 83 LRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLA 139
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181
+ H G P + G
Sbjct: 140 AAADAAHRAGVALSIDHPSRVRVS-----------IDGDVV------------------- 169
Query: 182 TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
+DD+ +G L L P
Sbjct: 170 LAYPATMPDANP-------QDDIRGIGASLYALLVNRWPLPE 204
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 60/289 (20%), Positives = 115/289 (39%), Gaps = 96/289 (33%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYL---GVNVQTGEEIAVK---------------- 46
K+ +++ F+L + +G+G++G+++L TG+ A+K
Sbjct: 50 KVGIEN-----FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 47 -------LELVKTKHP---QLHY----ESKLYMLL---QGGTGIPHLKWFGVEGDYNIMV 89
LE ++ + P LHY E+KL+++L GG
Sbjct: 105 TRTERQVLEHIR-QSPFLVTLHYAFQTETKLHLILDYINGG------------------- 144
Query: 90 IDLLGPSLEDLFN--YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM--- 144
+LF +F+ V + +++ +E++H G ++RDIK +N L+
Sbjct: 145 ---------ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 145 GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQ--SR 200
G V + D+GL+K + + + GT Y + + G + +
Sbjct: 196 G------HVVLTDFGLSK--------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 241
Query: 201 RDDLESLGYVLMY-FLRGSLPWQGLKAG-TKKQKYDKISEKKVSTPIEV 247
D SLG VLMY L G+ P+ ++ + +I + + P E+
Sbjct: 242 AVDWWSLG-VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 39/186 (20%), Positives = 77/186 (41%), Gaps = 54/186 (29%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY-------- 64
+ ++ + +GSG++G + V+ +TG ++A+K K P ++S+L+
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK----KLYRP---FQSELFAKRAYREL 75
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 118
LL+ H++ V G ++ D D + L M D
Sbjct: 76 RLLK------HMRHENVIGLLDVFTPDETLDDFTDFY--------LVMPFMGTDLGKLMK 121
Query: 119 --------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKK 163
Q++ + Y+H+ G +HRD+KP N + + ++ I+D+GLA++
Sbjct: 122 HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLARQ 177
Query: 164 YRDLQT 169
T
Sbjct: 178 ADSEMT 183
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 42/186 (22%), Positives = 77/186 (41%), Gaps = 54/186 (29%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY-------- 64
+ +++ +GSG++G + + +TG +AVK K P ++S ++
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP---FQSIIHAKRTYREL 79
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 118
LL+ H+K V G ++ D++ L T LM AD
Sbjct: 80 RLLK------HMKHENVIGLLDVFTPARSLEEFNDVY--------LVTHLMGADLNNIVK 125
Query: 119 --------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKK 163
Q++ ++Y+HS +HRD+KP N + + ++ I+D+GLA+
Sbjct: 126 CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLARH 181
Query: 164 YRDLQT 169
D T
Sbjct: 182 TADEMT 187
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 37/173 (21%), Positives = 73/173 (42%), Gaps = 19/173 (10%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLLQGGTG 72
LG +IG G+FGE++ G +AVK L + E+++
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH--- 171
Query: 73 IPHL-KWFGV--EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
P++ + GV + +V++L+ G + +KT+L + +EY+
Sbjct: 172 -PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK-----KYRDLQTHKHIPYR 176
S+ +HRD+ N L+ + N + I D+G+++ Y + +P +
Sbjct: 231 SKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 38/176 (21%), Positives = 70/176 (39%), Gaps = 50/176 (28%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY-------- 64
I ++++ IG+GS+G + + +A+K K +E +
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK----KILRV---FEDLIDCKRILREI 103
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIM-VIDLLGPSLEDLFN--YCNRKF---SLKTVLM--- 115
+L L +++ V+D++ P + F+ Y + K +
Sbjct: 104 AILN------RLN------HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 116 -LAD--------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLA 161
L + L+ V+Y+HS G LHRD+KP N L+ + V + D+GLA
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV----NQDCSVKVCDFGLA 203
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 8e-08
Identities = 42/171 (24%), Positives = 62/171 (36%), Gaps = 47/171 (27%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGE--EIAVKLELVKTKHPQLHYESKLYMLLQGGTGIP 74
FK + +GSG+FG +Y G+ + GE +I V +K L+ T
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKE--------------LREATSPK 59
Query: 75 HLKWFGVEGDYNIM-------VIDLLGPSLED-------------LFNY---CNRKFSLK 111
K E +M V LLG L L +Y +
Sbjct: 60 ANKEILDEA--YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+L Q+ + Y+ R +HRD+ N L+ V I D+GLAK
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 39/181 (21%), Positives = 66/181 (36%), Gaps = 60/181 (33%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY-------- 64
+ + + IG GS+G +YL + T + +A+K K +E +
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK----KVNRM---FEDLIDCKRILREI 76
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFN--YCNRKFSLKTVLMLAD---- 118
+L LK DY I + DL+ P F+ Y + + +D
Sbjct: 77 TILN------RLK-----SDYIIRLYDLIIPDDLLKFDELY------IVLEIADSDLKKL 119
Query: 119 -----------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGL 160
L+ ++H G +HRD+KP N L+ + V + D+GL
Sbjct: 120 FKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL----NQDCSVKVCDFGL 175
Query: 161 A 161
A
Sbjct: 176 A 176
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 30/183 (16%), Positives = 63/183 (34%), Gaps = 22/183 (12%)
Query: 15 GKFKLGRKIGSG--SFGELYLGVNVQTGEEIAVK---LELVKTKHPQ-LHYESKLYMLLQ 68
G ++L IG G + L TGE + V+ LE + L E + L
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 69 GGTGIPH---LKWFG--VEGDYNIMVIDLL-GPSLEDLF-NYCNRKFSLKTVLMLADQLI 121
H + + + + +V + S +DL + + + + ++
Sbjct: 85 ------HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181
++Y+H G++HR +K + L+ +VY+ + + + K
Sbjct: 139 KALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 182 TGT 184
Sbjct: 196 VKV 198
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 46/185 (24%), Positives = 80/185 (43%), Gaps = 61/185 (32%)
Query: 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY--- 64
R+D + K++L +K+G G++G ++ ++ +TGE +AVK K +++
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK----KIFDA---FQNSTDAQR 54
Query: 65 -----MLLQGGTGIPHLKWFGVEGDYNIM-VIDLLGP-SLEDLFNYCNRKFSLKTVLMLA 117
M+L L G NI+ ++++L + D++ L M
Sbjct: 55 TFREIMILT------ELS-----GHENIVNLLNVLRADNDRDVY--------LVFDYMET 95
Query: 118 D--------------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYII 156
D QLI ++Y+HS G LHRD+KP N L+ A V +
Sbjct: 96 DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVA 151
Query: 157 DYGLA 161
D+GL+
Sbjct: 152 DFGLS 156
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 20/159 (12%)
Query: 16 KFKLGRKIGSGSFGELYLGV----NVQTGEEIAVKL--ELVKTKHPQ-LHYESKLYMLLQ 68
K R +G G FG++ L N TGE +AVK +H E + L
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 69 GGTGIPHL-KWFGV---EGDYNIMVIDLLGPSLEDLFNY-CNRKFSLKTVLMLADQLINR 123
H+ K+ G G ++ ++ P L L +Y L +L+ A Q+
Sbjct: 92 H----EHIIKYKGCCEDAGAASLQLVMEYVP-LGSLRDYLPRHSIGLAQLLLFAQQICEG 146
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+ Y+H++ ++HRD+ N L+ V I D+GLAK
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 32/180 (17%), Positives = 73/180 (40%), Gaps = 53/180 (29%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY-------- 64
+ +++ + IGSG+ G + + +A+K K P ++++ +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK----KLSRP---FQNQTHAKRAYREL 112
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 118
+L++ + + N+ +D++ L LM A+
Sbjct: 113 VLMK------CVNHKNIISLLNVFTPQKTLEEFQDVY--------LVMELMDANLCQVIQ 158
Query: 119 -------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKY 164
Q++ ++++HS G +HRD+KP N ++ K++ + I+D+GLA+
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 2e-07
Identities = 31/201 (15%), Positives = 59/201 (29%), Gaps = 59/201 (29%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---------------------------- 47
K + KIG G FGE++ + +A+K+
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 48 ----------------------ELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85
V+ +P L ++ + G+ +F + +
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 86 NIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLM 144
++ + G LE + SL T + QL + + F HRD+ N L+
Sbjct: 139 IVLEFEFGGIDLE---QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 145 GLGRKANQVYIIDYGLAKKYR 165
+K + + K
Sbjct: 196 ---KKTSLKKLHYTLNGKSST 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 16/156 (10%)
Query: 17 FKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGI-- 73
+L K+G GSFG + G + +G+ ++V VK P + + +
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 74 ----PHL-KWFGVEGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEY 126
+L + +GV + ++ L P SL D F L T+ A Q+ + Y
Sbjct: 77 SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 127 MHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+ S+ F+HRD+ N L+ + V I D+GL +
Sbjct: 137 LESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 39/175 (22%), Positives = 69/175 (39%), Gaps = 46/175 (26%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIP 74
+ +LGR IG G FG+++ G+ +AV +KT + T
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVA---IKT--------------CKNCTSDS 58
Query: 75 HLKWFGVEGDYNIM-------VIDLLGPSLE-------------DLFNY---CNRKFSLK 111
+ F E M ++ L+G E +L ++ L
Sbjct: 59 VREKFLQEA--LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLA 116
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
++++ A QL + Y+ S+ F+HRDI N L+ + V + D+GL++ D
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMED 168
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 47/237 (19%), Positives = 101/237 (42%), Gaps = 27/237 (11%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTGI 73
F+ ++G+G+ G ++ + +G +A K LE+ Q+ E L +L + +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE--LQVLHECNS-- 90
Query: 74 PHL-KWFG---VEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
P++ ++G +G+ +I ++ + G SL+ + R + + ++ +I + Y+
Sbjct: 91 PYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 148
Query: 129 SRGF-LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 187
+ +HRD+KP N L+ ++ + D+G++ + D + + GT Y
Sbjct: 149 EKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSY 196
Query: 188 ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
S G S + D+ S+G L+ G P A + + E +
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 39/188 (20%), Positives = 60/188 (31%), Gaps = 59/188 (31%)
Query: 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK--LELVKTKHPQLHYESKLY--- 64
H + + + R I SGS+G + GV+ G +A+K V
Sbjct: 17 LHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 65 -----MLLQGGTGIPHLKWFGVEGDYNIM-VIDLLGPSLEDLFN--YCNRKFSLKTVLML 116
LL H NI+ + D+ E + Y L T LM
Sbjct: 76 VLREIRLLN------HFH------HPNILGLRDIFVHFEEPAMHKLY------LVTELMR 117
Query: 117 AD----------------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QV 153
D ++ + +H G +HRD+ P N L+ N +
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDI 173
Query: 154 YIIDYGLA 161
I D+ LA
Sbjct: 174 TICDFNLA 181
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 20/159 (12%)
Query: 17 FKLGRKIGSGSFGELYLGV----NVQTGEEIAVKL--ELVKTKHPQ-LHYESKLYMLLQG 69
K R +G G FG++ L TGE++AVK H L E ++ L
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82
Query: 70 GTGIPHL-KWFGV---EGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINR 123
++ K+ G+ +G I +I P SL++ K +LK L A Q+
Sbjct: 83 ----ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
++Y+ SR ++HRD+ N L+ +QV I D+GL K
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 19/157 (12%)
Query: 18 KLGRKIGSGSFGELYLGV----NVQTGEEIAVK-LELVKTKHPQ-LHYESKLYMLLQGGT 71
K ++G G+FG + L TG +AVK L+ + E ++ L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-- 83
Query: 72 GIPHL-KWFGV---EGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVE 125
+ K+ GV G ++ ++ P L D + +L+ + Q+ +E
Sbjct: 84 --DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 126 YMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
Y+ SR +HRD+ N L+ V I D+GLAK
Sbjct: 142 YLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 41/177 (23%), Positives = 68/177 (38%), Gaps = 49/177 (27%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIP 74
L R +G G FGE+Y GV GE+I V VKT + +
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVA---VKT--------------CKKDCTLD 55
Query: 75 HLKWFGVEGDYNIM-------VIDLLGPSLE-------------DLFNY---CNRKFSLK 111
+ + F E IM ++ L+G E +L +Y +
Sbjct: 56 NKEKFMSEA--VIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVL 113
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168
T+++ + Q+ + Y+ S +HRDI N L+ V + D+GL+ R ++
Sbjct: 114 TLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS---RYIE 164
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 35/181 (19%), Positives = 63/181 (34%), Gaps = 62/181 (34%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY-------- 64
+G ++ IG G++G + + +A+K K +E + Y
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----KISP----FEHQTYCQRTLREI 76
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIM-VIDLLGPSLEDLFN--YCNRKFSLKTVLMLAD--- 118
+L + NI+ + D++ + Y + LM D
Sbjct: 77 KILL------RFR------HENIIGINDIIRAPTIEQMKDVY------IVQDLMETDLYK 118
Query: 119 -----------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGL 160
Q++ ++Y+HS LHRD+KP N L+ + I D+GL
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGL 174
Query: 161 A 161
A
Sbjct: 175 A 175
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 32/177 (18%), Positives = 73/177 (41%), Gaps = 53/177 (29%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY-------- 64
+ +++ + IGSG+ G + + +A+K K P ++++ +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK----KLSRP---FQNQTHAKRAYREL 75
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 118
+L++ + + G N+ +D++ + LM A+
Sbjct: 76 VLMK------CVNHKNIIGLLNVFTPQKSLEEFQDVY--------IVMELMDANLCQVIQ 121
Query: 119 -------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLA 161
Q++ ++++HS G +HRD+KP N ++ K++ + I+D+GLA
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 28/135 (20%), Positives = 66/135 (48%), Gaps = 16/135 (11%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTGIPHL-K 77
+IG G++G + V+ +G+ +AVK + + + QL + L ++++ + P++ +
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD--LDVVMR-SSDCPYIVQ 85
Query: 78 WFG---VEGDYNIMVIDLLGPSLEDL----FNYCNRKFSLKTVLMLADQLINRVEYMHS- 129
++G EGD I ++L+ S + ++ + + + + + + ++
Sbjct: 86 FYGALFREGDCWI-CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 130 RGFLHRDIKPDNFLM 144
+HRDIKP N L+
Sbjct: 145 LKIIHRDIKPSNILL 159
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 31/134 (23%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 22 KIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTGIPHL-K 77
++G G++G + +V +G+ +AVK + + +L + L + ++ P
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD--LDISMR-TVDCPFTVT 70
Query: 78 WFG---VEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLA---DQLINRVEYMHS-R 130
++G EGD I ++L+ SL+ + K +L ++ +E++HS
Sbjct: 71 FYGALFREGDVWI-CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 131 GFLHRDIKPDNFLM 144
+HRD+KP N L+
Sbjct: 130 SVIHRDVKPSNVLI 143
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 40/169 (23%), Positives = 63/169 (37%), Gaps = 43/169 (25%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
FK + +GSG+FG +Y G+ + GE++ + + +K L+ T
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA-IKE--------------LREATSPKAN 61
Query: 77 KWFGVEGDYNIM-------VIDLLGPSLE-------------DLFNY---CNRKFSLKTV 113
K E +M V LLG L L +Y + +
Sbjct: 62 KEILDEA--YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 114 LMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
L Q+ + Y+ R +HRD+ N L+ V I D+GLAK
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 40/159 (25%), Positives = 70/159 (44%), Gaps = 23/159 (14%)
Query: 18 KLGRKIGSGSFGELYLGV----NVQTGEEIAVKLELVKTKHPQ----LHYESKLYMLLQG 69
K +++G G+FG + + TGE +AVK ++ + E ++ LQ
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSLQH 101
Query: 70 GTGIPHL-KWFGV---EGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINR 123
++ K+ GV G N+ +I P SL D + +L Q+
Sbjct: 102 ----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+EY+ ++ ++HRD+ N L+ N+V I D+GL K
Sbjct: 158 MEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 35/176 (19%), Positives = 69/176 (39%), Gaps = 47/176 (26%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIP 74
+ + +G+G FGE+ G + + +EI+V +KT L+ G
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVA---IKT--------------LKVGYTEK 88
Query: 75 HLKWFGVEGDYNIM-------VIDLLG------P-----------SLEDLFNYCNRKFSL 110
+ F E +IM +I L G P SL+ + +F++
Sbjct: 89 QRRDFLGEA--SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 111 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
++ + + + ++Y+ G++HRD+ N L+ + D+GL + D
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLED 199
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 16 KFKLGRKIGSGSFGELYLGV----NVQTGEEIAVKLELVKTKHPQ----LHYESKLYMLL 67
K +++G G+FG + + TGE +AVK ++ + E ++ L
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 68
Query: 68 QGGTGIPHL-KWFGV---EGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLI 121
Q ++ K+ GV G N+ +I P SL D + +L Q+
Sbjct: 69 QH----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+EY+ ++ ++HRD+ N L+ N+V I D+GL K
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 39/175 (22%), Positives = 69/175 (39%), Gaps = 46/175 (26%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIP 74
+ +LGR IG G FG+++ G+ +AV +KT + T
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVA---IKT--------------CKNCTSDS 433
Query: 75 HLKWFGVEGDYNIM-------VIDLLGPSLE-------------DLFNY---CNRKFSLK 111
+ F E M ++ L+G E +L ++ L
Sbjct: 434 VREKFLQEA--LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLA 491
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
++++ A QL + Y+ S+ F+HRDI N L+ + V + D+GL++ D
Sbjct: 492 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMED 543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 37/157 (23%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
+ K+G G +GE+Y GV + +AVK L+ + + E+ + ++ P
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----P 276
Query: 75 HL-KWFGV-EGDYNIMVIDLLGP--SLED-LFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
+L + GV + +I +L D L ++ S +L +A Q+ + +EY+
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+ F+HR++ N L+G + + V + D+GL++
Sbjct: 337 KNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTG 370
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 60/282 (21%), Positives = 116/282 (41%), Gaps = 39/282 (13%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGI 73
+L K+G G FGE+++G N T +A+K L+ E+++ L+
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 238
Query: 74 PHL-KWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRKF-SLKTVLMLADQLINRVEYMHS 129
L + + V + I ++ SL D K+ L ++ +A Q+ + + Y+
Sbjct: 239 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD----LQTHKHIPYRENKNLTGTA 185
++HRD++ N L+G + + D+GLA+ D + P + TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349
Query: 186 RYASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEKKVST 243
A++ + + D+ S G +L+ +G +P+ G+ ++ D++ E+
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRM 400
Query: 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285
P C P C E++P + YL+ D F
Sbjct: 401 PCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 29/170 (17%), Positives = 61/170 (35%), Gaps = 43/170 (25%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+ + + +GSG FG ++ GV + GE I + + +K ++ +G
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVC-IKV--------------IEDKSGRQS 58
Query: 76 LKWFGVEGDYNIM-------VIDLLGPSLE-------------DLFNY---CNRKFSLKT 112
+ + ++ LLG L ++ +
Sbjct: 59 FQAVTDHM--LAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL 116
Query: 113 VLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+L Q+ + Y+ G +HR++ N L+ +QV + D+G+A
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 38/173 (21%), Positives = 67/173 (38%), Gaps = 27/173 (15%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+ KL + IG G FG++ LG G ++AVK E+ + L+ +
Sbjct: 22 ELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----SN 75
Query: 76 L-KWFGV--EGDYNIMVIDLLGPSLE-----DLFNY----CNRKFSLKTVLMLADQLINR 123
L + GV E + ++ E L +Y +L + +
Sbjct: 76 LVQLLGVIVEEKGGLYIV------TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYR 176
+EY+ F+HRD+ N L+ + N + D+GL K+ Q +P +
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 42/185 (22%), Positives = 68/185 (36%), Gaps = 51/185 (27%)
Query: 18 KLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
IG G FG +Y G G++I VK+ L T I +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKS--------------LNRITDIGEV 134
Query: 77 KWFGVEGDYNIM-------VIDLLGPSLE---------------DLFNY---CNRKFSLK 111
F EG IM V+ LLG L DL N+ ++K
Sbjct: 135 SQFLTEG--IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 192
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171
++ Q+ ++++ S+ F+HRD+ N ++ + V + D+GLA RD+ +
Sbjct: 193 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---RDMYDKE 246
Query: 172 HIPYR 176
Sbjct: 247 FDSVH 251
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 36/170 (21%), Positives = 72/170 (42%), Gaps = 17/170 (10%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
+L K+G G FGE+++G +A+K L+ E+++ L+
Sbjct: 268 SLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH----E 322
Query: 75 HL-KWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRKF-SLKTVLMLADQLINRVEYMHSR 130
L + + V + I ++ SL D K+ L ++ +A Q+ + + Y+
Sbjct: 323 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD----LQTHKHIPYR 176
++HRD++ N L+G + + D+GLA+ D + P +
Sbjct: 383 NYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 44/192 (22%), Positives = 70/192 (36%), Gaps = 53/192 (27%)
Query: 18 KLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
IG G FG +Y G G++I VK+ L T I +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKS--------------LNRITDIGEV 70
Query: 77 KWFGVEGDYNIM-------VIDLLGPSLE---------------DLFNY---CNRKFSLK 111
F EG IM V+ LLG L DL N+ ++K
Sbjct: 71 SQFLTEGI--IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 128
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171
++ Q+ ++Y+ S+ F+HRD+ N ++ + V + D+GLA RD+ +
Sbjct: 129 DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---RDM--YD 180
Query: 172 HIPYRENKNLTG 183
Y +
Sbjct: 181 KEYYSVHNKTGA 192
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 40/181 (22%), Positives = 68/181 (37%), Gaps = 43/181 (23%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----------LE----LVKTKHPQLHYE 60
+ KL + IG G FG++ LG G ++AVK L + + +H L
Sbjct: 194 ELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNL--- 248
Query: 61 SKLYMLLQGGTGIPHLKWFGV--EGDYNIMVIDLLGP--SLED-LFNYCNRKFSLKTVLM 115
+L GV E + ++ SL D L + +L
Sbjct: 249 VQLL---------------GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 116 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175
+ + +EY+ F+HRD+ N L+ + N + D+GL K+ Q +P
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPV 350
Query: 176 R 176
+
Sbjct: 351 K 351
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 32/175 (18%), Positives = 61/175 (34%), Gaps = 47/175 (26%)
Query: 17 FKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+ + IGSG GE+ G V ++ V +K L+ G
Sbjct: 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA---IKA--------------LKAGYTERQ 93
Query: 76 LKWFGVEGDYNIM-------VIDLLG------P--------SLEDLFNY---CNRKFSLK 111
+ F E +IM +I L G L + + +F++
Sbjct: 94 RRDFLSEA--SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM 151
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
++ + + + Y+ G++HRD+ N L+ + D+GL++ D
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLED 203
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 6e-06
Identities = 33/154 (21%), Positives = 69/154 (44%), Gaps = 17/154 (11%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
+++G+G FG + G + ++A+K ++ + E+K+ M L
Sbjct: 25 DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH----E 79
Query: 75 HL-KWFGV--EGDYNIMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMH 128
L + +GV + ++ + + + L NY +F + +L + + +EY+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYM--ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
S+ FLHRD+ N L+ V + D+GL++
Sbjct: 138 SKQFLHRDLAARNCLVN---DQGVVKVSDFGLSR 168
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 7e-06
Identities = 34/157 (21%), Positives = 68/157 (43%), Gaps = 17/157 (10%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIPH 75
++IGSG FG ++LG +++A+K + E+++ M L P
Sbjct: 10 LTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH----PK 64
Query: 76 L-KWFGV--EGDYNIMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHS 129
L + +GV E +V + + L +Y F+ +T+L + + + Y+
Sbjct: 65 LVQLYGVCLEQAPICLVTEFM--EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+HRD+ N L+G + + + D+G+ + D
Sbjct: 123 ACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD 156
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 36/167 (21%), Positives = 59/167 (35%), Gaps = 45/167 (26%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKW 78
+++GSG+FG + G V VK L+ P LK
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVA---VKI--------------LKNEANDPALKD 63
Query: 79 -FGVEGDYNIM-------VIDLLGPSLE-------------DLFNY--CNRKFSLKTVLM 115
E N+M ++ ++G L Y NR K ++
Sbjct: 64 ELLAEA--NVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 121
Query: 116 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
L Q+ ++Y+ F+HRD+ N L+ + I D+GL+K
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 34/177 (19%), Positives = 64/177 (36%), Gaps = 48/177 (27%)
Query: 16 KFKLGRKIGSGSFGELYLGV--NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGI 73
+ IG+G FGE+Y G+ +E+ V +KT L+ G
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVA---IKT--------------LKAGYTE 87
Query: 74 PHLKWFGVEGDYNIM-------VIDLLGPSLE--------------DLFNY---CNRKFS 109
F E IM +I L G + L + + +FS
Sbjct: 88 KQRVDFLGEA--GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS 145
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+ ++ + + ++Y+ + ++HRD+ N L+ + D+GL++ D
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 30/151 (19%), Positives = 60/151 (39%), Gaps = 13/151 (8%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYML----LQGGTGIP 74
++G G+FG + GV ++I V +K M+ + P
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 75 HL-KWFGVEGDYNIMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
++ + GV +M++ + G L + + V L Q+ ++Y+ +
Sbjct: 397 YIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
F+HR++ N L+ + I D+GL+K
Sbjct: 457 FVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 40/189 (21%), Positives = 74/189 (39%), Gaps = 51/189 (26%)
Query: 18 KLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
R IG G FG +Y G Q I +K+ L T + +
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCA---IKS--------------LSRITEMQQV 66
Query: 77 KWFGVEGDYNIM-------VIDLLGPSLE---------------DLFNY---CNRKFSLK 111
+ F EG +M V+ L+G L DL + R ++K
Sbjct: 67 EAFLREG--LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK 124
Query: 112 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171
++ Q+ +EY+ + F+HRD+ N ++ ++ V + D+GLA RD+ +
Sbjct: 125 DLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---RDILDRE 178
Query: 172 HIPYRENKN 180
+ +++++
Sbjct: 179 YYSVQQHRH 187
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 25/163 (15%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQ-LHYESKLYMLLQGGTGIP 74
+ K+G G +GE+Y GV + +AVK T + E+ + ++ P
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----P 69
Query: 75 HL-KWFGV-EGDYNIMVIDLLGPSLE-----DLFNY---CNRK-FSLKTVLMLADQLINR 123
+L + GV + +I E +L +Y CNR+ S +L +A Q+ +
Sbjct: 70 NLVQLLGVCTREPPFYII------TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
+EY+ + F+HRD+ N L+G + + V + D+GL++
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 15/157 (9%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGI 73
KL +K+G+G FGE+++ N T ++AVK ++ E+ + LQ
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLAEANVMKTLQH---- 242
Query: 74 PHL-KWFGVEGDYNIMVIDLLGP--SLED-LFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
L K V I +I SL D L + K L ++ + Q+ + ++
Sbjct: 243 DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166
R ++HRD++ N L+ + I D+GLA+ D
Sbjct: 303 RNYIHRDLRAANILVS---ASLVCKIADFGLARVIED 336
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
+ L +++GSG FG + LG + ++AVK ++ + E++ M L P
Sbjct: 9 EITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH----P 63
Query: 75 HL-KWFGV--EGDYNIMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMH 128
L K++GV + +V + + S L NY + +L + + + ++
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYI--SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168
S F+HRD+ N L+ + V + D+G+ R +
Sbjct: 122 SHQFIHRDLAARNCLVD---RDLCVKVSDFGMT---RYVL 155
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 40/182 (21%), Positives = 65/182 (35%), Gaps = 42/182 (23%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG---T 71
+F LGR +G G FG + + G + V VK + S + L+
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVA---VKMLKADIIASSDIEEFLREAACMK 80
Query: 72 GIPH---LKWFGV-------EGDYNIMVIDLLGPSLE-----DLFNY--------CNRKF 108
H K GV MVI L DL +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVI------LPFMKHGDLHAFLLASRIGENPFNL 134
Query: 109 SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168
L+T++ + +EY+ SR F+HRD+ N ++ + V + D+GL+ R +
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLS---RKIY 188
Query: 169 TH 170
+
Sbjct: 189 SG 190
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 27/159 (16%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGI 73
KL ++G+G FGE+++G N T ++AVK L+ E+ L LQ
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLAEANLMKQLQH---- 67
Query: 74 PHL-KWFGVEGDYNIMVIDLLGPSLE-----DLFNY----CNRKFSLKTVLMLADQLINR 123
L + + V I +I E L ++ K ++ +L +A Q+
Sbjct: 68 QRLVRLYAVVTQEPIYII------TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+ ++ R ++HRD++ N L+ I D+GLA+
Sbjct: 122 MAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLAR 157
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 30/155 (19%), Positives = 60/155 (38%), Gaps = 14/155 (9%)
Query: 16 KFKLGR-KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYML----LQGG 70
+ ++G G+FG + GV ++I V +K M+ +
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 71 TGIPHL-KWFGVEGDYNIMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 127
P++ + GV +M++ + L + + V L Q+ ++Y+
Sbjct: 67 LDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 128 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
+ F+HRD+ N L+ + I D+GL+K
Sbjct: 127 EEKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 40/178 (22%), Positives = 66/178 (37%), Gaps = 41/178 (23%)
Query: 16 KFKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG---T 71
LG+ +G G FG + G + G + V VKT + ++ L
Sbjct: 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVA---VKTMKLDNSSQREIEEFLSEAACMK 91
Query: 72 GIPH---LKWFGV------EGDYNIMVIDLLGPSLE-----DLFNY--------CNRKFS 109
H ++ GV +G MVI L DL Y +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVI------LPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167
L+T+L + +EY+ +R FLHRD+ N ++ V + D+GL+ + +
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLS---KKI 197
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 30/181 (16%), Positives = 59/181 (32%), Gaps = 27/181 (14%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV--KT-KHPQLHY------ESKLYML 66
+G G+F +++ GV + G+ + V K +Y + +
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 67 LQGGTGIPHL-KWFGV--EGDYNIMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQL 120
L HL +GV GD NI+V + + L Y ++ L +A QL
Sbjct: 69 LSH----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAKQL 122
Query: 121 INRVEYMHSRGFLHRDIKPDNFL-----MGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175
+ ++ +H ++ N L + + D G++ +
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ-ERI 181
Query: 176 R 176
Sbjct: 182 P 182
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 38/199 (19%), Positives = 64/199 (32%), Gaps = 57/199 (28%)
Query: 16 KFKLGRKIGSGSFGELYLGV---NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTG 72
L R +G G+FGE+Y G + V VKT L
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKT--------------LPEVCS 73
Query: 73 IPHLKWFGVEGDYNIM-------VIDLLGPSLE--------------DLFNY-------- 103
F +E I+ ++ +G SL+ DL ++
Sbjct: 74 EQDELDFLMEA--LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 104 -CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
++ +L +A + +Y+ F+HRDI N L+ I D+G+A+
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 163 K-----YRDLQTHKHIPYR 176
Y +P +
Sbjct: 192 DIYRASYYRKGGCAMLPVK 210
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 38/199 (19%), Positives = 64/199 (32%), Gaps = 57/199 (28%)
Query: 16 KFKLGRKIGSGSFGELYLGV---NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTG 72
L R +G G+FGE+Y G + V VKT L
Sbjct: 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKT--------------LPEVCS 114
Query: 73 IPHLKWFGVEGDYNIM-------VIDLLGPSLE--------------DLFNY-------- 103
F +E I+ ++ +G SL+ DL ++
Sbjct: 115 EQDELDFLMEA--LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 104 -CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
++ +L +A + +Y+ F+HRDI N L+ I D+G+A+
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
Query: 163 K-----YRDLQTHKHIPYR 176
Y +P +
Sbjct: 233 DIYRAGYYRKGGCAMLPVK 251
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 9e-04
Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 40/175 (22%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG----TG 72
F IG G FG++Y GV ++ G ++A+K + ES QG T
Sbjct: 41 FDHKFLIGHGVFGKVYKGV-LRDGAKVALK---------RRTPESS-----QGIEEFETE 85
Query: 73 I--------PHL-KWFG--VEGDYNIMVIDLL--GPSLED-LFNYCNRKFSL--KTVLML 116
I PHL G E + I++ + G +L+ L+ S+ + L +
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG-NLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 117 ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL-QTH 170
+ Y+H+R +HRD+K N L+ I D+G++KK +L QTH
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILLDENFVPK---ITDFGISKKGTELDQTH 196
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 468 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.19 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.81 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.55 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.49 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.14 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.09 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.06 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.73 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.69 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.64 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.53 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.34 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.05 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.85 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.47 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.26 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-70 Score=574.89 Aligned_cols=454 Identities=61% Similarity=0.985 Sum_probs=277.4
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
|+.+++++|+++++||+|+||.||+|.+..+++.||||++.......++..|++++..+.++++++.+.+++.+.+..+|
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 57889999999999999999999999999999999999988888888999999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 89 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 89 v~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||||++++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+..+..+.+||+|||+++.+....
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999999999888899999999999999999999999999999999999999655578999999999999887766
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....++.......||+.|+|||++.+..++.++|||||||+||||++|..||.+.......+.+..+.........+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 66666777778899999999999999999999999999999999999999999998888888888888888888888889
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCCccCCCCCCCCCCCCC--CCCCCC
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQIGSSSKGRHSSGKVG--LTPGPS 326 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 326 (468)
+..+|+++.+||..||+.+|++||++.+|+++|++++...++++++.|||+.++..+......+..+..... ....|+
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~~~~~~~~~~s~~~~~ 320 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPP 320 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-------------------------
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCCCCCCCCCCCCCCCCCc
Confidence 999999999999999999999999999999999999999999999999999988766544333321111111 111122
Q ss_pred CCCCCCCCCCccccccccchhhHhhhcCCCC-CCCCCCCCCCCCC--CCCCCCCCCCCCCCCCccccCCCCCCcccccCC
Q 012192 327 AERPERGSVGKEIRDKLSGAVEAFSRKNAAG-TPHRDHPRHKSSD--DGPSSKHVNPDSEKGRSFSRYGSTSRKAVIAST 403 (468)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (468)
....++.+...+.++ +|......++..+. .+.+..++++++. +++.+++....+ +....|..+++|+.++|+|
T Consensus 321 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 396 (483)
T 3sv0_A 321 ALQNDRQSGVDEGRT--SGWSSMDRRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISA--SNFLGRSSGSSRRPAVSSS 396 (483)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccccCccccccc--cCCcccccccCCcccccccccccccCCCCCCccccccccccc--cccccccCCcccccccccc
Confidence 333344444433333 23222223333333 5556666666552 334444433333 3445799999999999999
Q ss_pred CCC---CCCCCCccccccccCCCC-CCCccccccCC--CCCcccccccccCCCcCCCCCccccccccccc
Q 012192 404 KPG---SSGEFSECRSSRLVSSSG-RLSTTQRLQSG--YDSRQSSFNRTAGGRICTRDDPIRSFEMLSIR 467 (468)
Q Consensus 404 ~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (468)
|.+ ++++++.+|+.+..+++. |.+++||+++. +++|+++++|++++++ |||+|||+||+|+|+
T Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 465 (483)
T 3sv0_A 397 RDVMPIDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVK-NYESALKGIEGLNFD 465 (483)
T ss_dssp ----------------------------------------------------------------------
T ss_pred ccccCCCCCCcccccccccCchhhhcCCCCcccCCCCccccccccccccccccc-cHHHHhhhhhhcccC
Confidence 986 677778899999988885 77777888776 6999999999999999 999999999999996
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=420.12 Aligned_cols=267 Identities=20% Similarity=0.307 Sum_probs=225.6
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
.++|++++.||+|+||+||+|.+..+++.||||++... .....+.+|++++..+.| ++|+.++.++.+.+..||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 46899999999999999999999999999999987532 334568899999998875 677888888889999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||||+ ||+|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence 99999 7899999985 4579999999999999999999999999999999999999 57899999999999876532
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
.. .....+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+. +..+.+.+|....+..|
T Consensus 186 ~~-----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~p--- 254 (311)
T 4aw0_A 186 SK-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKLEYDFP--- 254 (311)
T ss_dssp TT-----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCCC---
T ss_pred CC-----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCC---
Confidence 21 11235678999999999999999999999999999999999999999864 34556666666665554
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
..+++++.+||..||..||++||+++++.. .... ..++|+..+||+.+.
T Consensus 255 --~~~s~~~~dli~~lL~~dp~~R~t~~e~~~---~~~i-~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 255 --EKFFPKARDLVEKLLVLDATKRLGCEEMEG---YGPL-KAHPFFESVTWENLH 303 (311)
T ss_dssp --TTCCHHHHHHHHHHSCSSGGGSTTSGGGTC---HHHH-HTSGGGTTCCCTTGG
T ss_pred --cccCHHHHHHHHHHccCCHhHCcChHHHcC---CHHH-HCCCCcCCCCHHHhc
Confidence 356899999999999999999999987532 1111 347888899999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=407.91 Aligned_cols=294 Identities=74% Similarity=1.343 Sum_probs=259.1
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
|+..++++|++++.||+|+||.||+|.+..+++.||||+.........+..|++++..+.|++++..+..+....+..++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 45667899999999999999999999999999999999987777788899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 89 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 89 v~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||+++......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999999999999777889999999999999999999999999999999999999544578899999999999877665
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....++.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......+.+..+.......+.+.+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 55555666667789999999999999999999999999999999999999999987666555666666677777788888
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+..+|+++.++|..||+.+|++||++.+|++.|++++...+...++.+||+.++
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGCC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhcC
Confidence 889999999999999999999999999999999999999999999999999763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=404.82 Aligned_cols=294 Identities=74% Similarity=1.343 Sum_probs=264.7
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
|+..++++|++++.||+|+||.||+|.+..+++.||||++........+..|+.++..+.|+++++.+..+.......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 55678899999999999999999999999999999999988777778899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 89 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 89 v~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
+||+++++|.+++......+++..++.++.|++.||+|||++||+||||||+|||++..+.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999999999998777789999999999999999999999999999999999999655578899999999998877655
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....++.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......+.+..+.......+.+.+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 55555555667788999999999999999999999999999999999999999986655555556666666677777888
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
+..+|+++.++|..||+.||++||++.+|.+.|++++...+...++.+||+.++
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGCC
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 889999999999999999999999999999999999999999999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-53 Score=420.33 Aligned_cols=259 Identities=22% Similarity=0.227 Sum_probs=213.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
+.|++.++||+|+||+||+|.++.+|+.||||++.... ...+|+.++..+.| ++|+.++.++.+.+..||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~---~~~~E~~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSS-PRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCTHHHHTTTTCCC-TTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH---hHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeccC
Confidence 57999999999999999999999999999999876543 23569999888865 67778888888999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC-eEEEEeCCcccccccccCccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~-~vkL~DFGla~~~~~~~~~~~ 172 (468)
||+|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+||||+ .++ .+||+|||+|+.+.......
T Consensus 134 gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~~~~- 208 (336)
T 4g3f_A 134 GGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDGLGK- 208 (336)
T ss_dssp TCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCCccc-
Confidence 7899999985 45799999999999999999999999999999999999994 555 69999999998765422111
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccC
Q 012192 173 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
.......++||+.|||||++.+..|+.++|||||||+||||++|..||.+.........+ .... .+...+...+
T Consensus 209 -~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~~~~--~~~~~~~~~~ 282 (336)
T 4g3f_A 209 -SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI---ASEP--PPIREIPPSC 282 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH---HHSC--CGGGGSCTTS
T ss_pred -ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH---HcCC--CCchhcCccC
Confidence 111234568999999999999999999999999999999999999999876555443333 2222 2233445678
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 253 PSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
++++.+||.+||+.||++||++.+|.+.|...+...
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999998887764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=412.71 Aligned_cols=286 Identities=59% Similarity=1.076 Sum_probs=260.6
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.+++++|++++.||+|+||.||+|.+..+++.||||++........+..|+.++..+.+|++|+.+..++...+..++||
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 46789999999999999999999999999999999998877777789999999999978899999999999999999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCe-----EEEEeCCcccccc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ-----VYIIDYGLAKKYR 165 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~-----vkL~DFGla~~~~ 165 (468)
|+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++. +||+|||+++.+.
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESB
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeee
Confidence 9999999999997778899999999999999999999999999999999999995 4444 9999999999877
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
........++.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+.......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 65555556666667889999999999999999999999999999999999999999988777777777777777777788
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccc
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTV 300 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~ 300 (468)
+.++..+| ++.++|..||+.+|.+||++++|.+.|++++.+.++..+..+||+.
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 88888888 9999999999999999999999999999999999999999999984
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-53 Score=416.12 Aligned_cols=263 Identities=23% Similarity=0.344 Sum_probs=215.2
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
+.+|-.++|.+.++||+|+||+||+|++. .++..||||++..... ..++.+|++++.+++| +||+.+++++.
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~ 85 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCV 85 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEC
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCC-CCCccEEEEEe
Confidence 34566689999999999999999999875 3578999998754322 3468899999999975 67778888888
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCN------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR 148 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~ 148 (468)
+.+..+|||||+ +|+|.+++...+ ..|++..++.|+.||+.||+|||+++||||||||+|||+ +
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~ 162 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---G 162 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---C
Confidence 888999999999 899999997532 469999999999999999999999999999999999999 5
Q ss_pred CCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcc
Q 012192 149 KANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 227 (468)
Q Consensus 149 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~ 227 (468)
.++.+||+|||+|+....... +.......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+...
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~- 236 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN- 236 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred CCCcEEECCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 789999999999986543221 122345679999999999999999999999999999999998 9999988654
Q ss_pred cHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 228 TKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 228 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.+.+..+..... .+.+ ..+|+++.+||..||+.||++||++.+|.+.|+++...
T Consensus 237 --~~~~~~i~~~~~-~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 237 --NEVIECITQGRV-LQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp --HHHHHHHHHTCC-CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCC-CCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 334444444332 2222 35699999999999999999999999999999997664
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=419.77 Aligned_cols=245 Identities=18% Similarity=0.245 Sum_probs=207.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc--CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK--TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
+.|++.++||+|+||+||+|.+..+|+.||||++... .....+.+|++++..+.| ++|+.++.++.+.+..||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeC
Confidence 5799999999999999999999999999999987543 234568899999999875 6788888888899999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ ||+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCC--
Confidence 9 7899999984 579999999999999999999999999999999999999 5789999999999987654221
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
.....+||+.|||||++.+..|+.++|||||||+||||++|..||.+... .+.+..+..... . .......
T Consensus 226 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~~-~-~~~~~~~ 295 (346)
T 4fih_A 226 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNLP-P-RLKNLHK 295 (346)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSSC-C-CCSCGGG
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCCC-C-CCCcccc
Confidence 23567899999999999999999999999999999999999999987533 334444433221 1 1112346
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
+++++.+||..||..||++||++++|
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~ 321 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAEL 321 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 78999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=401.40 Aligned_cols=293 Identities=55% Similarity=0.986 Sum_probs=262.4
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
.+.+++++|++++.||+|+||.||+|.+..+++.||||++........+..|+.++..+.++++++.+..++......++
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp --CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 46789999999999999999999999999999999999987777778899999999999888999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc--CCCCeEEEEeCCccccccc
Q 012192 89 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 89 v~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~--~~~~~vkL~DFGla~~~~~ 166 (468)
|||+++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+... .....+||+|||+++....
T Consensus 84 v~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 84 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 99999999999999777789999999999999999999999999999999999999522 1233499999999998776
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
.......++.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......+.+..+.......+..
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 55555555556677889999999999999999999999999999999999999999877767777777777777777778
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVL 301 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 301 (468)
.++..+|+++.++|..||+.+|++||++.+|.+.|++++...+...+..+||+.+
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 298 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCCC
Confidence 8888999999999999999999999999999999999999999999999999853
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=406.10 Aligned_cols=259 Identities=25% Similarity=0.325 Sum_probs=200.6
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
.+.-|..+ ++|++++.||+|+||+||+|.+..+|+.||||++.... ....+.+|++++..+.| ++|+.++.++
T Consensus 5 ~l~~G~~i-g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~ 82 (275)
T 3hyh_A 5 SLADGAHI-GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-PHIIKLYDVI 82 (275)
T ss_dssp ----------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCC-TTBCCEEEEE
T ss_pred CCCCCCEe-eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEE
Confidence 34555566 58999999999999999999999999999999865432 23458899999999975 6788888888
Q ss_pred EeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 81 VEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 81 ~~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
.+.+..||||||++|+|.+++.. .+.+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~~~~~ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGl 158 (275)
T 3hyh_A 83 KSKDEIIMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGL 158 (275)
T ss_dssp ECSSEEEEEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSC
T ss_pred EECCEEEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCC
Confidence 89999999999999999999985 5689999999999999999999999999999999999999 5789999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
|+...... ...+.+||+.|||||++.+..| +.++|||||||++|+|++|..||.+. +..+.+..+...
T Consensus 159 a~~~~~~~--------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~ 227 (275)
T 3hyh_A 159 SNIMTDGN--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNG 227 (275)
T ss_dssp C-----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHT
T ss_pred CeecCCCC--------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcC
Confidence 98654322 1345789999999999998886 68999999999999999999999864 334555555555
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 289 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~ 289 (468)
....| ..+++++.+||..||+.||++||+++++ |++.+.+..
T Consensus 228 ~~~~p-----~~~s~~~~~li~~~L~~dP~~R~s~~ei---l~hpw~k~~ 269 (275)
T 3hyh_A 228 VYTLP-----KFLSPGAAGLIKRMLIVNPLNRISIHEI---MQDDWFKVD 269 (275)
T ss_dssp CCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHH---HHCHHHHTT
T ss_pred CCCCC-----CCCCHHHHHHHHHHccCChhHCcCHHHH---HcCcccccC
Confidence 54443 3568999999999999999999998854 556665543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=413.48 Aligned_cols=261 Identities=18% Similarity=0.241 Sum_probs=213.7
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeE
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKW 78 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~ 78 (468)
..+.++--.++++.++||+|+||+||+|.+. .+++.||||++..... ...+..|+.++.+++| +||+.+++
T Consensus 18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g 96 (308)
T 4gt4_A 18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH-PNVVCLLG 96 (308)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCC-TTBCCEEE
T ss_pred CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCC-CCCCCcce
Confidence 3456677788999999999999999999864 3678999998654332 3468899999999976 67777778
Q ss_pred eeEeCceeEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCce
Q 012192 79 FGVEGDYNIMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNF 142 (468)
Q Consensus 79 ~~~~~~~~~lv~el~-ggsL~~ll~~~---------------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~Ni 142 (468)
++.+.+..+|||||+ +|+|.+++... ...+++..++.|+.|||.||+|||+++||||||||+||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 888888899999999 89999999642 23589999999999999999999999999999999999
Q ss_pred eecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCC
Q 012192 143 LMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPW 221 (468)
Q Consensus 143 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf 221 (468)
|+ ++++.+||+|||+++....... +.......||+.|||||++.+..|+.++|||||||+||||++ |..||
T Consensus 177 Ll---~~~~~~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf 248 (308)
T 4gt4_A 177 LV---YDKLNVKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248 (308)
T ss_dssp EE---CGGGCEEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EE---CCCCCEEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCC
Confidence 99 5789999999999986543221 223456789999999999999999999999999999999998 89999
Q ss_pred CCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 222 QGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 222 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
.+.... +.+..+... ...+.+ ..+|+++.+||..||+.||++||++.+|++.|+.
T Consensus 249 ~~~~~~---~~~~~i~~~-~~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 249 CGYSNQ---DVVEMIRNR-QVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp TTCCHH---HHHHHHHTT-CCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCHH---HHHHHHHcC-CCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 886543 333333332 223332 3569999999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=415.64 Aligned_cols=261 Identities=21% Similarity=0.311 Sum_probs=207.5
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
.|-..+|.+.++||+|+||+||+|++. .++..||||++..... ...+.+|++++..++| +||+.+++++.+.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~ 115 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH-QHIVRFFGVCTEG 115 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC
Confidence 455578999999999999999999865 3688999998754332 3468899999999965 6777888888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN--------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR 148 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~--------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~ 148 (468)
+..+|||||+ +|+|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|||+ +
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence 8999999999 899999987532 359999999999999999999999999999999999999 5
Q ss_pred CCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcc
Q 012192 149 KANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 227 (468)
Q Consensus 149 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~ 227 (468)
.++.+||+|||+++....... +.......||+.|||||++.+..|+.++|||||||+||||++ |+.||.+....
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~ 267 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267 (329)
T ss_dssp TTTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred CCCcEEEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence 889999999999986543221 122345689999999999999999999999999999999998 99999876543
Q ss_pred cHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 228 TKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 228 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+.+..+.... ..+.+ ..+|+++.+||..||+.||++||++.+|.+.|+.+...
T Consensus 268 ---~~~~~i~~g~-~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 268 ---EAIDCITQGR-ELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HHHHHHHHTC-CCCCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HHHHHHHcCC-CCCCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 3343343322 22222 35699999999999999999999999999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=413.11 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=202.8
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
|-.++|+++++||+|+||+||+|++. ..||||++...... ..+..|+.++..++|+ +|+.+++++.+ +..+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~Hp-NIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHV-NILLFMGYMTK-DNLA 107 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCT-TBCCEEEEECS-SSCE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCC-CEeeEEEEEEC-CeEE
Confidence 44578899999999999999999853 36999986543322 3578899999999765 55566666654 4578
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
|||||+ +|+|.+++......+++..++.|+.|||.||+|||+++||||||||+|||| ++++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceeccc
Confidence 999999 899999998666789999999999999999999999999999999999999 4789999999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
... .......+||+.|||||++.+. .|+.++|||||||+||||++|..||.+.... ..+..+.......
T Consensus 185 ~~~-----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~~~~~~~~~~~ 256 (307)
T 3omv_A 185 WSG-----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQIIFMVGRGYAS 256 (307)
T ss_dssp --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHTTCCC
T ss_pred CCc-----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHHHHHHhcCCCC
Confidence 221 1123456899999999999753 5899999999999999999999999876542 2222233333322
Q ss_pred -CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 244 -PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 244 -~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
........+|+++.+||..||+.||++||++.+|++.|+.+
T Consensus 257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 23344567799999999999999999999999999988765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=419.16 Aligned_cols=252 Identities=21% Similarity=0.236 Sum_probs=206.0
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|+++++||+|+||+||+|++..+|+.||||++..... ...+.+|++++..|.| ++|+.++.++.+.+..||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-PNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999998765432 2357889999999975 67778888888999999999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||+ ||+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCc
Confidence 999 78999999754 3457999999999999999999999999999999999999 578999999999998764321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.. ..+.+.++....... .
T Consensus 180 ~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~----~ 245 (350)
T 4b9d_A 180 E-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLVLKIISGSFPP----V 245 (350)
T ss_dssp H-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCC----C
T ss_pred c-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCC----C
Confidence 1 1235689999999999999999999999999999999999999998743 345555555544321 2
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
...+++++.+||..||+.||++||++++| |++.|..
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~---l~hp~~~ 281 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSI---LEKGFIA 281 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHH---HTSHHHH
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHH---hcCHHhh
Confidence 24568999999999999999999999865 4555443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=417.55 Aligned_cols=263 Identities=19% Similarity=0.289 Sum_probs=216.3
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCC-----CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe-
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQT-----GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE- 82 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~-----~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~- 82 (468)
|-.++|+++++||+|+||+||+|.+..+ ++.||||.+..... ...+..|++++..+.||++|+.+++++.+
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 4457899999999999999999997654 36899998765433 24588899999999999988888877654
Q ss_pred CceeEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 146 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~---------------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~ 146 (468)
++..+|||||| +|+|.+++... ...+++..++.|+.|||.||+|||+++||||||||+|||+
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl-- 218 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 218 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence 56789999999 89999999753 2348999999999999999999999999999999999999
Q ss_pred cCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCC
Q 012192 147 GRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 225 (468)
Q Consensus 147 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~ 225 (468)
++++.+||+|||+|+....... +.......||+.|||||++.+..|+.++|||||||+||||++ |..||.+..
T Consensus 219 -~~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 219 -SEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred -CCCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 5788999999999986543222 222346789999999999999999999999999999999998 999999865
Q ss_pred cccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 226 AGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 226 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
... .+..+.......+.+ ..+|+++.++|..||+.||++||++.+|++.|+.++...
T Consensus 293 ~~~---~~~~~i~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 293 IDE---EFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CSH---HHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH---HHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 432 222233333333333 345899999999999999999999999999999987643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=422.58 Aligned_cols=245 Identities=18% Similarity=0.255 Sum_probs=207.4
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
++|+++++||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+|..+.| ++|+.++.++...+..||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCCCceEEEEEECCEEEEEEeC
Confidence 57999999999999999999999999999999876443 33468899999999875 6778888888899999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
| ||+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+|||| +.++.|||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc--
Confidence 9 7899999974 469999999999999999999999999999999999999 5789999999999987654221
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
.....+||+.|||||++.+..|+.++|||||||+||||++|..||.+... .+.+..+..... +.......
T Consensus 303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~~--~~~~~~~~ 372 (423)
T 4fie_A 303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNLP--PRLKNLHK 372 (423)
T ss_dssp -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCC--CCCSCTTS
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCCC--CCCccccc
Confidence 23567999999999999999999999999999999999999999987543 333444433221 11122346
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
+++++.+||..||..||++||++.+|
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~el 398 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAEL 398 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 78999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=409.90 Aligned_cols=265 Identities=22% Similarity=0.340 Sum_probs=211.8
Q ss_pred cCceEEEceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
.++|++++.||+|+||+||+|++. .+++.||||++.... ....+..|++++..+.| ++|+.++.++.+.+..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCC-TTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEE
Confidence 368999999999999999999874 367899999865332 23457789999888865 6778888888899999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
||||||+ ||+|.+++.. .+.+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence 9999999 8899999985 4579999999999999999999999999999999999999 578999999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+ ..+.+..+.......|
T Consensus 178 ~~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~p- 246 (304)
T 3ubd_A 178 DHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---RKETMTMILKAKLGMP- 246 (304)
T ss_dssp ---C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC-
T ss_pred CCCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---HHHHHHHHHcCCCCCC-
Confidence 3221 2346789999999999999999999999999999999999999998743 3455555665555444
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSY--LKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~--l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
..+++++.+||..||+.||++||++.. +.+++ .++|+..+||+.+...+
T Consensus 247 ----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil-------~Hp~f~~idw~~l~~~~ 297 (304)
T 3ubd_A 247 ----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK-------RHSFFSTIDWNKLYRRE 297 (304)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHH-------TSGGGTTCCHHHHHTTC
T ss_pred ----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHH-------cCccccCCCHHHHHhCC
Confidence 346899999999999999999998531 22333 35677788998875433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=399.84 Aligned_cols=248 Identities=20% Similarity=0.276 Sum_probs=199.3
Q ss_pred eecCce-EEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEe----
Q 012192 12 VIGGKF-KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVE---- 82 (468)
Q Consensus 12 ii~~~y-~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~---- 82 (468)
...++| ++.++||+|+||+||+|.+..++..||||++..... ...+.+|++++..+.| ++|+.+++++..
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEEEETT
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEeeccCC
Confidence 344566 788999999999999999999999999998764432 2357889999999976 556666655443
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~g--iiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
....||||||+ ||+|.+++.. ...+++..+..|+.||+.||+|||+++ ||||||||+|||+. +.++.+||+|||
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFG 177 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLG 177 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTT
T ss_pred CcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCc
Confidence 35679999999 8899999985 567999999999999999999999998 99999999999994 246899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
+|+..... .....+||+.|||||++.+ .|+.++|||||||+||||++|..||.+... ..+.+..+...
T Consensus 178 la~~~~~~---------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~ 245 (290)
T 3fpq_A 178 LATLKRAS---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSG 245 (290)
T ss_dssp GGGGCCTT---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTT
T ss_pred CCEeCCCC---------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcC
Confidence 99754321 1245689999999998875 699999999999999999999999986432 23333333333
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.. +......+++++.+||..||+.||++||++.+|+
T Consensus 246 ~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 246 VK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp CC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CC---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 22 1223345689999999999999999999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=393.61 Aligned_cols=265 Identities=22% Similarity=0.264 Sum_probs=197.9
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHH--HHHhCCCCCceeeEeeEeC----cee
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLY--MLLQGGTGIPHLKWFGVEG----DYN 86 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l--~~l~~~~~i~~l~~~~~~~----~~~ 86 (468)
|+.+|.+.++||+|+||+||+|++ +|+.||||++.... ...+..|.+++ ..++| +||+.+.+++.+. ...
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~H-pNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCC-CCCCcEEEEEEecCCCceEE
Confidence 467899999999999999999987 68999999875443 33455555554 34454 6666666665543 257
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCceeecccCCCCeEEEEe
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR--------GFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~--------giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
+|||||+ +|+|.+++.. ..++++.++.++.|++.||+|||++ +||||||||+|||+ +.++.+||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~D 151 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEe
Confidence 9999999 8999999984 5799999999999999999999987 99999999999999 5889999999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccCC------CCCCcchHHHHHHHHHHHHcCCCCCC---------
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV------EQSRRDDLESLGYVLMYFLRGSLPWQ--------- 222 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~------~~s~ksDvwSlGvvl~elltG~~Pf~--------- 222 (468)
||+|+......... .......+||+.|||||++.+. .++.++|||||||+||||++|..||.
T Consensus 152 FGla~~~~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 152 LGLAVRHDSATDTI---DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEE---SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred CCCCccccCCCCce---eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 99998765432211 1123356899999999999865 36779999999999999999976553
Q ss_pred -CCCcc--cHHHHHHHHhhcccCCCHHHhh--ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012192 223 -GLKAG--TKKQKYDKISEKKVSTPIEVLC--KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 289 (468)
Q Consensus 223 -~~~~~--~~~~~~~~i~~~~~~~~~~~l~--~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~ 289 (468)
+.... ...+....+......++.+... ...+..+.+||..||+.||++|||+.+|.+.|+.+...++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 32211 2233333344444443333222 1235689999999999999999999999999999876554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=400.39 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=206.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeE------
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGV------ 81 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~------ 81 (468)
-++++|+++++||+|+||+||+|.+..+|+.||||++...... ..+.+|+++|..|.| ++|+.++.++.
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH-DNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSSCTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCC-CCcceEeeeeecccccc
Confidence 3678999999999999999999999999999999987554332 346789999999976 56666665543
Q ss_pred eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 82 EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 82 ~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
+....||||||++|+|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|
T Consensus 130 ~~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeeccee
Confidence 2356899999999999999974 6689999999999999999999999999999999999999 57899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh--
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE-- 238 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~-- 238 (468)
+.+....... .....+.+||+.|+|||++.+.. |+.++|||||||++|||++|..||.+.......+.+.....
T Consensus 206 ~~~~~~~~~~---~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEH---QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp BCC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eecccCcccc---ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 8764322111 12245679999999999998864 69999999999999999999999987544332222221111
Q ss_pred ---------------------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 239 ---------------------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 239 ---------------------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.....+...+...+++++.+||.+||..||++||++.+ +|++.|.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e---~L~Hp~f 348 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA---ALRHPFL 348 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH---HTTSGGG
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH---HhcCHhh
Confidence 01112233445567899999999999999999999985 4444443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=393.96 Aligned_cols=292 Identities=30% Similarity=0.544 Sum_probs=230.7
Q ss_pred CCCCCceecC----ceEEEceEeeeCCeEEEEEEEcCC-----CcEEEEEEeeccCCCchhHHHHHHHHHHhC-------
Q 012192 6 KLRMDHVIGG----KFKLGRKIGSGSFGELYLGVNVQT-----GEEIAVKLELVKTKHPQLHYESKLYMLLQG------- 69 (468)
Q Consensus 6 ~l~~~~ii~~----~y~i~~~LG~G~fG~Vy~~~~~~~-----~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~------- 69 (468)
.+..+.++.+ +|+++++||+|+||.||+|.+..+ ++.||||++... ...+..|++++..+.+
T Consensus 22 ~~~~g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~~~~~~~~~~~~e~ 99 (364)
T 3op5_A 22 QFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD--NGPLFTELKFYQRAAKPEQIQKW 99 (364)
T ss_dssp CCCTTCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETT--CHHHHHHHHHHHHHCCHHHHHHH
T ss_pred hcCCCcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeecc--chhHHHHHHHHHhhhhhHHHHHH
Confidence 4666777664 999999999999999999998664 578999986543 3456777777776655
Q ss_pred -------CCCCceeeEeeEeC----ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 012192 70 -------GTGIPHLKWFGVEG----DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIK 138 (468)
Q Consensus 70 -------~~~i~~l~~~~~~~----~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIK 138 (468)
|++|+.+++++... .+.+||||+++++|.+++......+++..++.|+.||+.||+|||++||+|||||
T Consensus 100 ~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlk 179 (364)
T 3op5_A 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIK 179 (364)
T ss_dssp HHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCC
Confidence 78888887776653 5689999999999999998766789999999999999999999999999999999
Q ss_pred CCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCC
Q 012192 139 PDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS 218 (468)
Q Consensus 139 p~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~ 218 (468)
|+|||+.. +.++.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 180 p~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 180 ASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp GGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred HHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999942 15789999999999877654333222222335567999999999999999999999999999999999999
Q ss_pred CCCCCCCcccHHHHHHHHhhcccCCCHHHh---h---ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 012192 219 LPWQGLKAGTKKQKYDKISEKKVSTPIEVL---C---KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQF 292 (468)
Q Consensus 219 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l---~---~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~ 292 (468)
.||.+.......... ...........+ | ..+|+++.++|..||+.+|++||++.+|.+.|++++...+...
T Consensus 259 ~Pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 259 LPWEDNLKDPKYVRD---SKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp CTTGGGTTCHHHHHH---HHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCccccccCHHHHHH---HHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 999864332211111 111111122222 1 5679999999999999999999999999999999999999999
Q ss_pred CcccccccccC
Q 012192 293 DYVFDWTVLKY 303 (468)
Q Consensus 293 ~~~~dw~~~~~ 303 (468)
+..+||+....
T Consensus 336 ~~~~dw~~~~~ 346 (364)
T 3op5_A 336 DGKLDLSVVEN 346 (364)
T ss_dssp CCCCCC-----
T ss_pred CCccceEeccC
Confidence 99999997653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=382.47 Aligned_cols=251 Identities=22% Similarity=0.270 Sum_probs=182.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeC--------
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEG-------- 83 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~-------- 83 (468)
++|++++.||+|+||+||+|.++.+|+.||||++...... ..+.+|++++..+.| ++|+.++.++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-PGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEecCccccccc
Confidence 4699999999999999999999999999999987654332 357889999999976 5555555544322
Q ss_pred ----ceeEEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 84 ----DYNIMVIDLL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 84 ----~~~~lv~el~-ggsL~~ll~~~~--~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
.+.||||||+ +|+|.+++.... ....+..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEc
Confidence 2478999999 889999998532 135567789999999999999999999999999999999 478899999
Q ss_pred eCCcccccccccCccc-----ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH
Q 012192 157 DYGLAKKYRDLQTHKH-----IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 231 (468)
Q Consensus 157 DFGla~~~~~~~~~~~-----~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~ 231 (468)
|||+|+.+........ .........+||+.|||||++.+..|+.++|||||||+||||++ ||.+.. ....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 9999987654322110 01112345689999999999999999999999999999999996 886421 1222
Q ss_pred HHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 232 KYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 232 ~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+..+... ..|. .....++++.+||..||+.||++||++.+|+
T Consensus 236 ~~~~~~~~--~~p~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 278 (299)
T 4g31_A 236 TLTDVRNL--KFPP--LFTQKYPCEYVMVQDMLSPSPMERPEAINII 278 (299)
T ss_dssp HHHHHHTT--CCCH--HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHhcC--CCCC--CCcccCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 22222222 2222 2223356788999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=413.87 Aligned_cols=265 Identities=25% Similarity=0.298 Sum_probs=219.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHh--CCCCCceeeEeeEeCce
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQ--GGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~ 85 (468)
--++|++++.||+|+||+||+|+++.+|+.||||++... ........|..++..+. +|++|+.++.++.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 346899999999999999999999999999999987532 22234555666655554 57889999999999999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.||||||+ ||+|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+|||| +.++++||+|||+|+.+
T Consensus 267 lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeec
Confidence 99999999 8999999985 4679999999999999999999999999999999999999 58899999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
.... ..+.+||+.|||||++.+ ..|+.++|||||||+||||++|..||.+.......+.+..+.......
T Consensus 343 ~~~~---------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~ 413 (689)
T 3v5w_A 343 SKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 413 (689)
T ss_dssp SSCC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC
T ss_pred CCCC---------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC
Confidence 4322 346789999999999974 579999999999999999999999998755544445555555554444
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
| ..+++++.+||..||+.||.+|++ +++| ..++|+..+||+.+....
T Consensus 414 p-----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei----------~~HpfF~~idW~~l~~~~ 465 (689)
T 3v5w_A 414 P-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV----------KESPFFRSLDWQMVFLQK 465 (689)
T ss_dssp C-----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH----------TTSGGGTTCCHHHHHTTC
T ss_pred C-----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH----------hcCccccCCCHHHHHcCC
Confidence 4 456899999999999999999997 3433 457888899999875433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=387.68 Aligned_cols=257 Identities=22% Similarity=0.311 Sum_probs=201.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+.++|+++++||+|+||+||+|++. .+++.||||.+........+.+|++++..+.+|++|+.++.++...+..|||
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 5688999999999999999999875 4678999998776666667889999999998889999999999999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++. .+++..+..++.||+.||+|||++|||||||||+|||+. .+.+.+||+|||+|+...+..
T Consensus 99 mE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 99 MPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCS
T ss_pred EeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCcc
Confidence 9999 789999884 599999999999999999999999999999999999995 334799999999998654321
Q ss_pred Cccc---------------------ccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCc
Q 012192 169 THKH---------------------IPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKA 226 (468)
Q Consensus 169 ~~~~---------------------~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~ 226 (468)
.... .........+||+.|+|||++.+.. |+.++||||+||++|||++|+.||....+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1000 0001123458999999999998864 89999999999999999999999975433
Q ss_pred ccHHHHHHHHhh--------------------------------------cccCCC-----------HHHhhccCcHHHH
Q 012192 227 GTKKQKYDKISE--------------------------------------KKVSTP-----------IEVLCKSYPSEFV 257 (468)
Q Consensus 227 ~~~~~~~~~i~~--------------------------------------~~~~~~-----------~~~l~~~~p~~~~ 257 (468)
. ...+..|.. .....| .......+++++.
T Consensus 253 ~--~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 253 D--LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp H--HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred H--HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 1 111111110 000000 0011245688999
Q ss_pred HHHHHHhcCCCCCCCCHHHH
Q 012192 258 SYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 258 ~li~~cl~~~p~~RPs~~~l 277 (468)
+||.+||..||++|||++++
T Consensus 331 DLl~~lL~~dP~~R~ta~ea 350 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEA 350 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHH
T ss_pred HHHHHHCcCChhHCcCHHHH
Confidence 99999999999999999854
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=400.20 Aligned_cols=252 Identities=17% Similarity=0.265 Sum_probs=212.1
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+-++|++++.||+|+||+||+|.++.+|+.||||++..... ...+.+|+.+|..|.| ++|+.++.++.+....||+|
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEE
Confidence 34689999999999999999999999999999998765432 3457889999999875 67778888888999999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+ ||+|.+++......|++..+..|+.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+|+.+.....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc
Confidence 999 78999998755668999999999999999999999999999999999999952 2347899999999987653221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.. ..+.+..+.......+ ....
T Consensus 313 --------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~ 380 (573)
T 3uto_A 313 --------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWNMD-DSAF 380 (573)
T ss_dssp --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTCCCCC-SGGG
T ss_pred --------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHhCCCCCC-cccc
Confidence 235689999999999999999999999999999999999999998754 3445555555544433 2334
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..+++++.+||..||+.||.+||++.+++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l 409 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQAL 409 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 56799999999999999999999998653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=367.49 Aligned_cols=290 Identities=24% Similarity=0.389 Sum_probs=227.6
Q ss_pred CCCCCcee----cCceEEEceEeeeCCeEEEEEEEcCC--------CcEEEEEEeeccCCCchhHHHHHHHHHHhCCC--
Q 012192 6 KLRMDHVI----GGKFKLGRKIGSGSFGELYLGVNVQT--------GEEIAVKLELVKTKHPQLHYESKLYMLLQGGT-- 71 (468)
Q Consensus 6 ~l~~~~ii----~~~y~i~~~LG~G~fG~Vy~~~~~~~--------~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~-- 71 (468)
.+..+.++ +++|++++.||+|+||.||+|.+..+ ++.||||+.... ..+..|++++..+.|++
T Consensus 29 ~l~~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv 105 (352)
T 2jii_A 29 ALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQV 105 (352)
T ss_dssp CCCTTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHH
T ss_pred hCCCCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchh
Confidence 46667777 68999999999999999999998874 889999986543 56889999999987633
Q ss_pred ------------CCceeeEeeEe-CceeEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 012192 72 ------------GIPHLKWFGVE-GDYNIMVIDLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 137 (468)
Q Consensus 72 ------------~i~~l~~~~~~-~~~~~lv~el~ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDI 137 (468)
+++.+..++.. ....++|||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Di 185 (352)
T 2jii_A 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNV 185 (352)
T ss_dssp HHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred hhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 23335556655 7889999999999999999864 367999999999999999999999999999999
Q ss_pred CCCceeecccCCCC--eEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHH
Q 012192 138 KPDNFLMGLGRKAN--QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL 215 (468)
Q Consensus 138 Kp~NiLl~~~~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ell 215 (468)
||+|||+. .++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 186 kp~NIl~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 186 TAENIFVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp CGGGEEEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999994 555 8999999999876543322211112234568999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcccH--HHHHHHHhhcccCCC-HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 012192 216 RGSLPWQGLKAGTK--KQKYDKISEKKVSTP-IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQF 292 (468)
Q Consensus 216 tG~~Pf~~~~~~~~--~~~~~~i~~~~~~~~-~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~ 292 (468)
+|..||.+...... ......+........ .......+++++.+||..||+.||++||++.+|++.|+.++...+...
T Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 263 YGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp HSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred hCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 99999987542211 111111111111000 001113568999999999999999999999999999999999999999
Q ss_pred Ccccccccc
Q 012192 293 DYVFDWTVL 301 (468)
Q Consensus 293 ~~~~dw~~~ 301 (468)
+.++||+..
T Consensus 343 ~~~~dw~~~ 351 (352)
T 2jii_A 343 YDPIGLPMV 351 (352)
T ss_dssp TSCCCCCC-
T ss_pred CccccCcCC
Confidence 999999853
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.97 Aligned_cols=268 Identities=21% Similarity=0.350 Sum_probs=215.2
Q ss_pred CCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----chhHHHHHHHHHHhCCCCCceeeEe
Q 012192 5 GKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----PQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 5 ~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
|+..++.++.++|++++.||+|+||.||+|.+..++..||||++...... ..+..|+.++..+.| ++|+.+..+
T Consensus 1 Gs~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~ 79 (294)
T 4eqm_A 1 GSHMIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH-QNIVSMIDV 79 (294)
T ss_dssp ---CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCB-TTBCCEEEE
T ss_pred CCcchhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCC-CCCceEEEe
Confidence 46678999999999999999999999999999999999999986543322 356788888888865 677778888
Q ss_pred eEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeC
Q 012192 80 GVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDY 158 (468)
Q Consensus 80 ~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DF 158 (468)
+...+..++|||++ +++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Df 155 (294)
T 4eqm_A 80 DEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDF 155 (294)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC
T ss_pred eeeCCeEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeC
Confidence 88889999999999 7799999985 4579999999999999999999999999999999999999 57889999999
Q ss_pred CcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 159 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
|++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .........
T Consensus 156 g~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~ 226 (294)
T 4eqm_A 156 GIAKALSETSL------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA---VSIAIKHIQ 226 (294)
T ss_dssp SSSTTC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---HHHHHHHHS
T ss_pred CCccccccccc------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhh
Confidence 99986543221 123346799999999999999999999999999999999999999987543 222223333
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKP-DYSYLKRLFRDLFI 286 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RP-s~~~l~~~L~~~~~ 286 (468)
.............+|+.+.++|.+||+.||.+|| +++++.+.|+.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 227 DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 3333333455577899999999999999999998 88888888876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=363.40 Aligned_cols=271 Identities=20% Similarity=0.270 Sum_probs=222.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
+-.++|+++++||+|+||.||+|++..+++.||||++.... ....+..|..++..+..|++|+.+..++......
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 34578999999999999999999999999999999876432 2345788999999887889999999999999999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++||||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 129 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecc
Confidence 9999999 7899999885 4679999999999999999999999999999999999999 578999999999998533
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc------ccHHHHHHHHhhc
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYDKISEK 239 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~------~~~~~~~~~i~~~ 239 (468)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+..+...
T Consensus 205 ~~~-------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 277 (396)
T 4dc2_A 205 RPG-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277 (396)
T ss_dssp CTT-------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred cCC-------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence 211 123567899999999999999999999999999999999999999975322 1223344445555
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYS---YLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~---~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
....| ..+++++.+||..||+.||.+||++. .+.+++ .++|+..+||..+...+
T Consensus 278 ~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~-------~Hpff~~i~w~~l~~~~ 334 (396)
T 4dc2_A 278 QIRIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ-------GHPFFRNVDWDMMEQKQ 334 (396)
T ss_dssp CCCCC-----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHH-------HSTTTTTCCHHHHHTTC
T ss_pred ccCCC-----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHh-------cCccccCCCHHHHHcCC
Confidence 55444 34689999999999999999999862 233333 25777889999876443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=362.47 Aligned_cols=269 Identities=20% Similarity=0.258 Sum_probs=218.0
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
+..++|++++.||+|+||.||+|.+..+++.||||++... .....+..|..++..+.+|++|+.++.++...+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4458899999999999999999999999999999986543 23445778999998888889999999999999999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 100 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecc
Confidence 9999999 7899999885 4679999999999999999999999999999999999999 578999999999997533
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......|
T Consensus 176 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~p- 244 (353)
T 3txo_A 176 CNG-------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVVYP- 244 (353)
T ss_dssp C----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC-
T ss_pred cCC-------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCC-
Confidence 211 12345689999999999999899999999999999999999999998643 3455555666555444
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHH---HHHHHHHHHHHcCCCCCcccccccccCCCc
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSY---LKRLFRDLFIREGFQFDYVFDWTVLKYPQI 306 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~---l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~ 306 (468)
..+++++.++|..||+.||.+||++.+ ..++ ..++++..+||..+...++
T Consensus 245 ----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~i-------l~hp~f~~~~w~~l~~~~~ 297 (353)
T 3txo_A 245 ----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAI-------LRHPFFKEIDWAQLNHRQI 297 (353)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHH-------HTSGGGTTCCHHHHHTTCS
T ss_pred ----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHH-------hhCCcccCCCHHHHhcCcC
Confidence 335899999999999999999999721 0122 2356777889998764443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=352.88 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=216.7
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
--++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+.++..+. |++|+.+..++...+..+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEE
Confidence 347899999999999999999999999999999986542 23446788999988776 467888888888889999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+||||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhccc
Confidence 999999 7899999875 4579999999999999999999999999999999999999 5789999999999985332
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+.......|
T Consensus 158 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p-- 225 (337)
T 1o6l_A 158 DGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIRFP-- 225 (337)
T ss_dssp TTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC--
T ss_pred CCC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCC--
Confidence 111 2346789999999999999999999999999999999999999998643 3344445555544443
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
..+++++.++|..||+.||++|| ++.+|+ .++++..++|..+..
T Consensus 226 ---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~----------~h~~f~~~~~~~~~~ 274 (337)
T 1o6l_A 226 ---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM----------EHRFFLSINWQDVVQ 274 (337)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH----------TSGGGTTCCHHHHHT
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHH----------cCCCcCCCCHHHHHh
Confidence 35689999999999999999999 676543 256677789987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=358.42 Aligned_cols=270 Identities=21% Similarity=0.261 Sum_probs=221.2
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
..+..++|++++.||+|+||.||+|.+..+++.||||++... .....+..|..++..+.+|++|+.+..++...+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 345568999999999999999999999999999999986543 233457788888888878899999999999999
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBC
T ss_pred EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccc
Confidence 999999999 7899999985 4579999999999999999999999999999999999999 5789999999999985
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......
T Consensus 171 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~ 240 (353)
T 2i0e_A 171 NIWDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVAY 240 (353)
T ss_dssp CCCTT-------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCC
T ss_pred cccCC-------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHHHHhCCCCC
Confidence 33211 12346789999999999999999999999999999999999999998643 345555566655544
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
| ..+++++.+||..||..||++||++. .+.++ ..++++..+||..+....
T Consensus 241 p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i-------~~h~~f~~~~w~~l~~~~ 292 (353)
T 2i0e_A 241 P-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI-------KEHAFFRYIDWEKLERKE 292 (353)
T ss_dssp C-----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHH-------HTSGGGTTCCHHHHHTTC
T ss_pred C-----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH-------hcCccccCCCHHHHHhCC
Confidence 4 35689999999999999999999652 11122 235677788999875433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=347.25 Aligned_cols=259 Identities=16% Similarity=0.222 Sum_probs=203.0
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-------CCchhHHHHHHHHHHh--CCCCCceeeEe
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-------KHPQLHYESKLYMLLQ--GGTGIPHLKWF 79 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-------~~~~~~~E~~~l~~l~--~~~~i~~l~~~ 79 (468)
++.++.++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+. .|++|+.+..+
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 57788999999999999999999999999999999999865332 1346778999888877 35777777766
Q ss_pred eEeCc-----eeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 80 GVEGD-----YNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 80 ~~~~~-----~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
+.... ..+++||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~ 159 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTV 159 (308)
T ss_dssp EEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCE
T ss_pred eeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCE
Confidence 65544 579999999999999998543 239999999999999999999999999999999999999 478899
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 233 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 233 (468)
||+|||+++.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+
T Consensus 160 kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 231 (308)
T 3g33_A 160 KLADFGLARIYSYQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231 (308)
T ss_dssp EECSCSCTTTSTTCC--------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred EEeeCccccccCCCc--------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999997654321 123567899999999999999999999999999999999999999875543332222
Q ss_pred HHHhhc-------------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 234 DKISEK-------------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 234 ~~i~~~-------------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...... ....+.......+++++.+||..||+.||++||++.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 221110 011222344567889999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=349.18 Aligned_cols=252 Identities=18% Similarity=0.187 Sum_probs=207.0
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
...++++.++|+++++||+|+||+||+|.+..+++.||||+....... .....|+..+..+..|++|+.+..++.+
T Consensus 49 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp TSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 456777889999999999999999999999999999999986543322 2355566666777678899999999999
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 83 GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 83 ~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
....++|||+++++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||++.
T Consensus 129 ~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 129 GGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLV 205 (311)
T ss_dssp TTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCE
T ss_pred CCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeee
Confidence 99999999999999999998777789999999999999999999999999999999999999 578899999999987
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
...... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.+. ..+..+....
T Consensus 206 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~~-- 268 (311)
T 3p1a_A 206 ELGTAG--------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGWQQLRQGY-- 268 (311)
T ss_dssp ECC--------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHHHHHTTTC--
T ss_pred ecccCC--------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHhccC--
Confidence 654322 1234569999999999886 7999999999999999999997766542 1122222221
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+...+++++.++|..||+.||++||++.+|++
T Consensus 269 -~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 -LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 223455678999999999999999999999997654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=358.99 Aligned_cols=262 Identities=18% Similarity=0.299 Sum_probs=214.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEc-------CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNV-------QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~-------~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
.+..++|++++.||+|+||.||+|.+. .++..||||++..... ...+..|+.++..+..|++|+.+.+++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345689999999999999999999875 2456899998754432 235788999999996778888888888
Q ss_pred EeCceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceee
Q 012192 81 VEGDYNIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144 (468)
Q Consensus 81 ~~~~~~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl 144 (468)
...+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 8888899999999 779999998643 358999999999999999999999999999999999999
Q ss_pred cccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 012192 145 GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 223 (468)
Q Consensus 145 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~ 223 (468)
+.++.+||+|||+++....... +.......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 237 ---~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 237 ---TENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp ---CTTCCEEECCCSSCEETTCCCT-----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---CCCCCEEEccccCCcccCcccc-----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 5789999999999986543221 122344567899999999999999999999999999999999 9999988
Q ss_pred CCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 224 LKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 224 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
......... +... ...+ ....+++++.++|..||+.+|++||++.+|++.|+.++..
T Consensus 309 ~~~~~~~~~---~~~~-~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 309 IPVEELFKL---LKEG-HRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp CCGGGHHHH---HHTT-CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHH---HhcC-CCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 654433222 2222 2222 1235689999999999999999999999999999998864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=357.29 Aligned_cols=266 Identities=21% Similarity=0.290 Sum_probs=220.7
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+..++|++.+.||+|+||.||+|.+..+++.||||++... .....+..|..++..+.+|++|+.+..++...+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45568999999999999999999999999999999987543 3344577899998888778899999999999999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhc
Confidence 99999999 8899999985 4579999999999999999999999999999999999999 57889999999999754
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......+
T Consensus 169 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p 238 (345)
T 1xjd_A 169 MLGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPFYP 238 (345)
T ss_dssp CCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC
T ss_pred ccCCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCCCCC
Confidence 32111 1346789999999999999999999999999999999999999998643 3344445544443333
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
..+++++.++|..||..||++||++. +| ..+++...++|+.+....
T Consensus 239 -----~~~s~~~~~li~~lL~~dp~~R~~~~~~i----------~~hp~f~~~~w~~l~~~~ 285 (345)
T 1xjd_A 239 -----RWLEKEAKDLLVKLFVREPEKRLGVRGDI----------RQHPLFREINWEELERKE 285 (345)
T ss_dssp -----TTSCHHHHHHHHHHSCSSGGGSBTTBSCG----------GGSGGGTTCCHHHHHTTC
T ss_pred -----cccCHHHHHHHHHHhcCCHhHcCCChHHH----------HcCccccCCCHHHHhhCC
Confidence 34689999999999999999999986 32 236777788998875433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=352.71 Aligned_cols=273 Identities=20% Similarity=0.276 Sum_probs=221.6
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
..+-.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|..++..+.+|++|+.+..++....
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 44556789999999999999999999999999999998765432 2346788999888877889999999999999
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBC
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEecccccc
Confidence 999999999 7899999875 4579999999999999999999999999999999999999 5789999999999975
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc------ccHHHHHHHHh
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYDKIS 237 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~------~~~~~~~~~i~ 237 (468)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+..+.
T Consensus 160 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~ 232 (345)
T 3a8x_A 160 GLRPG-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232 (345)
T ss_dssp SCCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred ccCCC-------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence 33211 123456899999999999999999999999999999999999999975322 12233344454
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYS---YLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~---~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
......| ..++.++.++|..||+.||.+||++. .+.++ ..++++..+||+.+...+
T Consensus 233 ~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i-------~~hp~f~~~~w~~~~~~~ 291 (345)
T 3a8x_A 233 EKQIRIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADI-------QGHPFFRNVDWDMMEQKQ 291 (345)
T ss_dssp HCCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHH-------HTSGGGTTCCHHHHHTTC
T ss_pred cCCCCCC-----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHH-------hcCCccCCCCHHHHHhCC
Confidence 5444443 35689999999999999999999862 22222 346777888998875433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=353.85 Aligned_cols=262 Identities=19% Similarity=0.272 Sum_probs=212.8
Q ss_pred CCCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHh----CCCCCceeeE
Q 012192 4 DGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQ----GGTGIPHLKW 78 (468)
Q Consensus 4 ~~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~----~~~~i~~l~~ 78 (468)
..++..+.++.++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+. .|++|+.+..
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 4568899999999999999999999999999999999999999865422 2345677999999887 4688888888
Q ss_pred eeEeCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc----------
Q 012192 79 FGVEGDYNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG---------- 147 (468)
Q Consensus 79 ~~~~~~~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~---------- 147 (468)
++...+..++|||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+...
T Consensus 104 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 104 KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred eeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence 889999999999999999999998643 359999999999999999999999999999999999999421
Q ss_pred ------------CCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHH
Q 012192 148 ------------RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL 215 (468)
Q Consensus 148 ------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ell 215 (468)
...+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccccccccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 12788999999999764321 23567999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh-----------------------------------------hccCcH
Q 012192 216 RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL-----------------------------------------CKSYPS 254 (468)
Q Consensus 216 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l-----------------------------------------~~~~p~ 254 (468)
+|..||.+.........+ .......+...+ ....++
T Consensus 254 ~g~~pf~~~~~~~~~~~~---~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMM---ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HSSCSCCCSSHHHHHHHH---HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HCCCCCCCCcHHHHHHHH---HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 999999875433222222 222111221110 011237
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+.+||..||+.||++||++.+++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL 354 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELL 354 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHh
Confidence 788999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=353.88 Aligned_cols=252 Identities=19% Similarity=0.285 Sum_probs=212.0
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--------CchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--------HPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
...+.++|++++.||+|+||.||+|.+..+|..||||++..... ...+..|+.++..+.| ++|+.+..++.
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~ 85 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH-PNIITLHDVYE 85 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEE
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCC-cCCCcEEEEEE
Confidence 34567899999999999999999999999999999998765432 2457889999988875 67777888888
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC----eEEEE
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN----QVYII 156 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~----~vkL~ 156 (468)
.....++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+. ..+ .+||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~~~~~vkl~ 161 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLI 161 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---CCCCCccCEEEE
Confidence 889999999999 8999999974 56799999999999999999999999999999999999995 333 79999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 236 (468)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+
T Consensus 162 DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~~~i 230 (361)
T 2yab_A 162 DFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANI 230 (361)
T ss_dssp CCSSCEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHH
T ss_pred ecCCceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH
Confidence 999998755421 1245679999999999999999999999999999999999999998743 34445555
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.......+ +.....+++++.+||..||..||++||++.+++
T Consensus 231 ~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 231 TAVSYDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp HTTCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HhcCCCCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 55555444 334567899999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=346.64 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=203.6
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.++|++.++||+|+||.||+|.+..+++.||||+..... ....+..|+.++..+.| ++|+.+..++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCC-CCCCeEeEEEEECCEEEEEEE
Confidence 468999999999999999999999999999999865433 23457789999888766 677777778888889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc-
Confidence 99 8999999984 469999999999999999999999999999999999999 4788999999999986543221
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+....... .....
T Consensus 172 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~--~~~~~ 240 (297)
T 3fxz_A 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATNGTPE--LQNPE 240 (297)
T ss_dssp ------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHHCSCC--CSCGG
T ss_pred ------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCC--CCCcc
Confidence 234568999999999999999999999999999999999999999865432 2222222222111 11124
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+++.+.++|..||+.||++||++.+++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell 268 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELL 268 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 5689999999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.51 Aligned_cols=265 Identities=18% Similarity=0.267 Sum_probs=212.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+-.++|+++++||+|+||.||+|.+..+++.||||.+.... ....+..|++++..+.| ++|+.+..++.+....++|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-cCcccEEEEEecCCeeEEE
Confidence 44689999999999999999999999999999999764322 23457889999988875 6777888888889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccc
Confidence 9999 779999999777889999999999999999999999999999999999999 578899999999998765432
Q ss_pred Ccccc-------cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH--HHHHHhhc
Q 012192 169 THKHI-------PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYDKISEK 239 (468)
Q Consensus 169 ~~~~~-------~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~--~~~~i~~~ 239 (468)
..... .........||+.|+|||++.+..++.++||||||+++|+|++|..||.......... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 21100 0011125679999999999999999999999999999999999999997644322110 00001111
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.....+|+++.++|..||+.||++||++.+|.+.|+.+...
T Consensus 243 -------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 -------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp -------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11245688999999999999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=349.54 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=207.8
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
....++|++++.||+|+||.||+|.+..+|+.||||++...... ..+..|++++..+.| ++|+.+..++......
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-PNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEE
Confidence 34557899999999999999999999999999999987654332 347789999988875 6777788888888999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++|||++ +++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGS
T ss_pred EEEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecC
Confidence 9999999 8899999875 4579999999999999999999999999999999999999 578899999999997654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s-~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.. ..+....+.......|
T Consensus 166 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~p 234 (328)
T 3fe3_A 166 VGG--------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRGKYRIP 234 (328)
T ss_dssp SSC--------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC
T ss_pred CCC--------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC
Confidence 321 12456899999999999988875 79999999999999999999998754 3344444555555444
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
. .+++++.++|..||..||.+||++.+++
T Consensus 235 ~-----~~s~~~~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 235 F-----YMSTDCENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp T-----TSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred C-----CCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 2 3589999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=354.57 Aligned_cols=264 Identities=17% Similarity=0.269 Sum_probs=213.9
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCc---EEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGE---EIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
..++..++|++.+.||+|+||.||+|.+..++. .||||++..... ...+..|+.++..+.| ++|+.+..++..
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-PNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEe
Confidence 456778999999999999999999999875544 599998764422 2357889999988865 677778888888
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
....++|||++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcc
Confidence 88899999999 789999998666789999999999999999999999999999999999999 57889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
+.+....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... +.+..+...
T Consensus 199 ~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~~- 270 (325)
T 3kul_A 199 RVLEDDPDAA----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSVEEG- 270 (325)
T ss_dssp EECC----CC----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHHTT-
T ss_pred cccccCccce----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcC-
Confidence 8765432211 11234456889999999999899999999999999999999 99999875443 233323222
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
...+. ...+|+++.++|..||..||++||++.+|++.|+.++..
T Consensus 271 ~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 YRLPA---PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCC---CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 22222 235689999999999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=352.52 Aligned_cols=256 Identities=19% Similarity=0.231 Sum_probs=210.4
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-------CCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-------KHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
.++.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.+..++...
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~ 98 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH-PHIVELLETYSSD 98 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC-TTBCCEEEEEEET
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 356789999999999999999999999999999999864321 23568899999998865 6777777788888
Q ss_pred ceeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
+..++||||+ +++|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||+...+....+||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999 68998877532 3458999999999999999999999999999999999999644445569999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ....+..+...
T Consensus 179 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~~ 247 (351)
T 3c0i_A 179 VAIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKG 247 (351)
T ss_dssp TCEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHHT
T ss_pred ceeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHcC
Confidence 9987654221 123567999999999999999999999999999999999999999863 23444445555
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+. .....+++++.+||..||+.||++||++.++++
T Consensus 248 ~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYKMNP-RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 444443 334577999999999999999999999986543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=363.29 Aligned_cols=268 Identities=21% Similarity=0.299 Sum_probs=216.1
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+..++|+++++||+|+||+||+|.+..+++.||||++... .....+..|..++..+. |++|+.++.++.+.+.
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENY 135 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCE
Confidence 34568999999999999999999999999999999986532 23345788999987775 5788888888889999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.|+||||+ +++|.+++...+..+++..+..++.||+.||+|||++|||||||||+|||+ +.++++||+|||+++..
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheec
Confidence 99999999 899999998766789999999999999999999999999999999999999 57899999999999876
Q ss_pred ccccCcccccccCCCCcccccccccccccc-------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHL-------GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-------~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
..... ......+||+.|+|||++. +..|+.++|||||||++|||++|..||.+... .+.+..+.
T Consensus 213 ~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~ 283 (412)
T 2vd5_A 213 RADGT------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGKIV 283 (412)
T ss_dssp CTTSC------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH
T ss_pred cCCCc------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence 43221 1123568999999999998 35689999999999999999999999987433 34444444
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKP---DYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RP---s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
........+.....+++++.+||.+||. +|++|+ ++++|+ .++|+..+||+.+.
T Consensus 284 ~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~----------~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 284 HYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR----------THPFFFGLDWDGLR 340 (412)
T ss_dssp THHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH----------TSGGGTTCCSTTST
T ss_pred hcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh----------cCCCcCCCCHHHHh
Confidence 3221112222335679999999999999 999984 666542 36777888999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=363.96 Aligned_cols=268 Identities=19% Similarity=0.256 Sum_probs=218.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeec-----cCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV-----KTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
+..++|+++++||+|+||+||+|.+..+++.||||++.. ......+..|..++..+. |++|+.+..++.+.+..
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEE
Confidence 455799999999999999999999999999999998653 233445888999988774 57888888888899999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
+|||||+ +|+|.+++......+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence 9999998 899999998656789999999999999999999999999999999999999 578999999999997654
Q ss_pred cccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
.... ......+||+.|+|||++. ...|+.++|||||||++|||++|..||.+.. ..+.+..+....
T Consensus 227 ~~~~------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~ 297 (437)
T 4aw2_A 227 EDGT------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHK 297 (437)
T ss_dssp TTSC------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHH
T ss_pred cCCC------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC---hhHHHHhhhhcc
Confidence 3222 1123468999999999997 4568999999999999999999999998743 334444444332
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFED--KPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~--RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
.....+.....+++++.+||..||..+|+. ||++++|+ .++|+..+||+.+.
T Consensus 298 ~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil----------~Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 298 ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFK----------KHPFFSGIDWDNIR 351 (437)
T ss_dssp HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHH----------TSGGGTTCCTTTGG
T ss_pred ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHh----------CCCccCCCCHHHHh
Confidence 212222223457899999999999988887 89887653 36778889999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=348.36 Aligned_cols=260 Identities=20% Similarity=0.309 Sum_probs=218.1
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
...-++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+.++..+. |++|+.+..++.+...
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCE
Confidence 34557999999999999999999999999999999986543 23346778999988775 5777888888888899
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 116 ~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceec
Confidence 99999999 8899999985 4579999999999999999999999999999999999999 57889999999999865
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......|
T Consensus 192 ~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p 258 (350)
T 1rdq_E 192 KGR----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVSGKVRFP 258 (350)
T ss_dssp SSC----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC
T ss_pred cCC----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHHHHHHcCCCCCC
Confidence 431 235689999999999999999999999999999999999999998643 3455555655554443
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
..+++++.++|..||+.||.+||+ +++|. .++++..+||..+..
T Consensus 259 -----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~----------~h~~f~~~~w~~~~~ 307 (350)
T 1rdq_E 259 -----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK----------NHKWFATTDWIAIYQ 307 (350)
T ss_dssp -----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH----------TSGGGTTCCHHHHHT
T ss_pred -----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH----------hCcCcCCCCHHHHhh
Confidence 356899999999999999999998 55432 356777889987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=356.49 Aligned_cols=269 Identities=23% Similarity=0.317 Sum_probs=222.3
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
-+.+..++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+.++..+.| ++|+.++.++...
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH-PFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 3556678999999999999999999999999999999986532 233567889999988865 6777788888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+..++||+++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAA 163 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceee
Confidence 8999999999 8899999984 5679999999999999999999999999999999999999 578999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
.+.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..+...
T Consensus 164 ~~~~~~--------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~ 235 (384)
T 4fr4_A 164 MLPRET--------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235 (384)
T ss_dssp ECCTTC--------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC
T ss_pred eccCCC--------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc
Confidence 654321 2346789999999999974 45899999999999999999999999876655555555555544
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPD-YSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs-~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
....| ..+++++.+||..||+.||++||+ +++| ..+++...++|..+....
T Consensus 236 ~~~~p-----~~~s~~~~~li~~lL~~dP~~R~s~~~~l----------~~hp~f~~~~w~~~~~~~ 287 (384)
T 4fr4_A 236 VVTYP-----SAWSQEMVSLLKKLLEPNPDQRFSQLSDV----------QNFPYMNDINWDAVFQKR 287 (384)
T ss_dssp CCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCSHHHH----------HTSGGGTTCCHHHHHTTC
T ss_pred ccCCC-----CcCCHHHHHHHHHHhcCCHhHhcccHHHH----------HcChhhhcCCHHHHHhCC
Confidence 44433 345899999999999999999998 4432 246778888998875433
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=361.48 Aligned_cols=260 Identities=19% Similarity=0.291 Sum_probs=213.4
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
+-.++|+++++||+|+||+||+|.+..+++.||||+...... ...+..|++++..+.| ++|+.+.+++...+..++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCC-TTBCCEEEEECSSSSCEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEecCCCcEE
Confidence 445799999999999999999999988999999998654322 2357889999988865 677777778788888999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|||++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCC
Confidence 99999 789999998766679999999999999999999999999999999999999 47889999999999764331
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
.. ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+........ ........+.+
T Consensus 267 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~----~~~~~~~~~~~ 337 (377)
T 3cbl_A 267 VY-----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE----FVEKGGRLPCP 337 (377)
T ss_dssp EE-----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH----HHHTTCCCCCC
T ss_pred ce-----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCCCCCC
Confidence 11 011123346788999999998889999999999999999998 999998765432222 22333333333
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+|+++.++|..||+.||++||++.+|++.|+.+..+
T Consensus 338 ---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 338 ---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 34589999999999999999999999999999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.47 Aligned_cols=269 Identities=31% Similarity=0.509 Sum_probs=198.2
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcC---CCcEEEEEEeeccCC-------------CchhHHHHHHHHHHhCCCCC
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQ---TGEEIAVKLELVKTK-------------HPQLHYESKLYMLLQGGTGI 73 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~---~~~~vAIK~~~~~~~-------------~~~~~~E~~~l~~l~~~~~i 73 (468)
+++.+++|++++.||+|+||.||+|.+.. ++..||||+...... ...+..|+.++..+. |++|
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni 110 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGI 110 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCc
Confidence 33445799999999999999999999987 788999998654421 112334444444444 4667
Q ss_pred ceeeEeeEe----CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC
Q 012192 74 PHLKWFGVE----GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 74 ~~l~~~~~~----~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~ 149 (468)
+.+++++.. ....++|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+. .
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~ 186 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG---Y 186 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---S
T ss_pred ceeecccccccCCCcEEEEEEeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc---c
Confidence 777777666 7889999999999999998853 3899999999999999999999999999999999999995 3
Q ss_pred CC--eEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc
Q 012192 150 AN--QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 227 (468)
Q Consensus 150 ~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~ 227 (468)
++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 44 9999999999876543322111111224568999999999999999999999999999999999999999653222
Q ss_pred cHHHHHHHHhhcccCCCHH--Hhhc--cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 228 TKKQKYDKISEKKVSTPIE--VLCK--SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 228 ~~~~~~~~i~~~~~~~~~~--~l~~--~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
... ............+.. .... .+|+++.++|..||+.+|++||++.+|++.|+.+
T Consensus 267 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 267 PVA-VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHH-HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred cHH-HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111 111111111112211 1112 6799999999999999999999999999988764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=353.14 Aligned_cols=261 Identities=22% Similarity=0.244 Sum_probs=216.1
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....|++++..+.+|++|+.+..++.+....++|||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT--CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc--CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45678999999999999999999999999999999875543 3456899999999888999999999999999999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC-CCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~-~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...+ ..+.+||+|||+++.......
T Consensus 97 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 97 LMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99 7899999874 56799999999999999999999999999999999999985221 224599999999987543221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......+.+..+.......+. ...
T Consensus 176 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~~ 247 (342)
T 2qr7_A 176 -------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG-GYW 247 (342)
T ss_dssp -------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS-TTT
T ss_pred -------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc-ccc
Confidence 123567899999999999888999999999999999999999999876555556666666655554332 233
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+++++.+||..||..||++||++.++ |++.+.
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~i---l~hp~~ 281 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALV---LRHPWI 281 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHH---TTSHHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCCee
Confidence 5679999999999999999999998854 444443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=347.38 Aligned_cols=260 Identities=18% Similarity=0.235 Sum_probs=212.6
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--------CchhHHHHHHHHHHhCCCCCceee
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--------HPQLHYESKLYMLLQGGTGIPHLK 77 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~l~ 77 (468)
++-....+.++|++.+.||+|+||.||+|.+..++..||||++..... ...+..|+.++..+.| ++|+.+.
T Consensus 2 t~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~ 80 (326)
T 2y0a_A 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLH 80 (326)
T ss_dssp -CCBCSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEE
T ss_pred CccccCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCC-CCCCcEE
Confidence 334455677899999999999999999999999999999998654432 2457899999999975 6777788
Q ss_pred EeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC-CCCeEEE
Q 012192 78 WFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR-KANQVYI 155 (468)
Q Consensus 78 ~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~-~~~~vkL 155 (468)
.++......++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+.... ....+||
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 8888888999999999 7899999974 56799999999999999999999999999999999999995211 1228999
Q ss_pred EeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 156 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..
T Consensus 160 ~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~ 228 (326)
T 2y0a_A 160 IDFGLAHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLAN 228 (326)
T ss_dssp CCCTTCEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHH
T ss_pred EECCCCeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHH
Confidence 9999998754321 12356799999999999999999999999999999999999999986433 334444
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+.......+ ......+++++.+||..||..||++||++.++++
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 229 VSAVNYEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHTCCCCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhcCCCcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 444444333 3445677999999999999999999999987644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=354.07 Aligned_cols=263 Identities=19% Similarity=0.292 Sum_probs=211.6
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEE-----cCCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVN-----VQTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~-----~~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
++..++|+++++||+|+||.||+|.+ ..+++.||||++...... ..+..|++++..+.+|++|+.+..++..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 45678999999999999999999984 456789999987654332 3588999999999888888888877665
Q ss_pred -CceeEEEEecc-CCCHHHHHHHcCC------------------------------------------------------
Q 012192 83 -GDYNIMVIDLL-GPSLEDLFNYCNR------------------------------------------------------ 106 (468)
Q Consensus 83 -~~~~~lv~el~-ggsL~~ll~~~~~------------------------------------------------------ 106 (468)
....+++||++ +++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 45589999999 7799999975322
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccc
Q 012192 107 -----------KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175 (468)
Q Consensus 107 -----------~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 175 (468)
.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... +
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~-----~ 249 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPD-----Y 249 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTT-----C
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeeccccc-----c
Confidence 18999999999999999999999999999999999999 4788999999999986543221 1
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcH
Q 012192 176 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254 (468)
Q Consensus 176 ~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 254 (468)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....... ...+ ......+. ...+++
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~-~~~~~~~~---~~~~~~ 323 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRL-KEGTRMRA---PDYTTP 323 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHH-HHTCCCCC---CTTCCH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHH-HcCCCCCC---CCCCCH
Confidence 22345678999999999999999999999999999999998 99999876543221 1112 22222221 234689
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 255 EFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 255 ~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
++.++|..||+.+|++||++.+|++.|+.++..
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=343.12 Aligned_cols=259 Identities=18% Similarity=0.231 Sum_probs=208.1
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
.-.+.+.++|+++++||+|+||.||+|.+. +++.||||++...... ..+..|++++..+.| ++|+.+..++...
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~ 91 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH-PNIVSLIDVIHSE 91 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCC-TTBCCEEEEECCS
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCC-CCEeeeeeEEccC
Confidence 345667799999999999999999999984 5899999986544322 357789999999865 6777777787888
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 84 DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 84 ~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
...++|||++.++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARA 168 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCcee
Confidence 8999999999999999998766679999999999999999999999999999999999999 4788999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc-
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV- 241 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~- 241 (468)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+.....
T Consensus 169 ~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 241 (311)
T 3niz_A 169 FGIPV-------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241 (311)
T ss_dssp TTSCC-------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCT
T ss_pred cCCCc-------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCCh
Confidence 54321 12234578999999999987 4589999999999999999999999998766555444433322111
Q ss_pred ---------------------CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 242 ---------------------STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 242 ---------------------~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..+.......+++++.+||..||+.||++||++.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 1122334456788999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.56 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=215.4
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
-++|++++.||+|+||.||+|.+..+++.||||++... .....+..|..++..+. |++|+.+..++.+....++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEE
Confidence 46899999999999999999999999999999986543 23345677888887775 5778888888888899999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc
Confidence 99999 7899999985 5679999999999999999999999999999999999999 57899999999999865431
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+.......|
T Consensus 160 ----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~p--- 223 (318)
T 1fot_A 160 ----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILNAELRFP--- 223 (318)
T ss_dssp ----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHCCCCCC---
T ss_pred ----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC---
Confidence 235689999999999999999999999999999999999999998643 3445555555554444
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
..+++++.++|..||..||.+|| ++++|. .+++...++|..+..
T Consensus 224 --~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~----------~hp~f~~~~~~~~~~ 272 (318)
T 1fot_A 224 --PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK----------NHPWFKEVVWEKLLS 272 (318)
T ss_dssp --TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH----------TSGGGSSCCHHHHHT
T ss_pred --CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh----------cCccccCCCHHHHHh
Confidence 34689999999999999999999 555432 366777889988754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=349.65 Aligned_cols=258 Identities=18% Similarity=0.265 Sum_probs=213.9
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+.++|++++.||+|+||.||+|.+..++..||+|++..... ...+..|+.++..+.| ++|+.+..++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCC-CCCCeEeEEEecCCEEEEEEE
Confidence 46899999999999999999999999999999998654432 2357789999988865 677778888888999999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||++..+.....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE-
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCc-
Confidence 99 67999999865567999999999999999999999999999999999999952 1268999999999987643211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+.......+ .....
T Consensus 160 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~-~~~~~ 228 (321)
T 1tki_A 160 -------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFD-EEAFK 228 (321)
T ss_dssp -------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCC-HHHHT
T ss_pred -------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHcCCCCCC-hhhhc
Confidence 234578999999999999889999999999999999999999998743 3344555555555444 33456
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.+++++.++|..||..||++||++.++ |++.+..
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~---l~hp~~~ 262 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLK 262 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHH---hcChhhc
Confidence 789999999999999999999999865 4555544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=344.70 Aligned_cols=259 Identities=20% Similarity=0.295 Sum_probs=203.1
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
-++..++|++.++||+|+||.||+|.+ ++..||||++...... ..+..|++++..+.| ++|+.+..++.....
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPPN 108 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSTTC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCc
Confidence 346678999999999999999999986 6889999987654432 357789999999975 677777777788888
Q ss_pred eEEEEecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~--~ls~~~~~~ia~qia~gL~yLHs~g--iiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
.++|||++ +++|.+++..... .+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCC
Confidence 99999998 7799999984321 3999999999999999999999999 9999999999999 5788999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+..+....
T Consensus 186 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~~~~~ 255 (309)
T 3p86_A 186 SRLKASTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVGFKC 255 (309)
T ss_dssp -----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHHHSC
T ss_pred Cccccccc-------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcC
Confidence 97543311 1234567999999999999999999999999999999999999999875432 2332232222
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.... +...+++++.+||..||+.+|++||++.+|++.|+.++..
T Consensus 256 ~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 256 KRLE---IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2222 2245689999999999999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=356.51 Aligned_cols=269 Identities=20% Similarity=0.251 Sum_probs=213.7
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+..++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|..++....+|++|+.++.++...+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 455689999999999999999999999999999999875443 223455566554344456888888888899999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.|+||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGG
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCcccccc
Confidence 99999999 7899999885 4579999999999999999999999999999999999999 57899999999999864
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......+
T Consensus 190 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~~ 259 (373)
T 2r5t_A 190 IEHN-------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKPLQLK 259 (373)
T ss_dssp BCCC-------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHHHHHHHHHSCCCCC
T ss_pred ccCC-------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcccCCC
Confidence 3211 12346789999999999999999999999999999999999999998643 3455555555544333
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCC
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYP 304 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 304 (468)
..++.++.+||..||+.||.+||++.+.. ++ ...++++..+||+.+...
T Consensus 260 -----~~~~~~~~~li~~lL~~dp~~R~~~~~~~---~~---i~~h~~f~~~~w~~l~~~ 308 (373)
T 2r5t_A 260 -----PNITNSARHLLEGLLQKDRTKRLGAKDDF---ME---IKSHVFFSLINWDDLINK 308 (373)
T ss_dssp -----SSSCHHHHHHHHHHTCSSGGGSTTTTTTH---HH---HHTSGGGTTCCHHHHHTT
T ss_pred -----CCCCHHHHHHHHHHcccCHHhCCCCCCCH---HH---HhCCccccCCCHHHHHhC
Confidence 45689999999999999999999985322 11 134677788999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.92 Aligned_cols=256 Identities=22% Similarity=0.295 Sum_probs=212.0
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
....+.++|++.+.||+|+||.||+|.+..++..||||++...... ..+..|+.++..+.| ++|+.++.++.+..
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEES 101 (362)
T ss_dssp -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSS
T ss_pred CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCC
Confidence 3455678999999999999999999999999999999987654322 357789999998865 67778888888889
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...+.++.+||+|||++..
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999 7799988874 56799999999999999999999999999999999999996444456799999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+.......
T Consensus 181 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~ 249 (362)
T 2bdw_A 181 VNDSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDY 249 (362)
T ss_dssp CTTCC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCC
T ss_pred ecCCc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCC
Confidence 54321 1235689999999999999999999999999999999999999998643 334444455554444
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+.+ ....+++++.+||..||+.||++||++.+++
T Consensus 250 ~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 250 PSP-EWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp CTT-GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred Ccc-cccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 332 2356799999999999999999999998654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=356.59 Aligned_cols=257 Identities=19% Similarity=0.294 Sum_probs=204.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhC-CCCCceeeEeeEeCcee
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQG-GTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~-~~~i~~l~~~~~~~~~~ 86 (468)
+.+.+|+++++||+|+||.||+|.+. +++.||||++...... ..+..|+.++..+.+ +++|+.++.++...+..
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 44567999999999999999999875 4899999987654332 457889999999986 78999999999999999
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 87 IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 87 ~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+||||+.+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ .++.+||+|||+++.+..
T Consensus 132 ~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----SSSCEEECCCSSSCCC--
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----ECCeEEEEecCccccccC
Confidence 99999889999999986 4579999999999999999999999999999999999999 357899999999987643
Q ss_pred ccCcccccccCCCCccccccccccccccC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLG-----------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----------~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
... .......+||+.|+|||++.+ ..++.++|||||||+||||++|..||.+... ....+..
T Consensus 207 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~ 279 (390)
T 2zmd_A 207 DTT-----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA 279 (390)
T ss_dssp ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHH
T ss_pred CCc-----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHH
Confidence 221 111245679999999999976 3688999999999999999999999986432 2233333
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+.......+.+ ...+.++.+||..||+.||++||++.+| |++.+..
T Consensus 280 ~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~el---l~hp~~~ 325 (390)
T 2zmd_A 280 IIDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 325 (390)
T ss_dssp HHCTTSCCCCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred HhCccccCCCC---ccchHHHHHHHHHHcccChhhCCCHHHH---hhCcCcc
Confidence 44333322222 2347899999999999999999999865 4455543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=350.40 Aligned_cols=258 Identities=19% Similarity=0.292 Sum_probs=203.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCC-CCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGG-TGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~-~~i~~l~~~~~~~~~ 85 (468)
.+.+++|+++++||+|+||.||+|.+ .++..||||++...... ..+..|+.++..+.|+ ++|+.++.++.....
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 35678999999999999999999986 56889999987654332 3577899999999875 889999999999999
Q ss_pred eEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 86 NIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
.++|||+.+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+. ++.+||+|||+++.+.
T Consensus 84 ~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC-
T ss_pred EEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccC
Confidence 999999999999999985 56899999999999999999999999999999999999993 6789999999998764
Q ss_pred cccCcccccccCCCCccccccccccccccC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLG-----------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----------~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 234 (468)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ....+.
T Consensus 159 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~ 231 (343)
T 3dbq_A 159 PDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLH 231 (343)
T ss_dssp ----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHH
T ss_pred cccc-----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHH
Confidence 3221 112235679999999999975 6689999999999999999999999986433 223333
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.+......... ....++++.+||..||+.||++||++.++ |++.+..
T Consensus 232 ~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dp~~Rpt~~e~---l~hp~~~ 278 (343)
T 3dbq_A 232 AIIDPNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 278 (343)
T ss_dssp HHHCTTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred HHhcCCcccCC---cccCCHHHHHHHHHHcCCChhHCCCHHHH---HhCcccc
Confidence 33332222221 23347899999999999999999999865 4455544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=352.01 Aligned_cols=266 Identities=18% Similarity=0.290 Sum_probs=218.7
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCC-------CcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEe
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQT-------GEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~-------~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
.++..++|+++++||+|+||.||+|.+..+ +..||||++...... ..+..|++++..+..|++|+.+..+
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 467778999999999999999999997543 357999987654332 4578899999999777888888888
Q ss_pred eEeCceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcee
Q 012192 80 GVEGDYNIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL 143 (468)
Q Consensus 80 ~~~~~~~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiL 143 (468)
+...+..++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 88888899999999 779999998643 35999999999999999999999999999999999999
Q ss_pred ecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCC
Q 012192 144 MGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQ 222 (468)
Q Consensus 144 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~ 222 (468)
+ +.++.+||+|||+++....... +.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 224 l---~~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 224 V---TEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp E---CTTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred E---cCCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9 4788999999999986543221 122345567899999999999999999999999999999999 999998
Q ss_pred CCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012192 223 GLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGF 290 (468)
Q Consensus 223 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~ 290 (468)
+.... +....+... ..... ...+++++.+||..||+.+|++||++.+|++.|+.++.....
T Consensus 296 ~~~~~---~~~~~~~~~-~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 296 GVPVE---ELFKLLKEG-HRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp TCCHH---HHHHHHHTT-CCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred CCCHH---HHHHHHHcC-CCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 75432 233223222 22221 245689999999999999999999999999999999876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=357.88 Aligned_cols=265 Identities=18% Similarity=0.214 Sum_probs=203.4
Q ss_pred CCCCceecCceEEE-ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEe---
Q 012192 7 LRMDHVIGGKFKLG-RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVE--- 82 (468)
Q Consensus 7 l~~~~ii~~~y~i~-~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--- 82 (468)
+..+.++. +|.+. +.||+|+||.||+|.+..+++.||||++. ....+..|+.++.++.+|++|+.+..++..
T Consensus 54 ~~~~~~~~-~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~---~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 54 IKKNAIID-DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CBCSCGGG-TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cCCCcccc-cceeccceeeeccCeEEEEEEECCCCCEEEEEEeC---cchhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 44555665 56665 79999999999999999999999999864 245678899998888888888888776654
Q ss_pred -CceeEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 83 -GDYNIMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 83 -~~~~~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
....+|||||+ +++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|||+...+.++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 56789999999 77999999853 2469999999999999999999999999999999999999633337899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhh
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISE 238 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~-~~~~~~i~~ 238 (468)
+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... ......+..
T Consensus 210 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~ 281 (400)
T 1nxk_A 210 FAKETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281 (400)
T ss_dssp TCEECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred cccccCCCC--------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence 998654321 12356789999999999999999999999999999999999999986543221 111222333
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+..+.+ ....+++++.+||..||+.||++||++.+| |++.+..
T Consensus 282 ~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~ 326 (400)
T 1nxk_A 282 GQYEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIM 326 (400)
T ss_dssp TCCCCCTT-TTTTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHH
T ss_pred CcccCCCc-ccccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCcccc
Confidence 33333322 234578999999999999999999999865 4555543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=350.70 Aligned_cols=280 Identities=18% Similarity=0.254 Sum_probs=222.5
Q ss_pred CCCCCCCceecCceEEE-ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeE
Q 012192 4 DGKLRMDHVIGGKFKLG-RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKW 78 (468)
Q Consensus 4 ~~~l~~~~ii~~~y~i~-~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~ 78 (468)
+..+...+.+.++|.+. ++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.++++|+.+..
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 44567778888999998 899999999999999999999999998654322 3467889999999999999999999
Q ss_pred eeEeCceeEEEEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 79 FGVEGDYNIMVIDLL-GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 79 ~~~~~~~~~lv~el~-ggsL~~ll~~-~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
++......++|||++ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+......+.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999 6799888753 24679999999999999999999999999999999999999532336899999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 236 (468)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+..+
T Consensus 177 Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i 245 (327)
T 3lm5_A 177 DFGMSRKIGHACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNI 245 (327)
T ss_dssp CGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH
T ss_pred eCccccccCCccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHH
Confidence 9999986543211 2346799999999999999999999999999999999999999987543 3333333
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCC
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 305 (468)
.......+ ......+++++.+||..||+.||++||++.+|+ .+++...++|..+..+.
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll----------~h~~~~~~~~~~~~~~~ 303 (327)
T 3lm5_A 246 SQVNVDYS-EETFSSVSQLATDFIQSLLVKNPEKRPTAEICL----------SHSWLQQWDFENLFHPE 303 (327)
T ss_dssp HHTCCCCC-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT----------TCGGGCCCCTTCC----
T ss_pred HhcccccC-chhhcccCHHHHHHHHHHcCCChhhCcCHHHHh----------CCHhhcccccccccCcc
Confidence 33333322 233456789999999999999999999998654 24566667777665444
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.24 Aligned_cols=253 Identities=20% Similarity=0.301 Sum_probs=208.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeE-eCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGV-EGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-~~~~~~lv~ 90 (468)
+..++|++.++||+|+||.||+|.+ .+..||||++........+..|+.++..+.|+ +|+.+.+++. .....++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHS-NLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCT-TBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCC-CEEEEEEEEEcCCCceEEEE
Confidence 4567899999999999999999987 47799999987777777899999999999765 5555555544 444789999
Q ss_pred ecc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~-~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|++ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCccccccc-
Confidence 999 7899999986544 37999999999999999999999999999999999999 47889999999999754321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
.....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+ ......+.+
T Consensus 343 ---------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~~~~~~~p- 408 (450)
T 1k9a_A 343 ---------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDAP- 408 (450)
T ss_dssp -------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----HTTCCCCCC-
T ss_pred ---------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCCC-
Confidence 123367889999999999999999999999999999998 99999987665444333 222222222
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+|+++.++|..||+.||++||++.+|.+.|+++...
T Consensus 409 --~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 409 --DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 45699999999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=357.13 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=196.5
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
++..+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.+|++|+.+..++...+
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 566788999999999999999999999999999999998643322 2356789999999987788888877776433
Q ss_pred --eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 85 --YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 85 --~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
..++|||+++++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 83 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 83 DRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR 157 (388)
T ss_dssp SSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence 6899999999999999984 579999999999999999999999999999999999999 578899999999998
Q ss_pred ccccccCcc--------------cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc
Q 012192 163 KYRDLQTHK--------------HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 227 (468)
Q Consensus 163 ~~~~~~~~~--------------~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~ 227 (468)
.+....... ..........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 654311100 000112345689999999999987 56899999999999999999999999875433
Q ss_pred cHHHHHHHHhhcccCCCHHHh------------------------------------------hccCcHHHHHHHHHHhc
Q 012192 228 TKKQKYDKISEKKVSTPIEVL------------------------------------------CKSYPSEFVSYFHYCRS 265 (468)
Q Consensus 228 ~~~~~~~~i~~~~~~~~~~~l------------------------------------------~~~~p~~~~~li~~cl~ 265 (468)
. .+..+....-..+.+.+ ...+++++.+||.+||.
T Consensus 238 ~---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 N---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp H---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred H---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 2 22223221111111100 01568899999999999
Q ss_pred CCCCCCCCHHHHH
Q 012192 266 LRFEDKPDYSYLK 278 (468)
Q Consensus 266 ~~p~~RPs~~~l~ 278 (468)
.||++||++.+++
T Consensus 315 ~dP~~R~t~~e~l 327 (388)
T 3oz6_A 315 FNPNKRISANDAL 327 (388)
T ss_dssp SSGGGSCCHHHHT
T ss_pred cCcccCCCHHHHh
Confidence 9999999998543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=355.27 Aligned_cols=266 Identities=18% Similarity=0.274 Sum_probs=212.9
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEE-----EcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGV-----NVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~-----~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
+.++..++|+++++||+|+||.||+|. +..++..||||++..... ...+..|+.++..+.| ++|+.+..++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~ 143 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVS 143 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCC-CCCCeEEEEE
Confidence 456778999999999999999999999 445778999998653322 2357789999988865 6777777777
Q ss_pred EeCceeEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 81 VEGDYNIMVIDLL-GPSLEDLFNYCN------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 81 ~~~~~~~lv~el~-ggsL~~ll~~~~------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
......++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+.....+..+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 8888889999999 789999998643 359999999999999999999999999999999999999543355679
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 232 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~ 232 (468)
||+|||+++....... +.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+... .+.
T Consensus 224 kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~ 295 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEV 295 (367)
T ss_dssp EECCCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH
T ss_pred EECCCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 9999999986543221 122345678999999999999999999999999999999998 9999987543 233
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+..+..... .+. ...+|+++.+||..||+.+|++||++.+|++.|+.+...
T Consensus 296 ~~~i~~~~~-~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 296 LEFVTSGGR-MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHHTTCC-CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHcCCC-CCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 333333221 211 245689999999999999999999999999999887654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=342.45 Aligned_cols=265 Identities=19% Similarity=0.255 Sum_probs=204.2
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHH-hCCCCCceeeEeeEe----C
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLL-QGGTGIPHLKWFGVE----G 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l-~~~~~i~~l~~~~~~----~ 83 (468)
|++++.++|+++++||+|+||.||+|.+ +++.||||++... ....+..|.+++..+ ..|++|..+..++.. .
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 6788999999999999999999999987 7899999986543 344566788887763 245666666655432 3
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCceeecccCCCCeEE
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH--------SRGFLHRDIKPDNFLMGLGRKANQVY 154 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLH--------s~giiHrDIKp~NiLl~~~~~~~~vk 154 (468)
...++|||++ +++|.+++. ...+++..++.++.|++.||+||| +++|+||||||+|||+ +.++.+|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~k 153 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCC 153 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred ceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEE
Confidence 4578999999 779999996 467999999999999999999999 9999999999999999 4788999
Q ss_pred EEeCCcccccccccCcccccccCCCCccccccccccccccCC------CCCCcchHHHHHHHHHHHHcC----------C
Q 012192 155 IIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV------EQSRRDDLESLGYVLMYFLRG----------S 218 (468)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~------~~s~ksDvwSlGvvl~elltG----------~ 218 (468)
|+|||+++......... ........||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 154 l~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQL---DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp ECCCTTCEEEETTTTEE---ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EeeCCCeeecccccccc---cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999997655432211 1112345899999999999887 445799999999999999999 8
Q ss_pred CCCCCCCccc-HHHHHHHHh-h--cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 219 LPWQGLKAGT-KKQKYDKIS-E--KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 219 ~Pf~~~~~~~-~~~~~~~i~-~--~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
.||....... ....+.... . .....+.......+++++.++|..||+.||++||++.+|++.|+.+
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 8987653322 222222222 1 1222333333344578999999999999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=337.46 Aligned_cols=251 Identities=19% Similarity=0.232 Sum_probs=203.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|+++++||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+.| ++|+.+..++...+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCC-CCEeeEEeEEEeCCEEEEEE
Confidence 5899999999999999999999999999999987654332 356789999888875 67778888888999999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|++.++|.+.+......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-- 155 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC--
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc--
Confidence 999999999888777889999999999999999999999999999999999999 578899999999998654321
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST------ 243 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------ 243 (468)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... .....+..+.......
T Consensus 156 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 156 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp -----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCT
T ss_pred -----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhh
Confidence 2234567899999999998876 8999999999999999999888865432 2222332222211100
Q ss_pred ------------------CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 244 ------------------PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 244 ------------------~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
........+++++.+||..||+.||++||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 00112235789999999999999999999998654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=341.01 Aligned_cols=269 Identities=20% Similarity=0.265 Sum_probs=208.4
Q ss_pred CCceecCceEEE-ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 9 MDHVIGGKFKLG-RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 9 ~~~ii~~~y~i~-~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
+...+.++|++. +.||+|+||.||+|.+..+++.||||++..... ...+..|++++.++..|++|+.+..++...+.
T Consensus 6 ~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp SCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 345567899995 789999999999999999999999998755432 34688899999988778899999999999999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...+....+||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999 6899999985 457999999999999999999999999999999999999963333345999999998765
Q ss_pred ccccCcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc-----------
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----------- 228 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~----------- 228 (468)
..................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 4322111111111234569999999999975 458899999999999999999999998754321
Q ss_pred -HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 229 -KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 229 -~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+..+.......+.. ....+++++.+||..||+.||++||++.++++
T Consensus 245 ~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDK-DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHH-HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCcccCch-hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 223344454555544433 34567999999999999999999999987644
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=378.99 Aligned_cols=272 Identities=21% Similarity=0.257 Sum_probs=225.5
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeec-----cCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV-----KTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+..++|++++.||+|+||.||+|.+..+++.||||++.. ......+..|..++..+.+|++|+.++.++...+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 4456789999999999999999999999999999998653 23445678889998888889999999999999999
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.||||||+ +++|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++..
T Consensus 417 ~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEEC
T ss_pred EEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeecc
Confidence 99999999 7899999985 4579999999999999999999999999999999999999 57899999999999854
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
..... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||.+. +..+.+..|.......|
T Consensus 493 ~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~p 562 (674)
T 3pfq_A 493 IWDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVAYP 562 (674)
T ss_dssp CCTTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSCCCCC
T ss_pred ccCCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCCCC
Confidence 32211 234678999999999999999999999999999999999999999874 34456666666665554
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCCCc
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQI 306 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~ 306 (468)
..+++++.+||..||+.||++||++.. ...++ ...++|+..+||+.+...++
T Consensus 563 -----~~~s~~~~~li~~lL~~dP~~R~~~~~--~~~~e---i~~h~ff~~i~w~~l~~~~~ 614 (674)
T 3pfq_A 563 -----KSMSKEAVAICKGLMTKHPGKRLGCGP--EGERD---IKEHAFFRYIDWEKLERKEI 614 (674)
T ss_dssp -----TTSCHHHHHHHHHHSCSSSTTCTTCST--THHHH---HHSSGGGSSCCHHHHTTTCS
T ss_pred -----ccCCHHHHHHHHHHccCCHHHCCCCCC--CcHHH---HhcCccccCCCHHHHHhCCC
Confidence 356899999999999999999998721 00111 13467888899998865443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=358.98 Aligned_cols=256 Identities=21% Similarity=0.263 Sum_probs=211.8
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
..+.++|+++++||+|+||.||+|.+..++..||+|++..... ...+..|+.++..+.| ++|+.++.++.+....
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-PNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB-TTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-cCCCeEEEEEEECCEE
Confidence 3456899999999999999999999999999999998765432 2357889999998865 6777788888899999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+.....++.+||+|||++....
T Consensus 86 ~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999 7899998885 5679999999999999999999999999999999999999644457889999999997654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+.......+.
T Consensus 165 ~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 165 GEQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp TTCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCT
T ss_pred CCCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCCCCCc
Confidence 3221 1245689999999999999999999999999999999999999998643 34445555555544443
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+ ....+++++.+||..||+.||++||++.++++
T Consensus 235 ~-~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 P-EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp T-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c-ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2 23467899999999999999999999997654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=338.84 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=200.7
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|+++++||+|+||.||+|.+ .+++.||||++..... ...+..|+.++..+.| ++|+.+..++...+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCC-CCEeeeeeEEccCCeEEEEE
Confidence 5899999999999999999998 6789999998654322 3467789999988865 67777888888888999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|++.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc--
Confidence 999999999998767789999999999999999999999999999999999999 578899999999997654321
Q ss_pred ccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc---------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--------- 240 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 240 (468)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.......
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 112345789999999999865 48999999999999999999999998754433222222211110
Q ss_pred ------------cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 241 ------------VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 241 ------------~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...+.......+++++.+||..||+.||++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 01112233456889999999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=349.89 Aligned_cols=255 Identities=19% Similarity=0.215 Sum_probs=196.5
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+.+.++|++.+.||+|+||.||+|.+..+++.||||++........+..|+.++..+.| ++|+.+..++......++||
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCC-CCCcceeeeEecCCeEEEEE
Confidence 45667899999999999999999999999999999998776666778889999999976 67777778888888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...+.++.+||+|||+++......
T Consensus 128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 999 7899999874 5579999999999999999999999999999999999999644458899999999998654321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ...+..+.......+ ....
T Consensus 206 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~~~~~~~~-~~~~ 275 (349)
T 2w4o_A 206 -------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRILNCEYYFI-SPWW 275 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHHTTCCCCC-TTTT
T ss_pred -------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHHhCCCccC-Cchh
Confidence 123567999999999999999999999999999999999999999765432 223344444333222 2234
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..++.++.+||..||..||++||++.+++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 304 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 56789999999999999999999998654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=346.67 Aligned_cols=263 Identities=17% Similarity=0.264 Sum_probs=213.3
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
++-.++|++++.||+|+||.||+|.+. .++..||||++.... ....+..|+.++..+..|++|+.+..++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 345689999999999999999999973 366789999865432 345688999999999777888888888888
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNR----------------------KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 139 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~----------------------~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp 139 (468)
.+..++|||++ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 88999999999 7899999985432 378999999999999999999999999999999
Q ss_pred CceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CC
Q 012192 140 DNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GS 218 (468)
Q Consensus 140 ~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~ 218 (468)
+|||+ +.++.++|+|||++........ +.......||+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 201 ~NIll---~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 201 RNVLV---THGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp GGEEE---ETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred hhEEE---cCCCcEEeCCCccCcccccCcc-----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 99999 4788999999999986544221 112345568899999999999999999999999999999998 99
Q ss_pred CCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 219 LPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 219 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.||.+...... +..+.......+.+ ..+++++.++|..||..||.+||++.+|.+.|+.++..
T Consensus 273 ~p~~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 273 NPYPGIPVDAN---FYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSSTTCCCSHH---HHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCcccCCcHHH---HHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 99987654322 22233333322222 34589999999999999999999999999999988654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=342.22 Aligned_cols=268 Identities=19% Similarity=0.229 Sum_probs=205.3
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEE----EcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeE-
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGV----NVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGV- 81 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~----~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~- 81 (468)
...+..++|+++++||+|+||.||+|. +..+++.||||++..... ...+..|++++..+.| ++|+.+..++.
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 82 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYS 82 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECH
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEec
Confidence 467788999999999999999999998 456899999998654332 2457889999999976 55555655543
Q ss_pred -eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 82 -EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 82 -~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
.....++|||++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+. .++.+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCc
Confidence 235578999999 8899999987666799999999999999999999999999999999999994 78899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc---------c-H
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------T-K 229 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~---------~-~ 229 (468)
++......... ........+|..|+|||++.+..++.++||||||+++|+|++|..||...... . .
T Consensus 160 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 160 LTKVLPQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235 (295)
T ss_dssp SCC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTH
T ss_pred ccccccCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccc
Confidence 99876442211 11223456788899999999999999999999999999999999998642210 0 0
Q ss_pred --HHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 230 --KQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 230 --~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..............+. ...+|+++.++|..||+.||++||++.+|++.|+.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPR---PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHhccCcCCC---CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0011111111112222 245689999999999999999999999999999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=354.07 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=215.4
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeec-----cCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV-----KTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
+..++|+++++||+|+||.||+|.+..+++.||||++.. ......+..|+.++..+. |++|+.++.++.+....
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence 455799999999999999999999999999999998653 233455788999988775 57788888888899999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++||||+ ||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeec
Confidence 9999999 8899999974 469999999999999999999999999999999999999 578999999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc-
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK- 240 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 240 (468)
.... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.. ....+..+....
T Consensus 220 ~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 220 KEGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKN 290 (410)
T ss_dssp TTSE------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHHH
T ss_pred cCCc------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC---hhhHHHHHHhccc
Confidence 3211 1134678999999999998766 7899999999999999999999998643 334444444332
Q ss_pred -cCCCHHHhhccCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 241 -VSTPIEVLCKSYPSEFVSYFHYCRSLRFED--KPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 241 -~~~~~~~l~~~~p~~~~~li~~cl~~~p~~--RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
...|. ...+++++.+||..||..+|.+ ||++++|++ ++|+..++|..+..
T Consensus 291 ~~~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~----------Hp~f~~~~w~~~~~ 343 (410)
T 3v8s_A 291 SLTFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR----------HLFFKNDQWAWETL 343 (410)
T ss_dssp HCCCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT----------SGGGCCSSCCSTTG
T ss_pred cccCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhc----------CccccCCCHHHHhh
Confidence 22222 1356899999999999988888 999886543 56777777776543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=339.58 Aligned_cols=264 Identities=18% Similarity=0.304 Sum_probs=216.8
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEE-----cCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVN-----VQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~-----~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
++..++|++++.||+|+||.||+|.+ ..++..||||+...... ...+..|+.++..+..|++|+.+..++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 35568999999999999999999985 34678999998764432 24578899999999777888888888888
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceee
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNR-----------------KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~-----------------~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl 144 (468)
.+..+++||++ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 88999999999 6799999986432 48999999999999999999999999999999999999
Q ss_pred cccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 012192 145 GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 223 (468)
Q Consensus 145 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~ 223 (468)
+.++.+||+|||++........ +.......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 179 ---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 179 ---THGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp ---ETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ---cCCCCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 4788999999999986654321 112345568899999999999999999999999999999998 9999987
Q ss_pred CCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 224 LKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 224 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
...... +............ ...+|+++.++|..||+.||.+||++.+|++.|++++...
T Consensus 251 ~~~~~~---~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 251 MPVDSK---FYKMIKEGFRMLS---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp CCSSHH---HHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ccchhH---HHHHhccCCCCCC---cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 654322 2222222222221 2346899999999999999999999999999999988754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=345.00 Aligned_cols=262 Identities=19% Similarity=0.277 Sum_probs=204.5
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEE----EEEEeecc---CCCchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEI----AVKLELVK---TKHPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~v----AIK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
+..+..++|+++++||+|+||.||+|.+..++..| |+|..... .....+..|+.++..+.| ++|+.+..++.
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~ 87 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICL 87 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCB-TTBCCEEEEEE
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEe
Confidence 44556789999999999999999999988777654 77754332 223468889999999876 66777777777
Q ss_pred eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 82 EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 82 ~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
.....++++++.+++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 88 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLA 164 (327)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHH
T ss_pred cCCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcce
Confidence 776655555556999999998777789999999999999999999999999999999999999 47889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
+........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+ ...
T Consensus 165 ~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~----~~~ 235 (327)
T 3poz_A 165 KLLGAEEKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKG 235 (327)
T ss_dssp HHHTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTT
T ss_pred eEccCCccc-----ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH----HcC
Confidence 876543221 11234567889999999999999999999999999999999 99999886654433322 222
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
...+.+ ..++.++.+++..||+.+|++||++.+|++.|+.+..
T Consensus 236 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 236 ERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCCC---TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCC---ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222222 3358999999999999999999999999999988764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=342.35 Aligned_cols=266 Identities=18% Similarity=0.224 Sum_probs=208.1
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCc--
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD-- 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~-- 84 (468)
+.++.++|++.++||+|+||.||+|.+..+++.||||++.... ....+..|++++..+.| ++|+.+..++....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTR 82 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTC
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCcceEEEEeecCCCc
Confidence 4577899999999999999999999999999999999865432 23457789999999986 56666666655444
Q ss_pred eeEEEEecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc-CCCCeEEEEeCCc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDYGL 160 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~--~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~-~~~~~vkL~DFGl 160 (468)
..++|||++ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+... +..+.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 779999999 7899999985432 39999999999999999999999999999999999998332 3566799999999
Q ss_pred ccccccccCcccccccCCCCcccccccccccccc--------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-cHHH
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL--------GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQ 231 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~--------~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~-~~~~ 231 (468)
++....... .....||+.|+|||++. +..++.++|||||||++|||++|..||...... ...+
T Consensus 163 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 163 ARELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CEECCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred ceecCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 987654221 23457999999999987 567899999999999999999999999765432 2233
Q ss_pred HHHHHhhcccC-------------------CC-HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 232 KYDKISEKKVS-------------------TP-IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 232 ~~~~i~~~~~~-------------------~~-~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
.+..+...... .+ ...+...+++.+.++|..||+.||++||+++++++...+.
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 33334333211 01 1122234578899999999999999999999877766553
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.61 Aligned_cols=256 Identities=23% Similarity=0.273 Sum_probs=208.0
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+....-++|++.+.||+|+||.||+|.+..+++.||||++... .....+..|+.++..+.| ++|+.+..++...
T Consensus 3 i~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~ 81 (336)
T 3h4j_B 3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-PHIIKLYDVITTP 81 (336)
T ss_dssp -CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCC-TTBCCEEEEEECS
T ss_pred cCccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeC
Confidence 3445568999999999999999999999999999999986532 334568899999888875 6777788888888
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 84 DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 84 ~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
...++||||++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNI 157 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBT
T ss_pred CEEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEecccee
Confidence 89999999999999998875 4579999999999999999999999999999999999999 5788999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+...... +..+......
T Consensus 158 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~i~~~~~~ 226 (336)
T 3h4j_B 158 MTDGN--------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---FKKVNSCVYV 226 (336)
T ss_dssp TTTSB--------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---BCCCCSSCCC
T ss_pred ccCCc--------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---HHHHHcCCCC
Confidence 54322 1345679999999999998876 7899999999999999999999986433211 1111111111
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
....+++++.++|..||..||.+||++.+| +++.+...
T Consensus 227 -----~p~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~~ 264 (336)
T 3h4j_B 227 -----MPDFLSPGAQSLIRRMIVADPMQRITIQEI---RRDPWFNV 264 (336)
T ss_dssp -----CCTTSCHHHHHHHHTTSCSSGGGSCCHHHH---TTCHHHHT
T ss_pred -----CcccCCHHHHHHHHHHcCCChhHCcCHHHH---HhChhhcc
Confidence 223468999999999999999999999865 44555443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=352.16 Aligned_cols=264 Identities=19% Similarity=0.258 Sum_probs=206.2
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhC-------CCCCceee
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQG-------GTGIPHLK 77 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~-------~~~i~~l~ 77 (468)
.+.+++++.++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.+ |++|+.+.
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 47899999999999999999999999999999999999999875432 23467889999999974 45566666
Q ss_pred EeeE----eCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccC---
Q 012192 78 WFGV----EGDYNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGR--- 148 (468)
Q Consensus 78 ~~~~----~~~~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~--- 148 (468)
.++. .....++|||+++++|.+.+.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+...+
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred cceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 6554 456789999999999988877543 5799999999999999999999998 999999999999995211
Q ss_pred -------------------------------------------CCCeEEEEeCCcccccccccCcccccccCCCCccccc
Q 012192 149 -------------------------------------------KANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTA 185 (468)
Q Consensus 149 -------------------------------------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~ 185 (468)
....+||+|||++...... .....||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt~ 257 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQTR 257 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSCG
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCCC
Confidence 1137999999999765431 23457899
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc---HHHHHHHHhhcccCCCHHH---------------
Q 012192 186 RYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYDKISEKKVSTPIEV--------------- 247 (468)
Q Consensus 186 ~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~~~~~~--------------- 247 (468)
.|+|||++.+..++.++|||||||+||+|++|..||.+..... ....+..+....-..+...
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 9999999999999999999999999999999999998654322 1122222221111111110
Q ss_pred ----------------------hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 248 ----------------------LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 248 ----------------------l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....++++.+||..||+.||++||++.+|++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01223577899999999999999999997653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=333.61 Aligned_cols=257 Identities=19% Similarity=0.277 Sum_probs=212.1
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+-.++|++++.||+|+||.||+|.+. ++..||||+..... ....+..|++++..+.| ++|+.+..++.+....++||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCceEEEE
Confidence 34579999999999999999999976 57789999876543 34568899999999975 67777777878888899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|++ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccccc
Confidence 999 779999998666779999999999999999999999999999999999999 4678999999999986543221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+... .+....+... .....
T Consensus 162 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~-~~~~~--- 228 (269)
T 4hcu_A 162 ------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTG-FRLYK--- 228 (269)
T ss_dssp ------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTT-CCCCC---
T ss_pred ------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcC-ccCCC---
Confidence 12345567889999999999999999999999999999999 9999987543 2333333332 11111
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
...+++++.++|..||+.+|++||++.+|++.|+++..
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 13458999999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=344.95 Aligned_cols=251 Identities=26% Similarity=0.344 Sum_probs=203.9
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++|+.++.++.+.+..++|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCeEEEE
Confidence 45799999999999999999999999999999998654432 3568899999988875 6777788888889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 84 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 84 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred EEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccCC
Confidence 9999 7799988873 5579999999999999999999999999999999999999 578899999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..... ..+..+.......+.
T Consensus 160 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~-- 230 (323)
T 3tki_A 160 R-----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYLNP-- 230 (323)
T ss_dssp E-----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--HHHHHHHTTCTTSTT--
T ss_pred c-----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhcccccCCc--
Confidence 1 112345689999999999998775 789999999999999999999998754432 222223333222221
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...+++++.+||..||+.||++||++.+|+
T Consensus 231 -~~~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 231 -WKKIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred -cccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 245689999999999999999999998653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=338.57 Aligned_cols=265 Identities=21% Similarity=0.361 Sum_probs=200.6
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
....+++..++|++.++||+|+||.||+|.+ ...||||++...... ..+..|+.++..+.|+ +|..+..+.
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~- 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV-NILLFMGYS- 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCT-TBCCEEEEE-
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCC-cEEEEEeec-
Confidence 4567899999999999999999999999984 336999987654433 3578899999888765 555555554
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
.....++||+++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+. .++.++|+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~ 166 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGL 166 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC-
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEcccee
Confidence 445578888888 7899999976677899999999999999999999999999999999999994 788999999999
Q ss_pred ccccccccCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
+......... .......||+.|+|||++. +..++.++||||||+++|+|++|..||.+.... ......+.
T Consensus 167 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~ 239 (289)
T 3og7_A 167 ATEKSRWSGS-----HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVG 239 (289)
T ss_dssp ----------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHH
T ss_pred cccccccccc-----ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhc
Confidence 9765432111 1123467999999999987 566889999999999999999999999875432 23333344
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
......+...+...+|+++.+||..||+.+|++||++.+|++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 444444445555678999999999999999999999999999998763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=336.68 Aligned_cols=260 Identities=16% Similarity=0.281 Sum_probs=211.8
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
.+-.++|+++++||+|+||.||+|.+. ++..||||++.... ....+..|++++..+.| ++|+.+..++......++|
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCC-CCEeeEEEEEecCCCeEEE
Confidence 456689999999999999999999865 67789999876543 34568899999998875 6777777777888889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||++ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHH
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEccccccccccccc
Confidence 9999 889999998656789999999999999999999999999999999999999 478899999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .....+.... ....+
T Consensus 175 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~-~~~~~- 243 (283)
T 3gen_A 175 Y------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQGL-RLYRP- 243 (283)
T ss_dssp H------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTTC-CCCCC-
T ss_pred c------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHhccc-CCCCC-
Confidence 1 12334567889999999999899999999999999999998 99999875433 2333333322 12211
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
..+++++.++|..||+.+|++||++.+|++.|++++.++
T Consensus 244 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 --HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp --TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 344899999999999999999999999999999988653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=341.33 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=207.1
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccC------CCchhHHHHHHHHHHhCCCCCceeeEe
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKT------KHPQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
...+..++|++++.||+|+||.||+|.+. .+++.||||++.... ....+..|+.++..+.| ++|+.+..+
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~ 89 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH-PFIVDLIYA 89 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCC-TTBCCEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCC-CCccceeEE
Confidence 34567789999999999999999999985 588999999865432 23456789999998875 677777777
Q ss_pred eEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeC
Q 012192 80 GVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDY 158 (468)
Q Consensus 80 ~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DF 158 (468)
+...+..++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Df 165 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDF 165 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeC
Confidence 78888999999999 7899999885 4579999999999999999999999999999999999999 57889999999
Q ss_pred CcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 159 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
|+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+..
T Consensus 166 g~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~ 235 (327)
T 3a62_A 166 GLCKESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILK 235 (327)
T ss_dssp SCC-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHH
T ss_pred CcccccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHh
Confidence 99975432211 1235679999999999999999999999999999999999999998643 3344444555
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
.....+ ..+++++.++|..||..||.+||++. .+.++|+ +++...++|+.+..
T Consensus 236 ~~~~~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~-------hp~f~~~~~~~~~~ 290 (327)
T 3a62_A 236 CKLNLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA-------HPFFRHINWEELLA 290 (327)
T ss_dssp TCCCCC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH-------SGGGSSCCHHHHHT
T ss_pred CCCCCC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc-------CCcccCCCHHHHhh
Confidence 444433 34589999999999999999999432 2223333 45556678887643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=358.33 Aligned_cols=264 Identities=20% Similarity=0.277 Sum_probs=208.9
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
..+..++|+++++||+|+||.||+|.+..+++.||||++... .....+..|+.++..+.| ++|+.+..++...+
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHD 221 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSC-TTSCCEEEEEEETT
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCC-CeEeeEEEEEeeCC
Confidence 345568899999999999999999999999999999986532 223456778888777765 67778888888899
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
..++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+ +|||||||||+|||+ +.++.+||+|||+++
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCC
T ss_pred EEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCce
Confidence 999999999 7799999875 4579999999999999999999998 999999999999999 578899999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+......
T Consensus 298 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~ 367 (446)
T 4ejn_A 298 EGIKDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIR 367 (446)
T ss_dssp TTCC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC
T ss_pred eccCCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCC
Confidence 5432211 1345789999999999999999999999999999999999999998643 33444445554444
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
.| ..+++++.+||..||+.||.+|| ++.+|++ +++...++|..+..
T Consensus 368 ~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~----------hp~f~~~~~~~~~~ 418 (446)
T 4ejn_A 368 FP-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ----------HRFFAGIVWQHVYE 418 (446)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT----------SGGGTTCCHHHHHT
T ss_pred CC-----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh----------CccccCCCHHHHhh
Confidence 33 34689999999999999999999 8775432 56667788887653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=343.39 Aligned_cols=254 Identities=23% Similarity=0.263 Sum_probs=191.9
Q ss_pred cCceEEE---ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 14 GGKFKLG---RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 14 ~~~y~i~---~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
-++|++. +.||+|+||.||+|.+..+++.||||++... ....+..|+.++..+.+|++|+.+..++.+....++||
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 3578886 7899999999999999999999999986543 34567889999999998899999999999999999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...+....+||+|||+++.......
T Consensus 86 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 86 ELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred EccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999 7799999985 56799999999999999999999999999999999999996333344899999999986543221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc----ccHHHHHHHHhhcccCCCH
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~----~~~~~~~~~i~~~~~~~~~ 245 (468)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ....+.+..+.......+.
T Consensus 165 -------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 165 -------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp --------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred -------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence 12355789999999999999999999999999999999999999986433 2234445555554443332
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
.....+++++.+||..||+.||++||++.+|
T Consensus 238 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 268 (325)
T 3kn6_A 238 -EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268 (325)
T ss_dssp -HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTS
T ss_pred -ccccCCCHHHHHHHHHHCCCChhHCCCHHHH
Confidence 3345679999999999999999999998865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=335.79 Aligned_cols=256 Identities=18% Similarity=0.293 Sum_probs=205.8
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC---------chhHHHHHHHHHHhCCCCCceeeE
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH---------PQLHYESKLYMLLQGGTGIPHLKW 78 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~---------~~~~~E~~~l~~l~~~~~i~~l~~ 78 (468)
....+..++|++.+.||+|+||.||+|.+..+++.||||+....... ..+..|+.++..+.| ++|+.+..
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~ 90 (287)
T 4f0f_A 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH-PNIVKLYG 90 (287)
T ss_dssp CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCC-TTBCCEEE
T ss_pred hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCC-CCchhhhe
Confidence 45567789999999999999999999999999999999986543322 467889999988865 66666666
Q ss_pred eeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceeecccCCCC----
Q 012192 79 FGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKAN---- 151 (468)
Q Consensus 79 ~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~g--iiHrDIKp~NiLl~~~~~~~---- 151 (468)
++.... +++||++ +++|.+++......+++..++.++.|++.||+|||++| |+||||||+|||+. ..+
T Consensus 91 ~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~---~~~~~~~ 165 (287)
T 4f0f_A 91 LMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ---SLDENAP 165 (287)
T ss_dssp EETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES---CCCTTCS
T ss_pred eecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe---ccCCCCc
Confidence 654443 6899998 68999988766678999999999999999999999999 99999999999995 333
Q ss_pred -eEEEEeCCcccccccccCcccccccCCCCcccccccccccccc--CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc
Q 012192 152 -QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL--GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 228 (468)
Q Consensus 152 -~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~--~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~ 228 (468)
.+||+|||+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|..||.......
T Consensus 166 ~~~kl~Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp CCEEECCCTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred eeEEeCCCCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 3999999999754321 23467999999999984 4457899999999999999999999998765433
Q ss_pred HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 229 KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 229 ~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
. .....+........ ....+|+++.++|..||+.||++||++.+|++.|++
T Consensus 236 ~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 236 I-KFINMIREEGLRPT---IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp H-HHHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred H-HHHHHHhccCCCCC---CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 2 22323333333222 234569999999999999999999999999998875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=334.34 Aligned_cols=257 Identities=16% Similarity=0.216 Sum_probs=211.4
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++..++|++++.||+|+||.||+|.+. ++..||||+..... ....+..|++++..+.| ++|+.+..++......++|
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH-PKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCceEEE
Confidence 355689999999999999999999865 66789999876543 34568899999999985 6777777787888889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||++ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhh
Confidence 9999 789999998766679999999999999999999999999999999999999 578899999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .....+..... ...+
T Consensus 159 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~~-~~~~- 227 (268)
T 3sxs_A 159 Y------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKVSQGHR-LYRP- 227 (268)
T ss_dssp E------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTTCC-CCCC-
T ss_pred h------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHHHHHHcCCC-CCCC-
Confidence 1 12234567888999999999899999999999999999999 99999865432 22222322221 1111
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
..+++++.++|..||+.+|++||++.+|++.|+.+.
T Consensus 228 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 --HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp --TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred --CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 335899999999999999999999999999987754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.12 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=212.0
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
..+.++|++.++||+|+||.||+|.+..++..||||+....... ..+..|+.++..+.| ++|+.+..++......
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEcCCEE
Confidence 34678999999999999999999999999999999987654322 356789999999865 6777788888888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
+++||++ +++|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||+...+....+||+|||++....
T Consensus 81 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999 7799888875 4579999999999999999999999999999999999999644445669999999997654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ...+..+.......+.
T Consensus 160 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 160 DSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAYDYPS 228 (284)
T ss_dssp SSCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCCT
T ss_pred cCcc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHHHHHhccccCCc
Confidence 3221 2346799999999999999999999999999999999999999987433 3334444444443332
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+ ....+++++.++|..||+.||++||++.++ |++.+..
T Consensus 229 ~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~ 266 (284)
T 3kk8_A 229 P-EWDTVTPEAKSLIDSMLTVNPKKRITADQA---LKVPWIC 266 (284)
T ss_dssp T-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHH---TTSHHHH
T ss_pred h-hhcccCHHHHHHHHHHcccChhhCCCHHHH---hcCcccc
Confidence 2 234678999999999999999999999965 4454443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=342.50 Aligned_cols=257 Identities=20% Similarity=0.319 Sum_probs=197.7
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----chhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----PQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
+.....+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+.| ++|+.++.++.
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~ 82 (311)
T 3ork_A 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH-PAIVAVYDTGE 82 (311)
T ss_dssp CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCC-TTBCCEEEEEE
T ss_pred CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCC-CCcceEEEeee
Confidence 345567889999999999999999999999999999999987654322 246678888777765 55666665554
Q ss_pred eCc----eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 82 EGD----YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 82 ~~~----~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
... ..++|||++ +++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+. .++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~ 158 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVM 158 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEEC
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEe
Confidence 333 349999999 7899999985 45799999999999999999999999999999999999994 78899999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 236 (468)
|||++..+...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+
T Consensus 159 Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~~~~~ 231 (311)
T 3ork_A 159 DFGIARAIADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQH 231 (311)
T ss_dssp CCSCC----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH
T ss_pred eccCcccccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHH
Confidence 99999865442211 11234567999999999999999999999999999999999999999875432 222222
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSY 276 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~ 276 (468)
... ...+.......+++++.++|..||+.||++||+..+
T Consensus 232 ~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~ 270 (311)
T 3ork_A 232 VRE-DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270 (311)
T ss_dssp HHC-CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred hcC-CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence 222 234455556778999999999999999999996654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=333.81 Aligned_cols=261 Identities=20% Similarity=0.295 Sum_probs=199.9
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
-++..++|++++.||+|+||.||+|.+..+ +..||||+...... ...+..|+.++..+.| ++|+.+..++ ..
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~-~~ 87 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVI-TE 87 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-CS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CccceEEEEE-cc
Confidence 356779999999999999999999998653 45799998554322 2357789999888875 5566666665 44
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+..++|||++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+. .++.+||+|||+++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECcccccc
Confidence 5678999998 6799999987666799999999999999999999999999999999999994 68899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+......... +.....
T Consensus 165 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~---i~~~~~ 235 (281)
T 1mp8_A 165 YMEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGER 235 (281)
T ss_dssp --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTCC
T ss_pred ccCcccc------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH---HHcCCC
Confidence 7643221 11234467889999999999999999999999999999996 9999987655433322 222221
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
.+ ....+|+++.++|..||+.||++||++.+|.+.|+.++...
T Consensus 236 -~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 236 -LP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp -CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11 22456999999999999999999999999999999988653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.24 Aligned_cols=251 Identities=22% Similarity=0.232 Sum_probs=209.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc--CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK--TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+.++|++.++||+|+||.||+|.+..++..||+|..... .....+..|++++..+.| ++|+.+..++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-PNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCeEEEEE
Confidence 457899999999999999999999999999999986553 334568889999998865 67777888888889999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|++ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+..++.++.++|+|||++..+....
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 999 7799998875 5679999999999999999999999999999999999999655578899999999997654322
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+... .+....+.......+. ...
T Consensus 164 -------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~-~~~ 231 (277)
T 3f3z_A 164 -------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKIREGTFTFPE-KDW 231 (277)
T ss_dssp -------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCH-HHH
T ss_pred -------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCCCc-hhh
Confidence 12355799999999998764 89999999999999999999999987543 3444445455444443 334
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..+++++.++|..||+.||++||++.+++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l 260 (277)
T 3f3z_A 232 LNVSPQAESLIRRLLTKSPKQRITSLQAL 260 (277)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred hcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 56799999999999999999999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=344.12 Aligned_cols=260 Identities=19% Similarity=0.313 Sum_probs=211.7
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
.+..++|++++.||+|+||.||+|.+. .++..||||+...... ...+..|+.++..+.| ++|+.+..++..
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEcc
Confidence 566789999999999999999999987 3458999998654432 2357889999998865 677778788788
Q ss_pred CceeEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCN-----------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIK 138 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~-----------------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIK 138 (468)
.+..++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 88899999999 779999998632 579999999999999999999999999999999
Q ss_pred CCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-C
Q 012192 139 PDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-G 217 (468)
Q Consensus 139 p~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G 217 (468)
|+|||+ +.++.+||+|||+++....... +.......||+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 202 p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 202 TRNCLV---GENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp GGGEEE---CGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred cceEEE---CCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 999999 4778999999999986543221 122345678999999999999999999999999999999999 9
Q ss_pred CCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 218 SLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 218 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..||.+... .+....+...... + ....+|+++.++|..||+.+|++||++.+|.+.|+++..
T Consensus 274 ~~p~~~~~~---~~~~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 274 LQPYYGMAH---EEVIYYVRDGNIL-A---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp CCTTTTSCH---HHHHHHHHTTCCC-C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCcCCCCCh---HHHHHHHhCCCcC-C---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 999987543 2333333333221 1 224568999999999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=341.46 Aligned_cols=263 Identities=18% Similarity=0.304 Sum_probs=214.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCc-----EEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGE-----EIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~-----~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
++..++|++++.||+|+||.||+|.+..++. .||||+...... ...+..|+.++..+..|++|+.+..++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4556899999999999999999999877654 799998765432 24578899999999667888888888888
Q ss_pred CceeEEEEecc-CCCHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYC-------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR 148 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~-------------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~ 148 (468)
.+..++|||++ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+.
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~--- 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT--- 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE---
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC---
Confidence 88999999999 67999998753 34689999999999999999999999999999999999994
Q ss_pred CCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcc
Q 012192 149 KANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 227 (468)
Q Consensus 149 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~ 227 (468)
.++.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTT-----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred CCCeEEECccccccccccccc-----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 778999999999986543221 112345677899999999999999999999999999999998 99999876543
Q ss_pred cHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 228 TKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 228 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.. +..+.......+.+ ..+|+++.++|..||+.+|.+||++.+|.+.|+++...
T Consensus 274 ~~---~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 274 SK---FYKLVKDGYQMAQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HH---HHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---HHHHHhcCCCCCCC---CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 22 22222333322222 33589999999999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=340.89 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=189.0
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.+..++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH-ENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCB-TTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCC-CCcceEEEEEEECCeEEEEE
Confidence 468999999999999999999999999999999875443 23467889999988865 67777888888888999999
Q ss_pred eccCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 91 DLLGPSLEDLFNYCN-----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 91 el~ggsL~~ll~~~~-----~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
|++.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETT
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceecC
Confidence 999999999987532 458999999999999999999999999999999999999 578899999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC--
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS-- 242 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 242 (468)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.........
T Consensus 160 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 3211 12345789999999999874 5899999999999999999999999875543322222221111000
Q ss_pred -------------------CCH-----HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 243 -------------------TPI-----EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 243 -------------------~~~-----~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
... +.....+++++.+||..||+.||++||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 000 011125688999999999999999999998653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.32 Aligned_cols=255 Identities=19% Similarity=0.246 Sum_probs=206.3
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhC-----CCCCceeeEeeE
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQG-----GTGIPHLKWFGV 81 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~-----~~~i~~l~~~~~ 81 (468)
..++.+..+|+++++||+|+||.||+|.+..+++.||||++..... ...+..|++++..+.+ +++|..+..++.
T Consensus 90 ~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 3567888999999999999999999999999999999998654322 3467789999988864 457888888888
Q ss_pred eCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCe--EEEEeC
Q 012192 82 EGDYNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDY 158 (468)
Q Consensus 82 ~~~~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~--vkL~DF 158 (468)
.....++|||+++++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||+. .++. +||+||
T Consensus 170 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DF 246 (429)
T 3kvw_A 170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDF 246 (429)
T ss_dssp ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEECCC
T ss_pred cCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeec
Confidence 899999999999999999988643 4599999999999999999999999999999999999994 5554 999999
Q ss_pred CcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 159 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
|++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+...... +..+..
T Consensus 247 G~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~---l~~i~~ 313 (429)
T 3kvw_A 247 GSSCYEHQR----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ---LACMIE 313 (429)
T ss_dssp TTCEETTCC----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH
T ss_pred ccceecCCc----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH
Confidence 999654321 2356899999999999999999999999999999999999999987544322 222221
Q ss_pred cccCCCHH------------------------------------------------------HhhccCcHHHHHHHHHHh
Q 012192 239 KKVSTPIE------------------------------------------------------VLCKSYPSEFVSYFHYCR 264 (468)
Q Consensus 239 ~~~~~~~~------------------------------------------------------~l~~~~p~~~~~li~~cl 264 (468)
..-..+.. .+....++++.+||..||
T Consensus 314 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L 393 (429)
T 3kvw_A 314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL 393 (429)
T ss_dssp HHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHT
T ss_pred HcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHC
Confidence 11111110 111234788999999999
Q ss_pred cCCCCCCCCHHHHH
Q 012192 265 SLRFEDKPDYSYLK 278 (468)
Q Consensus 265 ~~~p~~RPs~~~l~ 278 (468)
+.||++||++.+++
T Consensus 394 ~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 394 EWDPAVRMTPGQAL 407 (429)
T ss_dssp CSSTTTSCCHHHHH
T ss_pred CCChhhCCCHHHHh
Confidence 99999999999654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=342.18 Aligned_cols=268 Identities=18% Similarity=0.223 Sum_probs=195.1
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeE--------
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGV-------- 81 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~-------- 81 (468)
+...+|++.++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.+|++|+.+..++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 445689999999999999999999999999999997644332 3457889999999986778877776663
Q ss_pred eCceeEEEEeccCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceeecccCCCCeEEEEe
Q 012192 82 EGDYNIMVIDLLGPSLEDLFNY--CNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 82 ~~~~~~lv~el~ggsL~~ll~~--~~~~ls~~~~~~ia~qia~gL~yLHs~g--iiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
.....+++||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~D 181 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCD 181 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCC
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEec
Confidence 3445799999999999999875 3456999999999999999999999999 9999999999999 4778999999
Q ss_pred CCcccccccccCcccc-----cccCCCCccccccccccccc---cCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH
Q 012192 158 YGLAKKYRDLQTHKHI-----PYRENKNLTGTARYASVNTH---LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 229 (468)
Q Consensus 158 FGla~~~~~~~~~~~~-----~~~~~~~~~Gt~~y~APE~~---~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~ 229 (468)
||+++........... .........||+.|+|||++ .+..++.++|||||||++|+|++|..||.+....
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 9999876542221100 00112245699999999998 5667899999999999999999999999754321
Q ss_pred HHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 012192 230 KQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQF 292 (468)
Q Consensus 230 ~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~ 292 (468)
.+.......+.. ..++..+.+||..||+.||++||++.+|++.|+.+........
T Consensus 260 -----~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 260 -----RIVNGKYSIPPH---DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp -----------CCCCTT---CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred -----HhhcCcccCCcc---cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 122222222222 3447889999999999999999999999999999987655443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.18 Aligned_cols=253 Identities=19% Similarity=0.283 Sum_probs=210.6
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--------CchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--------HPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
...+.++|++++.||+|+||.||+|.+..++..||||++..... ...+..|+.++..+.| ++|+.+..++.
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~ 85 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH-HNVITLHDVYE 85 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEE
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC-CCcceEEEEEe
Confidence 34567899999999999999999999999999999998665432 2357889999999876 56777777788
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC----eEEEE
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN----QVYII 156 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~----~vkL~ 156 (468)
.....++|||++ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+. .++ .++|+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~ 161 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLI 161 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEEC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEc
Confidence 888999999999 7899999984 56799999999999999999999999999999999999995 444 79999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 236 (468)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+.+..+
T Consensus 162 Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i 230 (321)
T 2a2a_A 162 DFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANI 230 (321)
T ss_dssp CCTTCEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHH
T ss_pred cCccceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH
Confidence 999998654321 12355799999999999999999999999999999999999999986432 3344444
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.......+ +.....+++++.++|..||+.||++||++.++++
T Consensus 231 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 231 TSVSYDFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HTTCCCCC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HhcccccC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 44443333 3455678999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=336.38 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=197.4
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----------------------------CCchhHHHH
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----------------------------KHPQLHYES 61 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----------------------------~~~~~~~E~ 61 (468)
+.+..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 3455689999999999999999999999999999999865432 124578899
Q ss_pred HHHHHHhCCCCCceeeEeeEe--CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 012192 62 KLYMLLQGGTGIPHLKWFGVE--GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIK 138 (468)
Q Consensus 62 ~~l~~l~~~~~i~~l~~~~~~--~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIK 138 (468)
+++..+.| ++|+.+..++.+ ....++|||++ +++|.+++. ...+++..+..++.||+.||+|||++||+|||||
T Consensus 88 ~~l~~l~h-~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 88 AILKKLDH-PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp HHHHTCCC-TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHhCCC-CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 99999976 566666666554 67889999999 678877654 4579999999999999999999999999999999
Q ss_pred CCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCC---CCCcchHHHHHHHHHHHH
Q 012192 139 PDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE---QSRRDDLESLGYVLMYFL 215 (468)
Q Consensus 139 p~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~---~s~ksDvwSlGvvl~ell 215 (468)
|+|||+ +.++.+||+|||+++.+..... ......||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 165 p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 165 PSNLLV---GEDGHIKIADFGVSNEFKGSDA-------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECSSSSC-------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---CCCCCEEEecCCCccccccccc-------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 999999 4788999999999986543221 123457999999999998765 378899999999999999
Q ss_pred cCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 216 RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 216 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+|..||.+... ......+.......+. ...+++++.++|..||+.||++||++.+|+
T Consensus 235 ~g~~pf~~~~~---~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 235 FGQCPFMDERI---MCLHSKIKSQALEFPD---QPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp HSSCSSCCSSH---HHHHHHHHHCCCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred HCCCCCCCccH---HHHHHHHhcccCCCCC---ccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 99999986432 2333334333333332 245689999999999999999999998764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=345.23 Aligned_cols=210 Identities=24% Similarity=0.315 Sum_probs=180.7
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCC-----CceeeEe
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTG-----IPHLKWF 79 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~-----i~~l~~~ 79 (468)
.+..++.+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.++++ ++.+..+
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 467788899999999999999999999999999999999998754321 3456778899998886664 7777788
Q ss_pred eEeCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCceeecccCCCCeEEEE
Q 012192 80 GVEGDYNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMH--SRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 80 ~~~~~~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLH--s~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
+...+..++|||+++++|.+++.... ..+++..+..++.|++.||.||| +.|||||||||+|||++. +..+.+||+
T Consensus 125 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEEC
T ss_pred eccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEE
Confidence 88889999999999999999998653 56999999999999999999999 579999999999999942 246789999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 226 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~ 226 (468)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 204 DFG~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 204 DFGSSCQLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CCTTCEETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eccCceecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999865431 2356789999999999999999999999999999999999999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.18 Aligned_cols=253 Identities=18% Similarity=0.229 Sum_probs=198.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++|+.+..++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCC-TTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCC-CCCCeeeeEEeeCCEEEEEec
Confidence 589999999999999999999999999999998654322 2245678999888875 677778888888889999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
++.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCcc--
Confidence 99999999998877789999999999999999999999999999999999999 4788999999999975443211
Q ss_pred cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC--------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS-------- 242 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 242 (468)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+......
T Consensus 156 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 -----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 1234578999999999987 56899999999999999999999999876543333333222211110
Q ss_pred --------------CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 243 --------------TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 243 --------------~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.........+++++.+||..||+.||++||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 011122345788999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=336.51 Aligned_cols=261 Identities=15% Similarity=0.265 Sum_probs=212.4
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
++..++|++++.||+|+||.||+|.+. .++..||||+....... ..+..|++++..+. |++|+.+..++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Confidence 556789999999999999999999874 35589999987544322 35778999988886 4677778778788
Q ss_pred CceeEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCN-----------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIK 138 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~-----------------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIK 138 (468)
....++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 88899999999 689999998532 238999999999999999999999999999999
Q ss_pred CCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-C
Q 012192 139 PDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-G 217 (468)
Q Consensus 139 p~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G 217 (468)
|+|||+ +.++.+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 178 p~NIli---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 178 ARNILV---AEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp GGGEEE---ETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred hheEEE---cCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 999999 4788999999999986543221 112334567899999999999889999999999999999999 9
Q ss_pred CCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 218 SLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 218 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..||.+.........+ ... .... ....+++++.++|..||+.||++||++.+|.+.|++++.+
T Consensus 250 ~~p~~~~~~~~~~~~~---~~~-~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLL---KTG-HRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCSSTTCCGGGHHHHH---HTT-CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHh---hcC-CcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9999876554333222 222 1111 2245689999999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=345.20 Aligned_cols=259 Identities=17% Similarity=0.226 Sum_probs=203.0
Q ss_pred ecCceEEEceEeee--CCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 13 IGGKFKLGRKIGSG--SFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 13 i~~~y~i~~~LG~G--~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
.+++|+++++||+| +||.||+|.+..+++.||||++...... ..+..|+.++..+.| ++|+.+..++...+..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCCCcEeEEEEECCEE
Confidence 46899999999999 9999999999999999999987654332 346779999988875 6777788888889999
Q ss_pred EEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
++|||++ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence 9999999 78999998754 3569999999999999999999999999999999999999 57889999999998765
Q ss_pred ccccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc-
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV- 241 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~- 241 (468)
..................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......... .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~ 255 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK---LNGTVP 255 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---hcCCCC
Confidence 4322211111222344589999999999988 57999999999999999999999999875543322111 00000
Q ss_pred ----------------------------------------CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 242 ----------------------------------------STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 242 ----------------------------------------~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..+.......+++++.+||..||+.||++||++.+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 0011113345788999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=334.55 Aligned_cols=260 Identities=17% Similarity=0.232 Sum_probs=208.0
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEE-cCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCC-----CCceeeE
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVN-VQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGT-----GIPHLKW 78 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~-~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~-----~i~~l~~ 78 (468)
.+..++++.++|+++++||+|+||.||+|.+ ..+++.||||+..... ....+..|++++..+.|++ +++.+..
T Consensus 5 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp TCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred eeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 4678999999999999999999999999998 4588999999865432 2346788999999887654 4677777
Q ss_pred eeEeCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC--------
Q 012192 79 FGVEGDYNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK-------- 149 (468)
Q Consensus 79 ~~~~~~~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~-------- 149 (468)
++...+..++|||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+...+.
T Consensus 85 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 85 WFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred ccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 888889999999999999999998643 36899999999999999999999999999999999999952111
Q ss_pred --------CCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCC
Q 012192 150 --------ANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 221 (468)
Q Consensus 150 --------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf 221 (468)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 567999999999764321 23567999999999999999999999999999999999999999
Q ss_pred CCCCcccHHHHHHHHhhcccCCCHHH---------------------------------------hhccCcHHHHHHHHH
Q 012192 222 QGLKAGTKKQKYDKISEKKVSTPIEV---------------------------------------LCKSYPSEFVSYFHY 262 (468)
Q Consensus 222 ~~~~~~~~~~~~~~i~~~~~~~~~~~---------------------------------------l~~~~p~~~~~li~~ 262 (468)
...........+..+.. ..|... .....++++.+||..
T Consensus 235 ~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 311 (339)
T 1z57_A 235 PTHDSKEHLAMMERILG---PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK 311 (339)
T ss_dssp CCSCHHHHHHHHHHHHC---SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCChHHHHHHHHHHhC---CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence 87544332222222211 111110 001235789999999
Q ss_pred HhcCCCCCCCCHHHHH
Q 012192 263 CRSLRFEDKPDYSYLK 278 (468)
Q Consensus 263 cl~~~p~~RPs~~~l~ 278 (468)
||+.||++||++.+|+
T Consensus 312 ~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 312 MLEYDPAKRITLREAL 327 (339)
T ss_dssp HTCSSTTTSCCHHHHT
T ss_pred HhCcCcccccCHHHHh
Confidence 9999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=340.34 Aligned_cols=266 Identities=17% Similarity=0.277 Sum_probs=195.1
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCc---EEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEe
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGE---EIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
+.-..+..++|++++.||+|+||.||+|.+..++. .||||+..... ....+..|++++..+.| ++|+.+..+
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~ 93 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH-PHVAKLVGV 93 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCC-TTBCCCCEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCC-Cceehhhce
Confidence 44556677899999999999999999999876664 89999865432 23467889999988855 667777766
Q ss_pred eEeCcee------EEEEecc-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc
Q 012192 80 GVEGDYN------IMVIDLL-GPSLEDLFNYCN-----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 147 (468)
Q Consensus 80 ~~~~~~~------~lv~el~-ggsL~~ll~~~~-----~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~ 147 (468)
+...... +++|+++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli--- 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML--- 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---
Confidence 6655544 8899998 779999986432 259999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCc
Q 012192 148 RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 226 (468)
Q Consensus 148 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~ 226 (468)
+.++.+||+|||+++....... +.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp CTTSCEEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cCCCCEEEeecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence 4788999999999986543221 112334567889999999999999999999999999999999 9999987655
Q ss_pred ccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 227 GTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 227 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
...... +...... + ....+++++.++|..||+.||++||++.+|.+.|++++...
T Consensus 246 ~~~~~~---~~~~~~~-~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 246 AEIYNY---LIGGNRL-K---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp GGHHHH---HHTTCCC-C---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHH---HhcCCCC-C---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 433322 2222211 1 12356899999999999999999999999999999988743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.19 Aligned_cols=271 Identities=21% Similarity=0.256 Sum_probs=213.5
Q ss_pred CCCCCCCceecCceEEEceEeeeCCeEEEEEE----EcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCcee
Q 012192 4 DGKLRMDHVIGGKFKLGRKIGSGSFGELYLGV----NVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHL 76 (468)
Q Consensus 4 ~~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~----~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l 76 (468)
...+..+.+...+|+++++||+|+||.||+|. +..+++.||||+..... ....+..|++++..+.| ++|+.+
T Consensus 10 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~ 88 (302)
T 4e5w_A 10 ATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-ENIVKY 88 (302)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCC-TTBCCE
T ss_pred ceecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCC-CCeeee
Confidence 34567788888999999999999999999998 46689999999865433 23467889999999876 566666
Q ss_pred eEeeEeC--ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 77 KWFGVEG--DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 77 ~~~~~~~--~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
..++... ...+++||++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+. .++.+
T Consensus 89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~ 165 (302)
T 4e5w_A 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQV 165 (302)
T ss_dssp EEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEE
T ss_pred eeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCE
Confidence 6665544 6678999999 7799999977677899999999999999999999999999999999999994 78899
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC--------
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLK-------- 225 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~-------- 225 (468)
+|+|||++........ .+.......||..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 166 kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 241 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKE----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241 (302)
T ss_dssp EECCCTTCEECCTTCC----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC
T ss_pred EECcccccccccCCCc----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccC
Confidence 9999999987654321 1122345678899999999999999999999999999999999999875321
Q ss_pred ---cccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 226 ---AGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 226 ---~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
.......+..........+ ....+|+++.++|..||+.||.+||++.+|++.|+.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 242 PTHGQMTVTRLVNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp SCCGGGHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccccCHHHHHHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111112222222222222 22456899999999999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=342.10 Aligned_cols=261 Identities=19% Similarity=0.281 Sum_probs=202.2
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEE----EEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEI----AVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~v----AIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
..+..++|+++++||+|+||.||+|.+..++..| |+|...... ....+..|+.++..+.| ++|+.+..++..
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 88 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLT 88 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCB-TTBCCCCEEEES
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC-CCeeEEEEEEec
Confidence 3455689999999999999999999998887765 555443222 23467889999988875 666777777776
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 83 GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 83 ~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
....++++++.+++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 89 ~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 89 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAK 165 (327)
T ss_dssp SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC--
T ss_pred CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCccee
Confidence 66555555556999999998777789999999999999999999999999999999999999 478899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
.+...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+ ....
T Consensus 166 ~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~~~ 236 (327)
T 3lzb_A 166 LLGAEEKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGE 236 (327)
T ss_dssp -------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTC
T ss_pred EccCcccc-----ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCC
Confidence 76432221 11234567889999999999999999999999999999999 99999886654433322 2222
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+.+ ..++.++.++|..||+.+|++||++.+|++.|+.+..
T Consensus 237 ~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 RLPQP---PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22222 3458999999999999999999999999999998864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=340.51 Aligned_cols=273 Identities=21% Similarity=0.306 Sum_probs=209.1
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHH-hCCCCCceeeEeeEeC-
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLL-QGGTGIPHLKWFGVEG- 83 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l-~~~~~i~~l~~~~~~~- 83 (468)
++..+..+.++|+++++||+|+||.||+|.+ +++.||||++.... ......|.+++..+ ..|++|+.+..++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3456677889999999999999999999987 48999999865432 34455666666544 2567777777777766
Q ss_pred ---ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCceeecccCCCC
Q 012192 84 ---DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR--------GFLHRDIKPDNFLMGLGRKAN 151 (468)
Q Consensus 84 ---~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~--------giiHrDIKp~NiLl~~~~~~~ 151 (468)
...++|||++ +++|.+++.. ..+++..++.++.|++.||+|||++ ||+||||||+|||+ +.++
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~ 179 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNG 179 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTS
T ss_pred CCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCC
Confidence 6889999999 7799999974 4799999999999999999999999 99999999999999 4788
Q ss_pred eEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCc------chHHHHHHHHHHHHcC--------
Q 012192 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRR------DDLESLGYVLMYFLRG-------- 217 (468)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~k------sDvwSlGvvl~elltG-------- 217 (468)
.+||+|||+++.+........ .......||+.|+|||++.+..+... +|||||||++|||++|
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVD---IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp CEEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CEEEEeCCCceeecccccccc---CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 999999999976654322111 11235679999999999998777665 9999999999999999
Q ss_pred --CCCCCCCCccc-HHHHHHH-HhhcccC--CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012192 218 --SLPWQGLKAGT-KKQKYDK-ISEKKVS--TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 289 (468)
Q Consensus 218 --~~Pf~~~~~~~-~~~~~~~-i~~~~~~--~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~ 289 (468)
..||....... ....... +...... .+.......+++++.+||..||+.||++||++.+|++.|+.+.....
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 78887653322 1122222 2222222 22222223558899999999999999999999999999999877544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.34 Aligned_cols=246 Identities=20% Similarity=0.289 Sum_probs=204.4
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----chhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
..+.|++++.||+|+||.||+|.+..+++.||||++...... ..+..|++++..+.| ++|+.+.+++...+..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCeEE
Confidence 346799999999999999999999999999999987644322 357789999998875 67777778888899999
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 88 lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+|||++.|+|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS-
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCC-
Confidence 999999999999987667789999999999999999999999999999999999999 4789999999999976532
Q ss_pred cCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.....||+.|+|||++. +..++.++|||||||++|||++|..||.+... ...+..+........
T Consensus 207 ----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~ 273 (348)
T 1u5q_A 207 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPAL 273 (348)
T ss_dssp ----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCC
T ss_pred ----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCC
Confidence 23457999999999985 45689999999999999999999999987543 223333333322211
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+++++.+||..||+.+|++||++.+|++
T Consensus 274 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 274 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 12456899999999999999999999996643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=353.01 Aligned_cols=263 Identities=16% Similarity=0.274 Sum_probs=201.8
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEc---CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
.++..++|++.+.||+|+||.||+|.+. .++..||||++..... ...+..|+.++..+.| ++|+.+.+++...
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~ 118 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-PNIIRLEGVVTKS 118 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeC
Confidence 3555679999999999999999999876 4677899998654432 2357889999988865 6777788888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...++|||++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGR 195 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC----
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccc
Confidence 8899999999 889999998666689999999999999999999999999999999999999 578899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
......... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.... +....+.. ..
T Consensus 196 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i~~-~~ 267 (373)
T 2qol_A 196 VLEDDPEAA----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAVDE-GY 267 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHHHT-TE
T ss_pred ccccCCccc----eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-CC
Confidence 765422111 11123346788999999999999999999999999999998 99999875432 22222222 22
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+.+ ..+|.++.++|..||+.+|++||++.+|++.|+.++..
T Consensus 268 ~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 RLPPP---MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ECCCC---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCC---ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 22222 34689999999999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=338.74 Aligned_cols=263 Identities=17% Similarity=0.314 Sum_probs=213.7
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEc-------CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNV-------QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~-------~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
++..++|++++.||+|+||.||+|.+. .++..||||+...... ...+..|++++..+..|++|+.+..++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 456789999999999999999999975 3567899998754432 235788999999997778888888888
Q ss_pred EeCceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceee
Q 012192 81 VEGDYNIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 144 (468)
Q Consensus 81 ~~~~~~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl 144 (468)
...+..++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 8888999999999 779999998533 248999999999999999999999999999999999999
Q ss_pred cccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 012192 145 GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 223 (468)
Q Consensus 145 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~ 223 (468)
+.++.+||+|||++........ +.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 191 ---~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 191 ---TENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp ---CTTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---cCCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 5788999999999986543221 112334567889999999998889999999999999999999 9999987
Q ss_pred CCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 224 LKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 224 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
.... +.+..+.... ..+ ....++.++.++|..||+.+|++||++.+|++.|+.++...
T Consensus 263 ~~~~---~~~~~~~~~~-~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 263 IPVE---ELFKLLKEGH-RMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp CCHH---HHHHHHHHTC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHH---HHHHHHhcCC-CCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 5432 2222222222 122 22456899999999999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.07 Aligned_cols=260 Identities=21% Similarity=0.229 Sum_probs=200.3
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
..++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.+..++......++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCC-CCCCcEEEEEeeCCEEEEEEE
Confidence 4589999999999999999999999999999999876543 34568899999988875 677778888888899999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+.. +....+||+|||+++......
T Consensus 97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC---------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccccccC--
Confidence 99 8899999875 457999999999999999999999999999999999999941 112359999999987433211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCc-chHHHHHHHHHHHHcCCCCCCCCCcc-cHHHHHHHHhhcccCCCHHHh
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~k-sDvwSlGvvl~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~l 248 (468)
......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.... .....+..+.......+..
T Consensus 173 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 244 (361)
T 3uc3_A 173 ------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD-- 244 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT--
T ss_pred ------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc--
Confidence 1235679999999999998887655 89999999999999999999875443 2334444444444444432
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 289 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~ 289 (468)
..+++++.+||..||+.+|++||++.+ +|++.+....
T Consensus 245 -~~~s~~~~~li~~~L~~dP~~Rps~~e---ll~hp~f~~~ 281 (361)
T 3uc3_A 245 -IRISPECCHLISRIFVADPATRISIPE---IKTHSWFLKN 281 (361)
T ss_dssp -SCCCHHHHHHHHHHSCSCTTTSCCHHH---HHTSHHHHTT
T ss_pred -CCCCHHHHHHHHHHccCChhHCcCHHH---HHhCcchhcC
Confidence 245899999999999999999999985 4555555443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=336.54 Aligned_cols=262 Identities=16% Similarity=0.225 Sum_probs=208.6
Q ss_pred CCCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCC-cEEEEEEeeccC-CCchhHHHHHHHHHHhCCCC-----Ccee
Q 012192 4 DGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTG-EEIAVKLELVKT-KHPQLHYESKLYMLLQGGTG-----IPHL 76 (468)
Q Consensus 4 ~~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~-~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~-----i~~l 76 (468)
...+.+++++.++|++++.||+|+||.||+|.+..++ ..||||++.... ....+..|+.++..+.|++. +..+
T Consensus 8 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 8 HLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred CcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 3457899999999999999999999999999998776 799999875432 23457789999999886543 6667
Q ss_pred eEeeEeCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc--------
Q 012192 77 KWFGVEGDYNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-------- 147 (468)
Q Consensus 77 ~~~~~~~~~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~-------- 147 (468)
..++......++|||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+...
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 77778888999999999999998887543 579999999999999999999999999999999999999422
Q ss_pred --------CCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCC
Q 012192 148 --------RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSL 219 (468)
Q Consensus 148 --------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~ 219 (468)
+..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 25788999999999764321 235679999999999999999999999999999999999999
Q ss_pred CCCCCCcccHHHHHHHHhhcccCCCHHHh---------------------------------------hccCcHHHHHHH
Q 012192 220 PWQGLKAGTKKQKYDKISEKKVSTPIEVL---------------------------------------CKSYPSEFVSYF 260 (468)
Q Consensus 220 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l---------------------------------------~~~~p~~~~~li 260 (468)
||.+.........+..+.. ..|.... ....+.++.+||
T Consensus 238 pf~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 314 (355)
T 2eu9_A 238 LFQTHENREHLVMMEKILG---PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314 (355)
T ss_dssp SCCCSSHHHHHHHHHHHHC---CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHcC---CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence 9987544332222222211 1111100 011246899999
Q ss_pred HHHhcCCCCCCCCHHHHH
Q 012192 261 HYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 261 ~~cl~~~p~~RPs~~~l~ 278 (468)
..||+.||++||++.+++
T Consensus 315 ~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 315 RRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHTCSSTTTSCCHHHHT
T ss_pred HHHhcCChhhCcCHHHHh
Confidence 999999999999998653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=333.39 Aligned_cols=266 Identities=18% Similarity=0.295 Sum_probs=220.1
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
+.--++..++|++.++||+|+||.||+|.+..++..||||+...... ...+..|++++..+.| ++|+.+..++.....
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPP 83 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCC
Confidence 44556788999999999999999999999999999999998765433 3568899999999975 667777777788888
Q ss_pred eEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
.++|||++ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCcccee
Confidence 99999999 58999999864 3459999999999999999999999999999999999999 4778999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.......+.+ .....
T Consensus 161 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~----~~~~~ 230 (288)
T 3kfa_A 161 MTGDTY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYR 230 (288)
T ss_dssp SCSSSS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HTTCC
T ss_pred ccCCcc------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hccCC
Confidence 543221 12234567889999999999999999999999999999999 99999876554333322 22222
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 289 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~ 289 (468)
... ...+|+++.++|..||..||++||++.+|.+.|+.++....
T Consensus 231 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 231 MER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCC---CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 221 24568999999999999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=363.89 Aligned_cols=258 Identities=19% Similarity=0.330 Sum_probs=215.2
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++-..+|++.++||+|+||.||+|.+..++..||||++.... ....+..|+.++..+.| ++|+.+.+++......++|
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCC-CCEeeEEEEEecCCcEEEE
Confidence 455678999999999999999999999889999999876543 34568899999999975 6777777777888889999
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||++ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCC
Confidence 9999 68999999864 3469999999999999999999999999999999999999 47889999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
. +.......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.......+.+ ......+.+
T Consensus 372 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~ 441 (495)
T 1opk_A 372 T------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMERP 441 (495)
T ss_dssp C------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HTTCCCCCC
T ss_pred c------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCCC
Confidence 1 222345567889999999999899999999999999999999 99999987654433322 233332222
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
..+|+++.+||..||+.+|++||++.+|++.|+.++
T Consensus 442 ---~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 442 ---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 356999999999999999999999999999998765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=350.60 Aligned_cols=257 Identities=21% Similarity=0.219 Sum_probs=209.4
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
++.+.+. ++|+++++||+|+||.||+|.+..+++.||+|++..... ...+..|+.++..+.| ++|+.+..++.+..
T Consensus 44 ~~~~~~~-~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~ 121 (387)
T 1kob_A 44 VKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKY 121 (387)
T ss_dssp CBCSCGG-GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSS
T ss_pred ccCCccc-cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCC-cCCCeEEEEEEeCC
Confidence 4444444 689999999999999999999999999999998765432 2357889999988865 67777888888889
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++|||++ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+++.
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEeccccee
Confidence 999999999 78999998755567999999999999999999999999999999999999941 1357899999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+.......
T Consensus 201 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~ 269 (387)
T 1kob_A 201 LNPDEI--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCDWEF 269 (387)
T ss_dssp CCTTSC--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCCCCC
T ss_pred cCCCcc--------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCC
Confidence 543211 1234799999999999999999999999999999999999999987533 33344444433332
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+ ......+++++.+||..||+.||++||++.+++
T Consensus 270 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 303 (387)
T 1kob_A 270 D-EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303 (387)
T ss_dssp C-SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred C-ccccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 2 223456799999999999999999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.63 Aligned_cols=267 Identities=19% Similarity=0.271 Sum_probs=212.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEc---CCCcEEEEEEeecc------CCCchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVK------TKHPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~---~~~~~vAIK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
+-.++|+++++||+|+||.||+|.+. .+++.||||++... .....+..|++++..+.+|++|+.+..++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 33479999999999999999999984 48899999985432 2345577899999999888999999999999
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
....++||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLS 206 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEE
T ss_pred CceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCC
Confidence 99999999999 7799999985 4579999999999999999999999999999999999999 57889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhh
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISE 238 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~-~~~~~~i~~ 238 (468)
+.+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ......+..
T Consensus 207 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 280 (355)
T 1vzo_A 207 KEFVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280 (355)
T ss_dssp EECCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eecccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc
Confidence 865432221 12346799999999999863 478999999999999999999999986543322 223333333
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
..... ...++..+.+||..||..||++|| ++.+|++ +.+...++|..+..
T Consensus 281 ~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~----------h~~f~~~~~~~l~~ 335 (355)
T 1vzo_A 281 SEPPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE----------HLFFQKINWDDLAA 335 (355)
T ss_dssp CCCCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT----------SGGGTTCCHHHHHT
T ss_pred cCCCC-----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc----------CcchhcCChhHhhh
Confidence 32222 245689999999999999999999 7765433 34455677877654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=337.08 Aligned_cols=264 Identities=20% Similarity=0.299 Sum_probs=212.2
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
.+..++|++++.||+|+||.||+|.+. .+++.||||++...... ..+..|+.++..+.+|++|+.+..++..
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 456789999999999999999999853 46789999987654332 3578899999999887888888776654
Q ss_pred -CceeEEEEecc-CCCHHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeec
Q 012192 83 -GDYNIMVIDLL-GPSLEDLFNYCNRK---------------FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG 145 (468)
Q Consensus 83 -~~~~~lv~el~-ggsL~~ll~~~~~~---------------ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~ 145 (468)
+...+++||++ +++|.+++...... +++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~- 181 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL- 181 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE-
Confidence 45689999999 67999999854322 8899999999999999999999999999999999999
Q ss_pred ccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCC
Q 012192 146 LGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGL 224 (468)
Q Consensus 146 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~ 224 (468)
+.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 182 --~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 182 --SEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp --CGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --CCCCCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 4778999999999986543221 112235578899999999999999999999999999999998 99999876
Q ss_pred CcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 225 KAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 225 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
..... ....+... ...+ ....+++++.++|..||+.+|.+||++.+|++.|+.++...
T Consensus 255 ~~~~~--~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDEE--FCRRLKEG-TRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSHH--HHHHHHHT-CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhHH--HHHHhccC-ccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 54321 22222222 1111 12345899999999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=335.98 Aligned_cols=246 Identities=18% Similarity=0.281 Sum_probs=202.2
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~ 93 (468)
.|...++||+|+||.||+|.+..+|+.||||+...... ...+..|+.++..+.| ++|+.+..++...+..++|||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-FNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEecC
Confidence 48899999999999999999988999999998764432 3457889999888865 66777777778888999999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCccc
Q 012192 94 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 94 -ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
+++|.+++. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 125 ~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~--- 196 (321)
T 2c30_A 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP--- 196 (321)
T ss_dssp CSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC---
T ss_pred CCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc---
Confidence 889999987 4579999999999999999999999999999999999999 4788999999999976543211
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccC
Q 012192 173 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+.+..+....... ......+
T Consensus 197 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~--~~~~~~~ 267 (321)
T 2c30_A 197 ----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPPK--LKNSHKV 267 (321)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSSCCC--CTTGGGS
T ss_pred ----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCC--cCccccC
Confidence 12456899999999999999999999999999999999999999986533 23333333322111 1123456
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 253 PSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
++++.++|..||+.||++||++.+|++
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 899999999999999999999996543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.77 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=201.9
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
.-.+.++|.+.++||+|+||.||+|.+..++..||||+...... ...+..|++++..+.| ++|+.+..++......
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH-PNIIKIFEVFEDYHNM 95 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCC-chHHhHHHheecCCeE
Confidence 33466899999999999999999999999999999998665432 3568889999998876 6777777888888899
Q ss_pred EEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 87 IMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
++|||++ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+...+..+.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999 67999988532 4679999999999999999999999999999999999999644456889999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
.+..... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.+.... .....+......
T Consensus 176 ~~~~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~ 243 (285)
T 3is5_A 176 LFKSDEH--------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQKATYKEPN 243 (285)
T ss_dssp C------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCC
T ss_pred ecCCccc--------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhhhccCCcc
Confidence 6543221 23567999999999875 56899999999999999999999999875432 222222222222
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.. ..+..+++++.++|..||+.||++||++.+|++
T Consensus 244 ~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YA--VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC--C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc--cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 21 223456899999999999999999999997653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.00 Aligned_cols=258 Identities=22% Similarity=0.225 Sum_probs=197.0
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
......++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++|+.+..++...+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-RNIIELKSVIHHNH 106 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC-TTBCCEEEEEEETT
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC-CCcceEEEEEecCC
Confidence 344556799999999999999999999999999999998654332 2356789999988865 67778888888999
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc--CCCCeEEEEeCCccc
Q 012192 85 YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDYGLAK 162 (468)
Q Consensus 85 ~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~--~~~~~vkL~DFGla~ 162 (468)
..++|||++.++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+... +..+.+||+|||++.
T Consensus 107 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999999999999999985 5579999999999999999999999999999999999999532 235569999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
.+..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..... .+..+.....
T Consensus 186 ~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~ 255 (329)
T 3gbz_A 186 AFGIPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLG 255 (329)
T ss_dssp HHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHC
T ss_pred ccCCccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhC
Confidence 6543211 223457899999999998754 8999999999999999999999998754332 2222222110
Q ss_pred CCC-------------------------HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 242 STP-------------------------IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 242 ~~~-------------------------~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..+ ...+...+++++.+||..||+.||++||++.+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 000 1112233689999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.06 Aligned_cols=262 Identities=18% Similarity=0.222 Sum_probs=185.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeE-----e
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGV-----E 82 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~-----~ 82 (468)
.+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|++++..+.| ++|+.+..++. .
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH-DHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCC-CCCCceEEEEecCCccc
Confidence 456899999999999999999999999999999998654322 2357789999999976 55666655553 2
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 83 GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 83 ~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
....|+|||+++++|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++
T Consensus 129 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccch
Confidence 256899999999999999984 5679999999999999999999999999999999999999 578899999999998
Q ss_pred ccccccCcccc--------------------cccCCCCcccccccccccccc-CCCCCCcchHHHHHHHHHHHHc-----
Q 012192 163 KYRDLQTHKHI--------------------PYRENKNLTGTARYASVNTHL-GVEQSRRDDLESLGYVLMYFLR----- 216 (468)
Q Consensus 163 ~~~~~~~~~~~--------------------~~~~~~~~~Gt~~y~APE~~~-~~~~s~ksDvwSlGvvl~ellt----- 216 (468)
........... ........+||+.|+|||++. +..|+.++|||||||+||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 76432211000 001234568899999999875 5569999999999999999998
Q ss_pred ------CCCCCCCCCcc-----------------cHHHHHHHHhh--------------------------cccCCCHHH
Q 012192 217 ------GSLPWQGLKAG-----------------TKKQKYDKISE--------------------------KKVSTPIEV 247 (468)
Q Consensus 217 ------G~~Pf~~~~~~-----------------~~~~~~~~i~~--------------------------~~~~~~~~~ 247 (468)
|..+|.+.... .....+..+.. .....+...
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 66677653210 00111111111 111112223
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+++++.+||..||..||++||++++++
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L 395 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECL 395 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 3455689999999999999999999998643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=340.14 Aligned_cols=264 Identities=19% Similarity=0.206 Sum_probs=200.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeC----cee
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEG----DYN 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~----~~~ 86 (468)
+-.++|+++++||+|+||.||+|.+ .++.||||++..... ......|+.++..+.| ++|+.+..++... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKH-ENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred cchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCC-CCchhhcceeccCCCCCceE
Confidence 3447899999999999999999987 478999998754332 2234557777777766 5555665555543 346
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCceeecccCCCCeEEE
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR----------GFLHRDIKPDNFLMGLGRKANQVYI 155 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~----------giiHrDIKp~NiLl~~~~~~~~vkL 155 (468)
++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+. ||+||||||+|||+ +.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEE
Confidence 9999999 7799999984 4699999999999999999999999 99999999999999 57889999
Q ss_pred EeCCcccccccccCcccccccCCCCccccccccccccccCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcc---
Q 012192 156 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--- 227 (468)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~--- 227 (468)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|..||.+....
T Consensus 173 ~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 173 ADFGLALKFEAGKS-----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCCTTCEEECTTSC-----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred ccCCcccccccccC-----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 99999987654322 1123346799999999999874 4567889999999999999999999864331
Q ss_pred ----------cHHHHHHHHhhcccCCCHHHhh--ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 228 ----------TKKQKYDKISEKKVSTPIEVLC--KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 228 ----------~~~~~~~~i~~~~~~~~~~~l~--~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
........+............. ...++++.+||..||+.||++||++.+|++.|+.+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1122222222222222222111 123567999999999999999999999999999986643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=339.43 Aligned_cols=262 Identities=18% Similarity=0.214 Sum_probs=205.8
Q ss_pred CCCCceec--CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 7 LRMDHVIG--GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 7 l~~~~ii~--~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
+..++++. ++|+++++||+|+||.||+|.+..++..||||++...... ..+..|++++..+.| ++|+.+..++.
T Consensus 17 ~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~ 95 (364)
T 3qyz_A 17 MVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-ENIIGINDIIR 95 (364)
T ss_dssp BCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCC-TTBCCCCEEEC
T ss_pred EEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCccceeEEe
Confidence 44555654 8999999999999999999999999999999987543322 457789999999976 45555555544
Q ss_pred eC-----ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 82 EG-----DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 82 ~~-----~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
.. ...++||++++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 96 ~~~~~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~ 170 (364)
T 3qyz_A 96 APTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKIC 170 (364)
T ss_dssp CSSTTTCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEEC
T ss_pred cCCccccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEE
Confidence 33 46799999999999999974 579999999999999999999999999999999999999 578899999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
|||++.......... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..
T Consensus 171 Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 246 (364)
T 3qyz_A 171 DFGLARVADPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246 (364)
T ss_dssp CCTTCEECCGGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH
T ss_pred eCcceEecCCCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH
Confidence 999998765432211 112456899999999987654 489999999999999999999999988665444333322
Q ss_pred Hhhc-----------------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 236 ISEK-----------------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 236 i~~~-----------------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+... ....+...+...+++++.+||..||+.||++||++.+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 312 (364)
T 3qyz_A 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312 (364)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 1110 112233444567789999999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=327.04 Aligned_cols=253 Identities=21% Similarity=0.378 Sum_probs=197.2
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC------CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK------HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
++-.++|++.++||+|+||.||+|.+ ++..||||+...... ...+..|++++..+.| ++|+.+..++....
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-PNIIALRGVCLKEP 79 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCC-TTBCCEEEEECCC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCC-CCEeeEEEEEecCC
Confidence 34568999999999999999999997 488999998544321 2457789999888875 67777888888888
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCceeecccC-----CCCeEEE
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG---FLHRDIKPDNFLMGLGR-----KANQVYI 155 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~g---iiHrDIKp~NiLl~~~~-----~~~~vkL 155 (468)
..+++||++ +++|.+++. .+.+++..+..++.|++.||+|||++| |+||||||+|||+.... ..+.++|
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 899999999 789999886 568999999999999999999999999 99999999999995211 2678999
Q ss_pred EeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 156 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
+|||++..+.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ......
T Consensus 158 ~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~ 225 (271)
T 3dtc_A 158 TDFGLAREWHRTT---------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYG 225 (271)
T ss_dssp CCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHH
T ss_pred ccCCccccccccc---------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHh
Confidence 9999997654321 2245789999999999999999999999999999999999999987543 222223
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
+.......+. ...+|+++.++|..||+.+|++||++.+|++.|+.
T Consensus 226 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 226 VAMNKLALPI---PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHTSCCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hhcCCCCCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 3333333332 24568999999999999999999999999998875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=339.51 Aligned_cols=259 Identities=17% Similarity=0.210 Sum_probs=202.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcE----EEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEE----IAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~----vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
.+..++|+++++||+|+||.||+|.+..++.. ||+|...... ....+..|+.++..+.| ++|+.+++++..
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~- 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH-AHIVRLLGLCPG- 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCC-TTBCCEEEEECB-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEcC-
Confidence 34568999999999999999999999888775 7777654332 23457788888888865 566666666654
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...++||+++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVAD 163 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccc
Confidence 4466777776 799999998655689999999999999999999999999999999999999 578899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
.+...... .......||..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+ ... .
T Consensus 164 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~-~ 234 (325)
T 3kex_A 164 LLPPDDKQ-----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---EKG-E 234 (325)
T ss_dssp GSCCCTTC-----CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH---HTT-C
T ss_pred ccCccccc-----ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH---HcC-C
Confidence 76543221 11235578889999999999999999999999999999999 99999876544333222 222 1
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+.+ ..++.++.++|..||..+|++||++.+|++.|+.+..
T Consensus 235 ~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 RLAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp BCCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 12211 2347889999999999999999999999999988753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=358.87 Aligned_cols=258 Identities=20% Similarity=0.371 Sum_probs=209.1
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++-.++|++.++||+|+||.||+|.+. .+..||||++.... ....+..|+.++..+.| ++|+.+..++. .+..++|
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH-DKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEC-SSSCEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCC-CCEeeEEEEEe-CCccEEE
Confidence 456689999999999999999999975 56789999876543 34568899999999876 55556666654 5678999
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||++ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCC
Confidence 9999 78999999743 3468999999999999999999999999999999999999 47889999999999875432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
. +.......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+..... .+..+. .....+.+
T Consensus 338 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~-~~~~~~~~ 407 (454)
T 1qcf_A 338 E------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE-RGYRMPRP 407 (454)
T ss_dssp H------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH-HTCCCCCC
T ss_pred c------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-cCCCCCCC
Confidence 1 112334567889999999998899999999999999999999 999998765432 222222 22333322
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+|+++.+||..||+.||++||++.+|.+.|++++..
T Consensus 408 ---~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 408 ---ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 34699999999999999999999999999999886543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=328.11 Aligned_cols=254 Identities=18% Similarity=0.268 Sum_probs=206.9
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--------CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--------HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
++.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++|+.+..++...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH-PNIITLHDIFENK 80 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC-CCeeehhheecCC
Confidence 567899999999999999999999999999999998654421 3457889999999875 6777788888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC-CCCeEEEEeCCcc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDYGLA 161 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~-~~~~vkL~DFGla 161 (468)
...+++||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+.... ....++|+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 8999999999 7899999975 45799999999999999999999999999999999999995211 1238999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ...+..+.....
T Consensus 160 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~ 228 (283)
T 3bhy_A 160 HKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISAVNY 228 (283)
T ss_dssp EECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCC
T ss_pred eeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHhccc
Confidence 86543221 2345689999999999999999999999999999999999999987533 333333444333
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..+ ......+++++.++|..||..||++||++.++++
T Consensus 229 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 DFD-EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCC-HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc-chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 333 3445678999999999999999999999997765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.50 Aligned_cols=267 Identities=20% Similarity=0.203 Sum_probs=216.9
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
..+..++|++.+.||+|+||.||+|.+..+|+.||||++... .....+..|+.++..+.| ++|+.+..++.+.+
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKD 257 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSS
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC-CCEeeEEEEEeeCC
Confidence 446678999999999999999999999999999999986542 233457889999988865 67777778888889
Q ss_pred eeEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
..++||||+ |++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccce
Confidence 999999999 889999987533 349999999999999999999999999999999999999 578999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~ 241 (468)
....... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+...... ......+.....
T Consensus 335 ~~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~ 406 (576)
T 2acx_A 335 HVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406 (576)
T ss_dssp ECCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC
T ss_pred ecccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc
Confidence 7543221 2345899999999999998999999999999999999999999987544322 223333333322
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
..+ ..+++++.+||..||+.||.+|| ++.+| + .+++...++|..+..
T Consensus 407 ~~p-----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~ei---l-------~HpfF~~i~w~~l~~ 458 (576)
T 2acx_A 407 EYS-----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREV---K-------EHPLFKKLNFKRLGA 458 (576)
T ss_dssp CCC-----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHH---H-------TSGGGTTCCHHHHHT
T ss_pred cCC-----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHH---H-------hChhhccCCHHHHhc
Confidence 222 45689999999999999999999 44543 2 356677788987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=329.82 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=196.1
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
-++|+++++||+|+||.||+|.+..+++.||||+....... ..+..|++++..+.| ++|+.+..++......++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH-PNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CCccchhheeecCCeEEEE
Confidence 47899999999999999999999999999999986554433 346789999998875 6777777888888999999
Q ss_pred EeccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLLG-PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~g-gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||++. ++|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 81 FEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence 99995 55666655 46679999999999999999999999999999999999999 478899999999998654322
Q ss_pred CcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc-------
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK------- 240 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 240 (468)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.......
T Consensus 157 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 157 D-------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c-------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 1 1234578999999999987 568999999999999999999999998765433222222211100
Q ss_pred ----------------cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 241 ----------------VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 241 ----------------~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...+.......+++++.+||..||+.||++||++.+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 01122233456789999999999999999999998654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=357.82 Aligned_cols=271 Identities=21% Similarity=0.259 Sum_probs=219.7
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
..+..++|++.+.||+|+||.||+|.+..+|+.||||++... .....+..|+.++..+.| ++|+.+..++....
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFIVSLAYAFETKT 258 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSS
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC-CCEeeEEEEEeeCC
Confidence 345568999999999999999999999999999999986543 223457889999988865 67777877888888
Q ss_pred eeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
..++||||+ |++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGl 335 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGL 335 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecce
Confidence 999999999 78999998753 3469999999999999999999999999999999999999 5789999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-cHHHHHHHHhhc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYDKISEK 239 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~-~~~~~~~~i~~~ 239 (468)
++.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.... ...+....+...
T Consensus 336 a~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~ 408 (543)
T 3c4z_A 336 AVELKAGQT-------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408 (543)
T ss_dssp CEECCTTCC-------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred eeeccCCCc-------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc
Confidence 987543221 123468999999999999999999999999999999999999999875432 233444445444
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCcccccccccC
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSY--LKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~--l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
....| ..+++++.+||..||+.||++||++.+ ..++ ..++++..++|..+..
T Consensus 409 ~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei-------~~Hpff~~i~w~~l~~ 462 (543)
T 3c4z_A 409 AVTYP-----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGL-------RTHPLFRDISWRQLEA 462 (543)
T ss_dssp CCCCC-----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHH-------HTSGGGTTCCHHHHHT
T ss_pred ccCCC-----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHH-------HcCccccCCCHHHHHc
Confidence 44333 456899999999999999999997632 1122 2466777889987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=328.41 Aligned_cols=254 Identities=19% Similarity=0.184 Sum_probs=203.8
Q ss_pred CCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 5 GKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 5 ~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
|.+.|...+.++|++++.||+|+||.||+|.+..+++.||||+...... ...+..|+..+..+..|++|+.+..++
T Consensus 1 g~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp ----CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred CCccccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 3456777788999999999999999999999999999999998665322 235777888888886778898999898
Q ss_pred EeCceeEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC--------
Q 012192 81 VEGDYNIMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR-------- 148 (468)
Q Consensus 81 ~~~~~~~lv~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~-------- 148 (468)
.+.+..++|||++ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+....
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccc
Confidence 9999999999999 77999998753 26799999999999999999999999999999999999995322
Q ss_pred --------CCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCC
Q 012192 149 --------KANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSL 219 (468)
Q Consensus 149 --------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~ 219 (468)
....++|+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSP-----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCS-----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred cccccccCCceEEEEcccccccccCCc-----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 4457999999999765431 234689999999999876 56789999999999999999988
Q ss_pred CCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 220 PWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 220 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
|+.... ....+...... .+...+++++.++|..||+.||++||++.+|++
T Consensus 230 ~~~~~~------~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 230 LPRNGD------QWHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCSSSH------HHHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcchh------HHHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 775421 12223332221 123456899999999999999999999997643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=331.89 Aligned_cols=259 Identities=18% Similarity=0.297 Sum_probs=205.0
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
.....++|++.+.||+|+||.||+|.+..++..||||+.........+..|+.++..+.| ++|+.+..++......+++
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS-PHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEEE
Confidence 445678999999999999999999999999999999998777777789999999998865 6777777777888899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||++ +++|.+++......+++..+..++.|++.||.|||+.||+|+||||+|||+ +.++.++|+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhc
Confidence 9999 569999998667789999999999999999999999999999999999999 478899999999997654321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.... .....+..... +....
T Consensus 180 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~~~~ 247 (314)
T 3com_A 180 A-------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAIFMIPTNPP--PTFRK 247 (314)
T ss_dssp S-------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCC--CCCSS
T ss_pred c-------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhcCCC--cccCC
Confidence 1 123457899999999999999999999999999999999999999865432 22222222211 11112
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
...++.++.++|..||..||.+||++.+| |++.+..
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~l---l~~~~~~ 283 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQL---LQHPFVR 283 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHH---TTSHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHH---HhCHHHh
Confidence 24468999999999999999999999865 4444443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=364.29 Aligned_cols=265 Identities=18% Similarity=0.287 Sum_probs=207.0
Q ss_pred ecCceEEEc-eEeeeCCeEEEEEEEcC--CCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 13 IGGKFKLGR-KIGSGSFGELYLGVNVQ--TGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 13 i~~~y~i~~-~LG~G~fG~Vy~~~~~~--~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
..++|.+.+ +||+|+||.||+|.+.. ++..||||++.... ....+..|++++..+.| ++|+.+++++.. +..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA-EAL 410 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCC-TTBCCEEEEEES-SSE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEecc-CCe
Confidence 345667776 89999999999998753 56789999876532 23568899999998865 566666666654 558
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
++|||++ +++|.+++......+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++...
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCccccc
Confidence 8999998 789999997666779999999999999999999999999999999999999 478899999999998754
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.... .+.......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+....... ..+... ...+
T Consensus 488 ~~~~----~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~~i~~~-~~~~ 559 (613)
T 2ozo_A 488 ADDS----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQG-KRME 559 (613)
T ss_dssp ------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---HHHHTT-CCCC
T ss_pred CCCc----eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcC-CCCC
Confidence 3221 1112233456789999999999999999999999999999998 99999987654322 223222 2222
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFD 293 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~ 293 (468)
.+ ..+|+++.+||..||+.+|++||++.+|++.|++++.......+
T Consensus 560 ~p---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 560 CP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp CC---TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred CC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 22 35699999999999999999999999999999999887655443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=346.54 Aligned_cols=262 Identities=17% Similarity=0.228 Sum_probs=195.3
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeC----
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEG---- 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~---- 83 (468)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|++++..+.| ++|+.+..++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS-DYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCC-CCcceEEEEEecCCCCc
Confidence 4678999999999999999999999999999999987543322 457889999999986 5555555555444
Q ss_pred -ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 -DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 -~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...|+|||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 102 FDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLAR 177 (432)
T ss_dssp CCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcc
Confidence 56899999999999999984 5679999999999999999999999999999999999999 578899999999998
Q ss_pred ccccccCcccc---------------cccCCCCcccccccccccccc-CCCCCCcchHHHHHHHHHHHHcCCCCCC----
Q 012192 163 KYRDLQTHKHI---------------PYRENKNLTGTARYASVNTHL-GVEQSRRDDLESLGYVLMYFLRGSLPWQ---- 222 (468)
Q Consensus 163 ~~~~~~~~~~~---------------~~~~~~~~~Gt~~y~APE~~~-~~~~s~ksDvwSlGvvl~elltG~~Pf~---- 222 (468)
........... ........+||+.|+|||++. +..++.++|||||||++|||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 76442211000 001235678999999999874 5569999999999999999998544443
Q ss_pred -------CCCcc--------------cHHHHHHHHh--------------------------hcccCCCHHHhhccCcHH
Q 012192 223 -------GLKAG--------------TKKQKYDKIS--------------------------EKKVSTPIEVLCKSYPSE 255 (468)
Q Consensus 223 -------~~~~~--------------~~~~~~~~i~--------------------------~~~~~~~~~~l~~~~p~~ 255 (468)
+.... .....+..+. ......+.......++++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 32100 0011111111 111122233344568999
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHH
Q 012192 256 FVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 256 ~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+.+||..||..||++||++.+++
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L 360 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQAL 360 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHhcCCcccCCCHHHHh
Confidence 99999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=338.06 Aligned_cols=258 Identities=21% Similarity=0.246 Sum_probs=200.0
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEe--------
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVE-------- 82 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-------- 82 (468)
++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++|+.+..++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH-ENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCC-TTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccC-CCcccHhheeeccccccccC
Confidence 689999999999999999999999999999998654432 2357789999999986 555555555544
Q ss_pred CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 83 GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 83 ~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
....++|||++.++|.+.+......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcc
Confidence 45689999999999999988666789999999999999999999999999999999999999 578899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
.+....... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+........
T Consensus 173 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSS---CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccccc---ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 765322211 1123456789999999999874 589999999999999999999999987554333333322211111
Q ss_pred CCCHHHh------------------------hccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 242 STPIEVL------------------------CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 242 ~~~~~~l------------------------~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+.. ....++++.+||..||+.||++||++.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000 0013678999999999999999999986443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.89 Aligned_cols=248 Identities=17% Similarity=0.211 Sum_probs=190.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeC----
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEG---- 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~---- 83 (468)
.+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..+.| ++|+.+..++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCC-CCCCcEEEEEccCCccc
Confidence 456899999999999999999999999999999998764322 3457789999998876 4555555554332
Q ss_pred --ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 84 --DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 84 --~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
...++||||+.++|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 138 ~~~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 138 EFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 211 (464)
T ss_dssp TCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC
T ss_pred cCCeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEee
Confidence 4579999999988887775 359999999999999999999999999999999999999 57889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
+...... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+..... .+..+....-
T Consensus 212 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg 280 (464)
T 3ttj_A 212 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLG 280 (464)
T ss_dssp -----CC--------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHC
T ss_pred eecCCCc--------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcC
Confidence 8654321 1345689999999999999999999999999999999999999998754322 2222222111
Q ss_pred CC-------------------------CHHHhhc------------cCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 242 ST-------------------------PIEVLCK------------SYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 242 ~~-------------------------~~~~l~~------------~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
.. ..+.... ..++++.+||.+||..||++||+++++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 353 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 01 1111111 115679999999999999999999854
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=324.37 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=211.1
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
-.++|++.+.||+|+||.||+|.+. ++..||||+..... ....+..|++++..+.| ++|+.+..++...+..+++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCeEEEEe
Confidence 3478999999999999999999975 67889999876543 33568899999998865 677777777788888999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
++ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~-- 158 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-- 158 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHH--
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccccccc--
Confidence 99 789999998766779999999999999999999999999999999999999 477899999999998654321
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
........+|..|+|||++.+..++.++||||||+++|+|++ |..||.+... .+....+.... .... .
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i~~~~-~~~~---~ 227 (267)
T 3t9t_A 159 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGF-RLYK---P 227 (267)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTC-CCCC---C
T ss_pred ----ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHHhcCC-cCCC---C
Confidence 112234567889999999998899999999999999999999 9999986543 23333333321 1111 1
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+++++.++|..||+.+|++||++.+|++.|+++..
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3458999999999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=336.17 Aligned_cols=263 Identities=16% Similarity=0.247 Sum_probs=206.2
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCC----cEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTG----EEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~----~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
.++..++|++.+.||+|+||.||+|.+..++ ..||||+...... ...+..|+.++..+.| ++|+.+.+++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEec
Confidence 4677789999999999999999999876543 4699998764432 2357789999888865 677777777788
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
.+..++|||++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLS 194 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcc
Confidence 88899999999 669999998766789999999999999999999999999999999999999 47889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
+......... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... +.+..+...
T Consensus 195 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~~- 266 (333)
T 1mqb_A 195 RVLEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAINDG- 266 (333)
T ss_dssp --------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT-
T ss_pred hhhccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHCC-
Confidence 8754322111 11223456889999999999999999999999999999998 99999875432 233333222
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
...+. ...+|+++.++|..||+.+|++||++.+|++.|+.++..
T Consensus 267 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 FRLPT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCCCC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CcCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 22222 235689999999999999999999999999999998864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=329.60 Aligned_cols=255 Identities=18% Similarity=0.238 Sum_probs=203.8
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEc-CCCcEEEEEEeeccC----CCchhHHHHHHHHHHh--CCCCCceeeEeeE----
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNV-QTGEEIAVKLELVKT----KHPQLHYESKLYMLLQ--GGTGIPHLKWFGV---- 81 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~-~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~---- 81 (468)
..++|++++.||+|+||.||+|.+. .+++.||||+..... ....+..|+.++..+. .|++|+.+..++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4589999999999999999999985 678999999865432 2346778999988885 5677777776665
Q ss_pred -eCceeEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 82 -EGDYNIMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 82 -~~~~~~lv~el~ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
.....++|||++.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecCc
Confidence 456789999999999999998643 359999999999999999999999999999999999999 478899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......
T Consensus 166 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 166 LARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp SCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 997654321 123567899999999999999999999999999999999999999875433222222111100
Q ss_pred -------------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 -------------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 -------------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+...+...+++++.+||..||..||++||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 011122334467899999999999999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=329.00 Aligned_cols=253 Identities=19% Similarity=0.269 Sum_probs=191.7
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
++..++|+++++||+|+||.||+|.+..+++.||||++...... .....|...+....+|++|+.+..++...+..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 45678999999999999999999999999999999986544322 223444444445556788888888888888999
Q ss_pred EEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 88 MVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 88 lv~el~ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
+|||++.++|.+++.. ....+++..+..++.|++.||+|||++ ||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-----
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCccc
Confidence 9999999999888764 356799999999999999999999998 99999999999999 4778999999999976
Q ss_pred cccccCcccccccCCCCccccccccccccc----cCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTH----LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~----~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
...... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||..... ....+......
T Consensus 160 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~ 229 (290)
T 3fme_A 160 LVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVEE 229 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHHS
T ss_pred cccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhcc
Confidence 543221 2344799999999996 556789999999999999999999999986432 22333333333
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...... ...+++++.++|..||+.+|++||++.++++
T Consensus 230 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PSPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 222211 2356899999999999999999999997654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=351.61 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=210.9
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
.+.++|+++++||+|+||.||+|.+..+++.||||++... .....+..|++++..+.| ++|+.+..++......+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC-CCcCeEEEEEEcCCEEE
Confidence 4568999999999999999999999999999999986432 234568899999999965 67777888888889999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+++.+..
T Consensus 98 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999998 7899988875 45799999999999999999999999999999999999996545667899999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... .+.+..+.......+.+
T Consensus 177 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 177 NT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYAFDLP 244 (486)
T ss_dssp C------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCSCSG
T ss_pred CC--------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCc
Confidence 21 1235579999999999886 599999999999999999999999987543 34444455554443332
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
....+++++.+||..||+.+|.+||++.+++ ++.+..
T Consensus 245 -~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l---~hp~~~ 281 (486)
T 3mwu_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCL---EHPWIQ 281 (486)
T ss_dssp -GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHH---HCHHHH
T ss_pred -ccCCCCHHHHHHHHHHcCCChhhCcCHHHHh---cCHhhc
Confidence 2356789999999999999999999998654 444443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=339.52 Aligned_cols=261 Identities=19% Similarity=0.295 Sum_probs=210.2
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
-++..++|++.+.||+|+||.||+|.+. .++..||||+....... ..+..|+.++..+.| ++|+.+..++.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~ 98 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVS 98 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEEC
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCEeeeEEEEc
Confidence 3566789999999999999999999876 35788999986544322 247789999888865 57777777778
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCC
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCN---------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKAN 151 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~---------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~ 151 (468)
..+..++|||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCC
Confidence 888899999999 679999987532 457999999999999999999999999999999999999 4788
Q ss_pred eEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHH
Q 012192 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 230 (468)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~ 230 (468)
.+||+|||+++....... +.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+... .
T Consensus 176 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~ 247 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---E 247 (322)
T ss_dssp CEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---H
T ss_pred eEEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---H
Confidence 999999999986543221 112234567899999999999999999999999999999999 8999987543 2
Q ss_pred HHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 231 QKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 231 ~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
+....+....... ....+|+++.++|..||+.+|++||++.+|++.|++.+.
T Consensus 248 ~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 QVLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 3333333332211 124568999999999999999999999999999887643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=349.64 Aligned_cols=270 Identities=18% Similarity=0.210 Sum_probs=212.1
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCc-
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD- 84 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~- 84 (468)
.+.+.+++|++.++||+|+||.||+|.+..+++.||||++.... ....+..|++++..+.| ++|+.+..++....
T Consensus 3 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTT 81 (396)
T ss_dssp EEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTT
T ss_pred CCCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCCCeEEEeeccCCC
Confidence 35677899999999999999999999999999999999865432 23457789999999976 56666666655443
Q ss_pred -eeEEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc-CCCCeEEEEeCC
Q 012192 85 -YNIMVIDLL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDYG 159 (468)
Q Consensus 85 -~~~lv~el~-ggsL~~ll~~~~--~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~-~~~~~vkL~DFG 159 (468)
..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+... +..+.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 679999999 789999987532 239999999999999999999999999999999999998332 345679999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccC--------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-cHH
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG--------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKK 230 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--------~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~-~~~ 230 (468)
+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||...... ...
T Consensus 162 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~ 233 (396)
T 4eut_A 162 AARELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233 (396)
T ss_dssp GCEECCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred CceEccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence 9987544221 234679999999999875 45788999999999999999999999764432 233
Q ss_pred HHHHHHhhcccCC--------------------CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 231 QKYDKISEKKVST--------------------PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 231 ~~~~~i~~~~~~~--------------------~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+.+..+....... ....+...+++.+.++|..||+.||++||++.++.+.+++++.+
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 3444443332110 01112234578899999999999999999999999999888764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=328.23 Aligned_cols=261 Identities=17% Similarity=0.237 Sum_probs=203.3
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
..+|++.++||+|+||.||+|.+..+ ...||||....... ...+..|+.++..+.|++.+..+..+.......+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35799999999999999999986543 34689997654332 2457789999999986554444444456667889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
++||++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence 999999 669999998666779999999999999999999999999999999999999 5788999999999986644
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... .........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+......... +........
T Consensus 181 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~- 253 (298)
T 3f66_A 181 KEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRLLQ- 253 (298)
T ss_dssp GGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---HHTTCCCCC-
T ss_pred cchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---HhcCCCCCC-
Confidence 2211 1122345678899999999999999999999999999999999 6667766544333222 222222111
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
...+|+++.++|..||+.+|++||++.+|++.|+.++..
T Consensus 254 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 254 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 234589999999999999999999999999999998864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.26 Aligned_cols=254 Identities=19% Similarity=0.283 Sum_probs=199.3
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+..++|++.+.||+|+||.||+|.+ ++..||||+.........+..|++++..+.|++.+..+..+.......+++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 4568999999999999999999987 58899999977666667789999999999865544444444445557899999
Q ss_pred cc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~-~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
++ +++|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeecccccccccc--
Confidence 99 5699999875432 38999999999999999999999999999999999999 47889999999998754431
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....+++.|+|||++.+..++.++||||||+++|+|++ |..||.......... .+.. ..... .
T Consensus 171 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~---~~~~-~~~~~---~ 235 (278)
T 1byg_A 171 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVEK-GYKMD---A 235 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH---HHTT-TCCCC---C
T ss_pred --------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHhc-CCCCC---C
Confidence 123467889999999999999999999999999999998 999998765433222 2222 21111 2
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
...+|+++.++|..||+.||++||++.+|.+.|+++...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 245699999999999999999999999999999998654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=332.44 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=200.7
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
-++|++.+.||+|+||.||+|.+..+++.||||+...... ...+..|+.++..+.| ++|+.+..++...+..++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-PHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCC-CCeeEEEEEEeeCCeEEE
Confidence 3689999999999999999999999999999998654322 1457789999888865 677778888888899999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+||++ +++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccccc
Confidence 99999 5699999985 4579999999999999999999999999999999999999 47789999999999765432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ..+........ .....
T Consensus 188 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~-~~~~~ 256 (309)
T 2h34_A 188 KL------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----SVMGAHINQAI-PRPST 256 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----HHHHHHHHSCC-CCGGG
T ss_pred cc------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----HHHHHHhccCC-CCccc
Confidence 11 122355799999999999999999999999999999999999999986432 12222222222 22334
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKP-DYSYLKRLFRDLFI 286 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RP-s~~~l~~~L~~~~~ 286 (468)
....+|+++.++|..||+.||++|| ++++|.+.|+.++.
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 4567899999999999999999999 99999999887654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=336.21 Aligned_cols=267 Identities=18% Similarity=0.273 Sum_probs=209.4
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEE-----EcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEe
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGV-----NVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~-----~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
.+.++..++|++++.||+|+||.||+|. +..++..||||++..... ...+..|+.++..+. |++|+.+.++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 101 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGV 101 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC-CCCCCeEEEE
Confidence 3567888999999999999999999998 456788999998653322 235778999998885 5677778888
Q ss_pred eEeCceeEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCe
Q 012192 80 GVEGDYNIMVIDLL-GPSLEDLFNYCN------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ 152 (468)
Q Consensus 80 ~~~~~~~~lv~el~-ggsL~~ll~~~~------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~ 152 (468)
+......++|||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+...+....
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 88888889999999 889999998643 35899999999999999999999999999999999999964445667
Q ss_pred EEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHH
Q 012192 153 VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 231 (468)
Q Consensus 153 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~ 231 (468)
++|+|||++........ ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+... ..
T Consensus 182 ~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~ 253 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QE 253 (327)
T ss_dssp EEECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred EEECccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HH
Confidence 99999999975443221 112334568899999999999999999999999999999998 9999986533 22
Q ss_pred HHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 232 KYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 232 ~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
....+...... . ....+++++.++|..||+.+|.+||++.+|++.|+.+...
T Consensus 254 ~~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 254 VLEFVTSGGRM-D---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHHHHTTCCC-C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcCCCC-C---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 33333332221 1 1245689999999999999999999999999999887654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=337.98 Aligned_cols=252 Identities=18% Similarity=0.196 Sum_probs=200.4
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-------CCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-------KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
.++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|++++..+.| ++|+.+..++......
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCC-CCCCeEEEEEeeCCce
Confidence 478999999999999999999998899999999865321 13467889999999875 6777777777788889
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 87 IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 87 ~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
++|||++.++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceeccC
Confidence 9999999999999998666679999999999999999999999999999999999999 5788999999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc----
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV---- 241 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---- 241 (468)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... ..+..+.....
T Consensus 165 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 165 PN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTE 234 (346)
T ss_dssp CC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCT
T ss_pred Cc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCCh
Confidence 22 123456789999999999765 4899999999999999999999999875432 22222222110
Q ss_pred -------------------CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 242 -------------------STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 242 -------------------~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..+...+...+++++.+||..||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 11223344667899999999999999999999986533
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=325.94 Aligned_cols=261 Identities=20% Similarity=0.307 Sum_probs=208.8
Q ss_pred eecCceEEEc-eEeeeCCeEEEEEEEc--CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 12 VIGGKFKLGR-KIGSGSFGELYLGVNV--QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 12 ii~~~y~i~~-~LG~G~fG~Vy~~~~~--~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
+-.++|.+.+ .||+|+||.||+|.+. .++..||||+...... ...+..|++++..+.| ++|+.+..++ ..+.
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVC-QAEA 83 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEE-ESSS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEe-cCCC
Confidence 3457788887 9999999999999864 4678899998765432 3457889999999965 5666666665 4556
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++|||++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+. .++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceeee
Confidence 88999998 6799999976667799999999999999999999999999999999999994 7889999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... ....+.... ..
T Consensus 161 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~~~-~~ 232 (287)
T 1u59_A 161 GADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK-RM 232 (287)
T ss_dssp TTCSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTTC-CC
T ss_pred ccCcce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhcCC-cC
Confidence 432211 112234567899999999998889999999999999999998 999998765432 222232222 11
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
+ ....+|+++.++|..||..+|++||++.+|.+.|+.++...
T Consensus 233 ~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 233 E---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp C---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C---CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 22456999999999999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=329.34 Aligned_cols=265 Identities=24% Similarity=0.295 Sum_probs=203.2
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
++....++|++.+.||+|+||.||+|.+..++..||||++..... ...+..|+.++..+.| ++|+.+..++...
T Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIED 104 (310)
T ss_dssp GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEET
T ss_pred cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcC
Confidence 455566899999999999999999999999999999998764322 2357789999888865 6777777888888
Q ss_pred ceeEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 84 DYNIMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
+..+++||++ +++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||+ +.++.++|+|||
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg 181 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLG 181 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC-
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEecc
Confidence 8999999999 6699999874 25679999999999999999999999999999999999999 578899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ........+...
T Consensus 182 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~ 253 (310)
T 2wqm_A 182 LGRFFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQC 253 (310)
T ss_dssp ------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTT
T ss_pred ceeeecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcc
Confidence 9876543211 12345789999999999999999999999999999999999999976432 222333333333
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
..... ....+++++.++|..||..||++||++.+|++.|+.+....
T Consensus 254 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 254 DYPPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CSCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 22211 12456899999999999999999999999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.95 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=208.4
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEe---
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVE--- 82 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--- 82 (468)
.-+++..++++|++++.||+|+||.||+|.+..+++.||||+.... ...+..|++++..+.| ++|..+..++..
T Consensus 2 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN--NEKAEREVKALAKLDH-VNIVHYNGCWDGFDY 78 (284)
T ss_dssp CCCCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC--SGGGHHHHHHHHHCCC-TTBCCEEEEEEEEEE
T ss_pred CccccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHhCCC-CCEEEEeeeEecccc
Confidence 4567888999999999999999999999999889999999986543 3578899999999976 455555554432
Q ss_pred -------------CceeEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc
Q 012192 83 -------------GDYNIMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 147 (468)
Q Consensus 83 -------------~~~~~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~ 147 (468)
....+++||++ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~--- 155 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL--- 155 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---
Confidence 44579999999 56999999753 4579999999999999999999999999999999999999
Q ss_pred CCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc
Q 012192 148 RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 227 (468)
Q Consensus 148 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~ 227 (468)
+.++.++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--- 224 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--- 224 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---
T ss_pred cCCCCEEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---
Confidence 4788999999999986544221 23457899999999999999999999999999999999999988531
Q ss_pred cHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 228 TKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 228 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
...+..+..... ...++.++.++|..||+.||++||++.+|++.|..+.
T Consensus 225 --~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 225 --SKFFTDLRDGII-------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --HHHHHHHHTTCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --HHHHHHhhcccc-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 122222222211 1346899999999999999999999999999887753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=333.77 Aligned_cols=254 Identities=17% Similarity=0.265 Sum_probs=204.1
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCC-------cEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEe
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTG-------EEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~-------~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
+.++..++|++.+.||+|+||.||+|.+..++ ..||||+..... ....+..|+.++..+.| ++|+.+..+
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~ 80 (289)
T 4fvq_A 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH-KHLVLNYGV 80 (289)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCC-TTBCCEEEE
T ss_pred eEEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEE
Confidence 35677899999999999999999999988776 479999865432 23467889999988875 677777778
Q ss_pred eEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCe------
Q 012192 80 GVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ------ 152 (468)
Q Consensus 80 ~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~------ 152 (468)
+...+..++|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+. .++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~ 157 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNP 157 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBC
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCccccccc
Confidence 78888889999999 6899999987666699999999999999999999999999999999999995 3443
Q ss_pred --EEEEeCCcccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcC-CCCCCCCCccc
Q 012192 153 --VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGT 228 (468)
Q Consensus 153 --vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG-~~Pf~~~~~~~ 228 (468)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++| ..||.....
T Consensus 158 ~~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-- 224 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-- 224 (289)
T ss_dssp CEEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred ceeeeccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--
Confidence 999999998754321 23468899999999998 6799999999999999999995 455544322
Q ss_pred HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 229 KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 229 ~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.... .........+ ..+++++.++|..||+.||++||++.+|++.|+.++.
T Consensus 225 -~~~~-~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 225 -QRKL-QFYEDRHQLP-----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -HHHH-HHHHTTCCCC-----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -HHHH-HHhhccCCCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111 1222222222 2347889999999999999999999999999988754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=330.20 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=209.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
..+.++|++.+.||+|+||.||+|.+..+++.||||+..... ....+..|+.++..+.| ++|+.+..++......++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-ENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCC-CCeeehhhhcccCCEEEE
Confidence 345689999999999999999999999999999999866442 23467889999999865 667777778888889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+||++ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+...+.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 84 VMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp EECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EEEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999 7899999875 457999999999999999999999999999999999999954456789999999998754321
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ...+..+.......+ ..
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~-~~ 229 (304)
T 2jam_A 163 ---------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIKEGYYEFE-SP 229 (304)
T ss_dssp ---------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHCCCCCC-TT
T ss_pred ---------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCCCC-cc
Confidence 11234689999999999999999999999999999999999999986432 333444444433322 22
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
....+++++.++|..||..||++||++.++ |++.+..
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~ 266 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKA---LSHPWID 266 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHH---HTSHHHH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHH---hcCcccc
Confidence 345679999999999999999999999865 4454443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=337.69 Aligned_cols=268 Identities=16% Similarity=0.219 Sum_probs=183.8
Q ss_pred CCCCCCCceecCceEEEc-eEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 4 DGKLRMDHVIGGKFKLGR-KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 4 ~~~l~~~~ii~~~y~i~~-~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
.|+......+.++|.+.+ .||+|+||.||+|.+..+++.||||++.. ......|+..+..+..|++|+.+..++..
T Consensus 17 ~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD---SPKARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp ---CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES---SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC---cHHHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 445556667889999966 59999999999999999999999998654 23455566666666667777777766654
Q ss_pred ----CceeEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 83 ----GDYNIMVIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 83 ----~~~~~lv~el~-ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
....++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+...+..+.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 45689999999 669999998543 469999999999999999999999999999999999999654456779999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH-HHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YDK 235 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~-~~~ 235 (468)
|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... ...
T Consensus 174 Dfg~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (336)
T 3fhr_A 174 DFGFAKETTQNA---------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244 (336)
T ss_dssp CCTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred ccccceeccccc---------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh
Confidence 999997654311 2345789999999999888899999999999999999999999976543322111 111
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+.......+. .....+++++.+||..||+.||++||++.+| |++.+..
T Consensus 245 ~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~~ 292 (336)
T 3fhr_A 245 IRLGQYGFPN-PEWSEVSEDAKQLIRLLLKTDPTERLTITQF---MNHPWIN 292 (336)
T ss_dssp ------CCCT-TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH---HHSHHHH
T ss_pred hhccccccCc-hhhccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCcccc
Confidence 1112222221 1224679999999999999999999999865 4455543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=334.90 Aligned_cols=251 Identities=21% Similarity=0.241 Sum_probs=209.0
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----------CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----------HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
+.++|++.+.||+|+||.||+|.+..+|+.||||+...... ...+..|+.++..+.+|++|+.+..++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 34689999999999999999999988999999998765432 23467899999999777888888888889
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
....++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFS 247 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred CCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcc
Confidence 99999999999 6799999885 4579999999999999999999999999999999999999 57889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~------~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ....+..
T Consensus 248 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~ 316 (365)
T 2y7j_A 248 CHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRM 316 (365)
T ss_dssp EECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH
T ss_pred cccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHH
Confidence 7654321 1235689999999999874 358899999999999999999999997643 2334444
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+.......+.+ ....++.++.++|..||+.||++||++.+|++
T Consensus 317 i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 44444444433 33567899999999999999999999997654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=333.16 Aligned_cols=260 Identities=17% Similarity=0.257 Sum_probs=211.7
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEE--EEEEeecc---CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEI--AVKLELVK---TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~v--AIK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+-.++|++.+.||+|+||.||+|.+..++..+ |||..... .....+..|+.++..+.+|++|+.+..++...+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 344589999999999999999999998888765 88876532 2345688899999999777889999999899999
Q ss_pred eEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCC
Q 012192 86 NIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 149 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~ 149 (468)
.++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cC
Confidence 99999999 789999997432 469999999999999999999999999999999999999 46
Q ss_pred CCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCccc
Q 012192 150 ANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 228 (468)
Q Consensus 150 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~ 228 (468)
++.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-- 247 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-- 247 (327)
T ss_dssp GGCEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred CCeEEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--
Confidence 7899999999987433211 1234467889999999998889999999999999999998 9999987543
Q ss_pred HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 229 KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 229 ~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
.+.+..+... .... ....+++++.++|..||..+|++||++.+|++.|+.++...
T Consensus 248 -~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 248 -AELYEKLPQG-YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp -HHHHHHGGGT-CCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -HHHHHHhhcC-CCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 2333333322 2121 12346899999999999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=339.55 Aligned_cols=247 Identities=18% Similarity=0.282 Sum_probs=193.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeC-----
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEG----- 83 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~----- 83 (468)
+.++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|++++..+.| ++|+.+..++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH-ENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCB-TTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCC-cCCCCceeeEecCCcccc
Confidence 568999999999999999999999999999999986543322 356789999999986 5555555554433
Q ss_pred -ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 -DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 -~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...++|||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 102 FTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 176 (367)
T ss_dssp CCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeeccc
Confidence 34599999999999999984 579999999999999999999999999999999999999 578899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|..||.+.... ..+..+.....
T Consensus 177 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g 243 (367)
T 1cm8_A 177 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTG 243 (367)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHC
T ss_pred ccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence 64321 235678999999999988 67999999999999999999999999875432 22222222111
Q ss_pred C--------------------------CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 242 S--------------------------TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 242 ~--------------------------~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
. .+...+...+++++.+||.+||..||++||++.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l 306 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHh
Confidence 1 112233456789999999999999999999998644
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=355.00 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=211.8
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
...++.++|++.++||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.++.++...
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~ 98 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH-PNIMKLYEFFEDK 98 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCC-TTBCCEEEEEECS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 44677889999999999999999999999999999999865432 23458889999998865 6777788888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999998 8899998874 5679999999999999999999999999999999999999644467899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... .+.+..+......
T Consensus 178 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~ 245 (484)
T 3nyv_A 178 HFEASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKKVEKGKYT 245 (484)
T ss_dssp HBCCCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCC
T ss_pred Ecccccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCC
Confidence 6643221 224579999999999887 699999999999999999999999987543 3444445555444
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+.+ ....+++++.+||..||+.+|.+||++.+++
T Consensus 246 ~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 280 (484)
T 3nyv_A 246 FELP-QWKKVSESAKDLIRKMLTYVPSMRISARDAL 280 (484)
T ss_dssp CCSG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 3332 2356799999999999999999999998654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=340.00 Aligned_cols=259 Identities=15% Similarity=0.187 Sum_probs=205.0
Q ss_pred eecCceEEEceEeeeCCeEEEEE-----EEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhC--CCCCceeeEeeEeCc
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLG-----VNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQG--GTGIPHLKWFGVEGD 84 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~-----~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~--~~~i~~l~~~~~~~~ 84 (468)
+..++|++.++||+|+||.||+| .+..+++.||||++.. .....+..|.+++..+.+ |+++..++.++...+
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS-CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC-CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 45688999999999999999999 4667899999998654 345567888888888763 466777888888888
Q ss_pred eeEEEEecc-CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecc--------cCCCC
Q 012192 85 YNIMVIDLL-GPSLEDLFNY----CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL--------GRKAN 151 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~----~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~--------~~~~~ 151 (468)
..++||||+ +++|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+|||+.. .+..+
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 899999999 7999999975 2567999999999999999999999999999999999999952 11178
Q ss_pred eEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH
Q 012192 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 231 (468)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~ 231 (468)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKG-----TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp TEEECCCTTCEEGGGSCTT-----EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred CEEEeeCchhhhhhccCCC-----ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 9999999999765432111 112456799999999999999999999999999999999999999965332110
Q ss_pred HHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCC-CCHHHHHHHHHHHHHHc
Q 012192 232 KYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDK-PDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 232 ~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~R-Ps~~~l~~~L~~~~~~~ 288 (468)
........ ...++.+.+++..|++.+|.+| |++.+|.+.|++.+...
T Consensus 294 --------~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 --------KPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp --------EECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --------eechhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00000000 0236789999999999999999 68999999999988764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=341.91 Aligned_cols=259 Identities=17% Similarity=0.236 Sum_probs=195.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEe-eEeCceeE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWF-GVEGDYNI 87 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~-~~~~~~~~ 87 (468)
..|++.++||+|+||.||+|.+..+ +..||||....... ...+..|+.++..+.| ++|+.+..+ .......+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCC-TTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCCCeE
Confidence 3588999999999999999987543 24689997654332 2357789999888876 455555554 45566788
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+|||++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccccc
Confidence 999999 679999998666779999999999999999999999999999999999999 5788999999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+ ..... ...
T Consensus 245 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~~~~~-~~~ 317 (373)
T 3c1x_A 245 KEFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRR-LLQ 317 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---HTTCC-CCC
T ss_pred cccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---HcCCC-CCC
Confidence 2211 1112234567889999999999999999999999999999999 78888876554433322 22221 111
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
...+|+++.++|..||+.+|++||++.+|++.|+.++..
T Consensus 318 ---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 318 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 134689999999999999999999999999999998875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=351.91 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=212.3
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
...+.+..++|.+++.||+|+||.||+|.+..+|+.||||++... .....+..|+.++..+.| ++|+.++.++.
T Consensus 8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~ 86 (476)
T 2y94_A 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-PHIIKLYQVIS 86 (476)
T ss_dssp -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCC-TTBCCEEEEEE
T ss_pred ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEE
Confidence 345677778999999999999999999999999999999986543 223467889999888875 67777888888
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
.....++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~ 162 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGL 162 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSS
T ss_pred ECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccc
Confidence 888999999999 8899999874 5679999999999999999999999999999999999999 5788999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
+....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+... ...+..+...
T Consensus 163 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~ 231 (476)
T 2y94_A 163 SNMMSDGE--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKICDG 231 (476)
T ss_dssp CEECCTTC--------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHHTT
T ss_pred hhhccccc--------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhcC
Confidence 98654321 1235679999999999998775 7899999999999999999999986543 3344445444
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
....| ..+++++.+||..||+.||++||++.+|+ ++.+..
T Consensus 232 ~~~~p-----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil---~hp~~~ 271 (476)
T 2y94_A 232 IFYTP-----QYLNPSVISLLKHMLQVDPMKRATIKDIR---EHEWFK 271 (476)
T ss_dssp CCCCC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHH---TCHHHH
T ss_pred CcCCC-----ccCCHHHHHHHHHHcCCCchhCcCHHHHH---hCHHhh
Confidence 44333 34589999999999999999999999654 444443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.83 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=210.4
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---------------CCchhHHHHHHHHHHhCCCCCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---------------KHPQLHYESKLYMLLQGGTGIP 74 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---------------~~~~~~~E~~~l~~l~~~~~i~ 74 (468)
...+.++|+++++||+|+||.||+|.+..++..||||++.... ....+..|+.++..+.| ++|+
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv 109 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH-PNII 109 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC-TTBC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC-CCCC
Confidence 3456789999999999999999999999999999999865432 23457889999998865 6788
Q ss_pred eeeEeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 75 HLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 75 ~l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
.++.++......++||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...+....+
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence 8888888999999999999 7799998875 4579999999999999999999999999999999999999633333479
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 233 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~ 233 (468)
||+|||++..+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... .+.+
T Consensus 189 kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~ 256 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--------KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDII 256 (504)
T ss_dssp EECCCTTCEECCTTS--------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH
T ss_pred EEEECCCCEEcCCCC--------ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHH
Confidence 999999998664321 1235679999999999874 699999999999999999999999987543 3445
Q ss_pred HHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 234 DKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 234 ~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+.......+.+ ....+++++.+||..||..||.+||++.++ |++.+..
T Consensus 257 ~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~---l~h~~~~ 306 (504)
T 3q5i_A 257 KKVEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEA---LNSRWIK 306 (504)
T ss_dssp HHHHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred HHHHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHH---hcCHhhh
Confidence 5555555544433 345789999999999999999999999865 4455443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=346.98 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=197.1
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----------CCchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----------KHPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
.+.++|.+.++||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.+..++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCC-TTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCC-CCEeeEEEEEe
Confidence 45689999999999999999999999999999999865432 12357899999999976 56666666654
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
.+..++|||++ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+...+.+..+||+|||+
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred -cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 44578999999 7899888763 56799999999999999999999999999999999999996544566799999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ ..+.
T Consensus 289 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--~~i~ 358 (419)
T 3i6u_A 289 SKILGETS--------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--DQIT 358 (419)
T ss_dssp TTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH--HHHH
T ss_pred ceecCCCc--------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH--HHHh
Confidence 98654321 1245689999999999864 568889999999999999999999998754432221 2233
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..... ..+.....+++++.+||..||+.||++||++.++++
T Consensus 359 ~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 SGKYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TTCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCC-CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 33333 334455678999999999999999999999986543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.69 Aligned_cols=257 Identities=21% Similarity=0.368 Sum_probs=203.1
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++-.++|++.++||+|+||.||+|.+.. +..||||++.... ....+..|+.++..+.| ++|+.+++++.+ +..++|
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECS-SSCEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEcC-CceEEE
Confidence 4566889999999999999999999764 4679999876543 23568899999999976 555566666544 667899
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||++ +++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCC
Confidence 9999 78999999743 4569999999999999999999999999999999999999 47789999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
. +.......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.... +.+..+ ......+.+
T Consensus 334 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i-~~~~~~~~~ 403 (452)
T 1fmk_A 334 E------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV-ERGYRMPCP 403 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH-HTTCCCCCC
T ss_pred c------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-HcCCCCCCC
Confidence 1 122334567889999999999999999999999999999999 99999876543 223222 222333322
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+|+++.++|..||+.+|++||++.+|.+.|++++.
T Consensus 404 ---~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 404 ---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 3569999999999999999999999999999988764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.29 Aligned_cols=255 Identities=18% Similarity=0.286 Sum_probs=200.9
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEe--CceeE
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVE--GDYNI 87 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~~~ 87 (468)
.-...++|+++++||+|+||.||+|.+..+++.||||++.. .....+..|+.++..+.+|++|+.+..++.. ....+
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 34456899999999999999999999999999999998653 3456789999999999988888888888776 66789
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
++|+++ +++|.+++. .+++..+..++.||+.||+|||++||+||||||+|||+. .+...+||+|||+++.+..
T Consensus 110 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCC
Confidence 999998 688888875 489999999999999999999999999999999999995 2344899999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc-HHHHH----------H
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKY----------D 234 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~-~~~~~----------~ 234 (468)
... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+ .
T Consensus 184 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 184 GQE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TCC--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCc--------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 221 234578999999999987 568999999999999999999999996533211 11110 0
Q ss_pred HHhhcccCCCHH-------------------HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 235 KISEKKVSTPIE-------------------VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 235 ~i~~~~~~~~~~-------------------~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+.......+.. .....+++++.+||..||+.||++||++.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011111111100 011236899999999999999999999986543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.59 Aligned_cols=269 Identities=20% Similarity=0.251 Sum_probs=209.7
Q ss_pred CCCcee-cCceEEEceEeeeCCeEEEEEE----EcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 8 RMDHVI-GGKFKLGRKIGSGSFGELYLGV----NVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 8 ~~~~ii-~~~y~i~~~LG~G~fG~Vy~~~----~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
++.+++ .++|+++++||+|+||.||+|. +..++..||||++..... ...+..|++++..+.| ++|+.+..++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~ 93 (327)
T 3lxl_A 15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFIVKYRGVS 93 (327)
T ss_dssp --CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEE
T ss_pred ChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCC-CceeEEEEEE
Confidence 455555 4899999999999999999998 456889999998654432 2347889999998865 5666666554
Q ss_pred E--eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEe
Q 012192 81 V--EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 81 ~--~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
. .....++|||++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~D 170 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIAD 170 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECC
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcc
Confidence 4 566789999999 899999998766679999999999999999999999999999999999999 4788999999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc----------
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------- 227 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~---------- 227 (468)
||++......... ........||..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 171 fg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 246 (327)
T 3lxl_A 171 FGLAKLLPLDKDY----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246 (327)
T ss_dssp GGGCEECCTTCSE----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----
T ss_pred cccceecccCCcc----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccc
Confidence 9999876432211 11234457889999999999988999999999999999999999999753211
Q ss_pred -cHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 228 -TKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 228 -~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.....+..........+. ...+++++.+||..||+.||++||++.+|++.|+.++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 247 VPALSRLLELLEEGQRLPA---PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp CCHHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred cccHHHHHHHhhcccCCCC---CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 011111112222222221 245689999999999999999999999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=332.32 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=192.3
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC------
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG------ 83 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~------ 83 (468)
+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|++++..+.| ++|+.++.++.+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-PGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCC-TTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCC-CCEeeEEEEEEEeccchhh
Confidence 34689999999999999999999999999999998764432 2467889999999976 5555555544332
Q ss_pred ---------------------------------------------------ceeEEEEecc-CCCHHHHHHHcC--CCCC
Q 012192 84 ---------------------------------------------------DYNIMVIDLL-GPSLEDLFNYCN--RKFS 109 (468)
Q Consensus 84 ---------------------------------------------------~~~~lv~el~-ggsL~~ll~~~~--~~ls 109 (468)
.+.+++||++ +++|.+++.... ....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 2479999999 779999998532 2356
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc-----cccCCCCcccc
Q 012192 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI-----PYRENKNLTGT 184 (468)
Q Consensus 110 ~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-----~~~~~~~~~Gt 184 (468)
+..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........... .+.......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 67789999999999999999999999999999999 47889999999999876543211100 11223456799
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHh
Q 012192 185 ARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCR 264 (468)
Q Consensus 185 ~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl 264 (468)
+.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+... .. +.....+++++.++|..||
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~--~~--~~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNL--KF--PLLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTT--CC--CHHHHHHCHHHHHHHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhcc--CC--CcccccCChhHHHHHHHHc
Confidence 999999999999999999999999999999998776532 11222222222 12 2223344788899999999
Q ss_pred cCCCCCCCCHHHHHH
Q 012192 265 SLRFEDKPDYSYLKR 279 (468)
Q Consensus 265 ~~~p~~RPs~~~l~~ 279 (468)
+.||++||++.+|++
T Consensus 311 ~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 311 SPSPTERPEATDIIE 325 (332)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCCCCcCCCHHHHhh
Confidence 999999999997654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=329.96 Aligned_cols=262 Identities=19% Similarity=0.286 Sum_probs=204.7
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhC-CCCCceeeEeeE
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQG-GTGIPHLKWFGV 81 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~-~~~i~~l~~~~~ 81 (468)
+....+.+++|++++.||+|+||.||+|.+. +++.||||++...... ..+..|+.++..+.+ +++|..+..++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 4455667788999999999999999999874 5889999987654332 457889999999986 788999999989
Q ss_pred eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 82 EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 82 ~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
.....+++||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+. ++.+||+|||++
T Consensus 99 ~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~ 173 (313)
T 3cek_A 99 TDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIA 173 (313)
T ss_dssp CSSEEEEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSS
T ss_pred cCCEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecccc
Confidence 9999999999889999999985 56799999999999999999999999999999999999993 589999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHH
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-----------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 230 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----------~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~ 230 (468)
..+...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ..
T Consensus 174 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~ 246 (313)
T 3cek_A 174 NQMQPDTTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QI 246 (313)
T ss_dssp CC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HH
T ss_pred ccccCcccc-----ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HH
Confidence 865432211 11234579999999999876 4688899999999999999999999986543 22
Q ss_pred HHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 231 QKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 231 ~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+..+......... ....++++.++|..||+.||++||++.+| |++.+..
T Consensus 247 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~el---l~h~~~~ 297 (313)
T 3cek_A 247 SKLHAIIDPNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 297 (313)
T ss_dssp HHHHHHHCTTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred HHHHHHHhcccccCC---cccchHHHHHHHHHHccCCcccCcCHHHH---hcCcccc
Confidence 223333333222221 23448899999999999999999999865 4444443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=327.68 Aligned_cols=252 Identities=19% Similarity=0.273 Sum_probs=197.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
+-.++|++.+.||+|+||.||+|.+ .+..||||++........+..|++++..+.| ++|+.+++++. +..++|||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~--~~~~lv~e 79 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH-PNIVKLYGACL--NPVCLVME 79 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCC-TTBCCEEEBCT--TTTEEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCC-CCcCeEEEEEc--CCcEEEEE
Confidence 4457999999999999999999987 5789999987665556678899999999976 55666655544 44789999
Q ss_pred cc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCceeecccCCCC-eEEEEeCCccccc
Q 012192 92 LL-GPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHS---RGFLHRDIKPDNFLMGLGRKAN-QVYIIDYGLAKKY 164 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~--~ls~~~~~~ia~qia~gL~yLHs---~giiHrDIKp~NiLl~~~~~~~-~vkL~DFGla~~~ 164 (468)
++ +++|.+++..... .+++..++.++.|++.||+|||+ +||+||||||+|||+. .++ .+||+|||++...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACDI 156 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC----
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccccccccc
Confidence 99 7899999985332 47899999999999999999999 8999999999999995 444 5899999999754
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ......+... ...
T Consensus 157 ~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~-~~~- 223 (307)
T 2eva_A 157 QTH----------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNG-TRP- 223 (307)
T ss_dssp ------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-HHHHHHHHTT-CCC-
T ss_pred ccc----------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-HHHHHHHhcC-CCC-
Confidence 321 123468999999999999999999999999999999999999998654322 2222122221 111
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.....+|+++.++|..||+.+|++||++.+|++.|+.+..
T Consensus 224 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 --PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp --CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred --CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2235679999999999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=338.01 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=204.0
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-------CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-------TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
+.++|++.+.||+|+||.||+|.+..++..||||++... .....+..|++++..+.| ++|+.+..++.+.+.
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH-PNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC-CCcceeehhhccCCe
Confidence 457899999999999999999999999999999986532 223468889999999975 777788888888999
Q ss_pred eEEEEecc-CCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 012192 86 NIMVIDLL-GPSLEDLFNYC---------------------------------------NRKFSLKTVLMLADQLINRVE 125 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~---------------------------------------~~~ls~~~~~~ia~qia~gL~ 125 (468)
.++|||++ +++|.+++... ...+++..+..++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999 89999988411 112357788899999999999
Q ss_pred HHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccC--CCCCCcch
Q 012192 126 YMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDD 203 (468)
Q Consensus 126 yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~s~ksD 203 (468)
|||++||+||||||+|||+.. +....+||+|||++..+....... +.......||+.|+|||++.+ ..++.++|
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999941 122389999999998764422211 112345679999999999975 67899999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 204 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 204 vwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
||||||++|+|++|..||.+... .+.+..+.......+.+ ....+++++.+||..||+.+|++||++.++ |++
T Consensus 259 iwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~---l~h 331 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKLCFENP-NYNVLSPLARDLLSNLLNRNVDERFDAMRA---LQH 331 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCTTSG-GGGGSCHHHHHHHHHHSCSCTTTSCCHHHH---HHS
T ss_pred HHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcccccCCc-ccccCCHHHHHHHHHHcCCChhHCCCHHHH---hcC
Confidence 99999999999999999987543 33344444444433322 234578999999999999999999999865 555
Q ss_pred HHHH
Q 012192 284 LFIR 287 (468)
Q Consensus 284 ~~~~ 287 (468)
.+..
T Consensus 332 p~~~ 335 (345)
T 3hko_A 332 PWIS 335 (345)
T ss_dssp HHHH
T ss_pred hhhc
Confidence 5543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=339.98 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=195.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEee-----------
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFG----------- 80 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~----------- 80 (468)
+..++|++++.||+|+||.||+|.+..+++.||||++.... ....+|++++..+.|+ +|+.+..++
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHV-NIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCT-TBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCC-CccchhheeeecCccccccc
Confidence 45689999999999999999999999999999999865443 3345799999888765 455554443
Q ss_pred ---------------------------EeCceeEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 012192 81 ---------------------------VEGDYNIMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSR 130 (468)
Q Consensus 81 ---------------------------~~~~~~~lv~el~ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~ 130 (468)
....+.++||||+.++|.+++.. .+..+++..+..++.||+.||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 23345889999999998888763 356799999999999999999999999
Q ss_pred CceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHH
Q 012192 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGY 209 (468)
Q Consensus 131 giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGv 209 (468)
||+||||||+|||+. ..++.+||+|||+++.+..... .....||..|+|||++.+.. ++.++|||||||
T Consensus 161 gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 161 GICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp TEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred cCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999999999994 2578999999999986543221 23557899999999998765 899999999999
Q ss_pred HHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC------------------------HHHhhccCcHHHHHHHHHHhc
Q 012192 210 VLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP------------------------IEVLCKSYPSEFVSYFHYCRS 265 (468)
Q Consensus 210 vl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~------------------------~~~l~~~~p~~~~~li~~cl~ 265 (468)
++|+|++|..||.+...... +..+....-..+ ...+...+|+++.+||..||+
T Consensus 231 il~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 99999999999987544322 222221111110 111234578999999999999
Q ss_pred CCCCCCCCHHHHHH
Q 012192 266 LRFEDKPDYSYLKR 279 (468)
Q Consensus 266 ~~p~~RPs~~~l~~ 279 (468)
.||++||++.++++
T Consensus 308 ~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 308 YEPDLRINPYEAMA 321 (383)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999997643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=327.20 Aligned_cols=258 Identities=19% Similarity=0.321 Sum_probs=204.3
Q ss_pred ecCceEEEc-eEeeeCCeEEEEEEE--cCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 13 IGGKFKLGR-KIGSGSFGELYLGVN--VQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 13 i~~~y~i~~-~LG~G~fG~Vy~~~~--~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
-.++|++.+ .||+|+||.||+|.+ ..++..||||+...... ...+..|+.++..+.| ++|+.+..++ ..+.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEE-CCCC
Confidence 357899999 999999999999954 45678999998655432 2457889999998875 5666666666 5666
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++|||++ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+. .++.++|+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcceee
Confidence 78999998 6899999985 56799999999999999999999999999999999999994 7789999999999865
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
...... +.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.... +....+... ...
T Consensus 168 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~-~~~ 239 (291)
T 1xbb_A 168 RADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEKG-ERM 239 (291)
T ss_dssp CTTCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTT-CCC
T ss_pred ccCCCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcC-CCC
Confidence 432211 111233457789999999998889999999999999999999 99999875442 222222222 111
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
. ....+|+++.++|..||+.||++||++.+|.+.|++++..
T Consensus 240 ~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 240 G---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp C---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 2245699999999999999999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=324.35 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=204.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.+..++|++++.||+|+||.||+|.+..++..||||+.... .....+..|+.++..+.| ++|+.+..++.+...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATR 83 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC-CCCcchhheEecCCE
Confidence 34557899999999999999999999999999999986432 223457788999888875 677788888888899
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.+++||++ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccC
Confidence 99999999 6799999875 4579999999999999999999999999999999999999 57889999999998654
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ...+..+.......+
T Consensus 160 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~ 227 (279)
T 3fdn_A 160 PSS---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISRVEFTFP 227 (279)
T ss_dssp -----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCCCC
T ss_pred Ccc---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHHHHHhCCCCCC
Confidence 321 12345789999999999999999999999999999999999999986433 333334444333333
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+++++.+||..||+.+|++||++.+|+ ++.+..
T Consensus 228 -----~~~~~~~~~li~~~l~~~p~~Rps~~e~l---~h~~~~ 262 (279)
T 3fdn_A 228 -----DFVTEGARDLISRLLKHNPSQRPMLREVL---EHPWIT 262 (279)
T ss_dssp -----TTSCHHHHHHHHHHCCSSGGGSCCHHHHH---HCHHHH
T ss_pred -----CcCCHHHHHHHHHHhccChhhCCCHHHHh---hCcccc
Confidence 34589999999999999999999998654 455543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=324.93 Aligned_cols=259 Identities=17% Similarity=0.261 Sum_probs=202.1
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCc---EEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeE-eCceeEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGE---EIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGV-EGDYNIM 88 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~---~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~-~~~~~~l 88 (468)
.|.+.++||+|+||.||+|.+..++. .||||+....... ..+..|+.++..+.| ++|+.+..++. .....++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH-PNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCC-TTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEecCCCCcEE
Confidence 57778999999999999999765544 7999986543332 357789999988876 55555555554 4444588
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+|+++ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCC
Confidence 88887 899999998667789999999999999999999999999999999999999 57889999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCC-CCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
.. ..........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |........... +.... ..+.
T Consensus 178 ~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~---~~~~~-~~~~- 249 (298)
T 3pls_A 178 EY---YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---LAQGR-RLPQ- 249 (298)
T ss_dssp GG---GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH---HHTTC-CCCC-
T ss_pred cc---cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH---hhcCC-CCCC-
Confidence 21 111223456789999999999999999999999999999999995555 544333222222 22221 1221
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
...+++++.++|..||+.+|.+||++.+|++.|+.++...
T Consensus 250 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 250 --PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 2346899999999999999999999999999999998764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.63 Aligned_cols=256 Identities=21% Similarity=0.235 Sum_probs=195.0
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEe-----Cce
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVE-----GDY 85 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-----~~~ 85 (468)
.....+|++++.||+|+||.||+|.+..+++.||||++.... ....+|++++..+.|++++..+..+... ..+
T Consensus 50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 344568999999999999999999999999999999865432 3345799999999875554444443322 224
Q ss_pred eEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 86 NIMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
.++||||+.++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||+. .+.+.+||+|||+++
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhh
Confidence 678999999888887653 356799999999999999999999999999999999999994 245678999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc--
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-- 239 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 239 (468)
.+.... ......||+.|+|||++.+. .++.++|||||||+||||++|..||.+.........+.+....
T Consensus 206 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 206 QLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp ECCTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred hcccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 654321 12356789999999999875 6999999999999999999999999875432222222111000
Q ss_pred ------------ccCC------C-HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 ------------KVST------P-IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 ------------~~~~------~-~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+.. + ...+...+++++.+||.+||..||++||++.+++
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 0000 0 0112245689999999999999999999998653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.78 Aligned_cols=266 Identities=18% Similarity=0.209 Sum_probs=203.3
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC-
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG- 83 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~- 83 (468)
.+...+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++|+.+..++...
T Consensus 4 ~~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH-ENIITIFNIQRPDS 82 (353)
T ss_dssp TCCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSC
T ss_pred ccccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcC-CCcCCeeeeecccc
Confidence 3556678999999999999999999999999999999998754332 2346789999999876 5565665554432
Q ss_pred ----ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 84 ----DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 84 ----~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
...+++||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 83 ~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg 157 (353)
T 2b9h_A 83 FENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFG 157 (353)
T ss_dssp STTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCT
T ss_pred cCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEecc
Confidence 67899999999999999884 579999999999999999999999999999999999999 478899999999
Q ss_pred cccccccccCccccc---ccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 160 LAKKYRDLQTHKHIP---YRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 160 la~~~~~~~~~~~~~---~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
++............+ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 998765322111100 011234578999999998875 6789999999999999999999999987543222221111
Q ss_pred Hhhc------------------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 236 ISEK------------------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 236 i~~~------------------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+... ....+.......+++++.+||..||+.||++||++.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1110 0112233445678999999999999999999999986543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=351.68 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=205.3
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
+.++|+++++||+|+||.||+|.+..++..||||++... .....+..|+.++..+.| ++|+.++.++......++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH-PNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 445899999999999999999999999999999986543 234568889999988865 677778888888899999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++..+...
T Consensus 114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999 7899988875 457999999999999999999999999999999999999964445677999999999876532
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+... .+.+..+.......+.+
T Consensus 193 ~--------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~- 259 (494)
T 3lij_A 193 K--------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKGKYTFDSP- 259 (494)
T ss_dssp B--------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCCSG-
T ss_pred c--------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCch-
Confidence 2 123567999999999876 4699999999999999999999999987543 34444454444443322
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+++++.+||..||+.+|.+||++.++++
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 33567999999999999999999999997654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=338.33 Aligned_cols=256 Identities=18% Similarity=0.266 Sum_probs=205.5
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
..++++..++|++.++||+|+||.||+|.+..++..||||+...... ...+..|+.++..+.| ++|+.+..++...
T Consensus 25 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSD 103 (360)
T ss_dssp HTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEET
T ss_pred hcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCC-CCEEEEeEEEEEC
Confidence 35788899999999999999999999999999999999998765432 2357788888888864 7777788888889
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
+..++|||++ +++|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||+ +.++.++|+|||++
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVS 179 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCC
T ss_pred CEEEEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCC
Confidence 9999999999 7799999985 45799999999999999999999996 99999999999999 57889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH---------
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK--------- 232 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~--------- 232 (468)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 180 ~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (360)
T 3eqc_A 180 GQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250 (360)
T ss_dssp HHHHHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred ccccccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence 7654321 2345799999999999999999999999999999999999999986443221111
Q ss_pred ------------------------------HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 233 ------------------------------YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 233 ------------------------------~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...+....... .....++.++.+||..||+.||++||++.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------------------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11111111100 011246889999999999999999999996543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=324.78 Aligned_cols=259 Identities=21% Similarity=0.374 Sum_probs=208.4
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
.+..++|++++.||+|+||.||+|.+. ++..||||++.... ....+..|++++..+.| ++|..+..+.. .+..+++
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SSSCEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCC-cCcceEEEEEc-CCCcEEE
Confidence 455689999999999999999999964 56789999876543 34568899999999976 55556666554 4457899
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||++ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCc
Confidence 9998 88999998742 2369999999999999999999999999999999999999 47889999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
. +.......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.... +.+..+... ....
T Consensus 163 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~-~~~~-- 230 (279)
T 1qpc_A 163 E------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLERG-YRMV-- 230 (279)
T ss_dssp C------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTT-CCCC--
T ss_pred c------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHHhcc-cCCC--
Confidence 1 112334567889999999998889999999999999999999 99999875432 222222222 2221
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
....+|+++.++|..||+.+|++||++.+|.+.|++++...
T Consensus 231 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 22456899999999999999999999999999999998763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=337.08 Aligned_cols=258 Identities=18% Similarity=0.258 Sum_probs=207.4
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----------CCchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----------KHPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.+..++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH-ANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEee
Confidence 4578999999999999999999999999999999866543 33467889999999865 677778888888
Q ss_pred CceeEEEEecc-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 83 GDYNIMVIDLL-GP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 83 ~~~~~lv~el~-gg-sL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
....++||+++ ++ +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence 89999999987 44 99999884 5579999999999999999999999999999999999999 4788999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
+........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ....
T Consensus 177 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~ 239 (335)
T 3dls_A 177 AAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEA 239 (335)
T ss_dssp CEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTTT
T ss_pred ceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHhh
Confidence 986543221 234579999999999998886 8899999999999999999999976322 1122
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVL 301 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 301 (468)
....+ ..+++++.+||..||+.||++||++.+| |++.+..... ....++|+..
T Consensus 240 ~~~~~-----~~~~~~l~~li~~~L~~dP~~Rps~~el---l~hp~~~~~~-~~~~~~~~~~ 292 (335)
T 3dls_A 240 AIHPP-----YLVSKELMSLVSGLLQPVPERRTTLEKL---VTDPWVTQPV-NLADYTWEEV 292 (335)
T ss_dssp CCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHH---HHCTTTTCCC-CGGGCCHHHH
T ss_pred ccCCC-----cccCHHHHHHHHHHccCChhhCcCHHHH---hcCccccCCc-cccccCHHHH
Confidence 22222 2358999999999999999999999865 4444433211 1234556554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=341.36 Aligned_cols=251 Identities=18% Similarity=0.252 Sum_probs=183.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEe-----
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVE----- 82 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~----- 82 (468)
.+.++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|++++..+.| ++|+.+..++..
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-ENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEecCCccc
Confidence 356899999999999999999999999999999998654322 2356789999999986 455555554433
Q ss_pred -CceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 -GDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 -~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
....+++|++++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 105 ~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a 179 (367)
T 2fst_X 105 EFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA 179 (367)
T ss_dssp GCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC----
T ss_pred cCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccc
Confidence 255799999999999999873 679999999999999999999999999999999999999 57889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh--
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE-- 238 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~-- 238 (468)
+..... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 180 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 180 RHTADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cccccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 864421 234679999999999987 6789999999999999999999999987554322222211110
Q ss_pred ---------------------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 239 ---------------------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 239 ---------------------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.....+.......+++++.+||.+||..||++||++.+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 0111223344556789999999999999999999998543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.64 Aligned_cols=259 Identities=19% Similarity=0.235 Sum_probs=205.6
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcC---CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQ---TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~---~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
.+..++|++.+.||+|+||.||+|.+.. ++..||||+...... ...+..|+.++..+.| ++|+.+..+..+ +
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH-PHIVKLIGIIEE-E 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCC-TTBCCEEEEECS-S
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCC-CCcceEEEEEcC-C
Confidence 4566899999999999999999998654 345699998654422 3467889999999976 556666666544 4
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..+++|+++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+. .++.++|+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCcc
Confidence 457888888 6899999987677799999999999999999999999999999999999994 678999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+ ... ..
T Consensus 163 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---~~~-~~ 232 (281)
T 3cc6_A 163 IEDEDY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---EKG-DR 232 (281)
T ss_dssp C---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---HHT-CC
T ss_pred cccccc------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---hcC-CC
Confidence 543221 11234567889999999998899999999999999999998 99999876554433322 221 11
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.+.+ ..+++.+.++|..||..+|++||++.+|++.|++++..
T Consensus 233 ~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 LPKP---DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 2212 34589999999999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=340.62 Aligned_cols=253 Identities=19% Similarity=0.218 Sum_probs=202.6
Q ss_pred ecCceEE--EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 13 IGGKFKL--GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 13 i~~~y~i--~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
+...|.+ .+.||+|+||.||+|.+..+++.||||++.... ....+..|++++..+.| ++|+.+..++...+..++
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-ANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEE
Confidence 3345665 678999999999999999999999999876543 23467889999988865 677778888888899999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+++.+...
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCc
Confidence 99999 78999988765667999999999999999999999999999999999999842 24678999999999876432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+.......+. .
T Consensus 243 ~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~-~ 310 (373)
T 2x4f_A 243 E--------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNILACRWDLED-E 310 (373)
T ss_dssp C--------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCCSCS-G
T ss_pred c--------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCCh-h
Confidence 2 12345799999999999988899999999999999999999999987543 3444445444443332 2
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+++++.+||..||+.||.+||++.++++
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 34567999999999999999999999997654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=324.05 Aligned_cols=251 Identities=18% Similarity=0.187 Sum_probs=208.3
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----------CchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----------HPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.+|++|+.+..++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45899999999999999999999999999999998754431 2346789999999987888999999989
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
.....++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+|+||||+|||+ +.++.++|+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence 999999999999 6899999985 4579999999999999999999999999999999999999 4788999999999
Q ss_pred ccccccccCcccccccCCCCcccccccccccccc------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL------GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~------~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 234 (468)
+....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.+... .....
T Consensus 171 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~ 239 (298)
T 1phk_A 171 SCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLR 239 (298)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH
T ss_pred hhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHH
Confidence 97654321 123457899999999986 45688999999999999999999999986433 33333
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+.......+.+ ....+++++.++|..||+.||++||++.+|++
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCcccCcc-cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 344444333322 23467999999999999999999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=330.62 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=210.4
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
+....++|.+++.||+|+||.||+|.+..+++.||+|+...... ...+..|+.++..+.| ++|+.+..++.+.+
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDND 114 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSS
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEecCC
Confidence 34456799999999999999999999999999999998665422 2357788988888865 67777888888889
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..+++||++ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCcee
Confidence 999999999 6899998875 4679999999999999999999999999999999999999 4788999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.+..+.......
T Consensus 191 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~ 260 (335)
T 2owb_A 191 VEYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKNEYSI 260 (335)
T ss_dssp CCSTTC-------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCCC
T ss_pred cccCcc-------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHhcCCCCC
Confidence 543211 12356799999999999999999999999999999999999999986432 33333444443333
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 289 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~ 289 (468)
+ ..+++++.+||..||+.||++||++.+| |++.+...+
T Consensus 261 ~-----~~~~~~~~~li~~~l~~dp~~Rps~~el---l~~~~~~~~ 298 (335)
T 2owb_A 261 P-----KHINPVAASLIQKMLQTDPTARPTINEL---LNDEFFTSG 298 (335)
T ss_dssp C-----TTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHHTS
T ss_pred C-----ccCCHHHHHHHHHHccCChhHCcCHHHH---hcCccccCC
Confidence 3 3468999999999999999999999865 445555443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=326.97 Aligned_cols=265 Identities=19% Similarity=0.297 Sum_probs=200.2
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcC---CCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEe
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQ---TGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWF 79 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~---~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~ 79 (468)
+.--.+..++|.+++.||+|+||.||+|.+.. ++..||||++...... ..+..|+.++..+.| ++|..+..+
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~ 104 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH-PNVIRLLGV 104 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCC-TTBCCCCEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCC-CCeeeeeEE
Confidence 44445667899999999999999999998765 5568999986644332 357789999988876 556666555
Q ss_pred eEeCc-----eeEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC
Q 012192 80 GVEGD-----YNIMVIDLL-GPSLEDLFNYC-----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR 148 (468)
Q Consensus 80 ~~~~~-----~~~lv~el~-ggsL~~ll~~~-----~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~ 148 (468)
+.... ..+++|+++ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---R 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---C
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---c
Confidence 54433 358999998 77999998532 3569999999999999999999999999999999999999 4
Q ss_pred CCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcc
Q 012192 149 KANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 227 (468)
Q Consensus 149 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~ 227 (468)
.++.+||+|||++........ +.......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp TTSCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCcEEEeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 778999999999986543221 112334567889999999999999999999999999999999 99999876554
Q ss_pred cHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 228 TKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 228 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..... +..... .. ....+++++.++|..||..+|++||++.+|++.|+.++..
T Consensus 257 ~~~~~---~~~~~~-~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 257 EMYDY---LLHGHR-LK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp GHHHH---HHTTCC-CC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH---HHcCCC-CC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 33322 222211 11 2245689999999999999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=335.38 Aligned_cols=275 Identities=22% Similarity=0.271 Sum_probs=213.8
Q ss_pred CCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHH-hCCCCCceeeEeeEeC
Q 012192 5 GKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLL-QGGTGIPHLKWFGVEG 83 (468)
Q Consensus 5 ~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l-~~~~~i~~l~~~~~~~ 83 (468)
.++.++..+.++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|.+++..+ ..|++|+.+..++...
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 34556777889999999999999999999987 6899999986543 345677888888774 3557777777776665
Q ss_pred c----eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCceeecccCCC
Q 012192 84 D----YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH--------SRGFLHRDIKPDNFLMGLGRKA 150 (468)
Q Consensus 84 ~----~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLH--------s~giiHrDIKp~NiLl~~~~~~ 150 (468)
. ..+++||++ +++|.+++.. ..+++..++.++.|++.||+||| +++|+||||||+|||+ +.+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~ 183 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKN 183 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTT
T ss_pred CCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCC
Confidence 4 789999999 6699999974 47999999999999999999999 8999999999999999 578
Q ss_pred CeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCC------CCCcchHHHHHHHHHHHHcC-------
Q 012192 151 NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE------QSRRDDLESLGYVLMYFLRG------- 217 (468)
Q Consensus 151 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~------~s~ksDvwSlGvvl~elltG------- 217 (468)
+.+||+|||++........... .......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEE---ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCEEEEECCCceeccccccccc---cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 8999999999987654322110 1234567999999999998763 33689999999999999999
Q ss_pred ---CCCCCCCCcc--cHHHHHHHHhhcccCCCHHH--hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012192 218 ---SLPWQGLKAG--TKKQKYDKISEKKVSTPIEV--LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGF 290 (468)
Q Consensus 218 ---~~Pf~~~~~~--~~~~~~~~i~~~~~~~~~~~--l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~ 290 (468)
..||...... ........+.........+. ....+++.+.++|..||+.||++||++.+|++.|+.+....+.
T Consensus 261 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred cccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 8899765432 22233333333333322221 1233467899999999999999999999999999998876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.70 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=183.2
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
+..+ ++|++.+.||+|+||.||+|.+..+++.||||+..... ....+..|+.++..+.| ++|+.+..++...+
T Consensus 7 g~~~-~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 7 GEKI-EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH-PSILELYNYFEDSN 84 (278)
T ss_dssp CSSG-GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCC-TTBCCEEEEEECSS
T ss_pred cccc-ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCC-CCeEeEEEEEccCC
Confidence 4444 57999999999999999999999999999999865432 22467889999888865 67777888888889
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..+++||++ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceee
Confidence 999999999 779999998656789999999999999999999999999999999999999 5788999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .+..+.......
T Consensus 162 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~ 231 (278)
T 3cok_A 162 LKMPHE-------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADYEM 231 (278)
T ss_dssp CC-----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCCCC
T ss_pred ccCCCC-------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhcccCC
Confidence 543211 1234578999999999999899999999999999999999999998654322 222222222222
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...++.++.++|..||+.||++||++.+|++
T Consensus 232 -----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 -----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2346899999999999999999999986543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.17 Aligned_cols=257 Identities=22% Similarity=0.290 Sum_probs=210.3
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
++....++|++++.||+|+||.||+|.+..+++.||+|+...... ...+..|+.++..+.| ++|+.+..++...
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~ 87 (294)
T 2rku_A 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDN 87 (294)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECS
T ss_pred eCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCC-CCEeeeeeeeccC
Confidence 345667899999999999999999999999999999998655432 2356778888888855 6777788888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+..+++||++ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLAT 163 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCce
Confidence 9999999999 6899998875 4579999999999999999999999999999999999999 578899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+.+..+......
T Consensus 164 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~ 233 (294)
T 2rku_A 164 KVEYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKNEYS 233 (294)
T ss_dssp ECCSTTC-------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCC
T ss_pred ecccCcc-------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhhccCC
Confidence 6543211 12346789999999999998999999999999999999999999986432 3333334443333
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
.+ ..+++++.++|..||+.||++||++.+|+ ++.+...
T Consensus 234 ~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll---~~~~~~~ 271 (294)
T 2rku_A 234 IP-----KHINPVAASLIQKMLQTDPTARPTINELL---NDEFFTS 271 (294)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGG---GSHHHHT
T ss_pred Cc-----cccCHHHHHHHHHHcccChhhCcCHHHHh---hChheec
Confidence 32 35689999999999999999999998654 4444443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=335.15 Aligned_cols=255 Identities=18% Similarity=0.233 Sum_probs=191.5
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCc---
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGD--- 84 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~--- 84 (468)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+.| ++|+.+..++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCC-CCccceEEeeccccccc
Confidence 4568999999999999999999999999999999987654322 356789999988876 55556655554433
Q ss_pred ---eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 85 ---YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 85 ---~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
..++|||++.++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 101 EFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 174 (371)
T ss_dssp TCCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC-
T ss_pred cccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeecc
Confidence 789999999999998886 369999999999999999999999999999999999999 57889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+.....
T Consensus 175 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~ 243 (371)
T 2xrw_A 175 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLG 243 (371)
T ss_dssp -----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CC
T ss_pred ccccccc--------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhC
Confidence 7654321 123467999999999999999999999999999999999999999875432 22322322111
Q ss_pred CCCHH-------------------------Hh------------hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 242 STPIE-------------------------VL------------CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 242 ~~~~~-------------------------~l------------~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
....+ .+ ....++++.+||..||..||++||++.+ +|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e---~l~hp 320 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE---ALQHP 320 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHH---HHHSH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHH---HhCCc
Confidence 11000 00 0112578999999999999999999985 45566
Q ss_pred HHH
Q 012192 285 FIR 287 (468)
Q Consensus 285 ~~~ 287 (468)
+..
T Consensus 321 ~~~ 323 (371)
T 2xrw_A 321 YIN 323 (371)
T ss_dssp HHH
T ss_pred chh
Confidence 554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=328.82 Aligned_cols=263 Identities=19% Similarity=0.246 Sum_probs=198.9
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEee------
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFG------ 80 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~------ 80 (468)
.+..++++|++++.||+|+||.||+|.+..+++.||||+...... ...+..|++++..+.|+ +|..+..+.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHD-NIVKVFEILGPSGSQ 83 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCT-TBCCEEEEECTTSCB
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCC-CeeEEEEeccccccc
Confidence 356788999999999999999999999999999999998654432 24578899999998765 455554433
Q ss_pred --------EeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCe
Q 012192 81 --------VEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ 152 (468)
Q Consensus 81 --------~~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~ 152 (468)
.+....++|||++.++|.+++. ...+++..+..++.|++.||+|||++||+||||||+|||+. ..++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~ 159 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLV 159 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTE
T ss_pred cccccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCe
Confidence 3456789999999999999987 46799999999999999999999999999999999999994 24679
Q ss_pred EEEEeCCcccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH
Q 012192 153 VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 231 (468)
Q Consensus 153 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~ 231 (468)
+||+|||+++......... .......+|..|+|||++.+ ..++.++||||||+++|+|++|..||.+......
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 233 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-- 233 (320)
T ss_dssp EEECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--
T ss_pred EEEccCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 9999999998654321111 11234567899999999876 6789999999999999999999999987543222
Q ss_pred HHHHHhhcc-------------------------cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 232 KYDKISEKK-------------------------VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 232 ~~~~i~~~~-------------------------~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
+..+.... ...+.......+++++.++|..||+.||++||++.++ |++.+.
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~ 309 (320)
T 2i6l_A 234 -MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA---LSHPYM 309 (320)
T ss_dssp -HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH---HTSHHH
T ss_pred -HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH---hCCccc
Confidence 22222111 1223344556789999999999999999999999865 444444
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=326.30 Aligned_cols=254 Identities=19% Similarity=0.321 Sum_probs=199.5
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-CCCchhHHHHHHHHHHhCCCCCceeeEeeEe------
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-TKHPQLHYESKLYMLLQGGTGIPHLKWFGVE------ 82 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------ 82 (468)
-....++|++++.||+|+||.||+|.+..+++.||||+.... .....+..|+.++..+.+|++|+.+..++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 344678999999999999999999999999999999986544 3456788999999999777888888777765
Q ss_pred CceeEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
....++|||++ +++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGV 175 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcC
Confidence 56789999999 56999999854 3579999999999999999999999999999999999999 4788999999999
Q ss_pred ccccccccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 235 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~ 235 (468)
+........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+.... ..+..
T Consensus 176 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~ 245 (326)
T 2x7f_A 176 SAQLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFL 245 (326)
T ss_dssp TC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH
T ss_pred ceecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHH
Confidence 876543211 123457999999999987 566899999999999999999999999865432 22222
Q ss_pred HhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 236 ISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 236 i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+....... .....+++++.++|..||..||++||++.+|++
T Consensus 246 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPRNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhcCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 22222111 123457899999999999999999999986544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=331.79 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=200.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----------CCchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----------KHPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|++++..+.| ++|+.+..++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~ 84 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFF 84 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCC-TTBCCEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCC-CCCceEeeEE
Confidence 456689999999999999999999999999999999865332 12357889999999966 5666666666
Q ss_pred EeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 81 VEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 81 ~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
.... .++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...+....+||+|||
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 5554 78999999 6799998874 5679999999999999999999999999999999999999643345569999999
Q ss_pred cccccccccCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 236 (468)
++........ .....||+.|+|||++. +..++.++|||||||++|+|++|..||.......... ..+
T Consensus 163 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~ 232 (322)
T 2ycf_A 163 HSKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--DQI 232 (322)
T ss_dssp TCEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH--HHH
T ss_pred cceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH--HHH
Confidence 9986543211 12356899999999974 4568999999999999999999999998654432211 122
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...... ..+.....+++++.++|..||..||++||++.++++
T Consensus 233 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccc-cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 233332 234455678999999999999999999999997653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=319.90 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=200.3
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEee
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFG 80 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~ 80 (468)
+..-+.+..++|++++.||+|+||.||+|.+..+++.||||+.... .....+..|+.++..+.| ++|+.+..++
T Consensus 2 s~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~ 80 (276)
T 2h6d_A 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-PHIIKLYQVI 80 (276)
T ss_dssp -----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEE
T ss_pred CcccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCC-CCEeEEEEEE
Confidence 4456778889999999999999999999999989999999986533 223467889999888875 6777777788
Q ss_pred EeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 81 VEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 81 ~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
......+++||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+|+||||+|||+ +.++.++|+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg 156 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFG 156 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecc
Confidence 8888999999999 7899999975 4579999999999999999999999999999999999999 478899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.. ....+..+..
T Consensus 157 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~ 225 (276)
T 2h6d_A 157 LSNMMSDGE--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRG 225 (276)
T ss_dssp GGGCCCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH
T ss_pred cccccCCCc--------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhc
Confidence 997654321 1234578999999999998775 689999999999999999999997643 2333434443
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.....+ ..++.++.++|..||+.||++||++.+|+ ++.+..
T Consensus 226 ~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l---~h~~~~ 266 (276)
T 2h6d_A 226 GVFYIP-----EYLNRSVATLLMHMLQVDPLKRATIKDIR---EHEWFK 266 (276)
T ss_dssp CCCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHH---HSHHHH
T ss_pred CcccCc-----hhcCHHHHHHHHHHccCChhhCCCHHHHH---hChhhc
Confidence 333222 34589999999999999999999999654 444443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=359.16 Aligned_cols=257 Identities=21% Similarity=0.366 Sum_probs=208.5
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++..++|++.++||+|+||.||+|.+.. +..||||++..... ...+..|++++..+.| ++|+.+++++.+ +..+||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECS-SSCEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEee-ccceEe
Confidence 4667899999999999999999999764 46799998765433 3578999999999986 455556665544 668899
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||++ +++|.+++... ...+++..++.|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+++.....
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCC
Confidence 9999 77999999743 4569999999999999999999999999999999999999 46789999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
. +.......+++.|+|||++.+..++.++|||||||+||||++ |..||.+.... +.+..+ ......+.+
T Consensus 417 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i-~~~~~~~~~ 486 (535)
T 2h8h_A 417 E------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV-ERGYRMPCP 486 (535)
T ss_dssp H------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHH-HTTCCCCCC
T ss_pred c------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-HcCCCCCCC
Confidence 1 122334567889999999999999999999999999999999 99999876543 223222 223333322
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+|+++.+||..||+.||++||++.+|++.|++++.
T Consensus 487 ---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 487 ---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 3569999999999999999999999999999988654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=320.55 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=205.6
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
...+..++|++.+.||+|+||.||+|.+..++..||||+.... .....+..|+.++..+.| ++|+.+..++...
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH-PNILRMYNYFHDR 86 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCC-CCEeeEEEEEEcC
Confidence 3445568999999999999999999999999999999986432 223467889999888865 6777778888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+..+++||++ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSV 162 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccc
Confidence 8999999999 6799999885 4579999999999999999999999999999999999999 478899999999986
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+......
T Consensus 163 ~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~ 230 (284)
T 2vgo_A 163 HAPSL---------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETHRRIVNVDLK 230 (284)
T ss_dssp ECSSS---------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCC
T ss_pred cCccc---------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHHHHHhccccC
Confidence 54321 12356789999999999999999999999999999999999999986433 2333334333333
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+ ..+++++.++|..||+.+|++||++.+|++
T Consensus 231 ~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC-----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 22 346899999999999999999999986543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=333.01 Aligned_cols=264 Identities=21% Similarity=0.273 Sum_probs=206.1
Q ss_pred ceecCce-EEEceEeeeCCeEEEEEEE----cCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 11 HVIGGKF-KLGRKIGSGSFGELYLGVN----VQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 11 ~ii~~~y-~i~~~LG~G~fG~Vy~~~~----~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
.++.++| +++++||+|+||.||+|.+ ..+++.||||++..... ...+..|++++..+.| ++|+.+..++..
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 104 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EHIIKYKGCCED 104 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCC-cchhhEEEEEec
Confidence 3466666 9999999999999988764 34788999998765432 2357889999999986 566666666655
Q ss_pred --CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 83 --GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 83 --~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
....++|||++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg 179 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFG 179 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGG
T ss_pred CCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcc
Confidence 46789999999 7799999974 459999999999999999999999999999999999999 578899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-----------c
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----------T 228 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~-----------~ 228 (468)
++..+..... .+.......||..|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 180 ~a~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 255 (318)
T 3lxp_A 180 LAKAVPEGHE----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255 (318)
T ss_dssp GCEECCTTCS----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred cccccccccc----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence 9987654221 112234556889999999999989999999999999999999999999753211 0
Q ss_pred HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 229 KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 229 ~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
....+..........+ ....+++++.+||..||+.||++||++.+|++.|+.+...
T Consensus 256 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 256 TVLRLTELLERGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 0111112222222222 2245689999999999999999999999999999998765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=330.95 Aligned_cols=256 Identities=19% Similarity=0.239 Sum_probs=198.0
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCc----hhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP----QLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~----~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
.-++|++++.||+|+||.||+|.+..+++.||||+........ .+..|+.++..+.| ++|+.+..++......++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH-ENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC-CCEeeEEEEeecCCEEEE
Confidence 4478999999999999999999999999999999865544332 35689999998875 677778888889999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 89 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 89 v~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||++.+.+.+.+......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCc
Confidence 99999555444444346679999999999999999999999999999999999999 478899999999997654322
Q ss_pred CcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc--------
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-------- 239 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~-------- 239 (468)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+......
T Consensus 179 ~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 179 E-------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c-------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 1 12345789999999999876 6899999999999999999999999875443222221111000
Q ss_pred ---------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 ---------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 ---------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+.......+++++.+||..||+.||++||++.+|++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112233344567899999999999999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=324.27 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=205.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
-..+.|+++++||+|+||.||+|.+..+++.||||+...... ...+..|+.++..+.| ++|+.+..++......++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEE
Confidence 345779999999999999999999999999999998765432 3567889999888855 677778888888889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|||++ +++|.+++. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 98 v~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 98 IMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTT
T ss_pred EEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCcc
Confidence 99999 669999987 4679999999999999999999999999999999999999 47889999999999765432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+..... +.
T Consensus 173 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~----~~ 238 (303)
T 3a7i_A 173 QI-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFLIPKNNP----PT 238 (303)
T ss_dssp BC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCC----CC
T ss_pred cc-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHHhhcCCC----CC
Confidence 21 123567899999999999999999999999999999999999999865432 22222222221 12
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
+...++.++.++|..||+.+|++||++.+|++
T Consensus 239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 33567899999999999999999999997654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=344.01 Aligned_cols=250 Identities=15% Similarity=0.119 Sum_probs=186.1
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-----CchhHHHHHHHHHHh-CCCCCce-ee------EeeE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-----HPQLHYESKLYMLLQ-GGTGIPH-LK------WFGV 81 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-----~~~~~~E~~~l~~l~-~~~~i~~-l~------~~~~ 81 (468)
.+|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+. .|+++.. +. .+..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999998776543 234667877777776 2455443 21 1221
Q ss_pred eC-----------------ceeEEEEeccCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHhCCceeccCC
Q 012192 82 EG-----------------DYNIMVIDLLGPSLEDLFNYCNRKFSLKTV------LMLADQLINRVEYMHSRGFLHRDIK 138 (468)
Q Consensus 82 ~~-----------------~~~~lv~el~ggsL~~ll~~~~~~ls~~~~------~~ia~qia~gL~yLHs~giiHrDIK 138 (468)
.. ...++||||+.++|.+++...+..+.+..+ +.++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 11 347999999999999999865555666666 7888999999999999999999999
Q ss_pred CCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHHc
Q 012192 139 PDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLR 216 (468)
Q Consensus 139 p~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~s~ksDvwSlGvvl~ellt 216 (468)
|+|||+ +.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 222 p~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFI---MPDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEE---CTTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---CCCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999 478899999999998654311 13457799999999987 679999999999999999999
Q ss_pred CCCCCCCCCcccHHHHHHHH--hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 217 GSLPWQGLKAGTKKQKYDKI--SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 217 G~~Pf~~~~~~~~~~~~~~i--~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
|..||.+....... .+..+ ............+..+++++.+||..||+.||++||++.+++
T Consensus 289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999875332110 00000 000000111122357799999999999999999999998764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=335.58 Aligned_cols=265 Identities=19% Similarity=0.241 Sum_probs=207.7
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
..++|++.+.||+|+||.||+|.+ .++..||||....... ...+..|+.++..+.| ++|+.+.+++...+..++||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRH-PHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCC-TTBCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEE
Confidence 457999999999999999999995 5789999998654432 2457888988888865 67777777888888899999
Q ss_pred ecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 91 DLL-GPSLEDLFNYCN---RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 91 el~-ggsL~~ll~~~~---~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
|++ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 999 789999886432 358999999999999999999999999999999999999 5788999999999976443
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH---H-HhhcccC
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD---K-ISEKKVS 242 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~---~-i~~~~~~ 242 (468)
... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+........... . .......
T Consensus 192 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 192 LDQ-----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp SSC-----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred ccc-----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 211 112234579999999999999999999999999999999999999998654432111111 0 1111100
Q ss_pred -----CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 243 -----TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 243 -----~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.........++.++.+++..||+.||++||++.+|++.|+.+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 001112233478899999999999999999999999999988753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.36 Aligned_cols=247 Identities=21% Similarity=0.332 Sum_probs=203.9
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--------CCchhHHHHHHHHHHhC-CCCCceee
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--------KHPQLHYESKLYMLLQG-GTGIPHLK 77 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--------~~~~~~~E~~~l~~l~~-~~~i~~l~ 77 (468)
...++.+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.+ +++|+.+.
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 4566788999999999999999999999999999999999865442 23467889999999985 78888888
Q ss_pred EeeEeCceeEEEEeccC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEE
Q 012192 78 WFGVEGDYNIMVIDLLG--PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYI 155 (468)
Q Consensus 78 ~~~~~~~~~~lv~el~g--gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL 155 (468)
.++...+..+++|+++. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+. .+++.+||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL 191 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKL 191 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEE
Confidence 88888899999999984 799999885 56799999999999999999999999999999999999994 25789999
Q ss_pred EeCCcccccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 012192 156 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 234 (468)
+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|..||....
T Consensus 192 ~Dfg~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------- 253 (320)
T 3a99_A 192 IDFGSGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------- 253 (320)
T ss_dssp CCCTTCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred eeCcccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------
Confidence 9999998654321 234579999999999987765 788999999999999999999997521
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+...... ....+++++.++|..||+.||++||++.+|++
T Consensus 254 ~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 EIIRGQVF-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHCCCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhccccc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11222221 12456899999999999999999999997643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.95 Aligned_cols=257 Identities=19% Similarity=0.292 Sum_probs=203.0
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
+..+.-..++|++++.||+|+||.||+|.+..++..||||+..... ....+..|++++..+.| ++|+.+.+++...+
T Consensus 11 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 11 VRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH-PYIVKLLGAYYHDG 89 (302)
T ss_dssp CBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCC-TTBCCEEEEEECC-
T ss_pred cccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCC-CCEeeeeeeeeeCC
Confidence 4555667789999999999999999999999999999999865443 23567889999988865 67777777777888
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++|||++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAK 166 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcc
Confidence 899999999 779999988767789999999999999999999999999999999999999 4788999999999764
Q ss_pred cccccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
..... .......||+.|+|||++. +..++.++||||||+++|+|++|..||...... ..+..+..
T Consensus 167 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~ 236 (302)
T 2j7t_A 167 NLKTL-------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAK 236 (302)
T ss_dssp HHHHH-------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH
T ss_pred ccccc-------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHHhc
Confidence 32211 1123457899999999984 667899999999999999999999999875432 22222322
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..... ......++.++.++|..||+.||++||++.+|++
T Consensus 237 ~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 237 SDPPT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SCCCC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCcc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 22111 1122456899999999999999999999987643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=333.42 Aligned_cols=250 Identities=18% Similarity=0.271 Sum_probs=194.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCcee-
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN- 86 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~- 86 (468)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+.| ++|+.+..++......
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCSSST
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCC-CCchhhhhheeccCCcc
Confidence 3668999999999999999999999999999999987654332 357789999998886 5555555555544433
Q ss_pred -----EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 87 -----IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 87 -----~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
++||+++.++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 118 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 118 NFYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLA 191 (371)
T ss_dssp TCCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC
T ss_pred cceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcc
Confidence 9999999998887764 459999999999999999999999999999999999999 57889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh--
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE-- 238 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~-- 238 (468)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 192 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 192 RHADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261 (371)
T ss_dssp ------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccC----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 764431 234678999999999987 6799999999999999999999999987543222222111100
Q ss_pred ---------------------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 239 ---------------------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 239 ---------------------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.............+++++.+||..||+.||++||++.+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 0011122233456789999999999999999999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=346.89 Aligned_cols=239 Identities=14% Similarity=0.115 Sum_probs=184.9
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHh--CCCCCceee-------Ee
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQ--GGTGIPHLK-------WF 79 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~--~~~~i~~l~-------~~ 79 (468)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+. .|++|+.++ .+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999988899999999865332 2245778886665554 455665544 33
Q ss_pred eEeCc-----------------eeEEEEeccCCCHHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCceec
Q 012192 80 GVEGD-----------------YNIMVIDLLGPSLEDLFNYCNRKFS-------LKTVLMLADQLINRVEYMHSRGFLHR 135 (468)
Q Consensus 80 ~~~~~-----------------~~~lv~el~ggsL~~ll~~~~~~ls-------~~~~~~ia~qia~gL~yLHs~giiHr 135 (468)
....+ ..+|+||+++|+|.+++.... .++ +..++.|+.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 33221 378999999999999998532 233 48888899999999999999999999
Q ss_pred cCCCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCC-----------CCCCcchH
Q 012192 136 DIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-----------EQSRRDDL 204 (468)
Q Consensus 136 DIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----------~~s~ksDv 204 (468)
||||+|||+ +.++.+||+|||+++..... .....| +.|+|||++.+. .++.++||
T Consensus 231 Dikp~NIll---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 231 YLRPVDIVL---DQRGGVFLTGFEHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp CCCGGGEEE---CTTCCEEECCGGGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred CCCHHHEEE---cCCCCEEEEechhheecCCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999 47789999999999853321 124567 999999999988 89999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 205 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 205 wSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
|||||++|||++|..||.+....... .... ..+..+|+++.+||..||+.||++||++.++++
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~-------~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGS-------EWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCS-------GGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCcccccccch-------hhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999999999764322110 1111 112467899999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=320.01 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=203.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+.++|++++.||+|+||.||+|.+..+++.||||+...... ...+..|+.++..+.| ++|+.+..++...+..+++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCC-CCceeeeeEEEcCCEEEEE
Confidence 45789999999999999999999999999999998654432 2457788988888865 6777788888889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||++ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred EEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCCc
Confidence 9999 6699988863 4579999999999999999999999999999999999999 477899999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
. ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+...... .+..+.......+
T Consensus 160 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~--- 229 (276)
T 2yex_A 160 R-----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYLN--- 229 (276)
T ss_dssp E-----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTTCTTST---
T ss_pred c-----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhcccccC---
Confidence 1 111245679999999999988775 7899999999999999999999987544322 2222333222222
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
....+++++.++|..||+.||++||++.+|++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 12456899999999999999999999986643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.91 Aligned_cols=259 Identities=24% Similarity=0.300 Sum_probs=197.8
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhC----------CCCCceeeE
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQG----------GTGIPHLKW 78 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~----------~~~i~~l~~ 78 (468)
+.+..++|+++++||+|+||.||+|.+..+++.||||+..... ....+..|++++..+.+ |++|+.+..
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 3445689999999999999999999999999999999865432 23457789999988874 456766666
Q ss_pred eeEeCc----eeEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeeccc---CC
Q 012192 79 FGVEGD----YNIMVIDLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLG---RK 149 (468)
Q Consensus 79 ~~~~~~----~~~lv~el~ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~---~~ 149 (468)
++.... ..+++|++++++|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+|||+... +.
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred HhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 655433 78999999999999999864 34699999999999999999999998 99999999999999532 23
Q ss_pred CCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc-
Q 012192 150 ANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT- 228 (468)
Q Consensus 150 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~- 228 (468)
.+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp EEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cceEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 448999999999765431 234578999999999999999999999999999999999999998643211
Q ss_pred --HHHHHHHHhhcccCCCHHH-------------------------------------hhccCcHHHHHHHHHHhcCCCC
Q 012192 229 --KKQKYDKISEKKVSTPIEV-------------------------------------LCKSYPSEFVSYFHYCRSLRFE 269 (468)
Q Consensus 229 --~~~~~~~i~~~~~~~~~~~-------------------------------------l~~~~p~~~~~li~~cl~~~p~ 269 (468)
....+..+....-..|... +...+++++.+||..||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 1222222222111111100 1123467899999999999999
Q ss_pred CCCCHHHHH
Q 012192 270 DKPDYSYLK 278 (468)
Q Consensus 270 ~RPs~~~l~ 278 (468)
+||++.+|+
T Consensus 324 ~Rpt~~ell 332 (373)
T 1q8y_A 324 KRADAGGLV 332 (373)
T ss_dssp TCBCHHHHH
T ss_pred ccCCHHHHh
Confidence 999998653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=335.83 Aligned_cols=256 Identities=19% Similarity=0.248 Sum_probs=194.4
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEee-Ee-----
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFG-VE----- 82 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~-~~----- 82 (468)
.+.....+|+++++||+|+||.||+|.+..++. ||||.+.... ....+|++++..+.|+ +|+.+..++ ..
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~--~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK--RFKNRELQIMRIVKHP-NVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT--TSCCHHHHHHHTCCCT-TBCCEEEEEEEESSSSS
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc--chHHHHHHHHHhCCCC-CcceEEEEEEecCCCCC
Confidence 566778899999999999999999999876665 8888755433 2334799999988765 555555444 32
Q ss_pred CceeEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 83 GDYNIMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 83 ~~~~~lv~el~ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
..+.++||||+.+++...+.. ....+++..+..++.||+.||+|||++||+||||||+|||+. ..++.+||+|||
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG 187 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFG 187 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCT
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCC
Confidence 234789999998887766542 356799999999999999999999999999999999999993 268899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+.+...
T Consensus 188 ~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 188 SAKILIAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp TCEECCTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CcccccCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9987543221 2356789999999999876 489999999999999999999999987543322222211110
Q ss_pred c----------------c----cCCCHH-HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 239 K----------------K----VSTPIE-VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 239 ~----------------~----~~~~~~-~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
. . ...+.. .+...+++++.+||..||..||.+||++.+++
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 0 0 001111 12234789999999999999999999998653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=318.37 Aligned_cols=251 Identities=10% Similarity=0.134 Sum_probs=202.2
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeC--c
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEG--D 84 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--~ 84 (468)
.+..++|++.++||+|+||.||+|.+ ++..||||+....... ..+..|+.++..+.| ++|+.+..++... .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH-PNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSC-TTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CchhheEEEEccCCCC
Confidence 45567899999999999999999997 4889999987654322 357788888888865 6666777666655 6
Q ss_pred eeEEEEecc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~-~ls~~~~~~ia~qia~gL~yLHs~g--iiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
..+++||++ +++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADV 159 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGS
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccc
Confidence 789999999 6799999985433 5899999999999999999999999 9999999999999 4788899999888
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCC---cchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSR---RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~---ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
+.... .....||+.|+|||++.+..++. ++||||||+++|+|++|..||.+.... .....+.
T Consensus 160 ~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~ 224 (271)
T 3kmu_A 160 KFSFQ------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM---EIGMKVA 224 (271)
T ss_dssp CCTTS------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH---HHHHHHH
T ss_pred eeeec------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH---HHHHHHH
Confidence 65422 23457899999999999876554 799999999999999999999875432 2223333
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
....... ....+++++.++|..||+.||++||++.+|++.|+.+.
T Consensus 225 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 225 LEGLRPT---IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred hcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 3333222 22456999999999999999999999999999998763
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=321.02 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=207.2
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
...+.++|+++++||+|+||.||+|.+..+++.||||+..... ....+..|++++..+.| ++|+.+..++.....
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccC-CCccEEEEEEeCCCe
Confidence 3456689999999999999999999999899999999865432 23467889999998865 677777778888889
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.+++||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...+....+||+|||++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999998 7899988874 457999999999999999999999999999999999999964444568999999999765
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... .+....+.......+
T Consensus 175 ~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~ 242 (287)
T 2wei_A 175 QQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYAFD 242 (287)
T ss_dssp CCCS--------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC
T ss_pred cCCC--------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCC
Confidence 4321 1234568999999999876 489999999999999999999999987543 233334444444333
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+ ....+++++.++|..||+.+|++||++.+|++
T Consensus 243 ~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 LP-QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SG-GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch-hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 22 23567899999999999999999999997654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=330.69 Aligned_cols=254 Identities=16% Similarity=0.205 Sum_probs=191.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-------------chhHHHHHHHHHHhCCCCCceeeE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-------------PQLHYESKLYMLLQGGTGIPHLKW 78 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-------------~~~~~E~~~l~~l~~~~~i~~l~~ 78 (468)
.+.++|++++.||+|+||.||+|.+. ++..||||++...... ..+..|++++..+.| ++|+.+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~ 96 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH-PNILGLRD 96 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC-TTBCCCSE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC-cCccceee
Confidence 45689999999999999999999875 4899999986443221 467899999999976 55555555
Q ss_pred eeE-----eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 79 FGV-----EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 79 ~~~-----~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
++. .....++|||++.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~ 173 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDI 173 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCE
T ss_pred eEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCE
Confidence 443 233679999999999999998656679999999999999999999999999999999999999 478899
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 232 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~ 232 (468)
||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........
T Consensus 174 kl~Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 174 TICDFNLAREDTADA--------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp EECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EEEecCccccccccc--------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999997543321 1234578999999999987 6689999999999999999999999987543322222
Q ss_pred HHHHhhc------------------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 233 YDKISEK------------------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 233 ~~~i~~~------------------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+...... ............+++.+.+||..||+.||++||++.+++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 2111100 001122234456789999999999999999999998653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=357.57 Aligned_cols=255 Identities=20% Similarity=0.336 Sum_probs=199.5
Q ss_pred ceEEE-ceEeeeCCeEEEEEEEc--CCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 16 KFKLG-RKIGSGSFGELYLGVNV--QTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 16 ~y~i~-~~LG~G~fG~Vy~~~~~--~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
.+.+. ++||+|+||.||+|.+. .++..||||++..... ...+..|++++..+.| ++|+.+++++.. +..++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCC-TTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEec-CCEEE
Confidence 34443 48999999999999653 5678999998765432 2468899999999976 566666666654 45789
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||||+ +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+++.+...
T Consensus 447 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC-
T ss_pred EEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccC
Confidence 99998 7899999975 56799999999999999999999999999999999999994 7889999999999876542
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
.. .+.......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...... ...+ ......+.+
T Consensus 523 ~~----~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i-~~~~~~~~p 594 (635)
T 4fl3_A 523 EN----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAML-EKGERMGCP 594 (635)
T ss_dssp ----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH-HTTCCCCCC
T ss_pred cc----ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH-HcCCCCCCC
Confidence 21 1122334567889999999999999999999999999999998 9999988654322 2222 222222222
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+|+++.+||..||+.||++||++.+|++.|++++..
T Consensus 595 ---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 595 ---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 35699999999999999999999999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=317.62 Aligned_cols=248 Identities=19% Similarity=0.259 Sum_probs=197.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEe----Cc
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVE----GD 84 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~----~~ 84 (468)
.+..|++.+.||+|+||.||+|.+..++..||||+....... ..+..|+.++..+.| ++|+.+..++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCC-CCeeeeeeeeccccCCCc
Confidence 356799999999999999999999999999999986654322 347789999988876 455555554432 56
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~g--iiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
..++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+. +.++.++|+|||++
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred eEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCc
Confidence 689999999 7799999985 467999999999999999999999999 99999999999994 36789999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... ....+..+.....
T Consensus 180 ~~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 180 TLKRAS---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVK 247 (290)
T ss_dssp GGCCTT---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCC
T ss_pred cccccc---------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCC
Confidence 754321 1234578999999998875 589999999999999999999999986443 2333333322221
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.......+++++.++|..||+.||.+||++.+|++
T Consensus 248 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 22334556899999999999999999999997653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=328.34 Aligned_cols=268 Identities=19% Similarity=0.227 Sum_probs=206.9
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEE----cCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVN----VQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~----~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
...+..++|+++++||+|+||.||+|.+ ..+++.||||+...... ...+..|++++..+.| ++|+.+..++..
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 113 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYS 113 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCC-TTBCCEEEEECC
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEe
Confidence 4456678899999999999999999984 56899999998655432 2357889999999976 555555554433
Q ss_pred --CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 83 --GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 83 --~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
....++|||++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.++|+|||
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg 190 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFG 190 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCT
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCc
Confidence 34678999999 779999998766779999999999999999999999999999999999999 468899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc---------c--
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------T-- 228 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~---------~-- 228 (468)
++......... ........++..|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 191 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 191 LTKVLPQDKEY----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 266 (326)
T ss_dssp TCEECCSSCSE----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH
T ss_pred chhhccccccc----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh
Confidence 99876542211 11123456788899999999888999999999999999999999998642110 0
Q ss_pred -HHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 229 -KKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 229 -~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
....+..........+ ....+|+++.++|..||+.||++||++.+|++.|+.+...
T Consensus 267 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0001111112221222 1245689999999999999999999999999999988654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=324.26 Aligned_cols=262 Identities=23% Similarity=0.288 Sum_probs=198.8
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcC-CC--cEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQ-TG--EEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~-~~--~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
..+..++|+++++||+|+||.||+|.+.. ++ ..||||+..... ....+..|++++..+.| ++|+.+..++.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~ 91 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVL 91 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEc
Confidence 34556899999999999999999998643 33 368999754332 23467889999998875 56666666665
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
... .+++|+++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||+
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGL 167 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTT
T ss_pred cCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccc
Confidence 554 67888887 789999998766779999999999999999999999999999999999999 4788999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
+......... ........+|..|+|||++.+..++.++||||||+++|+|++ |..||.+... .+.+..+...
T Consensus 168 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~ 240 (291)
T 1u46_A 168 MRALPQNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKE 240 (291)
T ss_dssp CEECCC-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTS
T ss_pred cccccccccc----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHcc
Confidence 9876442211 112234567889999999998889999999999999999999 9999987543 3333334333
Q ss_pred ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 240 KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 240 ~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
....+. ...+|+++.++|..||..+|++||++.+|.+.|+++..
T Consensus 241 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 GERLPR---PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCCC---CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 333322 24569999999999999999999999999999987643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=328.79 Aligned_cols=266 Identities=19% Similarity=0.226 Sum_probs=185.7
Q ss_pred CCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc---CCCchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 5 GKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK---TKHPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 5 ~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
.+.....+..++|++.+.||+|+||.||+|.+..+++.||||+.... .....+..|+.++..+.| ++|+.+..++.
T Consensus 5 s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~ 83 (303)
T 2vwi_A 5 SSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH-PNIVSYYTSFV 83 (303)
T ss_dssp --------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCC-TTBCCEEEEEE
T ss_pred ccccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCC-CCEeeEEEEEe
Confidence 33444567789999999999999999999998889999999975433 234457788888877764 67777778888
Q ss_pred eCceeEEEEecc-CCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNY-------CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~-------~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
..+..++|||++ +++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~ 160 (303)
T 2vwi_A 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSV 160 (303)
T ss_dssp SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCE
T ss_pred ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCE
Confidence 888899999999 8899999874 24569999999999999999999999999999999999999 478899
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 232 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~ 232 (468)
+|+|||++.......... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........
T Consensus 161 kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 238 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDIT--RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238 (303)
T ss_dssp EECCCHHHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred EEEeccchheeccCCCcc--chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH
Confidence 999999987654321110 1112245679999999999876 5689999999999999999999999987654332211
Q ss_pred HHHHhhcccCC-----CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 233 YDKISEKKVST-----PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 233 ~~~i~~~~~~~-----~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
........ ........+++++.++|..||+.||.+||++.+|++
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 ---TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ---HHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11111111 112234567899999999999999999999997654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=330.12 Aligned_cols=269 Identities=16% Similarity=0.206 Sum_probs=193.1
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHH-HhCCCCCceeeEeeE-----eCc
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYML-LQGGTGIPHLKWFGV-----EGD 84 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~-l~~~~~i~~l~~~~~-----~~~ 84 (468)
.+-.++|++++.||+|+||.||+|.+ +++.||||++.... ...+..|.+++.. ...|++|..+..+.. ...
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 34558999999999999999999976 78999999875432 3344555555432 234455655544222 234
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCceeecccCCCCeEE
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR---------GFLHRDIKPDNFLMGLGRKANQVY 154 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~---------giiHrDIKp~NiLl~~~~~~~~vk 154 (468)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+|||+ +.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEE
Confidence 568999999 8899999974 4568999999999999999999999 99999999999999 4778999
Q ss_pred EEeCCcccccccccCccc-ccccCCCCccccccccccccccC-------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCc
Q 012192 155 IIDYGLAKKYRDLQTHKH-IPYRENKNLTGTARYASVNTHLG-------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 226 (468)
Q Consensus 155 L~DFGla~~~~~~~~~~~-~~~~~~~~~~Gt~~y~APE~~~~-------~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~ 226 (468)
|+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987653221110 11112335579999999999987 3466789999999999999999777653222
Q ss_pred cc--------------HHHHHHH-HhhcccCCCHHHhh---ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 227 GT--------------KKQKYDK-ISEKKVSTPIEVLC---KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 227 ~~--------------~~~~~~~-i~~~~~~~~~~~l~---~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.. ....+.. +.........+..+ ..+++++.+||..||+.||++||++.+|++.|+.++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 11 0011111 11111111111111 11356899999999999999999999999999998853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.30 Aligned_cols=256 Identities=17% Similarity=0.279 Sum_probs=182.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
.+..++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|+..+.....|++|+.+.+++...+..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 34558999999999999999999999999999999987654322 245556665555556788888988888899999
Q ss_pred EEEeccCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 88 MVIDLLGPSLEDLFNY----CNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 88 lv~el~ggsL~~ll~~----~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+|||++.++|.+++.. ....+++..+..++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||+++
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSC
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCce
Confidence 9999999999988874 256799999999999999999999999 99999999999999 478899999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccc----cCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTH----LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~----~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
....... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||.+.... ...+..+..
T Consensus 175 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~ 244 (327)
T 3aln_A 175 QLVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVK 244 (327)
T ss_dssp C--------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCC
T ss_pred ecccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhc
Confidence 6543211 2234799999999998 4566899999999999999999999999864321 111111111
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.............+++++.+||..||+.||++||++.+|++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111122457899999999999999999999997754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=331.56 Aligned_cols=263 Identities=17% Similarity=0.224 Sum_probs=203.1
Q ss_pred CceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCcee
Q 012192 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYN 86 (468)
Q Consensus 10 ~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~ 86 (468)
..+..++|++.+.||+|+||.||+|.+ .++..||||++.... ....+..|++++..+.| ++|+.+..++......
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC-TTBCCCCEEECCSSCC
T ss_pred HHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC-CCccceEEEEecCCce
Confidence 345678999999999999999999984 578999999865432 23367889999888875 6777777777888888
Q ss_pred EEEEecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 87 IMVIDLL-GPSLEDLFNYCN---RKFSLKTVLMLADQLINRVEYMHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~---~~ls~~~~~~ia~qia~gL~yLHs~---giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
++|||++ +++|.+++.... ..+++..+..++.|++.||+|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg 179 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFG 179 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCS
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCc
Confidence 9999999 779999998532 3499999999999999999999999 99999999999999 478899999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-----CcccHHHHHH
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL-----KAGTKKQKYD 234 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~-----~~~~~~~~~~ 234 (468)
++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+.
T Consensus 180 ~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 180 LAKLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp SCEECCSSSSC------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred cccccCccccc------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99866432221 123456999999999999888999999999999999999999999521 1111111111
Q ss_pred HHhhcc-cCC-----CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 235 KISEKK-VST-----PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 235 ~i~~~~-~~~-----~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
...... ... .........++++.+++..||+.+|.+||++.+|++.|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 110000 000 0001112235789999999999999999999999998875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=327.69 Aligned_cols=262 Identities=18% Similarity=0.235 Sum_probs=198.3
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeE----eCce
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGV----EGDY 85 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~----~~~~ 85 (468)
+..++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.+..++. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-PNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCC-TTBCCCCEEEEEEETTEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCC-CCeeeEEEEEEeccCCCce
Confidence 44679999999999999999999999999999999765432 23457889999988866 55555555544 2346
Q ss_pred eEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 86 NIMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
.++|||++ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcc
Confidence 78999998 6699999875 35679999999999999999999999999999999999999 47889999999998
Q ss_pred cccccccCccc--ccccCCCCccccccccccccccCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCCcc--cHHHHHH
Q 012192 162 KKYRDLQTHKH--IPYRENKNLTGTARYASVNTHLGVE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYD 234 (468)
Q Consensus 162 ~~~~~~~~~~~--~~~~~~~~~~Gt~~y~APE~~~~~~---~s~ksDvwSlGvvl~elltG~~Pf~~~~~~--~~~~~~~ 234 (468)
........... ..........||+.|+|||++.+.. ++.++||||||+++|+|++|..||...... ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--- 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL--- 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH---
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH---
Confidence 76432111000 0000012345799999999998654 689999999999999999999999642111 1111
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
........+. ...+++++.++|..||+.||.+||++.+|++.|+.+
T Consensus 259 -~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 259 -AVQNQLSIPQ---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp -HHHCC--CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -HhhccCCCCc---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 1112222221 245689999999999999999999999999988764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=324.13 Aligned_cols=251 Identities=19% Similarity=0.221 Sum_probs=182.5
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEe-C------ce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVE-G------DY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-~------~~ 85 (468)
-++|++.++||+|+||.||+|.+..++..||||++..... ......|++.+..+.|+ +|+.+..++.. . .+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP-NIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCT-TBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCC-CcccHHHhhhcccccccccee
Confidence 4789999999999999999999999999999997654432 34566677777777664 55555544432 2 23
Q ss_pred eEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 86 NIMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLH--s~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
.++|||++.++|.+.+.. ....+++..+..++.|++.||.||| ++||+||||||+|||+. ..++.+||+|||+
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTT
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCC
Confidence 789999998888776553 3557899999999999999999999 99999999999999994 2378999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 239 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~ 239 (468)
++.+..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..... .+..+...
T Consensus 179 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~ 247 (360)
T 3e3p_A 179 AKKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVRV 247 (360)
T ss_dssp CBCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHH
T ss_pred ceecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHHH
Confidence 986654221 23567899999999997665 8999999999999999999999998754332 22222221
Q ss_pred ccCCC-----------------------HHHhh----ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 KVSTP-----------------------IEVLC----KSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 ~~~~~-----------------------~~~l~----~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+ ..... ..+++++.+||..||+.||++||++.+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 11111 11111 12578999999999999999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=320.52 Aligned_cols=251 Identities=19% Similarity=0.295 Sum_probs=186.7
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCc---hhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP---QLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~---~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
-++|++++.||+|+||.||+|.+..+++.||||++....... .+..|...+.....|++|..+..++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999999999999999876543322 33444444444556788888888888999999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|++++.+..+.......+++..+..++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|||++........
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCcc
Confidence 9998888888876677899999999999999999999996 99999999999999 5788999999999976543221
Q ss_pred cccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCC
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 244 (468)
.....||+.|+|||++. +..++.++||||||+++|+|++|..||..... ....+..+........
T Consensus 181 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 181 --------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPLL 250 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCCC
T ss_pred --------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCCC
Confidence 23457899999999995 45689999999999999999999999986432 2233333333322111
Q ss_pred HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 245 ~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....+++++.++|..||+.||.+||++.+|++
T Consensus 251 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 --PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 112356899999999999999999999997754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.04 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=200.4
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc------CCCchhHHHHHHHHHHhCCCCCceeeEee--EeCc
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK------TKHPQLHYESKLYMLLQGGTGIPHLKWFG--VEGD 84 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~--~~~~ 84 (468)
+.++|++++.||+|+||.||+|.+..++..||||+.... .....+..|++++..+.| ++|..+..++ ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH-KNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCC
Confidence 457899999999999999999999999999999986543 223568889999998875 5566666655 3456
Q ss_pred eeEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++|||++.+.|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEA 158 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccccc
Confidence 78999999988888888753 4579999999999999999999999999999999999999 4788999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 241 (468)
....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.. ..+.+..+.....
T Consensus 159 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAAD-----DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKGSY 230 (305)
T ss_dssp CCTTCSS-----CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCC
T ss_pred cCccccc-----cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcCCC
Confidence 5432111 1123456899999999998754 3789999999999999999999998643 2333444444433
Q ss_pred CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 242 ~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+ ..+++++.++|..||..||++||++.+|+ ++.+..
T Consensus 231 ~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll---~~~~~~ 268 (305)
T 2wtk_C 231 AIP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIR---QHSWFR 268 (305)
T ss_dssp CCC-----SSSCHHHHHHHHHHTCSSTTTSCCHHHHH---HSHHHH
T ss_pred CCC-----CccCHHHHHHHHHHccCChhhCCCHHHHh---cCcccc
Confidence 322 45689999999999999999999998654 444443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=338.19 Aligned_cols=263 Identities=17% Similarity=0.198 Sum_probs=186.2
Q ss_pred ceecCceEE-EceEeeeCCeEEEEEEEc--CCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeE--eCce
Q 012192 11 HVIGGKFKL-GRKIGSGSFGELYLGVNV--QTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGV--EGDY 85 (468)
Q Consensus 11 ~ii~~~y~i-~~~LG~G~fG~Vy~~~~~--~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~--~~~~ 85 (468)
..+.+.|++ +++||+|+||.||+|.+. .++..||||++........+..|+.++..+.| ++|+.+..++. ....
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKH-PNVISLQKVFLSHADRK 94 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCC-TTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCC-CCeeeEeeEEecCCCCe
Confidence 345577888 558999999999999966 47889999998766666788999999999986 55555555553 4678
Q ss_pred eEEEEeccCCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc-CCCCeEEEE
Q 012192 86 NIMVIDLLGPSLEDLFNYCN--------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKANQVYII 156 (468)
Q Consensus 86 ~~lv~el~ggsL~~ll~~~~--------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~-~~~~~vkL~ 156 (468)
.++||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+... +..+.+||+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 89999999999999886421 249999999999999999999999999999999999999532 356899999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcc------cH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TK 229 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~------~~ 229 (468)
|||+++.+..... +........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... ..
T Consensus 175 Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 175 DMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp CTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred ECCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 9999987643211 11223456899999999999885 4899999999999999999999999764331 00
Q ss_pred HHHHHHHhhcccCCCHH------------H---------------------hhccCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012192 230 KQKYDKISEKKVSTPIE------------V---------------------LCKSYPSEFVSYFHYCRSLRFEDKPDYSY 276 (468)
Q Consensus 230 ~~~~~~i~~~~~~~~~~------------~---------------------l~~~~p~~~~~li~~cl~~~p~~RPs~~~ 276 (468)
...+..+....-..+.. . .....++++.+||..||..||.+||++.+
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 11222221110000000 0 00112678899999999999999999985
Q ss_pred HH
Q 012192 277 LK 278 (468)
Q Consensus 277 l~ 278 (468)
++
T Consensus 331 ~L 332 (405)
T 3rgf_A 331 AM 332 (405)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=317.09 Aligned_cols=249 Identities=21% Similarity=0.234 Sum_probs=198.3
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeE--eCceeE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGV--EGDYNI 87 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~--~~~~~~ 87 (468)
.++|++++.||+|+||.||+|.+..+++.||||+...... ...+..|+.++..+.| ++|+.+..++. .....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-PNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCC-CCCCeEEEEEecCCCceEE
Confidence 4789999999999999999999999999999998765432 2357889999999976 55666655443 356789
Q ss_pred EEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCceeecccCCCCeEEEEeC
Q 012192 88 MVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDY 158 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~---~~~ls~~~~~~ia~qia~gL~yLHs~g-----iiHrDIKp~NiLl~~~~~~~~vkL~DF 158 (468)
+|||++ +++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecC
Confidence 999999 67999998753 345999999999999999999999999 9999999999999 47889999999
Q ss_pred CcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 159 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+..
T Consensus 161 g~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~ 230 (279)
T 2w5a_A 161 GLARILNHDTS-------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIRE 230 (279)
T ss_dssp CHHHHC---CH-------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH
T ss_pred chheeeccccc-------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhh
Confidence 99976543211 01234689999999999999999999999999999999999999987543 233333333
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRL 280 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~ 280 (468)
.... .+...+++++.++|..||+.+|++||++.+|++.
T Consensus 231 ~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 231 GKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 3321 1224568999999999999999999999977653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=319.22 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=198.7
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC------CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT------KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
|..+++||+|+||.||+|.+ ++..||||+..... ....+..|+.++..+.| ++|+.+.+++...+..+++|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH-ENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC-CCeEEEEEEEecCCceEEEE
Confidence 33458999999999999985 67899999865432 12457889999998875 67777777878888899999
Q ss_pred ecc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 91 DLL-GPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 91 el~-ggsL~~ll~~~--~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+++ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence 998 88999998743 3469999999999999999999999999999999999999 57889999999999765432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH-HHhhccc-----
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD-KISEKKV----- 241 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~-~i~~~~~----- 241 (468)
... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+. .+.....
T Consensus 187 ~~~-----~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 187 AQT-----VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp SSC-----EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred ccc-----ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 211 11234679999999998875 58999999999999999999999998755433221111 1111100
Q ss_pred -CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 242 -STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 242 -~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
..........+++.+.++|..||+.+|.+||++.+|++.|+++
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 0000011123368899999999999999999999999999886
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=325.81 Aligned_cols=250 Identities=18% Similarity=0.272 Sum_probs=193.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCc---
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGD--- 84 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~--- 84 (468)
.+.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+..|+.++..+.| ++|+.+..++....
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCSSGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCC-CCcccHhheEecccccc
Confidence 3568999999999999999999999999999999987554332 356789999998876 55555555554433
Q ss_pred ---eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 85 ---YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 85 ---~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
..+++|+++.++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 100 NFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLA 173 (353)
T ss_dssp GCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCT
T ss_pred cceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeecccc
Confidence 349999999988887764 469999999999999999999999999999999999999 47889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh--
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE-- 238 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~-- 238 (468)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 174 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 174 RHADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243 (353)
T ss_dssp TC------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBC
T ss_pred cCCCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 764321 234578999999999987 6789999999999999999999999987543222111111100
Q ss_pred ---------------------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 239 ---------------------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 239 ---------------------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.........+...+++++.+||..||+.||++||++.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 304 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0001111223346789999999999999999999998653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=327.48 Aligned_cols=277 Identities=17% Similarity=0.247 Sum_probs=202.8
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
+..-++..++|++.+.||+|+||.||+|.+.. .||||+..... ....+..|+.++..+.| ++|+.+.+++..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~ 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH-ENVVLFMGACMS 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCC-TTBCCCCEEEEC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCC-CCEeEEEEEEec
Confidence 34456677899999999999999999998743 49999865432 23457788888888865 667777777788
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
....+++||++ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+. ++.++|+|||++
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLF 176 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCC
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCc
Confidence 88899999999 7899999986556799999999999999999999999999999999999993 678999999998
Q ss_pred cccccccCcccccccCCCCccccccccccccccC---------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG---------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 232 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---------~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~ 232 (468)
.......... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+... ...
T Consensus 177 ~~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~ 251 (319)
T 2y4i_B 177 SISGVLQAGR--REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAI 251 (319)
T ss_dssp C------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHH
T ss_pred cccccccccc--cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH
Confidence 7643221111 1112334569999999999875 3578899999999999999999999986543 222
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccc
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 299 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~ 299 (468)
...+........ ....+|.++.++|..||..+|++||++.+|++.|+.+.............|.
T Consensus 252 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 252 IWQMGTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp HHHHHTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred HHHhccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 322322221111 1235689999999999999999999999999999988776544444444443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=318.86 Aligned_cols=245 Identities=20% Similarity=0.312 Sum_probs=191.6
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--------CCchhHHHHHHHHHHh---CCCCCceee
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--------KHPQLHYESKLYMLLQ---GGTGIPHLK 77 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--------~~~~~~~E~~~l~~l~---~~~~i~~l~ 77 (468)
-.+.+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+. .|++|+.+.
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 35677889999999999999999999998999999999865442 2345677999999885 567888888
Q ss_pred EeeEeCceeEEEEec-c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEE
Q 012192 78 WFGVEGDYNIMVIDL-L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYI 155 (468)
Q Consensus 78 ~~~~~~~~~~lv~el-~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL 155 (468)
.++...+..+++|++ + +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ..++.++|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEE
Confidence 887777888889987 3 8899999985 45799999999999999999999999999999999999994 26789999
Q ss_pred EeCCcccccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 012192 156 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 234 (468)
+|||++....... .....||..|+|||++.+..+ +.++||||||+++|+|++|..||....
T Consensus 182 ~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------- 243 (312)
T 2iwi_A 182 IDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------- 243 (312)
T ss_dssp CCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred EEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------
Confidence 9999998654321 234578999999999987765 458999999999999999999997521
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.+.......+ ..++.++.++|..||+.+|++||++.+|++
T Consensus 244 ~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 EILEAELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHTCCCCC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhhhccCCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1222222222 356899999999999999999999997653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=314.75 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=193.0
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CC
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GP 95 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-gg 95 (468)
....||+|+||.||+|.+..++..||||....... ...+..|+.++..+.| ++|+.+..++......+++||++ ++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCC-CCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 33489999999999999999999999998655432 3567889999888865 66777777788888999999999 78
Q ss_pred CHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 96 SLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 96 sL~~ll~~~~~--~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
+|.+++..... .+++..+..++.|++.||+|||++||+|+||||+|||+. ..++.++|+|||++........
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~---- 178 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP---- 178 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC----
Confidence 99999986433 467889999999999999999999999999999999995 2378999999999986543211
Q ss_pred cccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 174 PYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~--~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
......||+.|+|||++.+.. ++.++||||||+++|+|++|..||....... ............. .+...
T Consensus 179 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~---~~~~~ 250 (295)
T 2clq_A 179 ---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAMFKVGMFKVHP---EIPES 250 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHHHHHHHHCCCC---CCCTT
T ss_pred ---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHHHhhccccccc---ccccc
Confidence 123567899999999998654 8899999999999999999999997643221 1111111111111 12345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
+++++.++|..||+.||++||++.+|+
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 689999999999999999999998654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=350.83 Aligned_cols=260 Identities=20% Similarity=0.306 Sum_probs=205.9
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
++..++|++++.||+|+||.||+|.+..+ +..||||....... ...+..|+.++..+.| ++|+.+.+++. .+
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVIT-EN 463 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEe-cC
Confidence 45668899999999999999999998653 46799997554322 2457889999988876 55666666654 45
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++|||++ +++|.+++......+++..++.++.|++.||+|||++||+||||||+|||+. .++.+||+|||+++.
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCCee
Confidence 578999999 7899999987666799999999999999999999999999999999999994 788999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.... +.+..+.... .
T Consensus 541 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~~~~-~ 610 (656)
T 2j0j_A 541 MEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENGE-R 610 (656)
T ss_dssp CCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHHTC-C
T ss_pred cCCCcc------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCC-C
Confidence 543221 11234567889999999999999999999999999999997 99999876543 2333333222 1
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 288 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~ 288 (468)
.+ ....+|+++.++|..||..||++||++.+|.+.|+.++..+
T Consensus 611 ~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 611 LP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 22 22456899999999999999999999999999999988654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=314.63 Aligned_cols=257 Identities=19% Similarity=0.216 Sum_probs=191.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEe---------
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVE--------- 82 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--------- 82 (468)
+.++|++++.||+|+||.||+|.+..+++.||||+..... ....+..|+.++..+.|+ +|..+..++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ-YVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCT-TBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCch-HHHHHHHHHHhhcchhhhhc
Confidence 4578999999999999999999999999999999865432 234578899999888764 55555544432
Q ss_pred ----CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEe
Q 012192 83 ----GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 83 ----~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
....++|||++ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEee
Confidence 45679999999 779999998766678899999999999999999999999999999999999 4788999999
Q ss_pred CCcccccccccCccc-------ccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH
Q 012192 158 YGLAKKYRDLQTHKH-------IPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 229 (468)
Q Consensus 158 FGla~~~~~~~~~~~-------~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~ 229 (468)
||++........... ..........||+.|+|||++.+. .++.++|||||||++|+|++ ||.... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hH
Confidence 999986543211000 001122456799999999999865 68999999999999999998 665321 22
Q ss_pred HHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 230 KQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 230 ~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
...+..+.......+ +.+...+++.+.++|..||+.||.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTCCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccccccccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 223333333222222 2344566889999999999999999999997654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.55 Aligned_cols=262 Identities=21% Similarity=0.221 Sum_probs=194.3
Q ss_pred CCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 8 RMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 8 ~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
.++..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... ...+..|++++..+.+|++|+.+++++......+
T Consensus 8 ~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 8 NFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred chhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 3566778889999999999999998754 5689999999865432 3457889999988877888999998888999999
Q ss_pred EEEeccCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeeccc----------CCCC
Q 012192 88 MVIDLLGPSLEDLFNYCNRK------FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG----------RKAN 151 (468)
Q Consensus 88 lv~el~ggsL~~ll~~~~~~------ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~----------~~~~ 151 (468)
+|||+++++|.+++...... .++..++.++.||+.||+|||++||+||||||+|||+... +...
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999999999999843211 1223457799999999999999999999999999999532 2356
Q ss_pred eEEEEeCCcccccccccCcccccccCCCCccccccccccccccC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 012192 152 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-------VEQSRRDDLESLGYVLMYFLR-GSLPWQG 223 (468)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-------~~~s~ksDvwSlGvvl~ellt-G~~Pf~~ 223 (468)
.+||+|||+++......... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSF---RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp EEEECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EEEEcccccceecCCCCccc---eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 89999999998765422110 011234679999999999976 568999999999999999999 9999976
Q ss_pred CCcccHHHHHHHHhhcccCCCH--HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 224 LKAGTKKQKYDKISEKKVSTPI--EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 224 ~~~~~~~~~~~~i~~~~~~~~~--~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
..... ..+.......+. ......+++++.++|..||+.||.+||++.+|++
T Consensus 243 ~~~~~-----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 243 KYSRE-----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTTHH-----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhH-----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 43211 112222222111 0111234689999999999999999999997754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=323.11 Aligned_cols=256 Identities=15% Similarity=0.219 Sum_probs=206.5
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-------------------chhHHHHHHHHHH
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-------------------PQLHYESKLYMLL 67 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-------------------~~~~~E~~~l~~l 67 (468)
+..+.+..++|++++.||+|+||.||+|.+ ++..||||+....... ..+..|+.++..+
T Consensus 23 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp ESSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred hhhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 456777889999999999999999999998 8999999986543211 6788999999988
Q ss_pred hCCCCCceeeEeeEeCceeEEEEecc-CCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCC
Q 012192 68 QGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDL------FNYC-NRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIK 138 (468)
Q Consensus 68 ~~~~~i~~l~~~~~~~~~~~lv~el~-ggsL~~l------l~~~-~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIK 138 (468)
.| ++|+.+..++...+..++|||++ +++|.++ +... ...+++..+..++.|++.||.|||+ +||+|||||
T Consensus 101 ~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~ 179 (348)
T 2pml_X 101 KN-EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179 (348)
T ss_dssp CC-TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred CC-CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence 75 67777778888889999999999 5699987 5432 4679999999999999999999999 999999999
Q ss_pred CCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCC-CCCC-cchHHHHHHHHHHHHc
Q 012192 139 PDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSR-RDDLESLGYVLMYFLR 216 (468)
Q Consensus 139 p~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~-ksDvwSlGvvl~ellt 216 (468)
|+|||+ +.++.++|+|||++...... ......||..|+|||++.+. .++. ++||||||+++|+|++
T Consensus 180 p~Nil~---~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 247 (348)
T 2pml_X 180 PSNILM---DKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247 (348)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred hHhEEE---cCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999 57889999999999865432 12356799999999999987 5665 9999999999999999
Q ss_pred CCCCCCCCCcccHHHHHHHHhhcccCCCHH--------------HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 217 GSLPWQGLKAGTKKQKYDKISEKKVSTPIE--------------VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 217 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--------------~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
|..||...... .+.+..+.......+.. .....+++++.+||..||+.||++||++.++++
T Consensus 248 g~~pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 248 NVVPFSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SSCSSCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999875432 33344444443333311 112457899999999999999999999987644
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.48 Aligned_cols=239 Identities=15% Similarity=0.146 Sum_probs=184.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCce----------ee--
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPH----------LK-- 77 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~----------l~-- 77 (468)
..|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+..|+.++..+.|..++.. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35889999999999999999999999999999866322 23467788888887766322111 00
Q ss_pred ---------EeeEe-----CceeEEEEeccCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 012192 78 ---------WFGVE-----GDYNIMVIDLLGPSLEDLFNYC------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 137 (468)
Q Consensus 78 ---------~~~~~-----~~~~~lv~el~ggsL~~ll~~~------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDI 137 (468)
.+... ....+++|++++++|.+++... ...+++..++.++.||+.||+|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11111 2346888999999999999643 345788899999999999999999999999999
Q ss_pred CCCceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccc----------cCCCCCCcchHHHH
Q 012192 138 KPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH----------LGVEQSRRDDLESL 207 (468)
Q Consensus 138 Kp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~----------~~~~~s~ksDvwSl 207 (468)
||+|||+ +.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVL---DQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccceEEE---ecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999 57888999999998765432 234567 999999999 55568899999999
Q ss_pred HHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 208 GYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 208 Gvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
||++|||++|..||.+...... + .. ....+..+|+++.+||..||+.||++||++.++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~---~----~~-----~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG---S----EW-----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC---S----GG-----GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhhh---H----HH-----HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999999986543211 1 11 11122467899999999999999999999887643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=333.16 Aligned_cols=253 Identities=17% Similarity=0.185 Sum_probs=190.4
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccC
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLG 94 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~g 94 (468)
.+|.+.+.||+|+||+||.. ...+++.||||++.. .....+..|++++..+..|++|+.++.++.+....++|||+++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~-~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP-ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECT-TTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECH-HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 46999999999999997643 346889999998644 3345578899999999777888888888899999999999999
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC--CCCeEEEEeCCcccccccccCccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDYGLAKKYRDLQTHKH 172 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~--~~~~vkL~DFGla~~~~~~~~~~~ 172 (468)
++|.+++......+....++.++.||+.||+|||++||+||||||+|||+...+ ....++|+|||+++.......
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~--- 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH--- 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc---
Confidence 999999986555566667789999999999999999999999999999995332 234688999999987653221
Q ss_pred ccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 173 IPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 173 ~~~~~~~~~~Gt~~y~APE~~~---~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.+.......||+.|+|||++. +..++.++|||||||++|||++ |..||...... + ...+... ........
T Consensus 179 -~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~-~~~~~~~-~~~~~~~~ 252 (432)
T 3p23_A 179 -SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---Q-ANILLGA-CSLDCLHP 252 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---H-HHHHTTC-CCCTTSCT
T ss_pred -ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---H-HHHHhcc-CCccccCc
Confidence 111234567999999999998 4567889999999999999999 99999653221 1 1111111 11111001
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+..+.+||..||+.||.+||++.+|+
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 122356789999999999999999999765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=310.13 Aligned_cols=247 Identities=18% Similarity=0.226 Sum_probs=189.5
Q ss_pred CCCCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEe-
Q 012192 4 DGKLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVE- 82 (468)
Q Consensus 4 ~~~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~- 82 (468)
+..+..+.++++.+.+.+.||+|+||.||+|.+..+++.||||++.. ...+..|+.++.++.+|++|+.+..++..
T Consensus 7 ~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 44566777776544444889999999999999999999999998643 45678899998788788888888877765
Q ss_pred ---CceeEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEe
Q 012192 83 ---GDYNIMVIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 83 ---~~~~~lv~el~-ggsL~~ll~~~~-~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
....++|||++ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+...+.++.++|+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 67789999999 679999998643 4699999999999999999999999999999999999996433378999999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH-HHH
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-DKI 236 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~-~~i 236 (468)
||++.... +..++.++|||||||++|+|++|..||.+.......... ..+
T Consensus 164 fg~a~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 214 (299)
T 3m2w_A 164 FGFAKETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214 (299)
T ss_dssp CTTCEECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS
T ss_pred cccccccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH
Confidence 99986432 124677999999999999999999999764322110000 001
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.......+ ......+++++.++|..||+.||++||++.++ |++.+.
T Consensus 215 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~---l~hp~~ 260 (299)
T 3m2w_A 215 RMGQYEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWI 260 (299)
T ss_dssp CTTCCSSC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHH
T ss_pred hhccccCC-chhcccCCHHHHHHHHHHcccChhhCCCHHHH---hcChhh
Confidence 11111222 22335679999999999999999999999865 445544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=309.34 Aligned_cols=240 Identities=11% Similarity=0.074 Sum_probs=193.3
Q ss_pred CCCCCCCc-eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----chhHHHHHHHHHHhCCCCCceee
Q 012192 4 DGKLRMDH-VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----PQLHYESKLYMLLQGGTGIPHLK 77 (468)
Q Consensus 4 ~~~l~~~~-ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~ 77 (468)
+..+..++ +++++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+.| ++|+.++
T Consensus 19 ~~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~ 97 (286)
T 3uqc_A 19 DVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK-PGVARVL 97 (286)
T ss_dssp -CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCC-TTBCCEE
T ss_pred CCcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCC-CCcceee
Confidence 34577888 8999999999999999999999999999999999987655432 467888888877755 6788888
Q ss_pred EeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 78 WFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 78 ~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
.++...+..|+||||+ |++|.+++.. ......+..++.||+.||+|||++||+||||||+|||++ .++.++|+
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~ 171 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLA 171 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEEC
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEE
Confidence 8888899999999999 6899999863 346667899999999999999999999999999999994 77888887
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 236 (468)
+++. ++ .++.++|||||||++|||++|..||.+.............
T Consensus 172 ~~~~---------------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~ 217 (286)
T 3uqc_A 172 YPAT---------------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD 217 (286)
T ss_dssp SCCC---------------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC
T ss_pred eccc---------------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH
Confidence 5432 22 3688999999999999999999999875542211000000
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
. .....+...+...+|+++.++|.+||+.||++| ++.++++.|+.+..
T Consensus 218 ~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 218 T-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp T-TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred h-ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 1 111233445567789999999999999999999 99999999988754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.38 Aligned_cols=246 Identities=15% Similarity=0.237 Sum_probs=193.5
Q ss_pred CCCCceecCceEEEceEeeeCCeEEEEEEEcC-CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 7 LRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQ-TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 7 l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~-~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
+..++++.++|+++++||+|+||.||+|.+.. +++.||||++..... ...+..|+.++..+.| ++|+.++.++..
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 150 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH-PSIVQIFNFVEH 150 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCC-CCcCeEeeeEee
Confidence 56788999999999999999999999999976 789999998654322 2346788888888876 566666666554
Q ss_pred Cce-----eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 83 GDY-----NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 83 ~~~-----~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
.+. .||||||+ |++|.+++. ..+++..++.|+.||+.||.|||++|||||||||+|||+. .+.+||+
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~----~~~~kl~ 223 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLI 223 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSCEEEC
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe----CCcEEEE
Confidence 433 69999999 788888765 2799999999999999999999999999999999999994 3589999
Q ss_pred eCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 236 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i 236 (468)
|||+++..... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||.+.....
T Consensus 224 DFG~a~~~~~~-----------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------- 283 (681)
T 2pzi_A 224 DLGAVSRINSF-----------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------- 283 (681)
T ss_dssp CCTTCEETTCC-----------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------
T ss_pred ecccchhcccC-----------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------
Confidence 99999865431 345799999999998865 4889999999999999999999987532110
Q ss_pred hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 012192 237 SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKP-DYSYLKRLFRDLFI 286 (468)
Q Consensus 237 ~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RP-s~~~l~~~L~~~~~ 286 (468)
.....+ ....++.+.+||.+||+.||++|| +++++.+.|..++.
T Consensus 284 ----~~~~~~--~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 ----LPEDDP--VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ----CCTTCH--HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ----cccccc--ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 000101 112368899999999999999999 56677777766654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.65 Aligned_cols=264 Identities=16% Similarity=0.241 Sum_probs=195.5
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe------Cc
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE------GD 84 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~------~~ 84 (468)
.++|++.++||+|+||.||+|.+..++..||||++..... ...+..|++++..+.| ++|+.+..+... .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH-PNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCB-TTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCceeeeecccccccCCC
Confidence 3799999999999999999999988999999997654322 2357889999999975 566666555433 66
Q ss_pred eeEEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~--~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
..++|||++ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+..++....++|+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 779999999 889999998533 26899999999999999999999999999999999999964444456999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH------HHHHHH
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYDK 235 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~------~~~~~~ 235 (468)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... ......
T Consensus 172 ~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 172 KELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred ccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 8654322 12356799999999999999999999999999999999999999975311000 000000
Q ss_pred Hh-----hccc-----CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHH-----HHHHHHHHHH
Q 012192 236 IS-----EKKV-----STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSY-----LKRLFRDLFI 286 (468)
Q Consensus 236 i~-----~~~~-----~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~-----l~~~L~~~~~ 286 (468)
+. .... ......+...+++++.++|..||..||++||++.+ +.+.+++++.
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00 0000 01111233456899999999999999999999987 4455555543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=301.42 Aligned_cols=240 Identities=20% Similarity=0.177 Sum_probs=180.3
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----------chhHHHHHHHHHHh--------CCCCC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----------PQLHYESKLYMLLQ--------GGTGI 73 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----------~~~~~E~~~l~~l~--------~~~~i 73 (468)
+..++|+++++||+|+||+||+|.+ +++.||||++...... ..+..|+.++..+. .|+++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999997 7899999987654321 56889999999987 35555
Q ss_pred ceeeEeeE------------------------------eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH
Q 012192 74 PHLKWFGV------------------------------EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLIN 122 (468)
Q Consensus 74 ~~l~~~~~------------------------------~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~ 122 (468)
+.+..... .....++||||+ +|++.+.+. ...+++..+..++.||+.
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHH
Confidence 55544321 267899999998 665544443 357899999999999999
Q ss_pred HHHHHH-hCCceeccCCCCceeecccCCCC--------------------eEEEEeCCcccccccccCcccccccCCCCc
Q 012192 123 RVEYMH-SRGFLHRDIKPDNFLMGLGRKAN--------------------QVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181 (468)
Q Consensus 123 gL~yLH-s~giiHrDIKp~NiLl~~~~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 181 (468)
||+||| ++||+||||||+|||+. .++ .+||+|||+|+.... ...
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~---~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~~ 237 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLK---KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GIV 237 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEE---ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TEE
T ss_pred HHHHHHHhCCEeECCCCHHHEEEe---ccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------CcE
Confidence 999999 99999999999999995 333 899999999986543 234
Q ss_pred cccccccccccccCCCCCCcchHHHHHHH-HHHHHcCCCCCCCCCcccHHHHHHHHhhc-cc-CCCHHHhhccCcHHHHH
Q 012192 182 TGTARYASVNTHLGVEQSRRDDLESLGYV-LMYFLRGSLPWQGLKAGTKKQKYDKISEK-KV-STPIEVLCKSYPSEFVS 258 (468)
Q Consensus 182 ~Gt~~y~APE~~~~~~~s~ksDvwSlGvv-l~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~-~~~~~~l~~~~p~~~~~ 258 (468)
.||+.|+|||++.+.. +.++|||||+++ .++++.|..||.+... .......+... .. ..+.......+++++.+
T Consensus 238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHH
Confidence 7999999999999776 889999998877 6788889999953110 01111122211 11 11222234456899999
Q ss_pred HHHHHhcCCCCCCCCHHHHH
Q 012192 259 YFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 259 li~~cl~~~p~~RPs~~~l~ 278 (468)
||.+||+.| ++.+++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999966 776544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=274.38 Aligned_cols=185 Identities=16% Similarity=0.143 Sum_probs=131.2
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC------------CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK------------HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
..++.|++|.+..++....|+.||||++..... ..++.+|+++|.++.+|++|+.+..++++....||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 345678888777777777899999998654421 23588899999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||||+ |++|.+++.. ++.++.. .|+.||+.||+|||++|||||||||+|||+ +.++.|||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCC
Confidence 99999 8899999985 5567765 478999999999999999999999999999 57899999999999876542
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCC
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP 220 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~P 220 (468)
.+ ...+.+||+.|+|||++.+. +...+|+||+|++++++.++..+
T Consensus 393 ~~-------~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS-------WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C-------CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc-------cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 22 23456899999999999864 66789999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-26 Score=244.63 Aligned_cols=188 Identities=19% Similarity=0.194 Sum_probs=140.3
Q ss_pred EEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----------chhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----------PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 18 ~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----------~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
...+.||+|+||.||+|. ..+..+++|....+... ..+..|++++..+.| ++|+.+..+....+..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKD-FGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGG-GTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCC-CCcCceEEEEEeCCccE
Confidence 345689999999999994 46788999975443221 236889999999976 55554455555777789
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
|||||+ +++|.+++.. ++.++.|++.||+|||++||+||||||+|||+. . .+||+|||+++....
T Consensus 416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCC
T ss_pred EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCC
Confidence 999999 7999998874 568999999999999999999999999999994 3 999999999987654
Q ss_pred ccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCC
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQ 222 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~s~ksDvwSlGvvl~elltG~~Pf~ 222 (468)
........+.......||+.|+|||++.+ ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211111112246789999999999987 557888999999999998888877774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-23 Score=201.35 Aligned_cols=142 Identities=19% Similarity=0.268 Sum_probs=109.8
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--------------------CchhHHHHHHHHHHhCCCCCce
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--------------------HPQLHYESKLYMLLQGGTGIPH 75 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--------------------~~~~~~E~~~l~~l~~~~~i~~ 75 (468)
.|.+++.||+|+||.||+|.+ .+|+.||||+...... ...+..|+.++..+.+ ..++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-~~v~- 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-LAVP- 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-SSSC-
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-CCcC-
Confidence 455669999999999999998 8899999998643221 2347889999999983 3333
Q ss_pred eeEeeEeCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEE
Q 012192 76 LKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVY 154 (468)
Q Consensus 76 l~~~~~~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vk 154 (468)
..+ +.+..++|||++ |++|.+ +. ......++.|++.||.|||++||+||||||+|||+ + ++.++
T Consensus 168 -~~~--~~~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~vk 232 (282)
T 1zar_A 168 -KVY--AWEGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGIW 232 (282)
T ss_dssp -CEE--EEETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEEE
T ss_pred -eEE--eccceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcEE
Confidence 322 224569999999 668887 32 12355799999999999999999999999999999 4 88999
Q ss_pred EEeCCcccccccccCcccccccCCCCccccccccccccccC
Q 012192 155 IIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG 195 (468)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~ 195 (468)
|+|||+|+. +..|+|||++..
T Consensus 233 l~DFG~a~~--------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 233 IIDFPQSVE--------------------VGEEGWREILER 253 (282)
T ss_dssp ECCCTTCEE--------------------TTSTTHHHHHHH
T ss_pred EEECCCCeE--------------------CCCCCHHHHHHH
Confidence 999999863 234688888753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=180.40 Aligned_cols=136 Identities=19% Similarity=0.282 Sum_probs=105.7
Q ss_pred ceEEEceEeeeCCeEEEEEEEcCCCcE--EEEEEeeccCCC--------------------------chhHHHHHHHHHH
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQTGEE--IAVKLELVKTKH--------------------------PQLHYESKLYMLL 67 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~--vAIK~~~~~~~~--------------------------~~~~~E~~~l~~l 67 (468)
-|.+.+.||+|+||.||+|.+..+|+. ||||+....... ..+..|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778989 999985332100 1467899999999
Q ss_pred hCCC-CCceeeEeeEeCceeEEEEeccCC------CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCC
Q 012192 68 QGGT-GIPHLKWFGVEGDYNIMVIDLLGP------SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH-SRGFLHRDIKP 139 (468)
Q Consensus 68 ~~~~-~i~~l~~~~~~~~~~~lv~el~gg------sL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLH-s~giiHrDIKp 139 (468)
.++. .++.+..+ ...+|||||+++ +|.++... +++..+..++.|++.+|.||| +.|||||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8753 23333332 356899999953 67766432 234567889999999999999 99999999999
Q ss_pred CceeecccCCCCeEEEEeCCccccc
Q 012192 140 DNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 140 ~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.|||+. . .++|+|||+|...
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEET
T ss_pred HHEEEc---C--cEEEEECcccccC
Confidence 999994 3 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-16 Score=158.64 Aligned_cols=136 Identities=18% Similarity=0.272 Sum_probs=94.8
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--------CC--------ch--------hHHHHHHHHHHhCCCC
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--------KH--------PQ--------LHYESKLYMLLQGGTG 72 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--------~~--------~~--------~~~E~~~l~~l~~~~~ 72 (468)
|.++.+||.|+||.||+|.+ .+|+.||||+..... .. .. ...|...+.++.+ .+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~-~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE-EG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh-cC
Confidence 89999999999999999986 579999999743210 00 00 1346677777754 34
Q ss_pred CceeeEeeEeCceeEEEEeccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCC-
Q 012192 73 IPHLKWFGVEGDYNIMVIDLLG-PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKA- 150 (468)
Q Consensus 73 i~~l~~~~~~~~~~~lv~el~g-gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~- 150 (468)
++....+... ..+|||||++ ..|..+. ..+....++.||+.+|.|||+.|||||||||.|||+..+.+.
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 4333333222 2479999994 4554322 123345688999999999999999999999999999632110
Q ss_pred ------CeEEEEeCCcccc
Q 012192 151 ------NQVYIIDYGLAKK 163 (468)
Q Consensus 151 ------~~vkL~DFGla~~ 163 (468)
..++|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 1489999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=2.8e-11 Score=115.55 Aligned_cols=137 Identities=15% Similarity=0.246 Sum_probs=107.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc--CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK--TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~--~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
+.|++...++.|+++.||++.. .+..+++|+.... .....+..|..++..+..+..++.+..++......|++|++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 4599999999999999999874 3678999986542 33456899999999997777788888888888899999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS------------------------------------------ 129 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs------------------------------------------ 129 (468)
+ |.+|.+.+. +......++.+++.+|..||+
T Consensus 92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9 557765421 122334778899999999998
Q ss_pred -----------------CCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 130 -----------------RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 130 -----------------~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
..++|+|++|.|||+. ++..+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4589999999999993 44445699999864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=3.3e-10 Score=107.23 Aligned_cols=134 Identities=13% Similarity=0.072 Sum_probs=96.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCC-CceeeEeeEeCceeEEEEecc
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTG-IPHLKWFGVEGDYNIMVIDLL 93 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~l~~~~~~~~~~~lv~el~ 93 (468)
..|.+....+.|..+.||++. ..+|..++||+.... ....+..|..++..+.++.. ++.+..+....+..+++|+++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 357776555566679999986 456778999985443 34568899999999987644 677777777777789999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 012192 94 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG----------------------------------------- 131 (468)
Q Consensus 94 -ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~g----------------------------------------- 131 (468)
|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 44552 11 122 2256677777788887643
Q ss_pred -----------------ceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 132 -----------------FLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 132 -----------------iiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
++|+|++|.|||+. ++..+.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999993 44455699999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.8e-09 Score=105.65 Aligned_cols=138 Identities=13% Similarity=0.200 Sum_probs=98.7
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEee--ccC---CCchhHHHHHHHHHHhCC-CCCceeeEeeEeC---ceeEEE
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLEL--VKT---KHPQLHYESKLYMLLQGG-TGIPHLKWFGVEG---DYNIMV 89 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~--~~~---~~~~~~~E~~~l~~l~~~-~~i~~l~~~~~~~---~~~~lv 89 (468)
-++.|+.|.++.||+... .+..+++|+.. ... ....+..|..++..|... ..++.+..++.+. ...|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 457889999999999874 34578888654 221 234788899999999863 3367777766555 347899
Q ss_pred EeccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 012192 90 IDLLGP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS--------------------------------------- 129 (468)
Q Consensus 90 ~el~gg-sL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs--------------------------------------- 129 (468)
|+++.| .+.+ .....++......++.+++..|..||.
T Consensus 120 me~v~G~~l~~---~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWD---QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCC---TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCC---CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999954 4422 112357788888999999999999997
Q ss_pred -------------------CCceeccCCCCceeecccCCC-CeEEEEeCCcccc
Q 012192 130 -------------------RGFLHRDIKPDNFLMGLGRKA-NQVYIIDYGLAKK 163 (468)
Q Consensus 130 -------------------~giiHrDIKp~NiLl~~~~~~-~~vkL~DFGla~~ 163 (468)
..+||+|++|.|||+. ++. ..+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~--~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH--PTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC--SSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe--CCCCcEEEEECcccccc
Confidence 3589999999999994 122 3468999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.3e-09 Score=106.48 Aligned_cols=191 Identities=15% Similarity=0.151 Sum_probs=117.4
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCC--CceeeEeeEeCc---eeEEEEecc-
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTG--IPHLKWFGVEGD---YNIMVIDLL- 93 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~--i~~l~~~~~~~~---~~~lv~el~- 93 (468)
++.++.|.+..||+.. ..+++|+.........+..|..++..+..+.. ++.+..++.... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3568999999999853 46889974433234568899999988865433 444444433333 347889998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-------------------------------------------- 129 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs-------------------------------------------- 129 (468)
|..|.+... ..++.+....++.|++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 445543222 256777788888888888888885
Q ss_pred --------------CCceeccCCCCceeecccCC-CCeEEEEeCCcccccccccCccccccc---CC----CCccccccc
Q 012192 130 --------------RGFLHRDIKPDNFLMGLGRK-ANQVYIIDYGLAKKYRDLQTHKHIPYR---EN----KNLTGTARY 187 (468)
Q Consensus 130 --------------~giiHrDIKp~NiLl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~---~~----~~~~Gt~~y 187 (468)
..++|+|++|.|||+. ++ ...+.|+||+.+.......+....... .. ..+.....+
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~--~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFD--TEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEE--TTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEe--CCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1379999999999994 11 456789999998653221110000000 00 000000011
Q ss_pred cc-cccccCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 012192 188 AS-VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQ 222 (468)
Q Consensus 188 ~A-PE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~ 222 (468)
.. |+.... .....+.|++++++|.+.+|..+|.
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 222111 1123589999999999999988774
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.8e-06 Score=83.01 Aligned_cols=136 Identities=22% Similarity=0.252 Sum_probs=86.9
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCC--CCceeeEeeE-eCceeEEEEecc-CC
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGT--GIPHLKWFGV-EGDYNIMVIDLL-GP 95 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~--~i~~l~~~~~-~~~~~~lv~el~-gg 95 (468)
++.++.|....||+. +..++||+-........+..|.+++..+.++. .|+.+..++. .....+++|+++ |.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 345788889999986 46788897432222356889999999998743 3556655553 345568999998 44
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 012192 96 SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR--------------------------------------------- 130 (468)
Q Consensus 96 sL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~--------------------------------------------- 130 (468)
.|.+..- ..++......++.+++..|..||+.
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 4443211 1234444444555555555555432
Q ss_pred ---------------CceeccCCCCceeecccCCCCe-EEEEeCCcccc
Q 012192 131 ---------------GFLHRDIKPDNFLMGLGRKANQ-VYIIDYGLAKK 163 (468)
Q Consensus 131 ---------------giiHrDIKp~NiLl~~~~~~~~-vkL~DFGla~~ 163 (468)
.++|+|+.|.|||+...+.++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999952111344 58999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=5.5e-06 Score=78.79 Aligned_cols=132 Identities=17% Similarity=0.152 Sum_probs=90.7
Q ss_pred eEeeeCCe-EEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CCCHHH
Q 012192 22 KIGSGSFG-ELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLED 99 (468)
Q Consensus 22 ~LG~G~fG-~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-ggsL~~ 99 (468)
.+..|..| .||+......+..+++|+.... ....+..|...+..+...--|+.+..++.+.+..++||+++ |.++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 34445555 6898776666778999974432 23467889999999987666888888888889999999999 445555
Q ss_pred HHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------------
Q 012192 100 LFNYCNRKFSLKTVLMLADQLINRVEYMHSR------------------------------------------------- 130 (468)
Q Consensus 100 ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~------------------------------------------------- 130 (468)
..... ......++.+++..|..||..
T Consensus 110 ~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 110 VLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred cccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 44321 112233444555555555521
Q ss_pred ---------CceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 131 ---------GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 131 ---------giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
.++|+|+.+.|||+. ..+.+-|+||+.+.
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred hcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 278999999999993 44556699999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=8.9e-06 Score=82.15 Aligned_cols=74 Identities=12% Similarity=0.193 Sum_probs=50.0
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeecc---------CCCchhHHHHHHHHHHhCC--CCCceeeEeeEeCceeEE
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVK---------TKHPQLHYESKLYMLLQGG--TGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~---------~~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~~~~~~l 88 (468)
.+.||.|.++.||++.....+..|+||..... .....+..|.+++..+... ..++.++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 56899999999999975556678999974321 1223467899999888653 445666554 4555689
Q ss_pred EEeccCC
Q 012192 89 VIDLLGP 95 (468)
Q Consensus 89 v~el~gg 95 (468)
|||++.+
T Consensus 113 vmE~l~g 119 (397)
T 2olc_A 113 VMEDLSH 119 (397)
T ss_dssp EECCCTT
T ss_pred EEEeCCC
Confidence 9999854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1.3e-05 Score=79.49 Aligned_cols=79 Identities=11% Similarity=0.240 Sum_probs=53.0
Q ss_pred eEEEceE-eeeCCeEEEEEEEc--C----CCcEEEEEEeeccC-----CCchhHHHHHHHHHHhCC--CCCceeeEeeEe
Q 012192 17 FKLGRKI-GSGSFGELYLGVNV--Q----TGEEIAVKLELVKT-----KHPQLHYESKLYMLLQGG--TGIPHLKWFGVE 82 (468)
Q Consensus 17 y~i~~~L-G~G~fG~Vy~~~~~--~----~~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~ 82 (468)
....+.| +.|....+|+.... . ++..+++|+..... ....+..|..++..|... -.++.+..+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445677 88889999987642 0 15678899744322 135688999999988764 346666666544
Q ss_pred C---ceeEEEEeccCC
Q 012192 83 G---DYNIMVIDLLGP 95 (468)
Q Consensus 83 ~---~~~~lv~el~gg 95 (468)
. ...+++|+++.|
T Consensus 102 ~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEG 117 (357)
T ss_dssp STTTSSCEEEEECCCC
T ss_pred CCccCCceEEEEecCC
Confidence 4 245789999843
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00027 Score=69.02 Aligned_cols=71 Identities=10% Similarity=0.111 Sum_probs=40.9
Q ss_pred ceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCC-CCCceeeE------eeEeCceeEEEEecc
Q 012192 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG-TGIPHLKW------FGVEGDYNIMVIDLL 93 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~-~~i~~l~~------~~~~~~~~~lv~el~ 93 (468)
+.|+.|..+.||+... .. ..+++|+... ....+..|..++..|... -.++.+.. +....+..+++|+++
T Consensus 38 ~~l~gG~~n~~~~v~~-~~-~~~vlk~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT-DS-GAVCLKRIHR--PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEE-TT-EEEEEEEECS--CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEe-CC-CCEEEEecCC--CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 4566677899999874 23 4588997654 234556677777766532 12343332 223566788999998
Q ss_pred CC
Q 012192 94 GP 95 (468)
Q Consensus 94 gg 95 (468)
.|
T Consensus 114 ~G 115 (346)
T 2q83_A 114 EG 115 (346)
T ss_dssp CC
T ss_pred cC
Confidence 44
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00047 Score=66.62 Aligned_cols=68 Identities=10% Similarity=0.046 Sum_probs=46.0
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-CC
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GP 95 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~-gg 95 (468)
++.|+.|....+|+. ..+++|+-.... .......|..++..+......+.+..+ +.+..+++++++ +|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 678888999999998 467889754322 123456799888888765555666544 444457788888 54
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00031 Score=71.38 Aligned_cols=72 Identities=14% Similarity=0.294 Sum_probs=45.8
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeec-----cCC----CchhHHHHHHHHHHh--CCCCCceeeEeeEeCceeEE
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELV-----KTK----HPQLHYESKLYMLLQ--GGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~-----~~~----~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~l 88 (468)
++.||.|..+.||++.. .+..++||.... ... ......|.+++..+. .+..++.++.+. ....++
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 46789999999999853 567899994221 111 123445655554443 334566666654 566789
Q ss_pred EEecc-CC
Q 012192 89 VIDLL-GP 95 (468)
Q Consensus 89 v~el~-gg 95 (468)
||+++ .+
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 65
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0053 Score=59.47 Aligned_cols=140 Identities=17% Similarity=0.184 Sum_probs=76.7
Q ss_pred EEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCC-CceeeEe------eEeCceeEEEE
Q 012192 18 KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTG-IPHLKWF------GVEGDYNIMVI 90 (468)
Q Consensus 18 ~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~l~~~------~~~~~~~~lv~ 90 (468)
.-.+.|+.|....+|+... ..+ .+++|+.........+..|..++..|..... ++.+... ....+..++++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3456677888899999874 233 6788975543345677889999888765322 3433321 12345568889
Q ss_pred eccCCC-H-----H------HH---HHHcCCC--------CC---HHHHHH------------HHHHHHHHHHHHHh---
Q 012192 91 DLLGPS-L-----E------DL---FNYCNRK--------FS---LKTVLM------------LADQLINRVEYMHS--- 129 (468)
Q Consensus 91 el~ggs-L-----~------~l---l~~~~~~--------ls---~~~~~~------------ia~qia~gL~yLHs--- 129 (468)
+++.|. + . .. ++..... .. |..... +...+...+++++.
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 988442 1 1 11 1111111 11 111000 01123444555552
Q ss_pred ----CCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 130 ----RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 130 ----~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
.++||+|+.+.|||+. .+..+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 3699999999999993 34445799999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0046 Score=59.12 Aligned_cols=80 Identities=15% Similarity=0.103 Sum_probs=56.0
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
++.+.+..-++.+|.|..+.||+.+ ..+|+.|+||+...... ...+..|...|..|.....++....+..+.. ++
T Consensus 11 ~l~G~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~--~l 87 (288)
T 3f7w_A 11 ELTGREVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDR--TL 87 (288)
T ss_dssp HHHCCCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETT--EE
T ss_pred HhcCCCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCc--eE
Confidence 3456777888999999999999987 46788999997443322 2357789999999875444443333334443 67
Q ss_pred EEecc
Q 012192 89 VIDLL 93 (468)
Q Consensus 89 v~el~ 93 (468)
+|+++
T Consensus 88 v~e~l 92 (288)
T 3f7w_A 88 AMEWV 92 (288)
T ss_dssp EEECC
T ss_pred EEEee
Confidence 78877
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0025 Score=62.21 Aligned_cols=74 Identities=18% Similarity=0.248 Sum_probs=56.1
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhC--CCCCceeeEeeEeCceeEEEEeccCC
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQG--GTGIPHLKWFGVEGDYNIMVIDLLGP 95 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~--~~~i~~l~~~~~~~~~~~lv~el~gg 95 (468)
-.+.|+.|.+..+|+... .+..+++|+.... ....+..|...+..|.. ...++.+..++...+..+++|+++.|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456789999999999863 4668889975432 24567889999988864 35677777777777889999999943
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0062 Score=59.41 Aligned_cols=74 Identities=11% Similarity=0.009 Sum_probs=37.7
Q ss_pred ceEeeeCCeE-EEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCC-CCceeeEeeEeCceeEEEEeccCC-CH
Q 012192 21 RKIGSGSFGE-LYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGT-GIPHLKWFGVEGDYNIMVIDLLGP-SL 97 (468)
Q Consensus 21 ~~LG~G~fG~-Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~-~i~~l~~~~~~~~~~~lv~el~gg-sL 97 (468)
+.|+.|.... +|+... .++..+++|..... ....+..|..++..+.... .++.+..+.. +..+++|+.+++ .+
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~-~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPE-EGGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTT-TTCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCC-CCccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcch
Confidence 4565555444 667642 22566777753222 1256678888888887543 2555555422 223678888854 44
Q ss_pred H
Q 012192 98 E 98 (468)
Q Consensus 98 ~ 98 (468)
.
T Consensus 100 ~ 100 (333)
T 3csv_A 100 T 100 (333)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.007 Score=61.66 Aligned_cols=72 Identities=15% Similarity=0.099 Sum_probs=49.4
Q ss_pred EEceEeeeCCeEEEEEEEcC-------CCcEEEEEEeeccCCC-chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 19 LGRKIGSGSFGELYLGVNVQ-------TGEEIAVKLELVKTKH-PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~-------~~~~vAIK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
-++.|+.|-...||++.... .+..+++|+.... .. ..+..|..++..|......+.+.++.. + .+++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 34678888899999987542 2578999975332 23 566789999998877666676665432 2 3788
Q ss_pred eccCC
Q 012192 91 DLLGP 95 (468)
Q Consensus 91 el~gg 95 (468)
+++.|
T Consensus 152 e~l~G 156 (429)
T 1nw1_A 152 EYIPS 156 (429)
T ss_dssp CCCCE
T ss_pred EEeCC
Confidence 88743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.013 Score=56.72 Aligned_cols=72 Identities=13% Similarity=0.076 Sum_probs=45.0
Q ss_pred eEeeeCCeEEEEEEEcCCCcEEEEEEeecc-CCCchhHHHHHHHHHHhCCCC-CceeeEe-----eEeCceeEEEEeccC
Q 012192 22 KIGSGSFGELYLGVNVQTGEEIAVKLELVK-TKHPQLHYESKLYMLLQGGTG-IPHLKWF-----GVEGDYNIMVIDLLG 94 (468)
Q Consensus 22 ~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-~~~~~~~~E~~~l~~l~~~~~-i~~l~~~-----~~~~~~~~lv~el~g 94 (468)
.|+ |....||+... .+|..+++|+.... .....+..|..++..+..... ++.+... ....+..+++|+++.
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 456 78889998753 35667889986432 234567788888888764321 3333221 123456678999885
Q ss_pred C
Q 012192 95 P 95 (468)
Q Consensus 95 g 95 (468)
|
T Consensus 111 G 111 (328)
T 1zyl_A 111 G 111 (328)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0069 Score=60.10 Aligned_cols=72 Identities=13% Similarity=-0.047 Sum_probs=43.1
Q ss_pred EceEeeeCCeEEEEEEEcC--------CCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 20 GRKIGSGSFGELYLGVNVQ--------TGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~--------~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
.+.|+.|....+|+..... .+..+++|+...... ......|..++..+.....++.+.... . .+++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4577888889999987543 126788997433211 123468899988887655566665432 2 36788
Q ss_pred eccCC
Q 012192 91 DLLGP 95 (468)
Q Consensus 91 el~gg 95 (468)
+++.|
T Consensus 114 e~i~G 118 (369)
T 3c5i_A 114 EWLYG 118 (369)
T ss_dssp ECCCS
T ss_pred EEecC
Confidence 88844
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.55 E-value=0.033 Score=51.03 Aligned_cols=98 Identities=15% Similarity=0.136 Sum_probs=61.0
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 95 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH-SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 95 gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLH-s~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
-+|.+++..-+.++++++++.++.|.+.+|.-+- .+.-..+=+-|..|++ ..+|.|.+.+ ..+
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s------------ 96 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AAD------------ 96 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-ccc------------
Confidence 4799999988999999999999999999987762 1111122234566666 3566665442 110
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR 216 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt 216 (468)
......+.+||... ...+.+.=|||||+++|.-+-
T Consensus 97 -------~~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 97 -------DAGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -------cccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 01223456777653 234567889999999998766
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0077 Score=60.33 Aligned_cols=138 Identities=17% Similarity=0.161 Sum_probs=78.6
Q ss_pred ceEeeeCCeEEEEEEEcC-------CCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 21 RKIGSGSFGELYLGVNVQ-------TGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~-------~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
+.|..|-...+|++.... .+..+++|+-.... ....+.+|.+++..|......+.+.+++.. .+||++
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 466668888999987532 34688999742211 234566899999988876667777665432 288888
Q ss_pred cCC-CH--------------HHHHHHc-------CCCCC--HHHHHHHHHHHHH-------------------HHHHHH-
Q 012192 93 LGP-SL--------------EDLFNYC-------NRKFS--LKTVLMLADQLIN-------------------RVEYMH- 128 (468)
Q Consensus 93 ~gg-sL--------------~~ll~~~-------~~~ls--~~~~~~ia~qia~-------------------gL~yLH- 128 (468)
+.| .| .+.+... .+... +..+..+..++.. .++.|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 833 11 1112111 11122 3455555544322 233332
Q ss_pred ---h----CCceeccCCCCceeeccc-CCCCeEEEEeCCccc
Q 012192 129 ---S----RGFLHRDIKPDNFLMGLG-RKANQVYIIDYGLAK 162 (468)
Q Consensus 129 ---s----~giiHrDIKp~NiLl~~~-~~~~~vkL~DFGla~ 162 (468)
. ..++|+|+.+.|||+... +..+.+.|+||..|.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 258999999999999521 113689999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.34 E-value=0.084 Score=54.14 Aligned_cols=72 Identities=14% Similarity=0.028 Sum_probs=47.1
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEeccC
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLG 94 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~g 94 (468)
-++.|+.|-...+|++.....+..+++|+..... .......|..++..|......+.+.+++. + .++|+++.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 3467888989999998864435788899753322 11223689999999987666677766542 2 35888873
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.85 E-value=0.14 Score=50.12 Aligned_cols=31 Identities=32% Similarity=0.546 Sum_probs=25.9
Q ss_pred CCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 130 ~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++|+|+.+.|||+. .++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG---NEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEEC---GGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEe---CCCeEEEEECCCCee
Confidence 3699999999999993 456799999988754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.47 E-value=0.13 Score=52.25 Aligned_cols=72 Identities=13% Similarity=0.032 Sum_probs=48.1
Q ss_pred EceEeeeCCeEEEEEEEcCC-------CcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 20 GRKIGSGSFGELYLGVNVQT-------GEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~-------~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
++.|..|-...+|+...... +..+++++-..... .-....|..++..+......+.+.+. .. .+++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~--~~--~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIAD--FP--EGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEE--ET--TEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEE--cC--CCEEEE
Confidence 45677788889999876421 57889997433221 22457899999988876667776643 22 367889
Q ss_pred ccCC
Q 012192 92 LLGP 95 (468)
Q Consensus 92 l~gg 95 (468)
++.|
T Consensus 151 fI~G 154 (424)
T 3mes_A 151 FIDG 154 (424)
T ss_dssp CCCS
T ss_pred EeCC
Confidence 8844
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.26 E-value=0.38 Score=48.10 Aligned_cols=32 Identities=22% Similarity=0.424 Sum_probs=25.7
Q ss_pred ceeccCCCCceeecc---cCCCCeEEEEeCCcccc
Q 012192 132 FLHRDIKPDNFLMGL---GRKANQVYIIDYGLAKK 163 (468)
Q Consensus 132 iiHrDIKp~NiLl~~---~~~~~~vkL~DFGla~~ 163 (468)
++|+|+.+.|||+.. .++...++|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999942 13467899999998753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 468 | ||||
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-92 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-90 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-29 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-27 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-27 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-27 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-26 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-26 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-26 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-25 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-25 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-24 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-24 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-24 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-23 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-22 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-22 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-22 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-22 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-22 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-21 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-21 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-21 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-21 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-21 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-21 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-21 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-21 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-21 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-20 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-20 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-19 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-19 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-19 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-19 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-17 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-17 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-16 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-16 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-15 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 279 bits (714), Expect = 5e-92
Identities = 219/297 (73%), Positives = 269/297 (90%)
Query: 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ 68
M+ +G +++LGRKIGSGSFG++YLG ++ GEE+A+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
GG GIP ++W G EGDYN+MV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQ 305
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGA 297
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 274 bits (701), Expect = 4e-90
Identities = 162/292 (55%), Positives = 212/292 (72%), Gaps = 2/292 (0%)
Query: 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGT 71
V+G +K+GR+IG GSFG ++ G N+ +++A+K E ++ PQL E + Y LL G T
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 61
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
GIP++ +FG EG +N++VIDLLGPSLEDL + C RKFS+KTV M A Q++ RV+ +H +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 132 FLHRDIKPDNFLMGLG--RKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
++RDIKPDNFL+G + AN +Y++D+G+ K YRD T +HIPYRE KNL+GTARY S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 190 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249
+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKY++I EKK STP+ LC
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVL 301
+P EF Y HY R+L F+ PDY YL+ LF + R D FDW +L
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 115 bits (289), Expect = 3e-29
Identities = 50/263 (19%), Positives = 104/263 (39%), Gaps = 22/263 (8%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQ----LHYES 61
+++ DHV+ + + ++G+G+FG ++ TG A K V T H + E
Sbjct: 18 EIKHDHVLD-HYDIHEELGTGAFGVVHRVTERATGNNFAAKF--VMTPHESDKETVRKEI 74
Query: 62 KLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQL 120
+ +L+ + +L + + +M+ + + G L + + K S + Q+
Sbjct: 75 QTMSVLRH-PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180
+ +MH ++H D+KP+N + +++N++ +ID+GL Q+ K
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT------- 185
Query: 181 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240
TGTA +A+ G D+ S+G + L G P+ G + +
Sbjct: 186 -TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCD 241
Query: 241 VSTPIEVLCKSYPSEFVSYFHYC 263
+ + +
Sbjct: 242 WNMDDSAF-SGISEDGKDFIRKL 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 4e-29
Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 19/233 (8%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGT 71
F++GR +G G FG +YL Q+ +A+K+ +L K
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
I L + + ++++ KF + +L N + Y HS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 191
+HRDIKP+N L+G A ++ I D+G + H P L GT Y
Sbjct: 127 VIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTLDYLPPE 174
Query: 192 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
G + DL SLG + FL G P++ T ++ Y +IS + + P
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP 224
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 7e-29
Identities = 44/278 (15%), Positives = 108/278 (38%), Gaps = 19/278 (6%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
K+ + +G G FG ++ V + + K +++ T + E + + + I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 75 HLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 133
HL + +M+ + + G + + N + + + ++ Q+ ++++HS
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 134 HRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH 193
H DI+P+N + R+++ + II++G A++ + + + Y + H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175
Query: 194 LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP 253
S D+ SLG ++ L G P+ T +Q + I + + E K
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYTFDEEAF-KEIS 231
Query: 254 SEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQ 291
E + + + + + ++++ +
Sbjct: 232 IEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQKIE 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 111 bits (278), Expect = 1e-27
Identities = 53/256 (20%), Positives = 96/256 (37%), Gaps = 21/256 (8%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP----QLHYESKLYMLLQ 68
+ + + ++GSG+FG ++ V TG K + T +P + E + L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQLH 84
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 127
+ +L + +++++ L G L D + K S V+ Q +++M
Sbjct: 85 H-PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 128 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 187
H +H DIKP+N + +KA+ V IID+GLA K + K T TA +
Sbjct: 144 HEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEF 194
Query: 188 ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
A+ D+ ++G + L G P+ G + + +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWEFDEDA 251
Query: 248 LCKSYPSEFVSYFHYC 263
S E +
Sbjct: 252 F-SSVSPEAKDFIKNL 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-27
Identities = 50/238 (21%), Positives = 91/238 (38%), Gaps = 19/238 (7%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----LELVKTKHPQLHYESKLYMLLQGG 70
FK G+ +G GSF + L + T E A+K + + K P + E + L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH- 67
Query: 71 TGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
L + + + + L F ++++ +EY+H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHG 126
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
+G +HRD+KP+N L+ + + I D+G AK + GTA+Y S
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178
Query: 190 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
+ DL +LG ++ + G P++ G + + KI + + P +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYDFPEKF 233
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-27
Identities = 57/276 (20%), Positives = 115/276 (41%), Gaps = 19/276 (6%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIP 74
G+ +G++IGSGSFG +Y G + ++AVK+ V PQ K + + T
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 75 HL-KWFGVEGDYNI-MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
++ + G + +V G SL + KF + ++ +A Q ++Y+H++
Sbjct: 65 NILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 191
+HRD+K +N + + V I D+GLA + + L+G+ + +
Sbjct: 125 IIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSG-----SHQFEQLSGSILWMAPE 176
Query: 192 THLGVEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
++ S + D+ + G VL + G LP+ + + Q + +S + +
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDLSKV 234
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284
+ P C + +++P + + L
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 3e-27
Identities = 43/264 (16%), Positives = 93/264 (35%), Gaps = 19/264 (7%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTG 72
F+ ++G+G+ G ++ + +G +A K LE+ Q+ E ++
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPY 65
Query: 73 IPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR- 130
I + ++ + G SL+ + + + + ++ +I + Y+ +
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 190
+HRD+KP N L+ ++ + D+G++ + D + + GT Y S
Sbjct: 125 KIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYMSP 172
Query: 191 NTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250
G S + D+ S+G L+ G P A + + E +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 251 SYPSEFVSYFHYCRSLRFEDKPDY 274
+ + DY
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDY 256
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 4e-27
Identities = 43/224 (19%), Positives = 90/224 (40%), Gaps = 17/224 (7%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYM 65
+++ + +I + +G G G++ N +T E+ A+K + P+ E +L+
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHW 59
Query: 66 LLQGGTGIPHL----KWFGVEGDYNIMVIDLL-GPSLED-LFNYCNRKFSLKTVLMLADQ 119
I + + ++V++ L G L + + ++ F+ + +
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119
Query: 120 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENK 179
+ ++Y+HS HRD+KP+N L R + + D+G AK+ + Y
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---- 175
Query: 180 NLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
T Y + + + D+ SLG ++ L G P+
Sbjct: 176 ----TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-26
Identities = 57/290 (19%), Positives = 115/290 (39%), Gaps = 40/290 (13%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL--------ELVKTKHPQLHYESKLY 64
+ ++++G +GSG FG +Y G+ V +A+K ++ E L
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 65 MLLQGG-TGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLI 121
+ G +G+ L + D +++++ P DLF++ + + Q++
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVL 120
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181
V + H+ G LHRDIK +N L + ++ +ID+G +D +
Sbjct: 121 EAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKD---------TVYTDF 169
Query: 182 TGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240
GT Y+ R + SLG +L + G +P++ ++I +
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---------DEEIIRGQ 220
Query: 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR--LFRDLFIRE 288
V + SE +C +LR D+P + ++ +D+ + +
Sbjct: 221 VFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 48/244 (19%), Positives = 93/244 (38%), Gaps = 24/244 (9%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----LELVKTKHPQLHYE 60
K+ M+ F + +G G+FG++ L TG A+K + + K + E
Sbjct: 1 KVTMND-----FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 61 SKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQL 120
S++ + F ++ G L + F+ + ++
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEI 114
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180
++ +EY+HSR ++RDIK +N ++ K + I D+GL K+
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------T 164
Query: 181 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240
GT Y + + R D LG V+ + G LP+ ++ ++ I ++
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEE 221
Query: 241 VSTP 244
+ P
Sbjct: 222 IRFP 225
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-26
Identities = 47/270 (17%), Positives = 101/270 (37%), Gaps = 22/270 (8%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQ-GGTGIPH 75
+++ ++G G+FG++Y N +T A K+ K++ Y ++ +L I
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 76 LKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 134
L + ++I+ G +++ + R + + ++ Q ++ + Y+H +H
Sbjct: 74 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 133
Query: 135 RDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 194
RD+K N L + + D+G++ K + + GT + + +
Sbjct: 134 RDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAPEVVM 183
Query: 195 GVEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249
R D+ SLG L+ P L + KI++ + P
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE--PPTLAQP 238
Query: 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279
+ S F + C + + S L +
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-26
Identities = 60/281 (21%), Positives = 103/281 (36%), Gaps = 21/281 (7%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGT 71
+ L + +G G++GE+ L VN T E +AVK ++ + E + +L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 63
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
+ EG+ + ++ + QL+ V Y+H G
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 191
HRDIKP+N L+ + + + I D+GLA +R + + + GT Y +
Sbjct: 124 ITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVAPE 175
Query: 192 THLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250
E + D+ S G VL L G LPW Q+Y EKK K
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLNPW---K 230
Query: 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQ 291
S ++ H + + + +D + + +
Sbjct: 231 KIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKPLK 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 104 bits (261), Expect = 5e-26
Identities = 43/253 (16%), Positives = 81/253 (32%), Gaps = 22/253 (8%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----------LELVKTKHPQLHYESKLY 64
++ +G G + ++ T +E AVK E V+ E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINR 123
+ G I LK + +V DL+ L D S K + L+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEV 122
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 183
+ +H +HRD+KP+N L+ + + D+G + + + + + +
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 184 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243
+ + H G + D+ S G ++ L GS P+ + I
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNYQF 234
Query: 244 PIEVLCKSYPSEF 256
Y
Sbjct: 235 GSPEW-DDYSDTV 246
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 104 bits (259), Expect = 8e-26
Identities = 53/271 (19%), Positives = 107/271 (39%), Gaps = 23/271 (8%)
Query: 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----LELVKTKHPQLHYESKLYML 66
+ +++LG +G G E++L +++ ++AVK L + + + E++
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 67 LQGGTGIPHLKWFGVE----GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLI 121
L I + G G +V++ + G +L D+ + + K + +
Sbjct: 64 LN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADAC 121
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181
+ + H G +HRD+KP N ++ N V ++D+G+A+ D + +
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNS----VTQTAAV 174
Query: 182 TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241
GTA+Y S G R D+ SLG VL L G P+ G + + +
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG---DSPVSVAYQHVREDP 231
Query: 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKP 272
P + ++ + + E++
Sbjct: 232 -IPPSARHEGLSADLDAVVLKALAKNPENRY 261
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-25
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 17/223 (7%)
Query: 6 KLRMDHVIG---GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYES 61
KLR +G K+ KIG G+ G +Y ++V TG+E+A++ + L + +L
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 62 KLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQL 120
L M I + + GD +V++ L G SL D+ + + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCREC 125
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180
+ +E++HS +HRDIK DN L+ V + D+G + Q+ +
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------T 175
Query: 181 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
+ GT + + + D+ SLG + + + G P+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 3e-25
Identities = 64/293 (21%), Positives = 104/293 (35%), Gaps = 24/293 (8%)
Query: 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQG- 69
K++ KIG G+FGE++ + +TG+++A+K + E K+ LL+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 70 ------GTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 123
+ +V D L L + KF+L + + L+N
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 183
+ Y+H LHRD+K N L+ + + + D+GLA R K+ N
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLA---RAFSLAKNSQPNRYTNRVV 183
Query: 184 TARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242
T Y LG DL G ++ S QG T++ + IS+ S
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGS 240
Query: 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR--LFRDLFIREGFQFD 293
EV E + + + K R DL I + D
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL-IDKLLVLD 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 103 bits (257), Expect = 4e-25
Identities = 52/286 (18%), Positives = 109/286 (38%), Gaps = 23/286 (8%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
++L RK+G G + E++ +N+ E++ VK L K ++ E K+ L+GG I
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVK-ILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 76 LKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHR 135
L + + + D + + + +++ ++Y HS G +HR
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQL-YQTLTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 136 DIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG 195
D+KP N + + + ++ +ID+GLA+ Y Q + + + +
Sbjct: 154 DVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLVD 203
Query: 196 VEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPS 254
+ D+ SLG +L + P+ + +I++ + + Y
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 255 EFVSYFH-------YCRSLRFEDKPDYSYLKRLFRDLFIREGFQFD 293
E F+ R RF + + D + + ++D
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF-LDKLLRYD 306
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-25
Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 17/213 (7%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----LELVKTKHPQLHYESKLYMLLQGGT 71
F L + +G GSFG+++L +T + A+K + L+ E ++ L
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 72 GIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130
+ H+ + V++ L G L KF L A ++I ++++HS+
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 190
G ++RD+K DN L+ K + I D+G+ K+ + GT Y +
Sbjct: 123 GIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIAP 172
Query: 191 NTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 223
LG + + D S G +L L G P+ G
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (256), Expect = 4e-25
Identities = 46/251 (18%), Positives = 86/251 (34%), Gaps = 26/251 (10%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-----LELVKTKHPQLHYESKLYMLLQGG 70
F R+IG GSFG +Y +V+ E +A+K + K + E + L+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74
Query: 71 TGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 130
+ + +V++ S DL + + + + + Y+HS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 131 GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 190
+HRD+K N L+ + V + D+G A + GT + +
Sbjct: 135 NMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF-----------VGTPYWMAP 180
Query: 191 NTHLGVEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
L +++ + D D+ SLG + P + I++ +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPALQSG 237
Query: 248 LCKSYPSEFVS 258
Y FV
Sbjct: 238 HWSEYFRNFVD 248
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 1e-24
Identities = 47/255 (18%), Positives = 99/255 (38%), Gaps = 18/255 (7%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQG 69
I + +G+G+F E+ L + +T + +A+K + ++ K + E + ++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 70 GTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
I L G + +++ L+ G L D ++ + L Q+++ V+Y+H
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
G +HRD+KP+N L + +++ I D+GL+K GT Y
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGYV 176
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
+ S+ D S+G + L G P+ + +++I + +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYEFDSPYW 233
Query: 249 CKSYPSEFVSYFHYC 263
+ +
Sbjct: 234 -DDISDSAKDFIRHL 247
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 21/273 (7%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
KL ++G+G FGE+++G ++AVK L+ E+ L LQ +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLV 71
Query: 75 HLKWFGVEGDYNIMVIDLLGPSLED-LFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 133
L + I+ + SL D L K ++ +L +A Q+ + ++ R ++
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 134 HRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH 193
HRD++ N L+ I D+GLA+ D + + ++ +
Sbjct: 132 HRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTAPEAI 182
Query: 194 LGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252
+ + D+ S G +L + G +P+ G ++ + V +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNLERGYRMVRPDNC 235
Query: 253 PSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285
P E C R ED+P + YL+ + D F
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.8 bits (248), Expect = 6e-24
Identities = 50/232 (21%), Positives = 97/232 (41%), Gaps = 20/232 (8%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGTG 72
F++ R +G+GSFG ++L + G A+K+ +V+ K + + +L + +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 73 IPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 132
I + + M++D + +++F A ++ +EY+HS+
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 192
++RD+KP+N L+ K + I D+G AK D+ L GT Y +
Sbjct: 126 IYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYIAPEV 172
Query: 193 HLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
++ D S G ++ L G P+ + Y+KI ++ P
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELRFP 221
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 7e-24
Identities = 51/272 (18%), Positives = 104/272 (38%), Gaps = 19/272 (6%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
+L K+G G FGE+++G T +A+K L+ E+++ L+ +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 75 HLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 134
E Y + G L+ L + L ++ +A Q+ + + Y+ ++H
Sbjct: 77 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 136
Query: 135 RDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 194
RD++ N L+G + + D+GLA+ D + + ++ + L
Sbjct: 137 RDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR------QGAKFPIKWTAPEAAL 187
Query: 195 GVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP 253
+ + D+ S G +L +G +P+ G+ ++ D++ P
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPP----ECP 240
Query: 254 SEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285
C E++P + YL+ D F
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (249), Expect = 8e-24
Identities = 62/239 (25%), Positives = 96/239 (40%), Gaps = 20/239 (8%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLLQGGTG- 72
F + R IG G FGE+Y TG+ A+K + +K K + ++ ML TG
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 73 ---IPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
I + + D ++DL+ + FS + A ++I +E+MH+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
R ++RD+KP N L+ + V I D GLA + + H + GT Y +
Sbjct: 126 RFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMA 173
Query: 190 VNTHL-GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
GV D SLG +L LRG P++ K K + V P
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 3e-23
Identities = 58/289 (20%), Positives = 104/289 (35%), Gaps = 32/289 (11%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL 76
+ + IG+GSFG +Y +GE +A+K V + E ++ L +
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 77 KWFGVEGD-----YNIMVIDLLGPS-LEDLFNYCNRK--FSLKTVLMLADQLINRVEYMH 128
+F G+ Y +V+D + + +Y K + V + QL + Y+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH----KHIPYRENKNLTGT 184
S G HRDIKP N L + + D+G AK+ + + YR + + G
Sbjct: 140 SFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 185 ARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTP 244
Y + D+ S G VL L G + G + + +I + +
Sbjct: 198 TDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEIIKVLGTPT 243
Query: 245 IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFD 293
E + + P+ F ++ + K L ++
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPW-TKVFRPRTPPEAIAL-CSRLLEYT 290
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 4e-23
Identities = 59/286 (20%), Positives = 103/286 (36%), Gaps = 24/286 (8%)
Query: 9 MDHVIGGK-FKLGRKIGSGSFGELYLGV-NVQTGEEIAVKLELVKTKHP-------QLHY 59
+ +IG K +L K+G GSFG + G + +G+ ++V ++ +K
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 60 ESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ 119
E L + L + ++ SL D F L T+ A Q
Sbjct: 61 EVNAMHSLDH-RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 120 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENK 179
+ + Y+ S+ F+HRD+ N L+ + V I D+GL + H Y +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQE 172
Query: 180 NLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISE 238
+ + + + S D G L G PW GL Q KI +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDK 229
Query: 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284
+ P + P + + C + + ED+P + L+ +
Sbjct: 230 EGERLPRP---EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 1e-22
Identities = 52/278 (18%), Positives = 96/278 (34%), Gaps = 31/278 (11%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGT 71
+++ IG+GS+G G+ + K + + + L E L L+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 72 GIPHLKWFGVEGDYNI-MVIDLL-GPSLEDLFNYCNRK---FSLKTVLMLADQLINRVEY 126
+ + + + +V++ G L + ++ + VL + QL ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 127 MHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181
H R LHRD+KP N + V + D+GLA+ + K
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KAF 174
Query: 182 TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241
GT Y S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKF 231
Query: 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279
Y E +L+ +P +
Sbjct: 232 RRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 1e-22
Identities = 49/278 (17%), Positives = 100/278 (35%), Gaps = 27/278 (9%)
Query: 12 VIGGKF-KLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYML 66
G+F K +IG GSF +Y G++ +T E+A +L K++ + E+++
Sbjct: 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 64
Query: 67 LQGGTGIPHLKWF---GVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 123
LQ + + ++V +L+ + + +K + Q++
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124
Query: 124 VEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 181
++++H+R +HRD+K DN + V I D GLA R K +
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAV 173
Query: 182 TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV 241
GT + + + + D+ + G ++ P+ Q Y +++
Sbjct: 174 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVK 230
Query: 242 STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279
+ K E C +++ L
Sbjct: 231 PASFD---KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 3e-22
Identities = 51/292 (17%), Positives = 98/292 (33%), Gaps = 26/292 (8%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP----QLHYESKLYMLLQ 68
+G ++ IG G++G + + +A+K ++ +H + E K+ + +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTLREIKILLRFR 64
Query: 69 GGTGIPHLKWFGVEGDYN-----IMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 123
I + +V L+G L L + S + Q++
Sbjct: 65 -HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRG 121
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 183
++Y+HS LHRD+KP N L+ + I D+GLA+ H
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTE----YVA 174
Query: 184 TARYASVN-THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242
T Y + ++ D+ S+G +L L + G + + I S
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGILGS 231
Query: 243 TPIEVLCKSYPSEFVSY-FHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFD 293
E L + +Y + + DL + + F+
Sbjct: 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL-LDKMLTFN 282
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.0 bits (233), Expect = 3e-22
Identities = 50/275 (18%), Positives = 110/275 (40%), Gaps = 27/275 (9%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQ-----LHYESKLYMLLQGGTGIPH 75
++G G+FG + GV ++I V ++++K + + E+++ L P+
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70
Query: 76 L-KWFGV-EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 132
+ + GV + + ++V+++ G L + + V L Q+ ++Y+ + F
Sbjct: 71 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 133 LHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 192
+HRD+ N L+ + I D+GL+K ++ ++ +
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183
Query: 193 HLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251
+ S R D+ S G + L G P++ + + I + K
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGKRME----CPPE 236
Query: 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286
P E + C ++ED+PD+ +++ R +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 93.6 bits (232), Expect = 5e-22
Identities = 52/272 (19%), Positives = 109/272 (40%), Gaps = 17/272 (6%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIP 74
+ K+G G +GE+Y GV + +AVK L+ + + E+ + ++ +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 75 HLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFL 133
L E + I+ + +L D CNR+ S +L +A Q+ + +EY+ + F+
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 137
Query: 134 HRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH 193
HRD+ N L+G + + V + D+GL++ H + ++ + +
Sbjct: 138 HRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAPESL 188
Query: 194 LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP 253
+ S + D+ + G +L + G + ++ EK + P
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYP---GIDLSQVYELLEKDYRMERP---EGCP 242
Query: 254 SEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285
+ C D+P ++ + + F +F
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.9 bits (235), Expect = 5e-22
Identities = 50/236 (21%), Positives = 93/236 (39%), Gaps = 20/236 (8%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGT 71
+F + +G+GSFG + L + ++G A+K+ ++VK K + K +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
+ L++ + MV++ + +FS A Q++ EY+HS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 191
++RD+KP+N L+ + + D+G AK+ + GT +
Sbjct: 162 LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWTLC----------GTPEALAPE 208
Query: 192 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247
L ++ D +LG ++ G P+ Q Y+KI KV P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVRFPSHF 261
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 7e-22
Identities = 43/228 (18%), Positives = 88/228 (38%), Gaps = 19/228 (8%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP--------QLHYESKLYMLLQ 68
FK + +GSG+FG +Y G+ + GE++ + + +K ++ E+ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANKEILDEAYVMASVD 69
Query: 69 GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 128
+ L + ++ + L D + +L Q+ + Y+
Sbjct: 70 N-PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 129 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 188
R +HRD+ N L+ V I D+GLAK + H + ++
Sbjct: 129 DRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWM 180
Query: 189 SVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDK 235
++ + L + + D+ S G + + GS P+ G+ A +K
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.3 bits (233), Expect = 9e-22
Identities = 58/302 (19%), Positives = 103/302 (34%), Gaps = 32/302 (10%)
Query: 10 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQ 68
+ ++ L RK+G G F ++L ++ +A+K + K E KL +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 69 ----------GGTGIPHLKWFGVEGDYNIMVIDLLG-----PSLEDLFNYCNRKFSLKTV 113
G I L N + + ++ L + Y +R L V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 114 LMLADQLINRVEYM-HSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKH 172
++ QL+ ++YM G +H DIKP+N LM + + I H
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 173 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 232
T Y S LG D+ S ++ + G ++ + + +
Sbjct: 188 NSI-------QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDK--PDYSYLKRLFRDLFIREGF 290
D I++ I L PS + Y R+ + S LK + + E +
Sbjct: 241 DDHIAQ------IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 294
Query: 291 QF 292
+F
Sbjct: 295 KF 296
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 9e-22
Identities = 48/291 (16%), Positives = 107/291 (36%), Gaps = 31/291 (10%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQT-GEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGI 73
+++ +IG G++G+++ +++ G +A+K + + + + +L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 74 PH---LKWFGV--------EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLIN 122
H ++ F V E ++ + L +T+ + QL+
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 123 RVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 182
++++HS +HRD+KP N L+ + Q+ + D+GLA+ Y +
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV--------V 176
Query: 183 GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242
T Y + L + DL S+G + R ++G + + KI +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKILDVIGL 233
Query: 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFD 293
E + ++ + D L +DL + + F+
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDL-LLKCLTFN 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 1e-21
Identities = 55/282 (19%), Positives = 97/282 (34%), Gaps = 18/282 (6%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQGGTG 72
F+ KIG G++G +Y N TGE +A+K L+ P +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 73 IPHLKWFGVEGDYNIMVIDLLGPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRG 131
I L + +V + L L+ + L + QL+ + + HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 191
LHRD+KP N L+ + + D+GLA+ + + A
Sbjct: 123 VLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEI 173
Query: 192 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251
S D+ SLG + + + G ++ + +I + + TP EV+
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRI-FRTLGTPDEVVWPG 229
Query: 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFD 293
S + + R + L R L + + +D
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL-LSQMLHYD 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 2e-21
Identities = 48/270 (17%), Positives = 112/270 (41%), Gaps = 19/270 (7%)
Query: 21 RKIGSGSFGELYLGV--NVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHL-K 77
+++GSG+FG + G + + +AVK+ + P L E + P++ +
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 78 WFGV-EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRD 136
G+ E + ++V+++ + + NR K ++ L Q+ ++Y+ F+HRD
Sbjct: 73 MIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132
Query: 137 IKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV 196
+ N L+ + I D+GL+K R + + Y+ + ++ +
Sbjct: 133 LAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPECINYY 185
Query: 197 EQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSE 255
+ S + D+ S G ++ G P++G+ + + + + P E
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA----GCPRE 238
Query: 256 FVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285
+ C + E++P ++ ++ R+ +
Sbjct: 239 MYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 92.3 bits (228), Expect = 2e-21
Identities = 59/287 (20%), Positives = 109/287 (37%), Gaps = 30/287 (10%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHY----ESKLYMLLQGGT 71
K+ KIG G++G +Y N GE A+K ++ + + E + L+ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-S 60
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
I L ++V + L L+ L + C T QL+N + Y H R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH-----KHIPYRENKNLTGTAR 186
LHRD+KP N L+ + ++ I D+GLA+ + + YR L G+ +
Sbjct: 121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 187 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246
Y S D+ S+G + + G+ + G+ ++ + +I + + TP
Sbjct: 178 Y-----------STTIDIWSVGCIFAEMVNGTPLFPGV---SEADQLMRI-FRILGTPNS 222
Query: 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFD 293
+ ++ + L DL + + + D
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL-LSKMLKLD 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.3 bits (226), Expect = 2e-21
Identities = 38/227 (16%), Positives = 91/227 (40%), Gaps = 17/227 (7%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+++G+G FG + G + ++A+K ++ + E+K+ M L +
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQ 63
Query: 76 LKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 134
L + ++ + + L + +F + +L + + +EY+ S+ FLH
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 135 RDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 194
RD+ N L+ V + D+GL++ D + + R++ +
Sbjct: 124 RDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWSPPEVLM 174
Query: 195 GVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKK 240
+ S + D+ + G ++ G +P++ T + + I++
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGL 218
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 91.7 bits (227), Expect = 3e-21
Identities = 42/276 (15%), Positives = 98/276 (35%), Gaps = 21/276 (7%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEE---IAVK---LELVKTKHPQLHYESKLYMLLQGG 70
K+ + IG+G FGE+ G G+ +A+K + + E+ +
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH- 86
Query: 71 TGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
+ HL+ + +++ + + SL+ + +F++ ++ + + ++Y+
Sbjct: 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
++HRD+ N L+ + D+GL++ D + Y R+ +
Sbjct: 147 MNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRWTA 201
Query: 190 VNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
+ + D+ S G V+ + G P+ + T + + I + P
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDYRLPPPM-- 256
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284
PS C +P + + +
Sbjct: 257 --DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 3e-21
Identities = 48/291 (16%), Positives = 107/291 (36%), Gaps = 28/291 (9%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQ 68
+ ++ + +GSG++G + V+ +TG ++A+K + + + E +L ++
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 69 GGTGIPHLKWFGVEGDYNI-----MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 123
I L F + + +V+ +G L L + K + L Q++
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKG 133
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 183
+ Y+H+ G +HRD+KP N ++ K D + +
Sbjct: 134 LRYIHAAGIIHRDLKPGNLA------------VNEDCELKILDFGLARQADSEMTGYVVT 181
Query: 184 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243
A + ++ D+ S+G ++ + G ++G + +I + +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG---SDHLDQLKEIMKVTGTP 238
Query: 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPD-YSYLKRLFRDLFIREGFQFD 293
P E + + E +Y L +D + L +L + + D
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL-LEKMLVLD 288
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 4e-21
Identities = 50/276 (18%), Positives = 99/276 (35%), Gaps = 24/276 (8%)
Query: 16 KFKLGRKIGSGSFGELYLGVNV---QTGEEIAVK---LELVKTKHPQLHYESKLYMLLQG 69
+ +LGR IG G FG+++ G+ + +A+K + + E+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 70 GTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
I L E I++ L L ++++ A QL + Y+ S
Sbjct: 68 -PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
+ F+HRDI N L+ + V + D+GL++ D +K ++ +
Sbjct: 127 KRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPIKWMA 177
Query: 190 VNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248
+ + D+ G + L G P+QG+ K + + + + +
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGERLPM 230
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284
+ P S C + +P ++ LK +
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 4e-21
Identities = 46/296 (15%), Positives = 88/296 (29%), Gaps = 46/296 (15%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHP--------QLHYESKLYMLL 67
+ G+ +GSG+FG++ + VK L E K+ L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 68 QGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFS----------------- 109
I +L ++ + L + KFS
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 110 -----LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
+ +L A Q+ +E++ + +HRD+ N L+ V I D+GLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDI 214
Query: 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQG 223
+ N ++ + + + + D+ S G +L G P+ G
Sbjct: 215 MSDSNYVV-----RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 224 LKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279
+ + K+ + E C + +P + L
Sbjct: 270 I---PVDANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.1 bits (223), Expect = 5e-21
Identities = 49/271 (18%), Positives = 103/271 (38%), Gaps = 21/271 (7%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQLHYESKLYMLLQGGTGIPH 75
++IGSG FG ++LG +++A+K + E+++ M L +
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQ 64
Query: 76 LKWFGVEGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 134
L +E +V + + L D F+ +T+L + + + Y+ +H
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 124
Query: 135 RDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 194
RD+ N L+ + + + D+G+ + D Q + ++AS
Sbjct: 125 RDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPEVFS 175
Query: 195 GVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYP 253
S + D+ S G ++ G +P++ + + + IS +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR----LYKPRLAS 228
Query: 254 SEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284
+ ++C R ED+P +S L R ++
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.1 bits (225), Expect = 5e-21
Identities = 51/301 (16%), Positives = 98/301 (32%), Gaps = 47/301 (15%)
Query: 16 KFKLGRKIGSGSFGELYLG-----VNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLL 67
+ R IG G+FG ++ + + +AVK E E+ L
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 68 QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR--------------------- 106
+ L V ++ + L + +
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 107 --KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164
S L +A Q+ + Y+ R F+HRD+ N L+G + V I D+GL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNI 190
Query: 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQG 223
Y+ + N R+ + + D+ + G VL G P+ G
Sbjct: 191 YSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 224 LKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283
+ ++ + + + E + P E + C S D+P + + R+ +
Sbjct: 246 M---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
Query: 284 L 284
+
Sbjct: 299 M 299
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 2e-20
Identities = 50/247 (20%), Positives = 92/247 (37%), Gaps = 21/247 (8%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK-LELVKTKHPQ-------LHYESKLY 64
+ + G ++GSG F + TG + A K ++ +TK + + E +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 65 MLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRV 124
+Q + L I++++L+ F + + Q++N V
Sbjct: 68 KEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 125 EYMHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 183
Y+HS H D+KP+N ++ ++ IID+GLA K K+I G
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FG 178
Query: 184 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243
T + + D+ S+G + L G+ P+ G TK++ +S
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEF 235
Query: 244 PIEVLCK 250
E
Sbjct: 236 EDEYFSN 242
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (222), Expect = 2e-20
Identities = 49/291 (16%), Positives = 102/291 (35%), Gaps = 28/291 (9%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQ 68
+ +++ +GSG++G + + +TG +AVK + + E +L ++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 69 -----GGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 123
G + E + +V L+G L ++ +K + V L Q++
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRG 133
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 183
++Y+HS +HRD+KP N + + K D +H +
Sbjct: 134 LKYIHSADIIHRDLKPSNLAV------------NEDCELKILDFGLARHTDDEMTGYVAT 181
Query: 184 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243
A + ++ D+ S+G ++ L G + G + I +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVGTP 238
Query: 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPD-YSYLKRLFRDLFIREGFQFD 293
E+L K +Y + + + + L DL + + D
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL-LEKMLVLD 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 4e-20
Identities = 44/244 (18%), Positives = 84/244 (34%), Gaps = 36/244 (14%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKL-----ELVKTKHPQLHYESKLYMLLQGGT 71
K IG G+FG++ + G + + K H E ++ L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 72 GIPHLKWFGVEGDYNIMVIDLL-GPSLEDL---------------FNYCNRKFSLKTVLM 115
I +L Y + I+ +L D N S + +L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 116 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175
A + ++Y+ + F+HRD+ N L+G + I D+GL++
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG-- 186
Query: 176 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYD 234
R+ ++ + + D+ S G +L + G P+ G+ T + Y+
Sbjct: 187 ------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYE 237
Query: 235 KISE 238
K+ +
Sbjct: 238 KLPQ 241
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.6 bits (214), Expect = 1e-19
Identities = 50/272 (18%), Positives = 94/272 (34%), Gaps = 25/272 (9%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPH 75
+ KL + IG G FG++ LG G ++AVK E+ + L+ +
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 76 LKWFGVEGDYNIMVIDLL-GPSLED-LFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 133
L E +V + + SL D L + +L + + +EY+ F+
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 125
Query: 134 HRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH 193
HRD+ N L+ + N + D+GL K+ Q ++ +
Sbjct: 126 HRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWTAPEAL 172
Query: 194 LGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252
+ S + D+ S G +L G +P+ + K ++ + +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPD----GC 225
Query: 253 PSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284
P C L +P + L+ +
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 1e-19
Identities = 48/253 (18%), Positives = 108/253 (42%), Gaps = 30/253 (11%)
Query: 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKTKHPQ------ 56
K+ +++ F+L + +G+G++G+++L + TG+ A+K L K Q
Sbjct: 20 KVGIEN-----FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK-VLKKATIVQKAKTTE 73
Query: 57 -LHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLM 115
E ++ ++ + L + +++D + +F+ V +
Sbjct: 74 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 133
Query: 116 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPY 175
+++ +E++H G ++RDIK +N L+ V + D+GL+K++ +T + +
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 176 RENKNLTGTARYASVNTHLGVEQ--SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 233
GT Y + + G + + D SLG ++ L G+ P+ +K
Sbjct: 191 C------GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD---GEKNSQ 241
Query: 234 DKISEKKVSTPIE 246
+IS + + +
Sbjct: 242 AEISRRILKSEPP 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 1e-19
Identities = 43/292 (14%), Positives = 93/292 (31%), Gaps = 39/292 (13%)
Query: 16 KFKLGRKIGSGSFGELYLG-----VNVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLL 67
+ G+ +G+G+FG++ + +AVK+ T+ L E K+ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 68 QGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDL-----------------FNYCNRKFS 109
I +L G +++ + L +
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169
L+ +L + Q+ + ++ S+ +HRD+ N L+ I D+GLA+ ++
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSN 200
Query: 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 229
+ N ++ + + + D+ S G L
Sbjct: 201 YVV-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPV 253
Query: 230 KQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLF 281
K+ K+ ++ + P+E C +P + + +L
Sbjct: 254 DSKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (216), Expect = 1e-19
Identities = 46/251 (18%), Positives = 98/251 (39%), Gaps = 26/251 (10%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYESKLYMLLQG 69
+ +++ + IGSG+ G + + +A+K H + Y + M
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 70 GTGIPHLKWFGV------EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 123
I L E +V++L+ +L + + + L Q++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLCG 131
Query: 124 VEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 183
++++HS G +HRD+KP N ++ + + I+D+GLA+
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY--------VV 180
Query: 184 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243
T Y + LG+ D+ S+G ++ +R + + G +++K+ E+ +
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGTP 237
Query: 244 PIEVLCKSYPS 254
E + K P+
Sbjct: 238 CPEFMKKLQPT 248
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 2e-19
Identities = 39/276 (14%), Positives = 95/276 (34%), Gaps = 22/276 (7%)
Query: 17 FKLGRKIGSGSFGELYLGVNVQTGEE----IAVK---LELVKTKHPQLHYESKLYMLLQG 69
+ IG+G FGE+Y G+ + + +A+K + + E+ +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 70 GTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
I I+ + +L+ + +FS+ ++ + + ++Y+ +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
++HRD+ N L+ + D+GL++ D + R+ +
Sbjct: 129 MNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRWTA 181
Query: 190 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-KVSTPIEVL 248
+ + D+ S G V+ + + + I++ ++ TP++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGFRLPTPMDC- 238
Query: 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284
PS C +P ++ + + L
Sbjct: 239 ----PSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.2 bits (212), Expect = 2e-19
Identities = 58/283 (20%), Positives = 101/283 (35%), Gaps = 20/283 (7%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEEIAVKL----ELVKTKHPQLHYESKLYMLLQGGT 71
K++ KIG G++G ++ N +T E +A+K + + E L L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HK 61
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 131
I L +V + L+ F+ CN + V QL+ + + HSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 132 FLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 191
LHRD+KP N L+ + ++ + ++GLA+ + IP R T Y +
Sbjct: 122 VLHRDLKPQNLLIN---RNGELKLANFGLARAF-------GIPVRCYSAEVVTLWYRPPD 171
Query: 192 THLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250
G + S D+ S G + P + +I + + TP E
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRI-FRLLGTPTEEQWP 228
Query: 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFD 293
S + L RDL ++ + +
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL-LQNLLKCN 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 3e-19
Identities = 54/281 (19%), Positives = 92/281 (32%), Gaps = 25/281 (8%)
Query: 21 RKIGSGSFGELYLGVNVQTGEEIAVK-------LELVKTKHPQLHYESKLYMLLQGGTGI 73
+G G F +Y + T + +A+K E + E KL L I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNI 62
Query: 74 PHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 133
L +V D + LE + + + + + +EY+H L
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 134 HRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH 193
HRD+KP+N L+ + + + D+GLAK + P R + T Y +
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGS-------PNRAYTHQVVTRWYRAPELL 172
Query: 194 LGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252
G D+ ++G +L L G + + +I E + E
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 253 PSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFD 293
F + +S DL I+ F F+
Sbjct: 230 SLPDYVTFKSFPGIPLHHI--FSAAGDDLLDL-IQGLFLFN 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 3e-17
Identities = 42/236 (17%), Positives = 91/236 (38%), Gaps = 35/236 (14%)
Query: 16 KFKLGRKIGSGSFGELYLGVNVQTGEE-------IAVK---LELVKTKHPQLHYESKLYM 65
+ LG+ +G G+FG++ L + ++ +AVK + + L E ++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 66 LLQGGTGIPHLKWFGVEGDYNIMVIDLL-GPSLEDLFNYC---------------NRKFS 109
++ I +L + ++++ +L + + S
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 110 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I D+GLA+ +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 190
Query: 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGL 224
+K N ++ + + + D+ S G +L G P+ G+
Sbjct: 191 YKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (193), Expect = 8e-17
Identities = 48/294 (16%), Positives = 104/294 (35%), Gaps = 34/294 (11%)
Query: 16 KFKLGRKIGSGSFGELYLGVN-----VQTGEEIAVK---LELVKTKHPQLHYESKLYMLL 67
K + R++G GSFG +Y GV + +A+K + + E+ +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 68 QGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNR---------KFSLKTVLMLAD 118
+ L +++ + L+ SL ++ +A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 119 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYREN 178
++ + + Y+++ F+HRD+ N ++ + V I D+G+ + + YR+
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRKG 192
Query: 179 KNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKIS 237
R+ S + + D+ S G VL P+QGL + +Q +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFVM 249
Query: 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQ 291
E + + + P C + +P + + ++ + GF+
Sbjct: 250 EGGLLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE-MEPGFR 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.0 bits (191), Expect = 1e-16
Identities = 43/231 (18%), Positives = 86/231 (37%), Gaps = 33/231 (14%)
Query: 16 KFKLGRKIGSGSFGELYLGV-----NVQTGEEIAVKL---ELVKTKHPQLHYESKLYMLL 67
+ KLG+ +G G+FG++ T +AVK+ ++H L E K+ + +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 68 QGGTGIPHLKWFGVEGDYNIMVI--DLLGPSLEDLFNYCNRKF---------------SL 110
+ +L + +MVI +L +F +L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 111 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170
+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I D+GLA+ +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDY 190
Query: 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
+ ++ + T + + D+ S G +L
Sbjct: 191 VR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.8 bits (183), Expect = 2e-16
Identities = 26/161 (16%), Positives = 56/161 (34%), Gaps = 31/161 (19%)
Query: 19 LGRKIGSGSFGELYLGVNVQTGEEIAVK---LELVKTKHPQLHYE--------------S 61
+G+ +G G ++ + + E VK + K + +
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 62 KLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLI 121
+ LQ G+ K + EG+ +M E + + ++ + D ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLM---------ELIDAKELYRVRVENPDEVLDMIL 113
Query: 122 NRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162
V + RG +H D+ N L+ ++IID+ +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSV 150
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (186), Expect = 8e-16
Identities = 37/216 (17%), Positives = 82/216 (37%), Gaps = 18/216 (8%)
Query: 19 LGRKIGSGSFGELYLGVNV---QTGEEIAVKLELVKTKHP----QLHYESKLYMLLQGGT 71
IG G FG +Y G + AVK L + Q E +
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLTEGIIMKDFSH-P 88
Query: 72 GIPHLKWFGVEGDYNIMVI--DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 129
+ L + + + +V+ + L + ++K ++ Q+ ++++ S
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 130 RGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 189
+ F+HRD+ N ++ + V + D+GLA+ D + ++ +
Sbjct: 149 KKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMA 202
Query: 190 VNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGL 224
+ + + + + D+ S G +L + RG+ P+ +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 2e-15
Identities = 54/227 (23%), Positives = 79/227 (34%), Gaps = 27/227 (11%)
Query: 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGG-T 71
I L IG G FGE++ G GEE+AVK+ + E+++Y +
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKI-FSSREERSWFREAEIYQTVMLRHE 57
Query: 72 GIPHLKWFGVEGDYNIMVIDLLGPSLE--DLFNYCNR---------KFSLKTVLMLADQL 120
I + + + L+ E LF+Y NR K +L T LA
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 121 INRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKN 180
+ V HRD+K N L+ K I D GLA ++ I +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP---NH 171
Query: 181 LTGTARY------ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 221
GT RY E +R D+ ++G V R
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 468 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.72 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-59 Score=459.63 Aligned_cols=296 Identities=74% Similarity=1.338 Sum_probs=267.2
Q ss_pred CCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 9 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 9 ~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
|+--||++|+++++||+|+||+||+|.+..+|+.||||++.......++..|++++..+.|+++|+.+.+++.+.+..++
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 56678999999999999999999999999999999999988877788899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 89 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 89 v~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+++++|.+.+....+.+++..++.++.|++.||+|||++|||||||||+|||+...+.+..++|+|||+|+.+....
T Consensus 81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99999999999988778899999999999999999999999999999999999999766677889999999999887766
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....++.......||+.|+|||++.+..++.++|||||||++|||++|..||...........+..........+.+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 66666666777889999999999999999999999999999999999999999987766666666666667677788888
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccccCC
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLKYP 304 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 304 (468)
+..+|+++.+||..||+.+|++||++++|.++|++++.+.++..+++|||+.++..
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~ 296 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCC
Confidence 88999999999999999999999999999999999999999999999999998753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-58 Score=450.78 Aligned_cols=291 Identities=56% Similarity=0.989 Sum_probs=267.4
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
+|++++|+++++||+|+||+||+|.+..+|+.||||++........+..|++++..+.++++++.+..++......++||
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 58899999999999999999999999999999999998777777889999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC--CCCeEEEEeCCccccccccc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~--~~~~vkL~DFGla~~~~~~~ 168 (468)
|+++++|.+++......+++.++..++.|++.||+|||++|||||||||+|||++... ..+.+||+|||+|+.+....
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 9999999999987778899999999999999999999999999999999999996422 35789999999999887665
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....++......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+..+...+...+.+.+
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 55556666677889999999999999999999999999999999999999999988777777777777777777788889
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVL 301 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 301 (468)
++.+|+++.++|..||..+|++||+|+.|.++|++++.+.++..+++|||+.+
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 99999999999999999999999999999999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=391.77 Aligned_cols=242 Identities=23% Similarity=0.333 Sum_probs=207.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++++.||+|+||+||+|.+..+++.||||++... .....+.+|++++..+.| ++|+.++.++.+.+..++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCC-CCCCeEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999986532 234467889999988865 6788888888899999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +|+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC
T ss_pred EeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCCc
Confidence 9999 7899999985 4579999999999999999999999999999999999999 578899999999997654321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....||+.|+|||++.+..|+.++|||||||+||||++|..||.+.. ..+.+..+.......|
T Consensus 161 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~p---- 224 (263)
T d2j4za1 161 ---------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFTFP---- 224 (263)
T ss_dssp ---------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCCCC----
T ss_pred ---------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCC----
Confidence 234679999999999999999999999999999999999999998643 3445555555544433
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..+++++.+||..||+.||++||++++|+
T Consensus 225 -~~~s~~~~~li~~~L~~dp~~R~t~~eil 253 (263)
T d2j4za1 225 -DFVTEGARDLISRLLKHNPSQRPMLREVL 253 (263)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -ccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 34689999999999999999999999654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-51 Score=396.88 Aligned_cols=267 Identities=20% Similarity=0.314 Sum_probs=219.6
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
.++|++++.||+|+||+||+|.+..+++.||||++... .....+..|++++..+.| ++|+.++.++.+.+..||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCS-TTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCC-CCeeEEEEEEEECCEEEE
Confidence 46799999999999999999999999999999986532 333568899999998876 677788888888999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 89 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 89 v~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
||||+ +|+|.+++.. .+.+++..+..++.|++.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccC
Confidence 99999 7899998885 5689999999999999999999999999999999999999 57889999999999876432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
... ......+||+.|+|||++.+..|+.++|||||||+||||++|..||.+. +..+.+.++.......|
T Consensus 162 ~~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~p--- 230 (288)
T d1uu3a_ 162 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLEYDFP--- 230 (288)
T ss_dssp -------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCCCC---
T ss_pred Ccc-----cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCCCCCC---
Confidence 211 1234568999999999999999999999999999999999999999864 33455555655554443
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
..+++++.+||..||+.||++||+++++.+. ... ..++|+..+||+.+.
T Consensus 231 --~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~---~~i-~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 231 --EKFFPKARDLVEKLLVLDATKRLGCEEMEGY---GPL-KAHPFFESVTWENLH 279 (288)
T ss_dssp --TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH---HHH-HTSGGGTTCCCTTGG
T ss_pred --ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC---HHH-HcCCccCCCCHHHhh
Confidence 3568999999999999999999999976442 111 246788889998765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=396.24 Aligned_cols=245 Identities=21% Similarity=0.313 Sum_probs=205.3
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.++|+++++||+|+||+||+|.+..+|+.||||++.... ....+.+|++++..+.| ++|+.++.++.+.+..+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCC-CCEeeEeEEEEECCEEEEEEE
Confidence 468999999999999999999999999999999866443 33468899999988876 677788888888999999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 92 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 92 l~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
|+ ||+|.+++.. +.+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+.....
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccccc-
Confidence 99 8899998874 579999999999999999999999999999999999999 4778999999999987643221
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc-cCCCHHHhh
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK-VSTPIEVLC 249 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~~l~ 249 (468)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+... .+.+..+.... ...+ ..
T Consensus 172 ------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~~~~~~~~---~~ 239 (293)
T d1yhwa1 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPELQ---NP 239 (293)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCCS---SG
T ss_pred ------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCCCC---Cc
Confidence 12456899999999999999999999999999999999999999986443 22333333322 2222 22
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
..+++++.+||..||+.||++||++.++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~ei 267 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 4568999999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-51 Score=394.23 Aligned_cols=260 Identities=21% Similarity=0.330 Sum_probs=204.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
|-.++|+++++||+|+||+||+|++ +..||||++..... ...+..|++++..++| ++|+.+++++.+ ...+
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-VNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCC-TTBCCEEEEECS-SSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeeeeEEEec-cEEE
Confidence 4457899999999999999999974 34699998654322 2457789999999876 566677776544 4578
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+||||+ +|+|.+++......+++..++.|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC---
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeeccc
Confidence 999998 689999998666789999999999999999999999999999999999999 4789999999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
... ........||+.|+|||++.+. .|+.++|||||||+||||++|..||.+..... +....+.......
T Consensus 157 ~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p 229 (276)
T d1uwha_ 157 WSG-----SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSP 229 (276)
T ss_dssp --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCC
T ss_pred cCC-----cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCCC
Confidence 221 1123456899999999999753 48999999999999999999999998765432 2222233333333
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
........+|+++.+||..||+.||++||++.+|++.|+.+..
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3445556789999999999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-51 Score=392.82 Aligned_cols=249 Identities=26% Similarity=0.339 Sum_probs=204.1
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
-++|+++++||+|+||+||+|.+..+|+.||||++.... ....+.+|++++..+.| ++|+.++.++.+.+..+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCC-CCEeeEeeeeccCceeEEEE
Confidence 368999999999999999999999999999999865432 23468899999988875 67788888888999999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCCc
Confidence 999 7799998863 5679999999999999999999999999999999999999 4778999999999987653221
Q ss_pred cccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.......+||+.|+|||++.+..+ +.++|||||||+||||++|..||....... ..+..+.......+ .
T Consensus 159 -----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~~~~~~---~ 228 (271)
T d1nvra_ 159 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYLN---P 228 (271)
T ss_dssp -----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTTCTTST---T
T ss_pred -----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCCCCC---c
Confidence 112345789999999999998876 678999999999999999999998654332 22222323222222 1
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
...+++++.+||.+||+.||++||++++|
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~ei 257 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDI 257 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 24568999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=393.73 Aligned_cols=248 Identities=18% Similarity=0.265 Sum_probs=206.1
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
+.|+++++||+|+||+||+|.+..+++.||||++.... ....+..|++++..+.| ++|+.++.++.+.+..+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCeEEEEEec
Confidence 46999999999999999999999999999999876543 23578899999999875 6777888888889999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc--
Confidence 9 889999987667789999999999999999999999999999999999999 4788999999999976543211
Q ss_pred cccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 172 HIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~-----~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
......||+.|+|||++. +..|+.++|||||||++|||++|..||.+...... +..+....... .
T Consensus 166 -----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i~~~~~~~--~ 235 (288)
T d2jfla1 166 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIAKSEPPT--L 235 (288)
T ss_dssp -----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHHSCCCC--C
T ss_pred -----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHHHcCCCCC--C
Confidence 123568999999999984 45589999999999999999999999987654433 33333332211 1
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.....+++++.+||..||+.||++||++++|+
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 12245689999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-50 Score=395.96 Aligned_cols=264 Identities=16% Similarity=0.264 Sum_probs=202.8
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCc---EEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCc
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGE---EIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGD 84 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~ 84 (468)
++-.++|++.++||+|+||+||+|.+..++. .||||.+..... ...+.+|++++..++| ++|+.+++++...+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeCC
Confidence 3556789999999999999999999876654 588887544332 2358899999999865 67777888888888
Q ss_pred eeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 85 YNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 85 ~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
..++||||+ +|+|.+++......+++..++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+++.
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRF 177 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceE
Confidence 999999999 889999988767789999999999999999999999999999999999999 5789999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
........ .+.......||+.|+|||++.+..++.++|||||||+||||++ |..||.+.... +.+..+.. ...
T Consensus 178 ~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~~-~~~ 251 (299)
T d1jpaa_ 178 LEDDTSDP--TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIEQ-DYR 251 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHT-TCC
T ss_pred ccCCCCcc--eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-CCC
Confidence 65432211 1112234568999999999999999999999999999999998 89999876543 33333333 233
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
.+.+ ..+|+++.+||..||+.||++||++.+|++.|+.++..
T Consensus 252 ~~~~---~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 LPPP---MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCC---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 3322 34699999999999999999999999999999988753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-50 Score=398.09 Aligned_cols=252 Identities=19% Similarity=0.247 Sum_probs=198.8
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+.++|++++.||+|+||+||+|.+..+++.||||++.... ....+.+|++++..+.| ++|+.++.++.+.+..|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH-PNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEE
Confidence 4678999999999999999999999999999999865432 23457789999998865 6788888888899999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ |++|.+++.. .+.+++..+..++.||+.||+|||++|||||||||+|||+...++++.+||+|||+|+......
T Consensus 86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999 7899999974 5679999999999999999999999999999999999999765678899999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....+||+.|+|||++.+..|+.++|||||||+||||++|..||.+.. ..+.+..+.......+. ..
T Consensus 165 --------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~-~~ 232 (307)
T d1a06a_ 165 --------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQILKAEYEFDS-PY 232 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHTTCCCCCT-TT
T ss_pred --------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCCCCC-cc
Confidence 1245689999999999999999999999999999999999999998743 33444455554444332 23
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...+|+++.+||..||+.||++||++++|+
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 456799999999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=396.74 Aligned_cols=258 Identities=17% Similarity=0.261 Sum_probs=211.9
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCc-----EEEEEEeecc---CCCchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGE-----EIAVKLELVK---TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~-----~vAIK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+-.++|+++++||+|+||+||+|++..+++ .||||.+... .....+..|+.++..+.+|++|+.+++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 334789999999999999999999876543 6999976433 23346888999999998888999999999999
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN----------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPD 140 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~----------------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~ 140 (468)
+..+|||||+ +|+|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 9999999999 899999997432 24899999999999999999999999999999999
Q ss_pred ceeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCC
Q 012192 141 NFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSL 219 (468)
Q Consensus 141 NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~ 219 (468)
|||+ +.++.+||+|||+|+........ .......||+.|+|||++.+..|+.++|||||||+||||++ |..
T Consensus 194 Nill---~~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 194 NVLV---THGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp GEEE---ETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred cccc---ccCCeEEEeeccccccccCCCce-----eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence 9999 57899999999999875543221 12235678999999999999999999999999999999997 999
Q ss_pred CCCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 220 PWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 220 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
||.+.... +.+.++.......+.+ ..+|+++.+||..||+.||++||++++|++.|..
T Consensus 266 Pf~~~~~~---~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 266 PYPGIPVD---ANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SSTTCCCS---HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCHH---HHHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 99876543 2333444444444433 3458999999999999999999999999988853
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-50 Score=384.42 Aligned_cols=255 Identities=19% Similarity=0.277 Sum_probs=200.9
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
..+|+++++||+|+||+||+|.+. ++..||||++.... ...++.+|++++..++| ++|+.+++++...+..++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCC-CCcccccceeccCCceEEEEEe
Confidence 368999999999999999999975 56789999866443 34568999999999975 7788888888888889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +|+|.+++......++++.++.++.|+|.||+|||+++|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~-- 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY-- 156 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCc--
Confidence 9 899999988666789999999999999999999999999999999999999 5788999999999986644221
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
.......||+.|+|||++.+..|+.++|||||||++|||+++ ..||... ...+.+..+... ...+.+ .
T Consensus 157 ----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~-~~~~~p---~ 225 (263)
T d1sm2a_ 157 ----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTG-FRLYKP---R 225 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---CHHHHHHHHHHT-CCCCCC---T
T ss_pred ----eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---CHHHHHHHHHhc-CCCCCc---c
Confidence 122346789999999999999999999999999999999995 5555543 233334334332 222222 3
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.+|+++.+||..||+.||++||++++|++.|+++..
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 448999999999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-50 Score=392.42 Aligned_cols=260 Identities=18% Similarity=0.265 Sum_probs=214.0
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+|-.++|++.++||+|+||+||+|.+..+++.||||++..... ..++.+|++++..++| ++|+.+++++.+.+..+++
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCC-CCEecCCccEeeCCeeEEE
Confidence 3556799999999999999999999999999999998655433 3568899999999975 6777788888888889999
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 90 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
|||+ +|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCC
Confidence 9999 78999998753 4579999999999999999999999999999999999999 57889999999999876542
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEV 247 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 247 (468)
.. .......||+.|+|||++.+..|+.++|||||||++|||++|..||..... ..+. ..+.......+.+
T Consensus 169 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~-~~~i~~~~~~~~~- 238 (287)
T d1opja_ 169 TY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQV-YELLEKDYRMERP- 238 (287)
T ss_dssp SS------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHH-HHHHHTTCCCCCC-
T ss_pred Cc------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHH-HHHHhcCCCCCCC-
Confidence 21 122345689999999999999999999999999999999997776654322 2222 2333444333322
Q ss_pred hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 248 LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 248 l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+|+++.+||..||+.||++||++++|.+.|+.++.
T Consensus 239 --~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 239 --EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred --ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 4569999999999999999999999999998877643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-49 Score=397.50 Aligned_cols=258 Identities=18% Similarity=0.288 Sum_probs=215.2
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
.+.-++++ ++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.++..+.| ++|+.++.++.+.
T Consensus 18 ~l~~~~il-~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~ 95 (350)
T d1koaa2 18 EIKHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDD 95 (350)
T ss_dssp CCBCSCGG-GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEEET
T ss_pred cCCCCCCc-cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC
Confidence 34555555 689999999999999999999999999999998754432 2457889999999975 6777888888899
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+..+|||||+ ||+|.+++....+.+++..+..|+.||+.||+|||++|||||||||+|||+.. +.++.+||+|||+|+
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTA 174 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchhe
Confidence 9999999999 78999998655667999999999999999999999999999999999999942 235789999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
.+.... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.. ..+.+..+......
T Consensus 175 ~~~~~~--------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~ 243 (350)
T d1koaa2 175 HLDPKQ--------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWN 243 (350)
T ss_dssp ECCTTS--------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCC
T ss_pred eccccc--------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC
Confidence 765422 1235689999999999999999999999999999999999999998643 34455555555444
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+ ......+++++.+||.+||+.||++||++++|+
T Consensus 244 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 278 (350)
T d1koaa2 244 MD-DSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278 (350)
T ss_dssp SC-CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CC-cccccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 33 334467799999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=382.50 Aligned_cols=251 Identities=20% Similarity=0.272 Sum_probs=200.7
Q ss_pred CceecCce-EEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEe--
Q 012192 10 DHVIGGKF-KLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVE-- 82 (468)
Q Consensus 10 ~~ii~~~y-~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-- 82 (468)
|....++| ++.++||+|+||+||+|.+..+++.||||.+..... ...+.+|++++..++| ++|+.+++++..
T Consensus 3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTV 81 (270)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEES
T ss_pred CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEeecc
Confidence 44455666 788899999999999999999999999998665432 2357889999999986 556666655443
Q ss_pred --CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceeecccCCCCeEEEEe
Q 012192 83 --GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 83 --~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~g--iiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
....+|||||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||+. ++++.+||+|
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~D 158 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGD 158 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECC
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEee
Confidence 45679999998 8899999985 467999999999999999999999998 99999999999994 3468999999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 237 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~ 237 (468)
||+|+..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+... ..+.+..+.
T Consensus 159 FGla~~~~~~---------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~ 226 (270)
T d1t4ha_ 159 LGLATLKRAS---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVT 226 (270)
T ss_dssp TTGGGGCCTT---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHT
T ss_pred cCcceeccCC---------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHH
Confidence 9999754321 1235689999999999876 599999999999999999999999986532 333333343
Q ss_pred hcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 238 EKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 238 ~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.... ...+...+++++.+||.+||+.||++||++++|++
T Consensus 227 ~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 227 SGVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCC---CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 3222 22334566899999999999999999999997643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=391.56 Aligned_cols=259 Identities=21% Similarity=0.296 Sum_probs=217.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++++.||+|+||.||+|.++.+|+.||||++... .....+..|+.++..+.| ++|+.++.++.+.+..|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC-CCEEEEEeeeccccccccc
Confidence 5799999999999999999999999999999986532 234567889999988874 7888888888999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ ||+|.+++.. .+.+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCC
Confidence 9999 8899999885 5679999999999999999999999999999999999999 578999999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.. ..+.+..+.......|
T Consensus 160 ~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~~~~~p---- 225 (337)
T d1o6la_ 160 A-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIRFP---- 225 (337)
T ss_dssp C-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC----
T ss_pred c-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHHhcCCCCCC----
Confidence 1 2345789999999999999999999999999999999999999998754 3444555555555444
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
..+++++.+||..||+.||.+||+ +++| + .++++..++|..+..
T Consensus 226 -~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~ei---l-------~Hp~f~~i~~~~l~~ 274 (337)
T d1o6la_ 226 -RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV---M-------EHRFFLSINWQDVVQ 274 (337)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH---H-------TSGGGTTCCHHHHHT
T ss_pred -ccCCHHHHHHHHhhccCCchhhcccccccHHHH---H-------cCcccccCCHHHHHh
Confidence 456899999999999999999995 4433 2 356666778887653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=394.36 Aligned_cols=255 Identities=18% Similarity=0.268 Sum_probs=202.5
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
++..++|+++++||+|+||.||+|.+..+|+.||||++..... ...+.+|+.++..+.| ++|+.++.++.+....+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCC-TTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEE
Confidence 4567899999999999999999999999999999998765432 2357889999988875 67888888888899999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceeecccCCCCeEEEEeCCcccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYR 165 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~-giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~ 165 (468)
+||||+ +|+|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccC
Confidence 999998 7899999985 45799999999999999999999975 99999999999999 578899999999998764
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc------
Q 012192 166 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK------ 239 (468)
Q Consensus 166 ~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~------ 239 (468)
... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+................
T Consensus 157 ~~~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
T d1s9ja_ 157 DSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227 (322)
T ss_dssp HHT---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred CCc---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence 321 24578999999999999999999999999999999999999999875432211110000000
Q ss_pred -----------------ccC-------------CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 240 -----------------KVS-------------TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 240 -----------------~~~-------------~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
... .+.......++.++.+||.+||..||++|||++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 0000000124689999999999999999999996544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=383.80 Aligned_cols=254 Identities=19% Similarity=0.246 Sum_probs=212.0
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--------CchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--------HPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
.-+.++|+++++||+|+||+||+|.+..+|+.||||++..... ...+.+|++++..+.| ++|+.++.++.+
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEEC
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEE
Confidence 3356889999999999999999999999999999998654321 2357889999999975 677788888899
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccC-CCCeEEEEeCCc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDYGL 160 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~-~~~~vkL~DFGl 160 (468)
.+..+|||||+ +|+|.+++.. .+.+++..+..++.||+.||+|||+++|+||||||+|||+...+ ....+||+|||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCEEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999998 7899999985 45799999999999999999999999999999999999995322 123699999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+....
T Consensus 164 a~~~~~~~--------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~ 232 (293)
T d1jksa_ 164 AHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVN 232 (293)
T ss_dssp CEECTTSC--------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHTTC
T ss_pred hhhcCCCc--------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHHHHHhcC
Confidence 98764322 1345689999999999999999999999999999999999999998743 344455555555
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...+ ......+++++.+||..||+.||++||++++|+
T Consensus 233 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 233 YEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp CCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 4444 344567899999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=382.80 Aligned_cols=258 Identities=20% Similarity=0.311 Sum_probs=206.6
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
|-.++|+++++||+|+||+||+|.+. ++..||||++.... ....+.+|++++.+++| ++|+.+++++.+ +..++||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECS-SSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCC-CCEeEEEeeecc-CCeEEEE
Confidence 44579999999999999999999964 67899999876543 34568999999999976 566666666654 4468899
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||+ +|+|.+++... ...+++..++.|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+|+......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCc
Confidence 998 88999876532 3469999999999999999999999999999999999999 578999999999998765422
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. .......||+.|+|||++.+..++.++|||||||++|||++|..||.... ...+.+..+.. ....+.+
T Consensus 164 ~------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~~i~~-~~~~~~p-- 232 (272)
T d1qpca_ 164 Y------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLER-GYRMVRP-- 232 (272)
T ss_dssp E------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHT-TCCCCCC--
T ss_pred c------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHHHHHh-cCCCCCc--
Confidence 1 22345679999999999999899999999999999999999655544322 22333333333 2222222
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
..+|+++.+||..||+.||++||++++|++.|+++|..
T Consensus 233 -~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 233 -DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 35699999999999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=384.89 Aligned_cols=247 Identities=21% Similarity=0.238 Sum_probs=192.4
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeE--eCceeE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGV--EGDYNI 87 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~--~~~~~~ 87 (468)
.++|++++.||+|+||+||+|.++.+|+.||||++...... ..+..|++++..+.| ++|+.++.++. .....|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-PNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCC-TTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEeCCCCEEE
Confidence 36899999999999999999999999999999986554332 347789999888876 56666665554 345678
Q ss_pred EEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCceeecccCCCCeEEEEeC
Q 012192 88 MVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDY 158 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~---~~~~ls~~~~~~ia~qia~gL~yLHs~g-----iiHrDIKp~NiLl~~~~~~~~vkL~DF 158 (468)
+||||+ +|+|.+++.. ....+++..++.++.||+.||+|||+++ ||||||||+|||+ +.++.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence 999999 7899999864 2567999999999999999999999976 9999999999999 57889999999
Q ss_pred CcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 012192 159 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 238 (468)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~ 238 (468)
|+|+.+..... ......||+.|+|||++.+..|+.++|||||||++|||++|..||.+... .+.+..+..
T Consensus 159 G~a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i~~ 228 (269)
T d2java1 159 GLARILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIRE 228 (269)
T ss_dssp HHHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred cceeecccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHHHHHc
Confidence 99987654221 13457899999999999999999999999999999999999999987543 344444544
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..... +...+++++.+||.+||+.||++||++++|+
T Consensus 229 ~~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 229 GKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp TCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 43321 2245689999999999999999999999764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=384.80 Aligned_cols=258 Identities=19% Similarity=0.304 Sum_probs=208.6
Q ss_pred cCceEEEc-eEeeeCCeEEEEEEEcC--CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 14 GGKFKLGR-KIGSGSFGELYLGVNVQ--TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 14 ~~~y~i~~-~LG~G~fG~Vy~~~~~~--~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
.++|.+.+ +||+|+||+||+|.+.. ++..||||++..... ...+.+|++++..++| ++|+.+++++.. +..+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEES-SSEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCC-CCEeeEeeeecc-CeEE
Confidence 36788888 49999999999998754 456899998754432 2458889999999976 566667776654 4578
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
|||||+ +|+|.+++......+++..++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+++....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhcccc
Confidence 999999 789999987666789999999999999999999999999999999999999 4788999999999987654
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.... +.+..+... ...+.
T Consensus 162 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~~~-~~~~~ 233 (285)
T d1u59a_ 162 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQG-KRMEC 233 (285)
T ss_dssp CSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTT-CCCCC
T ss_pred cccc----cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC-CCCCC
Confidence 2211 112345678999999999999999999999999999999998 99999886543 233333322 22222
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
...+|+++.+||..||+.||++||++.+|.+.|++.+..
T Consensus 234 ---p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 245699999999999999999999999999999998765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-48 Score=388.63 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=215.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|+++++||+|+||+||+|.++.+|+.||||++... .....+..|++++..+.| ++|+.++.++......++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCC-CcEeecccccccccccccc
Confidence 6899999999999999999999999999999986532 233457889999988865 6777788888888889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|+++ +|+|.+++.. .+.+++..+..|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC-
T ss_pred cccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc-
Confidence 9988 8899998875 4579999999999999999999999999999999999999 57889999999999876432
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....||+.|+|||++.+..|+.++|||||||+||||++|..||.+.. ....+..+.......+
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~~~~~p---- 258 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVSGKVRFP---- 258 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC----
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHHHHhcCCCCCC----
Confidence 235689999999999999999999999999999999999999998643 3455555655554443
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
..+++++.+||..||..||.+|+ ++++|. .++|+..+||..+..
T Consensus 259 -~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell----------~Hp~f~~~~~~~~~~ 307 (350)
T d1rdqe_ 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK----------NHKWFATTDWIAIYQ 307 (350)
T ss_dssp -TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH----------TSGGGTTCCHHHHHT
T ss_pred -ccCCHHHHHHHHHHhhhCHHhccccccccHHHHH----------cCccccCCCHHHHHh
Confidence 35689999999999999999994 666543 367777788987653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-49 Score=386.64 Aligned_cols=242 Identities=19% Similarity=0.292 Sum_probs=200.5
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
+.|+++++||+|+||+||+|.+..+++.||||++...... ..+.+|++++..+.| ++|+.+++++.+.+..+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEECCEEEEE
Confidence 3599999999999999999999999999999987654332 347889999999875 6777888888889999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +++|..++. ....+++..+..++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS--
T ss_pred EEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC--
Confidence 9999 455554444 46789999999999999999999999999999999999999 4789999999999976432
Q ss_pred CcccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+... .+.+..+.........
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~ 235 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPALQ 235 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCS
T ss_pred ---------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCCCC
Confidence 234679999999999875 3589999999999999999999999987533 3444444444433222
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...+++++.+||..||+.||++||++++|+
T Consensus 236 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 265 (309)
T d1u5ra_ 236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (309)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred ---CCCCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 235689999999999999999999999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=380.55 Aligned_cols=262 Identities=15% Similarity=0.205 Sum_probs=203.2
Q ss_pred ceecCceEEEceEeeeCCeEEEEEEEcCCC----cEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 11 HVIGGKFKLGRKIGSGSFGELYLGVNVQTG----EEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 11 ~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~----~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+|-...|++.+.||+|+||+||+|.+..++ ..||||.+...... ..+.+|++++..++| ++|+.+++++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCC-CCEeeeeEEEecC
Confidence 455678999999999999999999977654 47999986543322 357889999999875 6777788888888
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+..+++||++ +++|.+++......+++..++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhh
Confidence 8889999998 778888888777789999999999999999999999999999999999999 578999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
......... .......||+.|+|||++.+..++.++|||||||++|||++|..||.... ...+.+..+. ....
T Consensus 159 ~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~-~~~~ 231 (283)
T d1mqba_ 159 VLEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAIN-DGFR 231 (283)
T ss_dssp -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHH-TTCC
T ss_pred cccCCCccc----eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHh-ccCC
Confidence 765432211 11234578999999999999999999999999999999999656554322 2233333333 3333
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.+.+ ..+|.++.+||..||+.||++||++.+|++.|+.+..
T Consensus 232 ~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 LPTP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCC---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCc---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 3322 3469999999999999999999999999999998775
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=380.44 Aligned_cols=252 Identities=16% Similarity=0.295 Sum_probs=210.9
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
.++|+++++||+|+||+||+|++ .++..||||++.... ...++.+|+.++..+.| ++|..+++++.+....++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~H-pnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCceEEEEEc
Confidence 36899999999999999999997 478899999876543 34678999999999865 6777788888888889999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ +|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~-- 155 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY-- 155 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSC--
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCc--
Confidence 8 789999987667789999999999999999999999999999999999999 5789999999999986543221
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCK 250 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 250 (468)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.... +....+.. ....+.+ .
T Consensus 156 ----~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~i~~-~~~~~~p---~ 224 (258)
T d1k2pa_ 156 ----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQ-GLRLYRP---H 224 (258)
T ss_dssp ----CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHHT-TCCCCCC---T
T ss_pred ----eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHHHHHh-CCCCCCc---c
Confidence 22345679999999999999999999999999999999998 89999876543 33333433 2333333 3
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012192 251 SYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRD 283 (468)
Q Consensus 251 ~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~ 283 (468)
.+|+++.+||..||+.||++||++++|++.|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 458999999999999999999999999888754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-49 Score=396.67 Aligned_cols=258 Identities=21% Similarity=0.217 Sum_probs=213.5
Q ss_pred CCCCCceecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC--CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 6 KLRMDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK--HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 6 ~l~~~~ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~--~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
.+.-+.++ ++|+++++||+|+||+||+|.+..+|+.||||++..... ...+.+|++++..+.| ++|+.++.++.+.
T Consensus 21 ~~~~~~~~-d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~ 98 (352)
T d1koba_ 21 EVKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDK 98 (352)
T ss_dssp CCBCSCGG-GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECS
T ss_pred cCCCCCcc-cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC
Confidence 34445554 689999999999999999999999999999998765432 2356789999998865 6777888888899
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
+..||||||+ ||+|.+++......+++..+..|+.||+.||+|||++|||||||||+|||+.. ...+.+||+|||+|+
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT 177 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccce
Confidence 9999999999 78999887755667999999999999999999999999999999999999942 146899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
.+.... ......||+.|+|||++.+..|+.++|||||||+||+|++|..||.+... .+.+..+......
T Consensus 178 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~ 246 (352)
T d1koba_ 178 KLNPDE--------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCDWE 246 (352)
T ss_dssp ECCTTS--------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCCCC
T ss_pred ecCCCC--------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC
Confidence 765422 12356799999999999999999999999999999999999999987543 3444445444443
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+ ......+++++.+||..||+.||++||++.+++
T Consensus 247 ~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 247 FD-EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp CC-SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CC-cccccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 33 334457799999999999999999999998663
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=390.49 Aligned_cols=264 Identities=18% Similarity=0.217 Sum_probs=209.5
Q ss_pred CCCCceecCceEEEc-eEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEe---
Q 012192 7 LRMDHVIGGKFKLGR-KIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVE--- 82 (468)
Q Consensus 7 l~~~~ii~~~y~i~~-~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--- 82 (468)
++.+.++ ++|++.. .||+|+||.||+|.+..+++.||||++.. ...+.+|+.++.++.+|++|+.++.++.+
T Consensus 4 ~~~~~i~-~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 4 IKKNAII-DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CBCSCGG-GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CCCCCcc-cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 4455566 5688875 59999999999999999999999998643 45688899998888777888888777654
Q ss_pred -CceeEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCC
Q 012192 83 -GDYNIMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYG 159 (468)
Q Consensus 83 -~~~~~lv~el~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFG 159 (468)
..+.||||||| ||+|.+++... ...|++..+..|+.||+.||+|||++||+||||||+|||+...+..+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46689999999 78999999754 3579999999999999999999999999999999999999654456789999999
Q ss_pred cccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH-HHHhh
Q 012192 160 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-DKISE 238 (468)
Q Consensus 160 la~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~-~~i~~ 238 (468)
+|+....... .....||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.........+ ..+..
T Consensus 160 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~ 231 (335)
T d2ozaa1 160 FAKETTSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231 (335)
T ss_dssp TCEECCCCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS
T ss_pred eeeeccCCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc
Confidence 9987554221 34568999999999999999999999999999999999999999875443322222 22222
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.....|.+ ....+++++.+||..||+.||++||++.+| |++.+.
T Consensus 232 ~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~ei---l~hp~~ 275 (335)
T d2ozaa1 232 GQYEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWI 275 (335)
T ss_dssp CSSSCCTT-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHH---HHSHHH
T ss_pred CCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHH---HcCHHh
Confidence 23333322 234578999999999999999999999865 444443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-48 Score=384.95 Aligned_cols=255 Identities=21% Similarity=0.322 Sum_probs=214.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|+++++||+|+||+||+|++..+|+.||||++... .....+..|+.++..+.| ++|+.++.++.+.+..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccC-cChhheeeeEeeCCeeeeE
Confidence 5799999999999999999999999999999986532 334567889999888865 6778888888899999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ |++|..++.. ...+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC-
T ss_pred eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc-
Confidence 9999 7888888874 6678999999999999999999999999999999999999 57899999999999875432
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
....+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.. ..+.+..+.......|
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~~~~~p---- 221 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILNAELRFP---- 221 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHCCCCCC----
T ss_pred ---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC---HHHHHHHHHcCCCCCC----
Confidence 235789999999999999999999999999999999999999998743 3444555555554443
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccc
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTVLK 302 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RP-----s~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 302 (468)
..+++++.++|.+||..||.+|+ ++++|+ .++|...++|+.+.
T Consensus 222 -~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il----------~Hp~f~~i~~~~l~ 269 (316)
T d1fota_ 222 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK----------NHPWFKEVVWEKLL 269 (316)
T ss_dssp -TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH----------TSGGGSSCCHHHHH
T ss_pred -CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHH----------cCcccccCCHHHHH
Confidence 34689999999999999999996 666542 35677778898764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-48 Score=390.91 Aligned_cols=262 Identities=25% Similarity=0.294 Sum_probs=212.4
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeecc-----CCCchhHHHHHHHHHHh--CCCCCceeeEeeEeCceeE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVK-----TKHPQLHYESKLYMLLQ--GGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~-----~~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~~~~~~~ 87 (468)
++|+++++||+|+||.||+|++..+|+.||||++... .....+..|..++..+. +|++|+.++.++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999999999999999986432 22234566666666655 4688888988889999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccc
Q 012192 88 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRD 166 (468)
Q Consensus 88 lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~ 166 (468)
+||||+ ||+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence 999999 7999999985 5679999999999999999999999999999999999999 5789999999999986553
Q ss_pred ccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCH
Q 012192 167 LQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPI 245 (468)
Q Consensus 167 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 245 (468)
.. .....||+.|+|||++.+ ..|+.++|||||||+||||++|..||.+............+......
T Consensus 160 ~~---------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~--- 227 (364)
T d1omwa3 160 KK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--- 227 (364)
T ss_dssp SC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCC---
T ss_pred Cc---------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC---
Confidence 22 245689999999999975 56899999999999999999999999876554444333222222222
Q ss_pred HHhhccCcHHHHHHHHHHhcCCCCCCCCH-----HHHHHHHHHHHHHcCCCCCcccccccccCC
Q 012192 246 EVLCKSYPSEFVSYFHYCRSLRFEDKPDY-----SYLKRLFRDLFIREGFQFDYVFDWTVLKYP 304 (468)
Q Consensus 246 ~~l~~~~p~~~~~li~~cl~~~p~~RPs~-----~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 304 (468)
....+++++.+||..||+.||++||+. ++| + .++|+..++|..+...
T Consensus 228 --~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei---l-------~Hp~f~~i~~~~~~~~ 279 (364)
T d1omwa3 228 --LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV---K-------ESPFFRSLDWQMVFLQ 279 (364)
T ss_dssp --CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH---H-------TSGGGTTCCHHHHHTT
T ss_pred --CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHH---H-------cCccccCCCHHHHhcC
Confidence 224679999999999999999999983 433 2 3567777889876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=387.19 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=217.0
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeec-----cCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELV-----KTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|+++++||+|+||+||+|.++.+++.||||++.. ......+..|..++....+|++|+.++.++.+.+..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 579999999999999999999999999999998753 233345778888877766778999999999999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 90 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
|||+ +|+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||+ +..+.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 9998 7899999985 5679999999999999999999999999999999999999 578999999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.. ..+.+..+.......|
T Consensus 158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~p---- 223 (320)
T d1xjda_ 158 A-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPFYP---- 223 (320)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC----
T ss_pred c-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCC----
Confidence 1 2345689999999999999999999999999999999999999998754 3344545554444333
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCcccccccccC
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGFQFDYVFDWTVLKY 303 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 303 (468)
+.+++++.+||.+||..||++||++. +|. .+++...++|+.+..
T Consensus 224 -~~~s~~~~dli~~~L~~dP~~R~s~~~~l~----------~hpff~~~~~~~l~~ 268 (320)
T d1xjda_ 224 -RWLEKEAKDLLVKLFVREPEKRLGVRGDIR----------QHPLFREINWEELER 268 (320)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG----------GSGGGTTCCHHHHHT
T ss_pred -ccCCHHHHHHHHHhcccCCCCCcCHHHHHH----------hCchhccCCHHHHHh
Confidence 35689999999999999999999985 432 245666678876643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=381.22 Aligned_cols=250 Identities=19% Similarity=0.333 Sum_probs=198.7
Q ss_pred ceEeeeCCeEEEEEEEcC--CCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEecc-
Q 012192 21 RKIGSGSFGELYLGVNVQ--TGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDLL- 93 (468)
Q Consensus 21 ~~LG~G~fG~Vy~~~~~~--~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el~- 93 (468)
++||+|+||+||+|.+.. +++.||||++..... ...+.+|++++.+++| ++|+.+++++.. +..+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCC-CCCceEEEEecc-CCEEEEEEcCC
Confidence 479999999999998643 567899998754332 2358899999999975 566667776654 4568999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcccc
Q 012192 94 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHI 173 (468)
Q Consensus 94 ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 173 (468)
+|+|.+++.. ...+++..++.|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+++.+......
T Consensus 91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~--- 163 (277)
T d1xbba_ 91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENY--- 163 (277)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSE---
T ss_pred CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhccccccc---
Confidence 7899999885 5679999999999999999999999999999999999999 47899999999999876432221
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhccC
Q 012192 174 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKSY 252 (468)
Q Consensus 174 ~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 252 (468)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.... +....+.. ....+.+ ..+
T Consensus 164 -~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i~~-~~~~~~p---~~~ 235 (277)
T d1xbba_ 164 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEK-GERMGCP---AGC 235 (277)
T ss_dssp -EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHT-TCCCCCC---TTC
T ss_pred -cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHHHc-CCCCCCC---ccc
Confidence 122345679999999999999999999999999999999998 99999876543 33333322 2222222 456
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 253 PSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 253 p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
|+++.+||..||+.||++||++++|.+.|++.+..
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=382.09 Aligned_cols=262 Identities=19% Similarity=0.279 Sum_probs=203.0
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe-
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE- 82 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~- 82 (468)
+-.++|+++++||+|+||+||+|.+.. +++.||||++..... ...+..|..++..+.||++|+.+..+...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 445789999999999999999999754 446899998654332 33577888888999888888877766554
Q ss_pred CceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 146 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~ 146 (468)
....+++|||+ +|+|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl-- 167 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 167 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence 55689999999 899999987432 348999999999999999999999999999999999999
Q ss_pred cCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCC
Q 012192 147 GRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG-SLPWQGLK 225 (468)
Q Consensus 147 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG-~~Pf~~~~ 225 (468)
+.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++| ..||.+..
T Consensus 168 -~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 168 -SEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp -CGGGCEEECC------CCSCTT-----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -CCCCcEEEccCcchhhcccccc-----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 5788999999999986544322 1123456899999999999999999999999999999999986 56787654
Q ss_pred cccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 226 AGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 226 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
... .+..+.......+.+ ..+++++.++|..||+.||++||++++|++.|+++++.
T Consensus 242 ~~~---~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 IDE---EFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSH---HHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH---HHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 332 222233333333322 34589999999999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-48 Score=375.83 Aligned_cols=261 Identities=19% Similarity=0.303 Sum_probs=202.8
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----chhHHHHHHHHHHhCCCCCceeeEeeEeC---
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----PQLHYESKLYMLLQGGTGIPHLKWFGVEG--- 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~--- 83 (468)
.+.++|++.+.||+|+||+||+|.+..+++.||||++...... ..+.+|++++..+.|++.+..+..+....
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 4678999999999999999999999999999999987644322 24788999998887765554444444333
Q ss_pred ceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
...||||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.++|+|||.++
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCE
T ss_pred ceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhhh
Confidence 3578999999 7899988875 5679999999999999999999999999999999999999 478999999999987
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
........ .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.....
T Consensus 160 ~~~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~~~~~~~- 231 (277)
T d1o6ya_ 160 AIADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVREDP- 231 (277)
T ss_dssp ECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCCC-
T ss_pred hhcccccc----ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH---HHHHHHHHhcCC-
Confidence 65432211 1123456899999999999999999999999999999999999999987433 333333443333
Q ss_pred CCHHHhhccCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHH
Q 012192 243 TPIEVLCKSYPSEFVSYFHYCRSLRFEDKP-DYSYLKRLFRDL 284 (468)
Q Consensus 243 ~~~~~l~~~~p~~~~~li~~cl~~~p~~RP-s~~~l~~~L~~~ 284 (468)
.+.......+|+++.++|.+||+.||.+|| ++++|.+.|..+
T Consensus 232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 333445567899999999999999999999 889888777654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=384.36 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=204.7
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCc----EEEEEEeeccC---CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGE----EIAVKLELVKT---KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNI 87 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~----~vAIK~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~ 87 (468)
.+|+++++||+|+||+||+|.+..+|+ .||||.+.... ....+..|++++..++| ++|+.+++++.+++..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTSTVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCC-TTBCCEEEEEESSSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCeeE
Confidence 479999999999999999999987776 57888654322 23468899999999975 67777778888887777
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccc
Q 012192 88 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDL 167 (468)
Q Consensus 88 lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~ 167 (468)
+++++.+++|.+++......+++..++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceecccc
Confidence 777777999999988777889999999999999999999999999999999999999 47889999999999876442
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHH
Q 012192 168 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIE 246 (468)
Q Consensus 168 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 246 (468)
... .......||+.|+|||++.+..|+.++|||||||+||||++ |..||.+.........+ ......+.+
T Consensus 165 ~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i----~~~~~~~~p 235 (317)
T d1xkka_ 165 EKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERLPQP 235 (317)
T ss_dssp CC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH----HHTCCCCCC
T ss_pred ccc-----ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCCCC
Confidence 221 12234578999999999999999999999999999999998 89999886654433322 233333332
Q ss_pred HhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 247 VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 247 ~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+|+++.+||..||+.||++||++.+|++.|..+..
T Consensus 236 ---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 236 ---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 3458999999999999999999999999998887654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-48 Score=374.77 Aligned_cols=250 Identities=18% Similarity=0.186 Sum_probs=210.9
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-----------chhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-----------PQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
+.++|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+.++..+..|++|+.++.++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 357999999999999999999999999999999987654321 247789999999998889999999999
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
+.+..||||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 156 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchh
Confidence 999999999999 7899999985 5579999999999999999999999999999999999999 5789999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 234 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~------~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~ 234 (468)
++...... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+... ...+.
T Consensus 157 a~~~~~~~--------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~ 225 (277)
T d1phka_ 157 SCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLR 225 (277)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH
T ss_pred eeEccCCC--------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHH
Confidence 98765422 1245689999999999863 3468899999999999999999999987543 33444
Q ss_pred HHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 235 KISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 235 ~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.+.......+.+ ....+++++.+||.+||+.||++||++++|+
T Consensus 226 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 226 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 455554433322 3356799999999999999999999998653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=382.00 Aligned_cols=257 Identities=18% Similarity=0.253 Sum_probs=214.5
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC-chhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH-PQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~-~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
-++|++++.||+|+||+||+|.++.+++.||||++...... ..+.+|++++..+.| ++|+.++.++.+.+..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEEec
Confidence 36899999999999999999999999999999987654432 347789999988876 6788888888899999999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 93 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 93 ~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
+ |++|.+++...+..+++..+..|+.||+.||+|||++||+||||||+|||+.. +....+||+|||+++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~-- 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCCc--
Confidence 9 67999999865667999999999999999999999999999999999999942 2356899999999986543211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhhcc
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLCKS 251 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 251 (468)
.....||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.. ..+.+..+.......+. .....
T Consensus 160 ------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~~-~~~~~ 229 (321)
T d1tkia_ 160 ------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFDE-EAFKE 229 (321)
T ss_dssp ------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCCH-HHHTT
T ss_pred ------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCh-hhccC
Confidence 234578999999999999999999999999999999999999998743 34555556665555443 34467
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 252 YPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 252 ~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+++++.+||..||..||++||+++++ |++.+..
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~ei---l~hp~~~ 262 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLK 262 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHH---hcCHhhc
Confidence 89999999999999999999999865 4454443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=373.48 Aligned_cols=258 Identities=20% Similarity=0.299 Sum_probs=198.8
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
|-.++|++++.||+|+||+||+|.+..+ +..||||........ ..+..|++++..++| ++|+.+++++. .+.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVIT-ENP 81 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEC-SSS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe-cCe
Confidence 3357899999999999999999998654 356888875433222 357889999999876 56666666654 456
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++|||++ +|+|.+++......+++..++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence 78999998 789999887767789999999999999999999999999999999999999 47889999999999865
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+......... +.... ..
T Consensus 159 ~~~~~------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~---i~~~~-~~ 228 (273)
T d1mp8a_ 159 EDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGE-RL 228 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HHTTC-CC
T ss_pred cCCcc------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH---HHcCC-CC
Confidence 43221 12345578999999999999999999999999999999998 8999988765443333 33322 22
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+ ....+|+++.+||..||+.||++||++.+|++.|+.++..
T Consensus 229 ~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 P---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2 2245699999999999999999999999999999988765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=370.07 Aligned_cols=240 Identities=22% Similarity=0.343 Sum_probs=200.5
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--------CCchhHHHHHHHHHHhC-CCCCceeeEeeEeC
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--------KHPQLHYESKLYMLLQG-GTGIPHLKWFGVEG 83 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--------~~~~~~~E~~~l~~l~~-~~~i~~l~~~~~~~ 83 (468)
+.++|++++.||+|+||+||+|.+..+|+.||||++.... ....+..|+.++..+.+ |++|+.++.++...
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4679999999999999999999999999999999865432 12346789999999974 68899999999999
Q ss_pred ceeEEEEeccC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 84 DYNIMVIDLLG--PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 84 ~~~~lv~el~g--gsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
+..++|||++. +++.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||+. .+.+.+||+|||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence 99999999983 577787774 56899999999999999999999999999999999999994 24579999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcc
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 240 (468)
+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.. .+....
T Consensus 159 ~~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~~~~ 220 (273)
T d1xwsa_ 159 ALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQ 220 (273)
T ss_dssp EECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHCC
T ss_pred eecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHhhcc
Confidence 764431 1345689999999999987765 678999999999999999999997521 122333
Q ss_pred cCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 241 VSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 241 ~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
...+ ..+|+++.+||.+||+.||++||++++++
T Consensus 221 ~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 221 VFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp CCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCC-----CCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 3222 45799999999999999999999999754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=370.89 Aligned_cols=260 Identities=17% Similarity=0.297 Sum_probs=210.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCC-------cEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTG-------EEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGV 81 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~-------~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~ 81 (468)
|-.++|+++++||+|+||.||+|++..++ ..||||++..... ..++..|...+.++.+|++|+.+++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34579999999999999999999876544 4799998655443 2457778899999988899999999988
Q ss_pred eCceeEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeec
Q 012192 82 EGDYNIMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG 145 (468)
Q Consensus 82 ~~~~~~lv~el~-ggsL~~ll~~~~---------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~ 145 (468)
+....++||||+ +|+|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl- 168 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 168 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee-
Confidence 889999999999 899999997432 458999999999999999999999999999999999999
Q ss_pred ccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCC
Q 012192 146 LGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGL 224 (468)
Q Consensus 146 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~ 224 (468)
+.++.+||+|||+++........ .......||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 169 --~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 169 --TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp --CTTCCEEECSTTCCCCGGGCCTT-----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --cCCCCeEeccchhhccccccccc-----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 57889999999999876543321 12345678999999999999999999999999999999998 79999865
Q ss_pred CcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 225 KAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 225 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
.. .+.+..+. .....+. ...+|+++.+||.+||+.||.+||++.+|++.|+.++.
T Consensus 242 ~~---~~~~~~i~-~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 242 PV---EELFKLLK-EGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CH---HHHHHHHH-TTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CH---HHHHHHHH-cCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 43 23333332 3333332 24569999999999999999999999999999998865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=367.06 Aligned_cols=251 Identities=19% Similarity=0.287 Sum_probs=199.9
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeE-eCceeEEEEe
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGV-EGDYNIMVID 91 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-~~~~~~lv~e 91 (468)
--++|+++++||+|+||.||+|.+ +|..||||++........+.+|++++.+++| ++|..+++++. ..+..+||||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCC-TTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEecCCcEEEEEe
Confidence 346899999999999999999997 5779999998777767789999999999965 67777777664 4455789999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 92 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 92 l~-ggsL~~ll~~~-~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|+ +|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCC--
Confidence 98 89999998643 2359999999999999999999999999999999999999 57899999999999865432
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
.....+|..|+|||++.+..++.++|||||||++|||++ |..||........ +..+.. ....+.
T Consensus 157 --------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i~~-~~~~~~--- 221 (262)
T d1byga_ 157 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEK-GYKMDA--- 221 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTT-TCCCCC---
T ss_pred --------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHc-CCCCCC---
Confidence 234568899999999999999999999999999999998 7899887654433 333332 222222
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
...+|+++.+||.+||..||.+||++.+|++.|+++-.
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 23458999999999999999999999999999988643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-47 Score=373.00 Aligned_cols=255 Identities=19% Similarity=0.315 Sum_probs=205.3
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.++|+++++||+|+||+||+|++.. ++..||||++..... ...+.+|+.++..++| ++|..+++++...+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCC-CCcccceeeeccCCc
Confidence 4689999999999999999999753 567899998654432 2458899999999876 566666777777888
Q ss_pred eEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCN-----------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDN 141 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~-----------------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~N 141 (468)
.+++|+++ +++|.+++.... ..+++..++.|+.|++.||+|||+++||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 89999998 889999986422 248899999999999999999999999999999999
Q ss_pred eeecccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCC-CC
Q 012192 142 FLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS-LP 220 (468)
Q Consensus 142 iLl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~-~P 220 (468)
||+ +.++.+||+|||+|+....... ........||+.|+|||.+.+..|+.++|||||||++|||++|. .|
T Consensus 171 ILl---d~~~~~Kl~DFGls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 171 CLV---GENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp EEE---CGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEE---CCCCcEEEccchhheeccCCcc-----ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999 5788999999999986544322 11234567899999999999999999999999999999999985 57
Q ss_pred CCCCCcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 221 WQGLKAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 221 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
|.+... .+.+..+..... .+. ...+|+++.+||..||+.+|++||++.+|.+.|+.+
T Consensus 243 ~~~~~~---~e~~~~v~~~~~-~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYGMAH---EEVIYYVRDGNI-LAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTSCH---HHHHHHHHTTCC-CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCH---HHHHHHHHcCCC-CCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 776533 333444444332 222 245699999999999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=370.41 Aligned_cols=262 Identities=18% Similarity=0.304 Sum_probs=216.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEc-----CCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~-----~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
+-.++|+++++||+|+||.||+|++. .++..||||++..... ...+.+|+.++..+.+|++|+.+++++...
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 45589999999999999999999863 3667999998754432 235788999999998889999999999999
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeec
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN-----------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG 145 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~-----------------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~ 145 (468)
+..+|+|||+ +|+|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~- 178 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence 9999999999 889999987532 258999999999999999999999999999999999999
Q ss_pred ccCCCCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCC
Q 012192 146 LGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGL 224 (468)
Q Consensus 146 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~ 224 (468)
+..+.++|+|||+++....... +.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 179 --~~~~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 179 --THGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp --ETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred --cccCcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 4789999999999987654322 123345789999999999999999999999999999999998 66666654
Q ss_pred CcccHHHHHHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 225 KAGTKKQKYDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 225 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
... ..+..+.........+ ..+|+++.+||..||+.||++||++++|++.|+..+..
T Consensus 252 ~~~---~~~~~~i~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 252 PVD---SKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp CSS---HHHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHH---HHHHHHHhcCCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 433 2233344444433332 34589999999999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=369.82 Aligned_cols=256 Identities=19% Similarity=0.296 Sum_probs=198.2
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
|-.++|+++++||+|+||+||+|.+..+ ..||||++..... ...+.+|+.++.+++|+ +|+.+++++.+. ..++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~-nIv~~~g~~~~~-~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE-KLVQLYAVVSEE-PIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCT-TBCCEEEEECSS-SCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccC-CEeEEEEEEecC-CeEEEE
Confidence 4457899999999999999999997654 6799998765443 34689999999998775 566666666544 467888
Q ss_pred ecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccccccc
Q 012192 91 DLL-GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQ 168 (468)
Q Consensus 91 el~-ggsL~~ll~~-~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~ 168 (468)
||+ +|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+....
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCC
Confidence 888 7889888763 34579999999999999999999999999999999999999 577899999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHh
Q 012192 169 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVL 248 (468)
Q Consensus 169 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 248 (468)
. .......||+.|+|||++.+..++.++|||||||+||||++|..||.... ...+.+..+.. ....+.+
T Consensus 168 ~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--~~~~~~~~i~~-~~~~~~~-- 236 (285)
T d1fmka3 168 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVER-GYRMPCP-- 236 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHT-TCCCCCC--
T ss_pred c------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHHh-cCCCCCC--
Confidence 1 12344679999999999999999999999999999999999655554322 22333433333 2333322
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 249 CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 249 ~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
..+|+++.+||.+||+.||++||++++|.+.|++.+
T Consensus 237 -~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 237 -PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 456999999999999999999999999999888755
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=366.90 Aligned_cols=253 Identities=20% Similarity=0.218 Sum_probs=202.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|+++++||+|+||+||+|.+..+|+.||||++.... ....+.+|+++++.+.| ++|+.++.++.+....|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-p~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEEeccccccccceeEEE
Confidence 58999999999999999999999999999999865432 24568899999988865 67778888889999999999
Q ss_pred eccCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLLGPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~ggsL~~ll~~-~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|++++.+.+++.. ....+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCS-
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCc-
Confidence 9998888777654 35679999999999999999999999999999999999999 578899999999998654322
Q ss_pred cccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc---------
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK--------- 239 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 239 (468)
.......||+.|+|||++.... ++.++|||||||++|+|++|..||.+.........+......
T Consensus 157 ------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp ------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 1234568999999999988766 589999999999999999999999875432221111111000
Q ss_pred ------------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 ------------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 ------------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+.......+++++.+||.+||..||++||++++|.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 011122234456778999999999999999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=367.25 Aligned_cols=253 Identities=19% Similarity=0.250 Sum_probs=198.9
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCC-CcEEEEEEeeccC----CCchhHHHHHHHHHHh--CCCCCceeeEeeE-----
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQT-GEEIAVKLELVKT----KHPQLHYESKLYMLLQ--GGTGIPHLKWFGV----- 81 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~-~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~--~~~~i~~l~~~~~----- 81 (468)
.++|+++++||+|+||+||+|.+..+ ++.||||++.... ....+.+|+.+++.+. +|++|+.++.++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999999765 6779999865432 2346778999988875 5677777766553
Q ss_pred eCceeEEEEeccCCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCc
Q 012192 82 EGDYNIMVIDLLGPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGL 160 (468)
Q Consensus 82 ~~~~~~lv~el~ggsL~~ll~-~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGl 160 (468)
.....+++||++.+.+..+.. .....+++..+..++.|++.||+|||++|||||||||+|||+ +..+.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchhh
Confidence 234678999999776655443 345679999999999999999999999999999999999999 5788999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh--
Q 012192 161 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE-- 238 (468)
Q Consensus 161 a~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~-- 238 (468)
++...... ......||+.|+|||++.+..|+.++|||||||++|||++|..||.+.........+.....
T Consensus 163 ~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 163 ARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhhhcccc--------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 87654322 23467899999999999999999999999999999999999999987544322222221110
Q ss_pred -----------------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 239 -----------------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 239 -----------------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
.....+.+.+...+++++.+||.+||+.||++|||+.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~ 290 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 011223334456678999999999999999999999865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=368.09 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=198.3
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccC-----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCce
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKT-----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDY 85 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~ 85 (468)
.++|++.++||+|+||+||+|.+... ...||||++.... ....+..|+.++..++| ++|+.+++++.+. .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~~~g~~~~~-~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLTP-P 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSS-S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeec-c
Confidence 36799999999999999999986542 3478999754321 12467899999999965 6777777776554 4
Q ss_pred eEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 86 NIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 86 ~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
.++||||+ +++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhc
Confidence 57788887 889998887667789999999999999999999999999999999999999 46889999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhcccCC
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKVST 243 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 243 (468)
....... .......||..|+|||++.+..++.++|||||||++|||++ |..||.+... .+.+..+.......
T Consensus 162 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 162 PQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGERL 234 (273)
T ss_dssp CC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCCCC
T ss_pred ccCCCcc----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHHHHhCCCCC
Confidence 5432211 12344568899999999999999999999999999999998 8999987543 34444555554444
Q ss_pred CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 244 PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 244 ~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+.+ ..+|+++.+||..||+.||++||++.+|.+.|++.
T Consensus 235 ~~~---~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 PRP---EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 433 45699999999999999999999999999888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=369.28 Aligned_cols=249 Identities=17% Similarity=0.164 Sum_probs=197.6
Q ss_pred EEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC-------CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEe
Q 012192 19 LGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK-------HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVID 91 (468)
Q Consensus 19 i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~e 91 (468)
.+++||+|+||+||+|.+..+|+.||||++..... ...+.+|+.++..+.| ++|+.++.++...+..+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCC-CCEeEEEeeeccCCceeehhh
Confidence 46899999999999999999999999998643321 2457899999999876 677777788888889999999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCcc
Q 012192 92 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHK 171 (468)
Q Consensus 92 l~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~~ 171 (468)
|+.+.+...+......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC--
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcc--
Confidence 99776666665556789999999999999999999999999999999999999 5789999999999986544221
Q ss_pred cccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc-----------
Q 012192 172 HIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK----------- 239 (468)
Q Consensus 172 ~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 239 (468)
.....+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.........+.+....
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -----cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 23456899999999998755 5899999999999999999999999875443322222221110
Q ss_pred ---------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 ---------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 ---------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+.......+++++.+||..||+.||++|||+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 001223344456789999999999999999999999653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=370.89 Aligned_cols=255 Identities=17% Similarity=0.250 Sum_probs=208.9
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcE--EEEEEeecc---CCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEE--IAVKLELVK---TKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMV 89 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~--vAIK~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv 89 (468)
++|++.++||+|+||+||+|.+..++.. ||||.+... .....+.+|++++..+.+|++|+.+++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6899999999999999999999888874 667764322 23456899999999987778999999999999999999
Q ss_pred Eecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 90 IDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 90 ~el~-ggsL~~ll~~~---------------~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
|||+ +|+|.+++... ...+++..++.++.||+.||.|||+++||||||||+|||+ +.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCce
Confidence 9999 89999998632 3579999999999999999999999999999999999999 578899
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCC-CCCCCCCcccHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQK 232 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~-~Pf~~~~~~~~~~~ 232 (468)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|. .||.+.. ..+.
T Consensus 167 kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAEL 235 (309)
T ss_dssp EECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHH
T ss_pred EEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHH
Confidence 9999999976543221 23457899999999999999999999999999999999965 5676643 3344
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 287 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~ 287 (468)
+..+... ...+.+ ..+|+++.+||.+||+.||++||++.+|++.|+.++..
T Consensus 236 ~~~i~~~-~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 236 YEKLPQG-YRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHGGGT-CCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHhc-CCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 4444332 222222 34589999999999999999999999999999998764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=368.25 Aligned_cols=256 Identities=19% Similarity=0.228 Sum_probs=197.7
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEeC-----c
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVEG-----D 84 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~-----~ 84 (468)
++.+|+++++||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+|..++|+ +|+.++.++... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp-~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE-NIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCT-TBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCC-CCCcEEEEEeeccccccc
Confidence 34789999999999999999999999999999998754332 23578899999999775 455555444322 3
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 85 YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 85 ~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
..+|+|++++++|.+++.. +.+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVA 159 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred eEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeec
Confidence 4688899999999999974 579999999999999999999999999999999999999 57899999999999876
Q ss_pred ccccCcccccccCCCCcccccccccccccc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH-------
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHL-GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI------- 236 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i------- 236 (468)
....... ......+||+.|+|||++. +..++.++||||+||++|+|++|..||.+.............
T Consensus 160 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 160 DPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CGGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cCCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 5432211 1234567999999999985 456799999999999999999999999875432211111110
Q ss_pred ----------------hhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 237 ----------------SEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 237 ----------------~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.......+...+...+++++.+||..||+.||++||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 011112333445566788999999999999999999999664
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-45 Score=358.51 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=200.2
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|+++++||+|+||+||+|++. +++.||||++.... ....+.+|+.++..++| ++|+.++.++...+..+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEeeeeecccCCceeEEE
Confidence 68999999999999999999975 78999999875432 23468899999998875 67777888888889999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
+++++.+.+.+....+.+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||++........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc-
Confidence 999888888877667889999999999999999999999999999999999999 5789999999999987543221
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc----------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK---------- 239 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 239 (468)
......|++.|+|||++.+.. ++.++|||||||++|||++|..||.+.........+......
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 123457899999999998654 699999999999999999999999875433222222111100
Q ss_pred -----------ccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 -----------KVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 -----------~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
....+.......+++++.+||.+||+.||++||++++|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 011122233456789999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=360.51 Aligned_cols=256 Identities=16% Similarity=0.226 Sum_probs=201.1
Q ss_pred EEEceEeeeCCeEEEEEEEcCC---CcEEEEEEeeccCC---CchhHHHHHHHHHHhCCCCCceeeEeeEe-CceeEEEE
Q 012192 18 KLGRKIGSGSFGELYLGVNVQT---GEEIAVKLELVKTK---HPQLHYESKLYMLLQGGTGIPHLKWFGVE-GDYNIMVI 90 (468)
Q Consensus 18 ~i~~~LG~G~fG~Vy~~~~~~~---~~~vAIK~~~~~~~---~~~~~~E~~~l~~l~~~~~i~~l~~~~~~-~~~~~lv~ 90 (468)
.+.++||+|+||+||+|.+..+ ...||||.+..... ...+..|++++.+++| ++|..+++++.. ....++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCC-TTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCEeEEeEEEEecCCceEEEE
Confidence 3468899999999999998654 34689998653222 2458999999999976 566666666554 56789999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
||+ +++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccc
Confidence 999 789999988666678899999999999999999999999999999999999 5789999999999987654322
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccCCCHHHhh
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVSTPIEVLC 249 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 249 (468)
.. ........||+.|+|||++.+..++.++||||||+++|||++|..||..... ..+....+.... ..+.+
T Consensus 186 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~-~~~~p--- 256 (311)
T d1r0pa_ 186 DS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGR-RLLQP--- 256 (311)
T ss_dssp CC---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTC-CCCCC---
T ss_pred cc---ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCC-CCCCc---
Confidence 11 1223456799999999999999999999999999999999998787765322 122222232222 22222
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012192 250 KSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 286 (468)
Q Consensus 250 ~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~ 286 (468)
..+|+++.+||..||+.||++||++.+|++.|+.++.
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3458999999999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=359.88 Aligned_cols=266 Identities=21% Similarity=0.245 Sum_probs=200.9
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHH--HHhCCCCCceeeEeeEeCc----ee
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYM--LLQGGTGIPHLKWFGVEGD----YN 86 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~--~l~~~~~i~~l~~~~~~~~----~~ 86 (468)
|..+|.+.++||+|+||.||+|++ +|+.||||++.... ...+..|.+++. .+ +|++|..+++++.+.+ ..
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEE
Confidence 457899999999999999999986 78899999875443 334555666553 33 4566667777665433 57
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCceeecccCCCCeEEEEe
Q 012192 87 IMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS--------RGFLHRDIKPDNFLMGLGRKANQVYIID 157 (468)
Q Consensus 87 ~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs--------~giiHrDIKp~NiLl~~~~~~~~vkL~D 157 (468)
++||||+ +|+|.+++.. ..++++.++.++.|++.||.|||+ +|||||||||+|||+ +.++.+||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~D 151 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEe
Confidence 8999999 8899999985 479999999999999999999996 699999999999999 5789999999
Q ss_pred CCcccccccccCcccccccCCCCccccccccccccccCCC------CCCcchHHHHHHHHHHHHcCCCCCCCCCc-----
Q 012192 158 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE------QSRRDDLESLGYVLMYFLRGSLPWQGLKA----- 226 (468)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~------~s~ksDvwSlGvvl~elltG~~Pf~~~~~----- 226 (468)
||+++.+........ .......||+.|+|||++.+.. ++.++|||||||+||||++|..||.....
T Consensus 152 FGl~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 152 LGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEEC---C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred cCccccccCCCccee---ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 999987654332111 1234568999999999987653 56789999999999999999887743221
Q ss_pred -------ccHHHHHHHHhhcccCCCHHH--hhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012192 227 -------GTKKQKYDKISEKKVSTPIEV--LCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGF 290 (468)
Q Consensus 227 -------~~~~~~~~~i~~~~~~~~~~~--l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~~~~~~ 290 (468)
.................+.+. .....+.++.++|..||+.||++||++.+|.+.|+++...++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 112222222333333322222 1223456799999999999999999999999999999887765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=362.48 Aligned_cols=257 Identities=19% Similarity=0.289 Sum_probs=207.3
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcC-----CCcEEEEEEeeccCCC---chhHHHHHHHHHHhCCCCCceeeEeeEeC
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEIAVKLELVKTKH---PQLHYESKLYMLLQGGTGIPHLKWFGVEG 83 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~-----~~~~vAIK~~~~~~~~---~~~~~E~~~l~~l~~~~~i~~l~~~~~~~ 83 (468)
|-.++|+++++||+|+||+||+|.+.. ++..||||++...... ..+.+|+.++.+++| ++|+.+.+++...
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQG 95 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCC-CCEeeeeeEEecC
Confidence 445899999999999999999998753 3578999987543332 247899999998876 5666777777778
Q ss_pred ceeEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeE
Q 012192 84 DYNIMVIDLL-GPSLEDLFNYCN---------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQV 153 (468)
Q Consensus 84 ~~~~lv~el~-ggsL~~ll~~~~---------~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~v 153 (468)
+..++|||++ +|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 8889999998 899999876431 347899999999999999999999999999999999999 688999
Q ss_pred EEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCcccHHHH
Q 012192 154 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQK 232 (468)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG-~~Pf~~~~~~~~~~~ 232 (468)
||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++| ..||.+.. ..+.
T Consensus 173 Kl~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~~~~ 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQV 244 (308)
T ss_dssp EECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHH
T ss_pred EEeecccceeccCCcce-----eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence 99999999876543221 123345789999999999999999999999999999999997 57787653 3344
Q ss_pred HHHHhhcccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012192 233 YDKISEKKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDL 284 (468)
Q Consensus 233 ~~~i~~~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~ 284 (468)
+..+..... .+.+ ..+|+++.++|..||+.+|++||++.+|++.|++.
T Consensus 245 ~~~i~~~~~-~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 245 LRFVMEGGL-LDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHTTCC-CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHhCCC-CCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 444444332 2222 34589999999999999999999999999888764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=364.41 Aligned_cols=251 Identities=18% Similarity=0.276 Sum_probs=194.2
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEeeEeCc----
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFGVEGD---- 84 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~---- 84 (468)
+.++|+++++||+|+||+||+|.+..+|+.||||++...... ..+.+|++++..+.|+ +|+.++.++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hp-niv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE-NVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBT-TBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCC-CeeEEEEEeccCccccc
Confidence 679999999999999999999999999999999987644332 3577899999999765 5555555544332
Q ss_pred --eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccc
Q 012192 85 --YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAK 162 (468)
Q Consensus 85 --~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~ 162 (468)
..++||||++.+|..++. ...+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 95 ~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 95 FTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 169 (346)
T ss_dssp CCCCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred cceEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---cccccccccccccee
Confidence 469999999999998887 3579999999999999999999999999999999999999 588999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh---
Q 012192 163 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE--- 238 (468)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~--- 238 (468)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.....
T Consensus 170 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 170 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccCCc----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 65432 2456899999999999875 468999999999999999999999987543222221111110
Q ss_pred --------------------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012192 239 --------------------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLKR 279 (468)
Q Consensus 239 --------------------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~ 279 (468)
.....+.......+++++.+||..||..||++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 01111222334567889999999999999999999996643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=359.50 Aligned_cols=270 Identities=18% Similarity=0.275 Sum_probs=216.7
Q ss_pred eecCceEEEceEeeeCCeEEEEEEEcC---CCcEEEEEEeecc------CCCchhHHHHHHHHHHhCCCCCceeeEeeEe
Q 012192 12 VIGGKFKLGRKIGSGSFGELYLGVNVQ---TGEEIAVKLELVK------TKHPQLHYESKLYMLLQGGTGIPHLKWFGVE 82 (468)
Q Consensus 12 ii~~~y~i~~~LG~G~fG~Vy~~~~~~---~~~~vAIK~~~~~------~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~ 82 (468)
+--++|+++++||+|+||+||+|.+.. +|+.||||++... .....+..|++++.++.|+++|+.++.+..+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 334789999999999999999998743 6899999975432 2345678899999999999999999999999
Q ss_pred CceeEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcc
Q 012192 83 GDYNIMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLA 161 (468)
Q Consensus 83 ~~~~~lv~el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla 161 (468)
....+++||++ +++|.+++.. .+.+.+..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||++
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLS 176 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEE
T ss_pred CCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccch
Confidence 99999999998 7899999885 5578899999999999999999999999999999999999 57889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh-h
Q 012192 162 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS-E 238 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~-~ 238 (468)
+.+..... .......|++.|+|||.+.+.. ++.++|||||||+||+|++|..||.+.........+.... .
T Consensus 177 ~~~~~~~~------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 177 KEFVADET------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp EECCGGGG------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred hhhccccc------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 87644222 1124567999999999998654 6889999999999999999999998876555444443322 2
Q ss_pred cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCcccccccccCCCc
Q 012192 239 KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGFQFDYVFDWTVLKYPQI 306 (468)
Q Consensus 239 ~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~ 306 (468)
.....+ ..+++++.+||.+||..||++||+ +++| |+ ++|...++|..+....+
T Consensus 251 ~~~~~~-----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~ei---l~-------Hpff~~i~~~~l~~~~~ 308 (322)
T d1vzoa_ 251 SEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI---KE-------HLFFQKINWDDLAAKKV 308 (322)
T ss_dssp CCCCCC-----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH---HT-------SGGGTTCCHHHHHTTCS
T ss_pred CCCCCc-----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHH---Hc-------CHhhcCCCHHHHHhCCC
Confidence 222222 356899999999999999999995 4543 32 55566678877654443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=355.14 Aligned_cols=262 Identities=20% Similarity=0.246 Sum_probs=197.3
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC----CCchhHHHHHHHHHHhCCCCCceeeEeeE-------eC
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT----KHPQLHYESKLYMLLQGGTGIPHLKWFGV-------EG 83 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~l~~~~~-------~~ 83 (468)
++|+++++||+|+||+||+|.+..+|+.||||++.... ....+.+|++++..++|++.+..+..+.. ..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 79999999999999999999999999999999864332 23457899999999987655555444322 23
Q ss_pred ceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccc
Q 012192 84 DYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKK 163 (468)
Q Consensus 84 ~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~ 163 (468)
...+++||++.+.+...+......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceeee
Confidence 4578999999888877777667789999999999999999999999999999999999999 5788999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhcccC
Q 012192 164 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKVS 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 242 (468)
+....... .......+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.........+..+......
T Consensus 167 ~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 65432211 1223456899999999999876 5899999999999999999999999875543333333222211100
Q ss_pred C----------------------CHHHh--hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012192 243 T----------------------PIEVL--CKSYPSEFVSYFHYCRSLRFEDKPDYSYLKRLFRDLF 285 (468)
Q Consensus 243 ~----------------------~~~~l--~~~~p~~~~~li~~cl~~~p~~RPs~~~l~~~L~~~~ 285 (468)
. +.... .....+++.+||.+||+.||++||++++ +|++.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e---lL~Hpf 307 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD---ALNHDF 307 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH---HHHSGG
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH---HHcChh
Confidence 0 00000 0113567889999999999999999995 445544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-44 Score=357.71 Aligned_cols=251 Identities=18% Similarity=0.285 Sum_probs=197.2
Q ss_pred ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEe--CceeEEEE
Q 012192 13 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVE--GDYNIMVI 90 (468)
Q Consensus 13 i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~--~~~~~lv~ 90 (468)
..++|+++++||+|+||+||+|++..+++.||||++.. .....+.+|+.++..+.+|++|+.+..++.. ....++||
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 34789999999999999999999999999999998653 3456788999999999988889888877763 45688999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccC
Q 012192 91 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQT 169 (468)
Q Consensus 91 el~-ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~ 169 (468)
|++ +++|..+ .+.+++..+..++.||+.||+|||++|||||||||+|||+. .+++.+||+|||+|+......
T Consensus 112 e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 112 EHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp ECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTC-
T ss_pred eecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCC-
Confidence 999 5666544 35799999999999999999999999999999999999995 245579999999998755422
Q ss_pred cccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhh---------
Q 012192 170 HKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISE--------- 238 (468)
Q Consensus 170 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~-~~~~~~i~~--------- 238 (468)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ...+..+..
T Consensus 185 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 185 -------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp -------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred -------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 134567999999999988765 79999999999999999999999986543211 111111100
Q ss_pred -cccCC-------------------CHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 239 -KKVST-------------------PIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 239 -~~~~~-------------------~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
..... ........+++++.+||.+||..||++|||+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00000 00011234678999999999999999999998753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=359.96 Aligned_cols=252 Identities=22% Similarity=0.275 Sum_probs=192.3
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeE------eCceeE
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGV------EGDYNI 87 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~------~~~~~~ 87 (468)
.-+|+.+++||+|+||+||+|++..+|+.||||++.... ....+|++++..++|++ |+.+..++. +..+.+
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~n-iv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCN-IVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCCTT-BCCEEEEEEEC--CCSCCEEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--hHHHHHHHHHHhcCCCC-CCcEEEEEEecCccCCceEEE
Confidence 347999999999999999999999999999999875543 34457999999997655 555544432 234578
Q ss_pred EEEeccCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 88 MVIDLLGPSLEDLFN---YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 88 lv~el~ggsL~~ll~---~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
|||||+++.+.+.+. .....+++..+..++.||+.||+|||++|||||||||+|||+. .+...+||+|||+++..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEEC
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhc
Confidence 999999887766554 2356799999999999999999999999999999999999994 23358999999999865
Q ss_pred ccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhc----
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK---- 239 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~---- 239 (468)
.... ......||..|+|||.+.+. .|+.++|||||||++|||++|..||...........+.+....
T Consensus 174 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 174 VRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CTTS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCCc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 4322 13456899999999998764 6899999999999999999999999875433222222111000
Q ss_pred ------------ccC----CC-HHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 240 ------------KVS----TP-IEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 240 ------------~~~----~~-~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
... .+ .......+++++.+||.+||..||++|||+.+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000 00 0111234688999999999999999999999653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=342.79 Aligned_cols=250 Identities=19% Similarity=0.230 Sum_probs=198.6
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC----CchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEE
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK----HPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVI 90 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~----~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~ 90 (468)
++|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+.++..+.| ++|+.+..++......++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCc-CCEEeeccccccccceeEEe
Confidence 589999999999999999999999999999998755433 2357889999988876 56777888888889999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCcccccccccCc
Q 012192 91 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTH 170 (468)
Q Consensus 91 el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~~~~~~~ 170 (468)
+++.+.+...+....+.+++..+..++.|++.||+|||++|||||||||+|||+ +.++.+||+|||.++.......
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS-
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc-
Confidence 999555444444467889999999999999999999999999999999999999 5788999999999987654322
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhccc--------
Q 012192 171 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKV-------- 241 (468)
Q Consensus 171 ~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 241 (468)
......++..|+|||++.+.. ++.++|||||||++|||++|..||....+ ..+.+..+.....
T Consensus 157 ------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp ------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCT
T ss_pred ------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhh
Confidence 223456788899999988765 69999999999999999999999865332 2222222221111
Q ss_pred ----------------CCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 242 ----------------STPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 242 ----------------~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
..........+++++.+||..||+.||.+|||+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~ 280 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 011122334567899999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-44 Score=356.54 Aligned_cols=250 Identities=20% Similarity=0.263 Sum_probs=193.7
Q ss_pred cCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeEee-----EeCc
Q 012192 14 GGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKWFG-----VEGD 84 (468)
Q Consensus 14 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~~~-----~~~~ 84 (468)
.++|+++++||+|+||+||+|.+..+|+.||||++...... ..+.+|++++..+.|++.|..+..+. .+..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 58999999999999999999999999999999987644322 35778999999998755554444332 2334
Q ss_pred eeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEEeCCccccc
Q 012192 85 YNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKY 164 (468)
Q Consensus 85 ~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~DFGla~~~ 164 (468)
..+++|++.+++|.+++. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhccc
Confidence 578888888999999986 4679999999999999999999999999999999999999 57899999999999754
Q ss_pred ccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh-----
Q 012192 165 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE----- 238 (468)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~~~~i~~----- 238 (468)
... .....||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+.....
T Consensus 172 ~~~----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 172 DDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp TGG----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred Ccc----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 431 24568999999999988765 68999999999999999999999987543222222211100
Q ss_pred ------------------cccCCCHHHhhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012192 239 ------------------KKVSTPIEVLCKSYPSEFVSYFHYCRSLRFEDKPDYSYLK 278 (468)
Q Consensus 239 ------------------~~~~~~~~~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l~ 278 (468)
.............+++++.+||..||..||.+|||+.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence 0011122233356789999999999999999999998653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=353.97 Aligned_cols=257 Identities=17% Similarity=0.188 Sum_probs=190.0
Q ss_pred CCCCCc-e--ecCceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCC----chhHHHHHHHHHHhCCCCCceeeE
Q 012192 6 KLRMDH-V--IGGKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKH----PQLHYESKLYMLLQGGTGIPHLKW 78 (468)
Q Consensus 6 ~l~~~~-i--i~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~----~~~~~E~~~l~~l~~~~~i~~l~~ 78 (468)
++.+|+ + +.++|+++++||+|+||+||+|.++.+|+.||||++...... ..+.+|+.++..++| ++|+.++.
T Consensus 5 ~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~ 83 (355)
T d2b1pa1 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISLLN 83 (355)
T ss_dssp EEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSE
T ss_pred EEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCC-CCeeEEEE
Confidence 456677 3 448999999999999999999999999999999987654332 247789999998865 56666555
Q ss_pred eeE------eCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCe
Q 012192 79 FGV------EGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQ 152 (468)
Q Consensus 79 ~~~------~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~ 152 (468)
++. .....|+||||+.+++.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.
T Consensus 84 ~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~ 157 (355)
T d2b1pa1 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCT 157 (355)
T ss_dssp EECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCC
T ss_pred EEecccccccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccc
Confidence 543 346789999999888776654 579999999999999999999999999999999999999 47889
Q ss_pred EEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH
Q 012192 153 VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 232 (468)
Q Consensus 153 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~~~~~~~~~ 232 (468)
++++|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.........
T Consensus 158 ~kl~df~~~~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~ 229 (355)
T d2b1pa1 158 LKILDFGLARTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229 (355)
T ss_dssp EEECCCCC-----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eeeechhhhhcccccc--------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHH
Confidence 9999999987654322 23456799999999999999999999999999999999999999987543322222
Q ss_pred HHHHh-------------------hccc---CCCHH------------HhhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012192 233 YDKIS-------------------EKKV---STPIE------------VLCKSYPSEFVSYFHYCRSLRFEDKPDYSYL 277 (468)
Q Consensus 233 ~~~i~-------------------~~~~---~~~~~------------~l~~~~p~~~~~li~~cl~~~p~~RPs~~~l 277 (468)
+.... .... ....+ ......++++.+||.+||..||++|||+++|
T Consensus 230 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el 308 (355)
T d2b1pa1 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308 (355)
T ss_dssp HHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 21100 0000 00000 0112236789999999999999999999965
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-39 Score=326.37 Aligned_cols=262 Identities=23% Similarity=0.269 Sum_probs=189.5
Q ss_pred CCCCCceec-CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC-CCchhHHHHHHHHHHhCC----------CCC
Q 012192 6 KLRMDHVIG-GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT-KHPQLHYESKLYMLLQGG----------TGI 73 (468)
Q Consensus 6 ~l~~~~ii~-~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~-~~~~~~~E~~~l~~l~~~----------~~i 73 (468)
++.+|+++. ++|+++++||+|+||+||+|++..+|+.||||++.... ....+..|+++++.+.|. ++|
T Consensus 3 p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp CCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 467899876 67999999999999999999999999999999876442 234567899999888753 456
Q ss_pred ceeeEeeE--eCceeEEEEecc--CCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceeeccc
Q 012192 74 PHLKWFGV--EGDYNIMVIDLL--GPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLG 147 (468)
Q Consensus 74 ~~l~~~~~--~~~~~~lv~el~--ggsL~~ll~-~~~~~ls~~~~~~ia~qia~gL~yLHs-~giiHrDIKp~NiLl~~~ 147 (468)
+.+..++. .....+++|.++ ++....... .....+++..+..++.||+.||+|||+ .||+||||||+|||+...
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 65555443 334555555554 444444433 335679999999999999999999998 899999999999999532
Q ss_pred CC---CCeEEEEeCCcccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 012192 148 RK---ANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL 224 (468)
Q Consensus 148 ~~---~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~s~ksDvwSlGvvl~elltG~~Pf~~~ 224 (468)
+. ...++|+|||.+...... .....||+.|+|||++.+..|+.++|||||||++++|++|..||...
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CcccccceeeEeecccccccccc----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 21 125899999998754331 23568999999999999999999999999999999999999999754
Q ss_pred Cccc---HHHHHHHHhhcccCC------------------------------CHHH-------hhccCcHHHHHHHHHHh
Q 012192 225 KAGT---KKQKYDKISEKKVST------------------------------PIEV-------LCKSYPSEFVSYFHYCR 264 (468)
Q Consensus 225 ~~~~---~~~~~~~i~~~~~~~------------------------------~~~~-------l~~~~p~~~~~li~~cl 264 (468)
.... ............-.. +... .....++++.+||.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 3211 111111110000000 0000 11234678999999999
Q ss_pred cCCCCCCCCHHHH
Q 012192 265 SLRFEDKPDYSYL 277 (468)
Q Consensus 265 ~~~p~~RPs~~~l 277 (468)
..||++|||++++
T Consensus 313 ~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 313 QLDPRKRADAGGL 325 (362)
T ss_dssp CSSTTTCBCHHHH
T ss_pred CCChhHCcCHHHH
Confidence 9999999999865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.2e-23 Score=191.14 Aligned_cols=163 Identities=18% Similarity=0.254 Sum_probs=112.3
Q ss_pred eEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCC------------C--------chhHHHHHHHHHHhCCCCCcee
Q 012192 17 FKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTK------------H--------PQLHYESKLYMLLQGGTGIPHL 76 (468)
Q Consensus 17 y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~------------~--------~~~~~E~~~l~~l~~~~~i~~l 76 (468)
+.++++||+|+||+||+|.+ .+|+.||||+...... . .....|...+..+.+. +++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL-AVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS-SSCCE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCC-CcceE
Confidence 46899999999999999987 4789999997432110 0 1123466677777654 34443
Q ss_pred eEeeEeCceeEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceeecccCCCCeEEEE
Q 012192 77 KWFGVEGDYNIMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKANQVYII 156 (468)
Q Consensus 77 ~~~~~~~~~~~lv~el~ggsL~~ll~~~~~~ls~~~~~~ia~qia~gL~yLHs~giiHrDIKp~NiLl~~~~~~~~vkL~ 156 (468)
+.+ .. .+++|+++.+... ..++......++.|++.+|.|||++||+||||||+|||+. ++.++|+
T Consensus 80 ~~~--~~--~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li 144 (191)
T d1zara2 80 YAW--EG--NAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII 144 (191)
T ss_dssp EEE--ET--TEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred EEe--cC--CEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence 332 22 4789999965321 2355566778999999999999999999999999999994 5669999
Q ss_pred eCCcccccccccCcccccccCCCCcccccccccc--c---cccCCCCCCcchHHHHHHHH
Q 012192 157 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV--N---THLGVEQSRRDDLESLGYVL 211 (468)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~y~AP--E---~~~~~~~s~ksDvwSlGvvl 211 (468)
|||+|+....+.. ..|... + .+....|+.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999975432111 011111 0 12245688899999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=7.1e-06 Score=75.28 Aligned_cols=79 Identities=14% Similarity=0.226 Sum_probs=57.8
Q ss_pred CceEEEceEeeeCCeEEEEEEEcCCCcEEEEEEeeccC--CCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEEEEec
Q 012192 15 GKFKLGRKIGSGSFGELYLGVNVQTGEEIAVKLELVKT--KHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIMVIDL 92 (468)
Q Consensus 15 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~lv~el 92 (468)
+.|++++..+-++...||+.. ..+..+.||+..... ....+..|...+..+..+-.++.+..+...++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 567777776556667999875 355667788754332 2345788999988887766678888888888889999999
Q ss_pred cCC
Q 012192 93 LGP 95 (468)
Q Consensus 93 ~gg 95 (468)
+.|
T Consensus 92 l~G 94 (263)
T d1j7la_ 92 ADG 94 (263)
T ss_dssp CSS
T ss_pred ccc
Confidence 844
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.92 E-value=1.8e-05 Score=77.72 Aligned_cols=74 Identities=12% Similarity=0.198 Sum_probs=48.4
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeec-----c----CCCchhHHHHHHHHHHhCC--CCCceeeEeeEeCceeEE
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELV-----K----TKHPQLHYESKLYMLLQGG--TGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~-----~----~~~~~~~~E~~~l~~l~~~--~~i~~l~~~~~~~~~~~l 88 (468)
.+.||.|....||+..+..+++.|+||.-.. . ........|.+.|..+... ..+|.++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998766778899996321 1 1123456788888877643 345555544 6667789
Q ss_pred EEeccCC
Q 012192 89 VIDLLGP 95 (468)
Q Consensus 89 v~el~gg 95 (468)
+||++.+
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999854
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.69 E-value=0.00013 Score=66.12 Aligned_cols=71 Identities=13% Similarity=0.016 Sum_probs=50.2
Q ss_pred eEeeeC-CeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCC-CceeeEeeEeCceeEEEEeccC
Q 012192 22 KIGSGS-FGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTG-IPHLKWFGVEGDYNIMVIDLLG 94 (468)
Q Consensus 22 ~LG~G~-fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~-i~~l~~~~~~~~~~~lv~el~g 94 (468)
.+..|. -+.||+.. ...+..+++|.... .....+..|...+..+..... ++.+..+..+.+..+++|+++.
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~-~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLS-GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECS-CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCc-cCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 334444 36899876 44566788897433 344568889999988876533 6777777778888899999983
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.94 E-value=0.0016 Score=63.18 Aligned_cols=74 Identities=15% Similarity=0.160 Sum_probs=51.4
Q ss_pred ceEEEceEeeeCCeEEEEEEEcC-------CCcEEEEEEeeccCCCchhHHHHHHHHHHhCCCCCceeeEeeEeCceeEE
Q 012192 16 KFKLGRKIGSGSFGELYLGVNVQ-------TGEEIAVKLELVKTKHPQLHYESKLYMLLQGGTGIPHLKWFGVEGDYNIM 88 (468)
Q Consensus 16 ~y~i~~~LG~G~fG~Vy~~~~~~-------~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~~~~i~~l~~~~~~~~~~~l 88 (468)
.+++ +.|+-|-.-.+|++.... ....|++++............|..+++.+......+.+++++. ..+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~ 118 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGR 118 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEE
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----Cce
Confidence 3444 678888999999988643 2356777775433333456789999998887777888877753 367
Q ss_pred EEeccC
Q 012192 89 VIDLLG 94 (468)
Q Consensus 89 v~el~g 94 (468)
||+++.
T Consensus 119 I~efi~ 124 (395)
T d1nw1a_ 119 LEEYIP 124 (395)
T ss_dssp EECCCC
T ss_pred EEEEec
Confidence 788873
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.01 E-value=0.017 Score=53.90 Aligned_cols=66 Identities=12% Similarity=0.063 Sum_probs=41.7
Q ss_pred eEEEEEEEcCCCcEEEEEEeecc-CCCchhHHHHHHHHHHhCCCC-Ccee-----eEeeEeCceeEEEEeccCC
Q 012192 29 GELYLGVNVQTGEEIAVKLELVK-TKHPQLHYESKLYMLLQGGTG-IPHL-----KWFGVEGDYNIMVIDLLGP 95 (468)
Q Consensus 29 G~Vy~~~~~~~~~~vAIK~~~~~-~~~~~~~~E~~~l~~l~~~~~-i~~l-----~~~~~~~~~~~lv~el~gg 95 (468)
-.||++. ..+|..|++|+-... ....++..|...+..|..... ++.. ......+...+.+++++.|
T Consensus 36 N~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 4799987 467888999985433 234568889888888774321 1111 1122456677888888743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.72 E-value=0.029 Score=51.74 Aligned_cols=48 Identities=15% Similarity=0.112 Sum_probs=29.4
Q ss_pred EceEeeeCCeEEEEEEEcCCCcEEEEEEeeccCCCchhHHHHHHHHHHhC
Q 012192 20 GRKIGSGSFGELYLGVNVQTGEEIAVKLELVKTKHPQLHYESKLYMLLQG 69 (468)
Q Consensus 20 ~~~LG~G~fG~Vy~~~~~~~~~~vAIK~~~~~~~~~~~~~E~~~l~~l~~ 69 (468)
.+.|..|---+.|+... ..| .+++|+........++..|.+++..|..
T Consensus 23 ~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAA 70 (316)
T ss_dssp EEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHH
T ss_pred eecCCCCcccCeEEEEE-CCC-cEEEEEcCCCCCHHHHHHHHHHHHhhhh
Confidence 44555666678899874 344 5788986554456678888888887764
|